1	hsa-let-7a-1	hsa03022	Basal transcription factors	2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_6873_2958_6884_2959_6880_6882_138474_6883	21	1.94E-35	1.26E-33	1.26E-33
2	hsa-let-7a-1	hsa05200	Pathways in cancer	5925_5594_6256_3326_4193_5970_7157_6688_3725_10401_4609_2353_2033_8554_7184	15	4.37E-11	2.84E-09	1.42E-09
3	hsa-let-7a-1	hsa05215	Prostate cancer	5925_5594_3326_4193_5970_7157_2033_7184	8	1.11E-08	7.24E-07	1.97E-07
4	hsa-let-7a-1	hsa05212	Pancreatic cancer	5925_5594_3326_4193_5970_7157_2033_7184	8	1.21E-08	7.87E-07	1.97E-07
5	hsa-let-7a-1	hsa05222	Small cell lung cancer	5925_6256_5970_7157_10401_4609_8554	7	1.92E-07	1.25E-05	2.50E-06
6	hsa-let-7a-1	hsa05220	Chronic myeloid leukemia	5925_5594_4193_5970_7157_4609	6	1.63E-06	0.000106142	1.77E-05
7	hsa-let-7a-1	hsa05219	Bladder cancer	5925_5594_4193_7157_4609	5	2.05E-06	0.000133441	1.91E-05
8	hsa-let-7a-1	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	3.76E-06	0.000244401	3.06E-05
9	hsa-let-7a-1	hsa05216	Thyroid cancer	5594_6256_7157_4609	4	1.34E-05	0.0008735	9.71E-05
10	hsa-let-7a-1	hsa04110	Cell cycle	5925_4193_7157_4171_4085_2033	6	2.01E-05	0.001309216	0.000130922
11	hsa-let-7a-1	hsa04010	MAPK signaling pathway	3727_5594_5970_3312_7157_3725_4609_2353	8	3.71E-05	0.002410564	0.000219142
12	hsa-let-7a-1	hsa05210	Colorectal cancer	5594_7157_3725_4609_2353	5	4.79E-05	0.003113308	0.000259442
13	hsa-let-7a-1	hsa04310	Wnt signaling pathway	1460_8607_7157_3725_4609_2033	6	7.49E-05	0.004865764	0.00037429
14	hsa-let-7a-1	hsa05223	Non-small cell lung cancer	5925_5594_6256_7157	4	0.000127933	0.008315673	0.000593977
15	hsa-let-7a-1	hsa05221	Acute myeloid leukemia	5594_5970_6688_4609	4	0.000176581	0.011477736	0.000765182
16	hsa-let-7a-1	hsa05016	Huntington's disease	6874_9001_5430_7157_3064_2033	6	0.000229523	0.014918981	0.000932436
17	hsa-let-7a-1	hsa05214	Glioma	5925_5594_4193_7157	4	0.000251091	0.01632092	0.000960054
18	hsa-let-7a-1	hsa05218	Melanoma	5925_5594_4193_7157	4	0.000345887	0.022482668	0.001249037
19	hsa-let-7a-1	hsa04662	B cell receptor signaling pathway	5594_5970_3725_2353	4	0.000421797	0.027416813	0.00144299
20	hsa-let-7a-1	hsa03420	Nucleotide excision repair	2967_2968_5887	3	0.001182634	0.07687119	0.00384356
21	hsa-let-7a-1	hsa04620	Toll-like receptor signaling pathway	5594_5970_3725_2353	4	0.001272446	0.08270899	0.003938523
22	hsa-let-7a-1	hsa04660	T cell receptor signaling pathway	5594_5970_3725_2353	4	0.001663531	0.1081295	0.004914977
23	hsa-let-7a-1	hsa05213	Endometrial cancer	5594_7157_4609	3	0.001864907	0.121218972	0.00527039
24	hsa-let-7a-1	hsa05211	Renal cell carcinoma	5594_3725_2033	3	0.004502222	0.292644441	0.012193518
25	hsa-let-7a-1	hsa04630	Jak-STAT signaling pathway	10401_4609_2033_8554	4	0.005490711	0.356896225	0.014275849
26	hsa-let-7a-1	hsa04520	Adherens junction	1460_5594_2033	3	0.005971651	0.388157339	0.014929128
27	hsa-let-7a-1	hsa04350	TGF-beta signaling pathway	5594_4609_2033	3	0.00746691	0.485349136	0.017333898
28	hsa-let-7a-1	hsa04012	ErbB signaling pathway	5594_3725_4609	3	0.00746691	0.485349136	0.017333898
29	hsa-let-7a-1	hsa04612	Antigen processing and presentation	3326_4801_3312	3	0.007931055	0.515518593	0.017776503
30	hsa-let-7a-1	hsa04330	Notch signaling pathway	2033_8850	2	0.019860078	1	0.043030168
31	hsa-let-7a-1	hsa04120	Ubiquitin mediated proteolysis	4193_10401_8554	3	0.025183516	1	0.052804147
32	hsa-let-7a-1	hsa05322	Systemic lupus erythematosus	8340_3014_3015	3	0.027522157	1	0.055904381
33	hsa-let-7a-1	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.037426761	1	0.073719378
34	hsa-let-7a-1	hsa04115	p53 signaling pathway	4193_7157	2	0.039420171	1	0.075362092
35	hsa-let-7a-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5970_3725	2	0.041453112	1	0.076984351
36	hsa-let-7a-1	hsa04720	Long-term potentiation	5594_2033	2	0.04563424	1	0.082395156
37	hsa-let-7a-2	hsa05200	Pathways in cancer	3320_5925_3326_1147_3551_1499_5595_5594_1387_6256_1487_367_8517_2932_6774_5970_6688_2113_4087_1869_862_6502_2353_4088_7175_3065_1488_2033_4791_4792	30	1.45E-23	1.07E-21	1.07E-21
38	hsa-let-7a-2	hsa05215	Prostate cancer	3320_5925_3326_1147_3551_1499_5595_5594_1387_367_8517_2932_5970_1869_2033_4792	16	2.22E-17	1.64E-15	6.42E-16
39	hsa-let-7a-2	hsa05212	Pancreatic cancer	3320_5925_3326_1147_3551_1499_5595_5594_1387_367_8517_2932_5970_1869_2033_4792	16	2.60E-17	1.93E-15	6.42E-16
40	hsa-let-7a-2	hsa04010	MAPK signaling pathway	1147_3551_5595_5594_6722_9261_1326_4208_3305_3303_5566_8517_7867_3312_5971_5970_3310_2353_1432_4791	20	2.03E-14	1.50E-12	3.76E-13
41	hsa-let-7a-2	hsa05220	Chronic myeloid leukemia	5925_1147_3551_5595_5594_1487_8517_5970_1869_4088_3065_1488_4792	13	4.09E-14	3.03E-12	6.05E-13
42	hsa-let-7a-2	hsa04660	T cell receptor signaling pathway	1147_3551_5595_5594_1326_8517_2932_5970_4794_2353_1432_4792_4793	13	3.39E-12	2.51E-10	4.18E-11
43	hsa-let-7a-2	hsa04310	Wnt signaling pathway	23291_1499_1387_8607_1487_5566_2932_8454_6500_4087_8945_4088_1488_2033	14	1.09E-11	8.07E-10	1.15E-10
44	hsa-let-7a-2	hsa04662	B cell receptor signaling pathway	1147_3551_5595_5594_8517_2932_5970_4794_2353_4792_4793	11	1.97E-11	1.46E-09	1.82E-10
45	hsa-let-7a-2	hsa04350	TGF-beta signaling pathway	5595_5594_1387_8454_3397_3398_6500_4087_3399_4088_2033	11	8.40E-11	6.22E-09	6.91E-10
46	hsa-let-7a-2	hsa04110	Cell cycle	5925_5591_1387_2932_8454_6500_4087_1869_6502_4088_3065_2033	12	1.28E-10	9.46E-09	9.46E-10
47	hsa-let-7a-2	hsa04330	Notch signaling pathway	388585_1387_4851_1487_9612_3065_1488_2033_8850	9	1.67E-10	1.24E-08	1.13E-09
48	hsa-let-7a-2	hsa05221	Acute myeloid leukemia	1147_3551_5595_5594_8517_6774_5970_6688_862	9	1.01E-09	7.51E-08	6.25E-09
49	hsa-let-7a-2	hsa04920	Adipocytokine signaling pathway	1147_3551_6256_8517_6774_5970_4794_4792_4793	9	2.80E-09	2.07E-07	1.59E-08
50	hsa-let-7a-2	hsa04620	Toll-like receptor signaling pathway	1147_3551_5595_5594_1326_8517_5970_2353_1432_4792	10	5.93E-09	4.39E-07	3.13E-08
51	hsa-let-7a-2	hsa04916	Melanogenesis	1499_5595_5594_1387_5566_2932_2033_808_801_805	10	7.04E-09	5.21E-07	3.47E-08
52	hsa-let-7a-2	hsa05222	Small cell lung cancer	5925_1147_3551_6256_8517_5970_1869_6502_4792	9	2.06E-08	1.52E-06	9.32E-08
53	hsa-let-7a-2	hsa04062	Chemokine signaling pathway	1147_3551_5595_5594_5566_8517_2932_6774_5970_653361_4792_4793	12	2.14E-08	1.58E-06	9.32E-08
54	hsa-let-7a-2	hsa04120	Ubiquitin mediated proteolysis	7329_23291_672_8454_6500_3093_8945_6502_10273_7323	10	9.17E-08	6.79E-06	3.77E-07
55	hsa-let-7a-2	hsa04720	Long-term potentiation	5595_5594_1387_5566_2033_808_801_805	8	1.12E-07	8.28E-06	4.36E-07
56	hsa-let-7a-2	hsa03020	RNA polymerase	25885_64425_5437_51082_84172_5441	6	1.36E-07	1.01E-05	5.04E-07
57	hsa-let-7a-2	hsa04520	Adherens junction	1499_5595_5594_1387_4087_4088_2033_71	8	1.77E-07	1.31E-05	6.24E-07
58	hsa-let-7a-2	hsa05131	Shigellosis	347733_1499_7278_10382_84617_203068_71	7	2.65E-07	1.96E-05	8.52E-07
59	hsa-let-7a-2	hsa05130	Pathogenic Escherichia coli infection	347733_1499_7278_10382_84617_203068_71	7	2.65E-07	1.96E-05	8.52E-07
60	hsa-let-7a-2	hsa04540	Gap junction	347733_5595_5594_5566_7278_10382_84617_203068	8	5.16E-07	3.82E-05	1.59E-06
61	hsa-let-7a-2	hsa05214	Glioma	5925_5595_5594_1869_808_801_805	7	6.69E-07	4.95E-05	1.98E-06
62	hsa-let-7a-2	hsa05210	Colorectal cancer	1499_5595_5594_2932_4087_2353_4088	7	3.29E-06	0.0002435	9.37E-06
63	hsa-let-7a-2	hsa05216	Thyroid cancer	1499_5595_5594_6256_7175	5	3.49E-06	0.00025816	9.56E-06
64	hsa-let-7a-2	hsa04612	Antigen processing and presentation	3320_3326_3309_3305_3303_3312_3310	7	4.71E-06	0.000348318	1.20E-05
65	hsa-let-7a-2	hsa04210	Apoptosis	1147_3551_5566_8517_5970_8837_4792	7	4.71E-06	0.000348318	1.20E-05
66	hsa-let-7a-2	hsa04910	Insulin signaling pathway	3551_5595_5594_5566_2932_808_801_805	8	8.25E-06	0.00061074	2.04E-05
67	hsa-let-7a-2	hsa04912	GnRH signaling pathway	5595_5594_5566_1432_808_801_805	7	1.55E-05	0.00114676	3.62E-05
68	hsa-let-7a-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_8517_5970_1432_4792	6	1.56E-05	0.001158045	3.62E-05
69	hsa-let-7a-2	hsa04270	Vascular smooth muscle contraction	5595_5594_5566_4637_808_801_805	7	2.66E-05	0.001969591	5.97E-05
70	hsa-let-7a-2	hsa05223	Non-small cell lung cancer	5925_5595_5594_6256_1869	5	5.46E-05	0.004039508	0.000118809
71	hsa-let-7a-2	hsa05016	Huntington's disease	1387_292_293_5437_1213_3065_2033_5441	8	6.83E-05	0.005056508	0.000144472
72	hsa-let-7a-2	hsa05211	Renal cell carcinoma	5595_5594_1387_2113_2033	5	0.000194888	0.014421747	0.000400604
73	hsa-let-7a-2	hsa04370	VEGF signaling pathway	5595_5594_9261_7867_1432	5	0.000261762	0.0193704	0.000523524
74	hsa-let-7a-2	hsa05219	Bladder cancer	5925_5595_5594_1869	4	0.000284132	0.02102579	0.00055331
75	hsa-let-7a-2	hsa04930	Type II diabetes mellitus	3551_5595_5594_3651	4	0.000363016	0.026863175	0.000688799
76	hsa-let-7a-2	hsa05213	Endometrial cancer	1499_5595_5594_2932	4	0.000606101	0.044851509	0.001121288
77	hsa-let-7a-2	hsa04340	Hedgehog signaling pathway	23291_5566_2932_8945	4	0.000838403	0.062041836	0.001513216
78	hsa-let-7a-2	hsa04810	Regulation of actin cytoskeleton	5595_5594_4627_4628_10788_10627_71	7	0.001013975	0.075034139	0.001786527
79	hsa-let-7a-2	hsa05010	Alzheimer's disease	5595_5594_2932_808_801_805	6	0.001736325	0.128488064	0.002988095
80	hsa-let-7a-2	hsa05218	Melanoma	5925_5595_5594_1869	4	0.001811904	0.134080919	0.003047294
81	hsa-let-7a-2	hsa04670	Leukocyte transendothelial migration	1499_653361_10627_1432_71	5	0.001901067	0.140678975	0.003126199
82	hsa-let-7a-2	hsa04020	Calcium signaling pathway	292_5566_293_808_801_805	6	0.002097188	0.155191878	0.003373736
83	hsa-let-7a-2	hsa04530	Tight junction	1499_4627_4628_10627_71	5	0.003084737	0.228270512	0.004856819
84	hsa-let-7a-2	hsa04510	Focal adhesion	1499_5595_5594_2932_10627_71	6	0.003605476	0.266805236	0.005558442
85	hsa-let-7a-2	hsa04630	Jak-STAT signaling pathway	3559_1387_6778_6774_2033	5	0.00511597	0.378581777	0.007726159
86	hsa-let-7a-2	hsa03010	Ribosome	6156_6128_6207_6202	4	0.00627975	0.464701466	0.009294029
87	hsa-let-7a-2	hsa04950	Maturity onset diabetes of the young	168620_3651	2	0.013755984	1	0.019959663
88	hsa-let-7a-2	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.017348445	1	0.024688171
89	hsa-let-7a-2	hsa04664	Fc epsilon RI signaling pathway	5595_5594_1432	3	0.019140709	1	0.026724763
90	hsa-let-7a-2	hsa04012	ErbB signaling pathway	5595_5594_2932	3	0.024402888	1	0.033440995
91	hsa-let-7a-2	hsa03410	Base excision repair	3146_142	2	0.028197096	1	0.037937911
92	hsa-let-7a-3	hsa04110	Cell cycle	1869_25_5925_545_995_1871_1026_5591_1870_983_4088_7534_1017_2932_4193_7027_902_1387_3066_7157_1031_9232_5347_1022_1029_4087_7532_3065_1111_2033_890_11200_8556_8555_472	35	7.96E-36	6.69E-34	6.69E-34
93	hsa-let-7a-3	hsa05200	Pathways in cancer	1147_3320_1869_5743_3326_5747_25_5925_675_998_1871_1026_5594_5595_5599_1870_596_5601_6789_1856_4088_613_1017_2932_4193_367_1387_5578_51588_8554_5371_3066_4436_7157_598_4609_1029_4087_5888_5728_3065_3091_2033_3910_4792_5602	46	5.71E-34	4.80E-32	2.40E-32
94	hsa-let-7a-3	hsa04115	p53 signaling pathway	50484_545_6241_1026_25898_983_1017_27113_4194_4193_900_7157_7161_1029_64326_5728_51246_1111_11200_472	20	7.73E-21	6.49E-19	2.16E-19
95	hsa-let-7a-3	hsa05215	Prostate cancer	1147_3320_1869_3326_5925_1871_1026_5594_5595_1385_1870_596_1017_2932_4193_367_1387_7157_5728_2033_4792	21	2.55E-20	2.14E-18	5.24E-19
96	hsa-let-7a-3	hsa05212	Pancreatic cancer	1147_3320_1869_3326_5925_1871_1026_5594_5595_1385_1870_596_1017_2932_4193_367_1387_7157_5728_2033_4792	21	3.12E-20	2.62E-18	5.24E-19
97	hsa-let-7a-3	hsa05220	Chronic myeloid leukemia	1147_1869_25_5925_1871_1026_5594_5595_1870_4088_613_4193_3066_7157_598_4609_1029_3065_4792	19	6.37E-19	5.35E-17	8.91E-18
98	hsa-let-7a-3	hsa05222	Small cell lung cancer	1147_1869_5743_5747_5925_1871_1870_596_1017_51588_8554_7157_598_4609_5728_3910_4792	17	1.67E-15	1.40E-13	2.00E-14
99	hsa-let-7a-3	hsa04310	Wnt signaling pathway	1460_5518_5515_5599_5601_1856_1457_4088_2932_1387_5578_7157_4609_1452_4087_5527_2033_5602	18	6.82E-13	5.73E-11	7.16E-12
100	hsa-let-7a-3	hsa05219	Bladder cancer	1869_5925_1871_1026_5594_5595_1870_4193_7157_4609_1029	11	1.24E-11	1.04E-09	1.15E-10
101	hsa-let-7a-3	hsa05214	Glioma	1869_5925_1871_1026_5594_5595_1870_4193_5578_7157_1029_5728	12	5.05E-11	4.24E-09	4.24E-10
102	hsa-let-7a-3	hsa05210	Colorectal cancer	5594_5595_5599_596_5601_1856_4088_2932_4436_7157_4609_4087_5602	13	5.63E-11	4.73E-09	4.30E-10
103	hsa-let-7a-3	hsa04010	MAPK signaling pathway	1147_998_5594_5595_5599_5601_3304_3305_3303_6789_3315_5578_3164_7157_4609_1386_1616_5923_5602	19	7.78E-10	6.53E-08	5.44E-09
104	hsa-let-7a-3	hsa05218	Melanoma	1869_5925_1871_1026_5594_5595_1870_4193_7157_1029_5728	11	1.71E-09	1.44E-07	1.06E-08
105	hsa-let-7a-3	hsa04120	Ubiquitin mediated proteolysis	10055_672_7319_25898_84447_4193_3093_51588_8554_5371_64326_7329_10075_7337	14	1.77E-09	1.49E-07	1.06E-08
106	hsa-let-7a-3	hsa05223	Non-small cell lung cancer	1869_5925_1871_5594_5595_1870_6789_5578_7157_1029	10	2.05E-09	1.72E-07	1.15E-08
107	hsa-let-7a-3	hsa04350	TGF-beta signaling pathway	5518_5515_5594_5595_6667_4088_7027_1387_4609_4087_2033	11	1.17E-08	9.82E-07	5.78E-08
108	hsa-let-7a-3	hsa04012	ErbB signaling pathway	5747_25_1026_5594_5595_5599_5601_2932_5578_4609_5602	11	1.17E-08	9.82E-07	5.78E-08
109	hsa-let-7a-3	hsa04330	Notch signaling pathway	1856_1387_3066_9612_3065_2033_8850_4851	8	1.54E-07	1.30E-05	7.20E-07
110	hsa-let-7a-3	hsa04510	Focal adhesion	5747_998_5594_5595_5599_596_5601_5499_2932_5578_5728_5923_3910_5602	14	1.79E-07	1.50E-05	7.91E-07
111	hsa-let-7a-3	hsa03022	Basal transcription factors	2965_2969_2957_6908_51616_2958_6880	7	4.98E-07	4.18E-05	2.09E-06
112	hsa-let-7a-3	hsa04520	Adherens junction	1460_998_5594_5595_1457_4088_1387_4087_2033	9	6.27E-07	5.26E-05	2.51E-06
113	hsa-let-7a-3	hsa03420	Nucleotide excision repair	2965_4331_2074_6117_2071_902_1022	7	1.41E-06	0.000118244	5.37E-06
114	hsa-let-7a-3	hsa05016	Huntington's disease	25942_3064_1385_6908_6667_27113_1387_3066_7157_3065_2033	11	1.43E-05	0.001199644	5.22E-05
115	hsa-let-7a-3	hsa04920	Adipocytokine signaling pathway	1147_5563_6794_5599_5601_4792_5602	7	1.76E-05	0.001480208	6.17E-05
116	hsa-let-7a-3	hsa04916	Melanogenesis	5594_5595_1385_1856_2932_1387_5578_2033	8	3.50E-05	0.002939104	0.000117564
117	hsa-let-7a-3	hsa04910	Insulin signaling pathway	5563_5594_5595_5599_5601_5499_6720_2932_5602	9	3.89E-05	0.003263685	0.000125526
118	hsa-let-7a-3	hsa04370	VEGF signaling pathway	5743_5747_998_5594_5595_3315_5578	7	4.04E-05	0.003391646	0.000125617
119	hsa-let-7a-3	hsa05213	Endometrial cancer	5594_5595_2932_7157_4609_5728	6	4.26E-05	0.003577475	0.000127767
120	hsa-let-7a-3	hsa04660	T cell receptor signaling pathway	1147_998_5594_5595_5601_2932_959_4792	8	5.08E-05	0.004271252	0.000147285
121	hsa-let-7a-3	hsa04612	Antigen processing and presentation	3320_3326_1385_3309_3304_3305_3303	7	9.49E-05	0.007975609	0.000257278
122	hsa-let-7a-3	hsa04210	Apoptosis	1147_823_596_7157_598_4792_472	7	9.49E-05	0.007975609	0.000257278
123	hsa-let-7a-3	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_998_5599_5601_4792_5602	6	0.000209418	0.017591088	0.000524517
124	hsa-let-7a-3	hsa04620	Toll-like receptor signaling pathway	1147_5594_5595_5599_5601_4792_5602	7	0.000210174	0.017654611	0.000524517
125	hsa-let-7a-3	hsa04530	Tight junction	1460_998_5518_5515_1457_5578_5728_5520	8	0.000214284	0.017999885	0.000524517
126	hsa-let-7a-3	hsa04930	Type II diabetes mellitus	5594_5595_5599_5601_5602	5	0.000221676	0.018620779	0.000524517
127	hsa-let-7a-3	hsa05211	Renal cell carcinoma	998_5594_5595_1387_3091_2033	6	0.000224793	0.018882604	0.000524517
128	hsa-let-7a-3	hsa04720	Long-term potentiation	5594_5595_5499_1387_5578_2033	6	0.000276309	0.02320994	0.000610788
129	hsa-let-7a-3	hsa04662	B cell receptor signaling pathway	1147_5594_5595_1380_2932_4792	6	0.000276309	0.02320994	0.000610788
130	hsa-let-7a-3	hsa04912	GnRH signaling pathway	998_5594_5595_5599_5601_5578_5602	7	0.000292196	0.024544437	0.000629345
131	hsa-let-7a-3	hsa04664	Fc epsilon RI signaling pathway	5594_5595_5599_5601_5578_5602	6	0.000358926	0.030149756	0.000753744
132	hsa-let-7a-3	hsa03440	Homologous recombination	675_6117_641_5888	4	0.000406941	0.034183052	0.000822811
133	hsa-let-7a-3	hsa04150	mTOR signaling pathway	5563_5594_6794_5595_3091	5	0.000411406	0.034558069	0.000822811
134	hsa-let-7a-3	hsa05216	Thyroid cancer	5594_5595_7157_4609	4	0.00045908	0.038562682	0.000896807
135	hsa-let-7a-3	hsa05131	Shigellosis	25_998_7534_5578_4691	5	0.000563955	0.047372238	0.001052716
136	hsa-let-7a-3	hsa05130	Pathogenic Escherichia coli infection	25_998_7534_5578_4691	5	0.000563955	0.047372238	0.001052716
137	hsa-let-7a-3	hsa05221	Acute myeloid leukemia	1147_5594_5595_5371_4609	5	0.00070362	0.059104072	0.001284871
138	hsa-let-7a-3	hsa04360	Axon guidance	5747_25_998_5594_5595_2932_1020	7	0.000872009	0.073248742	0.001558484
139	hsa-let-7a-3	hsa03410	Base excision repair	142_3146_328_4913	4	0.000965101	0.081068472	0.001688927
140	hsa-let-7a-3	hsa04730	Long-term depression	5518_5515_5594_5595_5578	5	0.001531602	0.128654553	0.002625603
141	hsa-let-7a-3	hsa04062	Chemokine signaling pathway	1147_5747_998_5594_5595_2932_6362_4792	8	0.001821434	0.153000495	0.00306001
142	hsa-let-7a-3	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_7157_598_1616	4	0.004335778	0.364205335	0.007141281
143	hsa-let-7a-3	hsa04540	Gap junction	5594_5595_983_1453_5578	5	0.004629628	0.388888738	0.00747863
144	hsa-let-7a-3	hsa03030	DNA replication	6117_5557_5422	3	0.009019878	0.757669732	0.01406608
145	hsa-let-7a-3	hsa04630	Jak-STAT signaling pathway	1387_51588_8554_598_4609_2033	6	0.00904248	0.759568339	0.01406608
146	hsa-let-7a-3	hsa03450	Non-homologous end-joining	5591_2547	2	0.013099625	1	0.0200067
147	hsa-let-7a-3	hsa05010	Alzheimer's disease	22926_5594_5595_823_2932_1020	6	0.016179838	1	0.024269757
148	hsa-let-7a-3	hsa05217	Basal cell carcinoma	1856_2932_7157	3	0.026152051	1	0.038539865
149	hsa-let-7a-3	hsa04340	Hedgehog signaling pathway	1453_2932_1452	3	0.028544853	1	0.041340822
150	hsa-let-7a-3	hsa03430	Mismatch repair	6117_4436	2	0.03069316	1	0.043698736
151	hsa-let-7a-3	hsa04270	Vascular smooth muscle contraction	5594_5595_5499_5578	4	0.046222328	1	0.06471126
152	hsa-let-7b	hsa04110	Cell cycle	1869_25_5925_545_995_1871_1026_5591_1870_983_4088_7534_1017_2932_4193_7027_902_1387_3066_7157_1031_9232_5347_1022_1029_4087_7532_3065_1111_2033_890_11200_8556_8555_472	35	7.96E-36	6.69E-34	6.69E-34
153	hsa-let-7b	hsa05200	Pathways in cancer	1147_3320_1869_5743_3326_5747_25_5925_675_998_1871_1026_5594_5595_5599_1870_596_5601_6789_1856_4088_613_1017_2932_4193_367_1387_5578_51588_8554_5371_3066_4436_7157_598_4609_1029_4087_5888_5728_3065_3091_2033_3910_4792_5602	46	5.71E-34	4.80E-32	2.40E-32
154	hsa-let-7b	hsa04115	p53 signaling pathway	50484_545_6241_1026_25898_983_1017_27113_4194_4193_900_7157_7161_1029_64326_5728_51246_1111_11200_472	20	7.73E-21	6.49E-19	2.16E-19
155	hsa-let-7b	hsa05215	Prostate cancer	1147_3320_1869_3326_5925_1871_1026_5594_5595_1385_1870_596_1017_2932_4193_367_1387_7157_5728_2033_4792	21	2.55E-20	2.14E-18	5.24E-19
156	hsa-let-7b	hsa05212	Pancreatic cancer	1147_3320_1869_3326_5925_1871_1026_5594_5595_1385_1870_596_1017_2932_4193_367_1387_7157_5728_2033_4792	21	3.12E-20	2.62E-18	5.24E-19
157	hsa-let-7b	hsa05220	Chronic myeloid leukemia	1147_1869_25_5925_1871_1026_5594_5595_1870_4088_613_4193_3066_7157_598_4609_1029_3065_4792	19	6.37E-19	5.35E-17	8.91E-18
158	hsa-let-7b	hsa05222	Small cell lung cancer	1147_1869_5743_5747_5925_1871_1870_596_1017_51588_8554_7157_598_4609_5728_3910_4792	17	1.67E-15	1.40E-13	2.00E-14
159	hsa-let-7b	hsa04310	Wnt signaling pathway	1460_5518_5515_5599_5601_1856_1457_4088_2932_1387_5578_7157_4609_1452_4087_5527_2033_5602	18	6.82E-13	5.73E-11	7.16E-12
160	hsa-let-7b	hsa05219	Bladder cancer	1869_5925_1871_1026_5594_5595_1870_4193_7157_4609_1029	11	1.24E-11	1.04E-09	1.15E-10
161	hsa-let-7b	hsa05214	Glioma	1869_5925_1871_1026_5594_5595_1870_4193_5578_7157_1029_5728	12	5.05E-11	4.24E-09	4.24E-10
162	hsa-let-7b	hsa05210	Colorectal cancer	5594_5595_5599_596_5601_1856_4088_2932_4436_7157_4609_4087_5602	13	5.63E-11	4.73E-09	4.30E-10
163	hsa-let-7b	hsa04010	MAPK signaling pathway	1147_998_5594_5595_5599_5601_3304_3305_3303_6789_3315_5578_3164_7157_4609_1386_1616_5923_5602	19	7.78E-10	6.53E-08	5.44E-09
164	hsa-let-7b	hsa05218	Melanoma	1869_5925_1871_1026_5594_5595_1870_4193_7157_1029_5728	11	1.71E-09	1.44E-07	1.06E-08
165	hsa-let-7b	hsa04120	Ubiquitin mediated proteolysis	10055_672_7319_25898_84447_4193_3093_51588_8554_5371_64326_7329_10075_7337	14	1.77E-09	1.49E-07	1.06E-08
166	hsa-let-7b	hsa05223	Non-small cell lung cancer	1869_5925_1871_5594_5595_1870_6789_5578_7157_1029	10	2.05E-09	1.72E-07	1.15E-08
167	hsa-let-7b	hsa04350	TGF-beta signaling pathway	5518_5515_5594_5595_6667_4088_7027_1387_4609_4087_2033	11	1.17E-08	9.82E-07	5.78E-08
168	hsa-let-7b	hsa04012	ErbB signaling pathway	5747_25_1026_5594_5595_5599_5601_2932_5578_4609_5602	11	1.17E-08	9.82E-07	5.78E-08
169	hsa-let-7b	hsa04330	Notch signaling pathway	1856_1387_3066_9612_3065_2033_8850_4851	8	1.54E-07	1.30E-05	7.20E-07
170	hsa-let-7b	hsa04510	Focal adhesion	5747_998_5594_5595_5599_596_5601_5499_2932_5578_5728_5923_3910_5602	14	1.79E-07	1.50E-05	7.91E-07
171	hsa-let-7b	hsa03022	Basal transcription factors	2965_2969_2957_6908_51616_2958_6880	7	4.98E-07	4.18E-05	2.09E-06
172	hsa-let-7b	hsa04520	Adherens junction	1460_998_5594_5595_1457_4088_1387_4087_2033	9	6.27E-07	5.26E-05	2.51E-06
173	hsa-let-7b	hsa03420	Nucleotide excision repair	2965_4331_2074_6117_2071_902_1022	7	1.41E-06	0.000118244	5.37E-06
174	hsa-let-7b	hsa05016	Huntington's disease	25942_3064_1385_6908_6667_27113_1387_3066_7157_3065_2033	11	1.43E-05	0.001199644	5.22E-05
175	hsa-let-7b	hsa04920	Adipocytokine signaling pathway	1147_5563_6794_5599_5601_4792_5602	7	1.76E-05	0.001480208	6.17E-05
176	hsa-let-7b	hsa04916	Melanogenesis	5594_5595_1385_1856_2932_1387_5578_2033	8	3.50E-05	0.002939104	0.000117564
177	hsa-let-7b	hsa04910	Insulin signaling pathway	5563_5594_5595_5599_5601_5499_6720_2932_5602	9	3.89E-05	0.003263685	0.000125526
178	hsa-let-7b	hsa04370	VEGF signaling pathway	5743_5747_998_5594_5595_3315_5578	7	4.04E-05	0.003391646	0.000125617
179	hsa-let-7b	hsa05213	Endometrial cancer	5594_5595_2932_7157_4609_5728	6	4.26E-05	0.003577475	0.000127767
180	hsa-let-7b	hsa04660	T cell receptor signaling pathway	1147_998_5594_5595_5601_2932_959_4792	8	5.08E-05	0.004271252	0.000147285
181	hsa-let-7b	hsa04612	Antigen processing and presentation	3320_3326_1385_3309_3304_3305_3303	7	9.49E-05	0.007975609	0.000257278
182	hsa-let-7b	hsa04210	Apoptosis	1147_823_596_7157_598_4792_472	7	9.49E-05	0.007975609	0.000257278
183	hsa-let-7b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_998_5599_5601_4792_5602	6	0.000209418	0.017591088	0.000524517
184	hsa-let-7b	hsa04620	Toll-like receptor signaling pathway	1147_5594_5595_5599_5601_4792_5602	7	0.000210174	0.017654611	0.000524517
185	hsa-let-7b	hsa04530	Tight junction	1460_998_5518_5515_1457_5578_5728_5520	8	0.000214284	0.017999885	0.000524517
186	hsa-let-7b	hsa04930	Type II diabetes mellitus	5594_5595_5599_5601_5602	5	0.000221676	0.018620779	0.000524517
187	hsa-let-7b	hsa05211	Renal cell carcinoma	998_5594_5595_1387_3091_2033	6	0.000224793	0.018882604	0.000524517
188	hsa-let-7b	hsa04720	Long-term potentiation	5594_5595_5499_1387_5578_2033	6	0.000276309	0.02320994	0.000610788
189	hsa-let-7b	hsa04662	B cell receptor signaling pathway	1147_5594_5595_1380_2932_4792	6	0.000276309	0.02320994	0.000610788
190	hsa-let-7b	hsa04912	GnRH signaling pathway	998_5594_5595_5599_5601_5578_5602	7	0.000292196	0.024544437	0.000629345
191	hsa-let-7b	hsa04664	Fc epsilon RI signaling pathway	5594_5595_5599_5601_5578_5602	6	0.000358926	0.030149756	0.000753744
192	hsa-let-7b	hsa03440	Homologous recombination	675_6117_641_5888	4	0.000406941	0.034183052	0.000822811
193	hsa-let-7b	hsa04150	mTOR signaling pathway	5563_5594_6794_5595_3091	5	0.000411406	0.034558069	0.000822811
194	hsa-let-7b	hsa05216	Thyroid cancer	5594_5595_7157_4609	4	0.00045908	0.038562682	0.000896807
195	hsa-let-7b	hsa05131	Shigellosis	25_998_7534_5578_4691	5	0.000563955	0.047372238	0.001052716
196	hsa-let-7b	hsa05130	Pathogenic Escherichia coli infection	25_998_7534_5578_4691	5	0.000563955	0.047372238	0.001052716
197	hsa-let-7b	hsa05221	Acute myeloid leukemia	1147_5594_5595_5371_4609	5	0.00070362	0.059104072	0.001284871
198	hsa-let-7b	hsa04360	Axon guidance	5747_25_998_5594_5595_2932_1020	7	0.000872009	0.073248742	0.001558484
199	hsa-let-7b	hsa03410	Base excision repair	142_3146_328_4913	4	0.000965101	0.081068472	0.001688927
200	hsa-let-7b	hsa04730	Long-term depression	5518_5515_5594_5595_5578	5	0.001531602	0.128654553	0.002625603
201	hsa-let-7b	hsa04062	Chemokine signaling pathway	1147_5747_998_5594_5595_2932_6362_4792	8	0.001821434	0.153000495	0.00306001
202	hsa-let-7b	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_7157_598_1616	4	0.004335778	0.364205335	0.007141281
203	hsa-let-7b	hsa04540	Gap junction	5594_5595_983_1453_5578	5	0.004629628	0.388888738	0.00747863
204	hsa-let-7b	hsa03030	DNA replication	6117_5557_5422	3	0.009019878	0.757669732	0.01406608
205	hsa-let-7b	hsa04630	Jak-STAT signaling pathway	1387_51588_8554_598_4609_2033	6	0.00904248	0.759568339	0.01406608
206	hsa-let-7b	hsa03450	Non-homologous end-joining	5591_2547	2	0.013099625	1	0.0200067
207	hsa-let-7b	hsa05010	Alzheimer's disease	22926_5594_5595_823_2932_1020	6	0.016179838	1	0.024269757
208	hsa-let-7b	hsa05217	Basal cell carcinoma	1856_2932_7157	3	0.026152051	1	0.038539865
209	hsa-let-7b	hsa04340	Hedgehog signaling pathway	1453_2932_1452	3	0.028544853	1	0.041340822
210	hsa-let-7b	hsa03430	Mismatch repair	6117_4436	2	0.03069316	1	0.043698736
211	hsa-let-7b	hsa04270	Vascular smooth muscle contraction	5594_5595_5499_5578	4	0.046222328	1	0.06471126
212	hsa-let-7c	hsa03022	Basal transcription factors	2967_2961_2960_2963_6881_54457_2968_6877_6874_6878_2957_6879_6908_6872_2958_6873_2959_6880_6882_138474_6884_6883	22	3.42E-30	2.49E-28	2.49E-28
213	hsa-let-7c	hsa05200	Pathways in cancer	2249_367_1499_5595_5594_5914_1387_6256_10401_1487_1488_2932_4193_6776_6777_5970_7157_6688_4609_3725_2353_3065_4087_4088_4089_5925_2033_207_208_3326_8554_7184	32	4.46E-22	3.25E-20	1.63E-20
214	hsa-let-7c	hsa05220	Chronic myeloid leukemia	5595_5594_1487_1488_4193_6776_6777_5970_7157_4609_3065_4088_4089_5925_207_208	16	1.96E-16	1.43E-14	4.78E-15
215	hsa-let-7c	hsa05215	Prostate cancer	367_1499_5595_5594_1387_2932_4193_5970_7157_468_5925_2033_207_208_3326_7184	16	1.80E-15	1.31E-13	3.08E-14
216	hsa-let-7c	hsa05212	Pancreatic cancer	367_1499_5595_5594_1387_2932_4193_5970_7157_468_5925_2033_207_208_3326_7184	16	2.11E-15	1.54E-13	3.08E-14
217	hsa-let-7c	hsa04110	Cell cycle	993_1387_4171_983_7534_7533_7532_2932_4193_4085_7157_3065_4087_4088_4089_5925_2033	17	8.34E-15	6.09E-13	1.01E-13
218	hsa-let-7c	hsa05210	Colorectal cancer	1499_5595_5594_2932_7157_4609_3725_2353_4087_4088_4089_207_208	13	5.10E-12	3.72E-10	5.32E-11
219	hsa-let-7c	hsa04310	Wnt signaling pathway	1460_1499_1387_8607_1487_1488_2932_7157_4609_3725_4087_4088_4089_2033	14	4.30E-10	3.14E-08	3.93E-09
220	hsa-let-7c	hsa05221	Acute myeloid leukemia	5595_5594_5914_6776_6777_5970_6688_4609_207_208	10	6.89E-10	5.03E-08	5.59E-09
221	hsa-let-7c	hsa04012	ErbB signaling pathway	6714_5595_5594_2932_6776_6777_4609_3725_5058_207_208	11	1.58E-09	1.16E-07	1.16E-08
222	hsa-let-7c	hsa04520	Adherens junction	1460_1499_6714_5595_5594_1387_4087_4088_4089_2033	10	9.80E-09	7.16E-07	6.51E-08
223	hsa-let-7c	hsa04010	MAPK signaling pathway	6722_3727_2249_5595_5594_1649_3312_5970_7157_468_4609_3725_2353_5058_207_208	16	1.13E-08	8.22E-07	6.85E-08
224	hsa-let-7c	hsa05213	Endometrial cancer	1499_5595_5594_2932_7157_4609_207_208	8	7.12E-08	5.20E-06	4.00E-07
225	hsa-let-7c	hsa05222	Small cell lung cancer	6256_10401_5970_7157_4609_5925_207_208_8554	9	2.19E-07	1.60E-05	1.14E-06
226	hsa-let-7c	hsa04350	TGF-beta signaling pathway	6667_5595_5594_1387_4609_4087_4088_4089_2033	9	2.40E-07	1.75E-05	1.17E-06
227	hsa-let-7c	hsa05016	Huntington's disease	6667_6874_25942_1387_6908_9001_5430_7157_3065_3064_10476_2033	12	3.34E-07	2.44E-05	1.52E-06
228	hsa-let-7c	hsa04330	Notch signaling pathway	1387_1487_1488_9612_3065_2033_8850	7	5.81E-07	4.24E-05	2.50E-06
229	hsa-let-7c	hsa05218	Melanoma	2249_5595_5594_4193_7157_5925_207_208	8	6.25E-07	4.56E-05	2.53E-06
230	hsa-let-7c	hsa05211	Renal cell carcinoma	5595_5594_1387_3725_5058_2033_207_208	8	6.89E-07	5.03E-05	2.53E-06
231	hsa-let-7c	hsa05216	Thyroid cancer	1499_5595_5594_6256_7157_4609	6	6.92E-07	5.05E-05	2.53E-06
232	hsa-let-7c	hsa04662	B cell receptor signaling pathway	5595_5594_2932_5970_3725_2353_207_208	8	9.16E-07	6.69E-05	3.19E-06
233	hsa-let-7c	hsa05223	Non-small cell lung cancer	5595_5594_6256_7157_5925_207_208	7	1.36E-06	9.90E-05	4.50E-06
234	hsa-let-7c	hsa04660	T cell receptor signaling pathway	5595_5594_2932_5970_3725_2353_5058_207_208	9	1.49E-06	0.000109123	4.74E-06
235	hsa-let-7c	hsa04630	Jak-STAT signaling pathway	1387_10401_6776_6777_4609_2033_3977_207_208_8554	10	2.95E-06	0.00021507	8.96E-06
236	hsa-let-7c	hsa05214	Glioma	5595_5594_4193_7157_5925_207_208	7	4.21E-06	0.000307121	1.23E-05
237	hsa-let-7c	hsa05219	Bladder cancer	5595_5594_4193_7157_4609_5925	6	4.74E-06	0.00034593	1.33E-05
238	hsa-let-7c	hsa04620	Toll-like receptor signaling pathway	5595_5594_5970_3725_2353_207_208	7	6.40E-05	0.004670189	0.00017297
239	hsa-let-7c	hsa04950	Maturity onset diabetes of the young	3651_6927_3172_5080	4	0.000114844	0.00838363	0.000299415
240	hsa-let-7c	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	0.000119815	0.008746512	0.000301604
241	hsa-let-7c	hsa04510	Focal adhesion	1499_6714_5595_5594_2932_3725_5058_207_208	9	0.000165803	0.012103594	0.000403453
242	hsa-let-7c	hsa04530	Tight junction	1460_1499_6714_4628_60412_207_208	7	0.00036051	0.026317233	0.000848943
243	hsa-let-7c	hsa04910	Insulin signaling pathway	5595_5594_2932_5211_207_208_2538	7	0.000375905	0.027441101	0.000857534
244	hsa-let-7c	hsa04920	Adipocytokine signaling pathway	6256_5970_207_208_2538	5	0.000507773	0.037067394	0.001109063
245	hsa-let-7c	hsa04916	Melanogenesis	1499_5595_5594_1387_2932_2033	6	0.000517339	0.037765725	0.001109063
246	hsa-let-7c	hsa04062	Chemokine signaling pathway	5595_5594_2932_6777_5970_5058_207_208	8	0.000531743	0.038817215	0.001109063
247	hsa-let-7c	hsa04720	Long-term potentiation	5595_5594_1387_468_2033	5	0.000822584	0.060048631	0.001668018
248	hsa-let-7c	hsa04370	VEGF signaling pathway	6714_5595_5594_207_208	5	0.000920009	0.067160675	0.001815153
249	hsa-let-7c	hsa03420	Nucleotide excision repair	2967_2968_4331_5887	4	0.000946548	0.069098018	0.001818369
250	hsa-let-7c	hsa04150	mTOR signaling pathway	5595_5594_207_208	4	0.001688186	0.123237547	0.003093072
251	hsa-let-7c	hsa04612	Antigen processing and presentation	4801_4800_1514_3312_3326	5	0.001694834	0.123722894	0.003093072
252	hsa-let-7c	hsa04540	Gap junction	6714_5595_5594_983_10382	5	0.002036302	0.148650031	0.003625611
253	hsa-let-7c	hsa04912	GnRH signaling pathway	6714_5595_5594_468_3725	5	0.003771824	0.275343176	0.00655579
254	hsa-let-7c	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_5970_3725_5058	4	0.00488524	0.356622545	0.008293548
255	hsa-let-7c	hsa04664	Fc epsilon RI signaling pathway	5595_5594_207_208	4	0.006981957	0.509682856	0.011583701
256	hsa-let-7c	hsa04930	Type II diabetes mellitus	3651_5595_5594	3	0.009486581	0.692520444	0.015389343
257	hsa-let-7c	hsa04210	Apoptosis	5970_7157_207_208	4	0.010342351	0.754991642	0.016412862
258	hsa-let-7c	hsa05217	Basal cell carcinoma	1499_2932_7157	3	0.015841104	1	0.024604268
259	hsa-let-7c	hsa05131	Shigellosis	1499_7534_10382	3	0.016580022	1	0.02470085
260	hsa-let-7c	hsa05130	Pathogenic Escherichia coli infection	1499_7534_10382	3	0.016580022	1	0.02470085
261	hsa-let-7c	hsa04115	p53 signaling pathway	983_4193_7157	3	0.027926018	1	0.040771987
262	hsa-let-7c	hsa04360	Axon guidance	5595_5594_2932_5058	4	0.035008199	1	0.050109775
263	hsa-let-7c	hsa04120	Ubiquitin mediated proteolysis	672_10401_4193_8554	4	0.041816075	1	0.058703337
264	hsa-let-7c	hsa03410	Base excision repair	3146_142	2	0.046648205	1	0.064251301
265	hsa-let-7e	hsa05200	Pathways in cancer	3320_25_1499_1387_6256_836_1019_1017_5578_7157_2113_3725_841_861_6774_4088_4089_3065_5925_2033_324	21	4.08E-20	2.61E-18	2.61E-18
266	hsa-let-7e	hsa04350	TGF-beta signaling pathway	3400_1387_6667_3397_3399_3398_4086_4088_4089_2033_4093_4092	12	1.22E-15	7.80E-14	3.90E-14
267	hsa-let-7e	hsa04110	Cell cycle	25_1387_1019_1017_7157_1028_4088_4089_3065_5925_2033	11	1.12E-12	7.15E-11	2.38E-11
268	hsa-let-7e	hsa05220	Chronic myeloid leukemia	25_1019_7157_861_4088_4089_3065_5925	8	5.31E-10	3.40E-08	8.49E-09
269	hsa-let-7e	hsa05016	Huntington's disease	1387_836_6667_3092_7157_841_1213_3065_2033_6908	10	2.02E-09	1.29E-07	2.59E-08
270	hsa-let-7e	hsa04310	Wnt signaling pathway	1499_1387_5578_7157_3725_4088_4089_2033_324	9	5.54E-09	3.54E-07	5.73E-08
271	hsa-let-7e	hsa05214	Glioma	1019_5578_7157_5925_808_801_805	7	6.27E-09	4.01E-07	5.73E-08
272	hsa-let-7e	hsa05210	Colorectal cancer	1499_836_7157_3725_4088_4089_324	7	3.26E-08	2.09E-06	2.61E-07
273	hsa-let-7e	hsa05215	Prostate cancer	3320_1499_1387_1017_7157_5925_2033	7	4.40E-08	2.82E-06	3.03E-07
274	hsa-let-7e	hsa05212	Pancreatic cancer	3320_1499_1387_1017_7157_5925_2033	7	4.74E-08	3.03E-06	3.03E-07
275	hsa-let-7e	hsa04916	Melanogenesis	1499_1387_5578_2033_808_801_805	7	1.29E-07	8.28E-06	7.52E-07
276	hsa-let-7e	hsa04720	Long-term potentiation	1387_5578_2033_808_801_805	6	4.09E-07	2.62E-05	2.18E-06
277	hsa-let-7e	hsa04330	Notch signaling pathway	1387_9612_3065_2033_8850	5	1.07E-06	6.85E-05	5.27E-06
278	hsa-let-7e	hsa05223	Non-small cell lung cancer	6256_1019_5578_7157_5925	5	2.02E-06	0.000129333	9.24E-06
279	hsa-let-7e	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_834_1432_7157_1616	5	2.39E-06	0.00015284	1.02E-05
280	hsa-let-7e	hsa04912	GnRH signaling pathway	1432_5578_3725_808_801_805	6	3.06E-06	0.000196046	1.23E-05
281	hsa-let-7e	hsa04115	p53 signaling pathway	836_1019_1017_7157_841	5	6.24E-06	0.000399249	2.35E-05
282	hsa-let-7e	hsa04010	MAPK signaling pathway	6722_836_1432_5578_4342_7157_3725_1616	8	6.65E-06	0.000425603	2.36E-05
283	hsa-let-7e	hsa04520	Adherens junction	1499_1387_4088_4089_2033	5	1.23E-05	0.000788648	4.15E-05
284	hsa-let-7e	hsa05222	Small cell lung cancer	6256_1019_1017_7157_5925	5	1.72E-05	0.001099743	5.50E-05
285	hsa-let-7e	hsa05211	Renal cell carcinoma	1387_2113_3725_2033	4	0.000147781	0.009458005	0.000450381
286	hsa-let-7e	hsa04070	Phosphatidylinositol signaling system	5578_808_801_805	4	0.000180241	0.011535414	0.000524337
287	hsa-let-7e	hsa05216	Thyroid cancer	1499_6256_7157	3	0.00018997	0.012158101	0.000528613
288	hsa-let-7e	hsa04210	Apoptosis	836_839_7157_841	4	0.000321395	0.02056929	0.000857054
289	hsa-let-7e	hsa05010	Alzheimer's disease	836_841_808_801_805	5	0.000452844	0.028982046	0.001159282
290	hsa-let-7e	hsa05219	Bladder cancer	1019_7157_5925	3	0.000525888	0.033656837	0.001294494
291	hsa-let-7e	hsa04270	Vascular smooth muscle contraction	5578_808_801_805	4	0.000894982	0.057278875	0.00212144
292	hsa-let-7e	hsa05213	Endometrial cancer	1499_7157_324	3	0.000948017	0.060673081	0.002166896
293	hsa-let-7e	hsa05217	Basal cell carcinoma	1499_7157_324	3	0.001106586	0.070821488	0.002400884
294	hsa-let-7e	hsa05131	Shigellosis	25_1499_5578	3	0.001162928	0.0744274	0.002400884
295	hsa-let-7e	hsa05130	Pathogenic Escherichia coli infection	25_1499_5578	3	0.001162928	0.0744274	0.002400884
296	hsa-let-7e	hsa04530	Tight junction	1499_1019_5578_9223	4	0.001528464	0.097821708	0.003056928
297	hsa-let-7e	hsa04120	Ubiquitin mediated proteolysis	11059_997_11060_7329	4	0.001609459	0.103005397	0.003121376
298	hsa-let-7e	hsa05218	Melanoma	1019_7157_5925	3	0.002232864	0.142903277	0.004082951
299	hsa-let-7e	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_1432_3725	3	0.002232864	0.142903277	0.004082951
300	hsa-let-7e	hsa04950	Maturity onset diabetes of the young	168620_4760	2	0.003707765	0.237296968	0.006591582
301	hsa-let-7e	hsa04012	ErbB signaling pathway	25_5578_3725	3	0.003886997	0.248767803	0.006723454
302	hsa-let-7e	hsa04020	Calcium signaling pathway	5578_808_801_805	4	0.004311545	0.275938909	0.00726155
303	hsa-let-7e	hsa04620	Toll-like receptor signaling pathway	1432_3725_841	3	0.005973302	0.382291328	0.009802342
304	hsa-let-7e	hsa04660	T cell receptor signaling pathway	1019_1432_3725	3	0.007312617	0.468007476	0.011700187
305	hsa-let-7e	hsa04670	Leukocyte transendothelial migration	1499_1432_5578	3	0.009630727	0.616366552	0.015033331
306	hsa-let-7e	hsa04910	Insulin signaling pathway	808_801_805	3	0.013318293	0.852370723	0.020294541
307	hsa-let-7e	hsa04630	Jak-STAT signaling pathway	1387_6774_2033	3	0.018005215	1	0.02679846
308	hsa-let-7e	hsa05221	Acute myeloid leukemia	861_6774	2	0.019290532	1	0.028058955
309	hsa-let-7e	hsa04920	Adipocytokine signaling pathway	6256_6774	2	0.024289515	1	0.034545088
310	hsa-let-7e	hsa04370	VEGF signaling pathway	1432_5578	2	0.031192771	1	0.043398638
311	hsa-let-7e	hsa04664	Fc epsilon RI signaling pathway	1432_5578	2	0.032656137	1	0.044467931
312	hsa-let-7e	hsa04510	Focal adhesion	1499_5578_3725	3	0.03690632	1	0.049208427
313	hsa-let-7e	hsa04710	Circadian rhythm - mammal	79365	1	0.047747485	1	0.062364062
314	hsa-let-7f-1	hsa04010	MAPK signaling pathway	9261_6722_8986_6195_207_9252_5595_1432_5594_6196_6197	11	4.51E-12	2.57E-10	2.57E-10
315	hsa-let-7f-1	hsa04150	mTOR signaling pathway	6195_207_5595_5594_6196_6197	6	1.19E-09	6.80E-08	3.40E-08
316	hsa-let-7f-1	hsa05221	Acute myeloid leukemia	6688_207_5595_6774_7704_5594	6	2.41E-09	1.37E-07	4.58E-08
317	hsa-let-7f-1	hsa04720	Long-term potentiation	6195_5595_5594_6196_6197_1387	6	9.25E-09	5.27E-07	1.32E-07
318	hsa-let-7f-1	hsa05200	Pathways in cancer	2736_6688_207_2932_5595_6774_7704_5594_1387	9	1.33E-08	7.57E-07	1.51E-07
319	hsa-let-7f-1	hsa04370	VEGF signaling pathway	9261_207_5595_1432_5594	5	4.57E-07	2.61E-05	4.35E-06
320	hsa-let-7f-1	hsa05215	Prostate cancer	207_2932_5595_5594_1387	5	8.58E-07	4.89E-05	6.45E-06
321	hsa-let-7f-1	hsa05212	Pancreatic cancer	207_2932_5595_5594_1387	5	9.05E-07	5.16E-05	6.45E-06
322	hsa-let-7f-1	hsa04660	T cell receptor signaling pathway	207_2932_5595_1432_5594	5	2.46E-06	0.000139979	1.56E-05
323	hsa-let-7f-1	hsa05213	Endometrial cancer	207_2932_5595_5594	4	3.69E-06	0.000210478	2.10E-05
324	hsa-let-7f-1	hsa05211	Renal cell carcinoma	207_5595_5594_1387	4	1.25E-05	0.000715167	6.50E-05
325	hsa-let-7f-1	hsa04662	B cell receptor signaling pathway	207_2932_5595_5594	4	1.46E-05	0.000834072	6.95E-05
326	hsa-let-7f-1	hsa04664	Fc epsilon RI signaling pathway	207_5595_1432_5594	4	1.78E-05	0.00101448	7.80E-05
327	hsa-let-7f-1	hsa05210	Colorectal cancer	207_2932_5595_5594	4	2.24E-05	0.001278485	9.13E-05
328	hsa-let-7f-1	hsa04012	ErbB signaling pathway	207_2932_5595_5594	4	2.56E-05	0.001459261	9.73E-05
329	hsa-let-7f-1	hsa04062	Chemokine signaling pathway	207_2932_5595_6774_5594	5	3.43E-05	0.001955023	0.000122189
330	hsa-let-7f-1	hsa04620	Toll-like receptor signaling pathway	207_5595_1432_5594	4	4.66E-05	0.002656712	0.000156277
331	hsa-let-7f-1	hsa04916	Melanogenesis	2932_5595_5594_1387	4	5.01E-05	0.002858131	0.000158785
332	hsa-let-7f-1	hsa05219	Bladder cancer	9252_5595_5594	3	8.22E-05	0.004687491	0.00024671
333	hsa-let-7f-1	hsa04930	Type II diabetes mellitus	3651_5595_5594	3	9.98E-05	0.00569094	0.000284547
334	hsa-let-7f-1	hsa04910	Insulin signaling pathway	207_2932_5595_5594	4	0.000144937	0.00826139	0.0003934
335	hsa-let-7f-1	hsa05223	Non-small cell lung cancer	207_5595_5594	3	0.000166909	0.009513827	0.000432447
336	hsa-let-7f-1	hsa05214	Glioma	207_5595_5594	3	0.000281762	0.016060457	0.000698281
337	hsa-let-7f-1	hsa05218	Melanoma	207_5595_5594	3	0.000361583	0.020610244	0.00082441
338	hsa-let-7f-1	hsa04730	Long-term depression	5595_5592_5594	3	0.000361583	0.020610244	0.00082441
339	hsa-let-7f-1	hsa05220	Chronic myeloid leukemia	207_5595_5594	3	0.000422116	0.024060589	0.000925407
340	hsa-let-7f-1	hsa04520	Adherens junction	5595_5594_1387	3	0.000506465	0.028868501	0.001069204
341	hsa-let-7f-1	hsa04510	Focal adhesion	207_2932_5595_5594	4	0.000640095	0.036485403	0.001261136
342	hsa-let-7f-1	hsa04350	TGF-beta signaling pathway	5595_5594_1387	3	0.000641631	0.036572946	0.001261136
343	hsa-let-7f-1	hsa04540	Gap junction	5595_5592_5594	3	0.000774218	0.04413043	0.001471014
344	hsa-let-7f-1	hsa04912	GnRH signaling pathway	5595_1432_5594	3	0.001178462	0.067172317	0.002166849
345	hsa-let-7f-1	hsa04270	Vascular smooth muscle contraction	5595_5592_5594	3	0.001510011	0.086070619	0.002645135
346	hsa-let-7f-1	hsa05216	Thyroid cancer	5595_5594	2	0.001531394	0.087289459	0.002645135
347	hsa-let-7f-1	hsa04360	Axon guidance	2932_5595_5594	3	0.002021081	0.115201604	0.003388282
348	hsa-let-7f-1	hsa04630	Jak-STAT signaling pathway	207_6774_1387	3	0.003221557	0.183628721	0.005246535
349	hsa-let-7f-1	hsa05010	Alzheimer's disease	2932_5595_5594	3	0.00463895	0.264420178	0.007345005
350	hsa-let-7f-1	hsa05217	Basal cell carcinoma	2736_2932	2	0.005095701	0.290454984	0.007850135
351	hsa-let-7f-1	hsa04340	Hedgehog signaling pathway	2736_2932	2	0.005449885	0.310643454	0.008174828
352	hsa-let-7f-1	hsa04920	Adipocytokine signaling pathway	207_6774	2	0.007384152	0.420896636	0.010792221
353	hsa-let-7f-1	hsa04110	Cell cycle	2932_1387	2	0.021486265	1	0.030617928
354	hsa-let-7f-1	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.028158506	1	0.039147191
355	hsa-let-7f-1	hsa04310	Wnt signaling pathway	2932_1387	2	0.033537225	1	0.045514806
356	hsa-let-7f-1	hsa04950	Maturity onset diabetes of the young	3651	1	0.045570794	1	0.060407797
357	hsa-let-7f-1	hsa05016	Huntington's disease	3064_1387	2	0.049000722	1	0.063478208
358	hsa-let-7i	hsa04110	Cell cycle	4088_4089_3066_1870_1871_7157_2033_1017_890_4193_1869_1029_5934_5933	14	1.32E-20	4.50E-19	4.50E-19
359	hsa-let-7i	hsa05220	Chronic myeloid leukemia	4088_4089_4609_3066_1870_1871_7157_4193_1869_1029	10	1.80E-15	6.13E-14	3.06E-14
360	hsa-let-7i	hsa05200	Pathways in cancer	4088_4089_4609_3066_1870_1871_1050_4149_7157_2033_1017_4193_1869_1029	14	9.73E-15	3.31E-13	1.10E-13
361	hsa-let-7i	hsa04350	TGF-beta signaling pathway	4088_4089_4609_1874_1875_6667_2033_5934_5933	9	4.15E-13	1.41E-11	3.53E-12
362	hsa-let-7i	hsa05219	Bladder cancer	4609_1870_1871_7157_4193_1869_1029	7	8.98E-12	3.05E-10	6.10E-11
363	hsa-let-7i	hsa05215	Prostate cancer	1870_1871_7157_2033_1017_4193_1869_1385	8	2.36E-11	8.01E-10	1.25E-10
364	hsa-let-7i	hsa05212	Pancreatic cancer	1870_1871_7157_2033_1017_4193_1869_1385	8	2.56E-11	8.72E-10	1.25E-10
365	hsa-let-7i	hsa05222	Small cell lung cancer	4609_1870_1871_4149_7157_1017_1869	7	9.23E-10	3.14E-08	3.92E-09
366	hsa-let-7i	hsa05214	Glioma	1870_1871_7157_4193_1869_1029	6	7.75E-09	2.63E-07	2.93E-08
367	hsa-let-7i	hsa05218	Melanoma	1870_1871_7157_4193_1869_1029	6	1.27E-08	4.32E-07	4.32E-08
368	hsa-let-7i	hsa05223	Non-small cell lung cancer	1870_1871_7157_1869_1029	5	1.45E-07	4.94E-06	4.50E-07
369	hsa-let-7i	hsa04310	Wnt signaling pathway	4088_4089_4609_7157_2033_8061	6	9.24E-07	3.14E-05	2.62E-06
370	hsa-let-7i	hsa04115	p53 signaling pathway	7157_1017_4193_1029	4	1.60E-05	0.000545487	4.20E-05
371	hsa-let-7i	hsa05210	Colorectal cancer	4088_4089_4609_7157	4	3.36E-05	0.001141975	8.16E-05
372	hsa-let-7i	hsa05016	Huntington's disease	3066_7157_6667_2033_1385	5	4.98E-05	0.001693159	0.000112877
373	hsa-let-7i	hsa04330	Notch signaling pathway	3066_2033_4851	3	0.000152791	0.005194898	0.000324681
374	hsa-let-7i	hsa04010	MAPK signaling pathway	4609_6722_4149_7157_1386	5	0.000274473	0.009332096	0.000548947
375	hsa-let-7i	hsa04520	Adherens junction	4088_4089_2033	3	0.00068242	0.023202278	0.001289015
376	hsa-let-7i	hsa04612	Antigen processing and presentation	4802_4800_1385	3	0.0009205	0.031297007	0.001647211
377	hsa-let-7i	hsa05216	Thyroid cancer	4609_7157	2	0.001872476	0.063664179	0.003183209
378	hsa-let-7i	hsa05213	Endometrial cancer	4609_7157	2	0.005589569	0.190045355	0.009049779
379	hsa-let-7i	hsa05221	Acute myeloid leukemia	4609_1050	2	0.00708229	0.240797861	0.010945357
380	hsa-let-7i	hsa04916	Melanogenesis	2033_1385	2	0.020298733	0.690156938	0.030006823
381	hsa-let-7i	hsa04120	Ubiquitin mediated proteolysis	4193_672	2	0.034390392	1	0.048719722
382	hsa-let-7i	hsa04630	Jak-STAT signaling pathway	4609_2033	2	0.041788796	1	0.056832762
383	hsa-mir-100	hsa05200	Pathways in cancer	3320_5925_3326_1147_3551_1499_5595_5594_1387_6256_1487_367_8517_2932_6774_5970_6688_2113_4087_1869_862_6502_2353_4088_7175_3065_1488_2033_4791_4792	30	1.45E-23	1.07E-21	1.07E-21
384	hsa-mir-100	hsa05215	Prostate cancer	3320_5925_3326_1147_3551_1499_5595_5594_1387_367_8517_2932_5970_1869_2033_4792	16	2.22E-17	1.64E-15	6.42E-16
385	hsa-mir-100	hsa05212	Pancreatic cancer	3320_5925_3326_1147_3551_1499_5595_5594_1387_367_8517_2932_5970_1869_2033_4792	16	2.60E-17	1.93E-15	6.42E-16
386	hsa-mir-100	hsa04010	MAPK signaling pathway	1147_3551_5595_5594_6722_9261_1326_4208_3305_3303_5566_8517_7867_3312_5971_5970_3310_2353_1432_4791	20	2.03E-14	1.50E-12	3.76E-13
387	hsa-mir-100	hsa05220	Chronic myeloid leukemia	5925_1147_3551_5595_5594_1487_8517_5970_1869_4088_3065_1488_4792	13	4.09E-14	3.03E-12	6.05E-13
388	hsa-mir-100	hsa04660	T cell receptor signaling pathway	1147_3551_5595_5594_1326_8517_2932_5970_4794_2353_1432_4792_4793	13	3.39E-12	2.51E-10	4.18E-11
389	hsa-mir-100	hsa04310	Wnt signaling pathway	23291_1499_1387_8607_1487_5566_2932_8454_6500_4087_8945_4088_1488_2033	14	1.09E-11	8.07E-10	1.15E-10
390	hsa-mir-100	hsa04662	B cell receptor signaling pathway	1147_3551_5595_5594_8517_2932_5970_4794_2353_4792_4793	11	1.97E-11	1.46E-09	1.82E-10
391	hsa-mir-100	hsa04350	TGF-beta signaling pathway	5595_5594_1387_8454_3397_3398_6500_4087_3399_4088_2033	11	8.40E-11	6.22E-09	6.91E-10
392	hsa-mir-100	hsa04110	Cell cycle	5925_5591_1387_2932_8454_6500_4087_1869_6502_4088_3065_2033	12	1.28E-10	9.46E-09	9.46E-10
393	hsa-mir-100	hsa04330	Notch signaling pathway	388585_1387_4851_1487_9612_3065_1488_2033_8850	9	1.67E-10	1.24E-08	1.13E-09
394	hsa-mir-100	hsa05221	Acute myeloid leukemia	1147_3551_5595_5594_8517_6774_5970_6688_862	9	1.01E-09	7.51E-08	6.25E-09
395	hsa-mir-100	hsa04920	Adipocytokine signaling pathway	1147_3551_6256_8517_6774_5970_4794_4792_4793	9	2.80E-09	2.07E-07	1.59E-08
396	hsa-mir-100	hsa04620	Toll-like receptor signaling pathway	1147_3551_5595_5594_1326_8517_5970_2353_1432_4792	10	5.93E-09	4.39E-07	3.13E-08
397	hsa-mir-100	hsa04916	Melanogenesis	1499_5595_5594_1387_5566_2932_2033_808_801_805	10	7.04E-09	5.21E-07	3.47E-08
398	hsa-mir-100	hsa05222	Small cell lung cancer	5925_1147_3551_6256_8517_5970_1869_6502_4792	9	2.06E-08	1.52E-06	9.32E-08
399	hsa-mir-100	hsa04062	Chemokine signaling pathway	1147_3551_5595_5594_5566_8517_2932_6774_5970_653361_4792_4793	12	2.14E-08	1.58E-06	9.32E-08
400	hsa-mir-100	hsa04120	Ubiquitin mediated proteolysis	7329_23291_672_8454_6500_3093_8945_6502_10273_7323	10	9.17E-08	6.79E-06	3.77E-07
401	hsa-mir-100	hsa04720	Long-term potentiation	5595_5594_1387_5566_2033_808_801_805	8	1.12E-07	8.28E-06	4.36E-07
402	hsa-mir-100	hsa03020	RNA polymerase	25885_64425_5437_51082_84172_5441	6	1.36E-07	1.01E-05	5.04E-07
403	hsa-mir-100	hsa04520	Adherens junction	1499_5595_5594_1387_4087_4088_2033_71	8	1.77E-07	1.31E-05	6.24E-07
404	hsa-mir-100	hsa05131	Shigellosis	347733_1499_7278_10382_84617_203068_71	7	2.65E-07	1.96E-05	8.52E-07
405	hsa-mir-100	hsa05130	Pathogenic Escherichia coli infection	347733_1499_7278_10382_84617_203068_71	7	2.65E-07	1.96E-05	8.52E-07
406	hsa-mir-100	hsa04540	Gap junction	347733_5595_5594_5566_7278_10382_84617_203068	8	5.16E-07	3.82E-05	1.59E-06
407	hsa-mir-100	hsa05214	Glioma	5925_5595_5594_1869_808_801_805	7	6.69E-07	4.95E-05	1.98E-06
408	hsa-mir-100	hsa05210	Colorectal cancer	1499_5595_5594_2932_4087_2353_4088	7	3.29E-06	0.0002435	9.37E-06
409	hsa-mir-100	hsa05216	Thyroid cancer	1499_5595_5594_6256_7175	5	3.49E-06	0.00025816	9.56E-06
410	hsa-mir-100	hsa04612	Antigen processing and presentation	3320_3326_3309_3305_3303_3312_3310	7	4.71E-06	0.000348318	1.20E-05
411	hsa-mir-100	hsa04210	Apoptosis	1147_3551_5566_8517_5970_8837_4792	7	4.71E-06	0.000348318	1.20E-05
412	hsa-mir-100	hsa04910	Insulin signaling pathway	3551_5595_5594_5566_2932_808_801_805	8	8.25E-06	0.00061074	2.04E-05
413	hsa-mir-100	hsa04912	GnRH signaling pathway	5595_5594_5566_1432_808_801_805	7	1.55E-05	0.00114676	3.62E-05
414	hsa-mir-100	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_8517_5970_1432_4792	6	1.56E-05	0.001158045	3.62E-05
415	hsa-mir-100	hsa04270	Vascular smooth muscle contraction	5595_5594_5566_4637_808_801_805	7	2.66E-05	0.001969591	5.97E-05
416	hsa-mir-100	hsa05223	Non-small cell lung cancer	5925_5595_5594_6256_1869	5	5.46E-05	0.004039508	0.000118809
417	hsa-mir-100	hsa05016	Huntington's disease	1387_292_293_5437_1213_3065_2033_5441	8	6.83E-05	0.005056508	0.000144472
418	hsa-mir-100	hsa05211	Renal cell carcinoma	5595_5594_1387_2113_2033	5	0.000194888	0.014421747	0.000400604
419	hsa-mir-100	hsa04370	VEGF signaling pathway	5595_5594_9261_7867_1432	5	0.000261762	0.0193704	0.000523524
420	hsa-mir-100	hsa05219	Bladder cancer	5925_5595_5594_1869	4	0.000284132	0.02102579	0.00055331
421	hsa-mir-100	hsa04930	Type II diabetes mellitus	3551_5595_5594_3651	4	0.000363016	0.026863175	0.000688799
422	hsa-mir-100	hsa05213	Endometrial cancer	1499_5595_5594_2932	4	0.000606101	0.044851509	0.001121288
423	hsa-mir-100	hsa04340	Hedgehog signaling pathway	23291_5566_2932_8945	4	0.000838403	0.062041836	0.001513216
424	hsa-mir-100	hsa04810	Regulation of actin cytoskeleton	5595_5594_4627_4628_10788_10627_71	7	0.001013975	0.075034139	0.001786527
425	hsa-mir-100	hsa05010	Alzheimer's disease	5595_5594_2932_808_801_805	6	0.001736325	0.128488064	0.002988095
426	hsa-mir-100	hsa05218	Melanoma	5925_5595_5594_1869	4	0.001811904	0.134080919	0.003047294
427	hsa-mir-100	hsa04670	Leukocyte transendothelial migration	1499_653361_10627_1432_71	5	0.001901067	0.140678975	0.003126199
428	hsa-mir-100	hsa04020	Calcium signaling pathway	292_5566_293_808_801_805	6	0.002097188	0.155191878	0.003373736
429	hsa-mir-100	hsa04530	Tight junction	1499_4627_4628_10627_71	5	0.003084737	0.228270512	0.004856819
430	hsa-mir-100	hsa04510	Focal adhesion	1499_5595_5594_2932_10627_71	6	0.003605476	0.266805236	0.005558442
431	hsa-mir-100	hsa04630	Jak-STAT signaling pathway	3559_1387_6778_6774_2033	5	0.00511597	0.378581777	0.007726159
432	hsa-mir-100	hsa03010	Ribosome	6156_6128_6207_6202	4	0.00627975	0.464701466	0.009294029
433	hsa-mir-100	hsa04950	Maturity onset diabetes of the young	168620_3651	2	0.013755984	1	0.019959663
434	hsa-mir-100	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.017348445	1	0.024688171
435	hsa-mir-100	hsa04664	Fc epsilon RI signaling pathway	5595_5594_1432	3	0.019140709	1	0.026724763
436	hsa-mir-100	hsa04012	ErbB signaling pathway	5595_5594_2932	3	0.024402888	1	0.033440995
437	hsa-mir-100	hsa03410	Base excision repair	3146_142	2	0.028197096	1	0.037937911
438	hsa-mir-101-1	hsa03022	Basal transcription factors	2959_6908	2	0.000307874	0.004925982	0.004925982
439	hsa-mir-101-1	hsa05215	Prostate cancer	2033_367	2	0.001630478	0.026087648	0.008887749
440	hsa-mir-101-1	hsa05212	Pancreatic cancer	2033_367	2	0.001666453	0.026663248	0.008887749
441	hsa-mir-101-1	hsa05016	Huntington's disease	2033_6908	2	0.007024157	0.112386512	0.028096628
442	hsa-mir-101-1	hsa05200	Pathways in cancer	2033_367	2	0.020546316	0.328741053	0.063014757
443	hsa-mir-101-1	hsa03410	Base excision repair	3146	1	0.024371354	0.389941658	0.063014757
444	hsa-mir-101-1	hsa03420	Nucleotide excision repair	4331	1	0.029566123	0.473057967	0.063014757
445	hsa-mir-101-1	hsa04330	Notch signaling pathway	2033	1	0.031507378	0.504118054	0.063014757
446	hsa-mir-101-1	hsa05211	Renal cell carcinoma	2033	1	0.047541657	0.760666506	0.07605444
447	hsa-mir-101-1	hsa04720	Long-term potentiation	2033	1	0.049448734	0.791179745	0.07605444
448	hsa-mir-101-2	hsa05200	Pathways in cancer	3716_3326_3725_25_1956_1387_2064_5159_5747_5156_2261_3815_2932_3265_6774_6776_6777_5879_8772_4609_2353_4087_4088_4089_3065_5925_2033_207_8554_5970_7046_7186	32	4.64E-32	3.11E-30	3.11E-30
449	hsa-mir-101-2	hsa04630	Jak-STAT signaling pathway	3717_3716_3560_3561_1387_6774_6776_6777_6773_3459_58985_3455_5781_7297_4609_1439_2033_207_8554_10379	20	1.55E-22	1.04E-20	5.19E-21
450	hsa-mir-101-2	hsa04010	MAPK signaling pathway	3725_1956_5159_5156_7132_3303_2261_2264_9252_3265_1432_1845_5879_22800_4609_2353_207_5970_7046_7186	20	4.78E-18	3.21E-16	1.07E-16
451	hsa-mir-101-2	hsa04012	ErbB signaling pathway	3725_25_818_817_1956_6714_2064_5747_2932_3265_6776_6777_4609_207	14	2.69E-17	1.80E-15	4.51E-16
452	hsa-mir-101-2	hsa04060	Cytokine-cytokine receptor interaction	2321_1956_3560_3561_90_5159_5156_7133_7132_1234_1230_3815_3459_3791_7852_58985_3455_1439_7046	19	4.10E-17	2.75E-15	5.49E-16
453	hsa-mir-101-2	hsa05220	Chronic myeloid leukemia	25_3265_6776_6777_5781_4609_4088_4089_3065_5925_207_5970_7046	13	1.61E-16	1.08E-14	1.80E-15
454	hsa-mir-101-2	hsa05210	Colorectal cancer	3725_1956_5159_5156_2932_5879_4609_2353_4087_4088_4089_207_7046	13	6.05E-16	4.05E-14	5.79E-15
455	hsa-mir-101-2	hsa04350	TGF-beta signaling pathway	1387_90_6667_4609_4086_4087_4088_4089_2033_4093_7046_57154	12	2.88E-14	1.93E-12	2.41E-13
456	hsa-mir-101-2	hsa05215	Prostate cancer	3326_1956_1387_2064_5159_5156_2932_3265_5925_2033_207_5970	12	3.26E-14	2.18E-12	2.43E-13
457	hsa-mir-101-2	hsa05212	Pancreatic cancer	3326_1956_1387_2064_5159_5156_2932_3265_5925_2033_207_5970	12	3.69E-14	2.47E-12	2.47E-13
458	hsa-mir-101-2	hsa04520	Adherens junction	1956_6714_1387_2064_5879_4087_4088_4089_2033_7046_2534	11	3.65E-13	2.44E-11	2.22E-12
459	hsa-mir-101-2	hsa04062	Chemokine signaling pathway	3717_5580_5747_1234_1230_2932_3265_6774_6777_6773_5879_7852_207_5970	14	6.81E-13	4.56E-11	3.80E-12
460	hsa-mir-101-2	hsa04510	Focal adhesion	3725_2321_1956_6714_2064_5159_5747_5156_2932_3265_5879_3791_207_2534	14	1.56E-12	1.05E-10	8.05E-12
461	hsa-mir-101-2	hsa04110	Cell cycle	25_1387_2932_4174_4172_4087_4088_4089_3065_5925_2033	11	1.93E-11	1.29E-09	9.24E-11
462	hsa-mir-101-2	hsa04920	Adipocytokine signaling pathway	3717_8717_7133_7132_6774_5781_207_5970_7186	9	6.55E-11	4.39E-09	2.93E-10
463	hsa-mir-101-2	hsa04310	Wnt signaling pathway	3725_818_817_1387_2932_5879_4609_4087_4088_4089_2033	11	2.24E-10	1.50E-08	9.39E-10
464	hsa-mir-101-2	hsa05221	Acute myeloid leukemia	3815_3265_6774_6776_6777_4609_207_5970	8	7.29E-10	4.88E-08	2.87E-09
465	hsa-mir-101-2	hsa05214	Glioma	818_817_1956_5159_5156_3265_5925_207	8	1.47E-09	9.83E-08	5.46E-09
466	hsa-mir-101-2	hsa05219	Bladder cancer	1956_2064_2261_9252_3265_4609_5925	7	2.39E-09	1.60E-07	8.44E-09
467	hsa-mir-101-2	hsa04660	T cell receptor signaling pathway	3725_3932_2932_3265_1432_2353_207_5970_2534	9	3.78E-09	2.53E-07	1.27E-08
468	hsa-mir-101-2	hsa04662	B cell receptor signaling pathway	3725_2932_3265_5879_6850_2353_207_5970	8	4.15E-09	2.78E-07	1.32E-08
469	hsa-mir-101-2	hsa04620	Toll-like receptor signaling pathway	3725_1432_5879_3455_8772_2353_207_5970	8	3.89E-08	2.61E-06	1.18E-07
470	hsa-mir-101-2	hsa04912	GnRH signaling pathway	3725_5580_818_817_1956_6714_3265_1432	8	5.90E-08	3.95E-06	1.72E-07
471	hsa-mir-101-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_1956_6714_1432_5879_5781_5970	7	6.60E-08	4.42E-06	1.84E-07
472	hsa-mir-101-2	hsa05211	Renal cell carcinoma	3725_1387_3265_5879_5781_2033_207	7	7.22E-08	4.83E-06	1.93E-07
473	hsa-mir-101-2	hsa04720	Long-term potentiation	818_817_1387_2902_2906_3265_2033	7	9.36E-08	6.27E-06	2.41E-07
474	hsa-mir-101-2	hsa04370	VEGF signaling pathway	6714_5747_3265_1432_5879_3791_207	7	1.11E-07	7.41E-06	2.75E-07
475	hsa-mir-101-2	hsa04664	Fc epsilon RI signaling pathway	5580_3265_1432_5879_6850_207_2534	7	1.30E-07	8.73E-06	3.12E-07
476	hsa-mir-101-2	hsa05222	Small cell lung cancer	5747_4609_5925_207_8554_5970_7186	7	2.24E-07	1.50E-05	5.17E-07
477	hsa-mir-101-2	hsa04020	Calcium signaling pathway	818_817_1956_2064_5159_2902_2906_5156_147	9	2.50E-07	1.67E-05	5.45E-07
478	hsa-mir-101-2	hsa05213	Endometrial cancer	1956_2064_2932_3265_4609_207	6	2.52E-07	1.69E-05	5.45E-07
479	hsa-mir-101-2	hsa04210	Apoptosis	8717_7132_8772_1439_207_5970_7186	7	2.78E-07	1.87E-05	5.83E-07
480	hsa-mir-101-2	hsa04650	Natural killer cell mediated cytotoxicity	3932_3265_5879_3459_6850_3455_5781_2534	8	3.49E-07	2.34E-05	7.09E-07
481	hsa-mir-101-2	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_2906_7133_7132_1432_5879	6	3.78E-07	2.53E-05	7.44E-07
482	hsa-mir-101-2	hsa04916	Melanogenesis	818_817_1387_3815_2932_3265_2033	7	7.50E-07	5.03E-05	1.44E-06
483	hsa-mir-101-2	hsa04810	Regulation of actin cytoskeleton	1956_5159_5747_5156_2261_2264_3265_5879_22800	9	1.01E-06	6.77E-05	1.88E-06
484	hsa-mir-101-2	hsa05218	Melanoma	1956_5159_5156_3265_5925_207	6	1.38E-06	9.23E-05	2.50E-06
485	hsa-mir-101-2	hsa04360	Axon guidance	25_5747_2932_3265_5879_7852_2534	7	3.23E-06	0.000216708	5.70E-06
486	hsa-mir-101-2	hsa05223	Non-small cell lung cancer	1956_2064_3265_5925_207	5	7.16E-06	0.00047948	1.23E-05
487	hsa-mir-101-2	hsa05010	Alzheimer's disease	22926_2902_2906_7132_2932_8772_351	7	2.12E-05	0.001421814	3.55E-05
488	hsa-mir-101-2	hsa04530	Tight junction	8573_5580_6714_3265_22800_207	6	4.87E-05	0.003260663	7.95E-05
489	hsa-mir-101-2	hsa04540	Gap junction	1956_6714_5159_5156_3265	5	8.43E-05	0.005650182	0.000134528
490	hsa-mir-101-2	hsa05016	Huntington's disease	1387_2902_6667_3065_2033_9519	6	0.000258777	0.017338039	0.00040321
491	hsa-mir-101-2	hsa04670	Leukocyte transendothelial migration	5747_1432_5879_7852_5781	5	0.000284419	0.019056056	0.000433092
492	hsa-mir-101-2	hsa04612	Antigen processing and presentation	3326_3303_4800_4801	4	0.000849088	0.056888919	0.001264198
493	hsa-mir-101-2	hsa04330	Notch signaling pathway	1387_3065_2033	3	0.001508851	0.101093038	0.002197675
494	hsa-mir-101-2	hsa04120	Ubiquitin mediated proteolysis	672_7329_8554_57154	4	0.00408537	0.273719802	0.005823826
495	hsa-mir-101-2	hsa05216	Thyroid cancer	3265_4609	2	0.00862898	0.578141663	0.012044618
496	hsa-mir-101-2	hsa05340	Primary immunodeficiency	3932_3561	2	0.012143112	0.813588491	0.016603847
497	hsa-mir-101-2	hsa03030	DNA replication	4174_4172	2	0.012780198	0.856273243	0.017125465
498	hsa-mir-101-2	hsa03022	Basal transcription factors	2969_9519	2	0.013431589	0.899916463	0.017645421
499	hsa-mir-101-2	hsa04910	Insulin signaling pathway	2932_3265_207	3	0.026183364	1	0.033736257
500	hsa-mir-101-2	hsa05131	Shigellosis	25_2534	2	0.028345339	1	0.035169217
501	hsa-mir-101-2	hsa05130	Pathogenic Escherichia coli infection	25_2534	2	0.028345339	1	0.035169217
502	hsa-mir-103-1	hsa05200	Pathways in cancer	3716_5371_675_1956_5595_5594_5599_1387_5159_5156_5601_9915_1399_1398_367_3815_2932_6774_6777_6772_3091_4436_7157_4609_3725_867_2353_4088_4089_1050_5925_2034_2033_5970	34	9.73E-26	6.81E-24	6.81E-24
503	hsa-mir-103-1	hsa04010	MAPK signaling pathway	1956_5595_5594_6722_5599_5159_5156_5601_5600_5603_1399_1398_1386_1432_1649_8550_7157_4773_4609_3725_3727_2353_5970_9252	24	4.84E-17	3.39E-15	1.69E-15
504	hsa-mir-103-1	hsa05210	Colorectal cancer	1956_5595_5594_5599_5159_5156_5601_2932_4436_7157_4609_3725_2353_4088_4089	15	3.66E-15	2.56E-13	8.53E-14
505	hsa-mir-103-1	hsa04012	ErbB signaling pathway	1956_6714_5595_5594_5599_2066_5601_1399_1398_2932_6777_4609_3725_867_6464	15	5.80E-15	4.06E-13	1.01E-13
506	hsa-mir-103-1	hsa05220	Chronic myeloid leukemia	5595_5594_1399_1398_6777_7157_5781_4609_867_4088_4089_5925_5970_6464	14	1.79E-14	1.26E-12	2.51E-13
507	hsa-mir-103-1	hsa04630	Jak-STAT signaling pathway	3717_3716_3718_85480_3560_3561_1387_3575_6774_6777_6772_2057_5781_4609_867_2690_2033	17	7.48E-14	5.23E-12	8.72E-13
508	hsa-mir-103-1	hsa04660	T cell receptor signaling pathway	3932_5595_5594_5601_5600_5603_919_2932_1432_4773_3725_867_2353_5970_1493	15	1.28E-13	8.93E-12	1.28E-12
509	hsa-mir-103-1	hsa05215	Prostate cancer	1956_5595_5594_1387_5159_5156_367_2932_7157_5925_2033_5970_9586	13	2.26E-12	1.58E-10	1.98E-11
510	hsa-mir-103-1	hsa05212	Pancreatic cancer	1956_5595_5594_1387_5159_5156_367_2932_7157_5925_2033_5970_9586	13	2.57E-12	1.80E-10	2.00E-11
511	hsa-mir-103-1	hsa04310	Wnt signaling pathway	5515_5599_1387_5601_2932_7157_8061_4773_4609_3725_1457_1459_4088_4089_2033	15	9.11E-12	6.38E-10	6.38E-11
512	hsa-mir-103-1	hsa04520	Adherens junction	1956_6714_3643_5595_5594_1387_5770_1457_1459_4088_4089_2033	12	1.37E-11	9.59E-10	8.72E-11
513	hsa-mir-103-1	hsa04350	TGF-beta signaling pathway	5515_5595_5594_1387_6667_7027_4609_3399_4088_4089_2033_4093	12	3.32E-11	2.32E-09	1.94E-10
514	hsa-mir-103-1	hsa05211	Renal cell carcinoma	5595_5594_1387_9915_1399_1398_3091_5781_3725_2034_2033	11	8.29E-11	5.80E-09	4.46E-10
515	hsa-mir-103-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_5599_5601_5600_5603_1432_5781_3725_5970	10	1.24E-09	8.69E-08	6.21E-09
516	hsa-mir-103-1	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5601_5600_5603_1432_6772_3725_2353_5970	11	2.41E-09	1.69E-07	1.12E-08
517	hsa-mir-103-1	hsa04910	Insulin signaling pathway	3643_5595_5594_5599_5601_1399_1398_2932_5770_23265_867_6464	12	4.29E-09	3.00E-07	1.86E-08
518	hsa-mir-103-1	hsa05221	Acute myeloid leukemia	5371_5595_5594_3815_6774_6777_4609_1050_5970	9	4.52E-09	3.17E-07	1.86E-08
519	hsa-mir-103-1	hsa04062	Chemokine signaling pathway	3717_3718_5595_5594_1399_1398_1234_2932_6774_6777_6772_5970_6464	13	1.71E-08	1.19E-06	6.63E-08
520	hsa-mir-103-1	hsa04662	B cell receptor signaling pathway	695_5595_5594_6850_2932_4773_3725_2353_5970	9	3.02E-08	2.11E-06	1.11E-07
521	hsa-mir-103-1	hsa04510	Focal adhesion	1956_6714_5595_5594_5599_5159_5156_5601_1399_1398_2932_3725_6464	13	3.52E-08	2.47E-06	1.23E-07
522	hsa-mir-103-1	hsa04664	Fc epsilon RI signaling pathway	695_5595_5594_5599_6850_5601_5600_5603_1432	9	4.55E-08	3.19E-06	1.52E-07
523	hsa-mir-103-1	hsa04912	GnRH signaling pathway	1956_6714_5595_5594_5599_5601_5600_5603_1432_3725	10	4.95E-08	3.47E-06	1.58E-07
524	hsa-mir-103-1	hsa04110	Cell cycle	1387_2932_7027_7157_4088_4089_5925_2033_891_8379	10	1.15E-07	8.08E-06	3.51E-07
525	hsa-mir-103-1	hsa05219	Bladder cancer	1956_5595_5594_7157_4609_5925_9252	7	1.43E-07	9.99E-06	4.16E-07
526	hsa-mir-103-1	hsa05214	Glioma	1956_5595_5594_5159_5156_7157_5925_6464	8	1.50E-07	1.05E-05	4.21E-07
527	hsa-mir-103-1	hsa05218	Melanoma	1956_5595_5594_5159_5156_7157_5925	7	3.59E-06	0.000251149	9.66E-06
528	hsa-mir-103-1	hsa04370	VEGF signaling pathway	6714_5595_5594_5600_5603_1432_4773	7	5.90E-06	0.000413057	1.53E-05
529	hsa-mir-103-1	hsa05213	Endometrial cancer	1956_5595_5594_2932_7157_4609	6	7.92E-06	0.000554235	1.98E-05
530	hsa-mir-103-1	hsa04060	Cytokine-cytokine receptor interaction	85480_1956_3560_3561_5159_5156_3575_1234_3815_2057_2690	11	1.69E-05	0.001184599	4.08E-05
531	hsa-mir-103-1	hsa05340	Primary immunodeficiency	3718_695_3932_3561_3575	5	1.82E-05	0.001271871	4.24E-05
532	hsa-mir-103-1	hsa04650	Natural killer cell mediated cytotoxicity	3932_5595_5594_6850_919_5781_4773_6464	8	2.82E-05	0.00197581	6.37E-05
533	hsa-mir-103-1	hsa04920	Adipocytokine signaling pathway	3717_5599_5601_6774_5781_5970	6	3.01E-05	0.002104784	6.58E-05
534	hsa-mir-103-1	hsa04930	Type II diabetes mellitus	3643_5595_5594_5599_5601	5	5.47E-05	0.003832045	0.000116123
535	hsa-mir-103-1	hsa05223	Non-small cell lung cancer	1956_5595_5594_7157_5925	5	0.000121855	0.008529833	0.000250877
536	hsa-mir-103-1	hsa05216	Thyroid cancer	5595_5594_7157_4609	4	0.000147415	0.010319074	0.000294831
537	hsa-mir-103-1	hsa04540	Gap junction	1956_6714_5595_5594_5159_5156	6	0.000165904	0.011613284	0.000322591
538	hsa-mir-103-1	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_867_64326_7325_7329	7	0.000205913	0.014413941	0.000389566
539	hsa-mir-103-1	hsa05016	Huntington's disease	1387_6908_4724_6667_1537_7157_2033_9586	8	0.000221	0.015470027	0.000407106
540	hsa-mir-103-1	hsa04916	Melanogenesis	5595_5594_1387_3815_2932_2033	6	0.000294361	0.020605261	0.00052834
541	hsa-mir-103-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	5600_5603_1432_7157	4	0.001478714	0.103510002	0.00258775
542	hsa-mir-103-1	hsa03010	Ribosome	6124_6129_6143_6222_6231	5	0.001884989	0.131949234	0.003218274
543	hsa-mir-103-1	hsa04810	Regulation of actin cytoskeleton	1956_5595_5594_5159_5156_1399_1398	7	0.00267116	0.186981215	0.004451934
544	hsa-mir-103-1	hsa05010	Alzheimer's disease	5595_5594_4724_2932_840_1537	6	0.004037956	0.282656885	0.006425756
545	hsa-mir-103-1	hsa04720	Long-term potentiation	5595_5594_1387_2033	4	0.004039047	0.282733269	0.006425756
546	hsa-mir-103-1	hsa03022	Basal transcription factors	2963_2969_6908	3	0.004253113	0.297717877	0.006615953
547	hsa-mir-103-1	hsa05222	Small cell lung cancer	7157_4609_5925_5970	4	0.006407962	0.448557318	0.009751246
548	hsa-mir-103-1	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.007948363	0.556385381	0.011837987
549	hsa-mir-103-1	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.010327109	0.722897638	0.015060367
550	hsa-mir-103-1	hsa04670	Leukocyte transendothelial migration	5600_5603_1432_5781	4	0.020027796	1	0.028611138
551	hsa-mir-103-1	hsa04115	p53 signaling pathway	7157_64326_891	3	0.02122746	1	0.029718444
552	hsa-mir-103-1	hsa04730	Long-term depression	5515_5595_5594	3	0.02280193	1	0.031296767
553	hsa-mir-103-1	hsa03440	Homologous recombination	675_4683	2	0.024860664	1	0.033064526
554	hsa-mir-103-1	hsa04360	Axon guidance	5595_5594_2932_4773	4	0.02503457	1	0.033064526
555	hsa-mir-103-1	hsa04530	Tight junction	5515_6714_1457_1459	4	0.028755536	1	0.037275695
556	hsa-mir-103-1	hsa04640	Hematopoietic cell lineage	3575_3815_2057	3	0.037615297	1	0.047874014
557	hsa-mir-103-1	hsa04210	Apoptosis	840_7157_5970	3	0.039740838	1	0.049676047
558	hsa-mir-103-1-as	hsa05200	Pathways in cancer	1387_3065_5925_2033_2249_8554_367_3725_6776_6777_2353_5914_5970_6256	14	1.98E-14	9.48E-13	9.48E-13
559	hsa-mir-103-1-as	hsa04330	Notch signaling pathway	9612_1387_3065_2033_8850	5	9.70E-08	4.66E-06	2.33E-06
560	hsa-mir-103-1-as	hsa04110	Cell cycle	1387_3065_993_5925_2033_983	6	3.09E-07	1.48E-05	4.95E-06
561	hsa-mir-103-1-as	hsa05220	Chronic myeloid leukemia	3065_5925_6776_6777_5970	5	8.57E-07	4.11E-05	1.03E-05
562	hsa-mir-103-1-as	hsa04630	Jak-STAT signaling pathway	1387_2033_3977_8554_6776_6777	6	1.37E-06	6.56E-05	1.31E-05
563	hsa-mir-103-1-as	hsa05215	Prostate cancer	1387_5925_2033_367_5970	5	1.81E-06	8.70E-05	1.31E-05
564	hsa-mir-103-1-as	hsa05212	Pancreatic cancer	1387_5925_2033_367_5970	5	1.91E-06	9.17E-05	1.31E-05
565	hsa-mir-103-1-as	hsa05221	Acute myeloid leukemia	6776_6777_5914_5970	4	1.08E-05	0.000516809	6.46E-05
566	hsa-mir-103-1-as	hsa05222	Small cell lung cancer	5925_8554_5970_6256	4	4.42E-05	0.002122055	0.000235784
567	hsa-mir-103-1-as	hsa05016	Huntington's disease	1387_3065_6908_6667_2033	5	6.26E-05	0.003002623	0.000300262
568	hsa-mir-103-1-as	hsa05211	Renal cell carcinoma	1387_2033_3725	3	0.000582757	0.027972319	0.002542938
569	hsa-mir-103-1-as	hsa04662	B cell receptor signaling pathway	3725_2353_5970	3	0.000653529	0.031369401	0.002614117
570	hsa-mir-103-1-as	hsa04350	TGF-beta signaling pathway	1387_6667_2033	3	0.000990752	0.047556088	0.003396863
571	hsa-mir-103-1-as	hsa04012	ErbB signaling pathway	3725_6776_6777	3	0.000990752	0.047556088	0.003396863
572	hsa-mir-103-1-as	hsa04620	Toll-like receptor signaling pathway	3725_2353_5970	3	0.001544899	0.074155155	0.004943677
573	hsa-mir-103-1-as	hsa04660	T cell receptor signaling pathway	3725_2353_5970	3	0.001906015	0.091488729	0.005718046
574	hsa-mir-103-1-as	hsa04010	MAPK signaling pathway	2249_3725_2353_5970	4	0.003072051	0.147458454	0.00820558
575	hsa-mir-103-1-as	hsa03410	Base excision repair	142_3146	2	0.003077092	0.147700434	0.00820558
576	hsa-mir-103-1-as	hsa04310	Wnt signaling pathway	1387_2033_3725	3	0.004646319	0.223023324	0.01173807
577	hsa-mir-103-1-as	hsa05223	Non-small cell lung cancer	5925_6256	2	0.006574318	0.315567269	0.015778363
578	hsa-mir-103-1-as	hsa04920	Adipocytokine signaling pathway	5970_6256	2	0.009836416	0.472147991	0.022483238
579	hsa-mir-103-1-as	hsa05218	Melanoma	5925_2249	2	0.010957991	0.525983591	0.022868852
580	hsa-mir-103-1-as	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.010957991	0.525983591	0.022868852
581	hsa-mir-103-1-as	hsa04720	Long-term potentiation	1387_2033	2	0.012133277	0.582397305	0.024266554
582	hsa-mir-103-1-as	hsa04520	Adherens junction	1387_2033	2	0.013676424	0.656468329	0.026258733
583	hsa-mir-103-1-as	hsa05210	Colorectal cancer	3725_2353	2	0.014968995	0.718511755	0.027635068
584	hsa-mir-103-1-as	hsa04612	Antigen processing and presentation	4800_1514	2	0.016655715	0.799474325	0.02961016
585	hsa-mir-103-1-as	hsa04916	Melanogenesis	1387_2033	2	0.022171809	1	0.038008816
586	hsa-mir-103-1-as	hsa03450	Non-homologous end-joining	2547	1	0.031950844	1	0.052884155
587	hsa-mir-103-1-as	hsa04120	Ubiquitin mediated proteolysis	672_8554	2	0.037479932	1	0.059967891
588	hsa-mir-103-2-as	hsa05200	Pathways in cancer	3320_4149_5371_1499_5595_5599_1387_5604_2932_2353_6774_6502_5970_5894_1029_4087_4088_5881_4292_1050_5925_2033	22	2.30E-21	1.43E-19	1.43E-19
589	hsa-mir-103-2-as	hsa04110	Cell cycle	990_993_1387_983_2932_8454_6502_6500_1029_4087_4088_5925_2033_5933	14	4.01E-17	2.48E-15	1.24E-15
590	hsa-mir-103-2-as	hsa05210	Colorectal cancer	1499_5595_5599_5604_2932_2353_5894_4087_4088_5881_4292	11	3.69E-14	2.29E-12	7.64E-13
591	hsa-mir-103-2-as	hsa04540	Gap junction	6714_5595_5598_983_5604_7277_7278_10376_5894_7846_51807	11	1.03E-13	6.38E-12	1.59E-12
592	hsa-mir-103-2-as	hsa04310	Wnt signaling pathway	1499_5599_1387_2932_8454_6500_1457_1459_4087_4088_5881_2033	12	6.43E-13	3.98E-11	7.97E-12
593	hsa-mir-103-2-as	hsa04520	Adherens junction	1499_6714_5595_1387_1457_1459_4087_4088_5881_2033	10	8.58E-13	5.32E-11	8.87E-12
594	hsa-mir-103-2-as	hsa05215	Prostate cancer	3320_1499_5595_1387_5604_2932_5970_5894_5925_2033	10	2.05E-12	1.27E-10	1.76E-11
595	hsa-mir-103-2-as	hsa05212	Pancreatic cancer	3320_1499_5595_1387_5604_2932_5970_5894_5925_2033	10	2.28E-12	1.41E-10	1.76E-11
596	hsa-mir-103-2-as	hsa04350	TGF-beta signaling pathway	5595_1387_6667_8454_6500_4087_4088_2033_5933	9	5.91E-11	3.67E-09	4.07E-10
597	hsa-mir-103-2-as	hsa05131	Shigellosis	1499_7277_7278_10376_7846_51807_4691	7	2.58E-09	1.60E-07	1.46E-08
598	hsa-mir-103-2-as	hsa05130	Pathogenic Escherichia coli infection	1499_7277_7278_10376_7846_51807_4691	7	2.58E-09	1.60E-07	1.46E-08
599	hsa-mir-103-2-as	hsa05221	Acute myeloid leukemia	5371_5595_5604_6774_5970_5894_1050	7	3.60E-09	2.23E-07	1.86E-08
600	hsa-mir-103-2-as	hsa05220	Chronic myeloid leukemia	5595_5604_5970_5894_1029_4088_5925	7	1.68E-08	1.04E-06	7.44E-08
601	hsa-mir-103-2-as	hsa04662	B cell receptor signaling pathway	5595_5604_2932_2353_5970_5894_5881	7	1.68E-08	1.04E-06	7.44E-08
602	hsa-mir-103-2-as	hsa05213	Endometrial cancer	1499_5595_5604_2932_5894_4292	6	5.76E-08	3.57E-06	2.38E-07
603	hsa-mir-103-2-as	hsa04010	MAPK signaling pathway	4149_5595_5599_5598_5604_2353_1386_5970_5894_5881	10	6.62E-08	4.10E-06	2.56E-07
604	hsa-mir-103-2-as	hsa04916	Melanogenesis	1499_5595_1387_5604_2932_5894_2033	7	1.38E-07	8.56E-06	5.03E-07
605	hsa-mir-103-2-as	hsa05219	Bladder cancer	5595_5604_5894_1029_5925	5	6.71E-07	4.16E-05	2.31E-06
606	hsa-mir-103-2-as	hsa04510	Focal adhesion	1499_6714_5595_5599_5604_2932_5894_5881	8	9.49E-07	5.88E-05	3.04E-06
607	hsa-mir-103-2-as	hsa04012	ErbB signaling pathway	6714_5595_5599_5604_2932_5894	6	9.82E-07	6.09E-05	3.04E-06
608	hsa-mir-103-2-as	hsa05223	Non-small cell lung cancer	5595_5604_5894_1029_5925	5	2.12E-06	0.000131276	6.25E-06
609	hsa-mir-103-2-as	hsa04912	GnRH signaling pathway	6714_5595_5599_5598_5604_5894	6	3.24E-06	0.00020066	9.12E-06
610	hsa-mir-103-2-as	hsa04660	T cell receptor signaling pathway	5595_5604_2932_2353_5970_5894	6	3.58E-06	0.000221987	9.65E-06
611	hsa-mir-103-2-as	hsa05214	Glioma	5595_5604_5894_1029_5925	5	4.96E-06	0.000307766	1.28E-05
612	hsa-mir-103-2-as	hsa04062	Chemokine signaling pathway	5595_5604_2932_6774_5970_5894_7074	7	7.19E-06	0.000445584	1.78E-05
613	hsa-mir-103-2-as	hsa05218	Melanoma	5595_5604_5894_1029_5925	5	7.45E-06	0.000461996	1.78E-05
614	hsa-mir-103-2-as	hsa05211	Renal cell carcinoma	5595_1387_5604_5894_2033	5	7.95E-06	0.000492702	1.82E-05
615	hsa-mir-103-2-as	hsa04720	Long-term potentiation	5595_1387_5604_5894_2033	5	9.59E-06	0.000594493	2.12E-05
616	hsa-mir-103-2-as	hsa04370	VEGF signaling pathway	6714_5595_5604_5894_5881	5	1.08E-05	0.000670995	2.31E-05
617	hsa-mir-103-2-as	hsa04664	Fc epsilon RI signaling pathway	5595_5599_5604_5894_5881	5	1.22E-05	0.000754975	2.52E-05
618	hsa-mir-103-2-as	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_8454_6502_6500	6	1.29E-05	0.000800905	2.58E-05
619	hsa-mir-103-2-as	hsa04330	Notch signaling pathway	1387_2033_2648_8850	4	3.19E-05	0.001980166	6.19E-05
620	hsa-mir-103-2-as	hsa04620	Toll-like receptor signaling pathway	5595_5599_5604_2353_5970	5	3.93E-05	0.002438392	7.39E-05
621	hsa-mir-103-2-as	hsa04910	Insulin signaling pathway	5595_5599_5604_2932_5894	5	0.000155403	0.00963498	0.000283382
622	hsa-mir-103-2-as	hsa05216	Thyroid cancer	1499_5595_5604	3	0.000195344	0.012111299	0.000346037
623	hsa-mir-103-2-as	hsa05222	Small cell lung cancer	4149_6502_5970_5925	4	0.00029394	0.018224292	0.00050623
624	hsa-mir-103-2-as	hsa04612	Antigen processing and presentation	3320_4801_4802_1514	4	0.000333173	0.020656737	0.00055829
625	hsa-mir-103-2-as	hsa03022	Basal transcription factors	2962_2969_6908	3	0.000381232	0.0236364	0.000622011
626	hsa-mir-103-2-as	hsa04810	Regulation of actin cytoskeleton	5595_5604_5894_5881_7074	5	0.00120141	0.074487395	0.001909933
627	hsa-mir-103-2-as	hsa04530	Tight junction	1499_6714_1457_1459	4	0.001582506	0.0981154	0.002452885
628	hsa-mir-103-2-as	hsa04650	Natural killer cell mediated cytotoxicity	5595_5604_5894_5881	4	0.001624017	0.100689065	0.002455831
629	hsa-mir-103-2-as	hsa04920	Adipocytokine signaling pathway	5599_6774_5970	3	0.001956661	0.121313007	0.002888405
630	hsa-mir-103-2-as	hsa04115	p53 signaling pathway	983_7161_1029	3	0.002120993	0.131501543	0.003058175
631	hsa-mir-103-2-as	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_5599_5970	3	0.002293658	0.1422068	0.003160151
632	hsa-mir-103-2-as	hsa04730	Long-term depression	5595_5604_5894	3	0.002293658	0.1422068	0.003160151
633	hsa-mir-103-2-as	hsa04950	Maturity onset diabetes of the young	3172_6928	2	0.003776824	0.234163114	0.005090502
634	hsa-mir-103-2-as	hsa05016	Huntington's disease	1387_6908_6667_2033	4	0.004802108	0.297730712	0.006334696
635	hsa-mir-103-2-as	hsa04270	Vascular smooth muscle contraction	5595_5604_5894	3	0.009045883	0.560844735	0.011684265
636	hsa-mir-103-2-as	hsa04360	Axon guidance	5595_2932_5881	3	0.011918876	0.738970318	0.014847468
637	hsa-mir-103-2-as	hsa04930	Type II diabetes mellitus	5595_5599	2	0.011973764	0.742373396	0.014847468
638	hsa-mir-103-2-as	hsa05217	Basal cell carcinoma	1499_2932	2	0.017280522	1	0.021007693
639	hsa-mir-103-2-as	hsa04630	Jak-STAT signaling pathway	1387_6774_2033	3	0.018458267	1	0.022007933
640	hsa-mir-105-1	hsa05200	Pathways in cancer	4087_4088_4089_5881_1050_836_2033_367_1499_6774_2353_1387	12	1.25E-14	5.73E-13	5.73E-13
641	hsa-mir-105-1	hsa04520	Adherens junction	4087_4088_4089_5881_2033_1499_6714_1387	8	2.24E-13	1.03E-11	5.14E-12
642	hsa-mir-105-1	hsa05210	Colorectal cancer	4087_4088_4089_5881_836_1499_2353	7	2.63E-11	1.21E-09	4.03E-10
643	hsa-mir-105-1	hsa04310	Wnt signaling pathway	4087_4088_4089_5881_2033_1499_1387	7	1.36E-09	6.25E-08	1.56E-08
644	hsa-mir-105-1	hsa04350	TGF-beta signaling pathway	4087_4088_4089_2033_1387	5	1.28E-07	5.89E-06	1.18E-06
645	hsa-mir-105-1	hsa04110	Cell cycle	4087_4088_4089_2033_1387	5	5.69E-07	2.62E-05	4.36E-06
646	hsa-mir-105-1	hsa05215	Prostate cancer	2033_367_1499_1387	4	6.24E-06	0.00028713	3.75E-05
647	hsa-mir-105-1	hsa05212	Pancreatic cancer	2033_367_1499_1387	4	6.52E-06	0.000299755	3.75E-05
648	hsa-mir-105-1	hsa04010	MAPK signaling pathway	5881_836_1432_5598_2353	5	2.91E-05	0.001340653	0.000148961
649	hsa-mir-105-1	hsa04330	Notch signaling pathway	2033_8850_1387	3	3.80E-05	0.001748671	0.000174867
650	hsa-mir-105-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_6714_1432	3	0.000123048	0.005660212	0.000514565
651	hsa-mir-105-1	hsa04370	VEGF signaling pathway	5881_6714_1432	3	0.000155118	0.007135424	0.000594619
652	hsa-mir-105-1	hsa04916	Melanogenesis	2033_1499_1387	3	0.000365777	0.016825735	0.001294287
653	hsa-mir-105-1	hsa04912	GnRH signaling pathway	6714_1432_5598	3	0.000407308	0.018736162	0.001338297
654	hsa-mir-105-1	hsa04950	Maturity onset diabetes of the young	6928_3172	2	0.000523383	0.024075624	0.001605042
655	hsa-mir-105-1	hsa04630	Jak-STAT signaling pathway	2033_6774_1387	3	0.001135503	0.052233137	0.003264571
656	hsa-mir-105-1	hsa05010	Alzheimer's disease	836_1020_840	3	0.001650097	0.075904473	0.004464969
657	hsa-mir-105-1	hsa05016	Huntington's disease	836_2033_1387	3	0.001954087	0.089888003	0.004993778
658	hsa-mir-105-1	hsa04510	Focal adhesion	5881_1499_6714	3	0.002522862	0.116051634	0.005964239
659	hsa-mir-105-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432	2	0.002593147	0.119284774	0.005964239
660	hsa-mir-105-1	hsa05221	Acute myeloid leukemia	1050_6774	2	0.002863781	0.131733935	0.006273045
661	hsa-mir-105-1	hsa05211	Renal cell carcinoma	2033_1387	2	0.004182142	0.192378517	0.008315763
662	hsa-mir-105-1	hsa04720	Long-term potentiation	2033_1387	2	0.004519436	0.207894064	0.008315763
663	hsa-mir-105-1	hsa05220	Chronic myeloid leukemia	4088_4089	2	0.004519436	0.207894064	0.008315763
664	hsa-mir-105-1	hsa04662	B cell receptor signaling pathway	5881_2353	2	0.004519436	0.207894064	0.008315763
665	hsa-mir-105-1	hsa04664	Fc epsilon RI signaling pathway	5881_1432	2	0.004988114	0.229453251	0.008825125
666	hsa-mir-105-1	hsa04210	Apoptosis	836_840	2	0.006253179	0.28764624	0.010653564
667	hsa-mir-105-1	hsa04540	Gap junction	6714_5598	2	0.00679597	0.312614628	0.011164808
668	hsa-mir-105-1	hsa04620	Toll-like receptor signaling pathway	1432_2353	2	0.008092526	0.372256178	0.01283642
669	hsa-mir-105-1	hsa04660	T cell receptor signaling pathway	1432_2353	2	0.009330911	0.429221901	0.014307397
670	hsa-mir-105-1	hsa04670	Leukocyte transendothelial migration	1499_1432	2	0.011336202	0.521465301	0.016821461
671	hsa-mir-105-1	hsa04360	Axon guidance	5881_1020	2	0.012953508	0.595861377	0.018620668
672	hsa-mir-105-1	hsa04530	Tight junction	1499_6714	2	0.01408438	0.647881463	0.0193158
673	hsa-mir-105-1	hsa04650	Natural killer cell mediated cytotoxicity	5881_836	2	0.014276895	0.656737184	0.0193158
674	hsa-mir-105-1	hsa05216	Thyroid cancer	1499	1	0.038243049	1	0.050262293
675	hsa-mir-105-2	hsa05200	Pathways in cancer	4087_4088_4089_5881_1050_836_2033_367_1499_6774_2353_1387	12	1.25E-14	5.73E-13	5.73E-13
676	hsa-mir-105-2	hsa04520	Adherens junction	4087_4088_4089_5881_2033_1499_6714_1387	8	2.24E-13	1.03E-11	5.14E-12
677	hsa-mir-105-2	hsa05210	Colorectal cancer	4087_4088_4089_5881_836_1499_2353	7	2.63E-11	1.21E-09	4.03E-10
678	hsa-mir-105-2	hsa04310	Wnt signaling pathway	4087_4088_4089_5881_2033_1499_1387	7	1.36E-09	6.25E-08	1.56E-08
679	hsa-mir-105-2	hsa04350	TGF-beta signaling pathway	4087_4088_4089_2033_1387	5	1.28E-07	5.89E-06	1.18E-06
680	hsa-mir-105-2	hsa04110	Cell cycle	4087_4088_4089_2033_1387	5	5.69E-07	2.62E-05	4.36E-06
681	hsa-mir-105-2	hsa05215	Prostate cancer	2033_367_1499_1387	4	6.24E-06	0.00028713	3.75E-05
682	hsa-mir-105-2	hsa05212	Pancreatic cancer	2033_367_1499_1387	4	6.52E-06	0.000299755	3.75E-05
683	hsa-mir-105-2	hsa04010	MAPK signaling pathway	5881_836_1432_5598_2353	5	2.91E-05	0.001340653	0.000148961
684	hsa-mir-105-2	hsa04330	Notch signaling pathway	2033_8850_1387	3	3.80E-05	0.001748671	0.000174867
685	hsa-mir-105-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_6714_1432	3	0.000123048	0.005660212	0.000514565
686	hsa-mir-105-2	hsa04370	VEGF signaling pathway	5881_6714_1432	3	0.000155118	0.007135424	0.000594619
687	hsa-mir-105-2	hsa04916	Melanogenesis	2033_1499_1387	3	0.000365777	0.016825735	0.001294287
688	hsa-mir-105-2	hsa04912	GnRH signaling pathway	6714_1432_5598	3	0.000407308	0.018736162	0.001338297
689	hsa-mir-105-2	hsa04950	Maturity onset diabetes of the young	6928_3172	2	0.000523383	0.024075624	0.001605042
690	hsa-mir-105-2	hsa04630	Jak-STAT signaling pathway	2033_6774_1387	3	0.001135503	0.052233137	0.003264571
691	hsa-mir-105-2	hsa05010	Alzheimer's disease	836_1020_840	3	0.001650097	0.075904473	0.004464969
692	hsa-mir-105-2	hsa05016	Huntington's disease	836_2033_1387	3	0.001954087	0.089888003	0.004993778
693	hsa-mir-105-2	hsa04510	Focal adhesion	5881_1499_6714	3	0.002522862	0.116051634	0.005964239
694	hsa-mir-105-2	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432	2	0.002593147	0.119284774	0.005964239
695	hsa-mir-105-2	hsa05221	Acute myeloid leukemia	1050_6774	2	0.002863781	0.131733935	0.006273045
696	hsa-mir-105-2	hsa05211	Renal cell carcinoma	2033_1387	2	0.004182142	0.192378517	0.008315763
697	hsa-mir-105-2	hsa04720	Long-term potentiation	2033_1387	2	0.004519436	0.207894064	0.008315763
698	hsa-mir-105-2	hsa05220	Chronic myeloid leukemia	4088_4089	2	0.004519436	0.207894064	0.008315763
699	hsa-mir-105-2	hsa04662	B cell receptor signaling pathway	5881_2353	2	0.004519436	0.207894064	0.008315763
700	hsa-mir-105-2	hsa04664	Fc epsilon RI signaling pathway	5881_1432	2	0.004988114	0.229453251	0.008825125
701	hsa-mir-105-2	hsa04210	Apoptosis	836_840	2	0.006253179	0.28764624	0.010653564
702	hsa-mir-105-2	hsa04540	Gap junction	6714_5598	2	0.00679597	0.312614628	0.011164808
703	hsa-mir-105-2	hsa04620	Toll-like receptor signaling pathway	1432_2353	2	0.008092526	0.372256178	0.01283642
704	hsa-mir-105-2	hsa04660	T cell receptor signaling pathway	1432_2353	2	0.009330911	0.429221901	0.014307397
705	hsa-mir-105-2	hsa04670	Leukocyte transendothelial migration	1499_1432	2	0.011336202	0.521465301	0.016821461
706	hsa-mir-105-2	hsa04360	Axon guidance	5881_1020	2	0.012953508	0.595861377	0.018620668
707	hsa-mir-105-2	hsa04530	Tight junction	1499_6714	2	0.01408438	0.647881463	0.0193158
708	hsa-mir-105-2	hsa04650	Natural killer cell mediated cytotoxicity	5881_836	2	0.014276895	0.656737184	0.0193158
709	hsa-mir-105-2	hsa05216	Thyroid cancer	1499	1	0.038243049	1	0.050262293
710	hsa-mir-106a	hsa05200	Pathways in cancer	3320_5371_1488_1017_5595_5594_5599_861_5914_1387_6256_595_6502_836_6258_367_2932_4193_4149_7704_842_6774_3091_5970_7428_1870_1871_7157_4824_4087_6688_5604_2113_4609_1869_3725_841_1029_1487_4088_4089_3066_3065_4292_1050_5925_2034_2033_4846_207_9915_5894	52	7.62E-41	5.11E-39	5.11E-39
711	hsa-mir-106a	hsa05220	Chronic myeloid leukemia	1488_5595_5594_861_595_4193_5970_1870_1871_7157_5604_4609_1869_1029_1487_4088_4089_3066_3065_5925_207_6464_5894	23	2.78E-24	1.86E-22	9.32E-23
712	hsa-mir-106a	hsa04110	Cell cycle	890_5591_1017_1387_595_983_6502_2932_4193_8454_6500_1870_1871_7157_4087_1869_1029_4088_4089_3066_3065_5925_2033_5933_5934_990	26	4.68E-24	3.13E-22	1.04E-22
713	hsa-mir-106a	hsa05215	Prostate cancer	3320_1017_5595_5594_1387_595_367_2932_4193_1385_842_5970_1870_1871_7157_4824_5604_1869_5925_2033_207_5894	22	1.24E-21	8.27E-20	2.04E-20
714	hsa-mir-106a	hsa05212	Pancreatic cancer	3320_1017_5595_5594_1387_595_367_2932_4193_1385_842_5970_1870_1871_7157_4824_5604_1869_5925_2033_207_5894	22	1.53E-21	1.02E-19	2.04E-20
715	hsa-mir-106a	hsa04350	TGF-beta signaling pathway	3399_5595_5594_1387_6667_8454_3398_6500_1874_1875_4087_4609_4088_4089_2033_5933_4093_5934	18	1.14E-16	7.67E-15	1.28E-15
716	hsa-mir-106a	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_6258_842_1870_1871_7157_5604_1869_1029_5925_207_5894	15	9.82E-16	6.58E-14	9.40E-15
717	hsa-mir-106a	hsa05210	Colorectal cancer	5595_5594_5599_595_836_2932_842_7157_4087_5604_4609_3725_4088_4089_4292_207_5894	17	1.13E-15	7.56E-14	9.45E-15
718	hsa-mir-106a	hsa05221	Acute myeloid leukemia	5371_5595_5594_861_5914_595_7704_6774_5970_6688_5604_4609_1050_207_5894	15	3.01E-15	2.02E-13	2.24E-14
719	hsa-mir-106a	hsa05214	Glioma	815_5595_5594_595_4193_1870_1871_7157_5604_1869_1029_5925_207_6464_5894	15	1.03E-14	6.91E-13	6.91E-14
720	hsa-mir-106a	hsa05222	Small cell lung cancer	1017_6256_595_6502_6258_4149_842_5970_1870_1871_7157_4609_1869_5925_4846_207	16	2.51E-14	1.68E-12	1.43E-13
721	hsa-mir-106a	hsa05219	Bladder cancer	5595_5594_595_4193_1870_1871_7157_5604_4609_1869_1029_5925_5894	13	2.55E-14	1.71E-12	1.43E-13
722	hsa-mir-106a	hsa04310	Wnt signaling pathway	815_1488_5599_1387_595_2932_8454_6500_7157_4087_4609_3725_1457_1487_1459_4088_4089_2033	18	6.49E-13	4.35E-11	3.34E-12
723	hsa-mir-106a	hsa04010	MAPK signaling pathway	5595_5594_5599_5598_4208_836_4149_3312_1386_5970_9261_7157_5604_4609_3725_6195_4763_1616_207_2002_2005_5894	22	2.25E-12	1.51E-10	1.08E-11
724	hsa-mir-106a	hsa05213	Endometrial cancer	5595_5594_595_2932_842_7157_5604_4609_4292_207_2002_5894	12	4.95E-12	3.32E-10	2.21E-11
725	hsa-mir-106a	hsa05218	Melanoma	5595_5594_595_4193_1870_1871_7157_5604_1869_1029_5925_207_5894	13	8.28E-12	5.55E-10	3.47E-11
726	hsa-mir-106a	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_7428_5604_2113_3725_2034_2033_207_9915_5894	13	9.68E-12	6.48E-10	3.81E-11
727	hsa-mir-106a	hsa04012	ErbB signaling pathway	815_6714_5595_5594_5599_2932_5604_4609_3725_207_6464_2002_5894	13	8.04E-11	5.38E-09	2.99E-10
728	hsa-mir-106a	hsa04540	Gap junction	6714_5595_5594_5598_983_7277_7278_5604_7846_51807_10376_5894	12	1.97E-09	1.32E-07	6.95E-09
729	hsa-mir-106a	hsa05216	Thyroid cancer	5595_5594_6256_595_6258_7157_5604_4609	8	5.68E-09	3.80E-07	1.90E-08
730	hsa-mir-106a	hsa04330	Notch signaling pathway	1488_1387_2648_1487_9612_3066_3065_2033_4851	9	1.00E-08	6.71E-07	3.19E-08
731	hsa-mir-106a	hsa04115	p53 signaling pathway	1017_595_983_836_4193_842_7157_841_7161_1029	10	1.64E-08	1.10E-06	4.99E-08
732	hsa-mir-106a	hsa04520	Adherens junction	6714_5595_5594_1387_4087_1457_1459_4088_4089_2033	10	5.84E-08	3.92E-06	1.68E-07
733	hsa-mir-106a	hsa05016	Huntington's disease	6874_1387_2902_6908_836_6667_1385_842_7157_841_3066_3065_3064_2033	14	6.00E-08	4.02E-06	1.68E-07
734	hsa-mir-106a	hsa04720	Long-term potentiation	815_5595_5594_1387_2902_5604_6195_2033_5894	9	3.72E-07	2.49E-05	9.96E-07
735	hsa-mir-106a	hsa04370	VEGF signaling pathway	6714_5595_5594_842_9261_5604_4846_207_5894	9	4.55E-07	3.05E-05	1.17E-06
736	hsa-mir-106a	hsa04912	GnRH signaling pathway	815_6714_5595_5594_5599_5598_5604_3725_2002_5894	10	7.59E-07	5.09E-05	1.88E-06
737	hsa-mir-106a	hsa04662	B cell receptor signaling pathway	5595_5594_2932_5970_5604_3725_207_5894	8	3.74E-06	0.000250732	8.95E-06
738	hsa-mir-106a	hsa04916	Melanogenesis	815_5595_5594_1387_2932_1385_5604_2033_5894	9	4.56E-06	0.000305637	1.05E-05
739	hsa-mir-106a	hsa04510	Focal adhesion	6714_5595_5594_5599_595_2932_5604_3725_207_6464_2002_5894	12	5.92E-06	0.000396333	1.28E-05
740	hsa-mir-106a	hsa04910	Insulin signaling pathway	6720_5595_5594_5599_2932_5604_207_6464_2002_5894	10	5.94E-06	0.000397869	1.28E-05
741	hsa-mir-106a	hsa04210	Apoptosis	836_839_842_840_5970_7157_841_207	8	1.20E-05	0.000804339	2.51E-05
742	hsa-mir-106a	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5970_5604_3725_841_207	8	3.01E-05	0.002015855	6.11E-05
743	hsa-mir-106a	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_6502_4193_8454_6500_7428_7329	9	4.00E-05	0.002682995	7.89E-05
744	hsa-mir-106a	hsa05010	Alzheimer's disease	22926_5595_5594_2902_836_2932_842_840_841_4846	10	4.52E-05	0.003026732	8.65E-05
745	hsa-mir-106a	hsa04660	T cell receptor signaling pathway	5595_5594_2932_5970_5604_3725_207_5894	8	4.98E-05	0.003336698	9.27E-05
746	hsa-mir-106a	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_842_7157_1616_4846	6	6.13E-05	0.004109065	0.000105361
747	hsa-mir-106a	hsa05131	Shigellosis	7277_7278_7846_51807_4691_10376	6	6.13E-05	0.004109065	0.000105361
748	hsa-mir-106a	hsa05130	Pathogenic Escherichia coli infection	7277_7278_7846_51807_4691_10376	6	6.13E-05	0.004109065	0.000105361
749	hsa-mir-106a	hsa04062	Chemokine signaling pathway	5595_5594_7074_2932_6774_5970_5604_207_6464_5894	10	8.98E-05	0.006014739	0.000150368
750	hsa-mir-106a	hsa03022	Basal transcription factors	2963_2962_6874_2969_6908	5	9.43E-05	0.006319284	0.000154129
751	hsa-mir-106a	hsa04920	Adipocytokine signaling pathway	5599_6256_6258_6774_5970_207	6	0.000153509	0.010285107	0.000244883
752	hsa-mir-106a	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5604_207_5894	6	0.000353322	0.023672599	0.000550526
753	hsa-mir-106a	hsa04150	mTOR signaling pathway	5595_5594_3091_6195_207	5	0.000405884	0.027194253	0.000618051
754	hsa-mir-106a	hsa04612	Antigen processing and presentation	3320_4800_4801_4802_1385_3312	6	0.000640768	0.042931444	0.000954032
755	hsa-mir-106a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_5599_836_5970_3725	5	0.001511809	0.101291179	0.002155131
756	hsa-mir-106a	hsa04730	Long-term depression	5595_5594_5604_4846_5894	5	0.001511809	0.101291179	0.002155131
757	hsa-mir-106a	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_5604_6464_5894	6	0.005263344	0.352644071	0.007346751
758	hsa-mir-106a	hsa04630	Jak-STAT signaling pathway	1387_595_6774_4609_2033_207	6	0.008919457	0.597603604	0.012195992
759	hsa-mir-106a	hsa04930	Type II diabetes mellitus	5595_5594_5599	3	0.015755146	1	0.021111895
760	hsa-mir-106a	hsa04270	Vascular smooth muscle contraction	5595_5594_5604_5894	4	0.045810228	1	0.060182064
761	hsa-mir-106b	hsa05200	Pathways in cancer	3320_5371_9063_5595_5594_5599_5914_1387_6256_595_1487_1488_836_367_1017_2932_2353_4149_7704_3091_5970_7428_1870_1871_2885_7157_2113_4609_1869_3725_5604_1029_5601_4087_4088_4089_3066_3065_4292_1050_5925_2034_2033_4846_6502_5894_7186	47	1.41E-42	9.43E-41	9.43E-41
762	hsa-mir-106b	hsa04110	Cell cycle	990_5591_1387_595_983_1017_2932_8454_6500_1870_1871_7157_1869_1029_4087_4088_4089_3066_3065_5925_2033_5933_890_6502_5934	25	1.15E-26	7.69E-25	3.85E-25
763	hsa-mir-106b	hsa05220	Chronic myeloid leukemia	5595_5594_595_1487_1488_5970_1870_1871_2885_7157_4609_1869_5604_1029_4088_4089_3066_3065_5925_6464_5894	21	7.91E-25	5.30E-23	1.77E-23
764	hsa-mir-106b	hsa04010	MAPK signaling pathway	6722_5595_5594_5599_5598_4208_5600_3303_836_2353_4149_3312_1386_1432_5970_9344_2885_7157_4609_3725_5604_5606_5601_4763_2005_5894_7186	27	6.41E-21	4.29E-19	1.07E-19
765	hsa-mir-106b	hsa05210	Colorectal cancer	5595_5594_5599_595_836_2932_2353_2885_7157_4609_3725_5604_5601_4087_4088_4089_4292_5894	18	1.21E-19	8.10E-18	1.62E-18
766	hsa-mir-106b	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_8454_3397_3399_3398_6500_1874_1875_4609_4087_4088_4089_2033_5933_5934	18	2.10E-19	1.40E-17	2.34E-18
767	hsa-mir-106b	hsa05215	Prostate cancer	3320_5595_5594_1387_595_367_1017_2932_5970_1870_1871_2885_7157_1869_5604_5925_2033_5894	18	2.51E-19	1.68E-17	2.40E-18
768	hsa-mir-106b	hsa05212	Pancreatic cancer	3320_5595_5594_1387_595_367_1017_2932_5970_1870_1871_2885_7157_1869_5604_5925_2033_5894	18	3.00E-19	2.01E-17	2.51E-18
769	hsa-mir-106b	hsa04310	Wnt signaling pathway	5599_1387_595_1487_1488_1459_2932_8454_6500_7157_8061_4609_3725_1457_5601_4087_4088_4089_2033	19	9.34E-17	6.26E-15	6.95E-16
770	hsa-mir-106b	hsa05222	Small cell lung cancer	9063_6256_595_1017_4149_5970_1870_1871_7157_4609_1869_5925_4846_6502_7186	15	2.11E-15	1.42E-13	1.42E-14
771	hsa-mir-106b	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_2885_7157_1869_5604_1029_5925_5894	13	4.24E-15	2.84E-13	2.58E-14
772	hsa-mir-106b	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_4609_1869_5604_1029_5925_5894	12	8.51E-15	5.70E-13	4.75E-14
773	hsa-mir-106b	hsa05214	Glioma	5595_5594_595_1870_1871_2885_7157_1869_5604_1029_5925_6464_5894	13	3.42E-14	2.29E-12	1.76E-13
774	hsa-mir-106b	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_5970_2885_4609_5604_1050_5894	12	2.83E-13	1.90E-11	1.36E-12
775	hsa-mir-106b	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_7428_2885_2113_3725_5604_2034_2033_5894	12	2.29E-12	1.53E-10	1.02E-11
776	hsa-mir-106b	hsa04540	Gap junction	5595_5594_5598_983_7277_2885_7846_5604_7278_51807_10376_5894	12	3.43E-11	2.30E-09	1.44E-10
777	hsa-mir-106b	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5604_1029_5925_5894	11	3.89E-11	2.61E-09	1.53E-10
778	hsa-mir-106b	hsa05213	Endometrial cancer	5595_5594_595_2932_2885_7157_4609_5604_4292_5894	10	4.61E-11	3.09E-09	1.72E-10
779	hsa-mir-106b	hsa04912	GnRH signaling pathway	5595_5594_5599_5598_5600_1432_2885_3725_5604_5606_5601_5894	12	1.67E-10	1.12E-08	5.90E-10
780	hsa-mir-106b	hsa04660	T cell receptor signaling pathway	5595_5594_5600_2932_2353_1432_5970_2885_3725_5604_5601_5894	12	2.03E-10	1.36E-08	6.81E-10
781	hsa-mir-106b	hsa04012	ErbB signaling pathway	5595_5594_5599_2932_2885_4609_3725_5604_5601_6464_5894	11	2.80E-10	1.87E-08	8.92E-10
782	hsa-mir-106b	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5600_2353_1432_5970_3725_5604_5606_5601	11	1.31E-09	8.79E-08	3.99E-09
783	hsa-mir-106b	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5600_1432_2885_5604_5606_5601_5894	10	1.82E-09	1.22E-07	5.30E-09
784	hsa-mir-106b	hsa04330	Notch signaling pathway	2648_1387_1487_1488_9612_3066_3065_2033	8	9.84E-09	6.59E-07	2.73E-08
785	hsa-mir-106b	hsa05216	Thyroid cancer	5595_5594_6256_595_7157_4609_5604	7	1.02E-08	6.82E-07	2.73E-08
786	hsa-mir-106b	hsa04662	B cell receptor signaling pathway	5595_5594_2932_2353_5970_2885_3725_5604_5894	9	1.83E-08	1.23E-06	4.72E-08
787	hsa-mir-106b	hsa04520	Adherens junction	5595_5594_1387_1459_1457_4087_4088_4089_2033	9	3.06E-08	2.05E-06	7.59E-08
788	hsa-mir-106b	hsa04910	Insulin signaling pathway	6720_5595_5594_5599_2932_2885_5604_5601_6464_5894	10	2.45E-07	1.64E-05	5.87E-07
789	hsa-mir-106b	hsa05016	Huntington's disease	6874_1387_2902_6908_836_6667_7157_3066_3065_3064_2033	11	4.63E-07	3.10E-05	1.07E-06
790	hsa-mir-106b	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_5600_836_1432_7157_5606_4846	7	5.66E-07	3.79E-05	1.26E-06
791	hsa-mir-106b	hsa04510	Focal adhesion	5595_5594_5599_595_2932_2885_3725_5604_5601_6464_5894	11	1.09E-06	7.30E-05	2.35E-06
792	hsa-mir-106b	hsa04115	p53 signaling pathway	595_983_836_1017_7157_7161_1029	7	2.05E-06	0.000137564	4.30E-06
793	hsa-mir-106b	hsa04120	Ubiquitin mediated proteolysis	55294_5371_9063_672_8454_6500_7428_7329_6502	9	2.38E-06	0.000159424	4.83E-06
794	hsa-mir-106b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5600_836_1432_5970_3725_5601	7	2.45E-06	0.000164083	4.83E-06
795	hsa-mir-106b	hsa04720	Long-term potentiation	5595_5594_1387_2902_5604_2033_5894	7	3.43E-06	0.000230036	6.57E-06
796	hsa-mir-106b	hsa04370	VEGF signaling pathway	5595_5594_5600_1432_5604_4846_5894	7	4.04E-06	0.000270509	7.51E-06
797	hsa-mir-106b	hsa05131	Shigellosis	7277_7846_7278_51807_4691_10376	6	8.42E-06	0.000564246	1.48E-05
798	hsa-mir-106b	hsa05130	Pathogenic Escherichia coli infection	7277_7846_7278_51807_4691_10376	6	8.42E-06	0.000564246	1.48E-05
799	hsa-mir-106b	hsa04916	Melanogenesis	5595_5594_1387_2932_5604_2033_5894	7	2.54E-05	0.001701205	4.36E-05
800	hsa-mir-106b	hsa04062	Chemokine signaling pathway	5595_5594_2932_5970_2885_5604_7074_6464_5894	9	2.92E-05	0.001957872	4.89E-05
801	hsa-mir-106b	hsa04612	Antigen processing and presentation	3320_3303_4800_4801_4802_3312	6	9.64E-05	0.006457281	0.000157495
802	hsa-mir-106b	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_2885_5604_6464_5894	7	0.00013836	0.009270124	0.000220717
803	hsa-mir-106b	hsa04920	Adipocytokine signaling pathway	5599_6256_5970_5601_7186	5	0.000239392	0.016039244	0.000373006
804	hsa-mir-106b	hsa03022	Basal transcription factors	2962_2969_6874_6908	4	0.000278325	0.018647788	0.000423813
805	hsa-mir-106b	hsa04730	Long-term depression	5595_5594_5604_4846_5894	5	0.000308313	0.020656972	0.000459044
806	hsa-mir-106b	hsa04930	Type II diabetes mellitus	5595_5594_5599_5601	4	0.000554925	0.037179954	0.00080826
807	hsa-mir-106b	hsa05010	Alzheimer's disease	5595_5594_2902_836_2932_6622_4846	7	0.000587752	0.039379394	0.000837859
808	hsa-mir-106b	hsa04630	Jak-STAT signaling pathway	9063_1387_595_2885_4609_2033	6	0.001603795	0.10745425	0.00223863
809	hsa-mir-106b	hsa04210	Apoptosis	836_5970_7157_7186	4	0.005877447	0.393788966	0.00803651
810	hsa-mir-106b	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.008828926	0.591538067	0.011830761
811	hsa-mir-106b	hsa04270	Vascular smooth muscle contraction	5595_5594_5604_5894	4	0.014889906	0.997623676	0.019561249
812	hsa-mir-106b	hsa04810	Regulation of actin cytoskeleton	5595_5594_5604_7074_5894	5	0.030189739	1	0.038898317
813	hsa-mir-107	hsa05200	Pathways in cancer	7046_1499_5914_596_598_1017_4193_5578_3091_2249_2064_3065_5925_613_7184_5743_5747_25_1956_6789_4824_4436_5970_2885_6774_10401_207_208_3716_1147_998_2261_5595_5594_5599_6258_1387_6256_836_367_2932_6777_6772_5879_7157_6688_1869_3725_6776_4087_4088_4089_9063_5888_5728_2033_3910_4790_4792_3320_3326_5371_675_5159_5156_5604_5601_5602_1856_3815_842_841_51588_8772_4609_1026_2353_8554	78	8.46E-49	7.36E-47	7.36E-47
814	hsa-mir-107	hsa04010	MAPK signaling pathway	6722_7046_6195_2264_9252_5578_1845_7132_2249_4773_5923_1956_3304_3305_3303_6789_1432_5970_2885_1616_207_208_1147_998_2261_5595_5594_5599_836_3312_3315_5879_3164_7157_3725_3727_9344_5058_4790_5159_9261_5156_5604_5606_5601_5600_5602_9479_4609_2353_2002_2005	52	6.48E-29	5.64E-27	2.82E-27
815	hsa-mir-107	hsa03022	Basal transcription factors	54457_6879_51616_138474_6883_6881_2965_2967_2961_2960_2963_2962_2969_2968_6878_6877_6874_6873_6872_6908_6884_2958_2959_6880_2957_6882	26	1.39E-26	1.21E-24	3.13E-25
816	hsa-mir-107	hsa05215	Prostate cancer	1499_596_1017_4193_2064_5925_7184_1956_4824_5970_2885_207_208_1147_5595_5594_1385_1387_367_2932_7157_1869_5728_2033_4790_4792_3320_3326_5159_5156_5604_842_1026	33	1.44E-26	1.25E-24	3.13E-25
817	hsa-mir-107	hsa05212	Pancreatic cancer	1499_596_1017_4193_2064_5925_7184_1956_4824_5970_2885_207_208_1147_5595_5594_1385_1387_367_2932_7157_1869_5728_2033_4790_4792_3320_3326_5159_5156_5604_842_1026	33	1.93E-26	1.68E-24	3.37E-25
818	hsa-mir-107	hsa04110	Cell cycle	4171_1017_4193_902_4174_4172_3065_5925_25_9232_545_995_5347_7534_5591_1387_11200_7532_2932_7027_7157_1869_4085_4087_4088_4089_2033_890_1031_983_1026_1022_1111_8556_8555_472	36	3.38E-26	2.94E-24	4.91E-25
819	hsa-mir-107	hsa05210	Colorectal cancer	7046_1499_596_1956_4436_2885_207_208_5595_5594_5599_836_2932_5879_7157_3725_4087_4088_4089_5159_5156_5604_5601_5602_1856_842_4609_2353	28	1.32E-21	1.15E-19	1.65E-20
820	hsa-mir-107	hsa05220	Chronic myeloid leukemia	7046_598_4193_3065_5925_613_25_5970_2885_207_208_1147_5595_5594_6777_7157_1869_6776_4088_4089_4790_4792_5604_5781_4609_1026	26	1.65E-20	1.44E-18	1.80E-19
821	hsa-mir-107	hsa04012	ErbB signaling pathway	818_815_817_5578_2064_5747_25_1956_6714_2885_207_208_5595_5594_5599_2932_6777_3725_6776_5058_5604_5601_5602_4609_1026_2002	26	3.58E-19	3.11E-17	3.46E-18
822	hsa-mir-107	hsa05222	Small cell lung cancer	596_598_1017_5925_5743_5747_5970_10401_207_208_1147_6258_6256_7157_1869_9063_5728_3910_4790_4792_842_51588_4609_8554	24	3.13E-17	2.73E-15	2.73E-16
823	hsa-mir-107	hsa04115	p53 signaling pathway	1017_4194_4193_900_50484_6241_51246_545_7161_11200_836_7157_64326_5728_27113_25898_983_842_841_1026_1111_472	22	6.32E-17	5.50E-15	5.00E-16
824	hsa-mir-107	hsa04310	Wnt signaling pathway	818_815_817_1499_8607_5578_4773_6423_1460_5599_1387_2932_5879_7157_3725_1457_1452_4087_4088_4089_2033_5518_5515_5601_5602_1856_4609_5527	28	8.14E-16	7.08E-14	5.90E-15
825	hsa-mir-107	hsa04630	Jak-STAT signaling pathway	598_58985_3455_3459_3560_3561_1439_2885_6774_10401_3977_207_208_3717_3716_1387_6777_6772_6773_7297_6776_9063_2033_51588_10379_5781_4609_8554	28	1.26E-15	1.10E-13	8.44E-15
826	hsa-mir-107	hsa04510	Focal adhesion	1499_596_5578_2064_5923_2534_5747_3791_1956_6714_5499_2885_207_208_998_5595_5594_5599_2932_5879_3725_5058_5728_3910_2321_5159_5156_5604_5601_5602_2002	31	3.36E-15	2.93E-13	2.09E-14
827	hsa-mir-107	hsa04920	Adipocytokine signaling pathway	6794_7132_8717_2538_5970_6774_207_208_3717_1147_5599_6258_6256_4790_4792_5601_5602_5563_5781_7133	20	4.70E-15	4.09E-13	2.72E-14
828	hsa-mir-107	hsa05214	Glioma	818_815_817_4193_5578_5925_1956_2885_207_208_5595_5594_7157_1869_5728_5159_5156_5604_1026	19	3.12E-14	2.72E-12	1.70E-13
829	hsa-mir-107	hsa04620	Toll-like receptor signaling pathway	3455_1432_5970_207_208_1147_5595_5594_5599_6772_5879_3725_4790_4792_5604_5606_5601_5600_5602_841_8772_2353	22	6.26E-14	5.45E-12	3.20E-13
830	hsa-mir-107	hsa04660	T cell receptor signaling pathway	4773_2534_3932_1432_5970_2885_207_208_1147_998_5595_5594_2932_3725_5058_959_4790_4792_5604_5601_5600_2353	22	2.38E-13	2.07E-11	1.15E-12
831	hsa-mir-107	hsa04210	Apoptosis	596_598_7132_8717_823_1439_5970_207_208_1147_836_839_7157_4790_4792_842_841_840_8772_472	20	4.48E-13	3.90E-11	2.05E-12
832	hsa-mir-107	hsa05221	Acute myeloid leukemia	5914_5970_2885_6774_207_208_1147_5595_5594_6777_6688_6776_4790_5371_5604_3815_4609	17	8.58E-13	7.47E-11	3.73E-12
833	hsa-mir-107	hsa04350	TGF-beta signaling pathway	7046_90_3398_57154_6667_3397_3399_659_5595_5594_1387_7027_4087_4088_4089_2033_5518_5515_4609	19	2.67E-12	2.32E-10	1.10E-11
834	hsa-mir-107	hsa05223	Non-small cell lung cancer	5578_2064_5925_1956_6789_2885_207_208_5595_5594_6258_6256_7157_1869_5604_842	16	2.82E-12	2.46E-10	1.12E-11
835	hsa-mir-107	hsa04370	VEGF signaling pathway	5578_4773_5743_5747_3791_6714_1432_207_208_998_5595_5594_3315_5879_9261_5604_5600_842	18	3.75E-12	3.26E-10	1.42E-11
836	hsa-mir-107	hsa04912	GnRH signaling pathway	818_815_817_5578_5580_1956_6714_1432_2885_998_5595_5594_5599_3725_5604_5606_5601_5600_5602_2002	20	1.00E-11	8.72E-10	3.63E-11
837	hsa-mir-107	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_1432_5970_1147_998_5599_836_5879_3725_5058_4790_4792_5601_5600_5602_5781	17	1.07E-11	9.33E-10	3.73E-11
838	hsa-mir-107	hsa05213	Endometrial cancer	1499_2064_1956_2885_207_208_5595_5594_2932_7157_5728_5604_842_4609_2002	15	1.87E-11	1.63E-09	6.27E-11
839	hsa-mir-107	hsa04662	B cell receptor signaling pathway	4773_6850_5970_2885_207_208_1147_5595_5594_1380_2932_5879_3725_4790_4792_5604_2353	17	2.27E-11	1.97E-09	7.31E-11
840	hsa-mir-107	hsa04062	Chemokine signaling pathway	1234_1230_5747_5580_7852_5970_2885_6362_6774_207_208_3717_1147_998_5595_5594_2932_6777_6772_6773_5879_5058_4790_4792_5604	25	3.02E-11	2.63E-09	9.39E-11
841	hsa-mir-107	hsa04664	Fc epsilon RI signaling pathway	5578_2534_5580_6850_1432_2885_207_208_5595_5594_5599_5879_5604_5606_5601_5600_5602	17	4.61E-11	4.01E-09	1.38E-10
842	hsa-mir-107	hsa04520	Adherens junction	7046_1499_2064_2534_1956_6714_1460_998_5595_5594_1387_5879_1457_4087_4088_4089_2033	17	5.48E-11	4.76E-09	1.59E-10
843	hsa-mir-107	hsa05219	Bladder cancer	9252_4193_2064_5925_1956_2261_5595_5594_7157_1869_5604_4609_1026	13	2.01E-10	1.75E-08	5.64E-10
844	hsa-mir-107	hsa05218	Melanoma	4193_2249_5925_1956_207_208_5595_5594_7157_1869_5728_5159_5156_5604_1026	15	7.96E-10	6.93E-08	2.16E-09
845	hsa-mir-107	hsa05211	Renal cell carcinoma	3091_2885_207_208_998_5595_5594_1387_5879_3725_5058_2033_5604_5781	14	7.42E-09	6.46E-07	1.96E-08
846	hsa-mir-107	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_598_7132_1432_1616_836_5879_7157_5606_5600_842_7133	12	3.44E-08	3.00E-06	8.81E-08
847	hsa-mir-107	hsa04120	Ubiquitin mediated proteolysis	4193_3093_57154_7319_84447_10401_10055_9063_64326_7337_7329_5371_672_25898_51588_10075_8554	17	9.27E-08	8.07E-06	2.31E-07
848	hsa-mir-107	hsa04060	Cytokine-cytokine receptor interaction	7046_1234_1230_7132_58985_3455_3459_90_3791_1956_3560_3561_1439_7852_6362_659_3977_959_2321_5159_5156_3815_7133	23	1.53E-07	1.33E-05	3.69E-07
849	hsa-mir-107	hsa03420	Nucleotide excision repair	902_5887_2965_2967_2968_4331_2071_2074_1022_6117	10	2.99E-07	2.61E-05	7.04E-07
850	hsa-mir-107	hsa04916	Melanogenesis	818_815_817_1499_5578_5595_5594_1385_1387_2932_2033_5604_1856_3815	14	4.41E-07	3.84E-05	1.01E-06
851	hsa-mir-107	hsa05216	Thyroid cancer	1499_5595_5594_6258_6256_7157_5604_4609	8	1.35E-06	0.000117116	3.00E-06
852	hsa-mir-107	hsa04910	Insulin signaling pathway	2538_5499_2885_5211_207_208_5595_5594_5599_2932_5604_5601_5602_5563_2002	15	2.03E-06	0.000176466	4.30E-06
853	hsa-mir-107	hsa04650	Natural killer cell mediated cytotoxicity	5578_3455_3459_4773_2534_3932_6850_2885_5595_5594_836_5879_5058_5604_5781	15	2.03E-06	0.000176466	4.30E-06
854	hsa-mir-107	hsa04720	Long-term potentiation	818_815_817_6195_5578_5499_5595_5594_1387_2033_5604	11	3.59E-06	0.000311932	7.43E-06
855	hsa-mir-107	hsa04540	Gap junction	5578_10382_1956_6714_2885_5595_5594_1453_5159_983_5156_5604	12	4.34E-06	0.000377243	8.77E-06
856	hsa-mir-107	hsa05016	Huntington's disease	3065_3064_25942_6667_1385_1387_836_9001_5430_7157_2033_27113_6874_6908_842_841	16	1.67E-05	0.001448962	3.29E-05
857	hsa-mir-107	hsa04530	Tight junction	1499_5578_5580_6714_207_208_1460_998_1457_5728_5518_5515_5520	13	3.61E-05	0.003142554	6.98E-05
858	hsa-mir-107	hsa04150	mTOR signaling pathway	6794_6195_3091_207_208_5595_5594_5563	8	5.67E-05	0.004929761	0.000107169
859	hsa-mir-107	hsa04612	Antigen processing and presentation	3309_3304_3305_3303_1385_3312_3320_3326_4800_4801	10	7.89E-05	0.006861822	0.000145996
860	hsa-mir-107	hsa05131	Shigellosis	1499_5578_10382_2534_25_998_7534_4691	8	9.06E-05	0.007882981	0.000160877
861	hsa-mir-107	hsa05130	Pathogenic Escherichia coli infection	1499_5578_10382_2534_25_998_7534_4691	8	9.06E-05	0.007882981	0.000160877
862	hsa-mir-107	hsa04360	Axon guidance	4773_2534_5747_25_7852_998_5595_5594_2932_5879_5058_1020	12	9.75E-05	0.00848403	0.000169681
863	hsa-mir-107	hsa03050	Proteasome	5684_5705_5701_5702_5719_5717_5710	7	0.000222088	0.019321646	0.000378856
864	hsa-mir-107	hsa03030	DNA replication	4171_4174_4172_5557_6117_5422	6	0.000330272	0.028733654	0.00055257
865	hsa-mir-107	hsa05010	Alzheimer's disease	7132_823_6622_22926_5595_5594_836_2932_842_841_840_8772_1020	13	0.000388213	0.033774492	0.000637255
866	hsa-mir-107	hsa04810	Regulation of actin cytoskeleton	2264_2249_5747_1956_5499_998_2261_5595_5594_5879_5058_5159_5156_5604	14	0.000860474	0.074861205	0.001386319
867	hsa-mir-107	hsa04930	Type II diabetes mellitus	5580_5595_5594_5599_5601_5602	6	0.000956103	0.083180925	0.00151238
868	hsa-mir-107	hsa04330	Notch signaling pathway	9612_3065_1387_2033_8850_1856	6	0.001173579	0.102101332	0.001823238
869	hsa-mir-107	hsa04670	Leukocyte transendothelial migration	1499_5578_5747_1432_7852_998_5879_5600_5781	9	0.002872714	0.249926153	0.004384669
870	hsa-mir-107	hsa03440	Homologous recombination	641_5888_675_6117	4	0.005497832	0.478311409	0.008246748
871	hsa-mir-107	hsa04730	Long-term depression	5578_5595_5594_5518_5515_5604	6	0.007722247	0.671835475	0.011387042
872	hsa-mir-107	hsa03410	Base excision repair	3146_142_4913_328	4	0.012139758	1	0.017602649
873	hsa-mir-107	hsa04950	Maturity onset diabetes of the young	5080_6927_3172	3	0.022084115	1	0.031497016
874	hsa-mir-107	hsa04270	Vascular smooth muscle contraction	5578_147_5580_5499_5595_5594_5604	7	0.022943321	1	0.032194659
875	hsa-mir-107	hsa04020	Calcium signaling pathway	818_815_817_5578_2064_147_1956_5159_5156	9	0.043215361	1	0.059086788
876	hsa-mir-107	hsa05217	Basal cell carcinoma	1499_2932_7157_1856	4	0.043466143	1	0.059086788
877	hsa-mir-107	hsa04340	Hedgehog signaling pathway	53944_2932_1452_1453	4	0.048154021	1	0.064452305
878	hsa-mir-107	hsa03450	Non-homologous end-joining	2547_5591	2	0.049061585	1	0.06467209
879	hsa-mir-10a	hsa05200	Pathways in cancer	3320_5371_3551_1499_5595_5594_5599_5914_1387_6257_6256_595_1487_1488_836_6258_367_1147_8517_2932_7704_3091_5970_7428_1870_1871_8031_7157_6688_2113_4609_1869_3725_862_5881_6774_6502_4087_4088_4089_7175_3066_3065_1050_5925_2034_2033_4846_207_3326_8554_4286_4791_4792_2353	55	2.63E-39	2.03E-37	2.03E-37
880	hsa-mir-10a	hsa05220	Chronic myeloid leukemia	3551_5595_5594_595_1487_1488_1147_8517_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_207_4792_6464	22	6.19E-21	4.76E-19	2.38E-19
881	hsa-mir-10a	hsa04110	Cell cycle	993_5591_1387_595_983_7532_2932_7534_1870_1871_7157_10912_1869_6502_6500_4087_4088_4089_3066_3065_5925_2033_4616_5933_8454	25	1.41E-20	1.08E-18	3.61E-19
882	hsa-mir-10a	hsa04010	MAPK signaling pathway	6722_1326_5598_3551_5595_5594_5599_9261_4208_836_1147_8517_7867_1432_5971_5970_3312_7157_10912_4609_3725_5881_3310_4763_5058_4616_3303_207_4791_3305_2353_5566	32	3.84E-19	2.96E-17	7.39E-18
883	hsa-mir-10a	hsa05215	Prostate cancer	3320_3551_1499_5595_5594_1387_595_367_1147_8517_2932_5970_1870_1871_7157_1869_5925_2033_207_3326_4792	21	1.81E-18	1.39E-16	2.78E-17
884	hsa-mir-10a	hsa05212	Pancreatic cancer	3320_3551_1499_5595_5594_1387_595_367_1147_8517_2932_5970_1870_1871_7157_1869_5925_2033_207_3326_4792	21	2.21E-18	1.70E-16	2.83E-17
885	hsa-mir-10a	hsa05222	Small cell lung cancer	3551_6257_6256_595_6258_1147_8517_5970_1870_1871_7157_4609_1869_6502_5925_4846_207_8554_4792	19	2.68E-16	2.06E-14	2.94E-15
886	hsa-mir-10a	hsa04310	Wnt signaling pathway	23291_1499_5599_1387_595_1487_1488_2932_7157_8945_8607_4609_3725_5881_1457_6500_4087_4088_4089_2033_8454_5566	22	3.02E-15	2.32E-13	2.91E-14
887	hsa-mir-10a	hsa05221	Acute myeloid leukemia	5371_3551_5595_5594_5914_595_1147_8517_7704_5970_6688_4609_862_6774_1050_207	16	3.97E-15	3.06E-13	3.40E-14
888	hsa-mir-10a	hsa04920	Adipocytokine signaling pathway	10891_3551_5599_6257_6256_6258_1147_8517_5970_4794_6774_207_4792_4793_2538	15	3.22E-13	2.48E-11	2.48E-12
889	hsa-mir-10a	hsa05210	Colorectal cancer	1499_5595_5594_5599_595_836_2932_7157_4609_3725_5881_4087_4088_4089_207_2353	16	4.60E-13	3.54E-11	3.22E-12
890	hsa-mir-10a	hsa05216	Thyroid cancer	1499_5595_5594_6257_6256_595_6258_8031_7157_4609_7175	11	4.01E-12	3.09E-10	2.58E-11
891	hsa-mir-10a	hsa04662	B cell receptor signaling pathway	3551_5595_5594_1147_8517_2932_5970_4794_3725_5881_207_4792_4793_2353	14	1.71E-11	1.32E-09	9.73E-11
892	hsa-mir-10a	hsa04660	T cell receptor signaling pathway	1326_3551_5595_5594_1147_8517_2932_1432_5970_4794_3725_5058_207_4792_4793_2353	16	1.77E-11	1.36E-09	9.73E-11
893	hsa-mir-10a	hsa05214	Glioma	5595_5594_595_1870_1871_7157_1869_5925_207_6464_808_801_805	13	4.26E-11	3.28E-09	2.19E-10
894	hsa-mir-10a	hsa05223	Non-small cell lung cancer	5595_5594_6257_6256_595_6258_1870_1871_7157_1869_5925_207	12	8.30E-11	6.39E-09	3.99E-10
895	hsa-mir-10a	hsa04350	TGF-beta signaling pathway	5595_5594_1387_3397_3399_3398_4609_6500_4087_4088_4089_2033_5933_8454	14	9.92E-11	7.63E-09	4.49E-10
896	hsa-mir-10a	hsa04520	Adherens junction	1499_6714_5595_5594_1387_71_5881_1457_4087_4088_4089_2033	12	4.45E-09	3.43E-07	1.85E-08
897	hsa-mir-10a	hsa04330	Notch signaling pathway	388585_1387_1487_1488_9612_3066_3065_2033_4851_8850	10	4.57E-09	3.52E-07	1.85E-08
898	hsa-mir-10a	hsa04620	Toll-like receptor signaling pathway	1326_3551_5595_5594_5599_1147_8517_1432_5970_3725_207_4792_2353	13	6.01E-09	4.63E-07	2.31E-08
899	hsa-mir-10a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3551_6714_5599_836_1147_8517_1432_5970_3725_5058_4792	11	1.46E-08	1.12E-06	5.36E-08
900	hsa-mir-10a	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_7428_2113_3725_5058_2034_2033_207	11	1.66E-08	1.28E-06	5.82E-08
901	hsa-mir-10a	hsa04910	Insulin signaling pathway	6720_10891_3551_5595_5594_5599_2932_207_6464_2538_808_801_5566_805	14	2.25E-08	1.73E-06	7.53E-08
902	hsa-mir-10a	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_4609_1869_5925	9	2.59E-08	2.00E-06	8.32E-08
903	hsa-mir-10a	hsa04210	Apoptosis	3551_836_1147_8517_840_5970_7157_8837_207_4792_5566	11	1.19E-07	9.15E-06	3.66E-07
904	hsa-mir-10a	hsa05016	Huntington's disease	6874_10891_1387_2902_836_293_1213_5437_7157_5441_292_3066_3065_3064_2033	15	1.35E-07	1.04E-05	3.99E-07
905	hsa-mir-10a	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5925_207_4286	10	1.49E-07	1.15E-05	4.25E-07
906	hsa-mir-10a	hsa04120	Ubiquitin mediated proteolysis	5371_23291_672_3093_7428_10273_8945_7329_6502_6500_7323_8554_8454	13	1.71E-07	1.32E-05	4.72E-07
907	hsa-mir-10a	hsa04540	Gap junction	203068_5598_6714_5595_5594_10382_983_7278_347733_84617_5566	11	1.78E-07	1.37E-05	4.73E-07
908	hsa-mir-10a	hsa04062	Chemokine signaling pathway	3551_5595_5594_1147_8517_2932_5970_653361_6774_5058_207_4792_4793_6464_5566	15	1.85E-07	1.42E-05	4.74E-07
909	hsa-mir-10a	hsa04916	Melanogenesis	1499_5595_5594_1387_2932_2033_4286_808_801_5566_805	11	4.98E-07	3.83E-05	1.24E-06
910	hsa-mir-10a	hsa04912	GnRH signaling pathway	5598_6714_5595_5594_5599_1432_3725_808_801_5566_805	11	7.03E-07	5.41E-05	1.69E-06
911	hsa-mir-10a	hsa04012	ErbB signaling pathway	6714_5595_5594_5599_2932_4609_3725_5058_207_6464	10	8.23E-07	6.34E-05	1.92E-06
912	hsa-mir-10a	hsa04612	Antigen processing and presentation	3320_4800_1514_3312_3310_3309_3303_4801_3326_3305	10	9.96E-07	7.67E-05	2.25E-06
913	hsa-mir-10a	hsa05213	Endometrial cancer	1499_5595_5594_595_2932_7157_4609_207	8	1.47E-06	0.000112863	3.22E-06
914	hsa-mir-10a	hsa04510	Focal adhesion	1499_6714_5595_5594_5599_10627_595_2932_71_3725_5881_5058_207_6464	14	2.11E-06	0.000162285	4.40E-06
915	hsa-mir-10a	hsa04720	Long-term potentiation	5595_5594_1387_2902_2033_808_801_5566_805	9	2.12E-06	0.000162925	4.40E-06
916	hsa-mir-10a	hsa05131	Shigellosis	203068_1499_10382_7534_7278_347733_71_84617	8	2.42E-06	0.000186242	4.78E-06
917	hsa-mir-10a	hsa05130	Pathogenic Escherichia coli infection	203068_1499_10382_7534_7278_347733_71_84617	8	2.42E-06	0.000186242	4.78E-06
918	hsa-mir-10a	hsa04370	VEGF signaling pathway	6714_5595_5594_9261_7867_1432_5881_4846_207	9	2.58E-06	0.000198726	4.97E-06
919	hsa-mir-10a	hsa03020	RNA polymerase	64425_5437_25885_5441_51082_84172	6	6.94E-06	0.000534274	1.30E-05
920	hsa-mir-10a	hsa05010	Alzheimer's disease	1020_5595_5594_2902_836_2932_840_4846_808_801_805	11	5.60E-05	0.0043104	0.000102629
921	hsa-mir-10a	hsa04630	Jak-STAT signaling pathway	3559_1387_595_6778_4609_6774_2033_207_8554	9	0.00042119	0.032431595	0.000754223
922	hsa-mir-10a	hsa04950	Maturity onset diabetes of the young	3651_6928_3172_168620	4	0.000525355	0.040452327	0.000919371
923	hsa-mir-10a	hsa04115	p53 signaling pathway	595_983_836_7157_10912_4616	6	0.00054592	0.042035802	0.000934129
924	hsa-mir-10a	hsa04930	Type II diabetes mellitus	3651_3551_5595_5594_5599	5	0.000571706	0.044021342	0.000956986
925	hsa-mir-10a	hsa04530	Tight junction	1499_6714_10627_4628_71_4627_1457_207	8	0.000841734	0.064813495	0.001379011
926	hsa-mir-10a	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_1432_5881_207	6	0.001058912	0.081536257	0.001698672
927	hsa-mir-10a	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_1432_7157_4846	5	0.00142169	0.109470135	0.002234084
928	hsa-mir-10a	hsa04340	Hedgehog signaling pathway	23291_53944_2932_8945_5566	5	0.001529456	0.117768127	0.002355363
929	hsa-mir-10a	hsa04270	Vascular smooth muscle contraction	5595_5594_4637_808_801_5566_805	7	0.001614625	0.12432615	0.002437768
930	hsa-mir-10a	hsa04810	Regulation of actin cytoskeleton	5595_5594_10627_4628_71_10788_4627_5881_5058	9	0.004108265	0.316336426	0.006083393
931	hsa-mir-10a	hsa04020	Calcium signaling pathway	2902_293_292_4846_808_801_5566_805	8	0.004842227	0.372851509	0.007034934
932	hsa-mir-10a	hsa04150	mTOR signaling pathway	5595_5594_3091_207	4	0.007001847	0.539142202	0.009984115
933	hsa-mir-10a	hsa04360	Axon guidance	1020_5595_5594_2932_5881_5058	6	0.011105128	0.855094875	0.01554718
934	hsa-mir-10a	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_5881_5058_6464	6	0.013929846	1	0.019153538
935	hsa-mir-10a	hsa03320	PPAR signaling pathway	6257_6256_6258_2168	4	0.018160509	1	0.024532618
936	hsa-mir-10a	hsa04670	Leukocyte transendothelial migration	1499_10627_1432_71_653361	5	0.029617891	1	0.039320303
937	hsa-mir-10a	hsa05217	Basal cell carcinoma	1499_2932_7157	3	0.044063154	1	0.057506151
938	hsa-mir-10b	hsa05200	Pathways in cancer	3716_1147_3320_3725_5371_405_3480_1956_5595_5594_5599_6654_6258_1387_6257_6256_8031_5601_10401_836_208_4193_367_7704_842_841_2064_6776_2885_6772_5970_8503_7157_4824_4087_595_5295_2736_3065_4088_4089_2033_5914_207_2308_3326_2932_8554_4790	49	1.60E-34	1.19E-32	1.19E-32
939	hsa-mir-10b	hsa05215	Prostate cancer	1147_3320_3480_1956_5595_5594_6654_1385_1387_208_4193_367_842_2064_2885_5970_8503_7157_4824_595_5295_2033_207_2308_3326_2932_4790	27	1.02E-26	7.55E-25	3.24E-25
940	hsa-mir-10b	hsa05212	Pancreatic cancer	1147_3320_3480_1956_5595_5594_6654_1385_1387_208_4193_367_842_2064_2885_5970_8503_7157_4824_595_5295_2033_207_2308_3326_2932_4790	27	1.31E-26	9.73E-25	3.24E-25
941	hsa-mir-10b	hsa04010	MAPK signaling pathway	1147_6722_3727_8986_3725_994_1956_5595_5594_5599_6654_9261_5601_3303_836_6197_208_4214_9252_3312_2885_5970_627_7157_10912_5566_1432_6195_6196_5058_4616_2872_207_4790_2002_2005	36	4.67E-24	3.45E-22	8.64E-23
942	hsa-mir-10b	hsa05210	Colorectal cancer	3725_3480_1956_5595_5594_5599_6654_5601_836_208_842_2885_8503_7157_4087_595_5295_4088_4089_207_2932	21	1.73E-19	1.28E-17	2.55E-18
943	hsa-mir-10b	hsa04012	ErbB signaling pathway	3725_815_1956_5595_6714_5594_5599_6654_5601_208_2064_6776_2885_8503_5295_5058_56924_207_2932_6464_2002	21	3.21E-19	2.38E-17	3.96E-18
944	hsa-mir-10b	hsa05220	Chronic myeloid leukemia	1147_5595_5594_6654_208_4193_6776_2885_5970_8503_7157_595_5295_3065_4088_4089_207_4790_6464	19	7.57E-18	5.60E-16	8.00E-17
945	hsa-mir-10b	hsa04910	Insulin signaling pathway	7249_10891_6720_5595_5594_5599_6654_5601_208_2885_8503_5770_5566_5295_2872_207_2308_2932_801_6464_2002_808_805	23	8.74E-18	6.47E-16	8.09E-17
946	hsa-mir-10b	hsa05214	Glioma	815_3480_1956_5595_5594_6654_208_4193_2885_8503_7157_595_5295_207_801_6464_808_805	18	1.47E-17	1.09E-15	1.21E-16
947	hsa-mir-10b	hsa05223	Non-small cell lung cancer	1956_5595_5594_6654_6258_6257_6256_208_842_2064_2885_8503_7157_595_5295_2309_207	17	1.92E-17	1.42E-15	1.42E-16
948	hsa-mir-10b	hsa05213	Endometrial cancer	1956_5595_5594_6654_208_842_2064_2885_8503_7157_595_5295_2309_207_2932_2002	16	2.31E-16	1.71E-14	1.56E-15
949	hsa-mir-10b	hsa05221	Acute myeloid leukemia	1147_5371_5595_5594_6654_208_7704_6776_2885_5970_8503_595_5295_5914_207_4790	16	1.24E-15	9.19E-14	7.66E-15
950	hsa-mir-10b	hsa04660	T cell receptor signaling pathway	1147_3725_3932_5595_5594_6654_5601_208_5777_2885_5970_8503_1432_5295_5058_56924_207_2932_4790	19	3.63E-15	2.68E-13	2.06E-14
951	hsa-mir-10b	hsa04630	Jak-STAT signaling pathway	3717_3716_6654_1387_10401_208_5777_6778_6776_2885_6772_8503_3454_3455_7297_595_5295_2033_207_8554_10379	21	9.71E-15	7.19E-13	5.13E-14
952	hsa-mir-10b	hsa04110	Cell cycle	994_5591_7531_1387_7534_7533_4193_7157_4087_10912_902_595_3065_4088_4089_1022_4616_2033_2932	19	1.30E-14	9.59E-13	6.39E-14
953	hsa-mir-10b	hsa04510	Focal adhesion	3725_9564_3480_1956_5595_6714_5594_5599_6654_5601_208_2064_2885_8503_857_595_5295_5058_56924_207_2932_6464_2002	23	2.21E-14	1.63E-12	1.02E-13
954	hsa-mir-10b	hsa04062	Chemokine signaling pathway	3717_1147_9564_5595_5594_6654_2770_208_2931_2885_6772_5970_8503_7852_5566_5295_5058_2309_207_2932_4790_6464	22	5.58E-14	4.13E-12	2.43E-13
955	hsa-mir-10b	hsa04620	Toll-like receptor signaling pathway	1147_3725_5595_5594_5599_5601_208_841_6772_5970_8503_3454_3455_1432_5295_207_4790	17	1.75E-13	1.29E-11	7.18E-13
956	hsa-mir-10b	hsa04912	GnRH signaling pathway	3725_815_1956_5595_6714_5594_5599_6654_5601_4214_2885_5566_1432_801_2002_808_805	17	4.00E-13	2.96E-11	1.56E-12
957	hsa-mir-10b	hsa04520	Adherens junction	3480_1956_5595_6714_5594_1387_5777_2064_4087_5770_1460_1457_4088_4089_2033	15	1.05E-12	7.74E-11	3.87E-12
958	hsa-mir-10b	hsa05222	Small cell lung cancer	1147_6258_6257_6256_10401_208_842_5970_8503_7157_595_5295_207_8554_4790	15	2.63E-12	1.95E-10	9.28E-12
959	hsa-mir-10b	hsa05211	Renal cell carcinoma	3725_405_5595_5594_6654_1387_208_2885_8503_5295_5058_56924_2033_207	14	3.89E-12	2.88E-10	1.31E-11
960	hsa-mir-10b	hsa04662	B cell receptor signaling pathway	1147_3725_5595_5594_6654_208_5777_2885_5970_8503_5295_207_2932_4790	14	6.33E-12	4.68E-10	2.04E-11
961	hsa-mir-10b	hsa03022	Basal transcription factors	2965_2963_2962_6881_2969_6879_6908_6872_2958_2959_6880	11	1.60E-11	1.19E-09	4.94E-11
962	hsa-mir-10b	hsa04210	Apoptosis	1147_836_839_208_842_841_840_5970_8503_7157_5566_5295_207_4790	14	4.87E-11	3.60E-09	1.44E-10
963	hsa-mir-10b	hsa04920	Adipocytokine signaling pathway	3717_1147_10891_5599_6258_6257_6256_5601_208_5970_207_4790	12	3.16E-10	2.34E-08	8.98E-10
964	hsa-mir-10b	hsa04720	Long-term potentiation	815_5595_5594_1387_6197_5566_6195_6196_2033_801_808_805	12	9.99E-10	7.39E-08	2.74E-09
965	hsa-mir-10b	hsa04310	Wnt signaling pathway	3725_815_5599_1387_5601_7157_4087_595_5566_1460_1457_4088_4089_2033_2932	15	3.66E-09	2.71E-07	9.68E-09
966	hsa-mir-10b	hsa04150	mTOR signaling pathway	7249_5595_5594_6197_208_8503_6195_6196_5295_207	10	5.28E-09	3.91E-07	1.35E-08
967	hsa-mir-10b	hsa05218	Melanoma	3480_1956_5595_5594_208_4193_8503_7157_595_5295_207	11	6.78E-09	5.02E-07	1.62E-08
968	hsa-mir-10b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3725_1956_6714_5599_5601_836_5970_1432_5058_4790	11	6.78E-09	5.02E-07	1.62E-08
969	hsa-mir-10b	hsa05216	Thyroid cancer	5595_5594_6258_6257_6256_8031_7157_595	8	1.63E-08	1.21E-06	3.77E-08
970	hsa-mir-10b	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_6654_5601_208_2885_8503_1432_5295_207	11	1.84E-08	1.36E-06	4.13E-08
971	hsa-mir-10b	hsa04916	Melanogenesis	815_5595_5594_1385_1387_2770_5566_2033_2932_801_808_805	12	2.79E-08	2.07E-06	6.08E-08
972	hsa-mir-10b	hsa04650	Natural killer cell mediated cytotoxicity	3932_5595_5594_6654_836_5777_2885_8503_3454_3455_5295_5058_6464	13	6.72E-08	4.97E-06	1.42E-07
973	hsa-mir-10b	hsa04370	VEGF signaling pathway	5595_6714_5594_9261_208_842_8503_1432_5295_207	10	1.49E-07	1.10E-05	3.06E-07
974	hsa-mir-10b	hsa05219	Bladder cancer	1956_5595_5594_9252_4193_2064_7157_595	8	1.97E-07	1.45E-05	3.93E-07
975	hsa-mir-10b	hsa04115	p53 signaling pathway	7249_836_4193_842_841_7157_10912_595_4616	9	6.07E-07	4.49E-05	1.18E-06
976	hsa-mir-10b	hsa05016	Huntington's disease	10891_1385_1387_6908_836_6667_842_841_627_7157_3065_3064_2033	13	1.80E-06	0.000133388	3.42E-06
977	hsa-mir-10b	hsa04930	Type II diabetes mellitus	5595_5594_5599_5601_3651_8503_5295	7	3.87E-06	0.000286083	7.15E-06
978	hsa-mir-10b	hsa04540	Gap junction	1956_5595_6714_5592_5594_6654_2770_2885_5566	9	5.85E-06	0.000432926	1.06E-05
979	hsa-mir-10b	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_4087_4088_4089_2033	8	2.72E-05	0.002014631	4.80E-05
980	hsa-mir-10b	hsa05010	Alzheimer's disease	22926_5595_5594_836_842_841_840_2932_801_808_805	11	2.85E-05	0.002111849	4.91E-05
981	hsa-mir-10b	hsa04612	Antigen processing and presentation	3320_1385_3303_4800_3312_6890_3326	7	0.000214648	0.015883972	0.000360999
982	hsa-mir-10b	hsa04360	Axon guidance	5595_5998_5594_2770_7852_5058_56924_2932	8	0.000391068	0.028939031	0.00064309
983	hsa-mir-10b	hsa04120	Ubiquitin mediated proteolysis	5371_672_10401_4214_4193_10273_7329_8554	8	0.000567587	0.04200146	0.000913075
984	hsa-mir-10b	hsa04270	Vascular smooth muscle contraction	5595_5592_5594_5566_801_808_805	7	0.001053617	0.077967645	0.001658886
985	hsa-mir-10b	hsa03450	Non-homologous end-joining	5591_7520_2547	3	0.001176369	0.087051333	0.001813569
986	hsa-mir-10b	hsa04530	Tight junction	6714_2770_208_8189_1460_1457_207	7	0.002371935	0.175523186	0.003582106
987	hsa-mir-10b	hsa04810	Regulation of actin cytoskeleton	9564_1956_5595_5594_6654_8503_5295_5058_56924	9	0.0025175	0.186295015	0.0037259
988	hsa-mir-10b	hsa04730	Long-term depression	3480_5595_5592_5594_2770	5	0.002724015	0.201577095	0.003952492
989	hsa-mir-10b	hsa03420	Nucleotide excision repair	2965_902_1022_4331	4	0.003094772	0.229013142	0.004404099
990	hsa-mir-10b	hsa04070	Phosphatidylinositol signaling system	8503_5295_801_808_805	5	0.003590455	0.265693646	0.005013088
991	hsa-mir-10b	hsa04330	Notch signaling pathway	1387_9612_3065_2033	4	0.003859274	0.285586261	0.005288634
992	hsa-mir-10b	hsa04950	Maturity onset diabetes of the young	3172_3651_4760	3	0.00461106	0.341218417	0.006203971
993	hsa-mir-10b	hsa04670	Leukocyte transendothelial migration	9564_2770_8503_7852_1432_5295	6	0.005705288	0.422191339	0.007539131
994	hsa-mir-10b	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_842_7157_1432	4	0.006895476	0.510265212	0.008952021
995	hsa-mir-10b	hsa04020	Calcium signaling pathway	815_1956_2064_5566_801_808_805	7	0.010823457	0.800935822	0.013809238
996	hsa-mir-10b	hsa03320	PPAR signaling pathway	6258_6257_6256_2168	4	0.014196696	1	0.017806025
997	hsa-mir-10b	hsa05217	Basal cell carcinoma	7157_2736_2932	3	0.036608421	1	0.045150385
998	hsa-mir-10b	hsa04340	Hedgehog signaling pathway	5566_2736_2932	3	0.03987016	1	0.04836708
999	hsa-mir-1179	hsa05200	Pathways in cancer	8031_4089_25_6688_2033_207_8554_5970_7704_5595_5594_6774_5599_6258_1387_6257_6256	17	2.24E-18	1.21E-16	1.21E-16
1000	hsa-mir-1179	hsa04920	Adipocytokine signaling pathway	10891_207_5970_6774_5599_6258_6257_6256	8	6.69E-12	3.61E-10	1.81E-10
1001	hsa-mir-1179	hsa05221	Acute myeloid leukemia	6688_207_5970_7704_5595_5594_6774	7	1.54E-10	8.33E-09	2.22E-09
1002	hsa-mir-1179	hsa05216	Thyroid cancer	8031_5595_5594_6258_6257_6256	6	1.65E-10	8.88E-09	2.22E-09
1003	hsa-mir-1179	hsa04350	TGF-beta signaling pathway	4086_4089_2033_4093_5595_5594_1387	7	1.93E-09	1.04E-07	2.08E-08
1004	hsa-mir-1179	hsa05223	Non-small cell lung cancer	207_5595_5594_6258_6257_6256	6	4.86E-09	2.62E-07	4.37E-08
1005	hsa-mir-1179	hsa05220	Chronic myeloid leukemia	4089_25_207_5970_5595_5594	6	3.03E-08	1.64E-06	2.34E-07
1006	hsa-mir-1179	hsa05222	Small cell lung cancer	207_8554_5970_6258_6257_6256	6	6.53E-08	3.53E-06	4.28E-07
1007	hsa-mir-1179	hsa05215	Prostate cancer	2033_207_5970_5595_5594_1387	6	7.44E-08	4.02E-06	4.28E-07
1008	hsa-mir-1179	hsa05212	Pancreatic cancer	2033_207_5970_5595_5594_1387	6	7.92E-08	4.28E-06	4.28E-07
1009	hsa-mir-1179	hsa04110	Cell cycle	4089_25_2033_4616_10912_1387	6	4.05E-07	2.19E-05	1.99E-06
1010	hsa-mir-1179	hsa05211	Renal cell carcinoma	2033_207_5595_5594_1387	5	8.87E-07	4.79E-05	3.99E-06
1011	hsa-mir-1179	hsa04520	Adherens junction	4089_2033_5595_5594_1387	5	1.45E-06	7.84E-05	6.03E-06
1012	hsa-mir-1179	hsa05210	Colorectal cancer	4089_207_5595_5594_5599	5	1.83E-06	9.86E-05	7.04E-06
1013	hsa-mir-1179	hsa04012	ErbB signaling pathway	25_207_5595_5594_5599	5	2.15E-06	0.000116151	7.74E-06
1014	hsa-mir-1179	hsa04010	MAPK signaling pathway	4616_207_10912_5970_5595_5594_5599	7	3.36E-06	0.000181576	1.13E-05
1015	hsa-mir-1179	hsa04620	Toll-like receptor signaling pathway	207_5970_5595_5594_5599	5	4.53E-06	0.000244605	1.44E-05
1016	hsa-mir-1179	hsa04910	Insulin signaling pathway	10891_207_5595_5594_5599	5	1.86E-05	0.001003344	5.57E-05
1017	hsa-mir-1179	hsa03320	PPAR signaling pathway	2168_6258_6257_6256	4	2.44E-05	0.001319165	6.94E-05
1018	hsa-mir-1179	hsa04720	Long-term potentiation	2033_5595_5594_1387	4	3.16E-05	0.00170801	7.82E-05
1019	hsa-mir-1179	hsa04662	B cell receptor signaling pathway	207_5970_5595_5594	4	3.16E-05	0.00170801	7.82E-05
1020	hsa-mir-1179	hsa04630	Jak-STAT signaling pathway	2033_207_8554_6774_1387	5	3.19E-05	0.00172108	7.82E-05
1021	hsa-mir-1179	hsa04664	Fc epsilon RI signaling pathway	207_5595_5594_5599	4	3.84E-05	0.00207482	9.02E-05
1022	hsa-mir-1179	hsa04062	Chemokine signaling pathway	207_5970_5595_5594_6774	5	8.76E-05	0.004732594	0.000197191
1023	hsa-mir-1179	hsa04916	Melanogenesis	2033_5595_5594_1387	4	0.000107397	0.005799435	0.000231977
1024	hsa-mir-1179	hsa04660	T cell receptor signaling pathway	207_5970_5595_5594	4	0.000132371	0.007148044	0.000274925
1025	hsa-mir-1179	hsa04930	Type II diabetes mellitus	5595_5594_5599	3	0.000177888	0.009605932	0.000355775
1026	hsa-mir-1179	hsa04330	Notch signaling pathway	9612_2033_1387	3	0.000200933	0.010850398	0.000387514
1027	hsa-mir-1179	hsa05213	Endometrial cancer	207_5595_5594	3	0.000266789	0.014406588	0.00048022
1028	hsa-mir-1179	hsa04150	mTOR signaling pathway	207_5595_5594	3	0.000266789	0.014406588	0.00048022
1029	hsa-mir-1179	hsa04310	Wnt signaling pathway	4089_2033_5599_1387	4	0.000438564	0.023682435	0.00076395
1030	hsa-mir-1179	hsa05214	Glioma	207_5595_5594	3	0.000499051	0.02694875	0.000842148
1031	hsa-mir-1179	hsa05218	Melanoma	207_5595_5594	3	0.000639292	0.034521785	0.001046115
1032	hsa-mir-1179	hsa04370	VEGF signaling pathway	207_5595_5594	3	0.000802456	0.043332644	0.00127449
1033	hsa-mir-1179	hsa04510	Focal adhesion	207_5595_5594_5599	4	0.001327768	0.071699486	0.002048557
1034	hsa-mir-1179	hsa04912	GnRH signaling pathway	5595_5594_5599	3	0.002060977	0.111292735	0.003091465
1035	hsa-mir-1179	hsa04360	Axon guidance	25_5595_5594	3	0.003510873	0.189587145	0.005123977
1036	hsa-mir-1179	hsa05219	Bladder cancer	5595_5594	2	0.004483881	0.2421296	0.006371832
1037	hsa-mir-1179	hsa05016	Huntington's disease	10891_2033_1387	3	0.009343516	0.504549889	0.012937177
1038	hsa-mir-1179	hsa04115	p53 signaling pathway	4616_10912	2	0.011325777	0.611591983	0.0152898
1039	hsa-mir-1179	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5970_5599	2	0.011942882	0.644915646	0.015355134
1040	hsa-mir-1179	hsa04730	Long-term depression	5595_5594	2	0.011942882	0.644915646	0.015355134
1041	hsa-mir-1179	hsa04210	Apoptosis	207_5970	2	0.018131591	0.979105918	0.022769905
1042	hsa-mir-1179	hsa04540	Gap junction	5595_5594	2	0.019656065	1	0.024123352
1043	hsa-mir-1179	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.030320989	1	0.036385186
1044	hsa-mir-1179	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.040151499	1	0.047134368
1045	hsa-mir-1181	hsa05200	Pathways in cancer	5371_5595_5594_5914_1387_6256_595_836_367_7704_842_841_3091_5970_7428_1870_1871_7157_4824_4087_2113_4609_1869_3725_3065_4088_4089_3066_5925_2034_2033_4846_6258	33	3.67E-32	2.31E-30	2.31E-30
1046	hsa-mir-1181	hsa05220	Chronic myeloid leukemia	5595_5594_595_5970_1870_1871_7157_4609_1869_3065_4088_4089_3066_5925_6464	15	3.75E-19	2.36E-17	1.18E-17
1047	hsa-mir-1181	hsa05215	Prostate cancer	5595_5594_1387_595_367_1385_842_5970_1870_1871_7157_4824_1869_5925_2033	15	3.16E-18	1.99E-16	5.80E-17
1048	hsa-mir-1181	hsa05212	Pancreatic cancer	5595_5594_1387_595_367_1385_842_5970_1870_1871_7157_4824_1869_5925_2033	15	3.68E-18	2.32E-16	5.80E-17
1049	hsa-mir-1181	hsa04110	Cell cycle	5591_1387_595_1870_1871_7157_4087_1869_3065_4088_4089_3066_5925_2033_5933	15	1.86E-16	1.17E-14	2.35E-15
1050	hsa-mir-1181	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_842_1870_1871_7157_1869_5925_6258	11	1.95E-14	1.23E-12	2.05E-13
1051	hsa-mir-1181	hsa05222	Small cell lung cancer	6256_595_842_5970_1870_1871_7157_4609_1869_5925_4846_6258	12	7.04E-14	4.44E-12	6.34E-13
1052	hsa-mir-1181	hsa05210	Colorectal cancer	5595_5594_595_836_842_7157_4087_4609_3725_4088_4089	11	1.50E-12	9.46E-11	1.18E-11
1053	hsa-mir-1181	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_4609_1869_5925	9	3.31E-12	2.08E-10	2.31E-11
1054	hsa-mir-1181	hsa05214	Glioma	815_5595_5594_595_1870_1871_7157_1869_5925_6464	10	3.77E-12	2.38E-10	2.38E-11
1055	hsa-mir-1181	hsa04010	MAPK signaling pathway	5595_5594_9261_4208_836_5970_3312_7157_4609_3725_6195_4763_2002_2005	14	1.72E-10	1.08E-08	9.86E-10
1056	hsa-mir-1181	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_7428_2113_3725_2034_2033	9	2.50E-10	1.58E-08	1.31E-09
1057	hsa-mir-1181	hsa05016	Huntington's disease	6874_1387_2902_836_1385_842_841_7157_3065_3066_3064_2033	12	3.46E-10	2.18E-08	1.68E-09
1058	hsa-mir-1181	hsa05216	Thyroid cancer	5595_5594_6256_595_7157_4609_6258	7	4.41E-10	2.78E-08	1.99E-09
1059	hsa-mir-1181	hsa04310	Wnt signaling pathway	815_1387_595_1457_7157_4087_4609_3725_4088_4089_2033	11	5.55E-10	3.49E-08	2.32E-09
1060	hsa-mir-1181	hsa04520	Adherens junction	6714_5595_5594_1387_1457_4087_4088_4089_2033	9	5.90E-10	3.71E-08	2.32E-09
1061	hsa-mir-1181	hsa04350	TGF-beta signaling pathway	5595_5594_1387_4087_4609_4088_4089_2033_5933	9	1.17E-09	7.36E-08	4.33E-09
1062	hsa-mir-1181	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_5970_4609	8	1.42E-09	8.97E-08	4.98E-09
1063	hsa-mir-1181	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5925	8	5.42E-09	3.41E-07	1.80E-08
1064	hsa-mir-1181	hsa05213	Endometrial cancer	5595_5594_595_842_7157_4609_2002	7	1.64E-08	1.03E-06	5.17E-08
1065	hsa-mir-1181	hsa04012	ErbB signaling pathway	815_6714_5595_5594_4609_3725_6464_2002	8	2.36E-08	1.49E-06	7.09E-08
1066	hsa-mir-1181	hsa04720	Long-term potentiation	815_5595_5594_1387_2902_6195_2033	7	1.66E-07	1.05E-05	4.77E-07
1067	hsa-mir-1181	hsa05010	Alzheimer's disease	22926_5595_5594_2902_836_842_841_840_4846	9	3.74E-07	2.36E-05	1.02E-06
1068	hsa-mir-1181	hsa04210	Apoptosis	836_839_842_841_840_5970_7157	7	4.93E-07	3.11E-05	1.29E-06
1069	hsa-mir-1181	hsa04370	VEGF signaling pathway	6714_5595_5594_9261_842_4846	6	3.50E-06	0.000220216	8.81E-06
1070	hsa-mir-1181	hsa04330	Notch signaling pathway	1387_9612_3065_3066_2033	5	5.75E-06	0.000362209	1.39E-05
1071	hsa-mir-1181	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_842_7157_4846	5	1.27E-05	0.000800205	2.96E-05
1072	hsa-mir-1181	hsa04916	Melanogenesis	815_5595_5594_1387_1385_2033	6	1.78E-05	0.001120953	4.00E-05
1073	hsa-mir-1181	hsa04912	GnRH signaling pathway	815_6714_5595_5594_3725_2002	6	2.18E-05	0.001373486	4.74E-05
1074	hsa-mir-1181	hsa04115	p53 signaling pathway	595_836_842_841_7157	5	3.27E-05	0.002058577	6.86E-05
1075	hsa-mir-1181	hsa04510	Focal adhesion	6714_5595_5594_595_3725_6464_2002	7	9.17E-05	0.005776005	0.000186323
1076	hsa-mir-1181	hsa04150	mTOR signaling pathway	5595_5594_3091_6195	4	0.000167953	0.01058105	0.000330658
1077	hsa-mir-1181	hsa04620	Toll-like receptor signaling pathway	5595_5594_841_5970_3725	5	0.000189406	0.011932602	0.000361594
1078	hsa-mir-1181	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_836_5970_3725	4	0.000517113	0.032578113	0.00095818
1079	hsa-mir-1181	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725	4	0.000629619	0.039666012	0.001133315
1080	hsa-mir-1181	hsa04910	Insulin signaling pathway	6720_5595_5594_6464_2002	5	0.000718419	0.045260393	0.001257233
1081	hsa-mir-1181	hsa03022	Basal transcription factors	2962_2969_6874	3	0.001002559	0.063161216	0.00170706
1082	hsa-mir-1181	hsa04612	Antigen processing and presentation	4800_4801_1385_3312	4	0.001160351	0.073102092	0.001923739
1083	hsa-mir-1181	hsa04660	T cell receptor signaling pathway	5595_5594_5970_3725	4	0.002449754	0.154334479	0.003957294
1084	hsa-mir-1181	hsa04920	Adipocytokine signaling pathway	6256_5970_6258	3	0.00499007	0.314374423	0.007859361
1085	hsa-mir-1181	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_6464	4	0.005364192	0.337944094	0.008242539
1086	hsa-mir-1181	hsa04730	Long-term depression	5595_5594_4846	3	0.005825795	0.367025112	0.008738693
1087	hsa-mir-1181	hsa04630	Jak-STAT signaling pathway	1387_595_4609_2033	4	0.007947985	0.500723045	0.011644722
1088	hsa-mir-1181	hsa04540	Gap junction	6714_5595_5594	3	0.011876588	0.748225026	0.017005114
1089	hsa-mir-1181	hsa04062	Chemokine signaling pathway	5595_5594_5970_6464	4	0.0163738	1	0.02292332
1090	hsa-mir-1181	hsa04930	Type II diabetes mellitus	5595_5594	2	0.022399356	1	0.030677379
1091	hsa-mir-1181	hsa04120	Ubiquitin mediated proteolysis	5371_672_7428	3	0.033029995	1	0.044274249
1092	hsa-mir-1181	hsa03320	PPAR signaling pathway	6256_6258	2	0.048937028	1	0.064229849
1093	hsa-mir-1182	hsa04110	Cell cycle	7533	1	0.003999867	0.003999867	0.003999867
1094	hsa-mir-1183	hsa05200	Pathways in cancer	5371_9063_7046_367_1499_5595_5594_5599_5914_1387_6256_595_5601_836_7704_6774_2885_6772_3091_5970_7428_1870_1871_7157_6688_2113_4609_1869_3725_5604_862_6502_2353_4087_4088_4089_3066_3065_1050_5925_2034_2033_4846_207_9915	45	9.42E-35	6.50E-33	6.50E-33
1095	hsa-mir-1183	hsa05220	Chronic myeloid leukemia	7046_5595_5594_595_2885_5970_1870_1871_7157_4609_1869_5604_4088_4089_3066_3065_5925_207_6464	19	1.04E-19	7.17E-18	3.58E-18
1096	hsa-mir-1183	hsa04010	MAPK signaling pathway	6722_7046_5595_5594_5599_4208_5601_5600_836_7867_3312_1432_2885_5970_9261_9344_7157_468_4609_3725_3727_5604_5606_2353_4763_207_2005	27	5.72E-18	3.95E-16	1.32E-16
1097	hsa-mir-1183	hsa05210	Colorectal cancer	7046_1499_5595_5594_5599_595_5601_836_2885_7157_4609_3725_5604_2353_4087_4088_4089_207	18	1.28E-17	8.83E-16	2.21E-16
1098	hsa-mir-1183	hsa05215	Prostate cancer	367_1499_5595_5594_1387_595_2885_5970_1870_1871_7157_468_1869_5604_5925_2033_207	17	4.73E-16	3.26E-14	6.42E-15
1099	hsa-mir-1183	hsa05212	Pancreatic cancer	367_1499_5595_5594_1387_595_2885_5970_1870_1871_7157_468_1869_5604_5925_2033_207	17	5.58E-16	3.85E-14	6.42E-15
1100	hsa-mir-1183	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_6774_2885_5970_6688_4609_5604_862_1050_207	15	7.58E-16	5.23E-14	7.47E-15
1101	hsa-mir-1183	hsa05214	Glioma	5595_5594_595_2885_1870_1871_7157_1869_5604_5925_207_6464_808_801_805	15	2.61E-15	1.80E-13	2.25E-14
1102	hsa-mir-1183	hsa04110	Cell cycle	5591_1387_595_1870_1871_7157_1869_6502_4087_4088_4089_3066_3065_5925_2033_5933	16	5.32E-13	3.67E-11	4.08E-12
1103	hsa-mir-1183	hsa04350	TGF-beta signaling pathway	7046_5595_5594_1387_3397_3398_4609_3399_4087_4088_4089_2033_4093_5933	14	1.74E-12	1.20E-10	1.20E-11
1104	hsa-mir-1183	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_2885_1870_1871_7157_1869_5604_5925_207	12	2.44E-12	1.69E-10	1.53E-11
1105	hsa-mir-1183	hsa05211	Renal cell carcinoma	5595_5594_1387_2885_3091_7428_2113_3725_5604_2034_2033_207_9915	13	3.00E-12	2.07E-10	1.72E-11
1106	hsa-mir-1183	hsa05222	Small cell lung cancer	9063_6256_595_5970_1870_1871_7157_4609_1869_6502_5925_4846_207	13	2.21E-11	1.53E-09	1.18E-10
1107	hsa-mir-1183	hsa04912	GnRH signaling pathway	5595_5594_5599_5601_5600_1432_2885_468_3725_5604_5606_808_801_805	14	2.40E-11	1.66E-09	1.19E-10
1108	hsa-mir-1183	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_4609_1869_5604_5925	10	9.40E-11	6.49E-09	4.33E-10
1109	hsa-mir-1183	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5601_5600_1432_6772_5970_3725_5604_5606_2353_207	13	1.52E-10	1.05E-08	6.54E-10
1110	hsa-mir-1183	hsa04520	Adherens junction	4301_7046_1499_5595_5594_1387_1457_4087_4088_4089_2033	11	1.94E-09	1.34E-07	7.87E-09
1111	hsa-mir-1183	hsa05216	Thyroid cancer	1499_5595_5594_6256_595_7157_4609_5604	8	2.73E-09	1.89E-07	1.05E-08
1112	hsa-mir-1183	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5604_5925_207	10	8.65E-09	5.97E-07	3.14E-08
1113	hsa-mir-1183	hsa05213	Endometrial cancer	1499_5595_5594_595_2885_7157_4609_5604_207	9	9.76E-09	6.73E-07	3.37E-08
1114	hsa-mir-1183	hsa04310	Wnt signaling pathway	1499_5599_1387_595_5601_7157_4609_3725_1457_4087_4088_4089_2033	13	1.32E-08	9.11E-07	4.34E-08
1115	hsa-mir-1183	hsa04720	Long-term potentiation	5595_5594_1387_2902_468_5604_2033_808_801_805	10	1.39E-08	9.60E-07	4.36E-08
1116	hsa-mir-1183	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5601_5600_1432_2885_5604_5606_207	10	2.18E-08	1.51E-06	6.55E-08
1117	hsa-mir-1183	hsa04660	T cell receptor signaling pathway	5595_5594_5601_5600_1432_2885_5970_3725_5604_2353_207	11	4.01E-08	2.77E-06	1.12E-07
1118	hsa-mir-1183	hsa04910	Insulin signaling pathway	6720_5595_5594_5599_5601_2885_5604_207_6464_808_801_805	12	4.06E-08	2.80E-06	1.12E-07
1119	hsa-mir-1183	hsa04012	ErbB signaling pathway	5595_5594_5599_5601_2885_4609_3725_5604_207_6464	10	5.03E-08	3.47E-06	1.33E-07
1120	hsa-mir-1183	hsa04370	VEGF signaling pathway	5595_5594_5600_7867_1432_9261_5604_4846_207	9	2.08E-07	1.43E-05	5.31E-07
1121	hsa-mir-1183	hsa05010	Alzheimer's disease	22926_5595_5594_823_2902_836_9451_6622_4846_808_801_805	12	5.06E-07	3.49E-05	1.25E-06
1122	hsa-mir-1183	hsa04330	Notch signaling pathway	1387_388585_9612_3066_3065_2033_8850	7	1.10E-06	7.62E-05	2.63E-06
1123	hsa-mir-1183	hsa04662	B cell receptor signaling pathway	5595_5594_2885_5970_3725_5604_2353_207	8	1.88E-06	0.000129459	4.32E-06
1124	hsa-mir-1183	hsa04916	Melanogenesis	1499_5595_5594_1387_5604_2033_808_801_805	9	2.13E-06	0.000147209	4.75E-06
1125	hsa-mir-1183	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_5600_836_1432_7157_5606_4846	7	3.19E-06	0.000220447	6.89E-06
1126	hsa-mir-1183	hsa05016	Huntington's disease	6874_1387_2902_6908_836_7157_23186_3066_3065_3064_2033	11	5.79E-06	0.000399312	1.21E-05
1127	hsa-mir-1183	hsa04510	Focal adhesion	1499_5595_5594_5599_595_5601_2885_3725_5604_207_6464	11	1.31E-05	0.000904618	2.65E-05
1128	hsa-mir-1183	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_5600_836_1432_5970_3725	7	1.34E-05	0.000926314	2.65E-05
1129	hsa-mir-1183	hsa04630	Jak-STAT signaling pathway	9063_1387_595_6774_2885_6772_4609_2033_207	9	4.34E-05	0.002993425	8.32E-05
1130	hsa-mir-1183	hsa04920	Adipocytokine signaling pathway	5599_6256_5601_6774_5970_207	6	9.23E-05	0.006367094	0.000172084
1131	hsa-mir-1183	hsa04930	Type II diabetes mellitus	3651_5595_5594_5599_5601	5	0.00014175	0.009780733	0.000257388
1132	hsa-mir-1183	hsa04062	Chemokine signaling pathway	5595_5594_6774_2885_6772_5970_5604_207_6464	9	0.000212532	0.014664688	0.000376018
1133	hsa-mir-1183	hsa03022	Basal transcription factors	2963_6874_6908_2959	4	0.000741509	0.051164113	0.001279103
1134	hsa-mir-1183	hsa04270	Vascular smooth muscle contraction	5595_5594_5604_808_801_805	6	0.001584292	0.109316117	0.002666247
1135	hsa-mir-1183	hsa04150	mTOR signaling pathway	5595_5594_3091_207	4	0.00239186	0.165038357	0.003929485
1136	hsa-mir-1183	hsa04210	Apoptosis	823_836_5970_7157_207	5	0.002570464	0.177362019	0.004124698
1137	hsa-mir-1183	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_2885_5604_6464	6	0.00335174	0.231270037	0.005256137
1138	hsa-mir-1183	hsa04120	Ubiquitin mediated proteolysis	5371_9063_672_7428_6502_7329	6	0.003467729	0.239273333	0.005317185
1139	hsa-mir-1183	hsa04730	Long-term depression	5595_5594_5604_4846	4	0.006828971	0.471199029	0.010243457
1140	hsa-mir-1183	hsa04540	Gap junction	5595_5594_2885_5604	4	0.016429125	1	0.024119353
1141	hsa-mir-1183	hsa04950	Maturity onset diabetes of the young	3651_168620	2	0.027654981	1	0.039754035
1142	hsa-mir-1183	hsa04115	p53 signaling pathway	595_836_7157	3	0.03560738	1	0.050141005
1143	hsa-mir-1183	hsa04670	Leukocyte transendothelial migration	4301_1499_5600_1432	4	0.038029944	1	0.052481323
1144	hsa-mir-1183	hsa04020	Calcium signaling pathway	2902_4846_808_801_805	5	0.041882342	1	0.056664345
1145	hsa-mir-1183	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.04489832	1	0.059576617
1146	hsa-mir-1185-1	hsa04630	Jak-STAT signaling pathway	3717_3716_3718_867_2057_3575_5781_2033_85480_8554_3560_3561_6774_6777_6772_2690	16	1.11E-21	6.99E-20	6.99E-20
1147	hsa-mir-1185-1	hsa05200	Pathways in cancer	5159_3716_867_1399_1398_2033_3815_675_1956_8554_5156_3320_5595_5594_6774_6777_6772	17	3.84E-18	2.42E-16	1.21E-16
1148	hsa-mir-1185-1	hsa04012	ErbB signaling pathway	867_1399_1398_1956_6714_5595_5594_6777_6464_2066	10	2.56E-14	1.61E-12	5.38E-13
1149	hsa-mir-1185-1	hsa04062	Chemokine signaling pathway	3717_3718_1399_1398_1234_5595_5594_6774_6777_6464_6772	11	1.63E-12	1.03E-10	2.57E-11
1150	hsa-mir-1185-1	hsa05220	Chronic myeloid leukemia	867_5781_1399_1398_5595_5594_6777_6464	8	1.96E-11	1.23E-09	2.47E-10
1151	hsa-mir-1185-1	hsa04520	Adherens junction	71_2033_1956_5770_6714_3643_5595_5594	8	3.16E-11	1.99E-09	3.32E-10
1152	hsa-mir-1185-1	hsa04060	Cytokine-cytokine receptor interaction	5159_2057_3575_1234_85480_3815_1956_5156_3560_3561_2690	11	3.80E-11	2.40E-09	3.42E-10
1153	hsa-mir-1185-1	hsa04510	Focal adhesion	5159_1399_1398_71_1956_6714_5156_5595_5594_6464	10	8.09E-11	5.09E-09	6.37E-10
1154	hsa-mir-1185-1	hsa04910	Insulin signaling pathway	867_1399_1398_5770_3643_5595_5594_6464	8	1.86E-09	1.17E-07	1.30E-08
1155	hsa-mir-1185-1	hsa05215	Prostate cancer	5159_2033_1956_5156_3320_5595_5594	7	2.56E-09	1.61E-07	1.58E-08
1156	hsa-mir-1185-1	hsa05212	Pancreatic cancer	5159_2033_1956_5156_3320_5595_5594	7	2.75E-09	1.73E-07	1.58E-08
1157	hsa-mir-1185-1	hsa05214	Glioma	5159_1956_5156_5595_5594_6464	6	1.63E-08	1.02E-06	8.53E-08
1158	hsa-mir-1185-1	hsa05211	Renal cell carcinoma	5781_1399_1398_2033_5595_5594	6	2.88E-08	1.81E-06	1.39E-07
1159	hsa-mir-1185-1	hsa05340	Primary immunodeficiency	3718_695_3575_3932_3561	5	3.65E-08	2.30E-06	1.64E-07
1160	hsa-mir-1185-1	hsa04650	Natural killer cell mediated cytotoxicity	6850_919_5781_3932_5595_5594_6464	7	4.87E-08	3.07E-06	2.05E-07
1161	hsa-mir-1185-1	hsa04810	Regulation of actin cytoskeleton	5159_1399_1398_71_1956_5156_5595_5594	8	5.88E-08	3.71E-06	2.32E-07
1162	hsa-mir-1185-1	hsa04540	Gap junction	5159_1956_6714_5156_5595_5594	6	1.21E-07	7.61E-06	4.48E-07
1163	hsa-mir-1185-1	hsa04660	T cell receptor signaling pathway	867_919_3932_5595_5594_1493	6	3.10E-07	1.95E-05	1.09E-06
1164	hsa-mir-1185-1	hsa05221	Acute myeloid leukemia	3815_5595_5594_6774_6777	5	4.05E-07	2.55E-05	1.34E-06
1165	hsa-mir-1185-1	hsa05218	Melanoma	5159_1956_5156_5595_5594	5	9.61E-07	6.05E-05	3.03E-06
1166	hsa-mir-1185-1	hsa05210	Colorectal cancer	5159_1956_5156_5595_5594	5	2.11E-06	0.000132831	6.33E-06
1167	hsa-mir-1185-1	hsa04010	MAPK signaling pathway	5159_1399_1398_1956_5156_5595_5594	7	4.09E-06	0.000257719	1.17E-05
1168	hsa-mir-1185-1	hsa04662	B cell receptor signaling pathway	6850_695_5595_5594	4	3.55E-05	0.002234016	9.71E-05
1169	hsa-mir-1185-1	hsa04664	Fc epsilon RI signaling pathway	6850_695_5595_5594	4	4.31E-05	0.002713219	0.000113051
1170	hsa-mir-1185-1	hsa04350	TGF-beta signaling pathway	2033_5595_5594_5515	4	6.18E-05	0.003891271	0.000155651
1171	hsa-mir-1185-1	hsa04916	Melanogenesis	2033_3815_5595_5594	4	0.00012022	0.00757389	0.000291303
1172	hsa-mir-1185-1	hsa04912	GnRH signaling pathway	1956_6714_5595_5594	4	0.000138356	0.008716426	0.000322831
1173	hsa-mir-1185-1	hsa05219	Bladder cancer	1956_5595_5594	3	0.000159818	0.010068521	0.00035959
1174	hsa-mir-1185-1	hsa04930	Type II diabetes mellitus	3643_5595_5594	3	0.000193828	0.012211183	0.000421075
1175	hsa-mir-1185-1	hsa05213	Endometrial cancer	1956_5595_5594	3	0.000290595	0.018307507	0.00061025
1176	hsa-mir-1185-1	hsa05223	Non-small cell lung cancer	1956_5595_5594	3	0.000323025	0.020350553	0.000656469
1177	hsa-mir-1185-1	hsa04920	Adipocytokine signaling pathway	3717_5781_6774	3	0.000591387	0.037257373	0.001164293
1178	hsa-mir-1185-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5781_1956_6714	3	0.000695688	0.043828323	0.001289068
1179	hsa-mir-1185-1	hsa04730	Long-term depression	5595_5594_5515	3	0.000695688	0.043828323	0.001289068
1180	hsa-mir-1185-1	hsa04720	Long-term potentiation	2033_5595_5594	3	0.000811033	0.051095107	0.00145986
1181	hsa-mir-1185-1	hsa04370	VEGF signaling pathway	6714_5595_5594	3	0.000872988	0.054998238	0.001527729
1182	hsa-mir-1185-1	hsa04020	Calcium signaling pathway	5159_1956_5156_2066	4	0.000983367	0.061952117	0.001674382
1183	hsa-mir-1185-1	hsa04640	Hematopoietic cell lineage	2057_3575_3815	3	0.001227719	0.077346324	0.00203543
1184	hsa-mir-1185-1	hsa03010	Ribosome	6143_6124_6129	3	0.001910896	0.120386474	0.003009662
1185	hsa-mir-1185-1	hsa04620	Toll-like receptor signaling pathway	5595_5594_6772	3	0.001910896	0.120386474	0.003009662
1186	hsa-mir-1185-1	hsa05216	Thyroid cancer	5595_5594	2	0.002377872	0.149805923	0.003653803
1187	hsa-mir-1185-1	hsa04530	Tight junction	71_6714_5515	3	0.004305678	0.271257715	0.006458517
1188	hsa-mir-1185-1	hsa04120	Ubiquitin mediated proteolysis	867_672_8554	3	0.004479402	0.282202309	0.006562844
1189	hsa-mir-1185-1	hsa04330	Notch signaling pathway	9612_2033	2	0.005853572	0.368775043	0.008381251
1190	hsa-mir-1185-1	hsa04150	mTOR signaling pathway	5595_5594	2	0.007069741	0.445393699	0.009897638
1191	hsa-mir-1185-1	hsa05010	Alzheimer's disease	4724_5595_5594	3	0.008608245	0.54231944	0.011789553
1192	hsa-mir-1185-1	hsa04612	Antigen processing and presentation	3308_3320	2	0.019145003	1	0.02566245
1193	hsa-mir-1185-1	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.031976091	1	0.041968619
1194	hsa-mir-1185-1	hsa04670	Leukocyte transendothelial migration	5781_71	2	0.03395124	1	0.043651594
1195	hsa-mir-1185-1	hsa04360	Axon guidance	5595_5594	2	0.038564023	1	0.048590668
1196	hsa-mir-1193	hsa04110	Cell cycle	4088_4089_1870_1871_7157_1017_890_1869_5934_5933	10	3.46E-16	1.21E-14	1.21E-14
1197	hsa-mir-1193	hsa05200	Pathways in cancer	4088_4089_1870_1871_1050_4149_7157_1017_8554_1869_3320	11	1.71E-13	5.98E-12	2.99E-12
1198	hsa-mir-1193	hsa05222	Small cell lung cancer	1870_1871_4149_7157_1017_8554_1869	7	1.68E-11	5.89E-10	1.96E-10
1199	hsa-mir-1193	hsa05220	Chronic myeloid leukemia	4088_4089_1870_1871_7157_1869	6	5.82E-10	2.04E-08	5.09E-09
1200	hsa-mir-1193	hsa04350	TGF-beta signaling pathway	4088_4089_1874_1875_5934_5933	6	1.35E-09	4.73E-08	7.69E-09
1201	hsa-mir-1193	hsa05215	Prostate cancer	1870_1871_7157_1017_1869_3320	6	1.44E-09	5.05E-08	7.69E-09
1202	hsa-mir-1193	hsa05212	Pancreatic cancer	1870_1871_7157_1017_1869_3320	6	1.54E-09	5.39E-08	7.69E-09
1203	hsa-mir-1193	hsa05219	Bladder cancer	1870_1871_7157_1869	4	2.74E-07	9.57E-06	1.20E-06
1204	hsa-mir-1193	hsa05223	Non-small cell lung cancer	1870_1871_7157_1869	4	7.04E-07	2.46E-05	2.74E-06
1205	hsa-mir-1193	hsa05214	Glioma	1870_1871_7157_1869	4	1.42E-06	4.97E-05	4.97E-06
1206	hsa-mir-1193	hsa05218	Melanoma	1870_1871_7157_1869	4	1.99E-06	6.96E-05	6.32E-06
1207	hsa-mir-1193	hsa04520	Adherens junction	4088_4089_71	3	0.000136013	0.004760462	0.000396705
1208	hsa-mir-1193	hsa05210	Colorectal cancer	4088_4089_7157	3	0.000156391	0.005473687	0.000421053
1209	hsa-mir-1193	hsa04310	Wnt signaling pathway	4088_4089_7157	3	0.00084929	0.029725142	0.002123224
1210	hsa-mir-1193	hsa04115	p53 signaling pathway	7157_1017	2	0.003295012	0.115325403	0.00768836
1211	hsa-mir-1193	hsa04612	Antigen processing and presentation	3308_3320	2	0.005348882	0.187210854	0.011700678
1212	hsa-mir-1193	hsa05216	Thyroid cancer	7157	1	0.035355663	1	0.07279107
1213	hsa-mir-1193	hsa04010	MAPK signaling pathway	4149_7157	2	0.042905558	1	0.083427474
1214	hsa-mir-1197	hsa05200	Pathways in cancer	1499_5914_6934_7704_6502_3091_3065_5925_7046_1956_4824_2113_861_862_867_207_3716_5595_5594_5599_6258_1387_6256_836_367_25_2932_6774_6776_6772_5970_7157_6688_2736_4087_4088_4089_2033_4790_4792_3320_5371_5159_5156_5601_5602_1399_1398_3815_3265_842_841_2353_3326_8554	55	7.00E-36	5.32E-34	5.32E-34
1215	hsa-mir-1197	hsa04010	MAPK signaling pathway	6722_6197_9252_7867_4773_7046_8986_1956_3303_1432_207_22800_5595_5594_5599_1386_836_3312_1649_5970_7157_468_3727_6195_6196_4790_5159_9261_5156_4208_5601_5600_5602_1399_1398_3265_2353_8550_2002_2005	40	1.58E-24	1.20E-22	5.99E-23
1216	hsa-mir-1197	hsa05215	Prostate cancer	1499_6934_5925_1956_4824_9586_207_5595_5594_1385_1387_367_2932_5970_7157_468_2033_4790_4792_3320_5159_5156_3265_842_3326	25	8.95E-22	6.80E-20	2.15E-20
1217	hsa-mir-1197	hsa05212	Pancreatic cancer	1499_6934_5925_1956_4824_9586_207_5595_5594_1385_1387_367_2932_5970_7157_468_2033_4790_4792_3320_5159_5156_3265_842_3326	25	1.13E-21	8.59E-20	2.15E-20
1218	hsa-mir-1197	hsa05220	Chronic myeloid leukemia	3065_5925_7046_861_867_207_5595_5594_25_6776_5970_7157_4088_4089_4790_4792_1399_1398_3265_5781_6464	21	2.17E-18	1.65E-16	3.30E-17
1219	hsa-mir-1197	hsa05210	Colorectal cancer	1499_6934_7046_1956_207_5595_5594_5599_836_2932_7157_4087_4088_4089_5159_5156_5601_5602_842_2353	20	2.07E-16	1.58E-14	2.63E-15
1220	hsa-mir-1197	hsa04012	ErbB signaling pathway	815_1956_6714_867_207_5595_5594_5599_2066_25_2932_6776_5601_5602_1399_1398_3265_6464_2002	19	4.61E-15	3.51E-13	5.01E-14
1221	hsa-mir-1197	hsa05221	Acute myeloid leukemia	5914_6934_7704_861_862_207_5595_5594_6774_6776_5970_6688_4790_5371_3815_3265	16	3.82E-14	2.91E-12	3.63E-13
1222	hsa-mir-1197	hsa04520	Adherens junction	1499_6934_5770_5777_7046_1956_6714_4301_5595_5594_1387_1457_4087_4088_4089_2033_3643	17	1.89E-13	1.44E-11	1.60E-12
1223	hsa-mir-1197	hsa04630	Jak-STAT signaling pathway	3717_3559_5777_3560_3566_2057_867_2690_207_3716_1387_3575_6774_6775_6776_6772_6773_2033_5781_8554	20	5.63E-12	4.28E-10	4.28E-11
1224	hsa-mir-1197	hsa04910	Insulin signaling pathway	5770_867_207_5590_5595_5594_5599_2932_808_801_805_3643_5601_5602_1399_1398_3265_6464_2002	19	6.90E-12	5.24E-10	4.77E-11
1225	hsa-mir-1197	hsa04720	Long-term potentiation	815_6197_2902_2906_5595_5594_1387_468_6195_6196_2033_808_801_805_3265	15	1.07E-11	8.15E-10	6.80E-11
1226	hsa-mir-1197	hsa04660	T cell receptor signaling pathway	1493_5777_4773_1432_867_207_5595_5594_2932_5970_4790_4792_5601_5600_919_3265_2353	17	1.73E-11	1.32E-09	1.01E-10
1227	hsa-mir-1197	hsa05214	Glioma	815_5925_1956_207_5595_5594_7157_808_801_805_5159_5156_3265_6464	14	2.21E-11	1.68E-09	1.20E-10
1228	hsa-mir-1197	hsa04110	Cell cycle	6502_3065_5925_993_7534_5591_1387_7531_7533_25_2932_7157_4087_4088_4089_2033_983	17	5.28E-11	4.01E-09	2.67E-10
1229	hsa-mir-1197	hsa04912	GnRH signaling pathway	815_1956_6714_1432_5595_5594_5599_468_808_801_805_5601_5600_5602_3265_2002	16	1.20E-10	9.14E-09	5.71E-10
1230	hsa-mir-1197	hsa04310	Wnt signaling pathway	815_1499_6934_4773_5599_1387_2932_7157_8061_1457_4087_4088_4089_2033_5515_5601_5602	17	1.63E-09	1.24E-07	7.28E-09
1231	hsa-mir-1197	hsa03022	Basal transcription factors	6879_2963_2962_2969_6872_6908_2958_2959_6880_9519	10	2.53E-09	1.92E-07	1.07E-08
1232	hsa-mir-1197	hsa05213	Endometrial cancer	1499_6934_1956_207_5595_5594_2932_7157_3265_842_2002	11	3.72E-09	2.83E-07	1.45E-08
1233	hsa-mir-1197	hsa04920	Adipocytokine signaling pathway	3717_207_5599_6258_6256_6774_5970_4790_4792_5601_5602_5781	12	3.82E-09	2.90E-07	1.45E-08
1234	hsa-mir-1197	hsa04620	Toll-like receptor signaling pathway	1432_207_5595_5594_5599_6772_5970_4790_4792_5601_5600_5602_841_2353	14	4.25E-09	3.23E-07	1.54E-08
1235	hsa-mir-1197	hsa04916	Melanogenesis	815_1499_6934_5595_5594_1385_1387_2932_2033_808_801_805_3815_3265	14	5.32E-09	4.04E-07	1.84E-08
1236	hsa-mir-1197	hsa04350	TGF-beta signaling pathway	6667_3397_7046_3399_3398_5595_5594_1387_4087_4088_4089_2033_5515	13	6.08E-09	4.62E-07	2.01E-08
1237	hsa-mir-1197	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_1432_5599_836_5970_4790_4792_5601_5600_5602_5781	12	6.83E-09	5.19E-07	2.16E-08
1238	hsa-mir-1197	hsa04062	Chemokine signaling pathway	3717_7852_207_5590_5595_5594_2932_2931_6774_6772_6773_5970_4790_4792_1399_1398_3265_6464	18	7.58E-09	5.76E-07	2.31E-08
1239	hsa-mir-1197	hsa05223	Non-small cell lung cancer	5925_1956_207_5595_5594_6258_6256_7157_3265_842	10	5.82E-08	4.43E-06	1.70E-07
1240	hsa-mir-1197	hsa05211	Renal cell carcinoma	3091_2113_207_5595_5594_1387_2033_1399_1398_3265_5781	11	7.36E-08	5.59E-06	2.07E-07
1241	hsa-mir-1197	hsa05216	Thyroid cancer	1499_6934_5595_5594_6258_6256_7157_3265	8	8.94E-08	6.80E-06	2.43E-07
1242	hsa-mir-1197	hsa04510	Focal adhesion	1499_1956_6714_207_5595_5594_5599_2932_5159_5156_5601_5602_1399_1398_3265_6464_2002	17	1.03E-07	7.82E-06	2.70E-07
1243	hsa-mir-1197	hsa04662	B cell receptor signaling pathway	5777_4773_207_5595_5594_2932_5970_4790_4792_3265_2353	11	1.07E-07	8.13E-06	2.71E-07
1244	hsa-mir-1197	hsa04370	VEGF signaling pathway	7867_4773_6714_1432_207_5595_5594_9261_5600_3265_842	11	1.36E-07	1.03E-05	3.34E-07
1245	hsa-mir-1197	hsa05222	Small cell lung cancer	6502_5925_207_6258_6256_5970_7157_4790_4792_842_8554	11	3.73E-07	2.83E-05	8.85E-07
1246	hsa-mir-1197	hsa04930	Type II diabetes mellitus	3651_5590_5595_5594_5599_3643_5601_5602	8	1.65E-06	0.00012527	3.80E-06
1247	hsa-mir-1197	hsa05010	Alzheimer's disease	2902_2906_22926_5595_5594_836_2932_808_351_801_805_842_841_840	14	2.19E-06	0.000166067	4.88E-06
1248	hsa-mir-1197	hsa04210	Apoptosis	207_836_839_5970_7157_4790_4792_842_841_840	10	3.67E-06	0.000279265	7.98E-06
1249	hsa-mir-1197	hsa05016	Huntington's disease	6667_3065_3064_2902_9586_1385_1387_836_7157_2033_6908_842_841_9519	14	4.21E-06	0.000319679	8.88E-06
1250	hsa-mir-1197	hsa05218	Melanoma	5925_1956_207_5595_5594_7157_5159_5156_3265	9	4.61E-06	0.000350232	9.47E-06
1251	hsa-mir-1197	hsa04664	Fc epsilon RI signaling pathway	1432_207_5595_5594_5599_5601_5600_5602_3265	9	1.02E-05	0.000772577	2.03E-05
1252	hsa-mir-1197	hsa05219	Bladder cancer	9252_5925_1956_5595_5594_7157_3265	7	1.09E-05	0.000825371	2.12E-05
1253	hsa-mir-1197	hsa04530	Tight junction	1499_6714_8573_8189_207_22800_4301_5590_1457_5515_3265	11	2.34E-05	0.001778785	4.45E-05
1254	hsa-mir-1197	hsa04540	Gap junction	1956_6714_5592_5595_5594_5159_983_5156_3265	9	3.36E-05	0.002553042	6.23E-05
1255	hsa-mir-1197	hsa04150	mTOR signaling pathway	6197_3091_207_5595_5594_6195_6196	7	3.77E-05	0.00286428	6.82E-05
1256	hsa-mir-1197	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_2906_1432_836_7157_5600_842	7	5.79E-05	0.004401612	0.000102363
1257	hsa-mir-1197	hsa04120	Ubiquitin mediated proteolysis	55294_6502_867_10273_7329_83737_64326_5371_672_8554	10	0.00012852	0.009767509	0.000221989
1258	hsa-mir-1197	hsa04330	Notch signaling pathway	3065_388585_1387_9612_2033_8850	6	0.000177398	0.013482211	0.000299605
1259	hsa-mir-1197	hsa04650	Natural killer cell mediated cytotoxicity	5777_4773_5595_5594_836_919_3265_5781_6464	9	0.000543872	0.041334292	0.000898572
1260	hsa-mir-1197	hsa04612	Antigen processing and presentation	3303_1385_3312_1514_3320_4800_3326	7	0.000801509	0.060914657	0.001296057
1261	hsa-mir-1197	hsa04020	Calcium signaling pathway	815_1956_2902_2906_2066_808_801_805_5159_5156	10	0.00103959	0.079008858	0.001646018
1262	hsa-mir-1197	hsa04115	p53 signaling pathway	836_7157_64326_983_842_841	6	0.001164975	0.088538104	0.0018069
1263	hsa-mir-1197	hsa04060	Cytokine-cytokine receptor interaction	3559_7046_1956_3560_3566_7852_2057_2690_3575_5159_5156_3815	12	0.001410902	0.107228585	0.002144572
1264	hsa-mir-1197	hsa03450	Non-homologous end-joining	2547_7520_5591	3	0.002213151	0.168199507	0.00329803
1265	hsa-mir-1197	hsa05217	Basal cell carcinoma	1499_6934_2932_7157_2736	5	0.00249834	0.189873837	0.00365142
1266	hsa-mir-1197	hsa04360	Axon guidance	4773_7852_5595_5594_25_2932_3265	7	0.006235997	0.473935786	0.008942185
1267	hsa-mir-1197	hsa04730	Long-term depression	5592_5595_5594_5515_3265	5	0.006896244	0.52411458	0.009705826
1268	hsa-mir-1197	hsa04950	Maturity onset diabetes of the young	3087_3651_168620	3	0.008478193	0.644342669	0.011715321
1269	hsa-mir-1197	hsa04810	Regulation of actin cytoskeleton	1956_22800_5595_5594_5159_5156_1399_1398_3265	9	0.01028338	0.781536875	0.013956016
1270	hsa-mir-1197	hsa04270	Vascular smooth muscle contraction	5592_5595_5594_808_801_805	6	0.013661069	1	0.018214758
1271	hsa-mir-1197	hsa04640	Hematopoietic cell lineage	3559_3566_2057_3575_3815	5	0.015000521	1	0.019655855
1272	hsa-mir-1197	hsa04670	Leukocyte transendothelial migration	1499_1432_7852_4301_5600_5781	6	0.015758836	1	0.020299517
1273	hsa-mir-1-2	hsa05200	Pathways in cancer	2353_6777_5925_1387_2249_367_3725_6776_5914_5970_6256	11	6.25E-11	3.00E-09	3.00E-09
1274	hsa-mir-1-2	hsa05221	Acute myeloid leukemia	6777_6776_5914_5970	4	7.31E-06	0.000350972	0.000175486
1275	hsa-mir-1-2	hsa05220	Chronic myeloid leukemia	6777_5925_6776_5970	4	1.80E-05	0.000864824	0.000288275
1276	hsa-mir-1-2	hsa05215	Prostate cancer	5925_1387_367_5970	4	3.29E-05	0.001578029	0.000329309
1277	hsa-mir-1-2	hsa05212	Pancreatic cancer	5925_1387_367_5970	4	3.43E-05	0.001646545	0.000329309
1278	hsa-mir-1-2	hsa04110	Cell cycle	5925_1387_993_983	4	0.000102092	0.004900397	0.000816733
1279	hsa-mir-1-2	hsa04330	Notch signaling pathway	9612_1387_8850	3	0.000131835	0.006328093	0.000904013
1280	hsa-mir-1-2	hsa04630	Jak-STAT signaling pathway	6777_1387_3977_6776	4	0.000273553	0.013130544	0.001641318
1281	hsa-mir-1-2	hsa04662	B cell receptor signaling pathway	2353_3725_5970	3	0.00049214	0.023622717	0.002624746
1282	hsa-mir-1-2	hsa05222	Small cell lung cancer	5925_5970_6256	3	0.000723499	0.03472794	0.003261414
1283	hsa-mir-1-2	hsa04012	ErbB signaling pathway	6777_3725_6776	3	0.000747407	0.035875549	0.003261414
1284	hsa-mir-1-2	hsa04620	Toll-like receptor signaling pathway	2353_3725_5970	3	0.001168022	0.056065076	0.00467209
1285	hsa-mir-1-2	hsa04660	T cell receptor signaling pathway	2353_3725_5970	3	0.001442738	0.069251446	0.005327034
1286	hsa-mir-1-2	hsa04010	MAPK signaling pathway	2353_2249_3725_5970	4	0.002157438	0.103557025	0.00739693
1287	hsa-mir-1-2	hsa03410	Base excision repair	3146_142	2	0.0025443	0.122126405	0.00814176
1288	hsa-mir-1-2	hsa05223	Non-small cell lung cancer	5925_6256	2	0.005448834	0.261544045	0.016346503
1289	hsa-mir-1-2	hsa05016	Huntington's disease	1387_6667_6908	3	0.006323217	0.303514414	0.017853789
1290	hsa-mir-1-2	hsa04920	Adipocytokine signaling pathway	5970_6256	2	0.008166321	0.391983398	0.021356179
1291	hsa-mir-1-2	hsa05218	Melanoma	5925_2249	2	0.009102203	0.436905745	0.021356179
1292	hsa-mir-1-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.009102203	0.436905745	0.021356179
1293	hsa-mir-1-2	hsa05211	Renal cell carcinoma	1387_3725	2	0.009343328	0.448479761	0.021356179
1294	hsa-mir-1-2	hsa05210	Colorectal cancer	2353_3725	2	0.012454915	0.597835905	0.027174359
1295	hsa-mir-1-2	hsa04350	TGF-beta signaling pathway	1387_6667	2	0.013294342	0.638128422	0.027734626
1296	hsa-mir-1-2	hsa04612	Antigen processing and presentation	4800_1514	2	0.013867313	0.66563102	0.027734626
1297	hsa-mir-1-2	hsa03450	Non-homologous end-joining	2547	1	0.029047666	1	0.055771519
1298	hsa-mir-1-2	hsa04310	Wnt signaling pathway	1387_3725	2	0.036887239	1	0.068099519
1299	hsa-mir-1-2	hsa04950	Maturity onset diabetes of the young	6927	1	0.047950283	1	0.085244947
1300	hsa-mir-1200	hsa05200	Pathways in cancer	3725_7046_1499_5914_595_3815_2261_4193_7704_6502_3066_3065_1050_5925_5747_25_1956_1487_4824_2113_10401_5894_862_207_3716_2249_4233_5595_5594_5599_6258_1387_2064_6256_836_367_6774_6776_6777_6772_5979_5970_7157_4087_4088_4089_2033_4790_4791_4792_5879_3320_3326_5371_3480_5159_5156_842_841_8772_4609_1026_2353_1488_1441_8554	66	2.82E-45	2.29E-43	2.29E-43
1301	hsa-mir-1200	hsa04630	Jak-STAT signaling pathway	3559_595_5777_58985_3454_3455_3459_3460_3560_3561_3566_1439_10401_2690_3977_207_3717_3716_3718_85480_1387_3575_3570_3572_6774_6776_6777_6772_6773_7297_2033_149233_3953_5781_4609_1441_8554_10379	38	2.96E-29	2.39E-27	1.20E-27
1302	hsa-mir-1200	hsa05215	Prostate cancer	1499_595_4193_5925_1956_4824_5894_207_5595_5594_1385_1387_2064_367_5970_7157_10488_2033_4790_4792_3320_3326_3480_5159_5156_842_1026	27	2.68E-23	2.17E-21	6.97E-22
1303	hsa-mir-1200	hsa05212	Pancreatic cancer	1499_595_4193_5925_1956_4824_5894_207_5595_5594_1385_1387_2064_367_5970_7157_10488_2033_4790_4792_3320_3326_3480_5159_5156_842_1026	27	3.44E-23	2.79E-21	6.97E-22
1304	hsa-mir-1200	hsa04010	MAPK signaling pathway	3925_6722_3725_7046_2261_2264_7867_1845_5536_1956_7132_3303_1432_5894_207_2249_5595_5594_5599_836_9252_5970_7157_6195_4790_4791_51701_5879_5159_9261_5156_4208_5566_6885_4609_2353_2002_2005	38	1.67E-21	1.36E-19	2.71E-20
1305	hsa-mir-1200	hsa05220	Chronic myeloid leukemia	7046_595_4193_3066_3065_5925_25_1487_5894_207_5595_5594_6776_6777_5970_7157_4088_4089_4790_4792_5781_4609_1026_1488	24	3.29E-21	2.66E-19	4.44E-20
1306	hsa-mir-1200	hsa04060	Cytokine-cytokine receptor interaction	3556_3559_7046_3815_1234_58985_3454_3455_3459_90_3460_3791_1956_3560_3561_3566_7133_7132_1439_7852_659_2690_3977_85480_4233_1230_3575_3570_3572_2321_149233_5159_5156_3953_1441	35	2.20E-19	1.79E-17	2.55E-18
1307	hsa-mir-1200	hsa05210	Colorectal cancer	3725_7046_1499_595_1956_5894_207_4233_5595_5594_5599_836_7157_4087_4088_4089_5879_3480_5159_5156_842_4609_2353	23	4.17E-19	3.38E-17	4.22E-18
1308	hsa-mir-1200	hsa04520	Adherens junction	7046_1499_5777_2534_1956_6714_2241_4233_5595_5594_1387_2064_1457_4087_4088_4089_2033_51701_5879_3480_6885	21	3.04E-17	2.46E-15	2.74E-16
1309	hsa-mir-1200	hsa05214	Glioma	818_815_817_595_4193_5925_1956_5894_207_5595_5594_7157_808_801_805_3480_5159_5156_1026	19	1.86E-16	1.51E-14	1.51E-15
1310	hsa-mir-1200	hsa05221	Acute myeloid leukemia	5914_595_3815_7704_1050_5894_862_207_5595_5594_6774_6776_6777_5970_4790_5371_4609	17	8.87E-15	7.18E-13	6.53E-14
1311	hsa-mir-1200	hsa04350	TGF-beta signaling pathway	6667_7046_90_3397_57154_3399_3398_659_3400_5595_5594_1387_4086_4087_4088_4089_2033_4609_4093	19	1.79E-14	1.45E-12	1.11E-13
1312	hsa-mir-1200	hsa04012	ErbB signaling pathway	3725_818_815_817_5747_25_1956_6714_5894_207_5595_5594_5599_2064_6776_6777_4609_1026_2002	19	1.79E-14	1.45E-12	1.11E-13
1313	hsa-mir-1200	hsa04620	Toll-like receptor signaling pathway	3725_3454_3455_1432_207_3654_5595_5594_5599_6772_5970_4790_4792_5879_841_8772_6885_2353	18	2.11E-12	1.71E-10	1.14E-11
1314	hsa-mir-1200	hsa04310	Wnt signaling pathway	3725_818_815_817_1499_595_1487_5599_1387_7157_1457_4087_4088_4089_2033_51701_5879_5566_6885_4609_1488	21	2.11E-12	1.71E-10	1.14E-11
1315	hsa-mir-1200	hsa04110	Cell cycle	595_4193_6502_4174_4172_3066_3065_5925_25_5591_1387_7533_7157_4087_4088_4089_2033_2810_1026	19	2.48E-12	2.01E-10	1.25E-11
1316	hsa-mir-1200	hsa04210	Apoptosis	3556_7132_1439_207_3654_8717_836_839_5970_7157_4790_4792_5566_842_841_840_8772	17	2.84E-12	2.30E-10	1.35E-11
1317	hsa-mir-1200	hsa04062	Chemokine signaling pathway	1234_5747_5580_7852_5894_207_3055_3717_3718_5590_5595_5594_1230_6774_6777_6772_6773_5970_4790_4792_5879_5566_2185	23	3.01E-12	2.43E-10	1.35E-11
1318	hsa-mir-1200	hsa04912	GnRH signaling pathway	3725_818_815_817_5580_1956_6714_1432_5894_5595_5594_5599_808_801_805_5566_2185_2002	18	4.95E-12	4.01E-10	2.11E-11
1319	hsa-mir-1200	hsa05219	Bladder cancer	595_2261_4193_5925_1956_5894_5595_5594_2064_9252_7157_4609_1026	13	6.04E-12	4.89E-10	2.45E-11
1320	hsa-mir-1200	hsa04920	Adipocytokine signaling pathway	10891_7133_7132_207_3717_8717_5599_6258_6256_6774_5970_4790_4792_3953_5781	15	7.61E-12	6.17E-10	2.94E-11
1321	hsa-mir-1200	hsa05218	Melanoma	595_4193_5925_1956_5894_207_2249_4233_5595_5594_7157_3480_5159_5156_1026	15	1.56E-11	1.27E-09	5.76E-11
1322	hsa-mir-1200	hsa05222	Small cell lung cancer	595_6502_5925_5747_10401_207_6258_6256_5970_7157_4790_4792_842_4609_8554	15	1.69E-10	1.37E-08	5.96E-10
1323	hsa-mir-1200	hsa04916	Melanogenesis	818_815_817_1499_3815_5894_5595_5594_1385_1387_10488_2033_808_801_805_5566	16	2.19E-10	1.77E-08	7.39E-10
1324	hsa-mir-1200	hsa04510	Focal adhesion	3725_1499_595_2534_5747_3791_1956_6714_5894_207_4233_5595_5594_5599_2064_5879_2321_3480_5159_5156_2002	21	3.73E-10	3.02E-08	1.21E-09
1325	hsa-mir-1200	hsa04660	T cell receptor signaling pathway	3725_5777_2534_3932_1432_5894_207_5595_5594_920_5970_4790_4792_915_6885_2353	16	4.59E-10	3.72E-08	1.43E-09
1326	hsa-mir-1200	hsa05213	Endometrial cancer	1499_595_1956_5894_207_5595_5594_2064_7157_842_4609_2002	12	7.12E-10	5.77E-08	2.14E-09
1327	hsa-mir-1200	hsa05223	Non-small cell lung cancer	595_5925_1956_5894_207_5595_5594_6258_2064_6256_7157_842	12	1.03E-09	8.38E-08	2.99E-09
1328	hsa-mir-1200	hsa04720	Long-term potentiation	818_815_817_5894_5595_5594_1387_6195_2033_808_801_805_5566	13	3.01E-09	2.44E-07	8.40E-09
1329	hsa-mir-1200	hsa05216	Thyroid cancer	1499_595_5595_5594_6258_6256_5979_7157_4609	9	1.11E-08	9.00E-07	3.00E-08
1330	hsa-mir-1200	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_1956_6714_1432_4233_5599_836_5970_4790_4792_5879_5781	12	1.57E-08	1.27E-06	4.10E-08
1331	hsa-mir-1200	hsa04662	B cell receptor signaling pathway	3725_5777_6850_5894_207_5595_5594_5970_4790_4792_5879_2353	12	2.70E-08	2.19E-06	6.84E-08
1332	hsa-mir-1200	hsa04370	VEGF signaling pathway	7867_5747_3791_6714_1432_5894_207_5595_5594_5879_9261_842	12	3.51E-08	2.84E-06	8.61E-08
1333	hsa-mir-1200	hsa04330	Notch signaling pathway	3066_3065_1487_3280_1387_9612_2033_8850_388585_1488	10	3.71E-08	3.01E-06	8.84E-08
1334	hsa-mir-1200	hsa04650	Natural killer cell mediated cytotoxicity	5777_3454_3455_3459_3460_2534_3932_6850_5894_5595_5594_836_5879_5781_2185	15	5.65E-08	4.58E-06	1.31E-07
1335	hsa-mir-1200	hsa05016	Huntington's disease	6667_10891_291_3066_3065_3064_1385_1387_836_5481_7157_23186_10488_2033_6908_842_841	17	8.87E-08	7.19E-06	2.00E-07
1336	hsa-mir-1200	hsa05211	Renal cell carcinoma	3725_2113_5894_207_4233_5595_5594_1387_2033_5879_5781	11	1.57E-07	1.27E-05	3.43E-07
1337	hsa-mir-1200	hsa04020	Calcium signaling pathway	818_815_817_291_147_1956_2064_5481_808_801_805_5159_5156_5566_2185	15	1.70E-06	0.000137459	3.62E-06
1338	hsa-mir-1200	hsa04664	Fc epsilon RI signaling pathway	2534_5580_6850_1432_5894_207_5595_5594_5599_5879	10	2.70E-06	0.000218474	5.60E-06
1339	hsa-mir-1200	hsa05340	Primary immunodeficiency	3932_3561_3718_920_3575_100_915	7	6.13E-06	0.000496808	1.24E-05
1340	hsa-mir-1200	hsa04950	Maturity onset diabetes of the young	6927_3280_4760_3651_168620_3175	6	9.55E-06	0.000773484	1.89E-05
1341	hsa-mir-1200	hsa04910	Insulin signaling pathway	10891_5894_207_5590_5595_5594_5599_808_801_805_5566_2002	12	1.01E-05	0.000814572	1.94E-05
1342	hsa-mir-1200	hsa05010	Alzheimer's disease	22926_3416_7132_5595_5594_836_808_801_805_842_841_840_8772	13	2.33E-05	0.001889077	4.39E-05
1343	hsa-mir-1200	hsa04612	Antigen processing and presentation	811_3303_920_1385_3320_3326_4800_4801_2923	9	4.38E-05	0.003544287	8.06E-05
1344	hsa-mir-1200	hsa04115	p53 signaling pathway	595_4193_836_7157_842_841_2810_1026	8	4.79E-05	0.00388158	8.63E-05
1345	hsa-mir-1200	hsa05014	Amyotrophic lateral sclerosis (ALS)	7133_7132_1432_836_7157_5879_842	7	9.27E-05	0.007504714	0.000163146
1346	hsa-mir-1200	hsa04640	Hematopoietic cell lineage	3559_3815_3566_920_3575_3570_915_1441	8	0.000212443	0.017207906	0.000362056
1347	hsa-mir-1200	hsa04930	Type II diabetes mellitus	5580_3651_5590_5595_5594_5599	6	0.000214551	0.017378665	0.000362056
1348	hsa-mir-1200	hsa04270	Vascular smooth muscle contraction	147_5580_5894_5595_5594_808_801_805_5566	9	0.000320402	0.025952538	0.000524004
1349	hsa-mir-1200	hsa04540	Gap junction	1956_6714_5894_5595_5594_5159_5156_5566	8	0.000323459	0.02620019	0.000524004
1350	hsa-mir-1200	hsa04360	Axon guidance	2534_5747_25_7852_2242_4233_5595_5594_5879	9	0.000653214	0.052910364	0.001037458
1351	hsa-mir-1200	hsa04810	Regulation of actin cytoskeleton	2261_2264_5747_1956_5894_2249_5595_5594_5879_5159_5156	11	0.001981546	0.160505186	0.003086638
1352	hsa-mir-1200	hsa04120	Ubiquitin mediated proteolysis	4193_6502_57154_10401_7329_5371_672_8554	8	0.003645606	0.295294058	0.005571586
1353	hsa-mir-1200	hsa03022	Basal transcription factors	2962_2969_6908_2959	4	0.004989121	0.404118838	0.007483682
1354	hsa-mir-1200	hsa04670	Leukocyte transendothelial migration	1499_5747_1432_7852_5879_5781_2185	7	0.006472966	0.524310229	0.009532913
1355	hsa-mir-1200	hsa04150	mTOR signaling pathway	207_5595_5594_6195	4	0.014851263	1	0.021481291
1356	hsa-mir-1200	hsa05131	Shigellosis	1499_2534_25_4691	4	0.018711658	1	0.026131799
1357	hsa-mir-1200	hsa05130	Pathogenic Escherichia coli infection	1499_2534_25_4691	4	0.018711658	1	0.026131799
1358	hsa-mir-1200	hsa03030	DNA replication	4174_4172_6118	3	0.028013356	1	0.038459014
1359	hsa-mir-1200	hsa03450	Non-homologous end-joining	2547_5591	2	0.02927955	1	0.039527392
1360	hsa-mir-1200	hsa04530	Tight junction	1499_5580_6714_207_5590_1457	6	0.035056092	1	0.046549892
1361	hsa-mir-1200	hsa04730	Long-term depression	5894_5595_5594_3480	4	0.038373789	1	0.050133498
1362	hsa-mir-1202	hsa04110	Cell cycle	5925_2033_1019_4088_1017_7027_1026_5933_1387	9	3.41E-11	1.57E-09	1.31E-09
1363	hsa-mir-1202	hsa05200	Pathways in cancer	6688_5925_2033_1019_4088_1017_367_8554_4609_1499_1026_1387	12	5.67E-11	2.61E-09	1.31E-09
1364	hsa-mir-1202	hsa05215	Prostate cancer	5925_2033_1017_367_468_1499_1026_1387	8	1.13E-10	5.21E-09	1.42E-09
1365	hsa-mir-1202	hsa05212	Pancreatic cancer	5925_2033_1017_367_468_1499_1026_1387	8	1.23E-10	5.67E-09	1.42E-09
1366	hsa-mir-1202	hsa04350	TGF-beta signaling pathway	1874_2033_4088_7027_4609_5933_1387	7	3.88E-09	1.78E-07	3.57E-08
1367	hsa-mir-1202	hsa05220	Chronic myeloid leukemia	5925_1019_4088_4609_1026	5	1.75E-06	8.05E-05	1.34E-05
1368	hsa-mir-1202	hsa05222	Small cell lung cancer	5925_1019_1017_8554_4609	5	3.31E-06	0.000152453	2.18E-05
1369	hsa-mir-1202	hsa05219	Bladder cancer	5925_1019_4609_1026	4	5.38E-06	0.000247287	3.09E-05
1370	hsa-mir-1202	hsa04950	Maturity onset diabetes of the young	5080_6927_3651	3	4.17E-05	0.001919609	0.00021329
1371	hsa-mir-1202	hsa04310	Wnt signaling pathway	2033_4088_4609_1499_1387	5	4.68E-05	0.002150601	0.00021506
1372	hsa-mir-1202	hsa04520	Adherens junction	2033_4088_1499_1387	4	5.92E-05	0.002721843	0.00024744
1373	hsa-mir-1202	hsa04530	Tight junction	1019_4628_60412_1499	4	0.000434668	0.01999474	0.001666228
1374	hsa-mir-1202	hsa05214	Glioma	5925_1019_1026	3	0.00066441	0.030562856	0.002243686
1375	hsa-mir-1202	hsa04630	Jak-STAT signaling pathway	2033_8554_4609_1387	4	0.000682861	0.031411604	0.002243686
1376	hsa-mir-1202	hsa04115	p53 signaling pathway	1019_1017_1026	3	0.000785046	0.036112102	0.002407473
1377	hsa-mir-1202	hsa05218	Melanoma	5925_1019_1026	3	0.000850242	0.039111116	0.002444445
1378	hsa-mir-1202	hsa04720	Long-term potentiation	2033_468_1387	3	0.000990726	0.045573404	0.002680788
1379	hsa-mir-1202	hsa05210	Colorectal cancer	4088_4609_1499	3	0.001358374	0.062485227	0.003326334
1380	hsa-mir-1202	hsa05016	Huntington's disease	2033_6908_10476_1387	4	0.001373921	0.063200349	0.003326334
1381	hsa-mir-1202	hsa04916	Melanogenesis	2033_1499_1387	3	0.00245466	0.112914339	0.005645717
1382	hsa-mir-1202	hsa05216	Thyroid cancer	4609_1499	2	0.002722714	0.125244854	0.005964041
1383	hsa-mir-1202	hsa03022	Basal transcription factors	2959_6908	2	0.004283246	0.197029328	0.008955879
1384	hsa-mir-1202	hsa04010	MAPK signaling pathway	468_4609_1649_1386	4	0.005128521	0.235911974	0.010257042
1385	hsa-mir-1202	hsa04330	Notch signaling pathway	2033_1387	2	0.006689302	0.307707875	0.012821161
1386	hsa-mir-1202	hsa05213	Endometrial cancer	4609_1499	2	0.008074715	0.371436884	0.014857475
1387	hsa-mir-1202	hsa05223	Non-small cell lung cancer	5925_1019	2	0.008661933	0.39844892	0.015324958
1388	hsa-mir-1202	hsa05221	Acute myeloid leukemia	6688_4609	2	0.010210894	0.469701144	0.017396339
1389	hsa-mir-1202	hsa05211	Renal cell carcinoma	2033_1387	2	0.014760487	0.678982423	0.024249372
1390	hsa-mir-1202	hsa04012	ErbB signaling pathway	4609_1026	2	0.020893884	0.961118644	0.033142022
1391	hsa-mir-1204	hsa04010	MAPK signaling pathway	9261_6722_8986_5601_6195_468_207_9252_3725_3727_1386_1432_1649_6196_6197_2353	16	4.83E-19	2.56E-17	2.56E-17
1392	hsa-mir-1204	hsa04660	T cell receptor signaling pathway	5601_207_2932_3725_1432_2353	6	1.35E-07	7.17E-06	3.59E-06
1393	hsa-mir-1204	hsa05200	Pathways in cancer	2736_5601_1050_207_2932_3725_2353_1387	8	4.31E-07	2.29E-05	7.62E-06
1394	hsa-mir-1204	hsa04720	Long-term potentiation	6195_468_6196_6197_1387	5	6.22E-07	3.30E-05	8.25E-06
1395	hsa-mir-1204	hsa05210	Colorectal cancer	5601_207_2932_3725_2353	5	1.06E-06	5.62E-05	1.12E-05
1396	hsa-mir-1204	hsa04620	Toll-like receptor signaling pathway	5601_207_3725_1432_2353	5	2.64E-06	0.000139905	2.33E-05
1397	hsa-mir-1204	hsa04150	mTOR signaling pathway	6195_207_6196_6197	4	5.21E-06	0.000275971	3.94E-05
1398	hsa-mir-1204	hsa04310	Wnt signaling pathway	5601_2932_8061_3725_1387	5	1.71E-05	0.000907783	0.000113473
1399	hsa-mir-1204	hsa04662	B cell receptor signaling pathway	207_2932_3725_2353	4	2.06E-05	0.00109028	0.000121142
1400	hsa-mir-1204	hsa04012	ErbB signaling pathway	5601_207_2932_3725	4	3.59E-05	0.001904493	0.000172855
1401	hsa-mir-1204	hsa05215	Prostate cancer	468_207_2932_1387	4	3.75E-05	0.00198805	0.000172855
1402	hsa-mir-1204	hsa05212	Pancreatic cancer	468_207_2932_1387	4	3.91E-05	0.002074259	0.000172855
1403	hsa-mir-1204	hsa03022	Basal transcription factors	2963_6874_6883	3	7.45E-05	0.003945997	0.000303538
1404	hsa-mir-1204	hsa04912	GnRH signaling pathway	5601_468_3725_1432	4	8.09E-05	0.004287319	0.000306237
1405	hsa-mir-1204	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5601_3725_1432	3	0.000465111	0.02465087	0.001602564
1406	hsa-mir-1204	hsa05211	Renal cell carcinoma	207_3725_1387	3	0.000483793	0.025641017	0.001602564
1407	hsa-mir-1204	hsa04370	VEGF signaling pathway	9261_207_1432	3	0.000584423	0.030974401	0.001822024
1408	hsa-mir-1204	hsa04664	Fc epsilon RI signaling pathway	5601_207_1432	3	0.000628135	0.033291177	0.00184951
1409	hsa-mir-1204	hsa04510	Focal adhesion	5601_207_2932_3725	4	0.000884532	0.046880206	0.002467379
1410	hsa-mir-1204	hsa04910	Insulin signaling pathway	5601_207_2932	3	0.00297994	0.157936827	0.007896841
1411	hsa-mir-1204	hsa04930	Type II diabetes mellitus	5601_3651	2	0.004128604	0.218816029	0.010419811
1412	hsa-mir-1204	hsa05213	Endometrial cancer	207_2932	2	0.00541581	0.287037907	0.013047178
1413	hsa-mir-1204	hsa05217	Basal cell carcinoma	2736_2932	2	0.006016769	0.318888769	0.013864729
1414	hsa-mir-1204	hsa04340	Hedgehog signaling pathway	2736_2932	2	0.00643357	0.340979207	0.014135933
1415	hsa-mir-1204	hsa05221	Acute myeloid leukemia	1050_207	2	0.006863174	0.363748197	0.014135933
1416	hsa-mir-1204	hsa05016	Huntington's disease	3064_6874_1387	3	0.006934609	0.367534258	0.014135933
1417	hsa-mir-1204	hsa04920	Adipocytokine signaling pathway	5601_207	2	0.008707483	0.461496596	0.017092467
1418	hsa-mir-1204	hsa04916	Melanogenesis	2932_1387	2	0.019689849	1	0.037270072
1419	hsa-mir-1204	hsa04110	Cell cycle	2932_1387	2	0.025195246	1	0.046046485
1420	hsa-mir-1204	hsa04630	Jak-STAT signaling pathway	207_1387	2	0.040579263	1	0.071690031
1421	hsa-mir-1204	hsa04950	Maturity onset diabetes of the young	3651	1	0.04953318	1	0.08468576
1422	hsa-mir-1205	hsa04010	MAPK signaling pathway	9261_6722_8986_5601_6195_468_207_9252_3725_3727_1386_1432_1649_6196_6197_2353	16	4.83E-19	2.56E-17	2.56E-17
1423	hsa-mir-1205	hsa04660	T cell receptor signaling pathway	5601_207_2932_3725_1432_2353	6	1.35E-07	7.17E-06	3.59E-06
1424	hsa-mir-1205	hsa05200	Pathways in cancer	2736_5601_1050_207_2932_3725_2353_1387	8	4.31E-07	2.29E-05	7.62E-06
1425	hsa-mir-1205	hsa04720	Long-term potentiation	6195_468_6196_6197_1387	5	6.22E-07	3.30E-05	8.25E-06
1426	hsa-mir-1205	hsa05210	Colorectal cancer	5601_207_2932_3725_2353	5	1.06E-06	5.62E-05	1.12E-05
1427	hsa-mir-1205	hsa04620	Toll-like receptor signaling pathway	5601_207_3725_1432_2353	5	2.64E-06	0.000139905	2.33E-05
1428	hsa-mir-1205	hsa04150	mTOR signaling pathway	6195_207_6196_6197	4	5.21E-06	0.000275971	3.94E-05
1429	hsa-mir-1205	hsa04310	Wnt signaling pathway	5601_2932_8061_3725_1387	5	1.71E-05	0.000907783	0.000113473
1430	hsa-mir-1205	hsa04662	B cell receptor signaling pathway	207_2932_3725_2353	4	2.06E-05	0.00109028	0.000121142
1431	hsa-mir-1205	hsa04012	ErbB signaling pathway	5601_207_2932_3725	4	3.59E-05	0.001904493	0.000172855
1432	hsa-mir-1205	hsa05215	Prostate cancer	468_207_2932_1387	4	3.75E-05	0.00198805	0.000172855
1433	hsa-mir-1205	hsa05212	Pancreatic cancer	468_207_2932_1387	4	3.91E-05	0.002074259	0.000172855
1434	hsa-mir-1205	hsa03022	Basal transcription factors	2963_6874_6883	3	7.45E-05	0.003945997	0.000303538
1435	hsa-mir-1205	hsa04912	GnRH signaling pathway	5601_468_3725_1432	4	8.09E-05	0.004287319	0.000306237
1436	hsa-mir-1205	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5601_3725_1432	3	0.000465111	0.02465087	0.001602564
1437	hsa-mir-1205	hsa05211	Renal cell carcinoma	207_3725_1387	3	0.000483793	0.025641017	0.001602564
1438	hsa-mir-1205	hsa04370	VEGF signaling pathway	9261_207_1432	3	0.000584423	0.030974401	0.001822024
1439	hsa-mir-1205	hsa04664	Fc epsilon RI signaling pathway	5601_207_1432	3	0.000628135	0.033291177	0.00184951
1440	hsa-mir-1205	hsa04510	Focal adhesion	5601_207_2932_3725	4	0.000884532	0.046880206	0.002467379
1441	hsa-mir-1205	hsa04910	Insulin signaling pathway	5601_207_2932	3	0.00297994	0.157936827	0.007896841
1442	hsa-mir-1205	hsa04930	Type II diabetes mellitus	5601_3651	2	0.004128604	0.218816029	0.010419811
1443	hsa-mir-1205	hsa05213	Endometrial cancer	207_2932	2	0.00541581	0.287037907	0.013047178
1444	hsa-mir-1205	hsa05217	Basal cell carcinoma	2736_2932	2	0.006016769	0.318888769	0.013864729
1445	hsa-mir-1205	hsa04340	Hedgehog signaling pathway	2736_2932	2	0.00643357	0.340979207	0.014135933
1446	hsa-mir-1205	hsa05221	Acute myeloid leukemia	1050_207	2	0.006863174	0.363748197	0.014135933
1447	hsa-mir-1205	hsa05016	Huntington's disease	3064_6874_1387	3	0.006934609	0.367534258	0.014135933
1448	hsa-mir-1205	hsa04920	Adipocytokine signaling pathway	5601_207	2	0.008707483	0.461496596	0.017092467
1449	hsa-mir-1205	hsa04916	Melanogenesis	2932_1387	2	0.019689849	1	0.037270072
1450	hsa-mir-1205	hsa04110	Cell cycle	2932_1387	2	0.025195246	1	0.046046485
1451	hsa-mir-1205	hsa04630	Jak-STAT signaling pathway	207_1387	2	0.040579263	1	0.071690031
1452	hsa-mir-1205	hsa04950	Maturity onset diabetes of the young	3651	1	0.04953318	1	0.08468576
1453	hsa-mir-1206	hsa04010	MAPK signaling pathway	9261_6722_8986_5601_6195_468_207_9252_3725_3727_1386_1432_1649_6196_6197_2353	16	4.83E-19	2.56E-17	2.56E-17
1454	hsa-mir-1206	hsa04660	T cell receptor signaling pathway	5601_207_2932_3725_1432_2353	6	1.35E-07	7.17E-06	3.59E-06
1455	hsa-mir-1206	hsa05200	Pathways in cancer	2736_5601_1050_207_2932_3725_2353_1387	8	4.31E-07	2.29E-05	7.62E-06
1456	hsa-mir-1206	hsa04720	Long-term potentiation	6195_468_6196_6197_1387	5	6.22E-07	3.30E-05	8.25E-06
1457	hsa-mir-1206	hsa05210	Colorectal cancer	5601_207_2932_3725_2353	5	1.06E-06	5.62E-05	1.12E-05
1458	hsa-mir-1206	hsa04620	Toll-like receptor signaling pathway	5601_207_3725_1432_2353	5	2.64E-06	0.000139905	2.33E-05
1459	hsa-mir-1206	hsa04150	mTOR signaling pathway	6195_207_6196_6197	4	5.21E-06	0.000275971	3.94E-05
1460	hsa-mir-1206	hsa04310	Wnt signaling pathway	5601_2932_8061_3725_1387	5	1.71E-05	0.000907783	0.000113473
1461	hsa-mir-1206	hsa04662	B cell receptor signaling pathway	207_2932_3725_2353	4	2.06E-05	0.00109028	0.000121142
1462	hsa-mir-1206	hsa04012	ErbB signaling pathway	5601_207_2932_3725	4	3.59E-05	0.001904493	0.000172855
1463	hsa-mir-1206	hsa05215	Prostate cancer	468_207_2932_1387	4	3.75E-05	0.00198805	0.000172855
1464	hsa-mir-1206	hsa05212	Pancreatic cancer	468_207_2932_1387	4	3.91E-05	0.002074259	0.000172855
1465	hsa-mir-1206	hsa03022	Basal transcription factors	2963_6874_6883	3	7.45E-05	0.003945997	0.000303538
1466	hsa-mir-1206	hsa04912	GnRH signaling pathway	5601_468_3725_1432	4	8.09E-05	0.004287319	0.000306237
1467	hsa-mir-1206	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5601_3725_1432	3	0.000465111	0.02465087	0.001602564
1468	hsa-mir-1206	hsa05211	Renal cell carcinoma	207_3725_1387	3	0.000483793	0.025641017	0.001602564
1469	hsa-mir-1206	hsa04370	VEGF signaling pathway	9261_207_1432	3	0.000584423	0.030974401	0.001822024
1470	hsa-mir-1206	hsa04664	Fc epsilon RI signaling pathway	5601_207_1432	3	0.000628135	0.033291177	0.00184951
1471	hsa-mir-1206	hsa04510	Focal adhesion	5601_207_2932_3725	4	0.000884532	0.046880206	0.002467379
1472	hsa-mir-1206	hsa04910	Insulin signaling pathway	5601_207_2932	3	0.00297994	0.157936827	0.007896841
1473	hsa-mir-1206	hsa04930	Type II diabetes mellitus	5601_3651	2	0.004128604	0.218816029	0.010419811
1474	hsa-mir-1206	hsa05213	Endometrial cancer	207_2932	2	0.00541581	0.287037907	0.013047178
1475	hsa-mir-1206	hsa05217	Basal cell carcinoma	2736_2932	2	0.006016769	0.318888769	0.013864729
1476	hsa-mir-1206	hsa04340	Hedgehog signaling pathway	2736_2932	2	0.00643357	0.340979207	0.014135933
1477	hsa-mir-1206	hsa05221	Acute myeloid leukemia	1050_207	2	0.006863174	0.363748197	0.014135933
1478	hsa-mir-1206	hsa05016	Huntington's disease	3064_6874_1387	3	0.006934609	0.367534258	0.014135933
1479	hsa-mir-1206	hsa04920	Adipocytokine signaling pathway	5601_207	2	0.008707483	0.461496596	0.017092467
1480	hsa-mir-1206	hsa04916	Melanogenesis	2932_1387	2	0.019689849	1	0.037270072
1481	hsa-mir-1206	hsa04110	Cell cycle	2932_1387	2	0.025195246	1	0.046046485
1482	hsa-mir-1206	hsa04630	Jak-STAT signaling pathway	207_1387	2	0.040579263	1	0.071690031
1483	hsa-mir-1206	hsa04950	Maturity onset diabetes of the young	3651	1	0.04953318	1	0.08468576
1484	hsa-mir-1207	hsa04010	MAPK signaling pathway	9261_6722_8986_5601_6195_468_207_9252_3725_3727_1386_1432_1649_6196_6197_2353	16	4.83E-19	2.56E-17	2.56E-17
1485	hsa-mir-1207	hsa04660	T cell receptor signaling pathway	5601_207_2932_3725_1432_2353	6	1.35E-07	7.17E-06	3.59E-06
1486	hsa-mir-1207	hsa05200	Pathways in cancer	2736_5601_1050_207_2932_3725_2353_1387	8	4.31E-07	2.29E-05	7.62E-06
1487	hsa-mir-1207	hsa04720	Long-term potentiation	6195_468_6196_6197_1387	5	6.22E-07	3.30E-05	8.25E-06
1488	hsa-mir-1207	hsa05210	Colorectal cancer	5601_207_2932_3725_2353	5	1.06E-06	5.62E-05	1.12E-05
1489	hsa-mir-1207	hsa04620	Toll-like receptor signaling pathway	5601_207_3725_1432_2353	5	2.64E-06	0.000139905	2.33E-05
1490	hsa-mir-1207	hsa04150	mTOR signaling pathway	6195_207_6196_6197	4	5.21E-06	0.000275971	3.94E-05
1491	hsa-mir-1207	hsa04310	Wnt signaling pathway	5601_2932_8061_3725_1387	5	1.71E-05	0.000907783	0.000113473
1492	hsa-mir-1207	hsa04662	B cell receptor signaling pathway	207_2932_3725_2353	4	2.06E-05	0.00109028	0.000121142
1493	hsa-mir-1207	hsa04012	ErbB signaling pathway	5601_207_2932_3725	4	3.59E-05	0.001904493	0.000172855
1494	hsa-mir-1207	hsa05215	Prostate cancer	468_207_2932_1387	4	3.75E-05	0.00198805	0.000172855
1495	hsa-mir-1207	hsa05212	Pancreatic cancer	468_207_2932_1387	4	3.91E-05	0.002074259	0.000172855
1496	hsa-mir-1207	hsa03022	Basal transcription factors	2963_6874_6883	3	7.45E-05	0.003945997	0.000303538
1497	hsa-mir-1207	hsa04912	GnRH signaling pathway	5601_468_3725_1432	4	8.09E-05	0.004287319	0.000306237
1498	hsa-mir-1207	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5601_3725_1432	3	0.000465111	0.02465087	0.001602564
1499	hsa-mir-1207	hsa05211	Renal cell carcinoma	207_3725_1387	3	0.000483793	0.025641017	0.001602564
1500	hsa-mir-1207	hsa04370	VEGF signaling pathway	9261_207_1432	3	0.000584423	0.030974401	0.001822024
1501	hsa-mir-1207	hsa04664	Fc epsilon RI signaling pathway	5601_207_1432	3	0.000628135	0.033291177	0.00184951
1502	hsa-mir-1207	hsa04510	Focal adhesion	5601_207_2932_3725	4	0.000884532	0.046880206	0.002467379
1503	hsa-mir-1207	hsa04910	Insulin signaling pathway	5601_207_2932	3	0.00297994	0.157936827	0.007896841
1504	hsa-mir-1207	hsa04930	Type II diabetes mellitus	5601_3651	2	0.004128604	0.218816029	0.010419811
1505	hsa-mir-1207	hsa05213	Endometrial cancer	207_2932	2	0.00541581	0.287037907	0.013047178
1506	hsa-mir-1207	hsa05217	Basal cell carcinoma	2736_2932	2	0.006016769	0.318888769	0.013864729
1507	hsa-mir-1207	hsa04340	Hedgehog signaling pathway	2736_2932	2	0.00643357	0.340979207	0.014135933
1508	hsa-mir-1207	hsa05221	Acute myeloid leukemia	1050_207	2	0.006863174	0.363748197	0.014135933
1509	hsa-mir-1207	hsa05016	Huntington's disease	3064_6874_1387	3	0.006934609	0.367534258	0.014135933
1510	hsa-mir-1207	hsa04920	Adipocytokine signaling pathway	5601_207	2	0.008707483	0.461496596	0.017092467
1511	hsa-mir-1207	hsa04916	Melanogenesis	2932_1387	2	0.019689849	1	0.037270072
1512	hsa-mir-1207	hsa04110	Cell cycle	2932_1387	2	0.025195246	1	0.046046485
1513	hsa-mir-1207	hsa04630	Jak-STAT signaling pathway	207_1387	2	0.040579263	1	0.071690031
1514	hsa-mir-1207	hsa04950	Maturity onset diabetes of the young	3651	1	0.04953318	1	0.08468576
1515	hsa-mir-122	hsa04110	Cell cycle	1387_993_983_5925	4	6.13E-07	1.53E-05	1.53E-05
1516	hsa-mir-122	hsa04330	Notch signaling pathway	1387_8850	2	0.000349508	0.008737699	0.004368849
1517	hsa-mir-122	hsa05215	Prostate cancer	1387_5925	2	0.001174155	0.029353887	0.007500885
1518	hsa-mir-122	hsa05212	Pancreatic cancer	1387_5925	2	0.001200142	0.03000354	0.007500885
1519	hsa-mir-122	hsa05200	Pathways in cancer	1387_5925	2	0.015034947	0.37587367	0.064921185
1520	hsa-mir-122	hsa03410	Base excision repair	3146	1	0.020754901	0.518872528	0.064921185
1521	hsa-mir-122	hsa05219	Bladder cancer	5925	1	0.024082113	0.60205283	0.064921185
1522	hsa-mir-122	hsa05223	Non-small cell lung cancer	5925	1	0.030704643	0.767616075	0.064921185
1523	hsa-mir-122	hsa05214	Glioma	5925	1	0.036738118	0.918452946	0.064921185
1524	hsa-mir-122	hsa04115	p53 signaling pathway	983	1	0.038923332	0.97308329	0.064921185
1525	hsa-mir-122	hsa05218	Melanoma	5925	1	0.040014188	1	0.064921185
1526	hsa-mir-122	hsa05211	Renal cell carcinoma	1387	1	0.040559179	1	0.064921185
1527	hsa-mir-122	hsa04720	Long-term potentiation	1387	1	0.042192406	1	0.064921185
1528	hsa-mir-122	hsa05220	Chronic myeloid leukemia	5925	1	0.042192406	1	0.064921185
1529	hsa-mir-122	hsa04520	Adherens junction	1387	1	0.044908637	1	0.064921185
1530	hsa-mir-122	hsa04512	ECM-receptor interaction	9672	1	0.0470764	1	0.064921185
1531	hsa-mir-122	hsa05222	Small cell lung cancer	5925	1	0.048158544	1	0.064921185
1532	hsa-mir-122	hsa04350	TGF-beta signaling pathway	1387	1	0.048699183	1	0.064921185
1533	hsa-mir-122	hsa04612	Antigen processing and presentation	1514	1	0.049779592	1	0.064921185
1534	hsa-mir-1224	hsa05200	Pathways in cancer	3320_3725_7046_1499_5595_5594_1387_6256_1019_1017_5578_6772_5970_7157_4088_862_6774_6502_4087_4089_3065_5925_2033	23	2.48E-19	1.59E-17	1.59E-17
1535	hsa-mir-1224	hsa04350	TGF-beta signaling pathway	6667_3400_7046_5595_5594_1387_3397_3399_3398_4088_4087_4089_2033_4092	14	8.15E-17	5.21E-15	2.61E-15
1536	hsa-mir-1224	hsa04520	Adherens junction	4301_7046_1499_5595_5594_1387_4088_1457_4087_4089_2033	11	8.59E-13	5.50E-11	1.83E-11
1537	hsa-mir-1224	hsa04110	Cell cycle	1387_1019_1017_7157_4088_1028_6502_4087_4089_3065_5925_2033	12	2.21E-12	1.42E-10	3.54E-11
1538	hsa-mir-1224	hsa05220	Chronic myeloid leukemia	7046_5595_5594_1019_5970_7157_4088_4089_3065_5925	10	1.28E-11	8.17E-10	1.63E-10
1539	hsa-mir-1224	hsa05215	Prostate cancer	3320_1499_5595_5594_1387_1017_5970_7157_5925_2033	10	5.41E-11	3.47E-09	5.48E-10
1540	hsa-mir-1224	hsa05212	Pancreatic cancer	3320_1499_5595_5594_1387_1017_5970_7157_5925_2033	10	6.00E-11	3.84E-09	5.48E-10
1541	hsa-mir-1224	hsa05214	Glioma	5595_5594_1019_5578_7157_5925_808_801_805	9	1.03E-10	6.57E-09	8.22E-10
1542	hsa-mir-1224	hsa04010	MAPK signaling pathway	6722_3725_7046_5595_5594_4208_7867_1432_5578_5970_9261_4342_7157_4773	14	1.57E-10	1.01E-08	1.12E-09
1543	hsa-mir-1224	hsa04310	Wnt signaling pathway	3725_1499_1387_5578_7157_4773_4088_1457_4087_4089_2033	11	5.16E-10	3.30E-08	3.30E-09
1544	hsa-mir-1224	hsa05210	Colorectal cancer	3725_7046_1499_5595_5594_7157_4088_4087_4089	9	8.26E-10	5.29E-08	4.81E-09
1545	hsa-mir-1224	hsa04916	Melanogenesis	1499_5595_5594_1387_5578_2033_808_801_805	9	4.72E-09	3.02E-07	2.52E-08
1546	hsa-mir-1224	hsa04720	Long-term potentiation	5595_5594_1387_5578_2033_808_801_805	8	7.64E-09	4.89E-07	3.76E-08
1547	hsa-mir-1224	hsa05223	Non-small cell lung cancer	5595_5594_6256_1019_5578_7157_5925	7	1.99E-08	1.27E-06	9.08E-08
1548	hsa-mir-1224	hsa04912	GnRH signaling pathway	3725_5595_5594_1432_5578_808_801_805	8	1.07E-07	6.88E-06	4.59E-07
1549	hsa-mir-1224	hsa04370	VEGF signaling pathway	5595_5594_7867_1432_5578_9261_4773	7	1.88E-07	1.20E-05	7.52E-07
1550	hsa-mir-1224	hsa04330	Notch signaling pathway	388585_1387_9612_3065_2033_8850	6	2.31E-07	1.48E-05	8.68E-07
1551	hsa-mir-1224	hsa05222	Small cell lung cancer	6256_1019_1017_5970_7157_6502_5925	7	3.79E-07	2.42E-05	1.35E-06
1552	hsa-mir-1224	hsa05216	Thyroid cancer	1499_5595_5594_6256_7157	5	6.39E-07	4.09E-05	2.15E-06
1553	hsa-mir-1224	hsa04660	T cell receptor signaling pathway	3725_5595_5594_1019_1432_5970_4773	7	1.80E-06	0.000115157	5.76E-06
1554	hsa-mir-1224	hsa05219	Bladder cancer	5595_5594_1019_7157_5925	5	3.35E-06	0.000214301	1.02E-05
1555	hsa-mir-1224	hsa04620	Toll-like receptor signaling pathway	3725_5595_5594_1432_6772_5970	6	1.54E-05	0.000987038	4.33E-05
1556	hsa-mir-1224	hsa05221	Acute myeloid leukemia	5595_5594_5970_862_6774	5	1.56E-05	0.000996582	4.33E-05
1557	hsa-mir-1224	hsa04270	Vascular smooth muscle contraction	5595_5594_5578_808_801_805	6	3.38E-05	0.002160843	9.00E-05
1558	hsa-mir-1224	hsa05218	Melanoma	5595_5594_1019_7157_5925	5	3.60E-05	0.00230408	9.22E-05
1559	hsa-mir-1224	hsa05211	Renal cell carcinoma	3725_5595_5594_1387_2033	5	3.84E-05	0.002454472	9.44E-05
1560	hsa-mir-1224	hsa04662	B cell receptor signaling pathway	3725_5595_5594_5970_4773	5	4.61E-05	0.00295163	0.00010932
1561	hsa-mir-1224	hsa05213	Endometrial cancer	1499_5595_5594_7157	4	0.000163659	0.010474198	0.000374079
1562	hsa-mir-1224	hsa04950	Maturity onset diabetes of the young	3651_168620_4760	3	0.0003049	0.019513568	0.000672882
1563	hsa-mir-1224	hsa04070	Phosphatidylinositol signaling system	5578_808_801_805	4	0.000643772	0.04120143	0.001373381
1564	hsa-mir-1224	hsa04530	Tight junction	4301_1499_1019_5578_1457	5	0.000675127	0.043208135	0.001393752
1565	hsa-mir-1224	hsa04910	Insulin signaling pathway	5595_5594_808_801_805	5	0.000696876	0.044600075	0.001393752
1566	hsa-mir-1224	hsa04664	Fc epsilon RI signaling pathway	5595_5594_1432_5578	4	0.000739597	0.047334196	0.00143437
1567	hsa-mir-1224	hsa04012	ErbB signaling pathway	3725_5595_5594_5578	4	0.001043815	0.066804161	0.001964828
1568	hsa-mir-1224	hsa04930	Type II diabetes mellitus	3651_5595_5594	3	0.001672954	0.107069048	0.003059116
1569	hsa-mir-1224	hsa05010	Alzheimer's disease	5595_5594_808_801_805	5	0.002031473	0.130014276	0.003611508
1570	hsa-mir-1224	hsa05016	Huntington's disease	6667_1387_7157_3065_2033	5	0.002619108	0.167622943	0.00453035
1571	hsa-mir-1224	hsa04062	Chemokine signaling pathway	5595_5594_6772_5970_6774	5	0.002923358	0.187094914	0.00492355
1572	hsa-mir-1224	hsa04670	Leukocyte transendothelial migration	4301_1499_1432_5578	4	0.003428574	0.219428719	0.005626377
1573	hsa-mir-1224	hsa04510	Focal adhesion	3725_1499_5595_5594_5578	5	0.003833119	0.245319629	0.006132991
1574	hsa-mir-1224	hsa04920	Adipocytokine signaling pathway	6256_5970_6774	3	0.004897428	0.313435366	0.007644765
1575	hsa-mir-1224	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_5578_4773	4	0.005238631	0.335272354	0.007885719
1576	hsa-mir-1224	hsa04115	p53 signaling pathway	1019_1017_7157	3	0.005298218	0.339085934	0.007885719
1577	hsa-mir-1224	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_1432_5970	3	0.005718187	0.365963968	0.008132533
1578	hsa-mir-1224	hsa04730	Long-term depression	5595_5594_5578	3	0.005718187	0.365963968	0.008132533
1579	hsa-mir-1224	hsa04630	Jak-STAT signaling pathway	1387_6772_6774_2033	4	0.007765277	0.49697773	0.010803864
1580	hsa-mir-1224	hsa04540	Gap junction	5595_5594_5578	3	0.011663339	0.746453696	0.015881994
1581	hsa-mir-1224	hsa04020	Calcium signaling pathway	5578_808_801_805	4	0.013710138	0.877448848	0.018280184
1582	hsa-mir-1224	hsa03050	Proteasome	5684_5710	2	0.024830139	1	0.032431202
1583	hsa-mir-1224	hsa04360	Axon guidance	5595_5594_4773	3	0.028021394	1	0.035867384
1584	hsa-mir-1224	hsa04150	mTOR signaling pathway	5595_5594	2	0.028642405	1	0.03594341
1585	hsa-mir-1224	hsa05217	Basal cell carcinoma	1499_7157	2	0.031644889	1	0.037339647
1586	hsa-mir-1224	hsa04120	Ubiquitin mediated proteolysis	997_7329_6502	3	0.032471912	1	0.037339647
1587	hsa-mir-1224	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_7157	2	0.032672191	1	0.037339647
1588	hsa-mir-1224	hsa05131	Shigellosis	1499_5578	2	0.032672191	1	0.037339647
1589	hsa-mir-1224	hsa05130	Pathogenic Escherichia coli infection	1499_5578	2	0.032672191	1	0.037339647
1590	hsa-mir-1225	hsa05200	Pathways in cancer	5371_5595_5594_5914_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846	28	4.16E-32	2.58E-30	2.58E-30
1591	hsa-mir-1225	hsa05220	Chronic myeloid leukemia	5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464	15	1.54E-22	9.54E-21	4.77E-21
1592	hsa-mir-1225	hsa04110	Cell cycle	5591_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933	14	3.66E-18	2.27E-16	7.56E-17
1593	hsa-mir-1225	hsa05215	Prostate cancer	5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033	11	9.26E-15	5.74E-13	1.29E-13
1594	hsa-mir-1225	hsa05212	Pancreatic cancer	5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033	11	1.04E-14	6.44E-13	1.29E-13
1595	hsa-mir-1225	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_4609_1869_5925	9	3.49E-14	2.16E-12	3.60E-13
1596	hsa-mir-1225	hsa05210	Colorectal cancer	5595_5594_595_836_7157_4087_4609_3725_4088_4089	10	2.52E-13	1.56E-11	2.04E-12
1597	hsa-mir-1225	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_7157_1869_5925	9	2.63E-13	1.63E-11	2.04E-12
1598	hsa-mir-1225	hsa05222	Small cell lung cancer	6256_595_5970_1870_1871_7157_4609_1869_5925_4846	10	3.13E-13	1.94E-11	2.16E-12
1599	hsa-mir-1225	hsa05214	Glioma	5595_5594_595_1870_1871_7157_1869_5925_6464	9	1.20E-12	7.43E-11	7.43E-12
1600	hsa-mir-1225	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_5970_4609	8	2.63E-11	1.63E-09	1.48E-10
1601	hsa-mir-1225	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5925	8	1.02E-10	6.34E-09	5.28E-10
1602	hsa-mir-1225	hsa05211	Renal cell carcinoma	5595_5594_3091_7428_2113_3725_2034_2033	8	1.13E-10	7.03E-09	5.40E-10
1603	hsa-mir-1225	hsa04350	TGF-beta signaling pathway	5595_5594_4087_4609_4088_4089_2033_5933	8	4.58E-10	2.84E-08	2.03E-09
1604	hsa-mir-1225	hsa05216	Thyroid cancer	5595_5594_6256_595_7157_4609	6	9.15E-10	5.67E-08	3.78E-09
1605	hsa-mir-1225	hsa04310	Wnt signaling pathway	595_7157_4087_4609_3725_1457_4088_4089_2033	9	1.40E-09	8.68E-08	5.42E-09
1606	hsa-mir-1225	hsa04520	Adherens junction	5595_5594_4087_1457_4088_4089_2033	7	8.13E-09	5.04E-07	2.96E-08
1607	hsa-mir-1225	hsa04010	MAPK signaling pathway	5595_5594_4208_836_3312_5970_7157_4609_3725_4763	10	1.36E-08	8.45E-07	4.69E-08
1608	hsa-mir-1225	hsa05016	Huntington's disease	6874_2902_836_7157_3066_3065_3064_2033	8	1.38E-07	8.55E-06	4.50E-07
1609	hsa-mir-1225	hsa05213	Endometrial cancer	5595_5594_595_7157_4609	5	7.92E-07	4.91E-05	2.46E-06
1610	hsa-mir-1225	hsa04012	ErbB signaling pathway	5595_5594_4609_3725_6464	5	8.57E-06	0.000531387	2.53E-05
1611	hsa-mir-1225	hsa04330	Notch signaling pathway	9612_3066_3065_2033	4	1.68E-05	0.001041198	4.73E-05
1612	hsa-mir-1225	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_7157_4846	4	3.21E-05	0.001990422	8.65E-05
1613	hsa-mir-1225	hsa04720	Long-term potentiation	5595_5594_2902_2033	4	9.47E-05	0.005872995	0.00023492
1614	hsa-mir-1225	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725	4	9.47E-05	0.005872995	0.00023492
1615	hsa-mir-1225	hsa05010	Alzheimer's disease	5595_5594_2902_836_4846	5	0.000222199	0.013776311	0.000529858
1616	hsa-mir-1225	hsa04620	Toll-like receptor signaling pathway	5595_5594_5970_3725	4	0.00029453	0.018260834	0.000676327
1617	hsa-mir-1225	hsa04660	T cell receptor signaling pathway	5595_5594_5970_3725	4	0.000388502	0.024087104	0.000860254
1618	hsa-mir-1225	hsa04510	Focal adhesion	5595_5594_595_3725_6464	5	0.000438211	0.027169068	0.000936864
1619	hsa-mir-1225	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.000606587	0.037608391	0.001253613
1620	hsa-mir-1225	hsa04910	Insulin signaling pathway	6720_5595_5594_6464	4	0.000887004	0.054994227	0.00171857
1621	hsa-mir-1225	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_6464	4	0.000887004	0.054994227	0.00171857
1622	hsa-mir-1225	hsa04115	p53 signaling pathway	595_836_7157	3	0.001329343	0.082419271	0.002497554
1623	hsa-mir-1225	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_5970_3725	3	0.001438684	0.089198411	0.002548526
1624	hsa-mir-1225	hsa04730	Long-term depression	5595_5594_4846	3	0.001438684	0.089198411	0.002548526
1625	hsa-mir-1225	hsa04370	VEGF signaling pathway	5595_5594_4846	3	0.001800045	0.11160278	0.003100077
1626	hsa-mir-1225	hsa04612	Antigen processing and presentation	4800_4801_3312	3	0.002681283	0.166239573	0.004374726
1627	hsa-mir-1225	hsa04210	Apoptosis	836_5970_7157	3	0.002681283	0.166239573	0.004374726
1628	hsa-mir-1225	hsa04062	Chemokine signaling pathway	5595_5594_5970_6464	4	0.002936341	0.182053166	0.00466803
1629	hsa-mir-1225	hsa04916	Melanogenesis	5595_5594_2033	3	0.004103678	0.25442802	0.0063607
1630	hsa-mir-1225	hsa04912	GnRH signaling pathway	5595_5594_3725	3	0.004546884	0.281906832	0.006875776
1631	hsa-mir-1225	hsa04930	Type II diabetes mellitus	5595_5594	2	0.008763359	0.543328272	0.012922499
1632	hsa-mir-1225	hsa04120	Ubiquitin mediated proteolysis	5371_672_7428	3	0.008962379	0.555667472	0.012922499
1633	hsa-mir-1225	hsa04630	Jak-STAT signaling pathway	595_4609_2033	3	0.011958015	0.741396911	0.01684993
1634	hsa-mir-1225	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.018228702	1	0.025115101
1635	hsa-mir-1225	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.024601767	1	0.033158903
1636	hsa-mir-1225	hsa04540	Gap junction	5595_5594	2	0.033006835	1	0.043540931
1637	hsa-mir-1225	hsa04710	Circadian rhythm - mammal	8863	1	0.041078632	1	0.0530599
1638	hsa-mir-1225	hsa03450	Non-homologous end-joining	5591	1	0.043948127	1	0.055607834
1639	hsa-mir-1227	hsa05215	Prostate cancer	10488	1	0.005924236	0.023696946	0.009316535
1640	hsa-mir-1227	hsa05212	Pancreatic cancer	10488	1	0.005990701	0.023962804	0.009316535
1641	hsa-mir-1227	hsa04916	Melanogenesis	10488	1	0.006987401	0.027949605	0.009316535
1642	hsa-mir-1227	hsa05016	Huntington's disease	10488	1	0.012559684	0.050238736	0.012559684
1643	hsa-mir-1228	hsa05200	Pathways in cancer	3716_1147_5747_3725_3551_1956_367_1499_5594_5599_6258_2064_6256_5159_8031_5156_2261_3815_2932_1387_6774_6257_6776_6777_5879_8772_2353_4087_4088_4089_2033_207_8554_5970_7046	35	1.67E-30	1.12E-28	1.12E-28
1644	hsa-mir-1228	hsa04010	MAPK signaling pathway	1147_3725_3727_3551_1956_5594_5599_1386_5159_5156_7132_2261_2264_9252_1432_1649_1845_5879_10912_468_2353_5058_4616_207_5970_7046	26	8.75E-22	5.86E-20	2.93E-20
1645	hsa-mir-1228	hsa04920	Adipocytokine signaling pathway	3717_1147_3551_10891_8717_5599_6258_6256_7133_7132_6774_6257_5781_207_5970_2538	16	1.73E-19	1.16E-17	3.87E-18
1646	hsa-mir-1228	hsa04630	Jak-STAT signaling pathway	3717_3716_3560_3561_1387_6774_6776_6777_6773_58985_3455_3459_5781_7297_1439_2033_207_8554_10379	19	4.67E-18	3.13E-16	7.81E-17
1647	hsa-mir-1228	hsa05215	Prostate cancer	1147_3551_1956_367_1499_5594_2064_5159_5156_2932_1387_468_2033_207_5970_90993	16	7.92E-18	5.30E-16	1.04E-16
1648	hsa-mir-1228	hsa05212	Pancreatic cancer	1147_3551_1956_367_1499_5594_2064_5159_5156_2932_1387_468_2033_207_5970_90993	16	9.29E-18	6.22E-16	1.04E-16
1649	hsa-mir-1228	hsa05210	Colorectal cancer	3725_1956_1499_5594_5599_5159_5156_2932_5879_2353_4087_4088_4089_207_7046	15	1.10E-16	7.37E-15	1.05E-15
1650	hsa-mir-1228	hsa04012	ErbB signaling pathway	5747_3725_818_817_1956_6714_5594_5599_2064_2932_6776_6777_5058_207	14	4.30E-15	2.88E-13	3.60E-14
1651	hsa-mir-1228	hsa04060	Cytokine-cytokine receptor interaction	2321_3791_1956_3560_3561_90_5159_5156_7133_7132_1234_1230_3815_7852_58985_3455_3459_1439_7046	19	3.45E-14	2.31E-12	2.51E-13
1652	hsa-mir-1228	hsa04520	Adherens junction	1956_1499_6714_5594_2064_1387_5879_4087_4088_4089_2033_7046_2534	13	3.75E-14	2.51E-12	2.51E-13
1653	hsa-mir-1228	hsa04062	Chemokine signaling pathway	3717_1147_5747_3551_5594_1234_1230_2932_5580_6774_6777_6773_5879_7852_5058_207_5970	17	4.27E-14	2.86E-12	2.60E-13
1654	hsa-mir-1228	hsa04510	Focal adhesion	5747_3725_2321_3791_1956_1499_6714_5594_5599_2064_5159_5156_2932_5879_5058_207_2534	17	1.15E-13	7.69E-12	6.41E-13
1655	hsa-mir-1228	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3725_3551_1956_6714_5599_1432_5879_5781_5058_5970	11	5.76E-12	3.86E-10	2.97E-11
1656	hsa-mir-1228	hsa05220	Chronic myeloid leukemia	1147_3551_5594_6776_6777_5781_4088_4089_207_5970_7046	11	9.84E-12	6.60E-10	4.71E-11
1657	hsa-mir-1228	hsa04620	Toll-like receptor signaling pathway	1147_3725_3551_5594_5599_1432_5879_3455_8772_2353_207_5970	12	1.16E-11	7.80E-10	5.20E-11
1658	hsa-mir-1228	hsa04660	T cell receptor signaling pathway	1147_3725_3551_3932_5594_2932_1432_2353_5058_207_5970_2534	12	2.61E-11	1.75E-09	1.09E-10
1659	hsa-mir-1228	hsa04110	Cell cycle	7532_7534_2932_1387_10912_4174_4172_4087_4088_4089_4616_2033	12	6.08E-11	4.07E-09	2.39E-10
1660	hsa-mir-1228	hsa04662	B cell receptor signaling pathway	1147_3725_3551_5594_6850_2932_5879_2353_207_5970	10	2.06E-10	1.38E-08	7.66E-10
1661	hsa-mir-1228	hsa05221	Acute myeloid leukemia	1147_3551_5594_3815_6774_6776_6777_207_5970	9	5.76E-10	3.86E-08	2.03E-09
1662	hsa-mir-1228	hsa04310	Wnt signaling pathway	3725_818_817_1499_5599_2932_1387_5879_4087_4088_4089_2033	12	8.33E-10	5.58E-08	2.79E-09
1663	hsa-mir-1228	hsa04912	GnRH signaling pathway	3725_818_817_1956_6714_5594_5599_1432_5580_468	10	5.33E-09	3.57E-07	1.70E-08
1664	hsa-mir-1228	hsa05222	Small cell lung cancer	1147_5747_3551_6258_6256_6257_207_8554_5970	9	1.18E-08	7.92E-07	3.60E-08
1665	hsa-mir-1228	hsa04350	TGF-beta signaling pathway	5594_90_1387_4087_4088_4089_2033_7046_57154	9	1.30E-08	8.69E-07	3.78E-08
1666	hsa-mir-1228	hsa05211	Renal cell carcinoma	3725_5594_1387_5879_5781_5058_2033_207	8	5.10E-08	3.42E-06	1.42E-07
1667	hsa-mir-1228	hsa04916	Melanogenesis	818_817_1499_5594_3815_2932_1387_2033_90993	9	5.44E-08	3.64E-06	1.46E-07
1668	hsa-mir-1228	hsa05216	Thyroid cancer	1499_5594_6258_6256_8031_6257	6	9.33E-08	6.25E-06	2.40E-07
1669	hsa-mir-1228	hsa04664	Fc epsilon RI signaling pathway	5594_5599_6850_1432_5580_5879_207_2534	8	9.90E-08	6.63E-06	2.46E-07
1670	hsa-mir-1228	hsa05223	Non-small cell lung cancer	1956_5594_6258_2064_6256_6257_207	7	1.37E-07	9.15E-06	3.27E-07
1671	hsa-mir-1228	hsa04210	Apoptosis	1147_3551_8717_7132_8772_1439_207_5970	8	2.32E-07	1.55E-05	5.35E-07
1672	hsa-mir-1228	hsa05214	Glioma	818_817_1956_5594_5159_5156_207	7	4.34E-07	2.91E-05	9.70E-07
1673	hsa-mir-1228	hsa04650	Natural killer cell mediated cytotoxicity	3932_5594_6850_5879_3455_3459_5781_5058_2534	9	5.19E-07	3.48E-05	1.12E-06
1674	hsa-mir-1228	hsa04370	VEGF signaling pathway	5747_3791_6714_5594_1432_5879_207	7	1.25E-06	8.39E-05	2.62E-06
1675	hsa-mir-1228	hsa05213	Endometrial cancer	1956_1499_5594_2064_2932_207	6	2.06E-06	0.000137755	4.17E-06
1676	hsa-mir-1228	hsa05219	Bladder cancer	1956_5594_2064_2261_9252	5	1.31E-05	0.000879855	2.59E-05
1677	hsa-mir-1228	hsa04720	Long-term potentiation	818_817_5594_1387_468_2033	6	1.46E-05	0.000976641	2.79E-05
1678	hsa-mir-1228	hsa04810	Regulation of actin cytoskeleton	5747_1956_5594_5159_5156_2261_2264_5879_5058	9	1.88E-05	0.001262328	3.51E-05
1679	hsa-mir-1228	hsa04360	Axon guidance	5747_5594_2932_5879_7852_5058_2534	7	3.34E-05	0.002237341	6.05E-05
1680	hsa-mir-1228	hsa04910	Insulin signaling pathway	3551_10891_5594_5599_2932_207_2538	7	4.58E-05	0.003068868	8.08E-05
1681	hsa-mir-1228	hsa03320	PPAR signaling pathway	10062_6258_6256_6257_2168	5	0.000127663	0.008553398	0.000219318
1682	hsa-mir-1228	hsa05218	Melanoma	1956_5594_5159_5156_207	5	0.000135943	0.009108164	0.000227704
1683	hsa-mir-1228	hsa04670	Leukocyte transendothelial migration	5747_1499_1432_5879_7852_5781	6	0.000189593	0.012702746	0.000309823
1684	hsa-mir-1228	hsa04020	Calcium signaling pathway	818_817_1956_2064_5159_5156_147	7	0.000254749	0.017068161	0.000406385
1685	hsa-mir-1228	hsa04930	Type II diabetes mellitus	3551_5594_5599_5580	4	0.00028469	0.019074245	0.000443587
1686	hsa-mir-1228	hsa04120	Ubiquitin mediated proteolysis	11059_672_4734_7329_8554_57154	6	0.000371241	0.024873116	0.000565298
1687	hsa-mir-1228	hsa04540	Gap junction	1956_6714_5594_5159_5156	5	0.000445663	0.029859404	0.000663542
1688	hsa-mir-1228	hsa05014	Amyotrophic lateral sclerosis (ALS)	7133_7132_1432_5879	4	0.00061998	0.041538692	0.000903015
1689	hsa-mir-1228	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.00415885	0.278642937	0.005928573
1690	hsa-mir-1228	hsa05131	Shigellosis	1499_7534_2534	3	0.006611851	0.442993993	0.009040694
1691	hsa-mir-1228	hsa05130	Pathogenic Escherichia coli infection	1499_7534_2534	3	0.006611851	0.442993993	0.009040694
1692	hsa-mir-1228	hsa04950	Maturity onset diabetes of the young	3172_4760	2	0.012179098	0.815999567	0.016319991
1693	hsa-mir-1228	hsa04530	Tight junction	1499_6714_5580_207	4	0.013403539	0.89803714	0.017608571
1694	hsa-mir-1228	hsa05340	Primary immunodeficiency	3932_3561	2	0.023829295	1	0.03070313
1695	hsa-mir-1228	hsa03030	DNA replication	4174_4172	2	0.025047902	1	0.031664329
1696	hsa-mir-1228	hsa05010	Alzheimer's disease	5594_7132_2932_8772	4	0.030192558	1	0.037461136
1697	hsa-mir-1228	hsa05016	Huntington's disease	10891_1387_2033_90993	4	0.036300292	1	0.044220356
1698	hsa-mir-1228	hsa04270	Vascular smooth muscle contraction	5594_5580_147	3	0.043894636	1	0.052516797
1699	hsa-mir-1228	hsa04150	mTOR signaling pathway	5594_207	2	0.047693006	1	0.0560602
1700	hsa-mir-1229	hsa05200	Pathways in cancer	3716_1147_4609_3320_3326_5970_675_1956_5468_5595_5594_5599_1387_6256_5159_595_5156_5601_898_1019_1399_1398_367_8517_3815_3551_5578_6774_6777_6772_10401_5371_4791_3725_867_1017_2353_4088_4089_3066_3065_5925_2033_8554_4790_4792	46	1.13E-28	9.01E-27	9.01E-27
1701	hsa-mir-1229	hsa05220	Chronic myeloid leukemia	1147_4609_5970_5595_5594_595_1019_1399_1398_8517_3551_6777_5781_867_4088_4089_3066_3065_5925_4790_4792_6464	22	2.50E-20	2.00E-18	1.00E-18
1702	hsa-mir-1229	hsa04010	MAPK signaling pathway	1147_4609_5970_1956_5595_5594_6722_5599_1386_5159_5156_5601_3305_3303_5566_1399_1398_8517_9252_3312_1432_3551_5578_1649_5971_1326_4342_5608_4791_6885_3725_9020_2353_4790	34	3.94E-20	3.16E-18	1.05E-18
1703	hsa-mir-1229	hsa04660	T cell receptor signaling pathway	1147_5970_3932_4794_5595_5594_5601_919_1019_8517_1432_3551_1326_6885_3725_9020_867_2353_4790_4792_4793_1493	22	2.86E-17	2.29E-15	5.72E-16
1704	hsa-mir-1229	hsa05215	Prostate cancer	1147_3320_3326_5970_1956_5595_5594_1387_5159_595_5156_898_367_8517_3551_1017_5925_2033_4790_4792	20	9.43E-17	7.54E-15	1.51E-15
1705	hsa-mir-1229	hsa05212	Pancreatic cancer	1147_3320_3326_5970_1956_5595_5594_1387_5159_595_5156_898_367_8517_3551_1017_5925_2033_4790_4792	20	1.14E-16	9.11E-15	1.52E-15
1706	hsa-mir-1229	hsa04630	Jak-STAT signaling pathway	3717_3716_4609_3718_8651_85480_3560_3561_1387_595_3575_6774_6777_6772_10401_2690_2057_5781_867_6778_2033_894_896_8554	24	1.78E-16	1.43E-14	2.04E-15
1707	hsa-mir-1229	hsa04620	Toll-like receptor signaling pathway	1147_5970_29110_5595_5594_5599_5601_3661_8517_9641_1432_3551_6772_1326_5608_6885_3725_2353_4790_4792	20	1.13E-15	9.01E-14	1.06E-14
1708	hsa-mir-1229	hsa04310	Wnt signaling pathway	4609_5515_23291_5519_5599_1387_595_8607_5601_5566_1457_8454_5578_8945_8061_6885_3725_6500_4088_4089_2033_894_896	23	1.19E-15	9.55E-14	1.06E-14
1709	hsa-mir-1229	hsa04920	Adipocytokine signaling pathway	3717_1147_5970_4794_5599_6256_5601_8517_3551_6774_5781_8471_4790_4792_4793_5465	16	5.91E-14	4.73E-12	4.73E-13
1710	hsa-mir-1229	hsa04110	Cell cycle	1111_5591_1387_595_898_1019_8454_5111_1028_1017_6500_4088_4089_3066_3065_5925_2033_894_896	19	1.57E-13	1.26E-11	1.12E-12
1711	hsa-mir-1229	hsa04350	TGF-beta signaling pathway	4609_5515_5519_3400_5595_5594_1387_6667_8454_3397_3399_3398_6500_4088_4089_2033_4092	17	1.68E-13	1.34E-11	1.12E-12
1712	hsa-mir-1229	hsa04062	Chemokine signaling pathway	3717_1147_3718_5970_5590_5595_5594_5566_1399_1398_1234_8517_3551_6774_6777_6772_653361_4790_4792_4793_6464	21	6.81E-12	5.45E-10	4.19E-11
1713	hsa-mir-1229	hsa04910	Insulin signaling pathway	8651_3643_5590_5595_5594_5599_5601_5566_1399_1398_5770_3551_8471_867_808_6464_801_805	18	1.46E-11	1.17E-09	8.34E-11
1714	hsa-mir-1229	hsa05222	Small cell lung cancer	1147_4609_5970_6256_595_898_1019_8517_3551_10401_1017_5925_8554_4790_4792	15	1.90E-11	1.52E-09	1.01E-10
1715	hsa-mir-1229	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_5970_1956_6714_5599_5601_8517_1432_3551_5781_3725_9020_4790_4792	14	2.11E-11	1.69E-09	1.03E-10
1716	hsa-mir-1229	hsa04012	ErbB signaling pathway	4609_1956_6714_5595_5594_5599_2066_5601_1399_1398_5578_6777_3725_867_6464	15	2.20E-11	1.76E-09	1.03E-10
1717	hsa-mir-1229	hsa05221	Acute myeloid leukemia	1147_4609_5970_5595_5594_595_8517_3815_3551_6774_6777_5371_4790	13	3.30E-11	2.64E-09	1.47E-10
1718	hsa-mir-1229	hsa04662	B cell receptor signaling pathway	1147_695_5970_4794_5595_5594_6850_8517_3551_3725_2353_4790_4792_4793	14	4.03E-11	3.22E-09	1.70E-10
1719	hsa-mir-1229	hsa05214	Glioma	1956_5595_5594_5159_595_5156_1019_5578_5925_808_6464_801_805	13	9.49E-11	7.59E-09	3.79E-10
1720	hsa-mir-1229	hsa04520	Adherens junction	1956_6714_3643_5595_5594_1387_1457_5770_71_6885_4088_4089_2033	13	9.18E-10	7.34E-08	3.50E-09
1721	hsa-mir-1229	hsa05210	Colorectal cancer	4609_1956_5595_5594_5599_5159_595_5156_5601_3725_2353_4088_4089	13	1.56E-09	1.25E-07	5.69E-09
1722	hsa-mir-1229	hsa04912	GnRH signaling pathway	1956_6714_5595_5594_5599_5601_5566_1432_5578_5608_3725_808_801_805	14	2.93E-09	2.34E-07	1.02E-08
1723	hsa-mir-1229	hsa04540	Gap junction	1956_6714_5595_5594_5159_5156_5566_5578_10382_347733_7278_203068_7846	13	4.75E-09	3.80E-07	1.58E-08
1724	hsa-mir-1229	hsa04510	Focal adhesion	1956_6714_5595_5594_5599_5159_595_5156_5601_1399_1398_5578_71_3725_894_896_6464	17	3.19E-08	2.55E-06	1.02E-07
1725	hsa-mir-1229	hsa04120	Ubiquitin mediated proteolysis	55294_8651_23291_997_672_51366_8454_10401_5371_8945_867_6500_64326_8554	14	5.46E-08	4.37E-06	1.68E-07
1726	hsa-mir-1229	hsa04930	Type II diabetes mellitus	8651_3643_5590_5595_5594_5599_5601_3551_8471	9	7.59E-08	6.07E-06	2.25E-07
1727	hsa-mir-1229	hsa05016	Huntington's disease	498_25942_5468_1387_292_6908_6667_1213_293_5437_3066_3065_2033_5441_4724	15	3.08E-07	2.47E-05	8.81E-07
1728	hsa-mir-1229	hsa04720	Long-term potentiation	814_5595_5594_1387_5566_5578_808_2033_801_805	10	4.28E-07	3.43E-05	1.18E-06
1729	hsa-mir-1229	hsa05219	Bladder cancer	4609_1956_5595_5594_595_1019_9252_5925	8	5.64E-07	4.51E-05	1.50E-06
1730	hsa-mir-1229	hsa03010	Ribosome	6124_6141_6155_6156_9349_6143_6129_6128_6207_6217_6188	11	7.88E-07	6.30E-05	2.03E-06
1731	hsa-mir-1229	hsa05223	Non-small cell lung cancer	1956_5595_5594_6256_595_1019_5578_5925	8	3.05E-06	0.000244396	7.64E-06
1732	hsa-mir-1229	hsa05131	Shigellosis	5578_71_10382_347733_7278_4691_203068_7846	8	3.90E-06	0.000311974	9.18E-06
1733	hsa-mir-1229	hsa05130	Pathogenic Escherichia coli infection	5578_71_10382_347733_7278_4691_203068_7846	8	3.90E-06	0.000311974	9.18E-06
1734	hsa-mir-1229	hsa04664	Fc epsilon RI signaling pathway	695_5595_5594_5599_6850_5601_1432_5578_5608	9	5.29E-06	0.000423184	1.21E-05
1735	hsa-mir-1229	hsa04916	Melanogenesis	5595_5594_1387_5566_3815_5578_808_2033_801_805	10	6.42E-06	0.000513548	1.43E-05
1736	hsa-mir-1229	hsa03020	RNA polymerase	64425_25885_5437_51082_84172_5441	6	1.00E-05	0.000802536	2.11E-05
1737	hsa-mir-1229	hsa05216	Thyroid cancer	4609_5468_5595_5594_6256_595	6	1.00E-05	0.000802536	2.11E-05
1738	hsa-mir-1229	hsa04330	Notch signaling pathway	1387_4851_9612_3066_3065_2033_8850	7	1.24E-05	0.000991236	2.54E-05
1739	hsa-mir-1229	hsa04210	Apoptosis	1147_5970_5566_8517_3551_9131_9020_4790_4792	9	1.28E-05	0.001026481	2.57E-05
1740	hsa-mir-1229	hsa04115	p53 signaling pathway	1111_595_898_1019_1017_64326_894_896	8	1.57E-05	0.001259267	3.07E-05
1741	hsa-mir-1229	hsa05218	Melanoma	1956_5595_5594_5159_595_5156_1019_5925	8	1.90E-05	0.001522522	3.63E-05
1742	hsa-mir-1229	hsa05211	Renal cell carcinoma	5595_5594_1387_1399_1398_5781_3725_2033	8	2.09E-05	0.001670562	3.89E-05
1743	hsa-mir-1229	hsa05340	Primary immunodeficiency	3718_695_3932_3561_3575_8517	6	2.58E-05	0.002066154	4.70E-05
1744	hsa-mir-1229	hsa04020	Calcium signaling pathway	814_1956_292_2066_5159_5156_5566_5578_293_808_801_805	12	3.12E-05	0.00249513	5.54E-05
1745	hsa-mir-1229	hsa03022	Basal transcription factors	2969_6878_6908_6872_6882_2959	6	3.42E-05	0.002733918	5.94E-05
1746	hsa-mir-1229	hsa04530	Tight junction	5515_5519_6714_5590_1457_1019_5578_71_4628	9	0.000286849	0.022947923	0.000488254
1747	hsa-mir-1229	hsa04810	Regulation of actin cytoskeleton	1956_5595_5594_5159_5156_1399_1398_71_4628_4342_10788	11	0.000564352	0.045148147	0.000940586
1748	hsa-mir-1229	hsa04650	Natural killer cell mediated cytotoxicity	3932_5595_5594_6850_919_5578_5781_6464	8	0.001330112	0.106408978	0.002171612
1749	hsa-mir-1229	hsa05213	Endometrial cancer	4609_1956_5595_5594_595	5	0.001392824	0.111425903	0.002228518
1750	hsa-mir-1229	hsa04060	Cytokine-cytokine receptor interaction	85480_1956_3560_3561_5159_5156_3575_1234_3815_2690_2057	11	0.002234982	0.178798526	0.003505853
1751	hsa-mir-1229	hsa04270	Vascular smooth muscle contraction	5595_5594_5566_5578_808_801_805	7	0.002324812	0.185984937	0.003576633
1752	hsa-mir-1229	hsa04612	Antigen processing and presentation	3320_3326_3309_3305_3303_3312	6	0.00259614	0.207691209	0.003918702
1753	hsa-mir-1229	hsa04730	Long-term depression	5515_5519_5595_5594_5578	5	0.004917881	0.393430453	0.007285749
1754	hsa-mir-1229	hsa04370	VEGF signaling pathway	6714_5595_5594_1432_5578	5	0.006771911	0.541752912	0.009850053
1755	hsa-mir-1229	hsa05012	Parkinson's disease	498_7314_292_293_7345_4724	6	0.017446439	1	0.024923485
1756	hsa-mir-1229	hsa05010	Alzheimer's disease	498_5595_5594_808_4724_801_805	7	0.017979711	1	0.025234682
1757	hsa-mir-1229	hsa03410	Base excision repair	5111_142_3146	3	0.018658448	1	0.025735791
1758	hsa-mir-1229	hsa03320	PPAR signaling pathway	10062_5468_6256_5465	4	0.022418418	1	0.030397854
1759	hsa-mir-1229	hsa04070	Phosphatidylinositol signaling system	5578_808_801_805	4	0.02882885	1	0.038438467
1760	hsa-mir-1229	hsa04670	Leukocyte transendothelial migration	1432_5578_71_5781_653361	5	0.037523933	1	0.049211715
1761	hsa-mir-1231	hsa05200	Pathways in cancer	7046_595_596_598_1017_4193_5578_3091_3066_3065_5925_613_5743_5747_25_1956_6789_2064_4436_5970_6774_207_3716_1147_998_367_4233_2261_5595_5594_5599_1387_10401_2932_6777_6772_5979_5879_1869_3725_6776_4087_4088_4089_5888_5728_2033_675_3910_4790_4792_3320_3326_5371_3480_5159_5156_5601_5602_1856_3815_51588_8772_1026_2353_1441_8554	67	1.11E-48	9.43E-47	9.43E-47
1762	hsa-mir-1231	hsa04110	Cell cycle	595_1017_4193_902_4174_4172_3066_3065_5925_25_9232_545_995_5347_5591_1387_11200_7534_7532_2932_7027_1869_4087_4088_4089_2033_890_1031_983_1026_1022_1111_8556_8555_472	35	1.56E-30	1.33E-28	6.65E-29
1763	hsa-mir-1231	hsa04630	Jak-STAT signaling pathway	3559_595_598_58985_3454_3455_3459_3560_3561_1439_6774_2690_207_3717_3716_3718_85480_1387_3575_3570_3572_10401_6777_6772_6773_7297_6776_2033_149233_3953_51588_10379_5781_1441_8554	35	3.42E-27	2.91E-25	9.69E-26
1764	hsa-mir-1231	hsa05215	Prostate cancer	595_596_1017_4193_5925_1956_2064_5970_207_1147_367_5595_5594_1387_2932_1869_5728_2033_4790_4792_3320_3326_3480_5159_5156_1026	26	4.99E-23	4.24E-21	1.06E-21
1765	hsa-mir-1231	hsa05212	Pancreatic cancer	595_596_1017_4193_5925_1956_2064_5970_207_1147_367_5595_5594_1387_2932_1869_5728_2033_4790_4792_3320_3326_3480_5159_5156_1026	26	6.36E-23	5.40E-21	1.08E-21
1766	hsa-mir-1231	hsa05220	Chronic myeloid leukemia	7046_595_598_4193_3066_3065_5925_613_25_5970_207_1147_5595_5594_6777_1869_6776_4088_4089_4790_4792_5781_1026	23	7.99E-21	6.79E-19	1.13E-19
1767	hsa-mir-1231	hsa04010	MAPK signaling pathway	3925_7046_2264_9252_5578_1845_7132_5923_1956_3304_3305_3303_6789_1432_5970_1616_207_1147_998_2261_5595_5594_5599_3315_5879_3164_3725_4790_51701_5159_5156_5601_5602_6885_2353	35	5.34E-20	4.54E-18	6.48E-19
1768	hsa-mir-1231	hsa05210	Colorectal cancer	7046_595_596_1956_4436_207_4233_5595_5594_5599_2932_5879_3725_4087_4088_4089_3480_5159_5156_5601_5602_1856_2353	23	6.84E-20	5.81E-18	7.26E-19
1769	hsa-mir-1231	hsa04060	Cytokine-cytokine receptor interaction	3556_3559_7046_1234_1230_7132_58985_3454_3455_3459_90_3791_1956_3560_3561_1439_7852_6362_2690_85480_4233_3575_3570_3572_959_2321_149233_5159_5156_3815_3953_7133_1441	33	1.03E-18	8.76E-17	9.74E-18
1770	hsa-mir-1231	hsa04520	Adherens junction	7046_2241_2534_1956_6714_2064_1460_998_4233_5595_5594_1387_5879_1457_4087_4088_4089_2033_51701_3480_6885	21	5.88E-18	5.00E-16	5.00E-17
1771	hsa-mir-1231	hsa04510	Focal adhesion	595_596_5578_5923_2534_5747_3791_1956_6714_5499_2064_207_998_4233_5595_5594_5599_2932_5879_3725_5728_3910_2321_3480_5159_5156_5601_5602	28	7.83E-17	6.66E-15	6.05E-16
1772	hsa-mir-1231	hsa04115	p53 signaling pathway	595_1017_4194_4193_900_50484_6241_51246_545_7161_11200_64326_5728_27113_25898_983_1026_1111_472	19	1.06E-16	9.04E-15	7.54E-16
1773	hsa-mir-1231	hsa04310	Wnt signaling pathway	818_817_595_5578_1460_5599_1387_2932_5879_3725_1457_1452_4087_4088_4089_2033_51701_5518_5515_5601_5602_1856_6885_5527	24	6.51E-16	5.53E-14	4.26E-15
1774	hsa-mir-1231	hsa04012	ErbB signaling pathway	818_817_5578_5747_25_1956_6714_2064_207_5595_5594_5599_2932_6777_3725_6776_5601_5602_1026	19	4.13E-15	3.51E-13	2.50E-14
1775	hsa-mir-1231	hsa04620	Toll-like receptor signaling pathway	3454_3455_1432_5970_207_1147_3654_5595_5594_5599_6772_5879_3725_4790_4792_5601_5602_8772_6885_2353	20	4.70E-15	4.00E-13	2.66E-14
1776	hsa-mir-1231	hsa04062	Chemokine signaling pathway	2185_1234_1230_5747_5580_5590_7852_5970_6362_6774_207_3055_3717_1147_3718_998_5595_5594_2932_6777_6772_6773_5879_4790_4792	25	9.83E-15	8.36E-13	5.22E-14
1777	hsa-mir-1231	hsa04920	Adipocytokine signaling pathway	6794_7132_8717_5970_6774_207_3717_1147_5599_4790_4792_5601_5602_5563_3953_5781_7133	17	1.39E-14	1.18E-12	6.97E-14
1778	hsa-mir-1231	hsa05222	Small cell lung cancer	595_596_598_1017_5925_5743_5747_5970_207_1147_10401_1869_5728_3910_4790_4792_51588_8554	18	4.15E-14	3.52E-12	1.96E-13
1779	hsa-mir-1231	hsa05214	Glioma	818_817_595_4193_5578_5925_1956_207_5595_5594_1869_5728_3480_5159_5156_1026	16	1.25E-13	1.07E-11	5.61E-13
1780	hsa-mir-1231	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_1432_5970_1147_998_4233_5599_5879_3725_4790_4792_5601_5602_5781	15	4.95E-12	4.21E-10	2.10E-11
1781	hsa-mir-1231	hsa04660	T cell receptor signaling pathway	2534_3932_1432_5970_207_1147_998_5595_5594_2932_3725_959_4790_4792_5601_6885_2353	17	1.57E-11	1.34E-09	6.37E-11
1782	hsa-mir-1231	hsa05218	Melanoma	595_4193_5925_1956_207_4233_5595_5594_1869_5728_3480_5159_5156_1026	14	5.72E-11	4.86E-09	2.21E-10
1783	hsa-mir-1231	hsa04350	TGF-beta signaling pathway	7046_90_57154_6667_5595_5594_1387_7027_4086_4087_4088_4089_2033_5518_5515	15	6.31E-11	5.37E-09	2.33E-10
1784	hsa-mir-1231	hsa04210	Apoptosis	3556_596_598_7132_8717_823_1439_5970_207_1147_3654_4790_4792_8772_472	15	8.39E-11	7.13E-09	2.97E-10
1785	hsa-mir-1231	hsa05219	Bladder cancer	595_9252_4193_5925_1956_2064_2261_5595_5594_1869_1026	11	4.97E-10	4.22E-08	1.69E-09
1786	hsa-mir-1231	hsa04912	GnRH signaling pathway	818_817_2185_5578_5580_1956_6714_1432_998_5595_5594_5599_3725_5601_5602	15	9.42E-10	8.00E-08	3.08E-09
1787	hsa-mir-1231	hsa05221	Acute myeloid leukemia	595_5970_6774_207_1147_5595_5594_6777_6776_4790_5371_3815	12	9.98E-10	8.48E-08	3.14E-09
1788	hsa-mir-1231	hsa04662	B cell receptor signaling pathway	6850_5970_207_1147_5595_5594_1380_2932_5879_3725_4790_4792_2353	13	1.13E-09	9.61E-08	3.43E-09
1789	hsa-mir-1231	hsa04120	Ubiquitin mediated proteolysis	4193_3093_57154_7319_84447_7329_10055_10401_64326_7337_5371_672_25898_51588_10075_8554	16	3.09E-09	2.63E-07	9.07E-09
1790	hsa-mir-1231	hsa04370	VEGF signaling pathway	5578_5743_5747_3791_6714_1432_207_998_5595_5594_3315_5879	12	1.44E-08	1.22E-06	4.07E-08
1791	hsa-mir-1231	hsa04664	Fc epsilon RI signaling pathway	5578_2534_5580_6850_1432_207_5595_5594_5599_5879_5601_5602	12	1.86E-08	1.58E-06	5.09E-08
1792	hsa-mir-1231	hsa05223	Non-small cell lung cancer	595_5578_5925_1956_6789_2064_207_5595_5594_1869	10	5.50E-08	4.67E-06	1.46E-07
1793	hsa-mir-1231	hsa05211	Renal cell carcinoma	3091_207_998_4233_5595_5594_1387_5879_3725_2033_5781	11	6.92E-08	5.88E-06	1.78E-07
1794	hsa-mir-1231	hsa03420	Nucleotide excision repair	902_2965_4331_2071_2074_6118_1022_6117	8	1.35E-06	0.000115161	3.39E-06
1795	hsa-mir-1231	hsa04330	Notch signaling pathway	3066_3065_3280_1387_2033_8850_388585_1856	8	2.10E-06	0.000178863	5.11E-06
1796	hsa-mir-1231	hsa04360	Axon guidance	2534_5747_25_7852_2242_998_4233_5595_5594_2932_5879_1020	12	2.69E-06	0.000228868	6.36E-06
1797	hsa-mir-1231	hsa05213	Endometrial cancer	595_1956_2064_207_5595_5594_2932_5728	8	4.13E-06	0.000351131	9.25E-06
1798	hsa-mir-1231	hsa04530	Tight junction	5578_5580_5590_6714_207_1460_998_1457_5728_5518_5515_5520	12	4.13E-06	0.000351414	9.25E-06
1799	hsa-mir-1231	hsa04650	Natural killer cell mediated cytotoxicity	2185_5578_3454_3455_3459_2534_3932_6850_5595_5594_5879_5781	12	4.43E-06	0.000376662	9.66E-06
1800	hsa-mir-1231	hsa03022	Basal transcription factors	51616_2965_2969_6908_2958_6880_2957	7	4.98E-06	0.000423095	1.06E-05
1801	hsa-mir-1231	hsa04916	Melanogenesis	818_817_5578_5595_5594_1387_2932_2033_1856_3815	10	1.23E-05	0.001049673	2.56E-05
1802	hsa-mir-1231	hsa04930	Type II diabetes mellitus	5580_5590_5595_5594_5599_5601_5602	7	1.56E-05	0.001326717	3.16E-05
1803	hsa-mir-1231	hsa04540	Gap junction	5578_1956_6714_5595_5594_1453_5159_983_5156	9	3.20E-05	0.002721177	6.33E-05
1804	hsa-mir-1231	hsa03030	DNA replication	4174_4172_5557_6118_6117_5422	6	4.53E-05	0.003850065	8.75E-05
1805	hsa-mir-1231	hsa04720	Long-term potentiation	818_817_5578_5499_5595_5594_1387_2033	8	4.66E-05	0.003960633	8.80E-05
1806	hsa-mir-1231	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_598_7132_1432_1616_5879_7133	7	5.57E-05	0.004735006	0.000102935
1807	hsa-mir-1231	hsa04910	Insulin signaling pathway	5590_5499_207_5595_5594_5599_2932_5601_5602_5563	10	0.000115586	0.00982481	0.000209039
1808	hsa-mir-1231	hsa03440	Homologous recombination	641_5888_675_6118_6117	5	0.000149113	0.012674584	0.000264054
1809	hsa-mir-1231	hsa04150	mTOR signaling pathway	6794_3091_207_5595_5594_5563	6	0.000283279	0.024078753	0.000491403
1810	hsa-mir-1231	hsa05340	Primary immunodeficiency	3932_3561_3718_3575_959	5	0.000378001	0.032130082	0.000642602
1811	hsa-mir-1231	hsa05131	Shigellosis	5578_2534_25_998_7534_4691	6	0.000408303	0.034705742	0.000667418
1812	hsa-mir-1231	hsa05130	Pathogenic Escherichia coli infection	5578_2534_25_998_7534_4691	6	0.000408303	0.034705742	0.000667418
1813	hsa-mir-1231	hsa04612	Antigen processing and presentation	3309_3304_3305_3303_3320_3326_2923	7	0.00077304	0.065708394	0.001239781
1814	hsa-mir-1231	hsa04670	Leukocyte transendothelial migration	2185_5578_5747_1432_7852_998_5879_5781	8	0.001017521	0.086489278	0.001601653
1815	hsa-mir-1231	hsa04810	Regulation of actin cytoskeleton	2264_5747_1956_5499_998_2261_5595_5594_5879_5159_5156	11	0.001042218	0.088588503	0.0016107
1816	hsa-mir-1231	hsa04730	Long-term depression	5578_5595_5594_3480_5518_5515	6	0.001294756	0.11005429	0.001965255
1817	hsa-mir-1231	hsa05216	Thyroid cancer	595_5595_5594_5979	4	0.001666975	0.141692869	0.00248584
1818	hsa-mir-1231	hsa04640	Hematopoietic cell lineage	3559_1380_3575_3570_3815_1441	6	0.003381548	0.287431622	0.004867091
1819	hsa-mir-1231	hsa03410	Base excision repair	3146_142_4913_328	4	0.003417395	0.290478599	0.004867091
1820	hsa-mir-1231	hsa04020	Calcium signaling pathway	818_817_2185_5578_147_1956_2064_5159_5156	9	0.003435594	0.29202545	0.004867091
1821	hsa-mir-1231	hsa05016	Huntington's disease	3066_3065_3064_25942_6667_1387_2033_27113_6908	9	0.0039305	0.334092536	0.005476927
1822	hsa-mir-1231	hsa03430	Mismatch repair	4436_6118_6117	3	0.007495393	0.637108392	0.010275942
1823	hsa-mir-1231	hsa04950	Maturity onset diabetes of the young	6927_3280_3172	3	0.008336116	0.708569896	0.011247141
1824	hsa-mir-1231	hsa04270	Vascular smooth muscle contraction	5578_147_5580_5499_5595_5594	6	0.013286319	1	0.017645892
1825	hsa-mir-1231	hsa04710	Circadian rhythm - mammal	1453_8553	2	0.022259675	1	0.029108806
1826	hsa-mir-1231	hsa03450	Non-homologous end-joining	2547_5591	2	0.025180827	1	0.032429853
1827	hsa-mir-1231	hsa05010	Alzheimer's disease	7132_823_5595_5594_2932_8772_1020	7	0.025804444	1	0.032736982
1828	hsa-mir-1236	hsa04110	Cell cycle	4088_983_595_993_5925_2033_894_896_1387	9	5.06E-13	1.87E-11	1.87E-11
1829	hsa-mir-1236	hsa04310	Wnt signaling pathway	4088_595_2033_894_896_3725_1387	7	6.24E-09	2.31E-07	1.15E-07
1830	hsa-mir-1236	hsa05200	Pathways in cancer	4088_595_5925_2033_367_3725_1387_2353	8	6.30E-08	2.33E-06	7.77E-07
1831	hsa-mir-1236	hsa05215	Prostate cancer	595_5925_2033_367_1387	5	3.93E-07	1.45E-05	3.07E-06
1832	hsa-mir-1236	hsa05212	Pancreatic cancer	595_5925_2033_367_1387	5	4.14E-07	1.53E-05	3.07E-06
1833	hsa-mir-1236	hsa04330	Notch signaling pathway	8850_9612_2033_1387	4	1.36E-06	5.01E-05	8.36E-06
1834	hsa-mir-1236	hsa04630	Jak-STAT signaling pathway	595_2033_894_896_1387	5	5.72E-06	0.000211713	2.66E-05
1835	hsa-mir-1236	hsa04115	p53 signaling pathway	983_595_894_896	4	5.75E-06	0.00021283	2.66E-05
1836	hsa-mir-1236	hsa05210	Colorectal cancer	4088_595_3725_2353	4	1.21E-05	0.000448039	4.98E-05
1837	hsa-mir-1236	hsa05211	Renal cell carcinoma	2033_3725_1387	3	0.000238273	0.008816093	0.000881609
1838	hsa-mir-1236	hsa05220	Chronic myeloid leukemia	4088_595_5925	3	0.000267546	0.009899201	0.000899927
1839	hsa-mir-1236	hsa04520	Adherens junction	4088_2033_1387	3	0.000321325	0.011889041	0.000990753
1840	hsa-mir-1236	hsa04510	Focal adhesion	595_894_896_3725	4	0.000354554	0.013118513	0.001009116
1841	hsa-mir-1236	hsa04350	TGF-beta signaling pathway	4088_2033_1387	3	0.000407643	0.015082809	0.001077344
1842	hsa-mir-1236	hsa05219	Bladder cancer	595_5925	2	0.002264782	0.083796921	0.005586461
1843	hsa-mir-1236	hsa05016	Huntington's disease	2033_25942_1387	3	0.003543673	0.131115887	0.007927076
1844	hsa-mir-1236	hsa05223	Non-small cell lung cancer	595_5925	2	0.00364217	0.134760299	0.007927076
1845	hsa-mir-1236	hsa05214	Glioma	595_5925	2	0.005171062	0.191329308	0.010629406
1846	hsa-mir-1236	hsa05218	Melanoma	595_5925	2	0.006109057	0.226035094	0.011896584
1847	hsa-mir-1236	hsa04720	Long-term potentiation	2033_1387	2	0.006774271	0.250648017	0.01193562
1848	hsa-mir-1236	hsa04662	B cell receptor signaling pathway	3725_2353	2	0.006774271	0.250648017	0.01193562
1849	hsa-mir-1236	hsa05222	Small cell lung cancer	595_5925	2	0.008764406	0.32428302	0.014740137
1850	hsa-mir-1236	hsa04620	Toll-like receptor signaling pathway	3725_2353	2	0.012066038	0.446443408	0.019288672
1851	hsa-mir-1236	hsa04916	Melanogenesis	2033_1387	2	0.012511571	0.46292812	0.019288672
1852	hsa-mir-1236	hsa04660	T cell receptor signaling pathway	3725_2353	2	0.013890774	0.51395865	0.020558346
1853	hsa-mir-1236	hsa05216	Thyroid cancer	595	1	0.046851743	1	0.066673635
1854	hsa-mir-1237	hsa04010	MAPK signaling pathway	1432_9344_6722_5606_5601_5600_2885_1649_3725_5595_5594_5604_5599_2005_2353_1386	16	1.36E-15	7.48E-14	7.48E-14
1855	hsa-mir-1237	hsa05210	Colorectal cancer	4088_5601_2885_4089_3725_5595_5594_5604_5599_2353	10	5.43E-13	2.99E-11	1.49E-11
1856	hsa-mir-1237	hsa04620	Toll-like receptor signaling pathway	1432_5606_5601_5600_3725_5595_5594_5604_5599_2353	10	3.24E-12	1.78E-10	5.94E-11
1857	hsa-mir-1237	hsa04912	GnRH signaling pathway	1432_5606_5601_5600_2885_3725_5595_5594_5604_5599	10	5.50E-12	3.02E-10	7.05E-11
1858	hsa-mir-1237	hsa05200	Pathways in cancer	4088_5601_2885_5925_2033_4089_9063_3725_5595_5594_5604_5599_2353_1387	14	6.41E-12	3.53E-10	7.05E-11
1859	hsa-mir-1237	hsa04664	Fc epsilon RI signaling pathway	1432_5606_5601_5600_2885_5595_5594_5604_5599	9	1.19E-11	6.54E-10	1.09E-10
1860	hsa-mir-1237	hsa04350	TGF-beta signaling pathway	4088_2033_4089_5595_5594_3397_3399_3398_1387	9	2.64E-11	1.45E-09	2.08E-10
1861	hsa-mir-1237	hsa04660	T cell receptor signaling pathway	1432_5601_5600_2885_3725_5595_5594_5604_2353	9	1.85E-10	1.02E-08	1.28E-09
1862	hsa-mir-1237	hsa05211	Renal cell carcinoma	2885_2033_3725_5595_5594_5604_1387	7	6.95E-09	3.82E-07	4.25E-08
1863	hsa-mir-1237	hsa05220	Chronic myeloid leukemia	4088_2885_5925_4089_5595_5594_5604	7	9.05E-09	4.98E-07	4.98E-08
1864	hsa-mir-1237	hsa04012	ErbB signaling pathway	5601_2885_3725_5595_5594_5604_5599	7	2.36E-08	1.30E-06	1.16E-07
1865	hsa-mir-1237	hsa05215	Prostate cancer	2885_5925_2033_5595_5594_5604_1387	7	2.54E-08	1.40E-06	1.16E-07
1866	hsa-mir-1237	hsa05212	Pancreatic cancer	2885_5925_2033_5595_5594_5604_1387	7	2.73E-08	1.50E-06	1.16E-07
1867	hsa-mir-1237	hsa04310	Wnt signaling pathway	4088_5601_2033_4089_8061_3725_5599_1387	8	5.18E-08	2.85E-06	2.03E-07
1868	hsa-mir-1237	hsa04110	Cell cycle	4088_983_5925_2033_4089_993_1387	7	1.79E-07	9.85E-06	6.57E-07
1869	hsa-mir-1237	hsa04662	B cell receptor signaling pathway	2885_3725_5595_5594_5604_2353	6	2.56E-07	1.41E-05	8.80E-07
1870	hsa-mir-1237	hsa04520	Adherens junction	4088_2033_4089_5595_5594_1387	6	3.66E-07	2.01E-05	1.18E-06
1871	hsa-mir-1237	hsa05223	Non-small cell lung cancer	2885_5925_5595_5594_5604	5	1.37E-06	7.52E-05	4.18E-06
1872	hsa-mir-1237	hsa05214	Glioma	2885_5925_5595_5594_5604	5	3.21E-06	0.000176707	9.30E-06
1873	hsa-mir-1237	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_5601_5600_3725_5599	5	4.83E-06	0.000265653	1.33E-05
1874	hsa-mir-1237	hsa04510	Focal adhesion	5601_2885_3725_5595_5594_5604_5599	7	6.04E-06	0.000331939	1.56E-05
1875	hsa-mir-1237	hsa04720	Long-term potentiation	2033_5595_5594_5604_1387	5	6.22E-06	0.000342178	1.56E-05
1876	hsa-mir-1237	hsa04370	VEGF signaling pathway	1432_5600_5595_5594_5604	5	7.03E-06	0.000386402	1.68E-05
1877	hsa-mir-1237	hsa04910	Insulin signaling pathway	5601_2885_5595_5594_5604_5599	6	7.46E-06	0.000410535	1.71E-05
1878	hsa-mir-1237	hsa05219	Bladder cancer	5925_5595_5594_5604	4	1.49E-05	0.000820068	3.28E-05
1879	hsa-mir-1237	hsa04540	Gap junction	983_2885_5595_5594_5604	5	1.68E-05	0.000923406	3.55E-05
1880	hsa-mir-1237	hsa04930	Type II diabetes mellitus	5601_5595_5594_5599	4	1.92E-05	0.001056907	3.91E-05
1881	hsa-mir-1237	hsa04916	Melanogenesis	2033_5595_5594_5604_1387	5	2.81E-05	0.001544794	5.52E-05
1882	hsa-mir-1237	hsa05213	Endometrial cancer	2885_5595_5594_5604	4	3.27E-05	0.001800806	6.21E-05
1883	hsa-mir-1237	hsa05221	Acute myeloid leukemia	2885_5595_5594_5604	4	5.22E-05	0.002870559	9.57E-05
1884	hsa-mir-1237	hsa05218	Melanoma	5925_5595_5594_5604	4	0.000103396	0.005686771	0.000183444
1885	hsa-mir-1237	hsa05216	Thyroid cancer	5595_5594_5604	3	0.000150396	0.008271789	0.000258493
1886	hsa-mir-1237	hsa04330	Notch signaling pathway	2033_8850_1387	3	0.000569859	0.031342228	0.000949764
1887	hsa-mir-1237	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_5606_5600	3	0.00092557	0.050906362	0.001497246
1888	hsa-mir-1237	hsa04650	Natural killer cell mediated cytotoxicity	2885_5595_5594_5604	4	0.001171578	0.064436783	0.001836917
1889	hsa-mir-1237	hsa04120	Ubiquitin mediated proteolysis	7329_64326_9063_672	4	0.001202346	0.066129003	0.001836917
1890	hsa-mir-1237	hsa04630	Jak-STAT signaling pathway	2885_2033_9063_1387	4	0.001774757	0.097611634	0.002579705
1891	hsa-mir-1237	hsa04730	Long-term depression	5595_5594_5604	3	0.001782342	0.098028783	0.002579705
1892	hsa-mir-1237	hsa04062	Chemokine signaling pathway	2885_5595_5594_5604	4	0.003840135	0.211207414	0.005415575
1893	hsa-mir-1237	hsa04270	Vascular smooth muscle contraction	5595_5594_5604	3	0.00710151	0.390583035	0.009764576
1894	hsa-mir-1237	hsa04150	mTOR signaling pathway	5595_5594	2	0.013193739	0.725655657	0.017698918
1895	hsa-mir-1237	hsa05010	Alzheimer's disease	6622_5595_5594	3	0.02058267	1	0.026817828
1896	hsa-mir-1237	hsa04920	Adipocytokine signaling pathway	5601_5599	2	0.020966666	1	0.026817828
1897	hsa-mir-1237	hsa04115	p53 signaling pathway	983_64326	2	0.022117092	1	0.027646365
1898	hsa-mir-1237	hsa05016	Huntington's disease	2033_6908_1387	3	0.024004056	1	0.02933829
1899	hsa-mir-1237	hsa05222	Small cell lung cancer	5925_9063	2	0.03289369	1	0.039329412
1900	hsa-mir-1237	hsa04810	Regulation of actin cytoskeleton	5595_5594_5604	3	0.035198795	1	0.041190079
1901	hsa-mir-124-1	hsa05200	Pathways in cancer	3551_1499_596_598_1017_8517_4193_7704_5578_6502_3091_2736_7175_3065_5925_613_7186_5743_5747_25_1487_1488_6789_4436_2113_862_207_1147_998_367_5595_5594_5599_861_1387_6256_836_2932_6774_5970_7157_6688_1869_3725_4087_4088_4089_5888_5728_2033_3910_4791_4792_3320_3326_5371_675_5601_5602_1856_51588_1026_2353_8554	64	4.17E-36	3.71E-34	3.71E-34
1902	hsa-mir-124-1	hsa04110	Cell cycle	1017_4193_902_6502_6500_3065_5925_25_891_10971_9232_545_995_5347_5591_1387_11200_7534_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_1031_983_8454_1026_1022_1111_8556_8555_472	37	1.66E-27	1.48E-25	7.38E-26
1903	hsa-mir-124-1	hsa04010	MAPK signaling pathway	6722_3551_6195_6197_8517_9252_7867_5578_4773_5923_7186_3304_3303_6789_1432_3305_1616_207_1147_998_5595_5594_5599_5598_8986_836_3310_3312_3315_5971_5970_3164_7157_3725_6196_4791_9261_1326_4208_5601_5602_2353_5566	43	1.51E-21	1.34E-19	4.48E-20
1904	hsa-mir-124-1	hsa04310	Wnt signaling pathway	1499_5578_6500_8945_4773_23291_1487_1488_8607_1460_5599_1387_2932_7157_3725_1457_1452_4087_4088_4089_2033_5518_5515_5601_5602_1856_8454_5527_5566	29	6.98E-17	6.21E-15	1.55E-15
1905	hsa-mir-124-1	hsa05220	Chronic myeloid leukemia	3551_598_8517_4193_3065_5925_613_25_1487_1488_207_1147_5595_5594_861_5970_7157_1869_4088_4089_4792_1026	22	1.91E-16	1.70E-14	3.41E-15
1906	hsa-mir-124-1	hsa05215	Prostate cancer	3551_1499_596_1017_8517_4193_5925_207_1147_367_5595_5594_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_1026	23	3.33E-16	2.96E-14	4.94E-15
1907	hsa-mir-124-1	hsa05212	Pancreatic cancer	3551_1499_596_1017_8517_4193_5925_207_1147_367_5595_5594_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_1026	23	4.11E-16	3.65E-14	5.22E-15
1908	hsa-mir-124-1	hsa04115	p53 signaling pathway	1017_4194_4193_50484_6241_891_51246_545_7161_11200_836_7157_900_64326_5728_27113_25898_983_1026_1111_472	21	4.99E-16	4.44E-14	5.55E-15
1909	hsa-mir-124-1	hsa05222	Small cell lung cancer	3551_596_598_1017_8517_6502_5925_7186_5743_5747_207_1147_6256_5970_7157_1869_5728_3910_4792_51588_8554	21	2.05E-14	1.82E-12	2.03E-13
1910	hsa-mir-124-1	hsa04350	TGF-beta signaling pathway	6500_3398_3400_6667_3397_3399_5595_5594_1387_7027_4086_4087_4088_4089_2033_5518_5515_8454_4093	19	1.98E-12	1.76E-10	1.76E-11
1911	hsa-mir-124-1	hsa05210	Colorectal cancer	1499_596_4436_207_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_5601_5602_1856_2353	18	9.95E-12	8.85E-10	7.72E-11
1912	hsa-mir-124-1	hsa04120	Ubiquitin mediated proteolysis	4193_6502_6500_3093_8945_23291_7319_84447_7325_7329_10055_10273_64326_7337_5371_672_25898_7323_8454_51588_10075_8554	22	1.04E-11	9.27E-10	7.72E-11
1913	hsa-mir-124-1	hsa04920	Adipocytokine signaling pathway	3551_6794_8517_7186_4794_207_1147_5599_6256_6774_5970_4792_4793_5601_5602_5563	16	3.49E-11	3.10E-09	2.39E-10
1914	hsa-mir-124-1	hsa04660	T cell receptor signaling pathway	3551_8517_4773_4794_1432_207_1147_998_5595_5594_2932_5970_3725_959_4792_4793_1326_5601_2353	19	7.10E-11	6.32E-09	4.52E-10
1915	hsa-mir-124-1	hsa04662	B cell receptor signaling pathway	3551_8517_4773_4794_207_1147_5595_5594_1380_2932_5970_3725_4792_4793_2353	15	1.22E-09	1.09E-07	7.24E-09
1916	hsa-mir-124-1	hsa04210	Apoptosis	3551_596_598_8517_8837_7186_823_207_1147_836_5970_7157_4792_840_472_5566	16	1.35E-09	1.20E-07	7.50E-09
1917	hsa-mir-124-1	hsa05131	Shigellosis	1499_5578_10382_25_10971_998_7534_203068_347733_7278_71_84617_4691	13	3.27E-09	2.91E-07	1.62E-08
1918	hsa-mir-124-1	hsa05130	Pathogenic Escherichia coli infection	1499_5578_10382_25_10971_998_7534_203068_347733_7278_71_84617_4691	13	3.27E-09	2.91E-07	1.62E-08
1919	hsa-mir-124-1	hsa05221	Acute myeloid leukemia	3551_8517_7704_862_207_1147_5595_5594_861_6774_5970_6688_5371	13	5.64E-09	5.02E-07	2.64E-08
1920	hsa-mir-124-1	hsa05214	Glioma	4193_5578_5925_207_5595_5594_7157_1869_5728_808_801_805_1026	13	1.55E-08	1.38E-06	6.91E-08
1921	hsa-mir-124-1	hsa04620	Toll-like receptor signaling pathway	3551_8517_1432_207_1147_5595_5594_5599_5970_3725_4792_1326_5601_5602_2353	15	4.86E-08	4.32E-06	2.06E-07
1922	hsa-mir-124-1	hsa04720	Long-term potentiation	6195_6197_5578_5499_5595_5594_1387_6196_2033_808_801_805_5566	13	6.91E-08	6.15E-06	2.80E-07
1923	hsa-mir-124-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3551_8517_1432_1147_998_5599_836_5970_3725_4792_5601_5602	12	2.81E-07	2.50E-05	1.09E-06
1924	hsa-mir-124-1	hsa04330	Notch signaling pathway	3065_1487_1488_1387_9612_2033_8850_1856_388585_4851	10	4.35E-07	3.87E-05	1.61E-06
1925	hsa-mir-124-1	hsa04912	GnRH signaling pathway	5578_1432_998_5595_5594_5599_5598_3725_808_801_805_5601_5602_5566	14	5.43E-07	4.83E-05	1.93E-06
1926	hsa-mir-124-1	hsa04370	VEGF signaling pathway	7867_5578_4773_5743_5747_1432_207_998_5595_5594_3315_9261	12	6.10E-07	5.43E-05	2.09E-06
1927	hsa-mir-124-1	hsa04540	Gap junction	5578_10382_5592_5595_5594_5598_1453_203068_347733_983_7278_84617_5566	13	6.37E-07	5.67E-05	2.10E-06
1928	hsa-mir-124-1	hsa04510	Focal adhesion	1499_596_5578_5923_5747_5499_10627_207_998_5595_5594_5599_2932_3725_5728_3910_5601_5602_71	19	7.13E-07	6.34E-05	2.27E-06
1929	hsa-mir-124-1	hsa04520	Adherens junction	1499_1460_998_5595_5594_1387_1457_4087_4088_4089_2033_71	12	8.78E-07	7.82E-05	2.70E-06
1930	hsa-mir-124-1	hsa04012	ErbB signaling pathway	5578_5747_25_207_5595_5594_5599_2932_3725_5601_5602_1026	12	1.94E-06	0.000173076	5.77E-06
1931	hsa-mir-124-1	hsa03022	Basal transcription factors	51616_2965_2963_2969_6908_2958_6880_2957	8	5.66E-06	0.000503718	1.62E-05
1932	hsa-mir-124-1	hsa04530	Tight junction	1499_5578_4627_4628_10627_207_1460_998_1457_5728_5518_5515_71_5520	14	6.98E-06	0.000621133	1.94E-05
1933	hsa-mir-124-1	hsa04150	mTOR signaling pathway	6794_6195_6197_3091_207_5595_5594_6196_5563	9	7.33E-06	0.000652809	1.97E-05
1934	hsa-mir-124-1	hsa04910	Insulin signaling pathway	3551_5499_207_5595_5594_5599_2932_808_801_805_5601_5602_5563_5566	14	7.53E-06	0.000670489	1.97E-05
1935	hsa-mir-124-1	hsa05223	Non-small cell lung cancer	5578_5925_6789_207_5595_5594_6256_7157_1869	9	9.63E-06	0.000856693	2.45E-05
1936	hsa-mir-124-1	hsa04916	Melanogenesis	1499_5578_5595_5594_1387_2932_2033_808_801_805_1856_5566	12	1.03E-05	0.000916464	2.55E-05
1937	hsa-mir-124-1	hsa05219	Bladder cancer	9252_4193_5925_5595_5594_7157_1869_1026	8	1.28E-05	0.00113863	3.08E-05
1938	hsa-mir-124-1	hsa05016	Huntington's disease	292_293_1537_3065_3064_25942_6667_5441_1387_836_5437_7157_2033_27113_6908_1213	16	1.35E-05	0.001201698	3.16E-05
1939	hsa-mir-124-1	hsa04062	Chemokine signaling pathway	3551_8517_653361_5747_6362_207_1147_998_5595_5594_2932_6774_5970_4792_4793_5566	16	1.82E-05	0.001623609	4.16E-05
1940	hsa-mir-124-1	hsa05218	Melanoma	4193_5925_207_5595_5594_7157_1869_5728_1026	9	6.76E-05	0.006019602	0.00015049
1941	hsa-mir-124-1	hsa05211	Renal cell carcinoma	3091_2113_207_998_5595_5594_1387_3725_2033	9	7.46E-05	0.006641147	0.000161979
1942	hsa-mir-124-1	hsa03020	RNA polymerase	64425_25885_51082_5441_5437_84172	6	0.000106281	0.009459004	0.000219977
1943	hsa-mir-124-1	hsa05216	Thyroid cancer	1499_7175_5595_5594_6256_7157	6	0.000106281	0.009459004	0.000219977
1944	hsa-mir-124-1	hsa03420	Nucleotide excision repair	902_2965_4331_2071_2074_1022_6117	7	0.00012314	0.010959455	0.000249079
1945	hsa-mir-124-1	hsa04930	Type II diabetes mellitus	3551_3651_5595_5594_5599_5601_5602	7	0.000139612	0.012425431	0.000276121
1946	hsa-mir-124-1	hsa05213	Endometrial cancer	1499_207_5595_5594_2932_7157_5728	7	0.000311646	0.027736459	0.000602967
1947	hsa-mir-124-1	hsa04950	Maturity onset diabetes of the young	3651_3172_168620_4760_5080	5	0.000394766	0.03513416	0.000747535
1948	hsa-mir-124-1	hsa04340	Hedgehog signaling pathway	2736_8945_23291_2932_1452_1453_5566	7	0.000516131	0.045935691	0.000956994
1949	hsa-mir-124-1	hsa04270	Vascular smooth muscle contraction	5578_5499_5592_5595_5594_4637_808_801_805_5566	10	0.000564073	0.050202514	0.001024541
1950	hsa-mir-124-1	hsa04664	Fc epsilon RI signaling pathway	5578_1432_207_5595_5594_5599_5601_5602	8	0.000682037	0.06070126	0.001214025
1951	hsa-mir-124-1	hsa04612	Antigen processing and presentation	3309_3304_3303_3305_3310_3312_3320_3326	8	0.001392727	0.123952684	0.002430445
1952	hsa-mir-124-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_598_1432_1616_836_7157	6	0.002435579	0.216766509	0.004168587
1953	hsa-mir-124-1	hsa05010	Alzheimer's disease	1537_823_5595_5594_836_2932_808_801_805_840_1020	11	0.00320074	0.284865858	0.005374828
1954	hsa-mir-124-1	hsa03440	Homologous recombination	5888_641_675_6117	4	0.005175932	0.460657973	0.008530703
1955	hsa-mir-124-1	hsa04730	Long-term depression	5578_5592_5595_5594_5518_5515	6	0.007125104	0.634134293	0.011529714
1956	hsa-mir-124-1	hsa04670	Leukocyte transendothelial migration	1499_5578_653361_5747_1432_10627_998_71	8	0.008353615	0.743471752	0.013276281
1957	hsa-mir-124-1	hsa05217	Basal cell carcinoma	1499_2736_2932_7157_1856	5	0.010381391	0.923943788	0.01620954
1958	hsa-mir-124-1	hsa03010	Ribosome	6207_6202_6156_6222_6128_6125_6231	7	0.010626036	0.945717184	0.016305469
1959	hsa-mir-124-1	hsa04630	Jak-STAT signaling pathway	3559_598_207_1387_6778_6774_2033_51588_8554	9	0.010890712	0.969273335	0.016428362
1960	hsa-mir-124-1	hsa03410	Base excision repair	3146_142_4913_328	4	0.01145601	1	0.016993081
1961	hsa-mir-124-1	hsa04360	Axon guidance	4773_5747_25_998_5595_5594_2932_1020	8	0.012215242	1	0.017822239
1962	hsa-mir-124-1	hsa03050	Proteasome	5705_5684_5717_5710	4	0.0276301	1	0.039662563
1963	hsa-mir-124-1	hsa04070	Phosphatidylinositol signaling system	5578_5728_808_801_805	5	0.033559911	1	0.047410033
1964	hsa-mir-124-1	hsa04810	Regulation of actin cytoskeleton	10788_5747_5499_4627_4628_10627_998_5595_5594_71	10	0.0375427	1	0.052207818
1965	hsa-mir-124-1	hsa03450	Non-homologous end-joining	2547_5591	2	0.047571084	1	0.065135792
1966	hsa-mir-124-2	hsa05200	Pathways in cancer	25_5371_2249_7046_1499_5595_5594_5599_5914_1387_862_595_5601_6502_1019_4088_367_1017_6776_6777_6772_5970_6256_4087_6688_4609_3725_1026_2353_4089_1050_5925_2033_8554	34	3.04E-21	2.28E-19	2.28E-19
1967	hsa-mir-124-2	hsa04350	TGF-beta signaling pathway	7046_5595_5594_1387_4088_7027_3397_3399_3398_1874_4087_4609_4086_4089_2033_4093_6667_5933	18	1.56E-16	1.17E-14	5.85E-15
1968	hsa-mir-124-2	hsa04110	Cell cycle	25_993_1387_595_983_6502_1019_4088_1017_7027_4087_1026_4089_5925_2033_894_896_5933	18	1.98E-14	1.49E-12	4.95E-13
1969	hsa-mir-124-2	hsa04010	MAPK signaling pathway	6722_2249_7046_5595_5594_5599_1386_9261_4208_5601_5600_9252_7867_1432_1649_5970_468_4609_3725_3727_2353_5603_8550	23	4.31E-13	3.23E-11	8.08E-12
1970	hsa-mir-124-2	hsa05220	Chronic myeloid leukemia	25_7046_5595_5594_595_1019_4088_6776_6777_5970_4609_1026_4089_5925	14	1.30E-12	9.74E-11	1.95E-11
1971	hsa-mir-124-2	hsa05215	Prostate cancer	1499_5595_5594_1387_595_367_1017_5970_468_9586_1026_10488_5925_2033	14	8.88E-12	6.66E-10	1.09E-10
1972	hsa-mir-124-2	hsa05212	Pancreatic cancer	1499_5595_5594_1387_595_367_1017_5970_468_9586_1026_10488_5925_2033	14	1.02E-11	7.63E-10	1.09E-10
1973	hsa-mir-124-2	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_862_595_6776_6777_5970_6688_4609_1050	12	2.21E-11	1.66E-09	2.07E-10
1974	hsa-mir-124-2	hsa05210	Colorectal cancer	7046_1499_5595_5594_5599_595_5601_4088_4087_4609_3725_2353_4089	13	6.75E-11	5.06E-09	5.63E-10
1975	hsa-mir-124-2	hsa04310	Wnt signaling pathway	1499_5599_1387_595_5601_4088_4087_8061_4609_3725_1457_1459_4089_2033_894_896	16	8.24E-11	6.18E-09	6.18E-10
1976	hsa-mir-124-2	hsa04520	Adherens junction	4301_7046_1499_5595_5594_1387_4088_4087_1457_1459_4089_2033	12	5.09E-10	3.81E-08	3.47E-09
1977	hsa-mir-124-2	hsa04912	GnRH signaling pathway	5595_5594_5599_5601_5600_1432_468_3725_5603_808_801_805	12	1.12E-08	8.38E-07	6.99E-08
1978	hsa-mir-124-2	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5601_5600_1432_6772_5970_3725_2353_5603	11	6.08E-08	4.56E-06	3.51E-07
1979	hsa-mir-124-2	hsa05219	Bladder cancer	5595_5594_595_1019_9252_4609_1026_5925	8	7.98E-08	5.99E-06	4.28E-07
1980	hsa-mir-124-2	hsa04012	ErbB signaling pathway	25_5595_5594_5599_5601_6776_6777_4609_3725_1026	10	1.41E-07	1.06E-05	6.68E-07
1981	hsa-mir-124-2	hsa05214	Glioma	5595_5594_595_1019_1026_5925_808_801_805	9	1.43E-07	1.07E-05	6.68E-07
1982	hsa-mir-124-2	hsa04660	T cell receptor signaling pathway	5595_5594_5601_5600_1019_1432_5970_3725_2353_5603	10	1.04E-06	7.80E-05	4.59E-06
1983	hsa-mir-124-2	hsa05222	Small cell lung cancer	595_6502_1019_1017_5970_6256_4609_5925_8554	9	1.23E-06	9.26E-05	5.14E-06
1984	hsa-mir-124-2	hsa05216	Thyroid cancer	1499_5595_5594_595_6256_4609	6	2.30E-06	0.000172473	9.08E-06
1985	hsa-mir-124-2	hsa04630	Jak-STAT signaling pathway	1387_595_6776_6777_6772_4609_2033_3977_894_896_8554	11	2.91E-06	0.000218522	1.09E-05
1986	hsa-mir-124-2	hsa04720	Long-term potentiation	5595_5594_1387_468_2033_808_801_805	8	4.26E-06	0.000319549	1.52E-05
1987	hsa-mir-124-2	hsa04916	Melanogenesis	1499_5595_5594_1387_10488_2033_808_801_805	9	5.26E-06	0.000394555	1.79E-05
1988	hsa-mir-124-2	hsa04115	p53 signaling pathway	595_983_1019_1017_1026_894_896	7	2.31E-05	0.001730883	7.53E-05
1989	hsa-mir-124-2	hsa05218	Melanoma	2249_5595_5594_595_1019_1026_5925	7	2.74E-05	0.002052183	8.21E-05
1990	hsa-mir-124-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_5600_1432_5970_3725_5603	7	2.74E-05	0.002052183	8.21E-05
1991	hsa-mir-124-2	hsa04370	VEGF signaling pathway	5595_5594_9261_5600_7867_1432_5603	7	4.43E-05	0.003322841	0.000127802
1992	hsa-mir-124-2	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5601_5600_1432_5603	7	5.16E-05	0.003867537	0.000143242
1993	hsa-mir-124-2	hsa05223	Non-small cell lung cancer	5595_5594_595_1019_6256_5925	6	5.61E-05	0.00420711	0.000150254
1994	hsa-mir-124-2	hsa04930	Type II diabetes mellitus	5595_5594_5599_5601_3651	5	0.000237231	0.017792326	0.000613528
1995	hsa-mir-124-2	hsa04950	Maturity onset diabetes of the young	3651_168620_6927_4760	4	0.000253671	0.019025297	0.000634177
1996	hsa-mir-124-2	hsa04330	Notch signaling pathway	388585_1387_9612_2033_8850	5	0.000285742	0.021430625	0.00069131
1997	hsa-mir-124-2	hsa05213	Endometrial cancer	1499_5595_5594_595_4609	5	0.000439863	0.032989696	0.001030928
1998	hsa-mir-124-2	hsa04510	Focal adhesion	1499_5595_5594_5599_595_5601_3725_894_896	9	0.000747018	0.05602633	0.001697768
1999	hsa-mir-124-2	hsa03022	Basal transcription factors	2963_6908_6874_6883	4	0.001119342	0.083950633	0.002469136
2000	hsa-mir-124-2	hsa04910	Insulin signaling pathway	5595_5594_5599_5601_808_801_805	7	0.001266483	0.094986218	0.002713892
2001	hsa-mir-124-2	hsa05016	Huntington's disease	25942_1387_6908_6874_9586_10488_2033_6667	8	0.0017047	0.127852463	0.003509027
2002	hsa-mir-124-2	hsa05211	Renal cell carcinoma	5595_5594_1387_3725_2033	5	0.00173112	0.12983399	0.003509027
2003	hsa-mir-124-2	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725_2353	5	0.002049928	0.153744588	0.00404591
2004	hsa-mir-124-2	hsa05010	Alzheimer's disease	5595_5594_823_9451_808_801_805	7	0.004800188	0.360014115	0.009231131
2005	hsa-mir-124-2	hsa04920	Adipocytokine signaling pathway	5599_5601_5970_6256	4	0.008270761	0.62030706	0.015507677
2006	hsa-mir-124-2	hsa04270	Vascular smooth muscle contraction	5595_5594_808_801_805	5	0.012520669	0.939050171	0.022903663
2007	hsa-mir-124-2	hsa04670	Leukocyte transendothelial migration	4301_1499_5600_1432_5603	5	0.014215596	1	0.025384992
2008	hsa-mir-124-2	hsa04530	Tight junction	4301_1499_1019_1457_1459	5	0.02192572	1	0.038242534
2009	hsa-mir-124-2	hsa04120	Ubiquitin mediated proteolysis	5371_6502_7329_672_8554	5	0.023123627	1	0.039415274
2010	hsa-mir-124-2	hsa05014	Amyotrophic lateral sclerosis (ALS)	5600_1432_5603	3	0.028379765	1	0.047299608
2011	hsa-mir-1243	hsa05200	Pathways in cancer	3320_5371_1499_5594_5914_1387_6256_595_1019_367_1017_2932_7704_5578_6774_3091_6688_3725_2353_4088_4089_3065_1050_5925_2033_207	26	1.58E-25	1.01E-23	1.01E-23
2012	hsa-mir-1243	hsa04110	Cell cycle	7534_1387_595_896_1019_1017_7532_2932_1028_4088_4089_3065_5925_2033_894	15	6.63E-18	4.24E-16	2.12E-16
2013	hsa-mir-1243	hsa04350	TGF-beta signaling pathway	6667_3400_5594_1387_3397_3398_3399_4088_4089_2033_4092	11	1.92E-13	1.23E-11	3.08E-12
2014	hsa-mir-1243	hsa05215	Prostate cancer	3320_1499_5594_1387_595_367_1017_2932_5925_2033_207	11	2.15E-13	1.38E-11	3.08E-12
2015	hsa-mir-1243	hsa05212	Pancreatic cancer	3320_1499_5594_1387_595_367_1017_2932_5925_2033_207	11	2.41E-13	1.54E-11	3.08E-12
2016	hsa-mir-1243	hsa05221	Acute myeloid leukemia	5371_5594_5914_595_7704_6774_6688_1050_207	9	6.99E-12	4.47E-10	7.46E-11
2017	hsa-mir-1243	hsa05214	Glioma	5594_595_1019_5578_5925_207_808_801_805	9	1.54E-11	9.84E-10	1.41E-10
2018	hsa-mir-1243	hsa04310	Wnt signaling pathway	1499_1387_595_896_2932_5578_3725_4088_4089_2033_894	11	5.29E-11	3.38E-09	4.23E-10
2019	hsa-mir-1243	hsa05210	Colorectal cancer	1499_5594_595_2932_3725_2353_4088_4089_207	9	1.26E-10	8.04E-09	8.94E-10
2020	hsa-mir-1243	hsa04916	Melanogenesis	1499_5594_1387_2932_5578_2033_808_801_805	9	7.30E-10	4.67E-08	4.67E-09
2021	hsa-mir-1243	hsa04510	Focal adhesion	1499_6714_5594_595_896_2932_5578_3725_5058_894_207	11	1.12E-09	7.19E-08	6.54E-09
2022	hsa-mir-1243	hsa05220	Chronic myeloid leukemia	5594_595_1019_4088_4089_3065_5925_207	8	1.44E-09	9.22E-08	7.69E-09
2023	hsa-mir-1243	hsa05223	Non-small cell lung cancer	5594_6256_595_1019_5578_5925_207	7	4.60E-09	2.94E-07	2.26E-08
2024	hsa-mir-1243	hsa04912	GnRH signaling pathway	6714_5594_1432_5578_3725_808_801_805	8	2.08E-08	1.33E-06	9.52E-08
2025	hsa-mir-1243	hsa04660	T cell receptor signaling pathway	5594_1019_2932_1432_3725_2353_5058_207	8	2.38E-08	1.53E-06	1.02E-07
2026	hsa-mir-1243	hsa05211	Renal cell carcinoma	5594_1387_3091_3725_5058_2033_207	7	2.88E-08	1.84E-06	1.15E-07
2027	hsa-mir-1243	hsa04720	Long-term potentiation	5594_1387_5578_2033_808_801_805	7	3.74E-08	2.39E-06	1.41E-07
2028	hsa-mir-1243	hsa04520	Adherens junction	1499_6714_5594_1387_4088_4089_2033	7	5.66E-08	3.62E-06	2.01E-07
2029	hsa-mir-1243	hsa04012	ErbB signaling pathway	6714_5594_2932_5578_3725_5058_207	7	9.69E-08	6.20E-06	3.26E-07
2030	hsa-mir-1243	hsa05222	Small cell lung cancer	6256_595_1019_1017_5925_207	6	1.81E-06	0.000115887	5.52E-06
2031	hsa-mir-1243	hsa04910	Insulin signaling pathway	5594_2932_207_2538_808_801_805	7	1.85E-06	0.000118465	5.52E-06
2032	hsa-mir-1243	hsa04010	MAPK signaling pathway	6722_5594_1432_5578_4342_3725_2353_5058_207	9	1.92E-06	0.000122659	5.52E-06
2033	hsa-mir-1243	hsa04330	Notch signaling pathway	1387_9612_3065_2033_8850	5	1.98E-06	0.00012685	5.52E-06
2034	hsa-mir-1243	hsa05213	Endometrial cancer	1499_5594_595_2932_207	5	3.14E-06	0.000201171	8.38E-06
2035	hsa-mir-1243	hsa04630	Jak-STAT signaling pathway	1387_595_896_6774_2033_894_207	7	3.87E-06	0.000247419	9.90E-06
2036	hsa-mir-1243	hsa05216	Thyroid cancer	1499_5594_6256_595	4	8.67E-06	0.000555178	2.14E-05
2037	hsa-mir-1243	hsa04115	p53 signaling pathway	595_896_1019_1017_894	5	1.15E-05	0.000733628	2.72E-05
2038	hsa-mir-1243	hsa05218	Melanoma	5594_595_1019_5925_207	5	1.31E-05	0.000836107	2.99E-05
2039	hsa-mir-1243	hsa04662	B cell receptor signaling pathway	5594_2932_3725_2353_207	5	1.68E-05	0.001074367	3.70E-05
2040	hsa-mir-1243	hsa04370	VEGF signaling pathway	6714_5594_1432_5578_207	5	1.89E-05	0.001211759	4.04E-05
2041	hsa-mir-1243	hsa05219	Bladder cancer	5594_595_1019_5925	4	3.32E-05	0.002127966	6.86E-05
2042	hsa-mir-1243	hsa04620	Toll-like receptor signaling pathway	5594_1432_3725_2353_207	5	6.82E-05	0.004364643	0.000136395
2043	hsa-mir-1243	hsa04270	Vascular smooth muscle contraction	5594_5578_808_801_805	5	0.000131826	0.008436855	0.000255662
2044	hsa-mir-1243	hsa04920	Adipocytokine signaling pathway	6256_6774_207_2538	4	0.000183473	0.011742287	0.000345361
2045	hsa-mir-1243	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_1432_3725_5058	4	0.000226741	0.014511398	0.000414611
2046	hsa-mir-1243	hsa04530	Tight junction	1499_6714_1019_5578_207	5	0.000257573	0.016484644	0.000457907
2047	hsa-mir-1243	hsa04070	Phosphatidylinositol signaling system	5578_808_801_805	4	0.000290596	0.018598152	0.000502653
2048	hsa-mir-1243	hsa04664	Fc epsilon RI signaling pathway	5594_1432_5578_207	4	0.00033458	0.021413119	0.000563503
2049	hsa-mir-1243	hsa05010	Alzheimer's disease	5594_2932_808_801_805	5	0.000798653	0.051113777	0.00131061
2050	hsa-mir-1243	hsa05016	Huntington's disease	6667_25942_1387_3065_2033	5	0.001038159	0.066442159	0.001661054
2051	hsa-mir-1243	hsa04062	Chemokine signaling pathway	5594_2932_6774_5058_207	5	0.001163078	0.074437013	0.001815537
2052	hsa-mir-1243	hsa04150	mTOR signaling pathway	5594_3091_207	3	0.001358207	0.086925226	0.002069648
2053	hsa-mir-1243	hsa05131	Shigellosis	7534_1499_5578	3	0.001663829	0.106485043	0.002420115
2054	hsa-mir-1243	hsa05130	Pathogenic Escherichia coli infection	7534_1499_5578	3	0.001663829	0.106485043	0.002420115
2055	hsa-mir-1243	hsa04950	Maturity onset diabetes of the young	168620_3172	2	0.004728351	0.30261445	0.006724766
2056	hsa-mir-1243	hsa04540	Gap junction	6714_5594_5578	3	0.006579337	0.421077541	0.009104107
2057	hsa-mir-1243	hsa04020	Calcium signaling pathway	5578_808_801_805	4	0.006685829	0.427893034	0.009104107
2058	hsa-mir-1243	hsa04670	Leukocyte transendothelial migration	1499_1432_5578	3	0.013475401	0.862425636	0.017967201
2059	hsa-mir-1243	hsa04360	Axon guidance	5594_2932_5058	3	0.016209833	1	0.021172027
2060	hsa-mir-1243	hsa04650	Natural killer cell mediated cytotoxicity	5594_5578_5058	3	0.018536322	1	0.023726493
2061	hsa-mir-1243	hsa05217	Basal cell carcinoma	1499_2932	2	0.021446677	1	0.026913476
2062	hsa-mir-1243	hsa04340	Hedgehog signaling pathway	53944_2932	2	0.022875092	1	0.02815396
2063	hsa-mir-1243	hsa04730	Long-term depression	5594_5578	2	0.033906089	1	0.040943202
2064	hsa-mir-124-3	hsa05200	Pathways in cancer	4087_4149_5371_2249_1871_5595_5594_5914_1387_6256_9915_367_1017_2932_7704_6776_6777_3091_5970_1870_7157_6688_836_4089_2113_1869_3725_861_6774_2353_4088_1050_5925_2034_2033_207	36	1.92E-33	1.23E-31	1.23E-31
2065	hsa-mir-124-3	hsa04350	TGF-beta signaling pathway	4087_5595_5594_1387_6667_3399_3398_1874_1875_4089_4088_2033_4093_5934_5933	15	3.76E-17	2.41E-15	1.20E-15
2066	hsa-mir-124-3	hsa05220	Chronic myeloid leukemia	1871_5595_5594_6776_6777_5970_1870_7157_4089_1869_861_4088_5925_207	14	1.63E-16	1.04E-14	3.47E-15
2067	hsa-mir-124-3	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_7704_6776_6777_5970_6688_861_6774_1050_207	13	3.03E-16	1.94E-14	4.85E-15
2068	hsa-mir-124-3	hsa05215	Prostate cancer	1871_5595_5594_1387_367_1017_2932_5970_1870_7157_1869_5925_2033_207	14	1.19E-15	7.60E-14	1.46E-14
2069	hsa-mir-124-3	hsa05212	Pancreatic cancer	1871_5595_5594_1387_367_1017_2932_5970_1870_7157_1869_5925_2033_207	14	1.37E-15	8.75E-14	1.46E-14
2070	hsa-mir-124-3	hsa04110	Cell cycle	4087_1871_1387_890_1017_2932_1870_7157_4089_1869_4088_5925_2033_5934_5933	15	2.51E-15	1.61E-13	2.30E-14
2071	hsa-mir-124-3	hsa05210	Colorectal cancer	4087_5595_5594_2932_7157_836_4089_3725_2353_4088_207	11	9.91E-12	6.34E-10	7.92E-11
2072	hsa-mir-124-3	hsa05211	Renal cell carcinoma	5595_5594_1387_9915_3091_2113_3725_2034_2033_207	10	5.24E-11	3.36E-09	3.73E-10
2073	hsa-mir-124-3	hsa05223	Non-small cell lung cancer	1871_5595_5594_6256_1870_7157_1869_5925_207	9	1.15E-10	7.35E-09	7.35E-10
2074	hsa-mir-124-3	hsa05222	Small cell lung cancer	4149_1871_6256_1017_5970_1870_7157_1869_5925_207	10	2.58E-10	1.65E-08	1.50E-09
2075	hsa-mir-124-3	hsa05218	Melanoma	2249_1871_5595_5594_1870_7157_1869_5925_207	9	1.03E-09	6.61E-08	5.51E-09
2076	hsa-mir-124-3	hsa04010	MAPK signaling pathway	4149_2249_5595_5594_1432_5598_5970_7157_836_4773_3725_2353_207_1616	14	1.68E-09	1.08E-07	8.29E-09
2077	hsa-mir-124-3	hsa05214	Glioma	1871_5595_5594_1870_7157_1869_5925_207	8	1.11E-08	7.11E-07	5.08E-08
2078	hsa-mir-124-3	hsa05219	Bladder cancer	1871_5595_5594_1870_7157_1869_5925	7	1.42E-08	9.11E-07	6.07E-08
2079	hsa-mir-124-3	hsa04662	B cell receptor signaling pathway	5595_5594_2932_5970_4773_3725_2353_207	8	3.10E-08	1.99E-06	1.24E-07
2080	hsa-mir-124-3	hsa04660	T cell receptor signaling pathway	5595_5594_2932_1432_5970_4773_3725_2353_207	9	3.55E-08	2.27E-06	1.34E-07
2081	hsa-mir-124-3	hsa04310	Wnt signaling pathway	4087_1387_2932_7157_4089_4773_3725_1457_4088_2033	10	4.24E-08	2.72E-06	1.51E-07
2082	hsa-mir-124-3	hsa04520	Adherens junction	4087_5595_5594_1387_4089_1457_4088_2033	8	4.93E-08	3.16E-06	1.66E-07
2083	hsa-mir-124-3	hsa04012	ErbB signaling pathway	5595_5594_2932_6776_6777_3725_207	7	1.36E-06	8.71E-05	4.35E-06
2084	hsa-mir-124-3	hsa04620	Toll-like receptor signaling pathway	5595_5594_1432_5970_3725_2353_207	7	3.68E-06	0.000235528	1.12E-05
2085	hsa-mir-124-3	hsa05213	Endometrial cancer	5595_5594_2932_7157_207	5	2.09E-05	0.00133656	6.08E-05
2086	hsa-mir-124-3	hsa05216	Thyroid cancer	5595_5594_6256_7157	4	4.01E-05	0.002566054	0.000111568
2087	hsa-mir-124-3	hsa04630	Jak-STAT signaling pathway	1387_6776_6777_6774_2033_3977_207	7	4.86E-05	0.003109314	0.000129555
2088	hsa-mir-124-3	hsa04370	VEGF signaling pathway	5595_5594_1432_4773_207	5	0.000121002	0.007744106	0.000309764
2089	hsa-mir-124-3	hsa04062	Chemokine signaling pathway	5595_5594_2932_6777_5970_6774_207	7	0.000181029	0.011585876	0.000445611
2090	hsa-mir-124-3	hsa04210	Apoptosis	840_5970_7157_836_207	5	0.000230103	0.014726576	0.000545429
2091	hsa-mir-124-3	hsa04150	mTOR signaling pathway	5595_5594_3091_207	4	0.000324196	0.020748557	0.00074102
2092	hsa-mir-124-3	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_7157_836_1616	4	0.000422693	0.027052353	0.00093284
2093	hsa-mir-124-3	hsa04916	Melanogenesis	5595_5594_1387_2932_2033	5	0.000456528	0.029217765	0.000973925
2094	hsa-mir-124-3	hsa04912	GnRH signaling pathway	5595_5594_1432_5598_3725	5	0.000538335	0.034453416	0.001111401
2095	hsa-mir-124-3	hsa05010	Alzheimer's disease	5595_5594_2932_840_836_1020	6	0.000740872	0.04741583	0.001481745
2096	hsa-mir-124-3	hsa04920	Adipocytokine signaling pathway	6256_5970_6774_207	4	0.000801352	0.05128655	0.001554138
2097	hsa-mir-124-3	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_5970_836_3725	4	0.000984487	0.063007157	0.001833309
2098	hsa-mir-124-3	hsa05016	Huntington's disease	1387_6908_6667_7157_836_2033	6	0.001002591	0.064165826	0.001833309
2099	hsa-mir-124-3	hsa04720	Long-term potentiation	5595_5594_1387_2033	4	0.001195214	0.076493703	0.002124825
2100	hsa-mir-124-3	hsa04360	Axon guidance	5595_5594_2932_4773_1020	5	0.001239889	0.079352903	0.002144673
2101	hsa-mir-124-3	hsa04664	Fc epsilon RI signaling pathway	5595_5594_1432_207	4	0.001435656	0.091882007	0.002417948
2102	hsa-mir-124-3	hsa04910	Insulin signaling pathway	5595_5594_2932_23265_207	5	0.001548106	0.099078763	0.002540481
2103	hsa-mir-124-3	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.003126004	0.20006424	0.005001606
2104	hsa-mir-124-3	hsa04510	Focal adhesion	5595_5594_2932_3725_207	5	0.008083177	0.517323297	0.012617641
2105	hsa-mir-124-3	hsa04115	p53 signaling pathway	1017_7157_836	3	0.008664387	0.554520796	0.013202876
2106	hsa-mir-124-3	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_4773	4	0.00973493	0.623035544	0.014489199
2107	hsa-mir-124-3	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_7329	4	0.009970522	0.638113437	0.014502578
2108	hsa-mir-124-3	hsa04540	Gap junction	5595_5594_5598	3	0.018760598	1	0.026681739
2109	hsa-mir-124-3	hsa03022	Basal transcription factors	2963_6908	2	0.021761179	1	0.030276424
2110	hsa-mir-124-3	hsa04930	Type II diabetes mellitus	5595_5594	2	0.030800692	1	0.041941367
2111	hsa-mir-124-3	hsa05217	Basal cell carcinoma	2932_7157	2	0.043795317	1	0.058393755
2112	hsa-mir-1244-1	hsa05200	Pathways in cancer	3725_4149_1499_596_598_1017_8517_4193_3551_5578_3091_3066_3065_1050_5925_613_5743_5747_25_6789_4436_1870_1871_2113_6774_10401_836_324_207_9915_3716_1147_998_367_5595_5594_5599_1387_6256_4286_2932_6772_5970_7157_1869_2736_4087_4088_4089_5888_5728_2034_2033_5468_3910_898_4790_4791_4792_3320_3326_5371_675_5601_5602_1856_51588_4609_1026_1029_2353_8554	72	8.08E-38	7.11E-36	7.11E-36
2113	hsa-mir-1244-1	hsa04110	Cell cycle	1017_4193_902_6500_5111_3066_3065_5925_25_1870_1871_9232_5934_5933_545_995_993_5347_5591_1387_11200_7534_7532_2932_7027_7157_1031_1869_4087_4088_4089_2033_890_898_983_8454_1026_1022_1029_1111_8556_8555_472	43	1.65E-30	1.45E-28	7.26E-29
2114	hsa-mir-1244-1	hsa04010	MAPK signaling pathway	6722_3725_4149_6195_6197_8517_9252_3551_5578_9020_5923_3304_3305_3303_6789_1432_836_207_1147_998_5595_5594_5599_8986_1386_3312_3315_5971_5970_3164_7157_6196_4790_4791_1616_9261_1326_5601_5602_5608_9479_6885_4609_2353_5566	45	7.77E-20	6.84E-18	2.28E-18
2115	hsa-mir-1244-1	hsa05215	Prostate cancer	1499_596_1017_8517_4193_3551_5925_1870_1871_207_1147_367_5595_5594_1385_1387_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_1026	28	4.11E-19	3.61E-17	9.03E-18
2116	hsa-mir-1244-1	hsa05212	Pancreatic cancer	1499_596_1017_8517_4193_3551_5925_1870_1871_207_1147_367_5595_5594_1385_1387_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_1026	28	5.26E-19	4.63E-17	9.26E-18
2117	hsa-mir-1244-1	hsa05220	Chronic myeloid leukemia	598_8517_4193_3551_3066_3065_5925_613_25_1870_1871_207_1147_5595_5594_5970_7157_1869_4088_4089_4790_4792_4609_1026_1029	25	1.31E-17	1.16E-15	1.93E-16
2118	hsa-mir-1244-1	hsa05222	Small cell lung cancer	4149_596_598_1017_8517_3551_5925_5743_5747_1870_1871_10401_207_1147_6256_5970_7157_1869_5728_3910_898_4790_4792_51588_4609_8554	26	2.16E-17	1.90E-15	2.71E-16
2119	hsa-mir-1244-1	hsa04310	Wnt signaling pathway	3725_1499_5578_6500_8945_23291_8607_324_1460_5599_1387_2932_7157_1457_1452_4087_4088_4089_2033_5519_5518_5515_5601_5602_1856_8454_6423_6885_4609_5527_5566	31	2.64E-16	2.32E-14	2.90E-15
2120	hsa-mir-1244-1	hsa04115	p53 signaling pathway	1017_4194_4193_900_50484_6241_836_51246_545_7161_11200_7157_64326_5728_898_27113_25898_983_1026_1029_1111_472	22	2.50E-15	2.20E-13	2.45E-14
2121	hsa-mir-1244-1	hsa04350	TGF-beta signaling pathway	6500_3398_1875_6667_3399_1874_5934_5933_5595_5594_1387_7027_4087_4088_4089_2033_5519_5518_5515_8454_4609_4093	22	1.38E-13	1.21E-11	1.21E-12
2122	hsa-mir-1244-1	hsa04660	T cell receptor signaling pathway	3725_8517_5777_3551_9020_4794_1432_207_1147_998_5595_5594_2932_5970_959_4790_4792_4793_1326_5601_1739_6885_2353	23	1.19E-12	1.05E-10	9.54E-12
2123	hsa-mir-1244-1	hsa04620	Toll-like receptor signaling pathway	3725_8517_3551_3661_1432_207_1147_29110_5595_5594_5599_6772_5970_4790_4792_1326_5601_5602_5608_9641_6885_2353	22	2.16E-12	1.90E-10	1.58E-11
2124	hsa-mir-1244-1	hsa05210	Colorectal cancer	3725_1499_596_4436_836_324_207_5595_5594_5599_2932_7157_4087_4088_4089_5601_5602_1856_4609_2353	20	4.56E-12	4.02E-10	3.09E-11
2125	hsa-mir-1244-1	hsa04920	Adipocytokine signaling pathway	5465_6794_8517_3551_4794_8471_6774_207_1147_5599_6256_5970_4790_4792_4793_5601_5602_5563	18	9.66E-12	8.50E-10	6.07E-11
2126	hsa-mir-1244-1	hsa04120	Ubiquitin mediated proteolysis	55294_4193_6500_3093_8945_23291_84447_10401_7329_51366_11059_8651_10055_11060_64326_7337_5371_672_7319_25898_8454_51588_10075_8554	24	1.38E-11	1.22E-09	8.12E-11
2127	hsa-mir-1244-1	hsa04662	B cell receptor signaling pathway	3725_8517_5777_3551_4794_207_1147_695_5595_5594_1380_2932_5970_4790_4792_4793_2353	17	3.53E-10	3.10E-08	1.94E-09
2128	hsa-mir-1244-1	hsa05214	Glioma	4193_5578_5925_1870_1871_207_5595_5594_7157_1869_5728_808_801_805_1026_1029	16	4.12E-10	3.63E-08	2.13E-09
2129	hsa-mir-1244-1	hsa04210	Apoptosis	596_598_8517_3551_9020_823_836_207_1147_839_5970_7157_9131_4790_4792_472_5566	17	3.44E-09	3.03E-07	1.68E-08
2130	hsa-mir-1244-1	hsa03022	Basal transcription factors	51616_6882_6872_2965_2963_2969_6878_6908_2958_2959_6880_2957	12	4.76E-09	4.19E-07	2.21E-08
2131	hsa-mir-1244-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_8517_3551_9020_6714_1432_836_1147_998_5599_5970_4790_4792_5601_5602	15	8.78E-09	7.73E-07	3.86E-08
2132	hsa-mir-1244-1	hsa05219	Bladder cancer	9252_4193_5925_1870_1871_5595_5594_7157_1869_4609_1026_1029	12	1.57E-08	1.38E-06	6.56E-08
2133	hsa-mir-1244-1	hsa04520	Adherens junction	1499_5777_6714_1460_998_5595_5594_1387_1457_4087_4088_4089_2033_71_6885	15	3.56E-08	3.13E-06	1.42E-07
2134	hsa-mir-1244-1	hsa04910	Insulin signaling pathway	6720_3551_5590_5499_8471_207_8651_5595_5594_5599_23265_2932_808_801_805_5601_5602_5563_5566	19	4.91E-08	4.32E-06	1.88E-07
2135	hsa-mir-1244-1	hsa04720	Long-term potentiation	814_6195_6197_5578_5499_5595_5594_1387_6196_2033_808_801_805_5566	14	1.06E-07	9.35E-06	3.90E-07
2136	hsa-mir-1244-1	hsa05223	Non-small cell lung cancer	5578_5925_6789_1870_1871_207_5595_5594_6256_7157_1869_1029	12	1.67E-07	1.47E-05	5.89E-07
2137	hsa-mir-1244-1	hsa05131	Shigellosis	1499_5578_10382_25_998_7534_347733_7846_7278_71_4691_203068	12	2.36E-07	2.07E-05	7.68E-07
2138	hsa-mir-1244-1	hsa05130	Pathogenic Escherichia coli infection	1499_5578_10382_25_998_7534_347733_7846_7278_71_4691_203068	12	2.36E-07	2.07E-05	7.68E-07
2139	hsa-mir-1244-1	hsa05016	Huntington's disease	292_293_3066_3065_3064_498_25942_6667_836_4716_1385_1387_5437_7157_1213_3092_2033_5468_27113_6908_5441	21	2.49E-07	2.19E-05	7.82E-07
2140	hsa-mir-1244-1	hsa05218	Melanoma	4193_5925_1870_1871_207_5595_5594_4286_7157_1869_5728_1026_1029	13	3.67E-07	3.23E-05	1.11E-06
2141	hsa-mir-1244-1	hsa05221	Acute myeloid leukemia	8517_3551_1050_6774_207_1147_5595_5594_5970_4790_5371_4609	12	3.85E-07	3.39E-05	1.13E-06
2142	hsa-mir-1244-1	hsa04012	ErbB signaling pathway	3725_5578_5747_25_6714_207_5595_5594_5599_2932_5601_5602_4609_1026	14	5.31E-07	4.67E-05	1.51E-06
2143	hsa-mir-1244-1	hsa04530	Tight junction	10207_1499_5578_9223_5590_6714_4628_207_1460_998_1457_5728_5519_5518_5515_71_5520	17	9.22E-07	8.11E-05	2.53E-06
2144	hsa-mir-1244-1	hsa04912	GnRH signaling pathway	3725_5578_6714_1432_998_5595_5594_5599_808_801_805_5601_5602_5608_5566	15	1.13E-06	9.92E-05	3.01E-06
2145	hsa-mir-1244-1	hsa04062	Chemokine signaling pathway	8517_3551_653361_5747_5590_6362_6774_207_1147_998_5595_5594_2932_6772_6773_5970_4790_4792_4793_5566	20	1.40E-06	0.000122947	3.62E-06
2146	hsa-mir-1244-1	hsa04930	Type II diabetes mellitus	3551_5590_8471_3651_8651_5595_5594_5599_5601_5602	10	1.79E-06	0.000157923	4.51E-06
2147	hsa-mir-1244-1	hsa04510	Focal adhesion	3725_1499_596_5578_5923_5747_6714_5499_207_998_5595_5594_5599_2932_1729_5728_3910_5601_5602_71	20	3.48E-06	0.00030662	8.44E-06
2148	hsa-mir-1244-1	hsa04916	Melanogenesis	1499_5578_5595_5594_1385_1387_4286_2932_2033_808_801_805_1856_5566	14	3.55E-06	0.000312302	8.44E-06
2149	hsa-mir-1244-1	hsa04540	Gap junction	5578_10382_6714_5592_5595_5594_347733_7846_1453_983_7278_203068_5566	13	5.44E-06	0.000478377	1.26E-05
2150	hsa-mir-1244-1	hsa03420	Nucleotide excision repair	5981_902_5111_2965_4331_2071_2074_1022_6117	9	1.06E-05	0.000933359	2.39E-05
2151	hsa-mir-1244-1	hsa05211	Renal cell carcinoma	3725_3091_2113_207_9915_998_5595_5594_1387_2034_2033	11	1.35E-05	0.001187252	2.97E-05
2152	hsa-mir-1244-1	hsa04630	Jak-STAT signaling pathway	598_5777_3566_6774_10401_207_3716_8651_1387_6778_6772_6773_2033_51588_4609_8554	16	1.62E-05	0.001424271	3.47E-05
2153	hsa-mir-1244-1	hsa04370	VEGF signaling pathway	5578_5743_5747_6714_1432_207_998_5595_5594_3315_9261	11	2.37E-05	0.002085131	4.96E-05
2154	hsa-mir-1244-1	hsa05213	Endometrial cancer	1499_324_207_5595_5594_2932_7157_5728_4609	9	3.43E-05	0.003016812	6.86E-05
2155	hsa-mir-1244-1	hsa04150	mTOR signaling pathway	6794_6195_6197_3091_207_5595_5594_6196_5563	9	3.43E-05	0.003016812	6.86E-05
2156	hsa-mir-1244-1	hsa05216	Thyroid cancer	1499_5595_5594_6256_7157_5468_4609	7	4.13E-05	0.003632171	8.07E-05
2157	hsa-mir-1244-1	hsa04612	Antigen processing and presentation	3309_3304_3305_3303_1385_3312_1514_3320_3326_4800_4801	11	7.84E-05	0.006899601	0.000149991
2158	hsa-mir-1244-1	hsa04330	Notch signaling pathway	3066_3065_1387_9612_2033_8850_1856_4851	8	0.000103538	0.009111385	0.000193859
2159	hsa-mir-1244-1	hsa04664	Fc epsilon RI signaling pathway	5578_1432_207_695_5595_5594_5599_5601_5602_5608	10	0.000137537	0.012103239	0.000252151
2160	hsa-mir-1244-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_598_1432_836_834_7157_1616_5608	8	0.000304561	0.026801354	0.000537912
2161	hsa-mir-1244-1	hsa03020	RNA polymerase	64425_25885_51082_5437_84172_5441	6	0.000305632	0.026895623	0.000537912
2162	hsa-mir-1244-1	hsa03010	Ribosome	6207_9349_6141_6217_6130_6155_6156_6128_6125_6188	10	0.000882968	0.077701164	0.001523552
2163	hsa-mir-1244-1	hsa04340	Hedgehog signaling pathway	8945_23291_2932_1452_1453_2736_5566	7	0.00160574	0.141305148	0.002717407
2164	hsa-mir-1244-1	hsa03030	DNA replication	5981_5111_5557_6117_5422	5	0.004625523	0.40704604	0.00753789
2165	hsa-mir-1244-1	hsa03410	Base excision repair	3146_5111_142_4913_328	5	0.004625523	0.40704604	0.00753789
2166	hsa-mir-1244-1	hsa04730	Long-term depression	5578_5592_5595_5594_5519_5518_5515	7	0.004952781	0.43584475	0.00792445
2167	hsa-mir-1244-1	hsa05010	Alzheimer's disease	498_823_836_4716_22926_5595_5594_2932_808_801_805_1020	12	0.005214076	0.458838646	0.008193547
2168	hsa-mir-1244-1	hsa03430	Mismatch repair	5981_5111_4436_6117	4	0.005520963	0.485844757	0.008523592
2169	hsa-mir-1244-1	hsa05217	Basal cell carcinoma	1499_324_2932_7157_2736_1856	6	0.005808605	0.511157238	0.008813056
2170	hsa-mir-1244-1	hsa04270	Vascular smooth muscle contraction	5578_5499_5592_5595_5594_808_801_805_5566	9	0.007364242	0.648053339	0.010983955
2171	hsa-mir-1244-1	hsa03440	Homologous recombination	641_5888_675_6117	4	0.010180744	0.895905434	0.014931757
2172	hsa-mir-1244-1	hsa04360	Axon guidance	5747_25_998_5595_5594_2932_5998_1020	8	0.034158129	1	0.0492773
2173	hsa-mir-1244-3	hsa05200	Pathways in cancer	3320_8031_7157_2033_8554_5970_5594_841_5599_6258_1387_6257_6256	13	5.81E-14	3.43E-12	3.43E-12
2174	hsa-mir-1244-3	hsa05216	Thyroid cancer	8031_7157_5594_6258_6257_6256	6	4.94E-11	2.92E-09	1.46E-09
2175	hsa-mir-1244-3	hsa04920	Adipocytokine signaling pathway	10891_5970_5599_6258_6257_6256	6	4.91E-09	2.90E-07	9.65E-08
2176	hsa-mir-1244-3	hsa05222	Small cell lung cancer	7157_8554_5970_6258_6257_6256	6	2.00E-08	1.18E-06	2.39E-07
2177	hsa-mir-1244-3	hsa05215	Prostate cancer	3320_7157_2033_5970_5594_1387	6	2.28E-08	1.34E-06	2.39E-07
2178	hsa-mir-1244-3	hsa05212	Pancreatic cancer	3320_7157_2033_5970_5594_1387	6	2.43E-08	1.43E-06	2.39E-07
2179	hsa-mir-1244-3	hsa05223	Non-small cell lung cancer	7157_5594_6258_6257_6256	5	8.67E-08	5.12E-06	7.31E-07
2180	hsa-mir-1244-3	hsa04110	Cell cycle	4616_7157_10912_2033_1387	5	3.56E-06	0.000209869	2.62E-05
2181	hsa-mir-1244-3	hsa04115	p53 signaling pathway	4616_7157_10912_841	4	1.07E-05	0.00063062	6.66E-05
2182	hsa-mir-1244-3	hsa03320	PPAR signaling pathway	6258_2168_6257_6256	4	1.13E-05	0.000665735	6.66E-05
2183	hsa-mir-1244-3	hsa04010	MAPK signaling pathway	4616_7157_10912_5970_5594_5599	6	1.33E-05	0.000786843	7.15E-05
2184	hsa-mir-1244-3	hsa04520	Adherens junction	71_2033_5594_1387	4	1.87E-05	0.001101057	9.18E-05
2185	hsa-mir-1244-3	hsa05016	Huntington's disease	7157_10891_2033_841_1387	5	3.04E-05	0.001790927	0.000137764
2186	hsa-mir-1244-3	hsa04620	Toll-like receptor signaling pathway	5970_5594_841_5599	4	4.66E-05	0.00274993	0.000196424
2187	hsa-mir-1244-3	hsa04330	Notch signaling pathway	9612_2033_1387	3	0.000112843	0.006657715	0.000443848
2188	hsa-mir-1244-3	hsa04310	Wnt signaling pathway	7157_2033_5599_1387	4	0.00020788	0.012264921	0.000766558
2189	hsa-mir-1244-3	hsa05211	Renal cell carcinoma	2033_5594_1387	3	0.000376153	0.022193041	0.001305473
2190	hsa-mir-1244-3	hsa04720	Long-term potentiation	2033_5594_1387	3	0.000422116	0.02490482	0.00131078
2191	hsa-mir-1244-3	hsa05220	Chronic myeloid leukemia	7157_5970_5594	3	0.000422116	0.02490482	0.00131078
2192	hsa-mir-1244-3	hsa05210	Colorectal cancer	7157_5594_5599	3	0.000581195	0.034290489	0.001714524
2193	hsa-mir-1244-3	hsa04350	TGF-beta signaling pathway	2033_5594_1387	3	0.000641631	0.037856207	0.001802677
2194	hsa-mir-1244-3	hsa04210	Apoptosis	7157_5970_841	3	0.000684067	0.040359929	0.001834542
2195	hsa-mir-1244-3	hsa04916	Melanogenesis	2033_5594_1387	3	0.001060074	0.062544346	0.002719319
2196	hsa-mir-1244-3	hsa04910	Insulin signaling pathway	10891_5594_5599	3	0.002335749	0.137809201	0.00574205
2197	hsa-mir-1244-3	hsa05219	Bladder cancer	7157_5594	2	0.003067525	0.180983964	0.007239359
2198	hsa-mir-1244-3	hsa04630	Jak-STAT signaling pathway	2033_8554_1387	3	0.003221557	0.190071834	0.007310455
2199	hsa-mir-1244-3	hsa04930	Type II diabetes mellitus	5594_5599	2	0.003492766	0.20607321	0.007632341
2200	hsa-mir-1244-3	hsa05213	Endometrial cancer	7157_5594	2	0.004585238	0.270529021	0.009661751
2201	hsa-mir-1244-3	hsa05221	Acute myeloid leukemia	5970_5594	2	0.00581507	0.34308913	0.01183066
2202	hsa-mir-1244-3	hsa05214	Glioma	7157_5594	2	0.006975796	0.411571943	0.013337756
2203	hsa-mir-1244-3	hsa04510	Focal adhesion	71_5594_5599	3	0.007007974	0.413470449	0.013337756
2204	hsa-mir-1244-3	hsa05218	Melanoma	7157_5594	2	0.008232541	0.485719942	0.014718786
2205	hsa-mir-1244-3	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5970_5599	2	0.008232541	0.485719942	0.014718786
2206	hsa-mir-1244-3	hsa04662	B cell receptor signaling pathway	5970_5594	2	0.009122627	0.538235004	0.015830441
2207	hsa-mir-1244-3	hsa04664	Fc epsilon RI signaling pathway	5594_5599	2	0.010053765	0.593172138	0.016947775
2208	hsa-mir-1244-3	hsa04012	ErbB signaling pathway	5594_5599	2	0.012036656	0.710162732	0.019726743
2209	hsa-mir-1244-3	hsa04612	Antigen processing and presentation	3320_3308	2	0.01255705	0.740865957	0.020023404
2210	hsa-mir-1244-3	hsa04912	GnRH signaling pathway	5594_5599	2	0.017974488	1	0.027907757
2211	hsa-mir-1244-3	hsa04660	T cell receptor signaling pathway	5970_5594	2	0.018593097	1	0.028128018
2212	hsa-mir-1244-3	hsa04120	Ubiquitin mediated proteolysis	7329_8554	2	0.028530056	1	0.042081833
2213	hsa-mir-1244-3	hsa05010	Alzheimer's disease	5594_841	2	0.044040346	1	0.063375132
2214	hsa-mir-1245	hsa03022	Basal transcription factors	2967_2961_2960_2963_2962_6881_2969_2968_6879_6878_6877_6874_6872_2957_54457_2958_6873_6884_2959_6880_6882_138474_6883	23	1.05E-32	7.46E-31	7.46E-31
2215	hsa-mir-1245	hsa05200	Pathways in cancer	5371_1499_5594_6258_1387_6256_836_1019_1017_4193_5914_7704_842_841_6774_3091_5970_4824_7157_6688_2113_4609_3725_1026_2353_10401_1050_5925_2033_207_3326_8554_7184	33	2.75E-24	1.95E-22	9.77E-23
2216	hsa-mir-1245	hsa05215	Prostate cancer	1499_5594_1385_1387_1017_4193_842_5970_4824_7157_468_1026_5925_2033_207_3326_7184	17	2.37E-17	1.68E-15	4.98E-16
2217	hsa-mir-1245	hsa05212	Pancreatic cancer	1499_5594_1385_1387_1017_4193_842_5970_4824_7157_468_1026_5925_2033_207_3326_7184	17	2.80E-17	1.99E-15	4.98E-16
2218	hsa-mir-1245	hsa05222	Small cell lung cancer	6258_6256_1019_1017_842_5970_7157_4609_10401_5925_207_8554	12	3.87E-11	2.75E-09	5.50E-10
2219	hsa-mir-1245	hsa04110	Cell cycle	4171_5591_1387_1019_1017_4193_7027_7157_1026_4085_5925_2033_5933	13	9.58E-11	6.80E-09	1.13E-09
2220	hsa-mir-1245	hsa05221	Acute myeloid leukemia	5371_5594_5914_7704_6774_5970_6688_4609_1050_207	10	3.09E-10	2.19E-08	3.13E-09
2221	hsa-mir-1245	hsa04010	MAPK signaling pathway	5594_1386_9261_836_3312_1649_5970_7157_468_4609_3725_3727_6195_2353_207_2002_2005	17	4.65E-10	3.30E-08	4.13E-09
2222	hsa-mir-1245	hsa05220	Chronic myeloid leukemia	5594_1019_4193_5970_7157_4609_1026_5925_207	9	3.70E-08	2.63E-06	2.92E-07
2223	hsa-mir-1245	hsa05223	Non-small cell lung cancer	5594_6258_6256_1019_842_7157_5925_207	8	4.90E-08	3.48E-06	3.48E-07
2224	hsa-mir-1245	hsa05210	Colorectal cancer	1499_5594_836_842_7157_4609_3725_2353_207	9	9.06E-08	6.43E-06	5.85E-07
2225	hsa-mir-1245	hsa05219	Bladder cancer	5594_1019_4193_7157_4609_1026_5925	7	1.68E-07	1.19E-05	9.84E-07
2226	hsa-mir-1245	hsa05214	Glioma	815_5594_1019_4193_7157_1026_5925_207	8	1.80E-07	1.28E-05	9.84E-07
2227	hsa-mir-1245	hsa04115	p53 signaling pathway	836_1019_1017_4193_842_841_7157_1026	8	2.74E-07	1.95E-05	1.39E-06
2228	hsa-mir-1245	hsa05216	Thyroid cancer	1499_5594_6258_6256_7157_4609	6	4.27E-07	3.03E-05	2.02E-06
2229	hsa-mir-1245	hsa05213	Endometrial cancer	1499_5594_842_7157_4609_207_2002	7	6.20E-07	4.40E-05	2.75E-06
2230	hsa-mir-1245	hsa05016	Huntington's disease	6874_3064_1385_1387_836_9001_842_841_5430_7157_2033	11	1.04E-06	7.35E-05	4.33E-06
2231	hsa-mir-1245	hsa04310	Wnt signaling pathway	815_1499_1387_8607_7157_4609_3725_1460_1457_2033	10	1.19E-06	8.45E-05	4.69E-06
2232	hsa-mir-1245	hsa04012	ErbB signaling pathway	815_6714_5594_4609_3725_1026_207_2002	8	1.39E-06	9.87E-05	5.20E-06
2233	hsa-mir-1245	hsa04210	Apoptosis	836_839_842_841_840_5970_7157_207	8	1.63E-06	0.0001157	5.79E-06
2234	hsa-mir-1245	hsa05218	Melanoma	5594_1019_4193_7157_1026_5925_207	7	4.20E-06	0.000297876	1.42E-05
2235	hsa-mir-1245	hsa05211	Renal cell carcinoma	5594_1387_3091_2113_3725_2033_207	7	4.57E-06	0.000324525	1.48E-05
2236	hsa-mir-1245	hsa04520	Adherens junction	1499_6714_5594_1387_1460_1457_2033	7	8.71E-06	0.000618096	2.69E-05
2237	hsa-mir-1245	hsa04350	TGF-beta signaling pathway	5594_1387_7027_1874_4609_2033_5933	7	1.45E-05	0.001030316	4.29E-05
2238	hsa-mir-1245	hsa04720	Long-term potentiation	815_5594_1387_468_6195_2033	6	6.19E-05	0.004397178	0.000175887
2239	hsa-mir-1245	hsa03050	Proteasome	5710_5705_5701_5702_5719	5	8.13E-05	0.005772881	0.000222034
2240	hsa-mir-1245	hsa04620	Toll-like receptor signaling pathway	5594_841_5970_3725_2353_207	6	0.000302727	0.021493651	0.000796061
2241	hsa-mir-1245	hsa04916	Melanogenesis	815_1499_5594_1385_1387_2033	6	0.00033418	0.023726782	0.000847385
2242	hsa-mir-1245	hsa04920	Adipocytokine signaling pathway	6258_6256_6774_5970_207	5	0.000348471	0.024741415	0.000853152
2243	hsa-mir-1245	hsa04912	GnRH signaling pathway	815_6714_5594_468_3725_2002	6	0.000404732	0.02873596	0.000957865
2244	hsa-mir-1245	hsa04660	T cell receptor signaling pathway	5594_1019_5970_3725_2353_207	6	0.000444109	0.031531716	0.000991508
2245	hsa-mir-1245	hsa04630	Jak-STAT signaling pathway	1387_6774_4609_10401_2033_207_8554	7	0.000446877	0.031728262	0.000991508
2246	hsa-mir-1245	hsa04662	B cell receptor signaling pathway	5594_5970_3725_2353_207	5	0.000567175	0.040269426	0.001220286
2247	hsa-mir-1245	hsa04370	VEGF signaling pathway	6714_5594_9261_842_207	5	0.000635094	0.045091651	0.001326225
2248	hsa-mir-1245	hsa03420	Nucleotide excision repair	2967_2968_5981_5887	4	0.00069612	0.049424507	0.001412129
2249	hsa-mir-1245	hsa04330	Notch signaling pathway	1387_9612_2033_8850	4	0.000876686	0.062244714	0.00172902
2250	hsa-mir-1245	hsa04612	Antigen processing and presentation	1385_4800_4801_3312_3326	5	0.001178189	0.083651441	0.00226085
2251	hsa-mir-1245	hsa04150	mTOR signaling pathway	5594_3091_6195_207	4	0.001247161	0.088548446	0.002330222
2252	hsa-mir-1245	hsa04530	Tight junction	1499_6714_1019_1460_1457_207	6	0.001326322	0.094168894	0.002414587
2253	hsa-mir-1245	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_836_5970_3725	4	0.003647584	0.25897844	0.006474461
2254	hsa-mir-1245	hsa05010	Alzheimer's disease	22926_5594_836_842_841_840	6	0.004530135	0.32163956	0.007844867
2255	hsa-mir-1245	hsa04510	Focal adhesion	1499_6714_5594_3725_207_2002	6	0.009084279	0.644983837	0.015356758
2256	hsa-mir-1245	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_842_7157	3	0.013316551	0.945475102	0.021987793
2257	hsa-mir-1245	hsa04950	Maturity onset diabetes of the young	5080_6927	2	0.019838911	1	0.032012789
2258	hsa-mir-1245	hsa04910	Insulin signaling pathway	5594_5211_207_2002	4	0.031689699	1	0.049999302
2259	hsa-mir-1245	hsa04120	Ubiquitin mediated proteolysis	5371_4193_10401_8554	4	0.032395215	1	0.050001311
2260	hsa-mir-1245	hsa03030	DNA replication	5981_4171	2	0.040203688	1	0.060733231
2261	hsa-mir-1245	hsa04540	Gap junction	6714_5594_10382	3	0.046828596	1	0.069267299
2262	hsa-mir-1247	hsa05200	Pathways in cancer	6654_9915_5914_595_598_1017_4193_5578_3091_3066_3065_5925_4149_1050_5743_5747_25_405_1956_2308_6789_613_1387_2064_8503_4436_1870_1871_2885_596_2113_10401_861_5879_6502_207_208_836_5894_3716_1147_4609_998_1026_4233_2261_5595_5594_5599_6256_4286_367_2932_6776_6777_6772_5979_5970_7157_7704_1869_3725_2736_4087_4088_4089_5295_5888_5728_2033_675_4846_3910_4790_4792_3320_3326_5371_3480_5159_5156_5604_5601_5602_1856_3265_841_4292_51588_7428_1029_2353_2034_1441_8554	95	8.62E-53	7.67E-51	7.67E-51
2263	hsa-mir-1247	hsa04010	MAPK signaling pathway	3925_6722_6654_2264_4214_9252_5578_4773_4616_5923_4149_1956_3304_3305_3303_6789_1432_627_2885_22800_4763_5879_1616_2872_207_208_836_5894_1147_4609_994_998_2261_5595_5594_5599_5598_8986_1386_3312_3315_1649_5970_3164_7157_10912_3725_3727_6195_6196_6197_5058_4790_51701_5159_9261_5156_5604_4208_5601_5602_5566_3265_6885_2353	65	2.67E-32	2.38E-30	1.19E-30
2264	hsa-mir-1247	hsa04110	Cell cycle	595_1017_4193_902_6500_995_3066_3065_4616_5925_25_1387_1870_1871_9232_6502_5934_5933_545_994_1026_7534_5591_11200_7533_7532_2932_7027_7157_10912_1869_4087_4088_4089_2033_890_1031_983_8454_5347_1022_1029_1111_8556_8555_472_990	47	1.23E-31	1.09E-29	3.63E-30
2265	hsa-mir-1247	hsa05220	Chronic myeloid leukemia	6654_595_598_4193_3066_3065_5925_25_613_8503_1870_1871_2885_861_207_208_5894_1147_4609_1026_5595_5594_6776_6777_5970_7157_1869_4088_4089_5295_4790_4792_5604_3265_5781_1029_6464	37	6.98E-28	6.21E-26	1.55E-26
2266	hsa-mir-1247	hsa05215	Prostate cancer	6654_595_1017_4193_5925_1956_2308_1387_2064_8503_1870_1871_2885_596_207_208_5894_1147_1026_5595_5594_367_2932_5970_7157_1869_5295_5728_2033_4790_4792_3320_3326_3480_5159_5156_5604_3265	38	6.05E-27	5.38E-25	1.08E-25
2267	hsa-mir-1247	hsa05212	Pancreatic cancer	6654_595_1017_4193_5925_1956_2308_1387_2064_8503_1870_1871_2885_596_207_208_5894_1147_1026_5595_5594_367_2932_5970_7157_1869_5295_5728_2033_4790_4792_3320_3326_3480_5159_5156_5604_3265	38	8.37E-27	7.45E-25	1.24E-25
2268	hsa-mir-1247	hsa05210	Colorectal cancer	6654_595_1956_8503_4436_2885_596_5879_207_208_836_5894_4609_4233_5595_5594_5599_2932_7157_3725_4087_4088_4089_5295_3480_5159_5156_5604_5601_5602_1856_4292_2353	33	1.52E-22	1.35E-20	1.93E-21
2269	hsa-mir-1247	hsa05214	Glioma	6654_595_4193_5578_5925_1956_8503_1870_1871_2885_207_208_5894_1026_5595_5594_7157_1869_5295_5728_808_801_805_3480_5159_5156_5604_3265_1029_6464	30	3.28E-22	2.92E-20	3.65E-21
2270	hsa-mir-1247	hsa04630	Jak-STAT signaling pathway	3559_6654_595_598_5777_3454_3455_3560_1387_1439_8503_2885_10401_2690_207_208_3717_3716_4609_3718_85480_3575_3570_3572_6778_6776_6777_6772_7297_5295_2033_149233_3953_51588_10379_5781_1441_8554	38	9.17E-20	8.16E-18	9.06E-19
2271	hsa-mir-1247	hsa05222	Small cell lung cancer	595_598_1017_5925_4149_5743_5747_8503_1870_1871_596_10401_6502_207_208_1147_4609_6256_5970_7157_1869_5295_5728_4846_3910_4790_4792_51588_8554	29	1.67E-18	1.48E-16	1.48E-17
2272	hsa-mir-1247	hsa04012	ErbB signaling pathway	6654_5578_5747_25_1956_6714_2064_8503_2885_207_208_5894_4609_1026_5595_5594_5599_56924_2932_6776_6777_3725_5295_5058_5604_5601_5602_3265_6464	29	2.16E-18	1.92E-16	1.75E-17
2273	hsa-mir-1247	hsa05223	Non-small cell lung cancer	6654_595_5578_5925_1956_2309_6789_2064_8503_1870_1871_2885_207_208_5894_5595_5594_6256_7157_1869_5295_5604_3265_1029	24	9.53E-18	8.48E-16	7.07E-17
2274	hsa-mir-1247	hsa04115	p53 signaling pathway	595_1017_4194_4193_900_4616_50484_6241_51246_836_545_1026_11200_7249_7157_10912_64326_5728_27113_25898_983_841_7161_1029_1111_472	26	1.07E-17	9.57E-16	7.36E-17
2275	hsa-mir-1247	hsa04510	Focal adhesion	6654_595_5578_857_5923_5747_9564_1956_6714_5499_2064_8503_2885_596_5879_207_208_5894_998_4233_5595_5594_5599_56924_2932_1729_3725_5295_5058_5728_3910_2321_3480_5159_5156_5604_5601_5602_3265_6464	40	1.24E-17	1.10E-15	7.85E-17
2276	hsa-mir-1247	hsa05211	Renal cell carcinoma	6654_9915_3091_405_1387_8503_2885_2113_5879_207_208_5894_998_4233_5595_5594_56924_3725_5295_5058_2033_5604_3265_7428_5781_2034	26	2.51E-17	2.23E-15	1.49E-16
2277	hsa-mir-1247	hsa04062	Chemokine signaling pathway	2185_6654_1234_1230_7074_5747_5580_9564_5590_2309_8503_2885_6362_5879_207_208_3055_5894_3717_1147_3718_998_5595_5594_2932_6777_6772_5970_5295_5058_4790_4792_2770_5604_5566_3265_7852_6464	38	5.39E-17	4.80E-15	3.00E-16
2278	hsa-mir-1247	hsa05218	Melanoma	595_4193_5925_1956_8503_1870_1871_207_208_5894_1026_4233_5595_5594_4286_7157_1869_5295_5728_3480_5159_5156_5604_3265_1029	25	1.67E-16	1.48E-14	8.73E-16
2279	hsa-mir-1247	hsa04660	T cell receptor signaling pathway	6654_5777_4773_3932_1432_8503_2885_207_208_5894_1147_998_5595_5594_56924_2932_5970_3725_5295_5058_4790_4792_5604_5601_3265_1739_6885_2353_959	29	4.09E-16	3.64E-14	2.02E-15
2280	hsa-mir-1247	hsa05221	Acute myeloid leukemia	6654_5914_595_1050_8503_2885_861_207_208_5894_1147_4609_5595_5594_6776_6777_5970_7704_5295_4790_5371_5604_3265	23	4.51E-16	4.01E-14	2.11E-15
2281	hsa-mir-1247	hsa05219	Bladder cancer	595_9252_4193_5925_1956_2064_1870_1871_5894_4609_1026_2261_5595_5594_7157_1869_5604_3265_1029	19	1.90E-14	1.69E-12	8.46E-14
2282	hsa-mir-1247	hsa04662	B cell receptor signaling pathway	6654_5777_4773_8503_2885_6850_5879_207_208_5894_1147_5595_5594_1380_2932_5970_3725_5295_4790_4792_5604_3265_2353	23	3.11E-14	2.76E-12	1.32E-13
2283	hsa-mir-1247	hsa05213	Endometrial cancer	6654_595_1956_2309_2064_8503_2885_207_208_5894_4609_5595_5594_2932_7157_5295_5728_5604_3265_4292	20	4.56E-14	4.05E-12	1.84E-13
2284	hsa-mir-1247	hsa04910	Insulin signaling pathway	6720_10891_6654_5770_5590_5499_2308_8503_2885_2872_207_208_5894_5595_5594_5599_7249_2932_5295_808_801_805_5604_5601_5602_5566_3265_5563_6464	29	6.37E-14	5.67E-12	2.47E-13
2285	hsa-mir-1247	hsa04310	Wnt signaling pathway	595_1457_5578_6500_4773_1387_5879_4609_1460_5599_1459_2932_7157_8061_3725_1452_4087_4088_4089_2033_51701_5518_5515_5601_5602_5566_1856_8454_6885_5527	30	9.87E-14	8.78E-12	3.66E-13
2286	hsa-mir-1247	hsa04520	Adherens junction	1457_5770_5777_2241_1956_6714_1387_2064_5879_1460_998_4233_5595_5594_1459_4087_4088_4089_2033_51701_3480_6885	22	7.13E-13	6.34E-11	2.54E-12
2287	hsa-mir-1247	hsa04620	Toll-like receptor signaling pathway	3454_3455_1432_8503_5879_207_208_1147_3654_5595_5594_5599_6772_5970_3725_5295_4790_4792_5604_5601_5602_841_6885_2353	24	1.15E-12	1.02E-10	3.94E-12
2288	hsa-mir-1247	hsa04540	Gap junction	5592_6654_5578_51807_1956_6714_2885_5894_5595_5594_5598_1453_7846_5159_2770_983_5156_5604_5566_3265_7277_7278_10376	23	1.40E-12	1.25E-10	4.63E-12
2289	hsa-mir-1247	hsa04350	TGF-beta signaling pathway	6500_3398_1875_6667_1387_3399_1874_5934_5933_4609_5595_5594_7027_4086_4087_4088_4089_2033_5518_5515_8454_4093	22	2.95E-12	2.63E-10	9.38E-12
2290	hsa-mir-1247	hsa04912	GnRH signaling pathway	2185_6654_4214_5578_5580_1956_6714_1432_2885_5894_998_5595_5594_5599_5598_3725_808_801_805_5604_5601_5602_5566_3265	24	3.29E-12	2.93E-10	1.01E-11
2291	hsa-mir-1247	hsa04370	VEGF signaling pathway	5578_4773_5743_5747_6714_1432_8503_5879_207_208_5894_998_5595_5594_3315_5295_4846_9261_5604_3265	20	1.90E-11	1.69E-09	5.63E-11
2292	hsa-mir-1247	hsa04210	Apoptosis	3556_598_823_1439_8503_596_207_208_836_1147_3654_5970_7157_5295_4790_4792_5566_841_840_472	20	1.76E-10	1.56E-08	5.04E-10
2293	hsa-mir-1247	hsa04664	Fc epsilon RI signaling pathway	6654_5578_5580_1432_8503_2885_6850_5879_207_208_5894_5595_5594_5599_5295_5604_5601_5602_3265	19	1.86E-10	1.65E-08	5.17E-10
2294	hsa-mir-1247	hsa04720	Long-term potentiation	5578_2902_2906_5499_1387_5894_5595_5594_6195_6196_6197_2033_808_801_805_5604_5566_3265	18	5.75E-10	5.11E-08	1.55E-09
2295	hsa-mir-1247	hsa04120	Ubiquitin mediated proteolysis	55294_4214_4193_6500_3093_7319_84447_10401_10273_7329_6502_11059_10055_64326_7337_5371_672_25898_8454_51588_7428_10075_8554	23	1.57E-09	1.39E-07	4.10E-09
2296	hsa-mir-1247	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_1432_5879_836_1147_998_4233_5599_5970_3725_5058_4790_4792_5601_5602_5781	17	1.78E-09	1.58E-07	4.52E-09
2297	hsa-mir-1247	hsa03022	Basal transcription factors	51616_2957_2965_2963_2962_2969_6874_6908_2958_2959_6880_6881_9519	13	3.13E-09	2.78E-07	7.73E-09
2298	hsa-mir-1247	hsa04920	Adipocytokine signaling pathway	10891_6794_207_208_3717_1147_5599_6256_5970_4790_4792_5601_5602_3953_5781_5563	16	5.50E-09	4.89E-07	1.32E-08
2299	hsa-mir-1247	hsa04650	Natural killer cell mediated cytotoxicity	2185_6654_5777_5578_3454_3455_4773_3932_8503_2885_6850_5879_836_5894_5595_5594_5295_5058_5604_3265_5781_6464	22	6.48E-09	5.77E-07	1.52E-08
2300	hsa-mir-1247	hsa04150	mTOR signaling pathway	6794_3091_8503_207_208_5595_5594_7249_6195_6196_6197_5295_5563	13	9.37E-08	8.34E-06	2.14E-07
2301	hsa-mir-1247	hsa04530	Tight junction	10207_1457_5578_5580_5590_6714_22800_8573_207_208_1460_998_1459_5728_5518_5515_2770_3265_5520	19	4.77E-07	4.24E-05	1.06E-06
2302	hsa-mir-1247	hsa04916	Melanogenesis	5578_1387_5894_5595_5594_4286_2932_2033_808_801_805_2770_5604_5566_1856_3265	16	1.12E-06	9.97E-05	2.43E-06
2303	hsa-mir-1247	hsa05216	Thyroid cancer	595_4609_5595_5594_6256_5979_7157_5604_3265	9	2.01E-06	0.000179047	4.26E-06
2304	hsa-mir-1247	hsa04810	Regulation of actin cytoskeleton	6654_2264_7074_5747_9564_1956_5499_8503_22800_5879_5894_998_2261_5595_5594_56924_1729_5295_5058_5159_5156_5604_3265	23	2.63E-06	0.000233665	5.43E-06
2305	hsa-mir-1247	hsa04360	Axon guidance	4773_5747_25_5879_2242_998_4233_5595_5594_56924_2932_5058_5998_2770_3265_7852_1020	17	4.25E-06	0.000377815	8.59E-06
2306	hsa-mir-1247	hsa04060	Cytokine-cytokine receptor interaction	3556_3559_1234_1230_3454_3455_8764_1956_3560_1439_6362_2690_85480_4233_3575_3570_3572_2321_149233_5159_5156_3953_7852_959_1441	25	4.71E-06	0.000419394	9.32E-06
2307	hsa-mir-1247	hsa04930	Type II diabetes mellitus	3651_5580_5590_8503_5595_5594_5599_5295_5601_5602	10	7.06E-06	0.000628403	1.37E-05
2308	hsa-mir-1247	hsa04330	Notch signaling pathway	3066_3065_1387_9612_2033_8850_2648_1856_3280_388585	10	9.85E-06	0.000876758	1.87E-05
2309	hsa-mir-1247	hsa04730	Long-term depression	5592_5578_5894_5595_5594_4846_3480_5518_5515_2770_5604_3265	12	1.04E-05	0.000929448	1.94E-05
2310	hsa-mir-1247	hsa05016	Huntington's disease	10891_3066_3065_3064_25942_2902_6667_1387_627_836_4716_7157_23186_2033_27113_6874_6908_841_9519	19	3.09E-05	0.002747411	5.61E-05
2311	hsa-mir-1247	hsa05014	Amyotrophic lateral sclerosis (ALS)	598_2902_2906_1432_596_5879_1616_836_7157_4846	10	3.73E-05	0.003322241	6.39E-05
2312	hsa-mir-1247	hsa05131	Shigellosis	5578_51807_25_998_7534_4691_7846_7277_7278_10376	10	3.73E-05	0.003322241	6.39E-05
2313	hsa-mir-1247	hsa05130	Pathogenic Escherichia coli infection	5578_51807_25_998_7534_4691_7846_7277_7278_10376	10	3.73E-05	0.003322241	6.39E-05
2314	hsa-mir-1247	hsa04612	Antigen processing and presentation	6890_3309_3304_3305_3303_3312_3320_3326_4800_4801_4802_2923	12	7.69E-05	0.006839911	0.000129055
2315	hsa-mir-1247	hsa03420	Nucleotide excision repair	902_6117_2965_4331_2071_2074_6118_1022	8	0.000199484	0.017754073	0.000328779
2316	hsa-mir-1247	hsa05010	Alzheimer's disease	823_2902_2906_836_4716_5595_5594_2932_4846_808_351_801_805_841_840_1020	16	0.000405801	0.03611631	0.00065666
2317	hsa-mir-1247	hsa04270	Vascular smooth muscle contraction	5592_5578_5580_5499_5894_5595_5594_808_801_805_5604_5566	12	0.000814897	0.072525801	0.001295104
2318	hsa-mir-1247	hsa04670	Leukocyte transendothelial migration	2185_5578_5747_9564_1432_8503_5879_998_5295_2770_7852_5781	12	0.001063795	0.094677725	0.001661013
2319	hsa-mir-1247	hsa03410	Base excision repair	4350_142_4913_3146_328_6996	6	0.001860922	0.165622101	0.002855553
2320	hsa-mir-1247	hsa04950	Maturity onset diabetes of the young	3651_6927_4760_3280_3172	5	0.001895135	0.168667047	0.002858764
2321	hsa-mir-1247	hsa03440	Homologous recombination	641_6117_5888_675_6118	5	0.003416411	0.304060572	0.005067676
2322	hsa-mir-1247	hsa05340	Primary immunodeficiency	6890_3932_3718_3575_959	5	0.007915007	0.704435664	0.011548126
2323	hsa-mir-1247	hsa03430	Mismatch repair	4436_6117_4292_6118	4	0.009453416	0.841353998	0.013570226
2324	hsa-mir-1247	hsa04020	Calcium signaling pathway	2185_5578_1956_2902_2906_2064_4846_808_801_805_5159_5156_5566	13	0.011350481	1	0.016034806
2325	hsa-mir-1247	hsa04710	Circadian rhythm - mammal	8863_1453_8553	3	0.012643927	1	0.017582962
2326	hsa-mir-1247	hsa04070	Phosphatidylinositol signaling system	5578_8503_5295_5728_808_801_805	7	0.015334927	1	0.020997054
2327	hsa-mir-1247	hsa04740	Olfactory transduction	5592_808_801_805_5566	5	0.028013147	1	0.037775305
2328	hsa-mir-1247	hsa03030	DNA replication	6117_5557_6118_5422	4	0.035829635	1	0.04759459
2329	hsa-mir-1247	hsa04340	Hedgehog signaling pathway	2932_1452_1453_2736_5566	5	0.044611603	1	0.058388716
2330	hsa-mir-1248	hsa03022	Basal transcription factors	2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_6873_2958_6884_2959_6880_6882_138474_6883	21	1.58E-33	1.03E-31	1.03E-31
2331	hsa-mir-1248	hsa05200	Pathways in cancer	1869_4149_5925_1870_5594_6256_3326_1487_1488_4193_5970_1871_7157_6688_3725_4089_10401_4087_4609_2353_4088_1050_2033_8554_1017_7184	26	6.70E-22	4.35E-20	2.18E-20
2332	hsa-mir-1248	hsa04110	Cell cycle	1869_5925_1870_4193_1871_7157_4089_4087_4171_4085_4088_2033_5933_890_5934_1017	16	3.00E-17	1.95E-15	6.50E-16
2333	hsa-mir-1248	hsa05220	Chronic myeloid leukemia	1869_5925_1870_5594_1487_1488_4193_5970_1871_7157_4089_4609_4088	13	1.61E-15	1.05E-13	2.62E-14
2334	hsa-mir-1248	hsa05222	Small cell lung cancer	1869_4149_5925_1870_6256_5970_1871_7157_10401_4609_8554_1017	12	2.08E-13	1.35E-11	2.70E-12
2335	hsa-mir-1248	hsa05215	Prostate cancer	1869_5925_1870_5594_3326_4193_5970_1871_7157_2033_1017_7184	12	2.67E-13	1.73E-11	2.80E-12
2336	hsa-mir-1248	hsa05212	Pancreatic cancer	1869_5925_1870_5594_3326_4193_5970_1871_7157_2033_1017_7184	12	3.01E-13	1.96E-11	2.80E-12
2337	hsa-mir-1248	hsa04350	TGF-beta signaling pathway	5594_1874_1875_4089_4087_4609_4088_2033_5933_5934	10	1.27E-10	8.26E-09	1.03E-09
2338	hsa-mir-1248	hsa05219	Bladder cancer	1869_5925_1870_5594_4193_1871_7157_4609	8	2.58E-10	1.68E-08	1.86E-09
2339	hsa-mir-1248	hsa04310	Wnt signaling pathway	1460_8607_1487_1488_7157_3725_4089_4087_4609_4088_2033	11	1.45E-09	9.40E-08	9.40E-09
2340	hsa-mir-1248	hsa05210	Colorectal cancer	5594_7157_3725_4089_4087_4609_2353_4088	8	3.70E-08	2.40E-06	2.10E-07
2341	hsa-mir-1248	hsa05223	Non-small cell lung cancer	1869_5925_1870_5594_6256_1871_7157	7	3.87E-08	2.52E-06	2.10E-07
2342	hsa-mir-1248	hsa05214	Glioma	1869_5925_1870_5594_4193_1871_7157	7	1.24E-07	8.09E-06	6.22E-07
2343	hsa-mir-1248	hsa05218	Melanoma	1869_5925_1870_5594_4193_1871_7157	7	2.17E-07	1.41E-05	1.01E-06
2344	hsa-mir-1248	hsa04520	Adherens junction	1460_5594_4089_4087_4088_2033	6	7.21E-06	0.000468846	3.13E-05
2345	hsa-mir-1248	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	9.79E-06	0.000636326	3.98E-05
2346	hsa-mir-1248	hsa04010	MAPK signaling pathway	3727_4149_5594_5970_3312_7157_3725_4609_2353	9	2.33E-05	0.001516837	8.92E-05
2347	hsa-mir-1248	hsa05221	Acute myeloid leukemia	5594_5970_6688_4609_1050	5	2.48E-05	0.001612116	8.96E-05
2348	hsa-mir-1248	hsa05216	Thyroid cancer	5594_6256_7157_4609	4	2.91E-05	0.001888712	9.94E-05
2349	hsa-mir-1248	hsa04330	Notch signaling pathway	1487_1488_2033_8850	4	0.000164602	0.010699162	0.000534958
2350	hsa-mir-1248	hsa05016	Huntington's disease	6874_9001_5430_7157_3064_2033	6	0.000653093	0.042451074	0.00202148
2351	hsa-mir-1248	hsa04662	B cell receptor signaling pathway	5594_5970_3725_2353	4	0.000880817	0.057253127	0.002602415
2352	hsa-mir-1248	hsa03420	Nucleotide excision repair	2967_2968_5887	3	0.002073613	0.134784847	0.005860211
2353	hsa-mir-1248	hsa04620	Toll-like receptor signaling pathway	5594_5970_3725_2353	4	0.002604071	0.16926459	0.007052691
2354	hsa-mir-1248	hsa05213	Endometrial cancer	5594_7157_4609	3	0.003251524	0.211349053	0.008453962
2355	hsa-mir-1248	hsa04660	T cell receptor signaling pathway	5594_5970_3725_2353	4	0.003384244	0.21997589	0.008460611
2356	hsa-mir-1248	hsa04115	p53 signaling pathway	4193_7157_1017	3	0.006917126	0.449613207	0.016652341
2357	hsa-mir-1248	hsa05211	Renal cell carcinoma	5594_3725_2033	3	0.007740702	0.503145646	0.017969487
2358	hsa-mir-1248	hsa04630	Jak-STAT signaling pathway	10401_4609_2033_8554	4	0.01080616	0.702400373	0.024220703
2359	hsa-mir-1248	hsa04012	ErbB signaling pathway	5594_3725_4609	3	0.012705107	0.825831951	0.027527732
2360	hsa-mir-1248	hsa04612	Antigen processing and presentation	3326_4801_3312	3	0.013476247	0.875956073	0.028256648
2361	hsa-mir-1248	hsa04120	Ubiquitin mediated proteolysis	4193_10401_8554	3	0.041360123	1	0.084012749
2362	hsa-mir-1248	hsa05322	Systemic lupus erythematosus	8340_3014_3015	3	0.045049889	1	0.08873463
2363	hsa-mir-1249	hsa05200	Pathways in cancer	5371_5595_5594_5914_1387_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846_4286	30	5.04E-30	3.23E-28	3.23E-28
2364	hsa-mir-1249	hsa04110	Cell cycle	993_5591_1387_595_983_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933	17	2.21E-20	1.41E-18	7.07E-19
2365	hsa-mir-1249	hsa05220	Chronic myeloid leukemia	5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464	15	4.50E-20	2.88E-18	9.60E-19
2366	hsa-mir-1249	hsa05215	Prostate cancer	5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033	12	1.72E-14	1.10E-12	2.49E-13
2367	hsa-mir-1249	hsa05212	Pancreatic cancer	5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033	12	1.94E-14	1.24E-12	2.49E-13
2368	hsa-mir-1249	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_4609_1869_5925	9	9.52E-13	6.09E-11	1.02E-11
2369	hsa-mir-1249	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_7157_1869_5925	9	7.09E-12	4.54E-10	6.49E-11
2370	hsa-mir-1249	hsa05210	Colorectal cancer	5595_5594_595_836_7157_4087_4609_3725_4088_4089	10	9.69E-12	6.20E-10	7.75E-11
2371	hsa-mir-1249	hsa05222	Small cell lung cancer	6256_595_5970_1870_1871_7157_4609_1869_5925_4846	10	1.20E-11	7.68E-10	8.53E-11
2372	hsa-mir-1249	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_4087_4609_4088_4089_2033_5933	10	1.33E-11	8.53E-10	8.53E-11
2373	hsa-mir-1249	hsa05214	Glioma	5595_5594_595_1870_1871_7157_1869_5925_6464	9	3.18E-11	2.04E-09	1.85E-10
2374	hsa-mir-1249	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5925_4286	9	6.54E-11	4.19E-09	3.49E-10
2375	hsa-mir-1249	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_7428_2113_3725_2034_2033	9	7.33E-11	4.69E-09	3.61E-10
2376	hsa-mir-1249	hsa04310	Wnt signaling pathway	1387_595_7157_4087_4773_4609_3725_1457_4088_4089_2033	11	1.27E-10	8.12E-09	5.80E-10
2377	hsa-mir-1249	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_5970_4609	8	4.79E-10	3.06E-08	2.04E-09
2378	hsa-mir-1249	hsa04520	Adherens junction	5595_5594_1387_4087_1457_4088_4089_2033	8	4.37E-09	2.80E-07	1.75E-08
2379	hsa-mir-1249	hsa05216	Thyroid cancer	5595_5594_6256_595_7157_4609	6	8.03E-09	5.14E-07	3.02E-08
2380	hsa-mir-1249	hsa05016	Huntington's disease	6874_1387_2902_836_6667_7157_3066_3065_3064_2033	10	1.49E-08	9.56E-07	5.31E-08
2381	hsa-mir-1249	hsa04010	MAPK signaling pathway	5595_5594_4208_836_3312_5970_7157_4773_4609_3725_4763	11	4.28E-08	2.74E-06	1.44E-07
2382	hsa-mir-1249	hsa04330	Notch signaling pathway	1387_9612_3066_3065_2033_8850	6	1.07E-07	6.83E-06	3.41E-07
2383	hsa-mir-1249	hsa05213	Endometrial cancer	5595_5594_595_7157_4609	5	4.66E-06	0.000298359	1.42E-05
2384	hsa-mir-1249	hsa04720	Long-term potentiation	5595_5594_1387_2902_2033	5	2.47E-05	0.001583414	6.88E-05
2385	hsa-mir-1249	hsa04662	B cell receptor signaling pathway	5595_5594_5970_4773_3725	5	2.47E-05	0.001583414	6.88E-05
2386	hsa-mir-1249	hsa04012	ErbB signaling pathway	5595_5594_4609_3725_6464	5	4.86E-05	0.003109001	0.000129542
2387	hsa-mir-1249	hsa04916	Melanogenesis	5595_5594_1387_2033_4286	5	0.000108902	0.006969709	0.000278788
2388	hsa-mir-1249	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_7157_4846	4	0.000129898	0.008313473	0.000319749
2389	hsa-mir-1249	hsa04660	T cell receptor signaling pathway	5595_5594_5970_4773_3725	5	0.000140167	0.008970667	0.000332247
2390	hsa-mir-1249	hsa04115	p53 signaling pathway	595_983_836_7157	4	0.00027776	0.017776628	0.00063488
2391	hsa-mir-1249	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_4773_6464	5	0.000385489	0.024671306	0.000850735
2392	hsa-mir-1249	hsa04370	VEGF signaling pathway	5595_5594_4773_4846	4	0.000413522	0.026465422	0.000882181
2393	hsa-mir-1249	hsa04612	Antigen processing and presentation	4800_4801_3312_1514	4	0.000697581	0.044645164	0.001440167
2394	hsa-mir-1249	hsa04620	Toll-like receptor signaling pathway	5595_5594_5970_3725	4	0.001137212	0.072781585	0.002220687
2395	hsa-mir-1249	hsa05010	Alzheimer's disease	5595_5594_2902_836_4846	5	0.001145042	0.073282685	0.002220687
2396	hsa-mir-1249	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.001709856	0.109430804	0.003218553
2397	hsa-mir-1249	hsa04510	Focal adhesion	5595_5594_595_3725_6464	5	0.002190666	0.140202609	0.004005789
2398	hsa-mir-1249	hsa04910	Insulin signaling pathway	6720_5595_5594_6464	4	0.003302758	0.211376492	0.005871569
2399	hsa-mir-1249	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_5970_3725	3	0.0039828	0.254899168	0.006707873
2400	hsa-mir-1249	hsa04730	Long-term depression	5595_5594_4846	3	0.0039828	0.254899168	0.006707873
2401	hsa-mir-1249	hsa04630	Jak-STAT signaling pathway	1387_595_4609_2033	4	0.004933857	0.315766835	0.008096586
2402	hsa-mir-1249	hsa04210	Apoptosis	836_5970_7157	3	0.00729768	0.467051515	0.011676288
2403	hsa-mir-1249	hsa04540	Gap junction	5595_5594_983	3	0.008201107	0.524870865	0.012801728
2404	hsa-mir-1249	hsa04062	Chemokine signaling pathway	5595_5594_5970_6464	4	0.010350299	0.66241914	0.015771884
2405	hsa-mir-1249	hsa04912	GnRH signaling pathway	5595_5594_3725	3	0.012156781	0.778033978	0.018093813
2406	hsa-mir-1249	hsa04930	Type II diabetes mellitus	5595_5594	2	0.017340874	1	0.02522309
2407	hsa-mir-1249	hsa03050	Proteasome	5684_5705	2	0.019488163	1	0.027716498
2408	hsa-mir-1249	hsa04360	Axon guidance	5595_5594_4773	3	0.020023892	1	0.027859329
2409	hsa-mir-1249	hsa04120	Ubiquitin mediated proteolysis	5371_672_7428	3	0.023282233	1	0.031703466
2410	hsa-mir-1249	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.035414679	1	0.047219572
2411	hsa-mir-1249	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.047325058	1	0.061812321
2412	hsa-mir-1250	hsa04110	Cell cycle	4088_4089_1870_1871_7157_4087_2033_1017_890_1869_5934_5933	12	1.43E-20	4.15E-19	4.15E-19
2413	hsa-mir-1250	hsa05200	Pathways in cancer	4088_4089_1487_1870_1871_1488_1050_4149_7157_4087_2033_1017_1869	13	3.61E-17	1.05E-15	5.24E-16
2414	hsa-mir-1250	hsa05220	Chronic myeloid leukemia	4088_4089_1487_1870_1871_1488_7157_1869	8	4.12E-14	1.19E-12	3.98E-13
2415	hsa-mir-1250	hsa04350	TGF-beta signaling pathway	4088_4089_1874_1875_4087_2033_5934_5933	8	1.26E-13	3.65E-12	9.12E-13
2416	hsa-mir-1250	hsa04310	Wnt signaling pathway	4088_4089_1487_1488_7157_4087_2033	7	4.87E-10	1.41E-08	2.82E-09
2417	hsa-mir-1250	hsa05222	Small cell lung cancer	1870_1871_4149_7157_1017_1869	6	8.79E-10	2.55E-08	3.87E-09
2418	hsa-mir-1250	hsa05215	Prostate cancer	1870_1871_7157_2033_1017_1869	6	1.00E-09	2.90E-08	3.87E-09
2419	hsa-mir-1250	hsa05212	Pancreatic cancer	1870_1871_7157_2033_1017_1869	6	1.07E-09	3.10E-08	3.87E-09
2420	hsa-mir-1250	hsa05219	Bladder cancer	1870_1871_7157_1869	4	2.16E-07	6.26E-06	6.96E-07
2421	hsa-mir-1250	hsa05223	Non-small cell lung cancer	1870_1871_7157_1869	4	5.56E-07	1.61E-05	1.61E-06
2422	hsa-mir-1250	hsa05214	Glioma	1870_1871_7157_1869	4	1.12E-06	3.26E-05	2.96E-06
2423	hsa-mir-1250	hsa05218	Melanoma	1870_1871_7157_1869	4	1.57E-06	4.56E-05	3.80E-06
2424	hsa-mir-1250	hsa04520	Adherens junction	4088_4089_4087_2033	4	2.48E-06	7.18E-05	5.52E-06
2425	hsa-mir-1250	hsa05210	Colorectal cancer	4088_4089_7157_4087	4	2.98E-06	8.65E-05	6.18E-06
2426	hsa-mir-1250	hsa04330	Notch signaling pathway	1487_1488_2033	3	2.50E-05	0.000726442	4.84E-05
2427	hsa-mir-1250	hsa04115	p53 signaling pathway	7157_1017	2	0.002943471	0.085360656	0.005335041
2428	hsa-mir-1250	hsa05016	Huntington's disease	7157_2033	2	0.019556962	0.567151887	0.033361876
2429	hsa-mir-1250	hsa05216	Thyroid cancer	7157	1	0.033425763	0.969347133	0.053852619
2430	hsa-mir-1250	hsa04010	MAPK signaling pathway	4149_7157	2	0.038666791	1	0.059017734
2431	hsa-mir-1251	hsa05200	Pathways in cancer	3320_25_5371_2249_367_1499_5594_5595_5599_5914_1387_6257_6256_8031_5601_6258_208_861_6934_6774_6776_6777_6772_3091_5970_4087_6688_2113_3725_2736_2353_4088_4089_5602_5925_2033_207_2932_8554	39	7.48E-29	5.31E-27	5.31E-27
2432	hsa-mir-1251	hsa04010	MAPK signaling pathway	6722_8986_2249_5594_5595_5599_1386_9261_5601_1649_208_9252_1432_6197_5970_10912_468_3725_3727_6195_6196_2353_5600_5602_4616_207_8550_4773	28	1.61E-19	1.14E-17	5.71E-18
2433	hsa-mir-1251	hsa05215	Prostate cancer	3320_367_1499_5594_5595_1387_208_6934_5970_468_9586_10488_5925_2033_207_2932	16	3.89E-15	2.76E-13	8.08E-14
2434	hsa-mir-1251	hsa05212	Pancreatic cancer	3320_367_1499_5594_5595_1387_208_6934_5970_468_9586_10488_5925_2033_207_2932	16	4.55E-15	3.23E-13	8.08E-14
2435	hsa-mir-1251	hsa05210	Colorectal cancer	1499_5594_5595_5599_5601_208_6934_4087_3725_2353_4088_4089_5602_207_2932	15	3.61E-14	2.56E-12	5.13E-13
2436	hsa-mir-1251	hsa05221	Acute myeloid leukemia	5371_5594_5595_5914_208_861_6934_6774_6776_6777_5970_6688_207	13	1.78E-13	1.26E-11	2.10E-12
2437	hsa-mir-1251	hsa05220	Chronic myeloid leukemia	25_5594_5595_208_861_6776_6777_5970_4088_4089_5925_207	12	4.25E-11	3.02E-09	4.31E-10
2438	hsa-mir-1251	hsa04310	Wnt signaling pathway	1499_5599_1387_5601_6934_4087_8061_3725_1457_4088_4089_5602_2033_2932_4773	15	8.24E-11	5.85E-09	6.71E-10
2439	hsa-mir-1251	hsa04620	Toll-like receptor signaling pathway	5594_5595_5599_5601_208_1432_6772_5970_3725_2353_5600_5602_207	13	8.51E-11	6.04E-09	6.71E-10
2440	hsa-mir-1251	hsa04012	ErbB signaling pathway	25_5594_5595_5599_5601_208_6776_6777_3725_5602_207_2932	12	2.00E-10	1.42E-08	1.41E-09
2441	hsa-mir-1251	hsa04920	Adipocytokine signaling pathway	10891_5599_6257_6256_5601_6258_208_6774_5970_5602_207	11	2.18E-10	1.55E-08	1.41E-09
2442	hsa-mir-1251	hsa04110	Cell cycle	25_5591_1387_7534_7533_4087_10912_4088_4089_5925_2033_4616_2932	13	4.86E-10	3.45E-08	2.87E-09
2443	hsa-mir-1251	hsa04520	Adherens junction	1499_5594_5595_1387_6934_71_4087_1457_4088_4089_2033	11	1.19E-09	8.43E-08	6.49E-09
2444	hsa-mir-1251	hsa05216	Thyroid cancer	1499_5594_5595_6257_6256_8031_6258_6934	8	1.89E-09	1.34E-07	9.60E-09
2445	hsa-mir-1251	hsa04660	T cell receptor signaling pathway	5594_5595_5601_208_1432_5970_3725_2353_5600_207_2932_4773	12	2.31E-09	1.64E-07	1.10E-08
2446	hsa-mir-1251	hsa05211	Renal cell carcinoma	5594_5595_1387_208_3091_2113_3725_2033_207	9	8.28E-08	5.88E-06	3.67E-07
2447	hsa-mir-1251	hsa04150	mTOR signaling pathway	5594_5595_208_3091_6197_6195_6196_207	8	1.04E-07	7.37E-06	4.33E-07
2448	hsa-mir-1251	hsa04662	B cell receptor signaling pathway	5594_5595_208_5970_3725_2353_207_2932_4773	9	1.14E-07	8.09E-06	4.50E-07
2449	hsa-mir-1251	hsa05223	Non-small cell lung cancer	5594_5595_6257_6256_6258_208_5925_207	8	1.35E-07	9.58E-06	5.04E-07
2450	hsa-mir-1251	hsa04664	Fc epsilon RI signaling pathway	5594_5595_5599_5601_208_1432_5600_5602_207	9	1.71E-07	1.21E-05	6.07E-07
2451	hsa-mir-1251	hsa04630	Jak-STAT signaling pathway	1387_208_6774_6775_6776_6777_6772_2033_3977_207_8554	11	6.29E-07	4.46E-05	2.13E-06
2452	hsa-mir-1251	hsa04720	Long-term potentiation	5594_5595_1387_6197_468_6195_6196_2033	8	1.32E-06	9.40E-05	4.27E-06
2453	hsa-mir-1251	hsa05213	Endometrial cancer	1499_5594_5595_208_6934_207_2932	7	1.49E-06	0.000106101	4.61E-06
2454	hsa-mir-1251	hsa04370	VEGF signaling pathway	5594_5595_9261_208_1432_5600_207_4773	8	1.59E-06	0.000112804	4.70E-06
2455	hsa-mir-1251	hsa04912	GnRH signaling pathway	5594_5595_5599_5601_1432_468_3725_5600_5602	9	1.94E-06	0.000137987	5.52E-06
2456	hsa-mir-1251	hsa05222	Small cell lung cancer	6257_6256_6258_208_5970_5925_207_8554	8	3.41E-06	0.000242298	9.32E-06
2457	hsa-mir-1251	hsa04350	TGF-beta signaling pathway	6667_5594_5595_1387_4087_4088_4089_2033	8	3.70E-06	0.000262412	9.72E-06
2458	hsa-mir-1251	hsa04510	Focal adhesion	1499_5594_5595_5599_5601_208_71_3725_5602_207_2932	11	8.46E-06	0.000600667	2.15E-05
2459	hsa-mir-1251	hsa04930	Type II diabetes mellitus	5594_5595_5599_5601_5602_3651	6	9.00E-06	0.000638688	2.20E-05
2460	hsa-mir-1251	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_1432_5970_3725_5600_5602	7	9.92E-06	0.000704083	2.35E-05
2461	hsa-mir-1251	hsa04916	Melanogenesis	1499_5594_5595_1387_6934_10488_2033_2932	8	1.26E-05	0.000892672	2.80E-05
2462	hsa-mir-1251	hsa04910	Insulin signaling pathway	10891_5594_5595_5599_5601_208_5602_207_2932	9	1.26E-05	0.00089638	2.80E-05
2463	hsa-mir-1251	hsa05218	Melanoma	2249_5594_5595_208_5925_207	6	9.63E-05	0.006833919	0.000207088
2464	hsa-mir-1251	hsa04062	Chemokine signaling pathway	5594_5595_208_6774_6777_6772_5970_207_2932	9	0.000149984	0.010648846	0.000313201
2465	hsa-mir-1251	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_83737_7329_64326_8554	7	0.000525173	0.037287311	0.001065352
2466	hsa-mir-1251	hsa05214	Glioma	5594_5595_208_5925_207	5	0.00055716	0.039558339	0.001098843
2467	hsa-mir-1251	hsa05016	Huntington's disease	6667_10891_1387_6908_9586_3064_10488_2033	8	0.000621766	0.044145397	0.001163203
2468	hsa-mir-1251	hsa03022	Basal transcription factors	2963_6908_6872_2959	4	0.00062256	0.044201726	0.001163203
2469	hsa-mir-1251	hsa05219	Bladder cancer	5594_5595_9252_5925	4	0.000966413	0.068615337	0.001759368
2470	hsa-mir-1251	hsa04950	Maturity onset diabetes of the young	6927_3087_3651	3	0.002122226	0.150678041	0.003766951
2471	hsa-mir-1251	hsa05217	Basal cell carcinoma	1499_6934_2736_2932	4	0.002446638	0.17371128	0.00423686
2472	hsa-mir-1251	hsa05131	Shigellosis	25_1499_7534_71	4	0.002601992	0.184741453	0.004296313
2473	hsa-mir-1251	hsa05130	Pathogenic Escherichia coli infection	25_1499_7534_71	4	0.002601992	0.184741453	0.004296313
2474	hsa-mir-1251	hsa03320	PPAR signaling pathway	6257_6256_6258_2168	4	0.005534527	0.392951391	0.008930713
2475	hsa-mir-1251	hsa03450	Non-homologous end-joining	5591_2547	2	0.009967323	0.70767996	0.015406509
2476	hsa-mir-1251	hsa04360	Axon guidance	25_5594_5595_2932_4773	5	0.009981682	0.708699425	0.015406509
2477	hsa-mir-1251	hsa04530	Tight junction	1499_208_71_1457_207	5	0.011871342	0.842865252	0.017910092
2478	hsa-mir-1251	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.012108231	0.859684412	0.017910092
2479	hsa-mir-1251	hsa04115	p53 signaling pathway	10912_64326_4616	3	0.031644886	1	0.045852793
2480	hsa-mir-1251	hsa04670	Leukocyte transendothelial migration	1499_1432_71_5600	4	0.032889514	1	0.04670311
2481	hsa-mir-1251	hsa04730	Long-term depression	5592_5594_5595	3	0.033926065	1	0.047230404
2482	hsa-mir-1252	hsa05200	Pathways in cancer	3716_5747_3725_1956_1499_5594_1387_2064_6256_5159_5156_836_1487_2261_3815_4193_1488_2353_6774_6776_6777_5879_5970_7157_6688_4087_8772_4609_10401_4088_4089_5881_5925_2033_207_2308_3326_1050_8554_7046_7184	41	4.18E-28	3.18E-26	1.76E-26
2483	hsa-mir-1252	hsa03022	Basal transcription factors	2961_2960_2963_6881_2969_2967_6877_6874_6872_2957_54457_6879_6878_6873_2958_2968_6884_2959_6880_6882_138474_6883	22	4.62E-28	3.51E-26	1.76E-26
2484	hsa-mir-1252	hsa04630	Jak-STAT signaling pathway	3717_3716_3560_3561_1387_6774_6776_6777_6773_58985_3455_3459_5781_7297_4609_10401_1439_2033_207_8554_10379	21	1.18E-15	8.95E-14	2.98E-14
2485	hsa-mir-1252	hsa05210	Colorectal cancer	3725_1956_1499_5594_5159_5156_836_2353_5879_7157_4087_4609_4088_4089_5881_207_7046	17	1.83E-15	1.39E-13	3.48E-14
2486	hsa-mir-1252	hsa05215	Prostate cancer	1956_1499_5594_1387_2064_5159_5156_4193_5970_7157_5925_2033_207_2308_3326_7184	16	5.41E-14	4.11E-12	8.01E-13
2487	hsa-mir-1252	hsa05212	Pancreatic cancer	1956_1499_5594_1387_2064_5159_5156_4193_5970_7157_5925_2033_207_2308_3326_7184	16	6.32E-14	4.80E-12	8.01E-13
2488	hsa-mir-1252	hsa05220	Chronic myeloid leukemia	5594_1487_4193_1488_6776_6777_5970_7157_5781_4609_4088_4089_5925_207_7046	15	9.87E-14	7.50E-12	1.07E-12
2489	hsa-mir-1252	hsa04520	Adherens junction	1460_1956_1499_6714_5594_1387_2064_5879_4087_4088_4089_5881_2033_7046_2534	15	2.26E-13	1.72E-11	2.15E-12
2490	hsa-mir-1252	hsa04010	MAPK signaling pathway	3725_1956_5594_5598_5159_5156_7132_836_2261_2264_9252_2353_3312_1432_1845_5879_5970_7157_4609_3727_5881_207_7046	23	5.49E-13	4.17E-11	4.63E-12
2491	hsa-mir-1252	hsa04310	Wnt signaling pathway	3725_818_1460_817_1499_1387_8607_1487_1488_5879_7157_4087_4609_4088_4089_5881_2033	17	1.05E-11	7.96E-10	7.96E-11
2492	hsa-mir-1252	hsa04110	Cell cycle	993_1387_983_4193_7157_4087_4174_4171_4172_4085_4088_4089_5925_2033	14	3.89E-10	2.96E-08	2.69E-09
2493	hsa-mir-1252	hsa04060	Cytokine-cytokine receptor interaction	2321_3791_1956_3560_3561_90_5159_5156_7133_7132_1234_1230_3815_7852_58985_3455_3459_1439_7046	19	6.34E-10	4.82E-08	4.02E-09
2494	hsa-mir-1252	hsa04920	Adipocytokine signaling pathway	3717_8717_6256_7133_7132_6774_10891_5970_5781_5563_207	11	1.30E-09	9.88E-08	7.48E-09
2495	hsa-mir-1252	hsa04012	ErbB signaling pathway	5747_3725_818_817_1956_6714_5594_2064_6776_6777_4609_207	12	1.38E-09	1.05E-07	7.48E-09
2496	hsa-mir-1252	hsa05219	Bladder cancer	1956_5594_2064_2261_9252_4193_7157_4609_5925	9	5.44E-09	4.13E-07	2.67E-08
2497	hsa-mir-1252	hsa05221	Acute myeloid leukemia	5594_3815_6774_6776_6777_5970_6688_4609_207_1050	10	5.63E-09	4.28E-07	2.67E-08
2498	hsa-mir-1252	hsa05214	Glioma	818_817_1956_5594_5159_5156_4193_7157_5925_207	10	1.29E-08	9.82E-07	5.78E-08
2499	hsa-mir-1252	hsa04350	TGF-beta signaling pathway	5594_1387_90_6667_4087_4609_4088_4089_2033_7046_57154	11	1.53E-08	1.16E-06	6.47E-08
2500	hsa-mir-1252	hsa04510	Focal adhesion	5747_3725_2321_3791_1956_1499_6714_5594_2064_5159_5156_5879_5881_207_2534	15	3.92E-08	2.98E-06	1.57E-07
2501	hsa-mir-1252	hsa04062	Chemokine signaling pathway	3717_5747_5580_5594_1234_1230_6774_6777_6773_5879_7852_5970_207	13	7.28E-07	5.54E-05	2.77E-06
2502	hsa-mir-1252	hsa05222	Small cell lung cancer	5747_6256_5970_7157_4609_10401_5925_207_8554	9	1.36E-06	0.00010322	4.92E-06
2503	hsa-mir-1252	hsa04210	Apoptosis	8717_7132_836_840_5970_7157_8772_1439_207	9	1.77E-06	0.0001342	6.10E-06
2504	hsa-mir-1252	hsa05218	Melanoma	1956_5594_5159_5156_4193_7157_5925_207	8	3.19E-06	0.000242506	1.01E-05
2505	hsa-mir-1252	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_1956_6714_836_1432_5879_5970_5781	8	3.19E-06	0.000242506	1.01E-05
2506	hsa-mir-1252	hsa05213	Endometrial cancer	1956_1499_5594_2064_7157_4609_207	7	4.57E-06	0.000347339	1.36E-05
2507	hsa-mir-1252	hsa04662	B cell receptor signaling pathway	3725_5594_2353_5879_5970_6850_5881_207	8	4.64E-06	0.000352558	1.36E-05
2508	hsa-mir-1252	hsa04620	Toll-like receptor signaling pathway	3725_5594_2353_1432_5879_5970_3455_8772_207	9	4.99E-06	0.000378959	1.40E-05
2509	hsa-mir-1252	hsa04370	VEGF signaling pathway	5747_3791_6714_5594_1432_5879_5881_207	8	5.55E-06	0.000421816	1.50E-05
2510	hsa-mir-1252	hsa05223	Non-small cell lung cancer	1956_5594_2064_6256_7157_5925_207	7	5.73E-06	0.000435679	1.50E-05
2511	hsa-mir-1252	hsa04664	Fc epsilon RI signaling pathway	5580_5594_1432_5879_6850_5881_207_2534	8	6.61E-06	0.000502249	1.67E-05
2512	hsa-mir-1252	hsa04650	Natural killer cell mediated cytotoxicity	3932_5594_836_5879_6850_3455_3459_5781_5881_2534	10	7.67E-06	0.000582819	1.82E-05
2513	hsa-mir-1252	hsa04912	GnRH signaling pathway	3725_5580_818_817_1956_6714_5594_5598_1432	9	7.68E-06	0.000583753	1.82E-05
2514	hsa-mir-1252	hsa04540	Gap junction	1956_6714_5594_5598_5159_983_5156_10382	8	1.99E-05	0.001514849	4.59E-05
2515	hsa-mir-1252	hsa04330	Notch signaling pathway	1387_1487_1488_9612_2033_8850	6	2.93E-05	0.002227342	6.55E-05
2516	hsa-mir-1252	hsa05211	Renal cell carcinoma	3725_5594_1387_5879_5781_2033_207	7	3.20E-05	0.002432973	6.95E-05
2517	hsa-mir-1252	hsa05216	Thyroid cancer	1499_5594_6256_7157_4609	5	3.81E-05	0.002895932	8.04E-05
2518	hsa-mir-1252	hsa04660	T cell receptor signaling pathway	3725_3932_5594_2353_1432_5970_207_2534	8	6.11E-05	0.004645043	0.000125542
2519	hsa-mir-1252	hsa05014	Amyotrophic lateral sclerosis (ALS)	7133_7132_836_1432_5879_7157	6	7.21E-05	0.005476595	0.000144121
2520	hsa-mir-1252	hsa05016	Huntington's disease	6874_1387_836_6667_9001_10891_5430_7157_3064_2033	10	9.29E-05	0.007058957	0.000180999
2521	hsa-mir-1252	hsa04950	Maturity onset diabetes of the young	6928_3172_6927_5080	4	0.000265107	0.020148146	0.000503704
2522	hsa-mir-1252	hsa04916	Melanogenesis	818_817_1499_5594_1387_3815_2033	7	0.000275702	0.020953338	0.000511057
2523	hsa-mir-1252	hsa03050	Proteasome	5719_5705_5701_5702_5710	5	0.000329709	0.025057885	0.000596616
2524	hsa-mir-1252	hsa04360	Axon guidance	5747_1020_5594_5879_7852_5881_2534	7	0.001015623	0.077187368	0.001795055
2525	hsa-mir-1252	hsa03030	DNA replication	79621_4174_4171_4172	4	0.001063653	0.080837595	0.001837218
2526	hsa-mir-1252	hsa04810	Regulation of actin cytoskeleton	5747_1956_5594_5159_5156_2261_2264_5879_5881	9	0.001222982	0.092946636	0.002065481
2527	hsa-mir-1252	hsa04720	Long-term potentiation	818_817_5594_1387_2033	5	0.002155635	0.163828292	0.003561485
2528	hsa-mir-1252	hsa04670	Leukocyte transendothelial migration	5747_1499_1432_5879_7852_5781	6	0.003417414	0.259723449	0.005526031
2529	hsa-mir-1252	hsa04910	Insulin signaling pathway	5594_10891_5563_5211_207_2308	6	0.006048674	0.459699221	0.009502049
2530	hsa-mir-1252	hsa04020	Calcium signaling pathway	818_817_1956_2064_5159_5156_147	7	0.006234911	0.473853222	0.009502049
2531	hsa-mir-1252	hsa04120	Ubiquitin mediated proteolysis	672_4193_7329_10401_8554_57154	6	0.006251348	0.475102438	0.009502049
2532	hsa-mir-1252	hsa04115	p53 signaling pathway	983_836_4193_7157	4	0.009473203	0.719963453	0.01411693
2533	hsa-mir-1252	hsa03420	Nucleotide excision repair	2967_2968_5887	3	0.016088134	1	0.023513426
2534	hsa-mir-1252	hsa05010	Alzheimer's disease	1020_5594_7132_836_840_8772	6	0.018165363	1	0.026048445
2535	hsa-mir-1252	hsa04612	Antigen processing and presentation	4801_3312_1514_3326	4	0.021349207	1	0.030047033
2536	hsa-mir-1252	hsa04530	Tight junction	5580_1460_1499_6714_207	5	0.022909968	1	0.031657411
2537	hsa-mir-1252	hsa04150	mTOR signaling pathway	5594_5563_207	3	0.024374509	1	0.033079691
2538	hsa-mir-1252	hsa05131	Shigellosis	1499_10382_2534	3	0.029231025	1	0.038302723
2539	hsa-mir-1252	hsa05130	Pathogenic Escherichia coli infection	1499_10382_2534	3	0.029231025	1	0.038302723
2540	hsa-mir-1253	hsa05200	Pathways in cancer	1147_3551_7046_1499_5914_595_2261_8517_4193_7704_3091_7175_3066_3065_5925_4087_5747_1956_1387_1870_1871_2113_5894_207_3716_5595_5594_5599_2064_6256_836_367_2932_6774_6776_6777_5970_7157_6688_1869_3725_4088_4089_2034_2033_4846_4790_4791_4792_5879_3320_3326_5371_1050_5159_5156_3815_7428_8772_4609_2353_8554	62	1.53E-46	1.19E-44	1.19E-44
2541	hsa-mir-1253	hsa05215	Prostate cancer	1147_3551_1499_595_8517_4193_5925_1956_1387_1870_1871_5894_207_5595_5594_1385_2064_367_2932_5970_7157_1869_2033_4790_4792_3320_3326_5159_5156	29	3.50E-28	2.73E-26	1.19E-26
2542	hsa-mir-1253	hsa05212	Pancreatic cancer	1147_3551_1499_595_8517_4193_5925_1956_1387_1870_1871_5894_207_5595_5594_1385_2064_367_2932_5970_7157_1869_2033_4790_4792_3320_3326_5159_5156	29	4.58E-28	3.57E-26	1.19E-26
2543	hsa-mir-1253	hsa05220	Chronic myeloid leukemia	1147_3551_7046_595_8517_4193_3066_3065_5925_1870_1871_5894_207_5595_5594_6776_6777_5970_7157_1869_4088_4089_4790_4792_5781_4609_6464	27	3.62E-27	2.83E-25	7.06E-26
2544	hsa-mir-1253	hsa04010	MAPK signaling pathway	1147_3551_7046_2261_2264_8517_1845_5536_1956_3305_3303_1432_5894_4763_207_5595_5594_5599_836_9252_3310_3312_5971_5970_7157_3725_4790_4791_5879_5159_1326_5156_4208_5566_4609_2353_7132	37	1.21E-23	9.47E-22	1.89E-22
2545	hsa-mir-1253	hsa05221	Acute myeloid leukemia	1147_3551_5914_595_8517_7704_5894_207_5595_5594_6774_6776_6777_5970_6688_4790_5371_1050_3815_4609	20	5.07E-20	3.96E-18	6.60E-19
2546	hsa-mir-1253	hsa05214	Glioma	818_817_595_4193_5925_1956_1870_1871_5894_207_5595_5594_7157_1869_808_801_805_5159_5156_6464	20	2.49E-19	1.94E-17	2.78E-18
2547	hsa-mir-1253	hsa05210	Colorectal cancer	7046_1499_595_4087_1956_5894_207_5595_5594_5599_836_2932_7157_3725_4088_4089_5879_5159_5156_4609_2353	21	1.17E-18	9.15E-17	1.14E-17
2548	hsa-mir-1253	hsa04110	Cell cycle	4172_595_4193_6500_4174_3066_3065_5925_4087_1387_1870_1871_5933_5591_7533_2932_7157_1869_4088_4089_2033_8454_2810	23	3.80E-18	2.96E-16	3.29E-17
2549	hsa-mir-1253	hsa04630	Jak-STAT signaling pathway	3559_595_58985_3455_3459_3560_3561_1387_1439_207_3717_3716_6778_6774_6776_6777_6773_7297_2033_3460_5781_4609_8554_10379	24	6.34E-17	4.95E-15	4.95E-16
2550	hsa-mir-1253	hsa04920	Adipocytokine signaling pathway	1147_3551_10891_8517_7133_207_3717_8717_5599_6256_6774_5970_4794_4790_4792_4793_5781_7132	18	1.20E-16	9.34E-15	8.49E-16
2551	hsa-mir-1253	hsa04660	T cell receptor signaling pathway	1147_3551_8517_2534_3932_1432_5894_207_5595_5594_920_2932_5970_3725_4794_4790_4792_4793_1326_915_2353	21	1.38E-16	1.08E-14	8.98E-16
2552	hsa-mir-1253	hsa04310	Wnt signaling pathway	818_817_1499_595_8607_6500_4087_8945_23291_1387_5599_2932_7157_8061_3725_1457_4088_4089_2033_5879_5566_8454_4609	23	4.45E-16	3.47E-14	2.67E-15
2553	hsa-mir-1253	hsa04062	Chemokine signaling pathway	1147_3551_8517_1230_653361_5747_5580_7852_5894_207_3717_5595_5594_1234_2932_6774_6777_6773_5970_4790_4792_4793_5879_5566_6464	25	6.09E-16	4.75E-14	3.39E-15
2554	hsa-mir-1253	hsa05219	Bladder cancer	595_2261_4193_5925_1956_1870_1871_5894_5595_5594_2064_9252_7157_1869_4609	15	1.28E-15	9.99E-14	6.66E-15
2555	hsa-mir-1253	hsa05222	Small cell lung cancer	1147_3551_595_8517_5925_5747_1870_1871_207_6256_5970_7157_1869_4846_4790_4792_4609_8554	18	5.19E-15	4.04E-13	2.53E-14
2556	hsa-mir-1253	hsa04662	B cell receptor signaling pathway	1147_3551_8517_6850_5894_207_5595_5594_2932_5970_3725_4794_4790_4792_4793_5879_2353	17	9.55E-15	7.45E-13	4.38E-14
2557	hsa-mir-1253	hsa04012	ErbB signaling pathway	818_817_5747_1956_6714_5894_207_5595_5594_5599_2064_2932_6776_6777_3725_4609_6464	17	8.00E-14	6.24E-12	3.47E-13
2558	hsa-mir-1253	hsa04520	Adherens junction	7046_1499_4087_2534_1956_6714_1387_71_5595_5594_2064_1457_4088_4089_2033_5879	16	3.17E-13	2.48E-11	1.30E-12
2559	hsa-mir-1253	hsa04620	Toll-like receptor signaling pathway	1147_3551_8517_3455_1432_207_5595_5594_5599_5970_3725_4790_4792_5879_1326_8772_2353	17	7.86E-13	6.13E-11	3.07E-12
2560	hsa-mir-1253	hsa04510	Focal adhesion	1499_595_2534_5747_3791_1956_6714_10627_5894_207_71_5595_5594_5599_2064_2932_3725_5879_2321_5159_5156_6464	22	1.21E-12	9.45E-11	4.50E-12
2561	hsa-mir-1253	hsa05223	Non-small cell lung cancer	595_5925_1956_1870_1871_5894_207_5595_5594_2064_6256_7157_1869	13	7.11E-12	5.55E-10	2.52E-11
2562	hsa-mir-1253	hsa05218	Melanoma	595_4193_5925_1956_1870_1871_5894_207_5595_5594_7157_1869_5159_5156	14	1.15E-11	8.97E-10	3.74E-11
2563	hsa-mir-1253	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_8517_1956_6714_1432_5599_836_5970_3725_4790_4792_5879_5781	14	1.15E-11	8.97E-10	3.74E-11
2564	hsa-mir-1253	hsa04210	Apoptosis	1147_3551_8517_8837_1439_207_8717_836_5970_7157_4790_4792_5566_8772_7132	15	1.54E-11	1.20E-09	4.79E-11
2565	hsa-mir-1253	hsa04060	Cytokine-cytokine receptor interaction	3559_7046_8600_1230_58985_3455_3459_90_3791_1956_3560_3561_7133_1439_7852_1234_2321_5159_5156_3815_3460_7132	22	9.27E-11	7.23E-09	2.78E-10
2566	hsa-mir-1253	hsa05016	Huntington's disease	10891_292_293_291_3066_3065_3064_2902_1387_1385_836_5481_5437_7157_1213_2033_6874_6908_5441	19	1.01E-10	7.87E-09	2.91E-10
2567	hsa-mir-1253	hsa04916	Melanogenesis	818_817_1499_1387_5894_5595_5594_1385_2932_2033_808_801_805_5566_3815	15	1.10E-10	8.61E-09	3.08E-10
2568	hsa-mir-1253	hsa04350	TGF-beta signaling pathway	7046_6500_90_4087_57154_1387_5933_5595_5594_4088_4089_2033_8454_4609	14	1.27E-10	9.92E-09	3.42E-10
2569	hsa-mir-1253	hsa05211	Renal cell carcinoma	3091_1387_2113_5894_207_5595_5594_3725_2034_2033_5879_7428_5781	13	1.65E-10	1.29E-08	4.30E-10
2570	hsa-mir-1253	hsa04912	GnRH signaling pathway	818_817_5580_1956_6714_1432_5894_5595_5594_5599_3725_808_801_805_5566	15	1.78E-10	1.39E-08	4.48E-10
2571	hsa-mir-1253	hsa05213	Endometrial cancer	1499_595_1956_5894_207_5595_5594_2064_2932_7157_4609	11	9.87E-10	7.70E-08	2.40E-09
2572	hsa-mir-1253	hsa04540	Gap junction	10382_203068_1956_6714_5894_5595_5594_347733_5159_5156_5566_7278_84617	13	2.74E-09	2.14E-07	6.48E-09
2573	hsa-mir-1253	hsa04720	Long-term potentiation	818_817_2902_1387_5894_5595_5594_2033_808_801_805_5566	12	2.86E-09	2.23E-07	6.57E-09
2574	hsa-mir-1253	hsa04020	Calcium signaling pathway	818_817_292_293_291_147_1956_2902_2064_5481_4846_808_801_805_5159_5156_5566	17	3.44E-09	2.68E-07	7.66E-09
2575	hsa-mir-1253	hsa04612	Antigen processing and presentation	811_3309_3305_3303_920_1385_3310_3312_3320_3326_4800_4801	12	1.62E-08	1.26E-06	3.50E-08
2576	hsa-mir-1253	hsa04910	Insulin signaling pathway	6720_3551_10891_5894_207_5595_5594_5599_2932_808_801_805_5566_6464	14	2.85E-08	2.22E-06	6.01E-08
2577	hsa-mir-1253	hsa04120	Ubiquitin mediated proteolysis	4193_6500_3093_8945_57154_23291_10273_7323_7329_5371_672_8454_7428_8554	14	3.10E-08	2.42E-06	6.36E-08
2578	hsa-mir-1253	hsa05216	Thyroid cancer	1499_595_7175_5595_5594_6256_7157_4609	8	3.36E-08	2.62E-06	6.72E-08
2579	hsa-mir-1253	hsa04650	Natural killer cell mediated cytotoxicity	3455_3459_2534_3932_6850_5894_5595_5594_836_5879_3460_5781_6464	13	1.97E-07	1.54E-05	3.85E-07
2580	hsa-mir-1253	hsa05131	Shigellosis	1499_10382_2534_203068_71_347733_7278_84617_4691	9	2.70E-07	2.11E-05	5.02E-07
2581	hsa-mir-1253	hsa05130	Pathogenic Escherichia coli infection	1499_10382_2534_203068_71_347733_7278_84617_4691	9	2.70E-07	2.11E-05	5.02E-07
2582	hsa-mir-1253	hsa04370	VEGF signaling pathway	5747_3791_6714_1432_5894_207_5595_5594_4846_5879	10	3.51E-07	2.74E-05	6.37E-07
2583	hsa-mir-1253	hsa04664	Fc epsilon RI signaling pathway	2534_5580_6850_1432_5894_207_5595_5594_5599_5879	10	4.36E-07	3.40E-05	7.72E-07
2584	hsa-mir-1253	hsa04810	Regulation of actin cytoskeleton	2261_2264_10788_5747_1956_4627_4628_10627_5894_71_5595_5594_5879_5159_5156	15	1.06E-06	8.24E-05	1.83E-06
2585	hsa-mir-1253	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_7133_1432_836_7157_4846_5879_7132	8	2.78E-06	0.00021703	4.72E-06
2586	hsa-mir-1253	hsa03020	RNA polymerase	25885_64425_51082_5437_84172_5441	6	7.73E-06	0.000602953	1.28E-05
2587	hsa-mir-1253	hsa04270	Vascular smooth muscle contraction	147_5580_5894_5595_5594_4637_808_801_805_5566	10	1.21E-05	0.000940821	1.96E-05
2588	hsa-mir-1253	hsa05010	Alzheimer's disease	3416_2902_5595_5594_836_2932_4846_808_801_805_8772_7132	12	1.39E-05	0.001081497	2.21E-05
2589	hsa-mir-1253	hsa05340	Primary immunodeficiency	8517_100_3932_3561_920_915	6	2.00E-05	0.001557483	3.11E-05
2590	hsa-mir-1253	hsa04330	Notch signaling pathway	3066_3065_1387_9612_2033_4851	6	8.87E-05	0.006916571	0.000134688
2591	hsa-mir-1253	hsa04670	Leukocyte transendothelial migration	1499_653361_5747_1432_7852_10627_71_5879_5781	9	8.98E-05	0.0070038	0.000134688
2592	hsa-mir-1253	hsa04530	Tight junction	1499_5580_6714_4627_4628_10627_207_71_1457	9	0.000204737	0.015969496	0.000301311
2593	hsa-mir-1253	hsa04930	Type II diabetes mellitus	3551_5580_5595_5594_5599	5	0.000622805	0.04857878	0.000899607
2594	hsa-mir-1253	hsa04360	Axon guidance	2534_5747_7852_5595_5594_2932_5879	7	0.003138134	0.244774427	0.004450444
2595	hsa-mir-1253	hsa04115	p53 signaling pathway	595_4193_836_7157_2810	5	0.003616861	0.282115184	0.005037771
2596	hsa-mir-1253	hsa04150	mTOR signaling pathway	3091_207_5595_5594	4	0.007475854	0.583116613	0.010230116
2597	hsa-mir-1253	hsa04640	Hematopoietic cell lineage	3559_920_915_914_3815	5	0.009035579	0.704775167	0.012151296
2598	hsa-mir-1253	hsa04340	Hedgehog signaling pathway	8945_23291_2932_5566	4	0.010067329	0.785251684	0.013309351
2599	hsa-mir-1253	hsa05012	Parkinson's disease	292_293_291_7314_836_5481	6	0.014237254	1	0.01850843
2600	hsa-mir-1253	hsa03022	Basal transcription factors	2969_6874_6908	3	0.01769889	1	0.022631368
2601	hsa-mir-1253	hsa04730	Long-term depression	5894_5595_5594_4846	4	0.02019386	1	0.025405179
2602	hsa-mir-1253	hsa05217	Basal cell carcinoma	1499_2932_7157	3	0.046167544	1	0.057159816
2603	hsa-mir-1254	hsa05200	Pathways in cancer	3320_25_4149_5371_5595_5594_5599_1387_5604_2932_6502_5970_5894_1029_4087_4088_4089_4292_1050_5925_2033	21	2.66E-20	1.54E-18	1.54E-18
2604	hsa-mir-1254	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_8454_3399_6500_4086_4087_4088_4089_2033_4093_5933	14	4.84E-19	2.80E-17	1.35E-17
2605	hsa-mir-1254	hsa04110	Cell cycle	25_990_1387_983_2932_8454_6502_6500_1029_4087_4088_4089_5925_2033_5933	15	6.99E-19	4.05E-17	1.35E-17
2606	hsa-mir-1254	hsa04540	Gap junction	5595_5594_5598_983_5604_7277_7278_10376_5894_7846_51807	11	7.45E-14	4.32E-12	1.08E-12
2607	hsa-mir-1254	hsa05220	Chronic myeloid leukemia	25_5595_5594_5604_5970_5894_1029_4088_4089_5925	10	3.55E-13	2.06E-11	4.12E-12
2608	hsa-mir-1254	hsa05210	Colorectal cancer	5595_5594_5599_5604_2932_5894_4087_4088_4089_4292	10	1.00E-12	5.81E-11	9.68E-12
2609	hsa-mir-1254	hsa05215	Prostate cancer	3320_5595_5594_1387_5604_2932_5970_5894_5925_2033	10	1.53E-12	8.90E-11	1.23E-11
2610	hsa-mir-1254	hsa05212	Pancreatic cancer	3320_5595_5594_1387_5604_2932_5970_5894_5925_2033	10	1.70E-12	9.87E-11	1.23E-11
2611	hsa-mir-1254	hsa04310	Wnt signaling pathway	5599_1387_2932_8454_6500_1457_1459_4087_4088_4089_2033	11	1.08E-11	6.28E-10	6.98E-11
2612	hsa-mir-1254	hsa04520	Adherens junction	5595_5594_1387_1457_1459_4087_4088_4089_2033	9	2.28E-11	1.32E-09	1.32E-10
2613	hsa-mir-1254	hsa05131	Shigellosis	25_7277_7278_10376_7846_51807_4691	7	2.11E-09	1.22E-07	1.02E-08
2614	hsa-mir-1254	hsa05130	Pathogenic Escherichia coli infection	25_7277_7278_10376_7846_51807_4691	7	2.11E-09	1.22E-07	1.02E-08
2615	hsa-mir-1254	hsa05221	Acute myeloid leukemia	5371_5595_5594_5604_5970_5894_1050	7	2.95E-09	1.71E-07	1.31E-08
2616	hsa-mir-1254	hsa05219	Bladder cancer	5595_5594_5604_5894_1029_5925	6	1.51E-08	8.77E-07	6.27E-08
2617	hsa-mir-1254	hsa04012	ErbB signaling pathway	25_5595_5594_5599_5604_2932_5894	7	3.58E-08	2.08E-06	1.38E-07
2618	hsa-mir-1254	hsa05213	Endometrial cancer	5595_5594_5604_2932_5894_4292	6	4.85E-08	2.81E-06	1.76E-07
2619	hsa-mir-1254	hsa05223	Non-small cell lung cancer	5595_5594_5604_5894_1029_5925	6	5.97E-08	3.46E-06	2.04E-07
2620	hsa-mir-1254	hsa04916	Melanogenesis	5595_5594_1387_5604_2932_5894_2033	7	1.13E-07	6.57E-06	3.65E-07
2621	hsa-mir-1254	hsa05214	Glioma	5595_5594_5604_5894_1029_5925	6	1.66E-07	9.61E-06	5.06E-07
2622	hsa-mir-1254	hsa05218	Melanoma	5595_5594_5604_5894_1029_5925	6	2.70E-07	1.56E-05	7.82E-07
2623	hsa-mir-1254	hsa05211	Renal cell carcinoma	5595_5594_1387_5604_5894_2033	6	2.91E-07	1.69E-05	8.05E-07
2624	hsa-mir-1254	hsa04720	Long-term potentiation	5595_5594_1387_5604_5894_2033	6	3.65E-07	2.12E-05	9.21E-07
2625	hsa-mir-1254	hsa04662	B cell receptor signaling pathway	5595_5594_5604_2932_5970_5894	6	3.65E-07	2.12E-05	9.21E-07
2626	hsa-mir-1254	hsa04010	MAPK signaling pathway	4149_5595_5594_5599_5598_5604_1386_5970_5894	9	5.69E-07	3.30E-05	1.38E-06
2627	hsa-mir-1254	hsa04910	Insulin signaling pathway	5595_5594_5599_5604_23265_2932_5894	7	7.00E-07	4.06E-05	1.63E-06
2628	hsa-mir-1254	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_8454_6502_6500_7329	7	7.34E-07	4.26E-05	1.64E-06
2629	hsa-mir-1254	hsa04912	GnRH signaling pathway	5595_5594_5599_5598_5604_5894	6	2.74E-06	0.000158882	5.88E-06
2630	hsa-mir-1254	hsa04660	T cell receptor signaling pathway	5595_5594_5604_2932_5970_5894	6	3.03E-06	0.000175799	6.28E-06
2631	hsa-mir-1254	hsa04062	Chemokine signaling pathway	5595_5594_5604_2932_5970_5894_7074	7	5.95E-06	0.000344853	1.19E-05
2632	hsa-mir-1254	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5604_5894	5	1.06E-05	0.000614394	2.05E-05
2633	hsa-mir-1254	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5604_5970	5	3.43E-05	0.001988092	6.41E-05
2634	hsa-mir-1254	hsa04510	Focal adhesion	5595_5594_5599_5604_2932_5894	6	9.21E-05	0.005340681	0.000166896
2635	hsa-mir-1254	hsa04730	Long-term depression	5595_5594_5604_5894	4	0.000130358	0.007560791	0.000229115
2636	hsa-mir-1254	hsa04370	VEGF signaling pathway	5595_5594_5604_5894	4	0.000175657	0.010188093	0.000297478
2637	hsa-mir-1254	hsa05216	Thyroid cancer	5595_5594_5604	3	0.000179513	0.010411746	0.000297478
2638	hsa-mir-1254	hsa05222	Small cell lung cancer	4149_6502_5970_5925	4	0.000263497	0.01528282	0.000424523
2639	hsa-mir-1254	hsa03022	Basal transcription factors	2962_2969_6908	3	0.000350544	0.020331574	0.000549502
2640	hsa-mir-1254	hsa04930	Type II diabetes mellitus	5595_5594_5599	3	0.000601608	0.034893287	0.000918244
2641	hsa-mir-1254	hsa04330	Notch signaling pathway	1387_2648_2033	3	0.000678377	0.039345891	0.001008869
2642	hsa-mir-1254	hsa04270	Vascular smooth muscle contraction	5595_5594_5604_5894	4	0.000833141	0.048322175	0.001208054
2643	hsa-mir-1254	hsa04810	Regulation of actin cytoskeleton	5595_5594_5604_5894_7074	5	0.001057083	0.061310829	0.001495386
2644	hsa-mir-1254	hsa04360	Axon guidance	25_5595_5594_2932	4	0.001213373	0.070375651	0.001675611
2645	hsa-mir-1254	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_5604_5894	4	0.001461722	0.08477985	0.001971624
2646	hsa-mir-1254	hsa04115	p53 signaling pathway	983_7161_1029	3	0.001954848	0.113381169	0.002576845
2647	hsa-mir-1254	hsa04612	Antigen processing and presentation	3320_4801_4802	3	0.003918069	0.227248026	0.005049956
2648	hsa-mir-1254	hsa05016	Huntington's disease	1387_6908_6667_2033	4	0.004338861	0.251653966	0.005470738
2649	hsa-mir-1254	hsa04150	mTOR signaling pathway	5595_5594	2	0.014778537	0.857155135	0.018237343
2650	hsa-mir-1254	hsa04920	Adipocytokine signaling pathway	5599_5970	2	0.023439873	1	0.028323179
2651	hsa-mir-1254	hsa05010	Alzheimer's disease	5595_5594_2932	3	0.024047427	1	0.028464301
2652	hsa-mir-1254	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5970	2	0.026027464	1	0.030191858
2653	hsa-mir-1255a	hsa05200	Pathways in cancer	3716_5879_5747_5371_1956_1499_2261_5595_5594_5914_2064_6256_5159_595_5156_836_2932_3815_367_7704_1387_842_6774_6776_6777_3091_5970_4824_7428_6258_1870_1871_7157_2113_8772_4609_1869_3725_862_841_2353_3065_4087_4088_4089_3066_5925_2034_2033_4846_6502_207_208_8554_9915_7046	56	4.43E-42	3.24E-40	3.24E-40
2654	hsa-mir-1255a	hsa05215	Prostate cancer	1956_1499_5595_5594_2064_5159_595_5156_2932_1385_367_1387_842_5970_4824_1870_1871_7157_1869_5925_2033_207_208	23	1.51E-21	1.10E-19	4.56E-20
2655	hsa-mir-1255a	hsa05212	Pancreatic cancer	1956_1499_5595_5594_2064_5159_595_5156_2932_1385_367_1387_842_5970_4824_1870_1871_7157_1869_5925_2033_207_208	23	1.87E-21	1.37E-19	4.56E-20
2656	hsa-mir-1255a	hsa04010	MAPK signaling pathway	5879_6722_1956_2261_5595_5594_2264_5159_9261_5156_4208_7132_836_6195_9252_7867_1386_1432_1845_5970_3312_7157_4773_4609_3725_2353_4763_5058_207_208_2002_7046_2005	33	5.23E-21	3.82E-19	9.55E-20
2657	hsa-mir-1255a	hsa05220	Chronic myeloid leukemia	5595_5594_595_6776_6777_5970_1870_1871_7157_5781_4609_1869_3065_4088_4089_3066_5925_207_208_6464_7046	21	2.61E-20	1.90E-18	3.81E-19
2658	hsa-mir-1255a	hsa05214	Glioma	818_815_817_1956_5595_5594_5159_595_5156_808_1870_1871_7157_1869_5925_207_208_6464_805_801	20	4.37E-20	3.19E-18	5.32E-19
2659	hsa-mir-1255a	hsa05210	Colorectal cancer	5879_1956_1499_5595_5594_5159_595_5156_836_2932_842_7157_4609_3725_2353_4087_4088_4089_207_208_7046	21	1.92E-19	1.40E-17	2.00E-18
2660	hsa-mir-1255a	hsa04012	ErbB signaling pathway	5747_818_815_817_1956_6714_5595_5594_2064_2932_6776_6777_4609_3725_5058_207_208_6464_2002	19	9.00E-17	6.57E-15	7.71E-16
2661	hsa-mir-1255a	hsa04110	Cell cycle	5591_7532_595_7534_2932_1387_1870_1871_7157_4172_1869_4174_3065_4087_4088_4089_3066_5925_2033_6502_5933	21	9.50E-17	6.93E-15	7.71E-16
2662	hsa-mir-1255a	hsa04630	Jak-STAT signaling pathway	3717_3716_3560_595_1387_6774_6776_6777_6773_3459_58985_3455_5781_7297_4609_3561_1439_2033_207_208_8554_10379	22	1.03E-15	7.56E-14	7.56E-15
2663	hsa-mir-1255a	hsa05223	Non-small cell lung cancer	1956_5595_5594_2064_6256_595_842_6258_1870_1871_7157_1869_5925_207_208	15	7.79E-15	5.69E-13	5.17E-14
2664	hsa-mir-1255a	hsa05222	Small cell lung cancer	5747_6256_595_842_5970_6258_1870_1871_7157_4609_1869_5925_4846_6502_207_208_8554	17	1.61E-14	1.17E-12	9.78E-14
2665	hsa-mir-1255a	hsa04350	TGF-beta signaling pathway	3399_5595_5594_90_1387_3398_4609_4087_4088_4089_2033_4093_3397_6667_57154_7046_5933	17	1.90E-14	1.39E-12	1.07E-13
2666	hsa-mir-1255a	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_3815_7704_6774_6776_6777_5970_4609_862_207_208	15	2.37E-14	1.73E-12	1.23E-13
2667	hsa-mir-1255a	hsa05219	Bladder cancer	1956_2261_5595_5594_2064_595_9252_1870_1871_7157_4609_1869_5925	13	1.54E-13	1.12E-11	7.50E-13
2668	hsa-mir-1255a	hsa05211	Renal cell carcinoma	5879_5595_5594_1387_3091_7428_5781_2113_3725_5058_2034_2033_207_208_9915	15	2.94E-13	2.15E-11	1.34E-12
2669	hsa-mir-1255a	hsa04520	Adherens junction	5879_1956_1499_6714_5595_5594_2064_1387_1457_4087_4088_4089_2033_7046_2534	15	1.13E-12	8.22E-11	4.84E-12
2670	hsa-mir-1255a	hsa05213	Endometrial cancer	1956_1499_5595_5594_2064_595_2932_842_7157_4609_207_208_2002	13	1.56E-12	1.14E-10	6.31E-12
2671	hsa-mir-1255a	hsa04510	Focal adhesion	5879_5747_2321_1956_1499_6714_5595_5594_2064_5159_595_5156_2932_3791_3725_5058_207_208_6464_2002_2534	21	1.67E-12	1.22E-10	6.42E-12
2672	hsa-mir-1255a	hsa04370	VEGF signaling pathway	5879_5747_6714_5595_5594_9261_7867_1432_842_3791_4773_4846_207_208	14	9.27E-12	6.77E-10	3.39E-11
2673	hsa-mir-1255a	hsa05218	Melanoma	1956_5595_5594_5159_595_5156_1870_1871_7157_1869_5925_207_208	13	4.77E-11	3.49E-09	1.66E-10
2674	hsa-mir-1255a	hsa04310	Wnt signaling pathway	5879_818_815_817_1499_595_2932_1387_7157_4773_4609_3725_1457_4087_4088_4089_2033	17	6.01E-11	4.39E-09	1.99E-10
2675	hsa-mir-1255a	hsa04062	Chemokine signaling pathway	3717_5879_5747_5580_5595_5594_1234_1230_2932_6774_6777_6773_5970_7852_5058_207_208_6464	18	2.52E-10	1.84E-08	8.00E-10
2676	hsa-mir-1255a	hsa04916	Melanogenesis	818_815_817_1499_5595_5594_808_2932_3815_1385_1387_2033_805_801	14	3.33E-10	2.43E-08	9.77E-10
2677	hsa-mir-1255a	hsa04920	Adipocytokine signaling pathway	3717_8717_6256_7133_7132_6774_5970_6258_5781_207_208_2538	12	3.35E-10	2.44E-08	9.77E-10
2678	hsa-mir-1255a	hsa04912	GnRH signaling pathway	5580_818_815_817_1956_6714_5595_5594_808_1432_3725_2002_805_801	14	5.21E-10	3.81E-08	1.46E-09
2679	hsa-mir-1255a	hsa04210	Apoptosis	839_8717_7132_836_842_840_5970_7157_8772_841_1439_207_208	13	5.81E-10	4.24E-08	1.57E-09
2680	hsa-mir-1255a	hsa04720	Long-term potentiation	818_815_817_5595_5594_2902_6195_808_1387_2033_805_801	12	1.06E-09	7.73E-08	2.76E-09
2681	hsa-mir-1255a	hsa04060	Cytokine-cytokine receptor interaction	2321_1956_3560_90_5159_5156_7133_7132_1234_1230_3815_3459_3791_7852_58985_3455_3561_1439_7046	19	3.99E-09	2.91E-07	1.00E-08
2682	hsa-mir-1255a	hsa04660	T cell receptor signaling pathway	3932_5595_5594_2932_1432_5970_4773_3725_2353_5058_207_208_2534	13	6.01E-09	4.39E-07	1.46E-08
2683	hsa-mir-1255a	hsa04662	B cell receptor signaling pathway	5879_5595_5594_6850_2932_5970_4773_3725_2353_207_208	11	1.19E-08	8.72E-07	2.81E-08
2684	hsa-mir-1255a	hsa05216	Thyroid cancer	1499_5595_5594_6256_595_6258_7157_4609	8	1.70E-08	1.24E-06	3.87E-08
2685	hsa-mir-1255a	hsa04620	Toll-like receptor signaling pathway	5879_5595_5594_1432_5970_3455_8772_3725_841_2353_207_208	12	2.43E-08	1.77E-06	5.37E-08
2686	hsa-mir-1255a	hsa05010	Alzheimer's disease	22926_5595_5594_2902_7132_836_808_2932_842_840_8772_841_4846_805_801	15	2.61E-08	1.90E-06	5.60E-08
2687	hsa-mir-1255a	hsa04650	Natural killer cell mediated cytotoxicity	5879_3932_5595_5594_6850_836_3459_3455_5781_4773_5058_6464_2534	13	7.13E-08	5.21E-06	1.49E-07
2688	hsa-mir-1255a	hsa05014	Amyotrophic lateral sclerosis (ALS)	5879_2902_7133_7132_836_1432_842_7157_4846	9	1.28E-07	9.37E-06	2.60E-07
2689	hsa-mir-1255a	hsa04910	Insulin signaling pathway	6720_5595_5594_808_2932_207_208_6464_2002_2538_805_801	12	5.05E-07	3.68E-05	9.95E-07
2690	hsa-mir-1255a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5879_1956_6714_836_1432_5970_5781_3725_5058	9	7.88E-07	5.75E-05	1.51E-06
2691	hsa-mir-1255a	hsa04020	Calcium signaling pathway	818_815_817_1956_2064_5159_2902_5156_808_4846_147_805_801	13	1.52E-06	0.000111294	2.85E-06
2692	hsa-mir-1255a	hsa04664	Fc epsilon RI signaling pathway	5879_5580_5595_5594_6850_1432_207_208_2534	9	1.78E-06	0.000129685	3.24E-06
2693	hsa-mir-1255a	hsa05016	Huntington's disease	6874_2902_836_1385_1387_842_7157_841_3065_3066_3064_2033_6667	13	1.91E-06	0.000139268	3.40E-06
2694	hsa-mir-1255a	hsa04330	Notch signaling pathway	1387_388585_9612_3065_8850_3066_2033	7	5.18E-06	0.000378151	9.00E-06
2695	hsa-mir-1255a	hsa04360	Axon guidance	5879_5747_5595_5594_2932_7852_4773_5058_2534	9	7.66E-05	0.005591988	0.000130046
2696	hsa-mir-1255a	hsa04150	mTOR signaling pathway	5595_5594_6195_3091_207_208	6	9.11E-05	0.006651317	0.000151166
2697	hsa-mir-1255a	hsa04810	Regulation of actin cytoskeleton	5879_5747_1956_2261_5595_5594_2264_5159_5156_5058	10	0.000718871	0.05247755	0.001166168
2698	hsa-mir-1255a	hsa04270	Vascular smooth muscle contraction	5580_5595_5594_808_147_805_801	7	0.001085422	0.079235816	0.001722518
2699	hsa-mir-1255a	hsa04540	Gap junction	1956_6714_5595_5594_5159_5156	6	0.001636235	0.119445167	0.002541387
2700	hsa-mir-1255a	hsa03022	Basal transcription factors	2963_2962_6874_2969	4	0.001758268	0.128353562	0.002674033
2701	hsa-mir-1255a	hsa04115	p53 signaling pathway	595_836_842_7157_841	5	0.002478481	0.18092909	0.00369243
2702	hsa-mir-1255a	hsa04120	Ubiquitin mediated proteolysis	5371_672_7428_7329_6502_8554_57154	7	0.002637157	0.192512453	0.003850249
2703	hsa-mir-1255a	hsa04930	Type II diabetes mellitus	3651_5580_5595_5594	4	0.003398852	0.248116194	0.004865023
2704	hsa-mir-1255a	hsa04950	Maturity onset diabetes of the young	3651_3172_168620	3	0.004677685	0.341470978	0.00656675
2705	hsa-mir-1255a	hsa04670	Leukocyte transendothelial migration	5879_5747_1499_1432_7852_5781	6	0.005846633	0.426804211	0.00805291
2706	hsa-mir-1255a	hsa04530	Tight junction	5580_1499_6714_1457_207_208	6	0.009848599	0.718947752	0.013313847
2707	hsa-mir-1255a	hsa03050	Proteasome	5684_5705_5710	3	0.026681604	1	0.035413765
2708	hsa-mir-1255a	hsa04612	Antigen processing and presentation	4800_1385_3312_4801	4	0.03047246	1	0.039723028
2709	hsa-mir-1255a	hsa05217	Basal cell carcinoma	1499_2932_7157	3	0.037083692	1	0.047493149
2710	hsa-mir-1255a	hsa05131	Shigellosis	1499_7534_2534	3	0.038715875	1	0.047902693
2711	hsa-mir-1255a	hsa05130	Pathogenic Escherichia coli infection	1499_7534_2534	3	0.038715875	1	0.047902693
2712	hsa-mir-1255b-2	hsa05200	Pathways in cancer	3326_25_7046_1499_5595_5594_1387_862_1487_1488_1019_367_1017_2932_51588_3265_6688_4609_3725_1026_6502_4087_4088_4089_3065_5925_2033_8554_7189	29	3.26E-25	2.25E-23	2.25E-23
2713	hsa-mir-1255b-2	hsa04350	TGF-beta signaling pathway	7046_5595_5594_1387_6667_7027_3397_3399_3398_1874_658_4609_4086_4087_4088_4089_2033_4093_5933	19	1.36E-23	9.40E-22	4.70E-22
2714	hsa-mir-1255b-2	hsa05220	Chronic myeloid leukemia	25_7046_5595_5594_1487_1488_1019_3265_4609_1026_4088_4089_3065_5925	14	7.77E-17	5.36E-15	1.79E-15
2715	hsa-mir-1255b-2	hsa04110	Cell cycle	25_1387_1019_1017_2932_7027_1026_6502_4087_4088_4089_3065_5925_2033_5933	15	1.15E-15	7.92E-14	1.98E-14
2716	hsa-mir-1255b-2	hsa05215	Prostate cancer	3326_1499_5595_5594_1387_367_1017_2932_3265_468_1026_5925_2033	13	1.53E-14	1.06E-12	2.01E-13
2717	hsa-mir-1255b-2	hsa05212	Pancreatic cancer	3326_1499_5595_5594_1387_367_1017_2932_3265_468_1026_5925_2033	13	1.74E-14	1.20E-12	2.01E-13
2718	hsa-mir-1255b-2	hsa04720	Long-term potentiation	5595_5594_1387_3265_2902_2906_468_2033_808_801_805	11	1.83E-12	1.27E-10	1.81E-11
2719	hsa-mir-1255b-2	hsa04010	MAPK signaling pathway	6722_7046_5595_5594_1386_9261_4208_7867_1432_1649_3265_468_4609_3725_22800_7189	16	7.57E-12	5.23E-10	6.53E-11
2720	hsa-mir-1255b-2	hsa05210	Colorectal cancer	7046_1499_5595_5594_2932_4609_3725_4087_4088_4089	10	1.25E-10	8.62E-09	9.57E-10
2721	hsa-mir-1255b-2	hsa05214	Glioma	5595_5594_1019_3265_1026_5925_808_801_805	9	3.19E-10	2.20E-08	2.20E-09
2722	hsa-mir-1255b-2	hsa04620	Toll-like receptor signaling pathway	3654_5595_5594_353376_3661_148022_1432_3725_4615_7189	10	7.18E-10	4.95E-08	4.18E-09
2723	hsa-mir-1255b-2	hsa04330	Notch signaling pathway	388585_1387_2648_1487_1488_3065_2033_8850	8	7.27E-10	5.02E-08	4.18E-09
2724	hsa-mir-1255b-2	hsa04916	Melanogenesis	1499_5595_5594_1387_2932_3265_2033_808_801_805	10	8.55E-10	5.90E-08	4.54E-09
2725	hsa-mir-1255b-2	hsa04520	Adherens junction	7046_1499_5595_5594_1387_4087_4088_4089_2033	9	1.71E-09	1.18E-07	8.43E-09
2726	hsa-mir-1255b-2	hsa04310	Wnt signaling pathway	1499_1387_1487_1488_2932_4609_3725_4087_4088_4089_2033	11	1.99E-09	1.37E-07	9.16E-09
2727	hsa-mir-1255b-2	hsa05219	Bladder cancer	5595_5594_1019_3265_4609_1026_5925	7	9.92E-09	6.84E-07	4.28E-08
2728	hsa-mir-1255b-2	hsa04912	GnRH signaling pathway	5595_5594_1432_3265_468_3725_808_801_805	9	1.95E-08	1.34E-06	7.90E-08
2729	hsa-mir-1255b-2	hsa05222	Small cell lung cancer	1019_1017_51588_4609_6502_5925_8554_7189	8	5.54E-08	3.82E-06	2.12E-07
2730	hsa-mir-1255b-2	hsa04012	ErbB signaling pathway	25_5595_5594_2932_3265_4609_3725_1026	8	6.02E-08	4.15E-06	2.19E-07
2731	hsa-mir-1255b-2	hsa05010	Alzheimer's disease	5595_5594_2932_2902_2906_808_351_22926_801_805	10	1.00E-07	6.92E-06	3.46E-07
2732	hsa-mir-1255b-2	hsa05213	Endometrial cancer	1499_5595_5594_2932_3265_4609	6	8.39E-07	5.79E-05	2.76E-06
2733	hsa-mir-1255b-2	hsa05216	Thyroid cancer	1499_5595_5594_3265_4609	5	1.20E-06	8.25E-05	3.75E-06
2734	hsa-mir-1255b-2	hsa05221	Acute myeloid leukemia	5595_5594_862_3265_6688_4609	6	1.66E-06	0.000114401	4.97E-06
2735	hsa-mir-1255b-2	hsa04660	T cell receptor signaling pathway	5595_5594_1019_2932_1432_3265_3725	7	4.18E-06	0.000288299	1.20E-05
2736	hsa-mir-1255b-2	hsa05218	Melanoma	5595_5594_1019_3265_1026_5925	6	4.51E-06	0.000310873	1.24E-05
2737	hsa-mir-1255b-2	hsa05211	Renal cell carcinoma	5595_5594_1387_3265_3725_2033	6	4.86E-06	0.000335245	1.29E-05
2738	hsa-mir-1255b-2	hsa04370	VEGF signaling pathway	5595_5594_9261_7867_1432_3265	6	6.98E-06	0.000481538	1.78E-05
2739	hsa-mir-1255b-2	hsa04910	Insulin signaling pathway	5595_5594_2932_3265_808_801_805	7	1.71E-05	0.001178853	4.21E-05
2740	hsa-mir-1255b-2	hsa05223	Non-small cell lung cancer	5595_5594_1019_3265_5925	5	1.93E-05	0.001328252	4.58E-05
2741	hsa-mir-1255b-2	hsa04662	B cell receptor signaling pathway	5595_5594_2932_3265_3725	5	8.42E-05	0.00580835	0.000193612
2742	hsa-mir-1255b-2	hsa05016	Huntington's disease	25942_1387_6667_2902_3065_2033_9519	7	0.000112108	0.007735443	0.00024953
2743	hsa-mir-1255b-2	hsa04950	Maturity onset diabetes of the young	168620_6927_3651	3	0.000441992	0.030497423	0.000953044
2744	hsa-mir-1255b-2	hsa04270	Vascular smooth muscle contraction	5595_5594_808_801_805	5	0.000625106	0.04313232	0.00130704
2745	hsa-mir-1255b-2	hsa04360	Axon guidance	25_5595_5594_2932_3265	5	0.00098309	0.06783323	0.001995095
2746	hsa-mir-1255b-2	hsa04664	Fc epsilon RI signaling pathway	5595_5594_1432_3265	4	0.001184784	0.081750089	0.002254393
2747	hsa-mir-1255b-2	hsa04530	Tight junction	8573_1499_1019_3265_22800	5	0.001191795	0.082233826	0.002254393
2748	hsa-mir-1255b-2	hsa04510	Focal adhesion	1499_5595_5594_2932_3265_3725	6	0.001208878	0.083412559	0.002254393
2749	hsa-mir-1255b-2	hsa04120	Ubiquitin mediated proteolysis	51588_7329_6502_8554_7189	5	0.001268144	0.087501914	0.002302682
2750	hsa-mir-1255b-2	hsa04630	Jak-STAT signaling pathway	1387_51588_4609_2033_8554	5	0.002015422	0.139064122	0.003565747
2751	hsa-mir-1255b-2	hsa04930	Type II diabetes mellitus	5595_5594_3651	3	0.002400421	0.165629053	0.004140726
2752	hsa-mir-1255b-2	hsa04020	Calcium signaling pathway	2902_2906_808_801_805	5	0.004119893	0.28427264	0.006933479
2753	hsa-mir-1255b-2	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_2902_2906	3	0.004315918	0.297798364	0.007090437
2754	hsa-mir-1255b-2	hsa04115	p53 signaling pathway	1019_1017_1026	3	0.007514565	0.518504964	0.012058255
2755	hsa-mir-1255b-2	hsa04730	Long-term depression	5595_5594_3265	3	0.008102448	0.559068907	0.012706112
2756	hsa-mir-1255b-2	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.00968803	0.668474051	0.014854979
2757	hsa-mir-1255b-2	hsa04612	Antigen processing and presentation	3326_4800_4801	3	0.014605442	1	0.021908163
2758	hsa-mir-1255b-2	hsa04540	Gap junction	5595_5594_3265	3	0.016354389	1	0.024009635
2759	hsa-mir-1255b-2	hsa04062	Chemokine signaling pathway	5595_5594_2932_3265	4	0.024216215	1	0.03481081
2760	hsa-mir-1255b-2	hsa04810	Regulation of actin cytoskeleton	5595_5594_3265_22800	4	0.035797332	1	0.049855799
2761	hsa-mir-1255b-2	hsa04150	mTOR signaling pathway	5595_5594	2	0.036127391	1	0.049855799
2762	hsa-mir-1255b-2	hsa05217	Basal cell carcinoma	1499_2932	2	0.039864093	1	0.053560818
2763	hsa-mir-1255b-2	hsa05131	Shigellosis	25_1499	2	0.041140918	1	0.053560818
2764	hsa-mir-1255b-2	hsa05130	Pathogenic Escherichia coli infection	25_1499	2	0.041140918	1	0.053560818
2765	hsa-mir-1255b-2	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_3265	3	0.043796375	1	0.055962035
2766	hsa-mir-1258	hsa05200	Pathways in cancer	1147_3551_5594_5599_6258_1387_6257_6256_8031_836_5970_7157_3725_2353_4087_4088_4089_1050_5925_2033_207_8554	22	5.79E-19	3.36E-17	3.36E-17
2767	hsa-mir-1258	hsa04010	MAPK signaling pathway	9479_1147_3551_5594_5599_5598_1386_836_1432_5970_7157_10912_468_3725_3727_2353_4616_207	18	1.21E-15	7.01E-14	3.50E-14
2768	hsa-mir-1258	hsa05215	Prostate cancer	1147_3551_5594_1387_5970_7157_468_10488_5925_2033_207	11	8.69E-13	5.04E-11	1.41E-11
2769	hsa-mir-1258	hsa05212	Pancreatic cancer	1147_3551_5594_1387_5970_7157_468_10488_5925_2033_207	11	9.73E-13	5.64E-11	1.41E-11
2770	hsa-mir-1258	hsa05210	Colorectal cancer	5594_5599_836_7157_3725_2353_4087_4088_4089_207	10	1.53E-11	8.85E-10	1.56E-10
2771	hsa-mir-1258	hsa04110	Cell cycle	1387_7534_7532_7157_10912_4087_4088_4089_4616_5925_2033	11	1.78E-11	1.03E-09	1.56E-10
2772	hsa-mir-1258	hsa05222	Small cell lung cancer	1147_3551_6258_6257_6256_5970_7157_5925_207_8554	10	1.89E-11	1.10E-09	1.56E-10
2773	hsa-mir-1258	hsa04920	Adipocytokine signaling pathway	1147_3551_10891_5599_6258_6257_6256_5970_207	9	6.13E-11	3.56E-09	4.45E-10
2774	hsa-mir-1258	hsa05220	Chronic myeloid leukemia	1147_3551_5594_5970_7157_4088_4089_5925_207	9	1.54E-10	8.92E-09	9.91E-10
2775	hsa-mir-1258	hsa04310	Wnt signaling pathway	5599_1387_6423_7157_8061_3725_1457_4087_4088_4089_2033	11	2.07E-10	1.20E-08	1.20E-09
2776	hsa-mir-1258	hsa04620	Toll-like receptor signaling pathway	1147_3551_5594_5599_1432_5970_3725_2353_207	9	1.91E-09	1.11E-07	1.00E-08
2777	hsa-mir-1258	hsa05216	Thyroid cancer	5594_6258_6257_6256_8031_7157	6	1.05E-08	6.11E-07	4.93E-08
2778	hsa-mir-1258	hsa05223	Non-small cell lung cancer	5594_6258_6257_6256_7157_5925_207	7	1.10E-08	6.40E-07	4.93E-08
2779	hsa-mir-1258	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_5599_836_1432_5970_3725	7	6.28E-08	3.64E-06	2.46E-07
2780	hsa-mir-1258	hsa04660	T cell receptor signaling pathway	1147_3551_5594_1432_5970_3725_2353_207	8	6.36E-08	3.69E-06	2.46E-07
2781	hsa-mir-1258	hsa04662	B cell receptor signaling pathway	1147_3551_5594_5970_3725_2353_207	7	8.90E-08	5.16E-06	3.23E-07
2782	hsa-mir-1258	hsa04520	Adherens junction	5594_1387_1457_4087_4088_4089_2033	7	1.34E-07	7.79E-06	4.58E-07
2783	hsa-mir-1258	hsa04350	TGF-beta signaling pathway	5594_1387_3398_4087_4088_4089_2033	7	2.29E-07	1.33E-05	7.38E-07
2784	hsa-mir-1258	hsa04210	Apoptosis	1147_3551_836_5970_7157_840_207	7	2.65E-07	1.54E-05	8.08E-07
2785	hsa-mir-1258	hsa05221	Acute myeloid leukemia	1147_3551_5594_5970_1050_207	6	4.81E-07	2.79E-05	1.39E-06
2786	hsa-mir-1258	hsa04912	GnRH signaling pathway	5594_5599_5598_1432_468_3725	6	1.30E-05	0.000752174	3.58E-05
2787	hsa-mir-1258	hsa03320	PPAR signaling pathway	10062_6258_6257_6256_2168	5	2.25E-05	0.001303659	5.93E-05
2788	hsa-mir-1258	hsa05211	Renal cell carcinoma	5594_1387_3725_2033_207	5	2.55E-05	0.001481719	6.44E-05
2789	hsa-mir-1258	hsa05016	Huntington's disease	10891_1387_836_7157_10488_2033	6	0.000248718	0.014425656	0.000601069
2790	hsa-mir-1258	hsa05214	Glioma	5594_7157_5925_207	4	0.000265739	0.015412853	0.000616514
2791	hsa-mir-1258	hsa04115	p53 signaling pathway	836_7157_10912_4616	4	0.000329979	0.019138794	0.000736107
2792	hsa-mir-1258	hsa05218	Melanoma	5594_7157_5925_207	4	0.000365951	0.02122514	0.000786116
2793	hsa-mir-1258	hsa04720	Long-term potentiation	5594_1387_468_2033	4	0.000446171	0.02587792	0.000924211
2794	hsa-mir-1258	hsa04910	Insulin signaling pathway	3551_10891_5594_5599_207	5	0.000474261	0.027507149	0.000948522
2795	hsa-mir-1258	hsa04664	Fc epsilon RI signaling pathway	5594_5599_1432_207	4	0.000538204	0.031215804	0.001040527
2796	hsa-mir-1258	hsa04012	ErbB signaling pathway	5594_5599_3725_207	4	0.000761472	0.044165375	0.00142469
2797	hsa-mir-1258	hsa05219	Bladder cancer	5594_7157_5925	3	0.001087215	0.063058457	0.001970577
2798	hsa-mir-1258	hsa04930	Type II diabetes mellitus	3551_5594_5599	3	0.001312282	0.076112382	0.002306436
2799	hsa-mir-1258	hsa04916	Melanogenesis	5594_1387_10488_2033	4	0.001440056	0.083523269	0.002448302
2800	hsa-mir-1258	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.001477423	0.085690553	0.002448302
2801	hsa-mir-1258	hsa05213	Endometrial cancer	5594_7157_207	3	0.001945598	0.112844682	0.003134574
2802	hsa-mir-1258	hsa04062	Chemokine signaling pathway	1147_3551_5594_5970_207	5	0.002024822	0.117439661	0.003174045
2803	hsa-mir-1258	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432_7157	3	0.002379685	0.138021705	0.00363215
2804	hsa-mir-1258	hsa04370	VEGF signaling pathway	5594_1432_207	3	0.005617691	0.325826078	0.008354515
2805	hsa-mir-1258	hsa04630	Jak-STAT signaling pathway	1387_2033_207_8554	4	0.005784195	0.335483298	0.008387082
2806	hsa-mir-1258	hsa05010	Alzheimer's disease	5594_836_1020_840	4	0.00905334	0.52509372	0.012807164
2807	hsa-mir-1258	hsa04510	Focal adhesion	5594_5599_3725_207	4	0.014934712	0.866213299	0.020624126
2808	hsa-mir-1258	hsa04150	mTOR signaling pathway	5594_207	2	0.024490216	1	0.033033314
2809	hsa-mir-125a	hsa05200	Pathways in cancer	3320_1387_6256_1019_1017_2932_841_5578_6774_7157_3725_2736_4088_4089_3065_5925_2033_207	18	1.26E-16	8.32E-15	8.32E-15
2810	hsa-mir-125a	hsa04110	Cell cycle	1387_1019_1017_2932_7157_1028_4088_4089_3065_5925_2033	11	6.48E-13	4.28E-11	2.14E-11
2811	hsa-mir-125a	hsa04350	TGF-beta signaling pathway	3399_6667_3400_1387_3398_3397_4088_4089_2033_4092	10	1.02E-12	6.75E-11	2.25E-11
2812	hsa-mir-125a	hsa04720	Long-term potentiation	1387_5578_6195_6196_6197_2033_808_801_805	9	1.02E-11	6.75E-10	1.69E-10
2813	hsa-mir-125a	hsa04010	MAPK signaling pathway	6722_8986_9261_9252_1432_5578_4342_7157_3725_6195_6196_6197_207	13	1.33E-11	8.80E-10	1.76E-10
2814	hsa-mir-125a	hsa05214	Glioma	1019_5578_7157_5925_207_808_801_805	8	1.26E-10	8.29E-09	1.38E-09
2815	hsa-mir-125a	hsa05215	Prostate cancer	3320_1387_1017_2932_7157_5925_2033_207	8	1.16E-09	7.68E-08	1.04E-08
2816	hsa-mir-125a	hsa05212	Pancreatic cancer	3320_1387_1017_2932_7157_5925_2033_207	8	1.26E-09	8.34E-08	1.04E-08
2817	hsa-mir-125a	hsa05220	Chronic myeloid leukemia	1019_7157_4088_4089_3065_5925_207	7	1.12E-08	7.39E-07	8.21E-08
2818	hsa-mir-125a	hsa05223	Non-small cell lung cancer	6256_1019_5578_7157_5925_207	6	5.00E-08	3.30E-06	3.30E-07
2819	hsa-mir-125a	hsa04310	Wnt signaling pathway	1387_2932_5578_7157_3725_4088_4089_2033	8	6.57E-08	4.34E-06	3.94E-07
2820	hsa-mir-125a	hsa04916	Melanogenesis	1387_2932_5578_2033_808_801_805	7	9.24E-08	6.10E-06	5.08E-07
2821	hsa-mir-125a	hsa05210	Colorectal cancer	2932_7157_3725_4088_4089_207	6	5.74E-07	3.79E-05	2.91E-06
2822	hsa-mir-125a	hsa05222	Small cell lung cancer	6256_1019_1017_7157_5925_207	6	6.54E-07	4.32E-05	3.08E-06
2823	hsa-mir-125a	hsa04330	Notch signaling pathway	1387_9612_3065_2033_8850	5	8.40E-07	5.54E-05	3.70E-06
2824	hsa-mir-125a	hsa04912	GnRH signaling pathway	1432_5578_3725_808_801_805	6	2.31E-06	0.00015221	9.51E-06
2825	hsa-mir-125a	hsa05016	Huntington's disease	6667_1387_841_7157_3065_3064_2033	7	4.14E-06	0.000273137	1.61E-05
2826	hsa-mir-125a	hsa05219	Bladder cancer	1019_9252_7157_5925	4	1.68E-05	0.001109554	6.16E-05
2827	hsa-mir-125a	hsa04150	mTOR signaling pathway	6195_6196_6197_207	4	3.69E-05	0.002434569	0.000128135
2828	hsa-mir-125a	hsa04660	T cell receptor signaling pathway	1019_2932_1432_3725_207	5	4.20E-05	0.002775247	0.000138762
2829	hsa-mir-125a	hsa04270	Vascular smooth muscle contraction	5592_5578_808_801_805	5	5.80E-05	0.003826116	0.000182196
2830	hsa-mir-125a	hsa04115	p53 signaling pathway	1019_1017_841_7157	4	0.000104688	0.006909413	0.000314064
2831	hsa-mir-125a	hsa05218	Melanoma	1019_7157_5925_207	4	0.000116313	0.007676637	0.000323302
2832	hsa-mir-125a	hsa04910	Insulin signaling pathway	2932_207_808_801_805	5	0.00011822	0.007802494	0.000323302
2833	hsa-mir-125a	hsa05211	Renal cell carcinoma	1387_3725_2033_207	4	0.000122463	0.008082559	0.000323302
2834	hsa-mir-125a	hsa04070	Phosphatidylinositol signaling system	5578_808_801_805	4	0.00014944	0.009863018	0.000379347
2835	hsa-mir-125a	hsa04370	VEGF signaling pathway	9261_1432_5578_207	4	0.000156804	0.010349071	0.000383299
2836	hsa-mir-125a	hsa04520	Adherens junction	1387_4088_4089_2033	4	0.000180472	0.011911136	0.000425398
2837	hsa-mir-125a	hsa04012	ErbB signaling pathway	2932_5578_3725_207	4	0.000245581	0.016208347	0.000558909
2838	hsa-mir-125a	hsa05010	Alzheimer's disease	2932_841_808_801_805	5	0.000362028	0.023893828	0.000796461
2839	hsa-mir-125a	hsa04620	Toll-like receptor signaling pathway	1432_841_3725_207	4	0.000439428	0.029002264	0.000935557
2840	hsa-mir-125a	hsa05213	Endometrial cancer	2932_7157_207	3	0.000823423	0.054345901	0.001698309
2841	hsa-mir-125a	hsa05217	Basal cell carcinoma	2932_7157_2736	3	0.000961505	0.0634593	0.001923009
2842	hsa-mir-125a	hsa04920	Adipocytokine signaling pathway	6256_6774_207	3	0.001657332	0.10938393	0.003217174
2843	hsa-mir-125a	hsa04630	Jak-STAT signaling pathway	1387_6774_2033_207	4	0.00198344	0.130907057	0.003740202
2844	hsa-mir-125a	hsa04662	B cell receptor signaling pathway	2932_3725_207	3	0.002259573	0.149131849	0.004142551
2845	hsa-mir-125a	hsa04664	Fc epsilon RI signaling pathway	1432_5578_207	3	0.002605296	0.171949512	0.004647284
2846	hsa-mir-125a	hsa04950	Maturity onset diabetes of the young	3651_168620	2	0.003371436	0.222514758	0.005855652
2847	hsa-mir-125a	hsa04210	Apoptosis	841_7157_207	3	0.003607048	0.238065199	0.005981253
2848	hsa-mir-125a	hsa04020	Calcium signaling pathway	5578_808_801_805	4	0.003625002	0.239250121	0.005981253
2849	hsa-mir-125a	hsa05216	Thyroid cancer	6256_7157	2	0.004771955	0.314949028	0.007681684
2850	hsa-mir-125a	hsa04510	Focal adhesion	2932_5578_3725_207	4	0.005358216	0.353642224	0.008420053
2851	hsa-mir-125a	hsa04530	Tight junction	1019_5578_207	3	0.011467107	0.756829063	0.017600676
2852	hsa-mir-125a	hsa04120	Ubiquitin mediated proteolysis	997_672_7329	3	0.0119126	0.786231574	0.017868899
2853	hsa-mir-125a	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_7157	2	0.016006753	1	0.02347657
2854	hsa-mir-125a	hsa04340	Hedgehog signaling pathway	2932_2736	2	0.016532934	1	0.023721166
2855	hsa-mir-125a	hsa05221	Acute myeloid leukemia	6774_207	2	0.017607221	1	0.024725034
2856	hsa-mir-125a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_3725	2	0.024644741	1	0.033194958
2857	hsa-mir-125a	hsa04730	Long-term depression	5592_5578	2	0.024644741	1	0.033194958
2858	hsa-mir-125a	hsa04062	Chemokine signaling pathway	2932_6774_207	3	0.027737095	1	0.036612965
2859	hsa-mir-125a	hsa04540	Gap junction	5592_5578	2	0.039956421	1	0.05170831
2860	hsa-mir-125a	hsa04740	Olfactory transduction	5592_808_801_805	4	0.041283849	1	0.052398731
2861	hsa-mir-125a	hsa04710	Circadian rhythm - mammal	79365	1	0.045530072	1	0.056697826
2862	hsa-mir-125b-1	hsa05200	Pathways in cancer	3320_5925_3326_1147_3551_1499_5595_5594_1387_6256_1487_367_8517_2932_6774_5970_6688_2113_4087_1869_862_6502_2353_4088_7175_3065_1488_2033_4791_4792	30	1.45E-23	1.07E-21	1.07E-21
2863	hsa-mir-125b-1	hsa05215	Prostate cancer	3320_5925_3326_1147_3551_1499_5595_5594_1387_367_8517_2932_5970_1869_2033_4792	16	2.22E-17	1.64E-15	6.42E-16
2864	hsa-mir-125b-1	hsa05212	Pancreatic cancer	3320_5925_3326_1147_3551_1499_5595_5594_1387_367_8517_2932_5970_1869_2033_4792	16	2.60E-17	1.93E-15	6.42E-16
2865	hsa-mir-125b-1	hsa04010	MAPK signaling pathway	1147_3551_5595_5594_6722_9261_1326_4208_3305_3303_5566_8517_7867_3312_5971_5970_3310_2353_1432_4791	20	2.03E-14	1.50E-12	3.76E-13
2866	hsa-mir-125b-1	hsa05220	Chronic myeloid leukemia	5925_1147_3551_5595_5594_1487_8517_5970_1869_4088_3065_1488_4792	13	4.09E-14	3.03E-12	6.05E-13
2867	hsa-mir-125b-1	hsa04660	T cell receptor signaling pathway	1147_3551_5595_5594_1326_8517_2932_5970_4794_2353_1432_4792_4793	13	3.39E-12	2.51E-10	4.18E-11
2868	hsa-mir-125b-1	hsa04310	Wnt signaling pathway	23291_1499_1387_8607_1487_5566_2932_8454_6500_4087_8945_4088_1488_2033	14	1.09E-11	8.07E-10	1.15E-10
2869	hsa-mir-125b-1	hsa04662	B cell receptor signaling pathway	1147_3551_5595_5594_8517_2932_5970_4794_2353_4792_4793	11	1.97E-11	1.46E-09	1.82E-10
2870	hsa-mir-125b-1	hsa04350	TGF-beta signaling pathway	5595_5594_1387_8454_3397_3398_6500_4087_3399_4088_2033	11	8.40E-11	6.22E-09	6.91E-10
2871	hsa-mir-125b-1	hsa04110	Cell cycle	5925_5591_1387_2932_8454_6500_4087_1869_6502_4088_3065_2033	12	1.28E-10	9.46E-09	9.46E-10
2872	hsa-mir-125b-1	hsa04330	Notch signaling pathway	388585_1387_4851_1487_9612_3065_1488_2033_8850	9	1.67E-10	1.24E-08	1.13E-09
2873	hsa-mir-125b-1	hsa05221	Acute myeloid leukemia	1147_3551_5595_5594_8517_6774_5970_6688_862	9	1.01E-09	7.51E-08	6.25E-09
2874	hsa-mir-125b-1	hsa04920	Adipocytokine signaling pathway	1147_3551_6256_8517_6774_5970_4794_4792_4793	9	2.80E-09	2.07E-07	1.59E-08
2875	hsa-mir-125b-1	hsa04620	Toll-like receptor signaling pathway	1147_3551_5595_5594_1326_8517_5970_2353_1432_4792	10	5.93E-09	4.39E-07	3.13E-08
2876	hsa-mir-125b-1	hsa04916	Melanogenesis	1499_5595_5594_1387_5566_2932_2033_808_801_805	10	7.04E-09	5.21E-07	3.47E-08
2877	hsa-mir-125b-1	hsa05222	Small cell lung cancer	5925_1147_3551_6256_8517_5970_1869_6502_4792	9	2.06E-08	1.52E-06	9.32E-08
2878	hsa-mir-125b-1	hsa04062	Chemokine signaling pathway	1147_3551_5595_5594_5566_8517_2932_6774_5970_653361_4792_4793	12	2.14E-08	1.58E-06	9.32E-08
2879	hsa-mir-125b-1	hsa04120	Ubiquitin mediated proteolysis	7329_23291_672_8454_6500_3093_8945_6502_10273_7323	10	9.17E-08	6.79E-06	3.77E-07
2880	hsa-mir-125b-1	hsa04720	Long-term potentiation	5595_5594_1387_5566_2033_808_801_805	8	1.12E-07	8.28E-06	4.36E-07
2881	hsa-mir-125b-1	hsa03020	RNA polymerase	25885_64425_5437_51082_84172_5441	6	1.36E-07	1.01E-05	5.04E-07
2882	hsa-mir-125b-1	hsa04520	Adherens junction	1499_5595_5594_1387_4087_4088_2033_71	8	1.77E-07	1.31E-05	6.24E-07
2883	hsa-mir-125b-1	hsa05131	Shigellosis	347733_1499_7278_10382_84617_203068_71	7	2.65E-07	1.96E-05	8.52E-07
2884	hsa-mir-125b-1	hsa05130	Pathogenic Escherichia coli infection	347733_1499_7278_10382_84617_203068_71	7	2.65E-07	1.96E-05	8.52E-07
2885	hsa-mir-125b-1	hsa04540	Gap junction	347733_5595_5594_5566_7278_10382_84617_203068	8	5.16E-07	3.82E-05	1.59E-06
2886	hsa-mir-125b-1	hsa05214	Glioma	5925_5595_5594_1869_808_801_805	7	6.69E-07	4.95E-05	1.98E-06
2887	hsa-mir-125b-1	hsa05210	Colorectal cancer	1499_5595_5594_2932_4087_2353_4088	7	3.29E-06	0.0002435	9.37E-06
2888	hsa-mir-125b-1	hsa05216	Thyroid cancer	1499_5595_5594_6256_7175	5	3.49E-06	0.00025816	9.56E-06
2889	hsa-mir-125b-1	hsa04612	Antigen processing and presentation	3320_3326_3309_3305_3303_3312_3310	7	4.71E-06	0.000348318	1.20E-05
2890	hsa-mir-125b-1	hsa04210	Apoptosis	1147_3551_5566_8517_5970_8837_4792	7	4.71E-06	0.000348318	1.20E-05
2891	hsa-mir-125b-1	hsa04910	Insulin signaling pathway	3551_5595_5594_5566_2932_808_801_805	8	8.25E-06	0.00061074	2.04E-05
2892	hsa-mir-125b-1	hsa04912	GnRH signaling pathway	5595_5594_5566_1432_808_801_805	7	1.55E-05	0.00114676	3.62E-05
2893	hsa-mir-125b-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_8517_5970_1432_4792	6	1.56E-05	0.001158045	3.62E-05
2894	hsa-mir-125b-1	hsa04270	Vascular smooth muscle contraction	5595_5594_5566_4637_808_801_805	7	2.66E-05	0.001969591	5.97E-05
2895	hsa-mir-125b-1	hsa05223	Non-small cell lung cancer	5925_5595_5594_6256_1869	5	5.46E-05	0.004039508	0.000118809
2896	hsa-mir-125b-1	hsa05016	Huntington's disease	1387_292_293_5437_1213_3065_2033_5441	8	6.83E-05	0.005056508	0.000144472
2897	hsa-mir-125b-1	hsa05211	Renal cell carcinoma	5595_5594_1387_2113_2033	5	0.000194888	0.014421747	0.000400604
2898	hsa-mir-125b-1	hsa04370	VEGF signaling pathway	5595_5594_9261_7867_1432	5	0.000261762	0.0193704	0.000523524
2899	hsa-mir-125b-1	hsa05219	Bladder cancer	5925_5595_5594_1869	4	0.000284132	0.02102579	0.00055331
2900	hsa-mir-125b-1	hsa04930	Type II diabetes mellitus	3551_5595_5594_3651	4	0.000363016	0.026863175	0.000688799
2901	hsa-mir-125b-1	hsa05213	Endometrial cancer	1499_5595_5594_2932	4	0.000606101	0.044851509	0.001121288
2902	hsa-mir-125b-1	hsa04340	Hedgehog signaling pathway	23291_5566_2932_8945	4	0.000838403	0.062041836	0.001513216
2903	hsa-mir-125b-1	hsa04810	Regulation of actin cytoskeleton	5595_5594_4627_4628_10788_10627_71	7	0.001013975	0.075034139	0.001786527
2904	hsa-mir-125b-1	hsa05010	Alzheimer's disease	5595_5594_2932_808_801_805	6	0.001736325	0.128488064	0.002988095
2905	hsa-mir-125b-1	hsa05218	Melanoma	5925_5595_5594_1869	4	0.001811904	0.134080919	0.003047294
2906	hsa-mir-125b-1	hsa04670	Leukocyte transendothelial migration	1499_653361_10627_1432_71	5	0.001901067	0.140678975	0.003126199
2907	hsa-mir-125b-1	hsa04020	Calcium signaling pathway	292_5566_293_808_801_805	6	0.002097188	0.155191878	0.003373736
2908	hsa-mir-125b-1	hsa04530	Tight junction	1499_4627_4628_10627_71	5	0.003084737	0.228270512	0.004856819
2909	hsa-mir-125b-1	hsa04510	Focal adhesion	1499_5595_5594_2932_10627_71	6	0.003605476	0.266805236	0.005558442
2910	hsa-mir-125b-1	hsa04630	Jak-STAT signaling pathway	3559_1387_6778_6774_2033	5	0.00511597	0.378581777	0.007726159
2911	hsa-mir-125b-1	hsa03010	Ribosome	6156_6128_6207_6202	4	0.00627975	0.464701466	0.009294029
2912	hsa-mir-125b-1	hsa04950	Maturity onset diabetes of the young	168620_3651	2	0.013755984	1	0.019959663
2913	hsa-mir-125b-1	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.017348445	1	0.024688171
2914	hsa-mir-125b-1	hsa04664	Fc epsilon RI signaling pathway	5595_5594_1432	3	0.019140709	1	0.026724763
2915	hsa-mir-125b-1	hsa04012	ErbB signaling pathway	5595_5594_2932	3	0.024402888	1	0.033440995
2916	hsa-mir-125b-1	hsa03410	Base excision repair	3146_142	2	0.028197096	1	0.037937911
2917	hsa-mir-125b-2	hsa03022	Basal transcription factors	2967_2961_2960_2963_6881_54457_2968_6877_6874_6878_2957_6879_6908_6872_2958_6873_2959_6880_6882_138474_6884_6883	22	3.42E-30	2.49E-28	2.49E-28
2918	hsa-mir-125b-2	hsa05200	Pathways in cancer	2249_367_1499_5595_5594_5914_1387_6256_10401_1487_1488_2932_4193_6776_6777_5970_7157_6688_4609_3725_2353_3065_4087_4088_4089_5925_2033_207_208_3326_8554_7184	32	4.46E-22	3.25E-20	1.63E-20
2919	hsa-mir-125b-2	hsa05220	Chronic myeloid leukemia	5595_5594_1487_1488_4193_6776_6777_5970_7157_4609_3065_4088_4089_5925_207_208	16	1.96E-16	1.43E-14	4.78E-15
2920	hsa-mir-125b-2	hsa05215	Prostate cancer	367_1499_5595_5594_1387_2932_4193_5970_7157_468_5925_2033_207_208_3326_7184	16	1.80E-15	1.31E-13	3.08E-14
2921	hsa-mir-125b-2	hsa05212	Pancreatic cancer	367_1499_5595_5594_1387_2932_4193_5970_7157_468_5925_2033_207_208_3326_7184	16	2.11E-15	1.54E-13	3.08E-14
2922	hsa-mir-125b-2	hsa04110	Cell cycle	993_1387_4171_983_7534_7533_7532_2932_4193_4085_7157_3065_4087_4088_4089_5925_2033	17	8.34E-15	6.09E-13	1.01E-13
2923	hsa-mir-125b-2	hsa05210	Colorectal cancer	1499_5595_5594_2932_7157_4609_3725_2353_4087_4088_4089_207_208	13	5.10E-12	3.72E-10	5.32E-11
2924	hsa-mir-125b-2	hsa04310	Wnt signaling pathway	1460_1499_1387_8607_1487_1488_2932_7157_4609_3725_4087_4088_4089_2033	14	4.30E-10	3.14E-08	3.93E-09
2925	hsa-mir-125b-2	hsa05221	Acute myeloid leukemia	5595_5594_5914_6776_6777_5970_6688_4609_207_208	10	6.89E-10	5.03E-08	5.59E-09
2926	hsa-mir-125b-2	hsa04012	ErbB signaling pathway	6714_5595_5594_2932_6776_6777_4609_3725_5058_207_208	11	1.58E-09	1.16E-07	1.16E-08
2927	hsa-mir-125b-2	hsa04520	Adherens junction	1460_1499_6714_5595_5594_1387_4087_4088_4089_2033	10	9.80E-09	7.16E-07	6.51E-08
2928	hsa-mir-125b-2	hsa04010	MAPK signaling pathway	6722_3727_2249_5595_5594_1649_3312_5970_7157_468_4609_3725_2353_5058_207_208	16	1.13E-08	8.22E-07	6.85E-08
2929	hsa-mir-125b-2	hsa05213	Endometrial cancer	1499_5595_5594_2932_7157_4609_207_208	8	7.12E-08	5.20E-06	4.00E-07
2930	hsa-mir-125b-2	hsa05222	Small cell lung cancer	6256_10401_5970_7157_4609_5925_207_208_8554	9	2.19E-07	1.60E-05	1.14E-06
2931	hsa-mir-125b-2	hsa04350	TGF-beta signaling pathway	6667_5595_5594_1387_4609_4087_4088_4089_2033	9	2.40E-07	1.75E-05	1.17E-06
2932	hsa-mir-125b-2	hsa05016	Huntington's disease	6667_6874_25942_1387_6908_9001_5430_7157_3065_3064_10476_2033	12	3.34E-07	2.44E-05	1.52E-06
2933	hsa-mir-125b-2	hsa04330	Notch signaling pathway	1387_1487_1488_9612_3065_2033_8850	7	5.81E-07	4.24E-05	2.50E-06
2934	hsa-mir-125b-2	hsa05218	Melanoma	2249_5595_5594_4193_7157_5925_207_208	8	6.25E-07	4.56E-05	2.53E-06
2935	hsa-mir-125b-2	hsa05211	Renal cell carcinoma	5595_5594_1387_3725_5058_2033_207_208	8	6.89E-07	5.03E-05	2.53E-06
2936	hsa-mir-125b-2	hsa05216	Thyroid cancer	1499_5595_5594_6256_7157_4609	6	6.92E-07	5.05E-05	2.53E-06
2937	hsa-mir-125b-2	hsa04662	B cell receptor signaling pathway	5595_5594_2932_5970_3725_2353_207_208	8	9.16E-07	6.69E-05	3.19E-06
2938	hsa-mir-125b-2	hsa05223	Non-small cell lung cancer	5595_5594_6256_7157_5925_207_208	7	1.36E-06	9.90E-05	4.50E-06
2939	hsa-mir-125b-2	hsa04660	T cell receptor signaling pathway	5595_5594_2932_5970_3725_2353_5058_207_208	9	1.49E-06	0.000109123	4.74E-06
2940	hsa-mir-125b-2	hsa04630	Jak-STAT signaling pathway	1387_10401_6776_6777_4609_2033_3977_207_208_8554	10	2.95E-06	0.00021507	8.96E-06
2941	hsa-mir-125b-2	hsa05214	Glioma	5595_5594_4193_7157_5925_207_208	7	4.21E-06	0.000307121	1.23E-05
2942	hsa-mir-125b-2	hsa05219	Bladder cancer	5595_5594_4193_7157_4609_5925	6	4.74E-06	0.00034593	1.33E-05
2943	hsa-mir-125b-2	hsa04620	Toll-like receptor signaling pathway	5595_5594_5970_3725_2353_207_208	7	6.40E-05	0.004670189	0.00017297
2944	hsa-mir-125b-2	hsa04950	Maturity onset diabetes of the young	3651_6927_3172_5080	4	0.000114844	0.00838363	0.000299415
2945	hsa-mir-125b-2	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	0.000119815	0.008746512	0.000301604
2946	hsa-mir-125b-2	hsa04510	Focal adhesion	1499_6714_5595_5594_2932_3725_5058_207_208	9	0.000165803	0.012103594	0.000403453
2947	hsa-mir-125b-2	hsa04530	Tight junction	1460_1499_6714_4628_60412_207_208	7	0.00036051	0.026317233	0.000848943
2948	hsa-mir-125b-2	hsa04910	Insulin signaling pathway	5595_5594_2932_5211_207_208_2538	7	0.000375905	0.027441101	0.000857534
2949	hsa-mir-125b-2	hsa04920	Adipocytokine signaling pathway	6256_5970_207_208_2538	5	0.000507773	0.037067394	0.001109063
2950	hsa-mir-125b-2	hsa04916	Melanogenesis	1499_5595_5594_1387_2932_2033	6	0.000517339	0.037765725	0.001109063
2951	hsa-mir-125b-2	hsa04062	Chemokine signaling pathway	5595_5594_2932_6777_5970_5058_207_208	8	0.000531743	0.038817215	0.001109063
2952	hsa-mir-125b-2	hsa04720	Long-term potentiation	5595_5594_1387_468_2033	5	0.000822584	0.060048631	0.001668018
2953	hsa-mir-125b-2	hsa04370	VEGF signaling pathway	6714_5595_5594_207_208	5	0.000920009	0.067160675	0.001815153
2954	hsa-mir-125b-2	hsa03420	Nucleotide excision repair	2967_2968_4331_5887	4	0.000946548	0.069098018	0.001818369
2955	hsa-mir-125b-2	hsa04150	mTOR signaling pathway	5595_5594_207_208	4	0.001688186	0.123237547	0.003093072
2956	hsa-mir-125b-2	hsa04612	Antigen processing and presentation	4801_4800_1514_3312_3326	5	0.001694834	0.123722894	0.003093072
2957	hsa-mir-125b-2	hsa04540	Gap junction	6714_5595_5594_983_10382	5	0.002036302	0.148650031	0.003625611
2958	hsa-mir-125b-2	hsa04912	GnRH signaling pathway	6714_5595_5594_468_3725	5	0.003771824	0.275343176	0.00655579
2959	hsa-mir-125b-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_5970_3725_5058	4	0.00488524	0.356622545	0.008293548
2960	hsa-mir-125b-2	hsa04664	Fc epsilon RI signaling pathway	5595_5594_207_208	4	0.006981957	0.509682856	0.011583701
2961	hsa-mir-125b-2	hsa04930	Type II diabetes mellitus	3651_5595_5594	3	0.009486581	0.692520444	0.015389343
2962	hsa-mir-125b-2	hsa04210	Apoptosis	5970_7157_207_208	4	0.010342351	0.754991642	0.016412862
2963	hsa-mir-125b-2	hsa05217	Basal cell carcinoma	1499_2932_7157	3	0.015841104	1	0.024604268
2964	hsa-mir-125b-2	hsa05131	Shigellosis	1499_7534_10382	3	0.016580022	1	0.02470085
2965	hsa-mir-125b-2	hsa05130	Pathogenic Escherichia coli infection	1499_7534_10382	3	0.016580022	1	0.02470085
2966	hsa-mir-125b-2	hsa04115	p53 signaling pathway	983_4193_7157	3	0.027926018	1	0.040771987
2967	hsa-mir-125b-2	hsa04360	Axon guidance	5595_5594_2932_5058	4	0.035008199	1	0.050109775
2968	hsa-mir-125b-2	hsa04120	Ubiquitin mediated proteolysis	672_10401_4193_8554	4	0.041816075	1	0.058703337
2969	hsa-mir-125b-2	hsa03410	Base excision repair	3146_142	2	0.046648205	1	0.064251301
2970	hsa-mir-126	hsa03022	Basal transcription factors	2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_6873_2958_2959_6880_6882_138474_6884_6883	21	1.38E-33	9.22E-32	9.22E-32
2971	hsa-mir-126	hsa05200	Pathways in cancer	5925_9063_5595_5594_5599_6256_3326_5601_4193_1387_5970_2885_7157_6688_3725_4609_5604_2353_10401_2033_8554_7184	22	2.82E-17	1.89E-15	9.46E-16
2972	hsa-mir-126	hsa04010	MAPK signaling pathway	6722_5595_5594_5599_5606_5601_5600_3312_1432_5970_2885_7157_3725_4609_3727_5604_2353_9344_2005	19	2.03E-15	1.36E-13	4.53E-14
2973	hsa-mir-126	hsa05215	Prostate cancer	5925_5595_5594_3326_4193_1387_5970_2885_7157_5604_2033_7184	12	2.48E-13	1.66E-11	3.75E-12
2974	hsa-mir-126	hsa05212	Pancreatic cancer	5925_5595_5594_3326_4193_1387_5970_2885_7157_5604_2033_7184	12	2.80E-13	1.87E-11	3.75E-12
2975	hsa-mir-126	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5606_5601_5600_1432_5970_3725_5604_2353	11	2.58E-11	1.73E-09	2.89E-10
2976	hsa-mir-126	hsa05210	Colorectal cancer	5595_5594_5599_5601_2885_7157_3725_4609_5604_2353	10	8.72E-11	5.84E-09	8.34E-10
2977	hsa-mir-126	hsa05220	Chronic myeloid leukemia	5925_5595_5594_4193_5970_2885_7157_4609_5604	9	7.35E-10	4.92E-08	6.15E-09
2978	hsa-mir-126	hsa04912	GnRH signaling pathway	5595_5594_5599_5606_5601_5600_1432_2885_3725_5604	10	8.42E-10	5.64E-08	6.27E-09
2979	hsa-mir-126	hsa04660	T cell receptor signaling pathway	5595_5594_5601_5600_1432_5970_2885_3725_5604_2353	10	9.94E-10	6.66E-08	6.66E-09
2980	hsa-mir-126	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5606_5601_5600_1432_2885_5604	9	1.12E-09	7.50E-08	6.82E-09
2981	hsa-mir-126	hsa05219	Bladder cancer	5925_5595_5594_4193_7157_4609_5604	7	7.71E-09	5.16E-07	4.30E-08
2982	hsa-mir-126	hsa05216	Thyroid cancer	5595_5594_6256_7157_4609_5604	6	3.01E-08	2.02E-06	1.55E-07
2983	hsa-mir-126	hsa05223	Non-small cell lung cancer	5925_5595_5594_6256_2885_7157_5604	7	3.71E-08	2.49E-06	1.78E-07
2984	hsa-mir-126	hsa05222	Small cell lung cancer	5925_9063_6256_5970_7157_4609_10401_8554	8	4.17E-08	2.80E-06	1.79E-07
2985	hsa-mir-126	hsa04350	TGF-beta signaling pathway	5595_5594_1387_3397_3398_4609_3399_2033	8	4.54E-08	3.04E-06	1.79E-07
2986	hsa-mir-126	hsa04012	ErbB signaling pathway	5595_5594_5599_5601_2885_3725_4609_5604	8	4.54E-08	3.04E-06	1.79E-07
2987	hsa-mir-126	hsa05221	Acute myeloid leukemia	5595_5594_5970_2885_6688_4609_5604	7	6.48E-08	4.34E-06	2.41E-07
2988	hsa-mir-126	hsa05214	Glioma	5925_5595_5594_4193_2885_7157_5604	7	1.19E-07	7.99E-06	4.21E-07
2989	hsa-mir-126	hsa04310	Wnt signaling pathway	1460_5599_8607_5601_1387_7157_3725_4609_2033	9	2.24E-07	1.50E-05	7.26E-07
2990	hsa-mir-126	hsa05211	Renal cell carcinoma	5595_5594_1387_2885_3725_5604_2033	7	2.27E-07	1.52E-05	7.26E-07
2991	hsa-mir-126	hsa04662	B cell receptor signaling pathway	5595_5594_5970_2885_3725_5604_2353	7	2.94E-07	1.97E-05	8.96E-07
2992	hsa-mir-126	hsa05213	Endometrial cancer	5595_5594_2885_7157_4609_5604	6	6.78E-07	4.54E-05	1.97E-06
2993	hsa-mir-126	hsa05218	Melanoma	5925_5595_5594_4193_7157_5604	6	3.65E-06	0.000244748	9.79E-06
2994	hsa-mir-126	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_5600_1432_5970_3725	6	3.65E-06	0.000244748	9.79E-06
2995	hsa-mir-126	hsa04110	Cell cycle	5925_4193_1387_7157_4171_4085_2033	7	5.37E-06	0.000359963	1.38E-05
2996	hsa-mir-126	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	9.50E-06	0.000636605	2.36E-05
2997	hsa-mir-126	hsa04910	Insulin signaling pathway	5595_5594_5599_5601_2885_5604_5211	7	1.35E-05	0.000904279	3.23E-05
2998	hsa-mir-126	hsa04630	Jak-STAT signaling pathway	9063_1387_2885_4609_10401_2033_8554	7	2.76E-05	0.001850479	6.38E-05
2999	hsa-mir-126	hsa04720	Long-term potentiation	5595_5594_1387_5604_2033	5	7.09E-05	0.004749181	0.000158306
3000	hsa-mir-126	hsa04370	VEGF signaling pathway	5595_5594_5600_1432_5604	5	7.98E-05	0.00534428	0.000172396
3001	hsa-mir-126	hsa05016	Huntington's disease	6874_9001_1387_5430_7157_3064_2033	7	8.93E-05	0.005984445	0.000187014
3002	hsa-mir-126	hsa04520	Adherens junction	1460_5595_5594_1387_2033	5	9.47E-05	0.006342626	0.000192201
3003	hsa-mir-126	hsa04120	Ubiquitin mediated proteolysis	9063_672_4193_10401_7329_8554	6	0.00013293	0.008906333	0.000261951
3004	hsa-mir-126	hsa04930	Type II diabetes mellitus	5595_5594_5599_5601	4	0.000137432	0.009207959	0.000263085
3005	hsa-mir-126	hsa04510	Focal adhesion	5595_5594_5599_5601_2885_3725_5604	7	0.000154428	0.010346658	0.000287407
3006	hsa-mir-126	hsa04540	Gap junction	5595_5594_10382_2885_5604	5	0.000185379	0.012420379	0.000335686
3007	hsa-mir-126	hsa05014	Amyotrophic lateral sclerosis (ALS)	5606_5600_1432_7157	4	0.000302214	0.020248334	0.000522692
3008	hsa-mir-126	hsa04916	Melanogenesis	5595_5594_1387_5604_2033	5	0.000304254	0.020384988	0.000522692
3009	hsa-mir-126	hsa04920	Adipocytokine signaling pathway	5599_6256_5601_5970	4	0.0005754	0.038551817	0.000963795
3010	hsa-mir-126	hsa03420	Nucleotide excision repair	2967_2968_5887	3	0.002037616	0.136520278	0.003329763
3011	hsa-mir-126	hsa04330	Notch signaling pathway	1387_2033_8850	3	0.002434378	0.163103324	0.003883412
3012	hsa-mir-126	hsa04062	Chemokine signaling pathway	5595_5594_5970_2885_5604	5	0.004298795	0.28801927	0.006698123
3013	hsa-mir-126	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_2885_5604	4	0.007182412	0.481221632	0.010921477
3014	hsa-mir-126	hsa04730	Long-term depression	5595_5594_5604	3	0.00733532	0.49146645	0.010921477
3015	hsa-mir-126	hsa04612	Antigen processing and presentation	3326_4801_3312	3	0.013256597	0.888191967	0.019308521
3016	hsa-mir-126	hsa04270	Vascular smooth muscle contraction	5595_5594_5604	3	0.027199974	1	0.038774431
3017	hsa-mir-126	hsa04150	mTOR signaling pathway	5595_5594	2	0.033810535	1	0.047193872
3018	hsa-mir-126	hsa05322	Systemic lupus erythematosus	3014_3015_8340	3	0.044372336	1	0.060672378
3019	hsa-mir-1260	hsa04330	Notch signaling pathway	9612_2033_3065	3	9.47E-07	1.52E-05	1.52E-05
3020	hsa-mir-1260	hsa05200	Pathways in cancer	8554_2033_3065	3	0.000281397	0.00450235	0.002251175
3021	hsa-mir-1260	hsa04110	Cell cycle	2033_3065	2	0.001036227	0.016579635	0.005526545
3022	hsa-mir-1260	hsa04630	Jak-STAT signaling pathway	8554_2033	2	0.001733966	0.027743449	0.006935862
3023	hsa-mir-1260	hsa05016	Huntington's disease	2033_3065	2	0.002523767	0.040380264	0.008076053
3024	hsa-mir-1260	hsa05211	Renal cell carcinoma	2033	1	0.028806201	0.460899224	0.043574592
3025	hsa-mir-1260	hsa04720	Long-term potentiation	2033	1	0.02997358	0.479577273	0.043574592
3026	hsa-mir-1260	hsa05220	Chronic myeloid leukemia	3065	1	0.02997358	0.479577273	0.043574592
3027	hsa-mir-1260	hsa04520	Adherens junction	2033	1	0.031916352	0.510661626	0.043574592
3028	hsa-mir-1260	hsa05222	Small cell lung cancer	8554	1	0.03424297	0.547887517	0.043574592
3029	hsa-mir-1260	hsa04350	TGF-beta signaling pathway	2033	1	0.034630241	0.554083853	0.043574592
3030	hsa-mir-1260	hsa05215	Prostate cancer	2033	1	0.035017369	0.560277911	0.043574592
3031	hsa-mir-1260	hsa05212	Pancreatic cancer	2033	1	0.035404356	0.566469692	0.043574592
3032	hsa-mir-1260	hsa04916	Melanogenesis	2033	1	0.041192105	0.659073685	0.047076692
3033	hsa-mir-1260b	hsa03022	Basal transcription factors	2967_2961_2960_2963_2962_6881_2969_2968_6877_6874_6878_54457_6879_6908_2958_2957_6873_6872_6884_2959_6880_6882_6883_138474	24	1.02E-29	7.77E-28	4.07E-28
3034	hsa-mir-1260b	hsa05200	Pathways in cancer	3320_4149_5371_2249_1956_1499_5595_5594_5914_1387_6256_862_1487_1488_2308_367_2932_4193_5599_10401_841_6776_6777_5970_7157_6688_5894_4609_3725_5604_861_1029_2353_4087_4088_4089_4292_1050_5925_2033_6502_3326_8554_4790_7184	45	1.07E-29	8.13E-28	4.07E-28
3035	hsa-mir-1260b	hsa05215	Prostate cancer	3320_1956_1499_5595_5594_1387_2308_367_2932_4193_1385_5970_7157_468_5894_5604_5925_2033_3326_4790_7184	21	7.74E-19	5.88E-17	1.48E-17
3036	hsa-mir-1260b	hsa05212	Pancreatic cancer	3320_1956_1499_5595_5594_1387_2308_367_2932_4193_1385_5970_7157_468_5894_5604_5925_2033_3326_4790_7184	21	9.45E-19	7.18E-17	1.48E-17
3037	hsa-mir-1260b	hsa04010	MAPK signaling pathway	9479_6722_3727_4149_2249_1956_5595_5594_5598_1386_9261_4208_1649_5566_9252_7867_5599_3312_5970_7157_468_5894_4609_3725_5604_6195_6196_2353_1432_4790_2002	31	9.71E-19	7.38E-17	1.48E-17
3038	hsa-mir-1260b	hsa04310	Wnt signaling pathway	815_1499_1387_1487_1488_1459_5566_1457_2932_8454_5599_6423_6500_7157_8061_4609_3725_4087_4088_4089_2033_1460_8607	23	1.20E-16	9.10E-15	1.52E-15
3039	hsa-mir-1260b	hsa05220	Chronic myeloid leukemia	5595_5594_1487_1488_4193_6776_6777_5970_7157_5894_4609_5604_861_1029_4088_4089_5925_4790	18	2.27E-16	1.73E-14	2.47E-15
3040	hsa-mir-1260b	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_862_6776_6777_5970_6688_5894_4609_5604_861_1050_4790	15	3.55E-14	2.70E-12	3.37E-13
3041	hsa-mir-1260b	hsa05210	Colorectal cancer	1956_1499_5595_5594_2932_5599_7157_5894_4609_3725_5604_2353_4087_4088_4089_4292	16	2.44E-13	1.85E-11	1.98E-12
3042	hsa-mir-1260b	hsa04110	Cell cycle	990_1387_4171_2932_4193_8454_6500_7157_983_1029_4085_4087_4088_4089_5925_2033_6502_5933	18	2.61E-13	1.98E-11	1.98E-12
3043	hsa-mir-1260b	hsa04350	TGF-beta signaling pathway	5595_5594_1387_8454_3399_3398_6500_4609_3397_4087_4088_4089_2033_6667_5933	15	4.88E-12	3.71E-10	3.37E-11
3044	hsa-mir-1260b	hsa04912	GnRH signaling pathway	815_1956_5595_5594_5598_5566_5599_468_5894_3725_5604_1432_2002_808_801_805	16	7.42E-12	5.64E-10	4.70E-11
3045	hsa-mir-1260b	hsa04720	Long-term potentiation	815_5595_5594_1387_5566_468_5894_5604_6195_6196_2033_808_801_805	14	9.83E-12	7.47E-10	5.75E-11
3046	hsa-mir-1260b	hsa05214	Glioma	815_1956_5595_5594_4193_7157_5894_5604_1029_5925_808_801_805	13	2.55E-11	1.94E-09	1.38E-10
3047	hsa-mir-1260b	hsa05219	Bladder cancer	1956_5595_5594_9252_4193_7157_5894_4609_5604_1029_5925	11	7.27E-11	5.52E-09	3.68E-10
3048	hsa-mir-1260b	hsa04540	Gap junction	1956_5595_5594_5598_5566_7277_10382_983_5894_7846_5604_7278_51807_10376	14	1.27E-10	9.64E-09	6.02E-10
3049	hsa-mir-1260b	hsa04916	Melanogenesis	815_1499_5595_5594_1387_5566_2932_1385_5894_5604_2033_808_801_805	14	4.78E-10	3.63E-08	2.14E-09
3050	hsa-mir-1260b	hsa05213	Endometrial cancer	1956_1499_5595_5594_2932_7157_5894_4609_5604_4292_2002	11	5.23E-10	3.97E-08	2.21E-09
3051	hsa-mir-1260b	hsa04012	ErbB signaling pathway	815_1956_5595_5594_2932_5599_6776_6777_5894_4609_3725_5604_2002	13	6.35E-10	4.82E-08	2.54E-09
3052	hsa-mir-1260b	hsa04520	Adherens junction	1956_1499_5595_5594_1387_1459_1457_4087_4088_4089_2033_1460	12	2.80E-09	2.13E-07	1.06E-08
3053	hsa-mir-1260b	hsa04910	Insulin signaling pathway	5595_5594_23265_2308_5566_2932_5599_5894_5604_5211_2002_808_801_805	14	1.34E-08	1.02E-06	4.84E-08
3054	hsa-mir-1260b	hsa05218	Melanoma	2249_1956_5595_5594_4193_7157_5894_5604_1029_5925	10	1.01E-07	7.71E-06	3.50E-07
3055	hsa-mir-1260b	hsa05223	Non-small cell lung cancer	1956_5595_5594_6256_7157_5894_5604_1029_5925	9	1.23E-07	9.35E-06	4.06E-07
3056	hsa-mir-1260b	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_841_5970_3725_5604_2353_1432_6348_4790	11	2.76E-07	2.10E-05	8.75E-07
3057	hsa-mir-1260b	hsa05216	Thyroid cancer	1499_5595_5594_6256_7157_4609_5604	7	3.58E-07	2.72E-05	1.09E-06
3058	hsa-mir-1260b	hsa05222	Small cell lung cancer	4149_6256_10401_5970_7157_4609_5925_6502_8554_4790	10	5.12E-07	3.89E-05	1.50E-06
3059	hsa-mir-1260b	hsa04330	Notch signaling pathway	388585_1387_1487_1488_9612_2033_2648_8850	8	5.41E-07	4.11E-05	1.52E-06
3060	hsa-mir-1260b	hsa04662	B cell receptor signaling pathway	5595_5594_2932_5970_5894_3725_5604_2353_4790	9	1.51E-06	0.000114386	4.09E-06
3061	hsa-mir-1260b	hsa05131	Shigellosis	1499_7277_10382_7846_7278_51807_4691_10376	8	1.78E-06	0.000135094	4.50E-06
3062	hsa-mir-1260b	hsa05130	Pathogenic Escherichia coli infection	1499_7277_10382_7846_7278_51807_4691_10376	8	1.78E-06	0.000135094	4.50E-06
3063	hsa-mir-1260b	hsa04660	T cell receptor signaling pathway	5595_5594_2932_5970_5894_3725_5604_2353_1432_4790	10	4.00E-06	0.000304084	9.81E-06
3064	hsa-mir-1260b	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_4193_8454_10401_6500_7329_6502_8554	10	2.70E-05	0.002050454	6.41E-05
3065	hsa-mir-1260b	hsa05016	Huntington's disease	6874_1387_6908_9001_1385_841_5430_7157_3064_2033_6667	11	6.45E-05	0.004902308	0.000148555
3066	hsa-mir-1260b	hsa05211	Renal cell carcinoma	5595_5594_1387_5894_3725_5604_2033	7	7.70E-05	0.005852725	0.000172139
3067	hsa-mir-1260b	hsa04062	Chemokine signaling pathway	5595_5594_5566_7074_2932_6777_5970_5894_5604_6348_4790	11	8.06E-05	0.006123704	0.000174963
3068	hsa-mir-1260b	hsa04370	VEGF signaling pathway	5595_5594_9261_7867_5894_5604_1432	7	0.000113834	0.008651397	0.000240317
3069	hsa-mir-1260b	hsa04270	Vascular smooth muscle contraction	5595_5594_5566_5894_5604_808_801_805	8	0.000250946	0.019071858	0.000515456
3070	hsa-mir-1260b	hsa04612	Antigen processing and presentation	3320_4800_4802_1385_3312_4801_3326	7	0.000262264	0.019932034	0.000524527
3071	hsa-mir-1260b	hsa04630	Jak-STAT signaling pathway	1387_10401_6778_6776_6777_4609_2033_3977_8554	9	0.000311527	0.023676024	0.000607078
3072	hsa-mir-1260b	hsa04115	p53 signaling pathway	7161_4193_841_7157_983_1029	6	0.000438732	0.033343612	0.00083288
3073	hsa-mir-1260b	hsa04950	Maturity onset diabetes of the young	3651_168620_6927_5080	4	0.000449317	0.034148095	0.00083288
3074	hsa-mir-1260b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_5599_5970_3725_1432_4790	6	0.000505489	0.038417179	0.000914695
3075	hsa-mir-1260b	hsa04510	Focal adhesion	1956_1499_5595_5594_2932_5599_5894_3725_5604_2002	10	0.000567133	0.043102073	0.001002374
3076	hsa-mir-1260b	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	0.000621334	0.047221353	0.001073213
3077	hsa-mir-1260b	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5894_5604_1432	6	0.00085493	0.064974675	0.001443882
3078	hsa-mir-1260b	hsa03420	Nucleotide excision repair	2967_2968_4331_5887	4	0.003482132	0.264642016	0.005753087
3079	hsa-mir-1260b	hsa04930	Type II diabetes mellitus	5595_5594_3651_5599	4	0.003753365	0.285255703	0.00606927
3080	hsa-mir-1260b	hsa04150	mTOR signaling pathway	5595_5594_6195_6196	4	0.006061071	0.460641371	0.009596695
3081	hsa-mir-1260b	hsa04210	Apoptosis	5566_841_5970_7157_4790	5	0.007718835	0.586631485	0.011972071
3082	hsa-mir-1260b	hsa05010	Alzheimer's disease	5595_5594_2932_841_808_801_805	7	0.010579008	0.804004629	0.016080093
3083	hsa-mir-1260b	hsa04920	Adipocytokine signaling pathway	6256_5599_5970_4790	4	0.013784497	1	0.020541603
3084	hsa-mir-1260b	hsa04730	Long-term depression	5595_5594_5894_5604	4	0.016565272	1	0.024210782
3085	hsa-mir-1260b	hsa04810	Regulation of actin cytoskeleton	2249_1956_5595_5594_7074_5894_5604	7	0.028959828	1	0.0415273
3086	hsa-mir-1260b	hsa04020	Calcium signaling pathway	815_1956_5566_808_801_805	6	0.038416344	1	0.054067447
3087	hsa-mir-1260b	hsa05217	Basal cell carcinoma	1499_2932_7157	3	0.03975342	1	0.054931999
3088	hsa-mir-1260b	hsa05014	Amyotrophic lateral sclerosis (ALS)	834_7157_1432	3	0.041492733	1	0.056311567
3089	hsa-mir-1262	hsa05200	Pathways in cancer	7046_1499_595_596_598_1019_2261_4193_5578_3091_2064_3066_3065_5925_7189_5743_5747_25_1956_6789_613_4436_2113_10401_3716_1147_998_1026_367_4233_1017_5595_5594_5599_861_1387_2932_6776_6777_6772_5979_5879_6688_1869_3725_4087_4088_5888_5728_2033_675_3910_4790_4792_5970_3320_3326_5371_3480_5159_5156_5601_5602_1856_51588_4609_1441_8554	68	7.67E-50	6.45E-48	6.45E-48
3090	hsa-mir-1262	hsa04110	Cell cycle	595_1019_4193_902_3066_3065_5925_25_9232_5933_545_995_1026_5591_1017_1387_11200_7534_7532_2932_7027_1869_4087_4088_2033_890_1031_983_5347_1022_1111_8556_8555_472	34	2.28E-29	1.92E-27	9.59E-28
3091	hsa-mir-1262	hsa05215	Prostate cancer	1499_595_596_4193_2064_5925_1956_1147_1026_367_1017_5595_5594_1387_2932_1869_5728_2033_4790_4792_5970_3320_3326_3480_5159_5156_468	27	2.97E-24	2.50E-22	8.01E-23
3092	hsa-mir-1262	hsa05212	Pancreatic cancer	1499_595_596_4193_2064_5925_1956_1147_1026_367_1017_5595_5594_1387_2932_1869_5728_2033_4790_4792_5970_3320_3326_3480_5159_5156_468	27	3.82E-24	3.21E-22	8.01E-23
3093	hsa-mir-1262	hsa05220	Chronic myeloid leukemia	7046_595_598_1019_4193_3066_3065_5925_25_613_1147_1026_5595_5594_861_6776_6777_1869_4088_4790_4792_5970_5781_4609	24	4.66E-22	3.91E-20	7.83E-21
3094	hsa-mir-1262	hsa04010	MAPK signaling pathway	3925_7046_2261_2264_9252_5578_5923_7189_1956_3304_3305_3303_6789_1616_1147_998_5595_5594_5599_1386_3315_1649_5879_3164_3725_3727_4790_51701_5970_5159_5156_5601_5602_6885_4609_468	36	6.21E-21	5.22E-19	8.70E-20
3095	hsa-mir-1262	hsa04630	Jak-STAT signaling pathway	3559_595_598_3454_3455_3560_1439_2690_10401_3717_3716_3718_85480_1387_3575_3570_3572_6776_6777_6772_2033_149233_3953_51588_5781_4609_1441_8554	28	9.61E-20	8.07E-18	1.15E-18
3096	hsa-mir-1262	hsa05210	Colorectal cancer	7046_1499_595_596_1956_4436_4233_5595_5594_5599_2932_5879_3725_4087_4088_3480_5159_5156_5601_5602_1856_4609	22	9.45E-19	7.94E-17	9.92E-18
3097	hsa-mir-1262	hsa04115	p53 signaling pathway	595_1019_4194_4193_900_50484_6241_27113_51246_545_1026_1017_11200_64326_5728_25898_983_7161_1111_472	20	6.81E-18	5.72E-16	6.35E-17
3098	hsa-mir-1262	hsa04520	Adherens junction	7046_1499_1460_2064_1956_6714_2241_998_4233_5595_5594_1387_5879_1457_4087_4088_2033_51701_3480_6885	20	7.86E-17	6.60E-15	6.60E-16
3099	hsa-mir-1262	hsa05222	Small cell lung cancer	595_596_598_1019_5925_7189_5743_5747_10401_1147_1017_1869_5728_3910_4790_4792_5970_51588_4609_8554	20	2.62E-16	2.20E-14	2.00E-15
3100	hsa-mir-1262	hsa04620	Toll-like receptor signaling pathway	3454_3455_4615_7189_3661_1147_3654_5595_5594_5599_6772_5879_3725_4790_4792_5970_5601_5602_353376_148022_6885	21	3.95E-16	3.32E-14	2.76E-15
3101	hsa-mir-1262	hsa04510	Focal adhesion	1499_595_596_5578_2064_5923_5747_1956_6714_5499_998_4233_5595_5594_5599_2932_5879_3725_5728_3910_2321_3480_5159_5156_5601_5602	26	4.75E-15	3.99E-13	3.07E-14
3102	hsa-mir-1262	hsa04310	Wnt signaling pathway	1499_595_5578_1460_5599_1387_2932_5879_3725_1457_1452_4087_4088_2033_51701_5518_5515_5601_5602_1856_6885_4609_5527	23	5.72E-15	4.80E-13	3.43E-14
3103	hsa-mir-1262	hsa04350	TGF-beta signaling pathway	7046_3398_6667_3399_1874_658_5933_5595_5594_1387_7027_4086_4087_4088_2033_5518_5515_4609	18	4.76E-14	4.00E-12	2.67E-13
3104	hsa-mir-1262	hsa04012	ErbB signaling pathway	5578_2064_5747_25_1956_6714_1026_5595_5594_5599_2932_6776_6777_3725_5601_5602_4609	17	5.45E-13	4.58E-11	2.86E-12
3105	hsa-mir-1262	hsa04060	Cytokine-cytokine receptor interaction	3556_3559_7046_1234_1230_3454_3455_1956_3560_1439_7852_6362_658_2690_85480_4233_3575_3570_3572_2321_149233_5159_5156_3953_959_1441	26	7.89E-13	6.63E-11	3.90E-12
3106	hsa-mir-1262	hsa05219	Bladder cancer	595_1019_2261_9252_4193_2064_5925_1956_1026_5595_5594_1869_4609	13	2.12E-12	1.78E-10	9.91E-12
3107	hsa-mir-1262	hsa04062	Chemokine signaling pathway	1234_1230_5747_5580_5590_7852_6362_3055_3717_1147_3718_998_5595_5594_2932_6777_6772_5879_4790_4792_5970_2185	22	3.89E-12	3.27E-10	1.72E-11
3108	hsa-mir-1262	hsa05214	Glioma	595_1019_4193_5578_5925_1956_1026_5595_5594_1869_5728_3480_5159_5156	14	1.98E-11	1.67E-09	8.33E-11
3109	hsa-mir-1262	hsa05218	Melanoma	595_1019_4193_5925_1956_1026_4233_5595_5594_1869_5728_3480_5159_5156	14	5.57E-11	4.68E-09	2.13E-10
3110	hsa-mir-1262	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_1147_998_4233_5599_5879_3725_4790_4792_5970_5601_5602_5781	14	5.57E-11	4.68E-09	2.13E-10
3111	hsa-mir-1262	hsa05221	Acute myeloid leukemia	595_1147_5595_5594_861_6776_6777_6688_4790_5970_5371_4609	12	9.75E-10	8.19E-08	3.56E-09
3112	hsa-mir-1262	hsa04120	Ubiquitin mediated proteolysis	4193_3093_7189_7319_84447_10401_7329_10055_64326_7337_5371_672_25898_51588_10075_8554	16	3.00E-09	2.52E-07	1.05E-08
3113	hsa-mir-1262	hsa04920	Adipocytokine signaling pathway	5563_6794_3717_1147_5599_4790_4792_5970_5601_5602_3953_5781	12	3.48E-09	2.93E-07	1.17E-08
3114	hsa-mir-1262	hsa04660	T cell receptor signaling pathway	1019_3932_1147_998_5595_5594_2932_3725_4790_4792_5970_5601_6885_959	14	9.18E-09	7.71E-07	2.97E-08
3115	hsa-mir-1262	hsa05223	Non-small cell lung cancer	595_1019_5578_2064_5925_1956_6789_5595_5594_1869	10	5.39E-08	4.53E-06	1.68E-07
3116	hsa-mir-1262	hsa04912	GnRH signaling pathway	5578_5580_1956_6714_998_5595_5594_5599_3725_5601_5602_2185_468	13	5.66E-08	4.75E-06	1.70E-07
3117	hsa-mir-1262	hsa04210	Apoptosis	3556_596_598_4615_823_1439_1147_3654_4790_4792_5970_472	12	5.96E-08	5.00E-06	1.73E-07
3118	hsa-mir-1262	hsa05211	Renal cell carcinoma	3091_2113_998_4233_5595_5594_1387_5879_3725_2033_5781	11	6.77E-08	5.69E-06	1.90E-07
3119	hsa-mir-1262	hsa04662	B cell receptor signaling pathway	6850_1147_5595_5594_1380_2932_5879_3725_4790_4792_5970	11	9.84E-08	8.27E-06	2.67E-07
3120	hsa-mir-1262	hsa03420	Nucleotide excision repair	5981_902_6117_2965_4331_2071_2074_6118_1022	9	1.19E-07	1.00E-05	3.13E-07
3121	hsa-mir-1262	hsa04330	Notch signaling pathway	3066_3065_3280_1387_2033_8850_1856_388585_2648	9	1.96E-07	1.64E-05	4.98E-07
3122	hsa-mir-1262	hsa05213	Endometrial cancer	1499_595_2064_1956_5595_5594_2932_5728_4609	9	4.18E-07	3.51E-05	1.03E-06
3123	hsa-mir-1262	hsa04530	Tight junction	1499_1019_5578_1460_5580_5590_6714_998_1457_5728_5518_5515_5520	13	7.02E-07	5.90E-05	1.68E-06
3124	hsa-mir-1262	hsa03022	Basal transcription factors	6880_51616_2965_2969_6908_2958_2957	7	4.91E-06	0.000412484	1.15E-05
3125	hsa-mir-1262	hsa04370	VEGF signaling pathway	5578_5743_5747_6714_998_5595_5594_3315_5879	9	7.87E-06	0.000661328	1.79E-05
3126	hsa-mir-1262	hsa04664	Fc epsilon RI signaling pathway	5578_5580_6850_5595_5594_5599_5879_5601_5602	9	9.52E-06	0.000799463	2.10E-05
3127	hsa-mir-1262	hsa04360	Axon guidance	5747_25_7852_2242_998_4233_5595_5594_2932_5879_1020	11	1.47E-05	0.001235873	3.16E-05
3128	hsa-mir-1262	hsa05216	Thyroid cancer	1499_595_5595_5594_5979_4609	6	1.52E-05	0.001275943	3.16E-05
3129	hsa-mir-1262	hsa04930	Type II diabetes mellitus	5580_5590_5595_5594_5599_5601_5602	7	1.54E-05	0.001293736	3.16E-05
3130	hsa-mir-1262	hsa04540	Gap junction	5578_1956_6714_5595_5594_1453_5159_983_5156	9	3.15E-05	0.002646143	6.30E-05
3131	hsa-mir-1262	hsa04650	Natural killer cell mediated cytotoxicity	5578_3454_3455_3932_6850_5595_5594_5879_5781_2185	10	0.000113648	0.009546461	0.000222011
3132	hsa-mir-1262	hsa04612	Antigen processing and presentation	3309_3304_3305_3303_3320_3326_4800_2923	8	0.000139263	0.0116981	0.000265866
3133	hsa-mir-1262	hsa03440	Homologous recombination	641_6117_5888_675_6118	5	0.000147679	0.012405033	0.000275667
3134	hsa-mir-1262	hsa04720	Long-term potentiation	5578_5499_5595_5594_1387_2033_468	7	0.000293334	0.024640083	0.000535654
3135	hsa-mir-1262	hsa04916	Melanogenesis	1499_5578_5595_5594_1387_2932_2033_1856	8	0.000374353	0.031445639	0.000669056
3136	hsa-mir-1262	hsa05131	Shigellosis	1499_5578_25_998_7534_4691	6	0.000403849	0.033923315	0.000692313
3137	hsa-mir-1262	hsa05130	Pathogenic Escherichia coli infection	1499_5578_25_998_7534_4691	6	0.000403849	0.033923315	0.000692313
3138	hsa-mir-1262	hsa03030	DNA replication	5981_6117_5557_6118_5422	5	0.00042104	0.035367371	0.000707347
3139	hsa-mir-1262	hsa04910	Insulin signaling pathway	5563_5590_5499_5595_5594_5599_2932_5601_5602	9	0.000512635	0.043061309	0.000844339
3140	hsa-mir-1262	hsa03430	Mismatch repair	5981_4436_6117_6118	4	0.000763678	0.064148935	0.001233633
3141	hsa-mir-1262	hsa04670	Leukocyte transendothelial migration	1499_5578_5747_7852_998_5879_5781_2185	8	0.001004128	0.084346728	0.001591448
3142	hsa-mir-1262	hsa04810	Regulation of actin cytoskeleton	2261_2264_5747_1956_5499_998_5595_5594_5879_5159_5156	11	0.001025012	0.086101031	0.001594464
3143	hsa-mir-1262	hsa04730	Long-term depression	5578_5595_5594_3480_5518_5515	6	0.001281152	0.10761673	0.001956668
3144	hsa-mir-1262	hsa04150	mTOR signaling pathway	5563_6794_3091_5595_5594	5	0.001919781	0.161261631	0.002879672
3145	hsa-mir-1262	hsa05340	Primary immunodeficiency	3932_3718_3575_959	4	0.00309042	0.259595317	0.004554304
3146	hsa-mir-1262	hsa03410	Base excision repair	3146_142_4913_328	4	0.003392196	0.284944504	0.004912836
3147	hsa-mir-1262	hsa05016	Huntington's disease	3066_3065_3064_25942_6667_27113_1387_2033_6908	9	0.003877965	0.325749083	0.005521171
3148	hsa-mir-1262	hsa04950	Maturity onset diabetes of the young	6927_3280_3172	3	0.008289069	0.696281774	0.011604696
3149	hsa-mir-1262	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_598_1616_5879	4	0.0142046	1	0.019560432
3150	hsa-mir-1262	hsa04640	Hematopoietic cell lineage	3559_1380_3575_3570_1441	5	0.014522579	1	0.019675752
3151	hsa-mir-1262	hsa04710	Circadian rhythm - mammal	1453_8553	2	0.022173578	1	0.02956477
3152	hsa-mir-1262	hsa03450	Non-homologous end-joining	2547_5591	2	0.025083958	1	0.032922695
3153	hsa-mir-1262	hsa04270	Vascular smooth muscle contraction	5578_5580_5499_5595_5594	5	0.043468931	1	0.056175234
3154	hsa-mir-1266	hsa05210	Colorectal cancer	4087_4088_4609	3	1.95E-06	3.32E-05	1.84E-05
3155	hsa-mir-1266	hsa04350	TGF-beta signaling pathway	4087_4088_4609	3	2.16E-06	3.68E-05	1.84E-05
3156	hsa-mir-1266	hsa04310	Wnt signaling pathway	4087_4088_4609	3	1.11E-05	0.000188646	6.29E-05
3157	hsa-mir-1266	hsa05200	Pathways in cancer	4087_4088_4609	3	0.000110184	0.00187313	0.000468282
3158	hsa-mir-1266	hsa05220	Chronic myeloid leukemia	4088_4609	2	0.000231234	0.003930974	0.000743029
3159	hsa-mir-1266	hsa04520	Adherens junction	4087_4088	2	0.000262245	0.004458172	0.000743029
3160	hsa-mir-1266	hsa04612	Antigen processing and presentation	4800_4801	2	0.000322912	0.005489511	0.000784216
3161	hsa-mir-1266	hsa04110	Cell cycle	4087_4088	2	0.000569823	0.00968699	0.001210874
3162	hsa-mir-1266	hsa05216	Thyroid cancer	4609	1	0.008962596	0.152364134	0.016929348
3163	hsa-mir-1266	hsa05219	Bladder cancer	4609	1	0.012824162	0.218010751	0.021801075
3164	hsa-mir-1266	hsa05213	Endometrial cancer	4609	1	0.01578549	0.268353325	0.024395757
3165	hsa-mir-1266	hsa05221	Acute myeloid leukemia	4609	1	0.017853718	0.303513211	0.025292768
3166	hsa-mir-1266	hsa05222	Small cell lung cancer	4609	1	0.025795031	0.43851552	0.031678351
3167	hsa-mir-1266	hsa04012	ErbB signaling pathway	4609	1	0.026088054	0.443496917	0.031678351
3168	hsa-mir-1266	hsa04630	Jak-STAT signaling pathway	4609	1	0.0458308	0.779123593	0.051941573
3169	hsa-mir-1267	hsa04010	MAPK signaling pathway	9261_6722_8986_5970_6195_207_9252_4790_1432_6196_6197	11	6.78E-12	3.87E-10	3.87E-10
3170	hsa-mir-1267	hsa05215	Prostate cancer	5970_4792_2033_207_2932_4790_1387	7	6.63E-10	3.78E-08	1.36E-08
3171	hsa-mir-1267	hsa05212	Pancreatic cancer	5970_4792_2033_207_2932_4790_1387	7	7.14E-10	4.07E-08	1.36E-08
3172	hsa-mir-1267	hsa05200	Pathways in cancer	2736_3716_5970_4792_2033_2113_207_2932_4790_1387	10	1.03E-09	5.85E-08	1.46E-08
3173	hsa-mir-1267	hsa04660	T cell receptor signaling pathway	5970_4792_207_2932_4790_5777_1432	7	2.88E-09	1.64E-07	3.28E-08
3174	hsa-mir-1267	hsa04662	B cell receptor signaling pathway	5970_4792_207_2932_4790_5777	6	1.15E-08	6.54E-07	1.09E-07
3175	hsa-mir-1267	hsa04630	Jak-STAT signaling pathway	3716_2033_207_3566_5777_6773_1387	7	2.77E-08	1.58E-06	2.25E-07
3176	hsa-mir-1267	hsa04062	Chemokine signaling pathway	5590_5970_4792_207_2932_4790_6773	7	1.17E-07	6.68E-06	8.35E-07
3177	hsa-mir-1267	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5970_4792_6714_4790_1432	5	3.73E-07	2.13E-05	2.36E-06
3178	hsa-mir-1267	hsa04720	Long-term potentiation	6195_2033_6196_6197_1387	5	4.83E-07	2.75E-05	2.75E-06
3179	hsa-mir-1267	hsa04620	Toll-like receptor signaling pathway	5970_4792_207_4790_1432	5	2.05E-06	0.000116932	1.06E-05
3180	hsa-mir-1267	hsa04150	mTOR signaling pathway	6195_207_6196_6197	4	4.25E-06	0.000242396	2.02E-05
3181	hsa-mir-1267	hsa04920	Adipocytokine signaling pathway	5970_4792_207_4790	4	1.10E-05	0.000627578	4.83E-05
3182	hsa-mir-1267	hsa05211	Renal cell carcinoma	2033_2113_207_1387	4	1.44E-05	0.000822747	5.88E-05
3183	hsa-mir-1267	hsa05220	Chronic myeloid leukemia	5970_4792_207_4790	4	1.68E-05	0.000959386	6.40E-05
3184	hsa-mir-1267	hsa04370	VEGF signaling pathway	9261_207_6714_1432	4	1.86E-05	0.001059297	6.62E-05
3185	hsa-mir-1267	hsa04520	Adherens junction	2033_6714_5777_1387	4	2.15E-05	0.00122323	7.20E-05
3186	hsa-mir-1267	hsa05222	Small cell lung cancer	5970_4792_207_4790	4	2.82E-05	0.00160601	8.92E-05
3187	hsa-mir-1267	hsa04210	Apoptosis	5970_4792_207_4790	4	3.21E-05	0.001827258	9.62E-05
3188	hsa-mir-1267	hsa05221	Acute myeloid leukemia	5970_207_4790	3	0.000237821	0.013555817	0.000677791
3189	hsa-mir-1267	hsa04012	ErbB signaling pathway	207_2932_6714	3	0.000711005	0.040527274	0.00192987
3190	hsa-mir-1267	hsa04916	Melanogenesis	2033_2932_1387	3	0.00117371	0.066901456	0.003040975
3191	hsa-mir-1267	hsa04110	Cell cycle	2033_2932_1387	3	0.001710519	0.097499582	0.004239112
3192	hsa-mir-1267	hsa04530	Tight junction	5590_207_6714	3	0.002530343	0.144229531	0.005886583
3193	hsa-mir-1267	hsa04910	Insulin signaling pathway	5590_207_2932	3	0.002581835	0.147164575	0.005886583
3194	hsa-mir-1267	hsa04310	Wnt signaling pathway	2033_2932_1387	3	0.003371643	0.192183667	0.007391679
3195	hsa-mir-1267	hsa04930	Type II diabetes mellitus	5590_3651	2	0.00374113	0.213244403	0.007897941
3196	hsa-mir-1267	hsa04330	Notch signaling pathway	2033_1387	2	0.004059862	0.23141216	0.00826472
3197	hsa-mir-1267	hsa05213	Endometrial cancer	207_2932	2	0.004909781	0.279857544	0.00965026
3198	hsa-mir-1267	hsa05217	Basal cell carcinoma	2736_2932	2	0.005455661	0.310972693	0.010365756
3199	hsa-mir-1267	hsa04340	Hedgehog signaling pathway	2736_2932	2	0.005834355	0.33255825	0.010727685
3200	hsa-mir-1267	hsa05016	Huntington's disease	3064_2033_1387	3	0.006030071	0.343714047	0.010741064
3201	hsa-mir-1267	hsa04510	Focal adhesion	207_2932_6714	3	0.007720803	0.44008579	0.013335933
3202	hsa-mir-1267	hsa04664	Fc epsilon RI signaling pathway	207_1432	2	0.010752732	0.612905713	0.018026639
3203	hsa-mir-1267	hsa05210	Colorectal cancer	207_2932	2	0.012055669	0.687173116	0.019633518
3204	hsa-mir-1267	hsa04350	TGF-beta signaling pathway	2033_1387	2	0.012869022	0.733534271	0.020375952
3205	hsa-mir-1267	hsa04540	Gap junction	6714_5592	2	0.01456546	0.830231213	0.022438681
3206	hsa-mir-1267	hsa04912	GnRH signaling pathway	6714_1432	2	0.019200085	1	0.028800127
3207	hsa-mir-1267	hsa05322	Systemic lupus erythematosus	333932_126961	2	0.0324414	1	0.047414354
3208	hsa-mir-1267	hsa04950	Maturity onset diabetes of the young	3651	1	0.047157806	1	0.067199874
3209	hsa-mir-1269	hsa05200	Pathways in cancer	5371_2249_1956_1499_5595_5594_1387_6256_862_595_6502_2308_1019_367_1017_5914_841_6776_6777_5970_6688_4609_3725_4088_1026_861_2353_4089_1050_5925_2033_8554_4790	33	2.50E-25	1.80E-23	1.80E-23
3210	hsa-mir-1269	hsa05215	Prostate cancer	1956_1499_5595_5594_1385_1387_595_2308_367_1017_5970_468_1026_5925_2033_4790	16	1.53E-16	1.11E-14	3.24E-15
3211	hsa-mir-1269	hsa04010	MAPK signaling pathway	6722_2249_1956_5595_5594_1386_9261_4208_5566_9252_7867_1649_5970_468_4609_3725_6195_6196_2353_1432_4790_51701_2002	23	1.77E-16	1.27E-14	3.24E-15
3212	hsa-mir-1269	hsa05212	Pancreatic cancer	1956_1499_5595_5594_1385_1387_595_2308_367_1017_5970_468_1026_5925_2033_4790	16	1.80E-16	1.29E-14	3.24E-15
3213	hsa-mir-1269	hsa05221	Acute myeloid leukemia	5371_5595_5594_862_595_5914_6776_6777_5970_6688_4609_861_1050_4790	14	4.90E-16	3.53E-14	7.05E-15
3214	hsa-mir-1269	hsa05220	Chronic myeloid leukemia	5595_5594_595_1019_6776_6777_5970_4609_4088_1026_861_4089_5925_4790	14	9.06E-15	6.52E-13	1.09E-13
3215	hsa-mir-1269	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_7027_3399_3398_1874_4609_4088_3397_4089_2033_5933	14	5.61E-14	4.04E-12	5.77E-13
3216	hsa-mir-1269	hsa04110	Cell cycle	1387_595_6502_1019_1017_7027_4088_1026_4089_5925_2033_894_896_5933	14	2.69E-12	1.94E-10	2.42E-11
3217	hsa-mir-1269	hsa04720	Long-term potentiation	815_5595_5594_1387_5566_468_6195_6196_2033_808_801_805	12	3.89E-12	2.80E-10	3.11E-11
3218	hsa-mir-1269	hsa05214	Glioma	815_1956_5595_5594_595_1019_1026_5925_808_801_805	11	1.82E-11	1.31E-09	1.31E-10
3219	hsa-mir-1269	hsa04310	Wnt signaling pathway	815_1499_1387_595_5566_4609_3725_4088_1457_4089_2033_894_896_51701	14	5.52E-11	3.97E-09	3.61E-10
3220	hsa-mir-1269	hsa04912	GnRH signaling pathway	815_1956_5595_5594_5566_468_3725_1432_2002_808_801_805	12	1.85E-10	1.33E-08	1.11E-09
3221	hsa-mir-1269	hsa05219	Bladder cancer	1956_5595_5594_595_1019_9252_4609_1026_5925	9	2.03E-10	1.46E-08	1.13E-09
3222	hsa-mir-1269	hsa04916	Melanogenesis	815_1499_5595_5594_1385_1387_5566_2033_808_801_805	11	1.73E-09	1.25E-07	8.90E-09
3223	hsa-mir-1269	hsa04520	Adherens junction	1956_1499_5595_5594_1387_4088_1457_4089_2033_51701	10	2.21E-09	1.59E-07	1.06E-08
3224	hsa-mir-1269	hsa05210	Colorectal cancer	1956_1499_5595_5594_595_4609_3725_4088_2353_4089	10	3.39E-09	2.44E-07	1.53E-08
3225	hsa-mir-1269	hsa05222	Small cell lung cancer	6256_595_6502_1019_1017_5970_4609_5925_8554_4790	10	4.18E-09	3.01E-07	1.77E-08
3226	hsa-mir-1269	hsa04012	ErbB signaling pathway	815_1956_5595_5594_6776_6777_4609_3725_1026_2002	10	4.63E-09	3.33E-07	1.85E-08
3227	hsa-mir-1269	hsa04630	Jak-STAT signaling pathway	1387_595_6778_6776_6777_4609_2033_3977_894_896_8554	11	8.10E-08	5.83E-06	3.07E-07
3228	hsa-mir-1269	hsa05218	Melanoma	2249_1956_5595_5594_595_1019_1026_5925	8	1.92E-07	1.38E-05	6.91E-07
3229	hsa-mir-1269	hsa04620	Toll-like receptor signaling pathway	5595_5594_841_5970_3725_2353_1432_6348_4790	9	2.26E-07	1.62E-05	7.73E-07
3230	hsa-mir-1269	hsa05216	Thyroid cancer	1499_5595_5594_6256_595_4609	6	2.78E-07	2.00E-05	9.10E-07
3231	hsa-mir-1269	hsa05213	Endometrial cancer	1956_1499_5595_5594_595_4609_2002	7	3.79E-07	2.73E-05	1.19E-06
3232	hsa-mir-1269	hsa05223	Non-small cell lung cancer	1956_5595_5594_6256_595_1019_5925	7	4.78E-07	3.44E-05	1.44E-06
3233	hsa-mir-1269	hsa04115	p53 signaling pathway	595_1019_1017_841_1026_894_896	7	2.17E-06	0.000156373	6.25E-06
3234	hsa-mir-1269	hsa04660	T cell receptor signaling pathway	5595_5594_1019_5970_3725_2353_1432_4790	8	4.15E-06	0.000298652	1.15E-05
3235	hsa-mir-1269	hsa04910	Insulin signaling pathway	5595_5594_2308_5566_2002_808_801_805	8	1.98E-05	0.00142776	5.29E-05
3236	hsa-mir-1269	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725_2353_4790	6	4.13E-05	0.002971086	0.00010611
3237	hsa-mir-1269	hsa04510	Focal adhesion	1956_1499_5595_5594_595_3725_894_896_2002	9	5.07E-05	0.003653236	0.000125889
3238	hsa-mir-1269	hsa04330	Notch signaling pathway	388585_1387_9612_2033_8850	5	5.25E-05	0.003776676	0.000125889
3239	hsa-mir-1269	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_5970_3725_1432_4790	5	0.000320547	0.023079387	0.000744496
3240	hsa-mir-1269	hsa05211	Renal cell carcinoma	5595_5594_1387_3725_2033	5	0.000340659	0.024527444	0.000766483
3241	hsa-mir-1269	hsa04270	Vascular smooth muscle contraction	5595_5594_5566_808_801_805	6	0.000430419	0.030990183	0.000939096
3242	hsa-mir-1269	hsa04370	VEGF signaling pathway	5595_5594_9261_7867_1432	5	0.000455897	0.032824561	0.000965428
3243	hsa-mir-1269	hsa05016	Huntington's disease	25942_1385_1387_6908_6667_841_2033	7	0.000869386	0.062595762	0.00178845
3244	hsa-mir-1269	hsa04150	mTOR signaling pathway	5595_5594_6195_6196	4	0.000951791	0.068528941	0.001903582
3245	hsa-mir-1269	hsa04062	Chemokine signaling pathway	5595_5594_5566_6777_5970_6348_4790	7	0.001007496	0.072539721	0.001960533
3246	hsa-mir-1269	hsa04950	Maturity onset diabetes of the young	3651_168620_6927	3	0.00118132	0.085055076	0.002238291
3247	hsa-mir-1269	hsa05010	Alzheimer's disease	5595_5594_841_808_801_805	6	0.003173313	0.22847851	0.005858423
3248	hsa-mir-1269	hsa04020	Calcium signaling pathway	815_1956_5566_808_801_805	6	0.003813367	0.274562394	0.00686406
3249	hsa-mir-1269	hsa04120	Ubiquitin mediated proteolysis	5371_672_6502_7329_8554	5	0.005456858	0.392893783	0.009582775
3250	hsa-mir-1269	hsa04210	Apoptosis	5566_841_5970_4790	4	0.00605371	0.435867155	0.010376976
3251	hsa-mir-1269	hsa04930	Type II diabetes mellitus	5595_5594_3651	3	0.006197361	0.446209978	0.010376976
3252	hsa-mir-1269	hsa04540	Gap junction	1956_5595_5594_5566	4	0.007013701	0.504986483	0.011476966
3253	hsa-mir-1269	hsa04920	Adipocytokine signaling pathway	6256_5970_4790	3	0.017320729	1	0.027713167
3254	hsa-mir-1269	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.023788643	1	0.037234398
3255	hsa-mir-1269	hsa04664	Fc epsilon RI signaling pathway	5595_5594_1432	3	0.026196698	1	0.040131112
3256	hsa-mir-1269	hsa03410	Base excision repair	3146_142	2	0.035203562	1	0.052805344
3257	hsa-mir-1269	hsa03022	Basal transcription factors	6908_6880	2	0.036920157	1	0.054250027
3258	hsa-mir-1269	hsa03420	Nucleotide excision repair	5981_4331	2	0.049787999	1	0.071694718
3259	hsa-mir-127	hsa05200	Pathways in cancer	1147_3320_3326_405_2249_3480_1956_5594_5595_6654_5599_5914_1387_2064_6256_595_1488_2308_1487_208_367_4193_7704_6774_6776_6777_2885_5970_8503_8554_6258_7157_4087_6688_6257_4089_2113_10401_3725_861_2736_2353_4088_5295_5925_8031_2033_207_5601_2932_4790	51	1.38E-34	1.11E-32	1.11E-32
3260	hsa-mir-127	hsa04010	MAPK signaling pathway	9479_1147_2249_994_1956_5594_5595_6722_6654_9252_5599_8986_1649_5566_208_4214_1616_1386_1432_2885_5970_627_7157_10912_9261_468_3725_3727_6195_6196_6197_2353_5058_4616_2872_207_5601_4790	38	1.37E-24	1.10E-22	5.48E-23
3261	hsa-mir-127	hsa05215	Prostate cancer	1147_3320_3326_3480_1956_5594_5595_6654_1387_2064_595_2308_208_367_4193_2885_5970_8503_7157_468_5295_5925_2033_207_2932_4790	26	2.41E-24	1.92E-22	6.14E-23
3262	hsa-mir-127	hsa05212	Pancreatic cancer	1147_3320_3326_3480_1956_5594_5595_6654_1387_2064_595_2308_208_367_4193_2885_5970_8503_7157_468_5295_5925_2033_207_2932_4790	26	3.07E-24	2.46E-22	6.14E-23
3263	hsa-mir-127	hsa05220	Chronic myeloid leukemia	1147_5594_5595_6654_595_1488_1487_208_4193_6776_6777_2885_5970_8503_7157_4089_861_4088_5295_5925_207_4790_6464	23	5.49E-22	4.39E-20	8.78E-21
3264	hsa-mir-127	hsa05221	Acute myeloid leukemia	1147_5594_5595_6654_5914_595_208_7704_6774_6776_6777_2885_5970_8503_6688_861_5295_207_4790	19	1.02E-18	8.14E-17	1.36E-17
3265	hsa-mir-127	hsa05210	Colorectal cancer	3480_1956_5594_5595_6654_5599_595_208_2885_8503_7157_4087_4089_3725_2353_4088_5295_207_5601_2932	20	1.87E-17	1.49E-15	2.13E-16
3266	hsa-mir-127	hsa04012	ErbB signaling pathway	1956_6714_5594_5595_6654_5599_2064_56924_208_6776_6777_2885_8503_3725_5295_5058_207_5601_2932_6464	20	3.36E-17	2.69E-15	3.36E-16
3267	hsa-mir-127	hsa05214	Glioma	3480_1956_5594_5595_6654_595_208_4193_2885_8503_7157_5295_5925_207_801_6464_808_805	18	7.92E-17	6.34E-15	7.04E-16
3268	hsa-mir-127	hsa05223	Non-small cell lung cancer	1956_5594_5595_6654_2064_6256_595_208_2885_8503_6258_7157_6257_5295_5925_2309_207	17	9.50E-17	7.60E-15	7.60E-16
3269	hsa-mir-127	hsa04910	Insulin signaling pathway	6720_10891_5594_5595_6654_5599_2308_5566_7249_208_5770_2885_8503_5295_2872_207_5601_2932_801_6464_808_805	22	7.77E-16	6.22E-14	5.65E-15
3270	hsa-mir-127	hsa04660	T cell receptor signaling pathway	1147_5594_5595_6654_56924_208_5777_1432_2885_5970_8503_3725_2353_5295_5058_207_5601_2932_3932_4790	20	1.76E-15	1.41E-13	1.17E-14
3271	hsa-mir-127	hsa04110	Cell cycle	994_993_891_1387_595_983_7533_4193_902_7157_4087_10912_4089_1022_4088_5925_2033_4616_2932	19	7.24E-14	5.79E-12	4.46E-13
3272	hsa-mir-127	hsa04510	Focal adhesion	9564_3480_1956_6714_5594_5595_6654_5599_2064_595_56924_208_2885_8503_857_3725_5295_5058_207_5601_2932_71_6464	23	1.66E-13	1.33E-11	9.49E-13
3273	hsa-mir-127	hsa05213	Endometrial cancer	1956_5594_5595_6654_2064_595_208_2885_8503_7157_5295_2309_207_2932	14	3.07E-13	2.46E-11	1.64E-12
3274	hsa-mir-127	hsa05211	Renal cell carcinoma	405_5594_5595_6654_1387_56924_208_2885_8503_2113_3725_5295_5058_2033_207	15	1.08E-12	8.68E-11	5.42E-12
3275	hsa-mir-127	hsa04662	B cell receptor signaling pathway	1147_5594_5595_6654_208_5777_2885_5970_8503_3725_2353_5295_207_2932_4790	15	1.82E-12	1.45E-10	8.55E-12
3276	hsa-mir-127	hsa04520	Adherens junction	1460_3480_1956_6714_5594_5595_1387_2064_5770_5777_4087_4089_4088_2033_71	15	4.11E-12	3.29E-10	1.83E-11
3277	hsa-mir-127	hsa05222	Small cell lung cancer	1147_6256_595_208_5970_8503_8554_6258_7157_6257_10401_5295_5925_207_4790	15	1.03E-11	8.22E-10	4.33E-11
3278	hsa-mir-127	hsa04912	GnRH signaling pathway	1956_6714_5594_5595_6654_5599_5566_4214_1432_2885_468_3725_5601_801_808_805	16	1.90E-11	1.52E-09	7.59E-11
3279	hsa-mir-127	hsa04062	Chemokine signaling pathway	1147_9564_5594_5595_6654_2770_5566_208_6774_6777_2885_5970_8503_5295_5058_2309_207_2932_4790_6464	20	2.23E-11	1.78E-09	8.49E-11
3280	hsa-mir-127	hsa04310	Wnt signaling pathway	1460_5518_5599_1387_595_1488_5566_1487_6423_8061_7157_4087_4089_3725_4088_2033_5601_2932	18	3.05E-11	2.44E-09	1.11E-10
3281	hsa-mir-127	hsa05218	Melanoma	2249_3480_1956_5594_5595_595_208_4193_8503_7157_5295_5925_207	13	1.46E-10	1.17E-08	5.08E-10
3282	hsa-mir-127	hsa04620	Toll-like receptor signaling pathway	1147_5594_5595_5599_208_1432_5970_8503_3725_2353_5295_207_5601_4790	14	8.57E-10	6.86E-08	2.86E-09
3283	hsa-mir-127	hsa04920	Adipocytokine signaling pathway	1147_10891_5599_6256_208_6774_5970_6258_6257_207_5601_4790	12	9.37E-10	7.50E-08	3.00E-09
3284	hsa-mir-127	hsa04630	Jak-STAT signaling pathway	6654_1387_595_208_5777_6774_6776_6777_2885_8503_8554_10401_5295_2033_3977_207	16	2.39E-09	1.91E-07	7.36E-09
3285	hsa-mir-127	hsa04720	Long-term potentiation	5594_5595_1387_5566_468_6195_6196_6197_2033_801_808_805	12	2.94E-09	2.35E-07	8.71E-09
3286	hsa-mir-127	hsa04150	mTOR signaling pathway	5594_5595_7249_208_8503_6195_6196_6197_5295_207	10	1.31E-08	1.05E-06	3.75E-08
3287	hsa-mir-127	hsa05219	Bladder cancer	1956_5594_5595_9252_2064_595_4193_7157_5925	9	3.11E-08	2.49E-06	8.58E-08
3288	hsa-mir-127	hsa05216	Thyroid cancer	5594_5595_6256_595_6258_7157_6257_8031	8	3.42E-08	2.74E-06	9.12E-08
3289	hsa-mir-127	hsa04664	Fc epsilon RI signaling pathway	5594_5595_6654_5599_208_1432_2885_8503_5295_207_5601	11	4.89E-08	3.91E-06	1.26E-07
3290	hsa-mir-127	hsa04350	TGF-beta signaling pathway	3399_6667_5518_5594_5595_1387_3398_4087_4089_4088_2033	11	1.19E-07	9.54E-06	2.98E-07
3291	hsa-mir-127	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_1956_6714_5599_1432_5970_3725_5058_5601_4790	10	1.81E-07	1.45E-05	4.40E-07
3292	hsa-mir-127	hsa04210	Apoptosis	1147_5566_208_5970_8503_823_7157_5295_207_4790	10	1.21E-06	9.65E-05	2.84E-06
3293	hsa-mir-127	hsa04115	p53 signaling pathway	891_595_983_7249_4193_7157_10912_64326_4616	9	1.34E-06	0.000107346	3.07E-06
3294	hsa-mir-127	hsa04540	Gap junction	1956_6714_5594_5592_5595_6654_2770_983_5566_2885	10	1.74E-06	0.000139102	3.86E-06
3295	hsa-mir-127	hsa04370	VEGF signaling pathway	6714_5594_5595_208_1432_8503_9261_5295_207	9	3.07E-06	0.000245567	6.64E-06
3296	hsa-mir-127	hsa04916	Melanogenesis	5594_5595_1387_2770_5566_2033_2932_801_808_805	10	4.38E-06	0.000350665	9.23E-06
3297	hsa-mir-127	hsa04930	Type II diabetes mellitus	3651_5594_5595_5599_8503_5295_5601	7	7.23E-06	0.00057874	1.48E-05
3298	hsa-mir-127	hsa04650	Natural killer cell mediated cytotoxicity	5594_5595_6654_5777_2885_8503_5295_5058_3932_6464	10	4.33E-05	0.003461493	8.65E-05
3299	hsa-mir-127	hsa04330	Notch signaling pathway	1387_1488_1487_9612_2033_8850	6	8.98E-05	0.007185666	0.00017526
3300	hsa-mir-127	hsa04120	Ubiquitin mediated proteolysis	7325_672_4214_4193_8554_10273_10401_64326_7329	9	0.000230634	0.018450687	0.000439302
3301	hsa-mir-127	hsa03022	Basal transcription factors	2965_2963_6908_2959_6881	5	0.000276651	0.022132095	0.0005147
3302	hsa-mir-127	hsa04810	Regulation of actin cytoskeleton	9564_2249_1956_5594_5595_6654_56924_8503_5295_5058_71	11	0.000393025	0.031442027	0.000714592
3303	hsa-mir-127	hsa04730	Long-term depression	3480_5518_5594_5592_5595_2770	6	0.000702184	0.056174734	0.001248327
3304	hsa-mir-127	hsa05010	Alzheimer's disease	5594_5595_1537_823_9451_2932_801_808_805	9	0.001201788	0.096143076	0.002090067
3305	hsa-mir-127	hsa05016	Huntington's disease	6667_10891_1387_6908_1537_627_7157_3064_2033	9	0.00178621	0.142896807	0.003035702
3306	hsa-mir-127	hsa04270	Vascular smooth muscle contraction	5594_5592_5595_5566_801_808_805	7	0.001821421	0.145713717	0.003035702
3307	hsa-mir-127	hsa04612	Antigen processing and presentation	3320_3326_1514_3308_4800_6890	6	0.002091308	0.167304659	0.003414381
3308	hsa-mir-127	hsa03410	Base excision repair	6996_4350_3146_142	4	0.002229209	0.178336704	0.003566734
3309	hsa-mir-127	hsa04360	Axon guidance	5998_5594_5595_2770_56924_5058_2932	7	0.003178803	0.254304204	0.004986357
3310	hsa-mir-127	hsa04530	Tight junction	1460_5518_6714_2770_208_207_71	7	0.004018612	0.321488929	0.006182479
3311	hsa-mir-127	hsa03420	Nucleotide excision repair	2965_4331_902_1022	4	0.00435242	0.34819359	0.00656969
3312	hsa-mir-127	hsa04070	Phosphatidylinositol signaling system	8503_5295_801_808_805	5	0.005372557	0.429804528	0.007959343
3313	hsa-mir-127	hsa04950	Maturity onset diabetes of the young	3172_3651_6927	3	0.006015355	0.481228395	0.008749607
3314	hsa-mir-127	hsa04670	Leukocyte transendothelial migration	9564_2770_1432_8503_5295_71	6	0.008943118	0.715449444	0.012775883
3315	hsa-mir-127	hsa03320	PPAR signaling pathway	6256_6258_6257_2168	4	0.019469445	1	0.027325537
3316	hsa-mir-127	hsa05217	Basal cell carcinoma	7157_2736_2932	3	0.046433992	1	0.064046886
3317	hsa-mir-127	hsa05014	Amyotrophic lateral sclerosis (ALS)	1616_1432_7157	3	0.048437115	1	0.065677443
3318	hsa-mir-127	hsa04020	Calcium signaling pathway	1956_2064_5566_801_808_805	6	0.049428923	1	0.06590523
3319	hsa-mir-1271	hsa04350	TGF-beta signaling pathway	6667_1387_5595_5594_3399	5	1.46E-09	6.55E-08	6.55E-08
3320	hsa-mir-1271	hsa05215	Prostate cancer	1387_5595_5594_2932	4	1.91E-07	8.58E-06	2.99E-06
3321	hsa-mir-1271	hsa05212	Pancreatic cancer	1387_5595_5594_2932	4	1.99E-07	8.97E-06	2.99E-06
3322	hsa-mir-1271	hsa04916	Melanogenesis	1387_5595_5594_2932	4	3.64E-07	1.64E-05	4.09E-06
3323	hsa-mir-1271	hsa04910	Insulin signaling pathway	5595_5594_2932_23265	4	1.09E-06	4.90E-05	9.80E-06
3324	hsa-mir-1271	hsa05213	Endometrial cancer	5595_5594_2932	3	3.89E-06	0.000174901	2.92E-05
3325	hsa-mir-1271	hsa05211	Renal cell carcinoma	1387_5595_5594	3	9.93E-06	0.00044703	5.59E-05
3326	hsa-mir-1271	hsa04720	Long-term potentiation	1387_5595_5594	3	1.12E-05	0.000503111	5.59E-05
3327	hsa-mir-1271	hsa04662	B cell receptor signaling pathway	5595_5594_2932	3	1.12E-05	0.000503111	5.59E-05
3328	hsa-mir-1271	hsa04520	Adherens junction	1387_5595_5594	3	1.35E-05	0.000606571	6.07E-05
3329	hsa-mir-1271	hsa05210	Colorectal cancer	5595_5594_2932	3	1.55E-05	0.000698769	6.35E-05
3330	hsa-mir-1271	hsa04012	ErbB signaling pathway	5595_5594_2932	3	1.72E-05	0.00077367	6.45E-05
3331	hsa-mir-1271	hsa05200	Pathways in cancer	1387_5595_5594_2932	4	3.27E-05	0.00147198	0.000109254
3332	hsa-mir-1271	hsa04660	T cell receptor signaling pathway	5595_5594_2932	3	3.40E-05	0.001529551	0.000109254
3333	hsa-mir-1271	hsa04360	Axon guidance	5595_5594_2932	3	5.65E-05	0.002542627	0.000169508
3334	hsa-mir-1271	hsa05010	Alzheimer's disease	5595_5594_2932	3	0.000135548	0.006099643	0.000368018
3335	hsa-mir-1271	hsa05216	Thyroid cancer	5595_5594	2	0.000139029	0.006256313	0.000368018
3336	hsa-mir-1271	hsa04062	Chemokine signaling pathway	5595_5594_2932	3	0.000174263	0.007841852	0.000435658
3337	hsa-mir-1271	hsa04510	Focal adhesion	5595_5594_2932	3	0.000210531	0.009473916	0.000498627
3338	hsa-mir-1271	hsa05219	Bladder cancer	5595_5594	2	0.00028162	0.012672913	0.000633646
3339	hsa-mir-1271	hsa04930	Type II diabetes mellitus	5595_5594	2	0.000321488	0.014466956	0.000688903
3340	hsa-mir-1271	hsa04150	mTOR signaling pathway	5595_5594	2	0.000424587	0.019106402	0.000868473
3341	hsa-mir-1271	hsa05223	Non-small cell lung cancer	5595_5594	2	0.000456624	0.02054806	0.000893394
3342	hsa-mir-1271	hsa05221	Acute myeloid leukemia	5595_5594	2	0.000541709	0.024376889	0.001015704
3343	hsa-mir-1271	hsa05214	Glioma	5595_5594	2	0.000653185	0.029393313	0.001175733
3344	hsa-mir-1271	hsa05218	Melanoma	5595_5594	2	0.000774828	0.034867262	0.00129138
3345	hsa-mir-1271	hsa04730	Long-term depression	5595_5594	2	0.000774828	0.034867262	0.00129138
3346	hsa-mir-1271	hsa05220	Chronic myeloid leukemia	5595_5594	2	0.000861541	0.038769362	0.00138462
3347	hsa-mir-1271	hsa04370	VEGF signaling pathway	5595_5594	2	0.000906576	0.040795942	0.001406757
3348	hsa-mir-1271	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.000952728	0.042872739	0.001429091
3349	hsa-mir-1271	hsa04540	Gap junction	5595_5594	2	0.001306839	0.058807753	0.001897024
3350	hsa-mir-1271	hsa04620	Toll-like receptor signaling pathway	5595_5594	2	0.001562935	0.070332068	0.002197877
3351	hsa-mir-1271	hsa04912	GnRH signaling pathway	5595_5594	2	0.001745914	0.07856611	0.002380791
3352	hsa-mir-1271	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.002072466	0.09326096	0.002708481
3353	hsa-mir-1271	hsa04110	Cell cycle	1387_2932	2	0.002106596	0.094796841	0.002708481
3354	hsa-mir-1271	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.002805524	0.126248575	0.003460069
3355	hsa-mir-1271	hsa04120	Ubiquitin mediated proteolysis	55294_7329	2	0.002844945	0.128022535	0.003460069
3356	hsa-mir-1271	hsa04310	Wnt signaling pathway	1387_2932	2	0.003381133	0.152150991	0.004003973
3357	hsa-mir-1271	hsa05016	Huntington's disease	6667_1387	2	0.005091795	0.229130791	0.005875148
3358	hsa-mir-1271	hsa04810	Regulation of actin cytoskeleton	5595_5594	2	0.006823388	0.307052456	0.007676311
3359	hsa-mir-1271	hsa04010	MAPK signaling pathway	5595_5594	2	0.01038693	0.467411838	0.011400289
3360	hsa-mir-1271	hsa04330	Notch signaling pathway	1387	1	0.026846659	1	0.028764278
3361	hsa-mir-1271	hsa05217	Basal cell carcinoma	2932	1	0.031254607	1	0.03270831
3362	hsa-mir-1271	hsa04340	Hedgehog signaling pathway	2932	1	0.032353654	1	0.033088964
3363	hsa-mir-1272	hsa04720	Long-term potentiation	5595_5594_1387_6197_6195_6196_2033_808_801_805	10	1.54E-12	9.38E-11	9.38E-11
3364	hsa-mir-1272	hsa05200	Pathways in cancer	5371_1499_5595_5594_1387_9915_2932_3091_862_6502_2736_5925_2034_2033_207	15	8.68E-12	5.29E-10	2.65E-10
3365	hsa-mir-1272	hsa04010	MAPK signaling pathway	6722_8986_5595_5594_9261_4208_6197_9252_7867_1432_6195_6196_207	13	1.24E-10	7.55E-09	2.52E-09
3366	hsa-mir-1272	hsa04916	Melanogenesis	1499_5595_5594_1387_2932_2033_808_801_805	9	7.30E-10	4.45E-08	1.11E-08
3367	hsa-mir-1272	hsa05211	Renal cell carcinoma	5595_5594_1387_9915_3091_2034_2033_207	8	1.07E-09	6.53E-08	1.31E-08
3368	hsa-mir-1272	hsa04150	mTOR signaling pathway	5595_5594_6197_3091_6195_6196_207	7	3.62E-09	2.21E-07	3.42E-08
3369	hsa-mir-1272	hsa04350	TGF-beta signaling pathway	5595_5594_1387_3397_3399_3398_2033_4093	8	4.27E-09	2.60E-07	3.42E-08
3370	hsa-mir-1272	hsa05215	Prostate cancer	1499_5595_5594_1387_2932_5925_2033_207	8	4.64E-09	2.83E-07	3.42E-08
3371	hsa-mir-1272	hsa05212	Pancreatic cancer	1499_5595_5594_1387_2932_5925_2033_207	8	5.04E-09	3.08E-07	3.42E-08
3372	hsa-mir-1272	hsa05214	Glioma	5595_5594_5925_207_808_801_805	7	1.50E-08	9.14E-07	9.14E-08
3373	hsa-mir-1272	hsa04370	VEGF signaling pathway	5595_5594_9261_7867_1432_207	6	9.87E-07	6.02E-05	5.47E-06
3374	hsa-mir-1272	hsa04520	Adherens junction	1499_5595_5594_1387_1457_2033	6	1.22E-06	7.42E-05	6.19E-06
3375	hsa-mir-1272	hsa04910	Insulin signaling pathway	5595_5594_2932_207_808_801_805	7	1.85E-06	0.000112912	8.64E-06
3376	hsa-mir-1272	hsa04330	Notch signaling pathway	388585_1387_9612_2033_8850	5	1.98E-06	0.000120904	8.64E-06
3377	hsa-mir-1272	hsa05213	Endometrial cancer	1499_5595_5594_2932_207	5	3.14E-06	0.000191741	1.28E-05
3378	hsa-mir-1272	hsa05221	Acute myeloid leukemia	5371_5595_5594_862_207	5	5.60E-06	0.00034154	2.13E-05
3379	hsa-mir-1272	hsa04912	GnRH signaling pathway	5595_5594_1432_808_801_805	6	6.31E-06	0.000384951	2.26E-05
3380	hsa-mir-1272	hsa04270	Vascular smooth muscle contraction	5592_5595_5594_808_801_805	6	1.02E-05	0.000624217	3.47E-05
3381	hsa-mir-1272	hsa05210	Colorectal cancer	1499_5595_5594_2932_207	5	2.82E-05	0.001718736	9.05E-05
3382	hsa-mir-1272	hsa05219	Bladder cancer	5595_5594_9252_5925	4	3.32E-05	0.002028218	0.000101411
3383	hsa-mir-1272	hsa05223	Non-small cell lung cancer	5595_5594_5925_207	4	8.33E-05	0.00508404	0.000242097
3384	hsa-mir-1272	hsa05010	Alzheimer's disease	5595_5594_2932_808_801_805	6	9.11E-05	0.005557024	0.000252592
3385	hsa-mir-1272	hsa04660	T cell receptor signaling pathway	5595_5594_2932_1432_207	5	9.60E-05	0.005856923	0.000254649
3386	hsa-mir-1272	hsa04110	Cell cycle	1387_2932_6502_5925_2033	5	0.000136935	0.008353023	0.000348043
3387	hsa-mir-1272	hsa05218	Melanoma	5595_5594_5925_207	4	0.000226741	0.013831176	0.000553247
3388	hsa-mir-1272	hsa05216	Thyroid cancer	1499_5595_5594	3	0.000274327	0.016733917	0.000603259
3389	hsa-mir-1272	hsa05220	Chronic myeloid leukemia	5595_5594_5925_207	4	0.000276906	0.016891245	0.000603259
3390	hsa-mir-1272	hsa04662	B cell receptor signaling pathway	5595_5594_2932_207	4	0.000276906	0.016891245	0.000603259
3391	hsa-mir-1272	hsa04664	Fc epsilon RI signaling pathway	5595_5594_1432_207	4	0.00033458	0.020409379	0.000703772
3392	hsa-mir-1272	hsa04310	Wnt signaling pathway	1499_1387_2932_1457_2033	5	0.000408841	0.024939279	0.000831309
3393	hsa-mir-1272	hsa04012	ErbB signaling pathway	5595_5594_2932_207	4	0.000474953	0.028972146	0.000934585
3394	hsa-mir-1272	hsa04620	Toll-like receptor signaling pathway	5595_5594_1432_207	4	0.000843577	0.051458215	0.001608069
3395	hsa-mir-1272	hsa04930	Type II diabetes mellitus	3651_5595_5594	3	0.000913595	0.055729265	0.001688766
3396	hsa-mir-1272	hsa04510	Focal adhesion	1499_5595_5594_2932_207	5	0.001539833	0.093929826	0.002760267
3397	hsa-mir-1272	hsa05217	Basal cell carcinoma	1499_2932_2736	3	0.00158376	0.096609336	0.002760267
3398	hsa-mir-1272	hsa04120	Ubiquitin mediated proteolysis	7329_5371_672_6502	4	0.002536256	0.154711646	0.004297546
3399	hsa-mir-1272	hsa04730	Long-term depression	5592_5595_5594	3	0.003178324	0.193877777	0.00523994
3400	hsa-mir-1272	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.003822262	0.233157968	0.006135736
3401	hsa-mir-1272	hsa04950	Maturity onset diabetes of the young	3651_168620	2	0.004728351	0.288429397	0.007395626
3402	hsa-mir-1272	hsa05222	Small cell lung cancer	6502_5925_207	3	0.005334706	0.32541709	0.008135427
3403	hsa-mir-1272	hsa04540	Gap junction	5592_5595_5594	3	0.006579337	0.401339531	0.009788769
3404	hsa-mir-1272	hsa04062	Chemokine signaling pathway	5595_5594_2932_207	4	0.007858104	0.479344372	0.011412961
3405	hsa-mir-1272	hsa04360	Axon guidance	5595_5594_2932	3	0.016209833	0.988799824	0.022995345
3406	hsa-mir-1272	hsa04530	Tight junction	1499_1457_207	3	0.018193217	1	0.025222414
3407	hsa-mir-1272	hsa04340	Hedgehog signaling pathway	2932_2736	2	0.022875092	1	0.031008458
3408	hsa-mir-1272	hsa04630	Jak-STAT signaling pathway	1387_2033_207	3	0.02491943	1	0.033045331
3409	hsa-mir-1272	hsa04020	Calcium signaling pathway	808_801_805	3	0.038199013	1	0.049577442
3410	hsa-mir-1272	hsa05016	Huntington's disease	1387_3064_2033	3	0.040264047	1	0.051168893
3411	hsa-mir-1273	hsa05215	Prostate cancer	2033_367	2	0.001630478	0.026087648	0.013331624
3412	hsa-mir-1273	hsa05212	Pancreatic cancer	2033_367	2	0.001666453	0.026663248	0.013331624
3413	hsa-mir-1273	hsa05200	Pathways in cancer	2033_367	2	0.020546316	0.328741053	0.073494042
3414	hsa-mir-1273	hsa03410	Base excision repair	3146	1	0.024371354	0.389941658	0.073494042
3415	hsa-mir-1273	hsa03420	Nucleotide excision repair	4331	1	0.029566123	0.473057967	0.073494042
3416	hsa-mir-1273	hsa04330	Notch signaling pathway	2033	1	0.031507378	0.504118054	0.073494042
3417	hsa-mir-1273	hsa03050	Proteasome	5705	1	0.032153643	0.514458293	0.073494042
3418	hsa-mir-1273	hsa05211	Renal cell carcinoma	2033	1	0.047541657	0.760666506	0.08296848
3419	hsa-mir-1273	hsa04720	Long-term potentiation	2033	1	0.049448734	0.791179745	0.08296848
3420	hsa-mir-1273c	hsa04310	Wnt signaling pathway	595_2033_894_896_3725_1387	6	5.21E-09	1.67E-07	1.67E-07
3421	hsa-mir-1273c	hsa04110	Cell cycle	595_2033_894_896_1387	5	8.31E-08	2.66E-06	1.33E-06
3422	hsa-mir-1273c	hsa04630	Jak-STAT signaling pathway	595_2033_894_896_1387	5	2.96E-07	9.48E-06	3.16E-06
3423	hsa-mir-1273c	hsa05200	Pathways in cancer	595_2033_367_3725_1387_2353	6	4.72E-07	1.51E-05	3.78E-06
3424	hsa-mir-1273c	hsa05215	Prostate cancer	595_2033_367_1387	4	1.37E-06	4.39E-05	7.64E-06
3425	hsa-mir-1273c	hsa05212	Pancreatic cancer	595_2033_367_1387	4	1.43E-06	4.58E-05	7.64E-06
3426	hsa-mir-1273c	hsa04330	Notch signaling pathway	9612_2033_1387	3	1.24E-05	0.000395324	5.65E-05
3427	hsa-mir-1273c	hsa04510	Focal adhesion	595_894_896_3725	4	3.60E-05	0.001150823	0.000131907
3428	hsa-mir-1273c	hsa04115	p53 signaling pathway	595_894_896	3	3.71E-05	0.001187161	0.000131907
3429	hsa-mir-1273c	hsa05211	Renal cell carcinoma	2033_3725_1387	3	4.19E-05	0.001341702	0.00013417
3430	hsa-mir-1273c	hsa05210	Colorectal cancer	595_3725_2353	3	6.53E-05	0.002091004	0.000190091
3431	hsa-mir-1273c	hsa05016	Huntington's disease	2033_25942_1387	3	0.000662189	0.021190052	0.001765838
3432	hsa-mir-1273c	hsa04720	Long-term potentiation	2033_1387	2	0.002185478	0.069935297	0.004995378
3433	hsa-mir-1273c	hsa04662	B cell receptor signaling pathway	3725_2353	2	0.002185478	0.069935297	0.004995378
3434	hsa-mir-1273c	hsa04520	Adherens junction	2033_1387	2	0.002473657	0.079157024	0.005277135
3435	hsa-mir-1273c	hsa04350	TGF-beta signaling pathway	2033_1387	2	0.002905572	0.092978298	0.005811144
3436	hsa-mir-1273c	hsa04620	Toll-like receptor signaling pathway	3725_2353	2	0.003941193	0.126118187	0.007271931
3437	hsa-mir-1273c	hsa04916	Melanogenesis	2033_1387	2	0.004090461	0.130894763	0.007271931
3438	hsa-mir-1273c	hsa04660	T cell receptor signaling pathway	3725_2353	2	0.004553845	0.145723044	0.007669634
3439	hsa-mir-1273c	hsa04010	MAPK signaling pathway	3725_2353	2	0.025232456	0.807438607	0.04037193
3440	hsa-mir-1273c	hsa05216	Thyroid cancer	595	1	0.026639638	0.852468432	0.040593735
3441	hsa-mir-1273c	hsa05219	Bladder cancer	595	1	0.037970041	1	0.055229151
3442	hsa-mir-1273c	hsa05213	Endometrial cancer	595	1	0.046599202	1	0.064421422
3443	hsa-mir-1273c	hsa05223	Non-small cell lung cancer	595	1	0.048316067	1	0.064421422
3444	hsa-mir-1273d	hsa05200	Pathways in cancer	1869_5371_367_1499_5595_5594_5914_1387_6256_595_836_1019_1017_2932_4149_7704_3091_5970_7428_2735_1870_1871_7157_4087_6688_2113_4609_3725_1026_2736_2737_4088_4089_3066_3065_1050_5925_2034_2033_4846_207_8554	42	1.52E-38	1.08E-36	1.08E-36
3445	hsa-mir-1273d	hsa04110	Cell cycle	1869_5591_1387_595_1019_1017_2932_7027_1870_1871_7157_4087_1026_4088_4089_3066_3065_5925_2033_890_5934_5933	22	1.05E-23	7.44E-22	3.72E-22
3446	hsa-mir-1273d	hsa05220	Chronic myeloid leukemia	1869_5595_5594_595_1019_5970_1870_1871_7157_4609_1026_4088_4089_3066_3065_5925_207_6464	18	2.23E-21	1.58E-19	5.27E-20
3447	hsa-mir-1273d	hsa05215	Prostate cancer	1869_367_1499_5595_5594_1387_595_1017_2932_5970_1870_1871_7157_468_1026_5925_2033_207	18	2.73E-20	1.94E-18	4.64E-19
3448	hsa-mir-1273d	hsa05212	Pancreatic cancer	1869_367_1499_5595_5594_1387_595_1017_2932_5970_1870_1871_7157_468_1026_5925_2033_207	18	3.26E-20	2.32E-18	4.64E-19
3449	hsa-mir-1273d	hsa04010	MAPK signaling pathway	5595_5594_6722_9261_4208_836_6195_6197_9252_4149_1386_1432_1649_5970_3312_7157_468_4609_3725_3727_6196_8986_4763_207	24	7.20E-19	5.11E-17	8.52E-18
3450	hsa-mir-1273d	hsa05222	Small cell lung cancer	1869_6256_595_1019_1017_4149_5970_1870_1871_7157_4609_5925_4846_207_8554	15	3.41E-16	2.42E-14	3.46E-15
3451	hsa-mir-1273d	hsa05219	Bladder cancer	1869_5595_5594_595_1019_9252_1870_1871_7157_4609_1026_5925	12	1.96E-15	1.39E-13	1.74E-14
3452	hsa-mir-1273d	hsa05210	Colorectal cancer	1499_5595_5594_595_836_2932_7157_4087_4609_3725_4088_4089_207	13	1.33E-13	9.44E-12	1.05E-12
3453	hsa-mir-1273d	hsa05214	Glioma	1869_5595_5594_595_1019_1870_1871_7157_1026_5925_207_6464	12	1.83E-13	1.30E-11	1.29E-12
3454	hsa-mir-1273d	hsa04350	TGF-beta signaling pathway	5595_5594_1387_7027_1874_1875_4087_4609_4088_4089_2033_5934_5933	13	1.99E-13	1.41E-11	1.29E-12
3455	hsa-mir-1273d	hsa05223	Non-small cell lung cancer	1869_5595_5594_6256_595_1019_1870_1871_7157_5925_207	11	7.36E-13	5.23E-11	4.36E-12
3456	hsa-mir-1273d	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_5970_6688_4609_1050_207	11	1.73E-12	1.23E-10	9.44E-12
3457	hsa-mir-1273d	hsa05218	Melanoma	1869_5595_5594_595_1019_1870_1871_7157_1026_5925_207	11	1.04E-11	7.39E-10	5.28E-11
3458	hsa-mir-1273d	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_7428_2113_3725_2034_2033_207	10	2.44E-10	1.73E-08	1.15E-09
3459	hsa-mir-1273d	hsa04310	Wnt signaling pathway	1499_1387_595_2932_7157_4087_4609_3725_1457_4088_4089_2033	12	1.55E-09	1.10E-07	6.88E-09
3460	hsa-mir-1273d	hsa05216	Thyroid cancer	1499_5595_5594_6256_595_7157_4609	7	4.37E-09	3.10E-07	1.83E-08
3461	hsa-mir-1273d	hsa04720	Long-term potentiation	5595_5594_1387_2902_6195_6197_468_6196_2033	9	6.34E-09	4.50E-07	2.50E-08
3462	hsa-mir-1273d	hsa05213	Endometrial cancer	1499_5595_5594_595_2932_7157_4609_207	8	7.71E-09	5.47E-07	2.88E-08
3463	hsa-mir-1273d	hsa04520	Adherens junction	1499_5595_5594_1387_4087_1457_4088_4089_2033	9	1.06E-08	7.54E-07	3.77E-08
3464	hsa-mir-1273d	hsa04150	mTOR signaling pathway	5595_5594_6195_6197_3091_6196_207	7	1.57E-07	1.11E-05	5.29E-07
3465	hsa-mir-1273d	hsa04012	ErbB signaling pathway	5595_5594_2932_4609_3725_1026_207_6464	8	2.99E-07	2.12E-05	9.64E-07
3466	hsa-mir-1273d	hsa04660	T cell receptor signaling pathway	5595_5594_1019_2932_1432_5970_3725_207	8	1.57E-06	0.000111632	4.85E-06
3467	hsa-mir-1273d	hsa05217	Basal cell carcinoma	1499_2932_2735_7157_2736_2737	6	3.80E-06	0.000269815	1.12E-05
3468	hsa-mir-1273d	hsa05016	Huntington's disease	6874_1387_2902_836_7157_3066_3065_3064_2033	9	9.08E-06	0.000644753	2.58E-05
3469	hsa-mir-1273d	hsa04115	p53 signaling pathway	595_836_1019_1017_7157_1026	6	1.27E-05	0.000903935	3.48E-05
3470	hsa-mir-1273d	hsa04662	B cell receptor signaling pathway	5595_5594_2932_5970_3725_207	6	1.98E-05	0.001408319	5.22E-05
3471	hsa-mir-1273d	hsa04370	VEGF signaling pathway	5595_5594_9261_1432_4846_207	6	2.28E-05	0.001619496	5.78E-05
3472	hsa-mir-1273d	hsa04330	Notch signaling pathway	1387_9612_3066_3065_2033	5	2.81E-05	0.001998308	6.89E-05
3473	hsa-mir-1273d	hsa05010	Alzheimer's disease	5595_5594_823_2902_836_2932_9451_4846	8	4.25E-05	0.003019254	0.000100642
3474	hsa-mir-1273d	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_1432_7157_4846	5	6.13E-05	0.004352417	0.000140401
3475	hsa-mir-1273d	hsa04620	Toll-like receptor signaling pathway	5595_5594_1432_5970_3725_207	6	0.000100423	0.007130009	0.000222813
3476	hsa-mir-1273d	hsa04916	Melanogenesis	1499_5595_5594_1387_2932_2033	6	0.000111144	0.007891212	0.000239128
3477	hsa-mir-1273d	hsa04510	Focal adhesion	1499_5595_5594_595_2932_3725_207_6464	8	0.000117713	0.00835763	0.000245813
3478	hsa-mir-1273d	hsa04210	Apoptosis	823_836_5970_7157_207	5	0.000471637	0.033486217	0.000941924
3479	hsa-mir-1273d	hsa04910	Insulin signaling pathway	6720_5595_5594_2932_207_6464	6	0.000477596	0.033909281	0.000941924
3480	hsa-mir-1273d	hsa04340	Hedgehog signaling pathway	2932_2735_2736_2737	4	0.00080901	0.057439712	0.001552425
3481	hsa-mir-1273d	hsa04630	Jak-STAT signaling pathway	1387_595_4609_2033_207_8554	6	0.000857685	0.06089567	0.001602518
3482	hsa-mir-1273d	hsa04912	GnRH signaling pathway	5595_5594_1432_468_3725	5	0.001086695	0.077155361	0.001978343
3483	hsa-mir-1273d	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_1432_5970_3725	4	0.00174964	0.124224426	0.003029864
3484	hsa-mir-1273d	hsa04730	Long-term depression	5592_5595_5594_4846	4	0.00174964	0.124224426	0.003029864
3485	hsa-mir-1273d	hsa04062	Chemokine signaling pathway	5595_5594_2932_5970_207_6464	6	0.002518376	0.178804686	0.004187029
3486	hsa-mir-1273d	hsa04664	Fc epsilon RI signaling pathway	5595_5594_1432_207	4	0.002535806	0.180042258	0.004187029
3487	hsa-mir-1273d	hsa04930	Type II diabetes mellitus	3651_5595_5594	3	0.004314071	0.306299013	0.006961341
3488	hsa-mir-1273d	hsa04920	Adipocytokine signaling pathway	6256_5970_207	3	0.01224135	0.869135858	0.01931413
3489	hsa-mir-1273d	hsa04950	Maturity onset diabetes of the young	3651_6927	2	0.013507957	0.959064933	0.020849238
3490	hsa-mir-1273d	hsa04530	Tight junction	1499_1019_1457_207	4	0.016063861	1	0.024266684
3491	hsa-mir-1273d	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_6464	4	0.016443665	1	0.024322921
3492	hsa-mir-1273d	hsa04120	Ubiquitin mediated proteolysis	5371_672_7428_8554	4	0.016829059	1	0.024384963
3493	hsa-mir-1273d	hsa04612	Antigen processing and presentation	4800_4801_3312	3	0.025199351	1	0.035783079
3494	hsa-mir-1273d	hsa04540	Gap junction	5592_5595_5594	3	0.028114111	1	0.039139253
3495	hsa-mir-1273d	hsa03022	Basal transcription factors	2963_6874	2	0.029071409	1	0.039693655
3496	hsa-mir-1277	hsa04310	Wnt signaling pathway	6423_5599	2	0.000717967	0.016513243	0.016513243
3497	hsa-mir-1277	hsa04010	MAPK signaling pathway	9479_5599	2	0.002259216	0.051961969	0.025365731
3498	hsa-mir-1277	hsa05200	Pathways in cancer	5599_5925	2	0.003308574	0.076097192	0.025365731
3499	hsa-mir-1277	hsa05219	Bladder cancer	5925	1	0.011407604	0.2623749	0.030342088
3500	hsa-mir-1277	hsa04930	Type II diabetes mellitus	5599	1	0.012199217	0.280581992	0.030342088
3501	hsa-mir-1277	hsa05223	Non-small cell lung cancer	5925	1	0.014570728	0.335126752	0.030342088
3502	hsa-mir-1277	hsa05214	Glioma	5925	1	0.017462476	0.401636937	0.030342088
3503	hsa-mir-1277	hsa04920	Adipocytokine signaling pathway	5599	1	0.017987449	0.413711332	0.030342088
3504	hsa-mir-1277	hsa05218	Melanoma	5925	1	0.01903666	0.437843189	0.030342088
3505	hsa-mir-1277	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599	1	0.01903666	0.437843189	0.030342088
3506	hsa-mir-1277	hsa05220	Chronic myeloid leukemia	5925	1	0.020084891	0.461952482	0.030342088
3507	hsa-mir-1277	hsa04664	Fc epsilon RI signaling pathway	5599	1	0.02113214	0.486039231	0.030342088
3508	hsa-mir-1277	hsa05210	Colorectal cancer	5599	1	0.022439826	0.516115989	0.030342088
3509	hsa-mir-1277	hsa05222	Small cell lung cancer	5925	1	0.022962472	0.528136845	0.030342088
3510	hsa-mir-1277	hsa04350	TGF-beta signaling pathway	3398	1	0.023223703	0.534145164	0.030342088
3511	hsa-mir-1277	hsa04012	ErbB signaling pathway	5599	1	0.023223703	0.534145164	0.030342088
3512	hsa-mir-1277	hsa05215	Prostate cancer	5925	1	0.023484873	0.540152077	0.030342088
3513	hsa-mir-1277	hsa05212	Pancreatic cancer	5925	1	0.023745982	0.546157584	0.030342088
3514	hsa-mir-1277	hsa04620	Toll-like receptor signaling pathway	5599	1	0.027134844	0.62410142	0.032847443
3515	hsa-mir-1277	hsa04912	GnRH signaling pathway	5599	1	0.02869546	0.659995577	0.032999779
3516	hsa-mir-1277	hsa04110	Cell cycle	5925	1	0.0315509	0.725670696	0.034555747
3517	hsa-mir-1277	hsa04910	Insulin signaling pathway	5599	1	0.036465726	0.838711693	0.038123259
3518	hsa-mir-1278	hsa05200	Pathways in cancer	3320_3326_1871_1387_6256_1487_1488_9915_1019_1017_2932_3265_4149_5578_3091_5371_1870_7157_4087_1869_3725_6774_4088_4089_3065_1050_5925_2034_2033	29	9.77E-29	6.55E-27	6.55E-27
3519	hsa-mir-1278	hsa04110	Cell cycle	890_1871_1387_1019_1017_2932_1870_7157_4087_1869_1028_4088_4089_3065_5925_2033_5934_5933	18	5.42E-22	3.63E-20	1.82E-20
3520	hsa-mir-1278	hsa04350	TGF-beta signaling pathway	3400_1387_6667_3397_3399_3398_1874_1875_4087_4088_4089_2033_4093_4092_5934_5933	16	7.04E-21	4.72E-19	1.57E-19
3521	hsa-mir-1278	hsa05220	Chronic myeloid leukemia	1871_1487_1488_1019_3265_1870_7157_1869_4088_4089_3065_5925	12	2.76E-15	1.85E-13	4.63E-14
3522	hsa-mir-1278	hsa05215	Prostate cancer	3320_3326_1871_1387_1017_2932_3265_1870_7157_1869_5925_2033	12	1.56E-14	1.05E-12	1.97E-13
3523	hsa-mir-1278	hsa05212	Pancreatic cancer	3320_3326_1871_1387_1017_2932_3265_1870_7157_1869_5925_2033	12	1.77E-14	1.18E-12	1.97E-13
3524	hsa-mir-1278	hsa05214	Glioma	1871_1019_3265_5578_1870_7157_1869_5925_808_801_805	11	2.38E-14	1.60E-12	2.28E-13
3525	hsa-mir-1278	hsa04310	Wnt signaling pathway	1387_1487_1488_2932_5578_7157_4087_3725_1457_4088_4089_2033	12	6.20E-12	4.15E-10	4.92E-11
3526	hsa-mir-1278	hsa05223	Non-small cell lung cancer	1871_6256_1019_3265_5578_1870_7157_1869_5925	9	6.61E-12	4.43E-10	4.92E-11
3527	hsa-mir-1278	hsa04720	Long-term potentiation	1387_2902_2906_3265_5578_2033_808_801_805	9	9.54E-11	6.39E-09	6.39E-10
3528	hsa-mir-1278	hsa05222	Small cell lung cancer	1871_6256_1019_1017_4149_1870_7157_1869_5925	9	2.93E-10	1.96E-08	1.78E-09
3529	hsa-mir-1278	hsa05219	Bladder cancer	1871_1019_3265_1870_7157_1869_5925	7	1.57E-09	1.05E-07	8.75E-09
3530	hsa-mir-1278	hsa04330	Notch signaling pathway	1387_1487_1488_9612_3065_2033_8850	7	3.18E-09	2.13E-07	1.64E-08
3531	hsa-mir-1278	hsa04916	Melanogenesis	1387_2932_3265_5578_2033_808_801_805	8	2.80E-08	1.87E-06	1.34E-07
3532	hsa-mir-1278	hsa05218	Melanoma	1871_1019_3265_1870_7157_1869_5925	7	4.35E-08	2.92E-06	1.95E-07
3533	hsa-mir-1278	hsa05211	Renal cell carcinoma	1387_9915_3265_3091_3725_2034_2033	7	4.76E-08	3.19E-06	1.99E-07
3534	hsa-mir-1278	hsa04912	GnRH signaling pathway	3265_1432_5578_3725_808_801_805	7	6.34E-07	4.25E-05	2.50E-06
3535	hsa-mir-1278	hsa04520	Adherens junction	1387_4087_1457_4088_4089_2033	6	1.86E-06	0.000124658	6.93E-06
3536	hsa-mir-1278	hsa05210	Colorectal cancer	2932_7157_4087_3725_4088_4089	6	2.43E-06	0.00016281	8.57E-06
3537	hsa-mir-1278	hsa04010	MAPK signaling pathway	6722_3265_4149_1432_5578_4342_7157_22800_3725	9	3.50E-06	0.000234638	1.17E-05
3538	hsa-mir-1278	hsa05010	Alzheimer's disease	2902_2906_2932_808_351_801_805	7	1.43E-05	0.000960988	4.58E-05
3539	hsa-mir-1278	hsa05016	Huntington's disease	1387_2902_6667_7157_3065_2033_9519	7	2.09E-05	0.001397554	6.35E-05
3540	hsa-mir-1278	hsa04530	Tight junction	1019_3265_5578_22800_8573_1457	6	3.47E-05	0.002324663	0.000101072
3541	hsa-mir-1278	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_2906_1432_7157	4	0.000126073	0.008446875	0.000351953
3542	hsa-mir-1278	hsa04660	T cell receptor signaling pathway	1019_2932_3265_1432_3725	5	0.000135163	0.009055899	0.000362236
3543	hsa-mir-1278	hsa05221	Acute myeloid leukemia	3265_5371_6774_1050	4	0.000152496	0.010217238	0.000392971
3544	hsa-mir-1278	hsa04020	Calcium signaling pathway	2902_2906_5578_808_801_805	6	0.00016668	0.011167554	0.000413613
3545	hsa-mir-1278	hsa05216	Thyroid cancer	6256_3265_7157	3	0.000339503	0.022746685	0.000812382
3546	hsa-mir-1278	hsa04910	Insulin signaling pathway	2932_3265_808_801_805	5	0.000372008	0.024924563	0.000855332
3547	hsa-mir-1278	hsa04070	Phosphatidylinositol signaling system	5578_808_801_805	4	0.000382984	0.025659961	0.000855332
3548	hsa-mir-1278	hsa04012	ErbB signaling pathway	2932_3265_5578_3725	4	0.000624345	0.041831087	0.00134939
3549	hsa-mir-1278	hsa05213	Endometrial cancer	2932_3265_7157	3	0.001672398	0.112050656	0.003501583
3550	hsa-mir-1278	hsa04270	Vascular smooth muscle contraction	5578_808_801_805	4	0.00185464	0.124260853	0.00376548
3551	hsa-mir-1278	hsa04115	p53 signaling pathway	1019_1017_7157	3	0.003607799	0.241722523	0.007109486
3552	hsa-mir-1278	hsa04662	B cell receptor signaling pathway	2932_3265_3725	3	0.004517931	0.30270138	0.008648611
3553	hsa-mir-1278	hsa04370	VEGF signaling pathway	3265_1432_5578	3	0.00484935	0.324906462	0.00902518
3554	hsa-mir-1278	hsa04664	Fc epsilon RI signaling pathway	3265_1432_5578	3	0.005195089	0.348070943	0.009407323
3555	hsa-mir-1278	hsa03022	Basal transcription factors	2963_9519	2	0.011975762	0.802376058	0.021115159
3556	hsa-mir-1278	hsa04510	Focal adhesion	2932_3265_5578_3725	4	0.012507406	0.837996204	0.021487082
3557	hsa-mir-1278	hsa04120	Ubiquitin mediated proteolysis	997_5371_7329	3	0.022819546	1	0.03822274
3558	hsa-mir-1278	hsa05217	Basal cell carcinoma	2932_7157	2	0.024548139	1	0.040115252
3559	hsa-mir-1278	hsa04630	Jak-STAT signaling pathway	1387_6774_2033	3	0.030013134	1	0.047878094
3560	hsa-mir-1278	hsa04920	Adipocytokine signaling pathway	6256_6774	2	0.034918408	1	0.054407752
3561	hsa-mir-1278	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_3725	2	0.038691172	1	0.057606856
3562	hsa-mir-1278	hsa04730	Long-term depression	3265_5578	2	0.038691172	1	0.057606856
3563	hsa-mir-1279	hsa05200	Pathways in cancer	5371_1499_5594_5599_6258_1387_6257_6256_8031_1487_1488_836_367_842_841_6774_5970_4824_6688_2113_3725_4087_4088_5881_1050_5925_2033_8554_2353_7186	30	1.04E-26	6.94E-25	6.94E-25
3564	hsa-mir-1279	hsa04010	MAPK signaling pathway	5594_5599_9261_3303_836_1649_5970_10912_468_3725_3727_6195_5881_4616_2353_2002_2005_7186	18	3.82E-14	2.56E-12	1.28E-12
3565	hsa-mir-1279	hsa05215	Prostate cancer	1499_5594_1385_1387_367_842_5970_4824_468_5925_2033	11	7.30E-12	4.89E-10	1.37E-10
3566	hsa-mir-1279	hsa05212	Pancreatic cancer	1499_5594_1385_1387_367_842_5970_4824_468_5925_2033	11	8.16E-12	5.47E-10	1.37E-10
3567	hsa-mir-1279	hsa05210	Colorectal cancer	1499_5594_5599_836_842_3725_4087_4088_5881_2353	10	1.05E-10	7.00E-09	1.27E-09
3568	hsa-mir-1279	hsa04310	Wnt signaling pathway	815_1499_5599_1387_1487_1488_3725_1457_4087_4088_5881_2033	12	1.14E-10	7.64E-09	1.27E-09
3569	hsa-mir-1279	hsa04520	Adherens junction	1499_6714_5594_1387_1457_4087_4088_5881_2033	9	1.46E-09	9.77E-08	1.40E-08
3570	hsa-mir-1279	hsa04110	Cell cycle	993_5591_1387_983_10912_4087_4088_4616_5925_2033	10	2.42E-09	1.62E-07	2.02E-08
3571	hsa-mir-1279	hsa04920	Adipocytokine signaling pathway	10891_5599_6258_6257_6256_6774_5970_7186	8	7.96E-09	5.34E-07	5.93E-08
3572	hsa-mir-1279	hsa05216	Thyroid cancer	1499_5594_6258_6257_6256_8031	6	3.36E-08	2.25E-06	2.25E-07
3573	hsa-mir-1279	hsa05222	Small cell lung cancer	6258_6257_6256_842_5970_5925_8554_7186	8	4.81E-08	3.23E-06	2.93E-07
3574	hsa-mir-1279	hsa04330	Notch signaling pathway	1387_1487_1488_9612_2033_8850	6	4.38E-07	2.93E-05	2.44E-06
3575	hsa-mir-1279	hsa05223	Non-small cell lung cancer	5594_6258_6257_6256_842_5925	6	9.25E-07	6.20E-05	4.69E-06
3576	hsa-mir-1279	hsa04210	Apoptosis	836_839_842_841_840_5970_7186	7	9.81E-07	6.57E-05	4.69E-06
3577	hsa-mir-1279	hsa05221	Acute myeloid leukemia	5371_5594_6774_5970_6688_1050	6	1.49E-06	0.000100028	6.67E-06
3578	hsa-mir-1279	hsa04912	GnRH signaling pathway	815_6714_5594_5599_468_3725_2002	7	3.31E-06	0.000221557	1.37E-05
3579	hsa-mir-1279	hsa04115	p53 signaling pathway	983_836_842_841_10912_4616	6	3.48E-06	0.000233161	1.37E-05
3580	hsa-mir-1279	hsa04720	Long-term potentiation	815_5594_1387_468_6195_2033	6	5.46E-06	0.000365832	1.93E-05
3581	hsa-mir-1279	hsa05220	Chronic myeloid leukemia	5594_1487_1488_5970_4088_5925	6	5.46E-06	0.000365832	1.93E-05
3582	hsa-mir-1279	hsa04350	TGF-beta signaling pathway	5594_1387_659_4087_4088_2033	6	1.22E-05	0.000814296	3.86E-05
3583	hsa-mir-1279	hsa04012	ErbB signaling pathway	815_6714_5594_5599_3725_2002	6	1.22E-05	0.000814296	3.86E-05
3584	hsa-mir-1279	hsa05016	Huntington's disease	10891_1385_1387_6908_836_842_841_2033	8	1.27E-05	0.000848174	3.86E-05
3585	hsa-mir-1279	hsa04620	Toll-like receptor signaling pathway	5594_5599_841_5970_3725_2353	6	2.85E-05	0.001911614	8.31E-05
3586	hsa-mir-1279	hsa04916	Melanogenesis	815_1499_5594_1385_1387_2033	6	3.17E-05	0.002120643	8.84E-05
3587	hsa-mir-1279	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_5599_836_5970_3725	5	6.05E-05	0.004050966	0.000162039
3588	hsa-mir-1279	hsa05211	Renal cell carcinoma	5594_1387_2113_3725_2033	5	6.44E-05	0.004313388	0.0001659
3589	hsa-mir-1279	hsa03022	Basal transcription factors	2962_2969_6908_2959	4	7.29E-05	0.004885445	0.000180942
3590	hsa-mir-1279	hsa04662	B cell receptor signaling pathway	5594_5970_3725_5881_2353	5	7.73E-05	0.005179892	0.000184996
3591	hsa-mir-1279	hsa04370	VEGF signaling pathway	6714_5594_9261_842_5881	5	8.70E-05	0.005828012	0.000200966
3592	hsa-mir-1279	hsa04510	Focal adhesion	1499_6714_5594_5599_3725_5881_2002	7	0.000172955	0.011587994	0.000386266
3593	hsa-mir-1279	hsa05213	Endometrial cancer	1499_5594_842_2002	4	0.000248222	0.01663085	0.000536479
3594	hsa-mir-1279	hsa05010	Alzheimer's disease	22926_5594_836_842_841_840	6	0.000512584	0.034343138	0.001073223
3595	hsa-mir-1279	hsa03320	PPAR signaling pathway	6258_6257_6256_2168	4	0.000720827	0.048295398	0.001463497
3596	hsa-mir-1279	hsa04612	Antigen processing and presentation	1385_3303_4800_1514	4	0.001688818	0.113150828	0.003327966
3597	hsa-mir-1279	hsa04660	T cell receptor signaling pathway	5594_5970_3725_2353	4	0.003534898	0.236838193	0.006766806
3598	hsa-mir-1279	hsa05214	Glioma	815_5594_5925	3	0.006105966	0.409099709	0.011363881
3599	hsa-mir-1279	hsa04910	Insulin signaling pathway	10891_5594_5599_2002	4	0.00765279	0.512736919	0.013857755
3600	hsa-mir-1279	hsa04950	Maturity onset diabetes of the young	3172_6928	2	0.008764897	0.587248113	0.015453898
3601	hsa-mir-1279	hsa04664	Fc epsilon RI signaling pathway	5594_5599_5881	3	0.010210894	0.684129919	0.017541793
3602	hsa-mir-1279	hsa04630	Jak-STAT signaling pathway	1387_6774_2033_8554	4	0.011261611	0.754527962	0.018863199
3603	hsa-mir-1279	hsa04540	Gap junction	6714_5594_983	3	0.015593219	1	0.025481602
3604	hsa-mir-1279	hsa05219	Bladder cancer	5594_5925	2	0.023939006	1	0.038188415
3605	hsa-mir-1279	hsa04930	Type II diabetes mellitus	5594_5599	2	0.027067872	1	0.042175521
3606	hsa-mir-1279	hsa04150	mTOR signaling pathway	5594_6195	2	0.034961506	1	0.053236839
3607	hsa-mir-1279	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_842	2	0.039823266	1	0.059292418
3608	hsa-mir-1279	hsa04530	Tight junction	1499_6714_1457	3	0.041156755	1	0.05971427
3609	hsa-mir-1279	hsa04650	Natural killer cell mediated cytotoxicity	5594_836_5881	3	0.041889115	1	0.05971427
3610	hsa-mir-1280	hsa04010	MAPK signaling pathway	9344_6722_5606_5601_5600_2885_5595_1432_5594_5604_5599_2005_2353	13	7.65E-18	3.82E-16	3.82E-16
3611	hsa-mir-1280	hsa04664	Fc epsilon RI signaling pathway	5606_5601_5600_2885_5595_1432_5594_5604_5599	9	9.21E-16	4.61E-14	2.30E-14
3612	hsa-mir-1280	hsa04620	Toll-like receptor signaling pathway	5606_5601_5600_5595_1432_5594_5604_5599_2353	9	8.00E-15	4.00E-13	1.33E-13
3613	hsa-mir-1280	hsa04912	GnRH signaling pathway	5606_5601_5600_2885_5595_1432_5594_5604_5599	9	1.30E-14	6.50E-13	1.63E-13
3614	hsa-mir-1280	hsa04350	TGF-beta signaling pathway	2033_5518_5595_5594_3397_3399_3398_1387	8	2.08E-13	1.04E-11	2.08E-12
3615	hsa-mir-1280	hsa04660	T cell receptor signaling pathway	5601_5600_2885_5595_1432_5594_5604_2353	8	1.23E-12	6.15E-11	1.03E-11
3616	hsa-mir-1280	hsa05200	Pathways in cancer	5601_2885_2033_9063_5595_5594_5604_5599_2353_1387	10	6.28E-12	3.14E-10	4.49E-11
3617	hsa-mir-1280	hsa05210	Colorectal cancer	5601_2885_5595_5594_5604_5599_2353	7	1.44E-11	7.20E-10	8.99E-11
3618	hsa-mir-1280	hsa05211	Renal cell carcinoma	2885_2033_5595_5594_5604_1387	6	4.61E-10	2.31E-08	2.56E-09
3619	hsa-mir-1280	hsa04012	ErbB signaling pathway	5601_2885_5595_5594_5604_5599	6	1.35E-09	6.76E-08	6.41E-09
3620	hsa-mir-1280	hsa05215	Prostate cancer	2885_2033_5595_5594_5604_1387	6	1.44E-09	7.21E-08	6.41E-09
3621	hsa-mir-1280	hsa05212	Pancreatic cancer	2885_2033_5595_5594_5604_1387	6	1.54E-09	7.69E-08	6.41E-09
3622	hsa-mir-1280	hsa04910	Insulin signaling pathway	5601_2885_5595_5594_5604_5599	6	1.89E-08	9.46E-07	7.28E-08
3623	hsa-mir-1280	hsa04720	Long-term potentiation	2033_5595_5594_5604_1387	5	4.17E-08	2.09E-06	1.39E-07
3624	hsa-mir-1280	hsa04662	B cell receptor signaling pathway	2885_5595_5594_5604_2353	5	4.17E-08	2.09E-06	1.39E-07
3625	hsa-mir-1280	hsa04370	VEGF signaling pathway	5600_5595_1432_5594_5604	5	4.73E-08	2.36E-06	1.48E-07
3626	hsa-mir-1280	hsa04510	Focal adhesion	5601_2885_5595_5594_5604_5599	6	1.88E-07	9.40E-06	5.49E-07
3627	hsa-mir-1280	hsa04916	Melanogenesis	2033_5595_5594_5604_1387	5	1.98E-07	9.89E-06	5.49E-07
3628	hsa-mir-1280	hsa04930	Type II diabetes mellitus	5601_5595_5594_5599	4	3.54E-07	1.77E-05	9.32E-07
3629	hsa-mir-1280	hsa05213	Endometrial cancer	2885_5595_5594_5604	4	6.10E-07	3.05E-05	1.53E-06
3630	hsa-mir-1280	hsa05223	Non-small cell lung cancer	2885_5595_5594_5604	4	7.04E-07	3.52E-05	1.68E-06
3631	hsa-mir-1280	hsa05221	Acute myeloid leukemia	2885_5595_5594_5604	4	9.84E-07	4.92E-05	2.24E-06
3632	hsa-mir-1280	hsa04310	Wnt signaling pathway	5601_2033_5518_5599_1387	5	1.21E-06	6.05E-05	2.63E-06
3633	hsa-mir-1280	hsa05214	Glioma	2885_5595_5594_5604	4	1.42E-06	7.10E-05	2.96E-06
3634	hsa-mir-1280	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5601_5600_1432_5599	4	1.99E-06	9.94E-05	3.82E-06
3635	hsa-mir-1280	hsa04730	Long-term depression	5518_5595_5594_5604	4	1.99E-06	9.94E-05	3.82E-06
3636	hsa-mir-1280	hsa05220	Chronic myeloid leukemia	2885_5595_5594_5604	4	2.45E-06	0.000122433	4.53E-06
3637	hsa-mir-1280	hsa04520	Adherens junction	2033_5595_5594_1387	4	3.13E-06	0.000156559	5.59E-06
3638	hsa-mir-1280	hsa04540	Gap junction	2885_5595_5594_5604	4	5.56E-06	0.000278038	9.59E-06
3639	hsa-mir-1280	hsa05216	Thyroid cancer	5595_5594_5604	3	7.66E-06	0.000382859	1.28E-05
3640	hsa-mir-1280	hsa05219	Bladder cancer	5595_5594_5604	3	2.17E-05	0.001083652	3.50E-05
3641	hsa-mir-1280	hsa04650	Natural killer cell mediated cytotoxicity	2885_5595_5594_5604	4	2.51E-05	0.001253747	3.92E-05
3642	hsa-mir-1280	hsa04630	Jak-STAT signaling pathway	2885_2033_9063_1387	4	3.90E-05	0.001951416	5.91E-05
3643	hsa-mir-1280	hsa05014	Amyotrophic lateral sclerosis (ALS)	5606_5600_1432	3	4.91E-05	0.002454174	7.22E-05
3644	hsa-mir-1280	hsa04062	Chemokine signaling pathway	2885_5595_5594_5604	4	8.97E-05	0.004485156	0.000128147
3645	hsa-mir-1280	hsa05218	Melanoma	5595_5594_5604	3	9.67E-05	0.004833666	0.000134268
3646	hsa-mir-1280	hsa04270	Vascular smooth muscle contraction	5595_5594_5604	3	0.000413191	0.020659557	0.000558366
3647	hsa-mir-1280	hsa04120	Ubiquitin mediated proteolysis	7329_9063_672	3	0.000658843	0.032942171	0.000866899
3648	hsa-mir-1280	hsa05010	Alzheimer's disease	6622_5595_5594	3	0.001306622	0.065331101	0.001675156
3649	hsa-mir-1280	hsa04330	Notch signaling pathway	2033_1387	2	0.001585339	0.07926697	0.001981674
3650	hsa-mir-1280	hsa04150	mTOR signaling pathway	5595_5594	2	0.001921856	0.096092782	0.002343726
3651	hsa-mir-1280	hsa04810	Regulation of actin cytoskeleton	5595_5594_5604	3	0.002375874	0.118793691	0.002828421
3652	hsa-mir-1280	hsa04920	Adipocytokine signaling pathway	5601_5599	2	0.003115381	0.155769066	0.003622536
3653	hsa-mir-1280	hsa04110	Cell cycle	2033_1387	2	0.009272164	0.463608215	0.01053655
3654	hsa-mir-1280	hsa04670	Leukocyte transendothelial migration	5600_1432	2	0.009717756	0.485887824	0.010797507
3655	hsa-mir-1280	hsa04360	Axon guidance	5595_5594	2	0.011110669	0.555533448	0.012076814
3656	hsa-mir-1280	hsa05016	Huntington's disease	2033_1387	2	0.021779742	1	0.023169938
3657	hsa-mir-1281	hsa05200	Pathways in cancer	7046_5467_1499_595_1019_2261_8517_4193_6934_7704_3551_5578_3091_7175_3066_3065_1050_5925_7184_5747_25_405_1956_1487_4436_2113_861_10401_207_4286_3716_1147_4233_1017_5595_5594_5599_1387_2064_6256_9915_367_2932_6774_6776_6777_6772_5979_5879_7157_6688_7849_1869_3725_4088_4089_2034_2033_5468_4790_4791_4792_5970_3320_3326_51176_5371_3480_5159_5156_5604_5601_3815_3265_4087_8772_4609_2956_1026_2736_2353_1488_1441_8554	84	1.81E-42	1.54E-40	1.54E-40
3658	hsa-mir-1281	hsa04010	MAPK signaling pathway	3925_6722_3727_7046_6195_6197_2261_2264_8517_3551_5578_1845_4773_8986_1956_7132_3303_1432_4342_22800_3305_207_1147_5595_5594_5599_1386_9252_3310_3312_1649_5971_5879_3164_7157_468_3725_6196_4790_4791_51701_5970_1616_5159_9261_1326_5156_5604_4208_5601_5600_5603_3265_6885_4609_2353_8550_2002_5566	59	5.42E-27	4.61E-25	2.30E-25
3659	hsa-mir-1281	hsa05215	Prostate cancer	1499_595_8517_4193_6934_3551_5925_7184_1956_207_9586_1147_1017_5595_5594_1387_2064_367_2932_7157_468_1869_2033_4790_4792_5970_3320_3326_51176_3480_5159_5156_5604_3265_1026	35	1.20E-23	1.02E-21	3.39E-22
3660	hsa-mir-1281	hsa05212	Pancreatic cancer	1499_595_8517_4193_6934_3551_5925_7184_1956_207_9586_1147_1017_5595_5594_1387_2064_367_2932_7157_468_1869_2033_4790_4792_5970_3320_3326_51176_3480_5159_5156_5604_3265_1026	35	1.62E-23	1.38E-21	3.44E-22
3661	hsa-mir-1281	hsa05220	Chronic myeloid leukemia	7046_595_1019_8517_4193_3551_3066_3065_5925_25_1487_861_207_1147_5595_5594_6776_6777_7157_1869_4088_4089_4790_4792_5970_5604_3265_5781_4609_1026_1488	31	1.70E-21	1.45E-19	2.90E-20
3662	hsa-mir-1281	hsa03022	Basal transcription factors	6880_6881_54457_2958_6872_138474_6883_2960_2957_6879_2967_2961_2963_2969_2968_6878_6877_6874_6873_6908_6884_6882_2959_9519	24	2.01E-20	1.71E-18	2.85E-19
3663	hsa-mir-1281	hsa04310	Wnt signaling pathway	818_817_5467_1499_595_6934_5578_4772_4773_1460_8945_23291_1487_5599_1387_2932_5879_7157_8061_3725_1457_1459_4088_4089_2033_8607_51701_51176_5601_6500_8454_4087_6885_4609_5527_1488_5566	37	7.22E-19	6.14E-17	8.77E-18
3664	hsa-mir-1281	hsa04630	Jak-STAT signaling pathway	3559_595_58985_3454_3455_3459_3560_3561_1439_2690_10401_207_3717_3716_3718_85480_1387_3575_3570_3572_6778_6774_6776_6777_6772_6773_7297_2033_149233_3953_5781_4609_1441_8554_10379	35	4.77E-17	4.05E-15	5.07E-16
3665	hsa-mir-1281	hsa05221	Acute myeloid leukemia	5467_595_8517_6934_7704_3551_1050_861_207_1147_5595_5594_6774_6776_6777_6688_4790_5970_51176_5371_5604_3815_3265_4609	24	7.93E-17	6.74E-15	7.49E-16
3666	hsa-mir-1281	hsa05210	Colorectal cancer	7046_1499_595_6934_1956_4436_207_4233_5595_5594_5599_2932_5879_7157_3725_4088_4089_51176_3480_5159_5156_5604_5601_4087_4609_2956_2353	27	1.20E-16	1.02E-14	1.02E-15
3667	hsa-mir-1281	hsa04110	Cell cycle	595_1019_4193_4174_4171_4172_3066_3065_5925_25_8379_5934_5933_5591_1017_1387_2932_7027_7157_5111_1869_4088_4089_2033_6500_8454_4085_4087_1026_1028	30	6.55E-16	5.57E-14	5.06E-15
3668	hsa-mir-1281	hsa04350	TGF-beta signaling pathway	7046_4086_90_57154_1875_6667_3397_3399_3398_1874_5934_5933_3400_5595_5594_1387_7027_4088_4089_2033_4093_6500_8454_4087_4609_4092	26	1.88E-15	1.60E-13	1.33E-14
3669	hsa-mir-1281	hsa04520	Adherens junction	7046_1499_6934_1460_2534_1956_6714_71_2241_4233_5595_5594_1387_2064_5879_1457_1459_4088_4089_2033_51701_51176_3480_4087_6885	25	2.77E-15	2.36E-13	1.81E-14
3670	hsa-mir-1281	hsa04620	Toll-like receptor signaling pathway	8517_3551_3454_3455_3665_3661_1432_207_1147_3654_5595_5594_5599_6772_5879_3725_4790_4792_5970_1326_5604_5601_5600_5603_8772_6885_2353	27	6.73E-15	5.72E-13	4.09E-14
3671	hsa-mir-1281	hsa04660	T cell receptor signaling pathway	1019_8517_3551_4772_4773_2534_3932_1432_4794_207_1147_5595_5594_2932_3725_4790_4792_4793_5970_1326_5604_5601_5600_5603_3265_6885_2353	27	3.22E-14	2.74E-12	1.78E-13
3672	hsa-mir-1281	hsa05214	Glioma	818_817_595_1019_4193_5578_5925_1956_207_5595_5594_7157_1869_808_801_805_3480_5159_5156_5604_3265_1026	22	3.35E-14	2.84E-12	1.78E-13
3673	hsa-mir-1281	hsa04920	Adipocytokine signaling pathway	10891_5465_8517_3551_7133_7132_4794_207_3717_1147_8717_5599_6256_6774_4790_4792_4793_5970_5601_3953_5781	21	4.41E-13	3.74E-11	2.20E-12
3674	hsa-mir-1281	hsa05216	Thyroid cancer	1499_595_6934_7175_5595_5594_6256_5979_7157_7849_5468_51176_5604_3265_4609	15	3.34E-12	2.84E-10	1.58E-11
3675	hsa-mir-1281	hsa04012	ErbB signaling pathway	818_817_5578_5747_25_1956_6714_207_5595_5594_5599_2064_2932_6776_6777_3725_5604_5601_3265_4609_1026_2002	22	4.60E-12	3.91E-10	2.06E-11
3676	hsa-mir-1281	hsa04062	Chemokine signaling pathway	1234_8517_3551_653361_5747_5580_7852_2309_207_3055_3717_1147_3718_5590_5595_5594_1230_2932_6774_6777_6772_6773_5879_4790_4792_4793_5970_5604_3265_2185_5566	31	8.20E-12	6.97E-10	3.48E-11
3677	hsa-mir-1281	hsa04662	B cell receptor signaling pathway	8517_3551_4772_4773_6850_4794_207_1147_5595_5594_2932_5879_3725_4790_4792_4793_5970_5604_3265_2353	20	1.90E-11	1.61E-09	7.68E-11
3678	hsa-mir-1281	hsa05219	Bladder cancer	595_1019_2261_4193_5925_1956_5595_5594_2064_9252_7157_1869_5604_3265_4609_1026	16	2.48E-11	2.11E-09	9.57E-11
3679	hsa-mir-1281	hsa04912	GnRH signaling pathway	818_817_5578_5580_1956_6714_1432_5595_5594_5599_468_3725_808_801_805_5604_5601_5600_5603_3265_2185_2002_5566	23	3.08E-11	2.62E-09	1.14E-10
3680	hsa-mir-1281	hsa04720	Long-term potentiation	818_817_6195_6197_5578_2902_5595_5594_1387_468_6196_2033_808_801_805_5604_3265_2906_5566	19	1.28E-10	1.08E-08	4.52E-10
3681	hsa-mir-1281	hsa05213	Endometrial cancer	1499_595_6934_1956_2309_207_5595_5594_2064_2932_7157_51176_5604_3265_4609_2002	16	3.37E-10	2.87E-08	1.15E-09
3682	hsa-mir-1281	hsa05218	Melanoma	595_1019_4193_5925_1956_207_4286_4233_5595_5594_7157_1869_3480_5159_5156_5604_3265_1026	18	3.87E-10	3.29E-08	1.26E-09
3683	hsa-mir-1281	hsa04330	Notch signaling pathway	1840_3066_3065_22938_1487_3280_2648_388585_1387_9612_2033_8850_9794_1488_4851	15	7.90E-10	6.71E-08	2.49E-09
3684	hsa-mir-1281	hsa04060	Cytokine-cytokine receptor interaction	3556_3559_7046_8600_1234_58985_3454_3455_3459_90_3791_1956_7852_3560_3561_7133_7132_1439_2690_85480_4233_1230_3575_3570_3572_2321_149233_5159_5156_3815_3953_1441	32	2.00E-09	1.70E-07	6.06E-09
3685	hsa-mir-1281	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	8517_3551_1956_6714_1432_1147_4233_5599_5879_3725_4790_4792_5970_5601_5600_5603_5781	17	2.50E-09	2.12E-07	7.31E-09
3686	hsa-mir-1281	hsa05223	Non-small cell lung cancer	595_1019_5578_5925_1956_2309_207_5595_5594_2064_6256_7157_1869_5604_3265	15	3.90E-09	3.32E-07	1.11E-08
3687	hsa-mir-1281	hsa05222	Small cell lung cancer	595_1019_8517_3551_5925_5747_10401_207_1147_1017_6256_7157_1869_4790_4792_5970_4609_8554	18	5.39E-09	4.58E-07	1.48E-08
3688	hsa-mir-1281	hsa04510	Focal adhesion	1499_595_5578_2534_5747_3791_1956_6714_10627_207_71_4233_5595_5594_5599_2064_2932_5879_3725_2321_3480_5159_5156_5604_5601_3265_2002	27	9.47E-09	8.05E-07	2.52E-08
3689	hsa-mir-1281	hsa04916	Melanogenesis	818_817_1499_6934_5578_4286_5595_5594_1387_2932_2033_808_801_805_51176_5604_3815_3265_5566	19	1.43E-08	1.22E-06	3.69E-08
3690	hsa-mir-1281	hsa05211	Renal cell carcinoma	3091_405_2113_207_4233_5595_5594_1387_9915_5879_3725_2034_2033_5604_3265_5781	16	1.82E-08	1.55E-06	4.56E-08
3691	hsa-mir-1281	hsa04370	VEGF signaling pathway	5578_4772_4773_5747_3791_6714_1432_207_5595_5594_5879_9261_5604_5600_5603_3265	16	4.13E-08	3.51E-06	1.00E-07
3692	hsa-mir-1281	hsa04210	Apoptosis	3556_8517_3551_8837_7132_1439_207_1147_3654_8717_7157_4790_4792_5970_840_8772_5566	17	4.63E-08	3.93E-06	1.09E-07
3693	hsa-mir-1281	hsa04664	Fc epsilon RI signaling pathway	5578_2534_5580_6850_1432_207_5595_5594_5599_5879_5604_5601_5600_5603_3265	15	3.03E-07	2.58E-05	6.97E-07
3694	hsa-mir-1281	hsa05322	Systemic lupus erythematosus	3021_3020_9555_8349_8365_8368_8364_3015_3014_8294_8370_121504_8361_8360_8363_8362_8367_8366_8359_8340	20	3.36E-07	2.86E-05	7.52E-07
3695	hsa-mir-1281	hsa04540	Gap junction	5592_5578_10382_7278_203068_1956_6714_5595_5594_347733_5159_5156_5604_3265_84617_5566	16	4.01E-07	3.41E-05	8.75E-07
3696	hsa-mir-1281	hsa05016	Huntington's disease	10891_293_1213_292_3066_3065_3064_2902_6667_5441_9586_1387_9001_5430_5437_7157_23186_2033_5468_6874_6908_9519	22	1.24E-06	0.000105247	2.63E-06
3697	hsa-mir-1281	hsa04910	Insulin signaling pathway	10891_3551_5211_207_5590_5595_5594_5599_23265_2932_808_801_805_5604_5601_3265_2002_5566	18	2.87E-06	0.000244235	5.96E-06
3698	hsa-mir-1281	hsa04530	Tight junction	1499_1019_5578_1460_5580_6714_4627_4628_22800_8573_10627_207_71_5590_1457_1459_3265	17	9.77E-06	0.000830549	1.98E-05
3699	hsa-mir-1281	hsa04120	Ubiquitin mediated proteolysis	55294_4193_3093_8945_57154_23291_10401_7323_8925_997_10273_5371_672_6500_8454_7329_8554	17	1.16E-05	0.000986305	2.29E-05
3700	hsa-mir-1281	hsa04650	Natural killer cell mediated cytotoxicity	5578_3454_3455_3459_4772_4773_2534_3932_6850_5595_5594_5879_5604_3265_5781_2185	16	3.76E-05	0.003194428	7.26E-05
3701	hsa-mir-1281	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_7133_7132_1432_5879_7157_1616_5600_5603_2906	10	4.52E-05	0.003840173	8.17E-05
3702	hsa-mir-1281	hsa05131	Shigellosis	1499_5578_10382_7278_2534_25_203068_71_347733_84617	10	4.52E-05	0.003840173	8.17E-05
3703	hsa-mir-1281	hsa05130	Pathogenic Escherichia coli infection	1499_5578_10382_7278_2534_25_203068_71_347733_84617	10	4.52E-05	0.003840173	8.17E-05
3704	hsa-mir-1281	hsa03410	Base excision repair	4350_142_252969_3146_328_2237_5111_6996	8	6.87E-05	0.005837572	0.000121616
3705	hsa-mir-1281	hsa03020	RNA polymerase	25885_51082_5441_64425_5430_5437_84172	7	0.000125622	0.010677899	0.000217916
3706	hsa-mir-1281	hsa04930	Type II diabetes mellitus	3551_5580_3651_5590_5595_5594_5599_5601	8	0.000266384	0.022642641	0.000452853
3707	hsa-mir-1281	hsa04020	Calcium signaling pathway	818_817_293_5578_292_147_1956_2902_2064_808_801_805_5159_5156_2906_2185_5566	17	0.000278565	0.023678041	0.000464275
3708	hsa-mir-1281	hsa04270	Vascular smooth muscle contraction	5592_5578_147_5580_5595_5594_4637_808_801_805_59_5604_5566	13	0.000308695	0.026239048	0.000504597
3709	hsa-mir-1281	hsa04950	Maturity onset diabetes of the young	5080_6927_3280_3651_168620_4760	6	0.00032719	0.027811129	0.000524738
3710	hsa-mir-1281	hsa03030	DNA replication	5981_4174_4171_4172_2237_5111_6118	7	0.000399142	0.033927091	0.000628279
3711	hsa-mir-1281	hsa04670	Leukocyte transendothelial migration	1499_5578_653361_5747_7852_1432_10627_71_5879_5600_5603_5781_2185	13	0.000413778	0.035171144	0.000639475
3712	hsa-mir-1281	hsa04360	Axon guidance	4772_4773_2534_5747_25_7852_2242_4233_5595_5594_2932_5879_3265	13	0.000765252	0.06504639	0.001161543
3713	hsa-mir-1281	hsa04810	Regulation of actin cytoskeleton	2261_2264_5747_1956_4627_4628_4342_22800_10627_71_5595_5594_5879_5159_5156_5604_3265_10788	18	0.001114121	0.094700322	0.001661409
3714	hsa-mir-1281	hsa03420	Nucleotide excision repair	5981_5886_5111_5887_2967_2968_6118	7	0.001148979	0.097663236	0.001683849
3715	hsa-mir-1281	hsa04612	Antigen processing and presentation	3309_3303_3305_3310_3312_3320_3326_4800_4801_2923	10	0.001293573	0.109953734	0.001863623
3716	hsa-mir-1281	hsa03430	Mismatch repair	5981_4436_5111_2956_6118	5	0.001778349	0.151159641	0.002519327
3717	hsa-mir-1281	hsa03450	Non-homologous end-joining	10111_2237_5591_4361	4	0.002237679	0.190202721	0.003118077
3718	hsa-mir-1281	hsa04150	mTOR signaling pathway	6195_6197_3091_207_5595_5594_6196	7	0.002715303	0.230800783	0.003722593
3719	hsa-mir-1281	hsa04115	p53 signaling pathway	595_1019_4194_4193_1017_7157_1026_7161	8	0.003227627	0.274348266	0.004354734
3720	hsa-mir-1281	hsa05340	Primary immunodeficiency	8517_3932_3561_3718_3575	5	0.00868455	0.738186716	0.011534167
3721	hsa-mir-1281	hsa04730	Long-term depression	5592_5578_5595_5594_3480_5604_3265	7	0.012503366	1	0.016350556
3722	hsa-mir-1281	hsa05217	Basal cell carcinoma	1499_6934_2932_7157_51176_2736	6	0.013248698	1	0.017051694
3723	hsa-mir-1281	hsa04710	Circadian rhythm - mammal	4862_79365_8553	3	0.013440747	1	0.017051694
3724	hsa-mir-1281	hsa03440	Homologous recombination	10111_4683_6118_4361	4	0.018464249	1	0.023080311
3725	hsa-mir-1281	hsa05010	Alzheimer's disease	2902_7132_5595_5594_2932_808_351_801_805_840_2906_8772	12	0.02126003	1	0.026189893
3726	hsa-mir-1281	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	0.027017888	1	0.032807436
3727	hsa-mir-1281	hsa04340	Hedgehog signaling pathway	8945_23291_2932_2736_5566	5	0.048346463	1	0.057879568
3728	hsa-mir-128-1	hsa05200	Pathways in cancer	3320_25_4149_5371_9063_1499_5595_5594_5599_5914_1387_6256_595_5601_5602_836_367_2932_861_7704_6772_3091_5970_7428_6934_1870_1871_2885_7157_4087_6688_2113_5894_4609_1869_3725_5604_862_1029_6774_6502_2353_4088_4089_3066_3065_4292_1050_5925_2034_2033_4846_8554	53	3.21E-38	2.34E-36	2.34E-36
3729	hsa-mir-128-1	hsa04010	MAPK signaling pathway	6722_4149_3727_5595_5594_5599_5598_9261_4208_5601_5600_5602_836_7867_3312_1386_1432_5970_9344_2885_7157_468_5894_4773_4609_3725_5604_5606_2353_4763_1649_8550_2005	33	1.06E-20	7.77E-19	3.88E-19
3730	hsa-mir-128-1	hsa05220	Chronic myeloid leukemia	25_5595_5594_595_861_5970_1870_1871_2885_7157_5894_4609_1869_5604_1029_4088_4089_3066_3065_5925_6464	21	4.18E-20	3.05E-18	1.02E-18
3731	hsa-mir-128-1	hsa04110	Cell cycle	25_990_5591_7533_1387_595_983_2932_8454_6500_1870_1871_7157_4087_1869_1029_6502_4088_4089_3066_3065_5925_2033_5933	24	6.48E-20	4.73E-18	1.18E-18
3732	hsa-mir-128-1	hsa05210	Colorectal cancer	1499_5595_5594_5599_595_5601_5602_836_2932_6934_2885_7157_4087_5894_4609_3725_5604_2353_4088_4089_4292	21	3.07E-19	2.24E-17	4.48E-18
3733	hsa-mir-128-1	hsa05215	Prostate cancer	3320_1499_5595_5594_1387_595_367_2932_5970_6934_1870_1871_2885_7157_468_5894_1869_5604_5925_2033_9586	21	6.98E-19	5.10E-17	8.50E-18
3734	hsa-mir-128-1	hsa05212	Pancreatic cancer	3320_1499_5595_5594_1387_595_367_2932_5970_6934_1870_1871_2885_7157_468_5894_1869_5604_5925_2033_9586	21	8.53E-19	6.23E-17	8.90E-18
3735	hsa-mir-128-1	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_861_7704_5970_6934_2885_6688_5894_4609_5604_862_6774_1050	17	1.07E-16	7.79E-15	9.73E-16
3736	hsa-mir-128-1	hsa05214	Glioma	5595_5594_595_1870_1871_2885_7157_5894_1869_5604_1029_5925_6464_808_801_805	16	7.05E-15	5.14E-13	5.72E-14
3737	hsa-mir-128-1	hsa04310	Wnt signaling pathway	1499_5599_1387_595_5601_5602_1459_2932_8454_6500_6934_7157_4087_4773_4609_3725_1457_4088_4089_2033_8061	21	1.19E-14	8.68E-13	8.68E-14
3738	hsa-mir-128-1	hsa04350	TGF-beta signaling pathway	3400_5595_5594_1387_8454_3397_3399_3398_6500_4087_4609_4088_4089_2033_5933_6667	16	3.64E-13	2.66E-11	2.41E-12
3739	hsa-mir-128-1	hsa04912	GnRH signaling pathway	5595_5594_5599_5598_5601_5600_5602_1432_2885_468_5894_3725_5604_5606_808_801_805	17	6.27E-13	4.58E-11	3.81E-12
3740	hsa-mir-128-1	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_2885_7157_5894_1869_5604_1029_5925	13	3.13E-12	2.29E-10	1.76E-11
3741	hsa-mir-128-1	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_5894_4609_1869_5604_1029_5925	12	3.89E-12	2.84E-10	2.03E-11
3742	hsa-mir-128-1	hsa05213	Endometrial cancer	1499_5595_5594_595_2932_6934_2885_7157_5894_4609_5604_4292	12	3.31E-11	2.42E-09	1.61E-10
3743	hsa-mir-128-1	hsa05222	Small cell lung cancer	4149_9063_6256_595_5970_1870_1871_7157_4609_1869_6502_5925_4846_8554	14	4.68E-11	3.42E-09	2.14E-10
3744	hsa-mir-128-1	hsa04012	ErbB signaling pathway	25_5595_5594_5599_5601_5602_2932_2885_5894_4609_3725_5604_6464	13	5.97E-10	4.36E-08	2.56E-09
3745	hsa-mir-128-1	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_7428_2885_2113_5894_3725_5604_2034_2033	12	9.04E-10	6.60E-08	3.67E-09
3746	hsa-mir-128-1	hsa05216	Thyroid cancer	1499_5595_5594_6256_595_6934_7157_4609_5604	9	1.08E-09	7.88E-08	4.15E-09
3747	hsa-mir-128-1	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5601_5600_5602_1432_6772_5970_3725_5604_5606_2353	13	3.45E-09	2.52E-07	1.26E-08
3748	hsa-mir-128-1	hsa04660	T cell receptor signaling pathway	5595_5594_5601_5600_2932_1432_5970_2885_5894_4773_3725_5604_2353	13	7.89E-09	5.76E-07	2.74E-08
3749	hsa-mir-128-1	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_5894_1869_5604_1029_5925	11	9.05E-09	6.61E-07	3.00E-08
3750	hsa-mir-128-1	hsa04540	Gap junction	5595_5594_5598_983_7277_2885_5894_7846_5604_7278_51807_10376	12	1.22E-08	8.93E-07	3.82E-08
3751	hsa-mir-128-1	hsa04910	Insulin signaling pathway	6720_5595_5594_5599_5601_5602_2932_2885_5894_5604_6464_808_801_805	14	1.26E-08	9.17E-07	3.82E-08
3752	hsa-mir-128-1	hsa04720	Long-term potentiation	5595_5594_1387_2902_468_5894_5604_2033_808_801_805	11	1.51E-08	1.10E-06	4.41E-08
3753	hsa-mir-128-1	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5601_5600_5602_1432_2885_5894_5604_5606	11	2.45E-08	1.79E-06	6.88E-08
3754	hsa-mir-128-1	hsa04520	Adherens junction	1499_5595_5594_1387_1459_6934_4087_1457_4088_4089_2033	11	2.76E-08	2.01E-06	7.45E-08
3755	hsa-mir-128-1	hsa04916	Melanogenesis	1499_5595_5594_1387_2932_6934_5894_5604_2033_808_801_805	12	3.80E-08	2.77E-06	9.90E-08
3756	hsa-mir-128-1	hsa04662	B cell receptor signaling pathway	5595_5594_2932_5970_2885_5894_4773_3725_5604_2353	10	1.54E-07	1.12E-05	3.88E-07
3757	hsa-mir-128-1	hsa04370	VEGF signaling pathway	5595_5594_9261_5600_7867_1432_5894_4773_5604_4846	10	1.93E-07	1.41E-05	4.68E-07
3758	hsa-mir-128-1	hsa04330	Notch signaling pathway	388585_1387_9612_3066_3065_2033_2648_8850	8	5.21E-07	3.81E-05	1.23E-06
3759	hsa-mir-128-1	hsa04120	Ubiquitin mediated proteolysis	55294_5371_83737_9063_672_8454_6500_7428_7329_6502_64326_8554	12	6.90E-07	5.03E-05	1.57E-06
3760	hsa-mir-128-1	hsa03022	Basal transcription factors	2963_2962_2959_6874_2969_6908_6872	7	1.45E-06	0.000106155	3.22E-06
3761	hsa-mir-128-1	hsa05131	Shigellosis	25_1499_7277_7846_7278_51807_4691_10376	8	1.71E-06	0.000125022	3.57E-06
3762	hsa-mir-128-1	hsa05130	Pathogenic Escherichia coli infection	25_1499_7277_7846_7278_51807_4691_10376	8	1.71E-06	0.000125022	3.57E-06
3763	hsa-mir-128-1	hsa04510	Focal adhesion	1499_5595_5594_5599_595_5601_5602_2932_2885_5894_3725_5604_6464	13	6.27E-06	0.000457999	1.27E-05
3764	hsa-mir-128-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_5600_5602_836_1432_5970_3725	8	8.53E-06	0.000622582	1.68E-05
3765	hsa-mir-128-1	hsa05016	Huntington's disease	6874_1387_2902_6908_836_7157_3066_3065_3064_2033_6667_9586	12	1.28E-05	0.000932001	2.45E-05
3766	hsa-mir-128-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_5600_836_1432_7157_5606_4846	7	1.70E-05	0.001241331	3.18E-05
3767	hsa-mir-128-1	hsa04930	Type II diabetes mellitus	3651_5595_5594_5599_5601_5602	6	4.96E-05	0.003618878	9.05E-05
3768	hsa-mir-128-1	hsa04115	p53 signaling pathway	7161_595_983_836_7157_1029_64326	7	5.82E-05	0.004247805	0.000103605
3769	hsa-mir-128-1	hsa04630	Jak-STAT signaling pathway	6775_9063_1387_595_6772_2885_4609_6774_2033_8554	10	6.16E-05	0.004497736	0.000107089
3770	hsa-mir-128-1	hsa04062	Chemokine signaling pathway	5595_5594_2932_6772_5970_2885_5894_5604_6774_7074_6464	11	7.71E-05	0.005626615	0.000130852
3771	hsa-mir-128-1	hsa05010	Alzheimer's disease	5595_5594_2902_836_2932_6622_4846_808_801_805	10	0.000173416	0.012659336	0.000287712
3772	hsa-mir-128-1	hsa04920	Adipocytokine signaling pathway	5599_6256_5601_5602_5970_6774	6	0.000369127	0.026946299	0.000598807
3773	hsa-mir-128-1	hsa04950	Maturity onset diabetes of the young	3651_3087_4760_168620	4	0.000440917	0.032186962	0.000699717
3774	hsa-mir-128-1	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_2885_5894_4773_5604_6464	8	0.000651371	0.04755011	0.001011704
3775	hsa-mir-128-1	hsa04270	Vascular smooth muscle contraction	5595_5594_5894_5604_808_801_805	7	0.001237953	0.090370567	0.00188272
3776	hsa-mir-128-1	hsa04730	Long-term depression	5595_5594_5894_5604_4846	5	0.003071229	0.224199701	0.004575504
3777	hsa-mir-128-1	hsa05217	Basal cell carcinoma	1499_2932_6934_7157	4	0.007161264	0.522772249	0.010455445
3778	hsa-mir-128-1	hsa04612	Antigen processing and presentation	3320_4800_4801_4802_3312	5	0.007562572	0.552067782	0.010824858
3779	hsa-mir-128-1	hsa04360	Axon guidance	25_5595_5594_2932_4773	5	0.032147783	1	0.045130541
3780	hsa-mir-128-1	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.034328984	1	0.047283317
3781	hsa-mir-1282	hsa05200	Pathways in cancer	25_5594_5599_6258_1387_6257_6256_8031_1487_1488_5970_7157_6688_2113_3725_4087_4088_4089_2033_8554	20	1.29E-19	7.35E-18	7.35E-18
3782	hsa-mir-1282	hsa04350	TGF-beta signaling pathway	5594_1387_659_4086_4087_4088_4089_2033_4093	9	2.40E-11	1.37E-09	6.85E-10
3783	hsa-mir-1282	hsa04310	Wnt signaling pathway	5599_1387_1487_1488_7157_3725_4087_4088_4089_2033	10	1.17E-10	6.67E-09	2.22E-09
3784	hsa-mir-1282	hsa05220	Chronic myeloid leukemia	25_5594_1487_1488_5970_7157_4088_4089	8	2.58E-10	1.47E-08	3.68E-09
3785	hsa-mir-1282	hsa04110	Cell cycle	25_1387_7157_10912_4087_4088_4089_4616_2033	9	3.25E-10	1.85E-08	3.71E-09
3786	hsa-mir-1282	hsa05216	Thyroid cancer	5594_6258_6257_6256_8031_7157	6	1.35E-09	7.72E-08	1.29E-08
3787	hsa-mir-1282	hsa05210	Colorectal cancer	5594_5599_7157_3725_4087_4088_4089	7	1.75E-08	9.98E-07	1.43E-07
3788	hsa-mir-1282	hsa04920	Adipocytokine signaling pathway	10891_5599_6258_6257_6256_5970	6	1.29E-07	7.34E-06	9.18E-07
3789	hsa-mir-1282	hsa04010	MAPK signaling pathway	3727_5594_5599_5970_7157_10912_468_3725_4616	9	3.12E-07	1.78E-05	1.96E-06
3790	hsa-mir-1282	hsa04520	Adherens junction	5594_1387_4087_4088_4089_2033	6	3.44E-07	1.96E-05	1.96E-06
3791	hsa-mir-1282	hsa05222	Small cell lung cancer	6258_6257_6256_5970_7157_8554	6	5.14E-07	2.93E-05	2.66E-06
3792	hsa-mir-1282	hsa05215	Prostate cancer	5594_1387_5970_7157_468_2033	6	5.84E-07	3.33E-05	2.73E-06
3793	hsa-mir-1282	hsa05212	Pancreatic cancer	5594_1387_5970_7157_468_2033	6	6.22E-07	3.54E-05	2.73E-06
3794	hsa-mir-1282	hsa04330	Notch signaling pathway	1387_1487_1488_9612_2033	5	6.86E-07	3.91E-05	2.79E-06
3795	hsa-mir-1282	hsa05223	Non-small cell lung cancer	5594_6258_6257_6256_7157	5	1.30E-06	7.40E-05	4.93E-06
3796	hsa-mir-1282	hsa05211	Renal cell carcinoma	5594_1387_2113_3725_2033	5	4.90E-06	0.000279146	1.74E-05
3797	hsa-mir-1282	hsa03320	PPAR signaling pathway	6258_6257_6256_2168	4	9.43E-05	0.005372986	0.000316058
3798	hsa-mir-1282	hsa04720	Long-term potentiation	5594_1387_468_2033	4	0.0001216	0.006931196	0.000385066
3799	hsa-mir-1282	hsa04012	ErbB signaling pathway	25_5594_5599_3725	4	0.000210078	0.011974461	0.000630235
3800	hsa-mir-1282	hsa04620	Toll-like receptor signaling pathway	5594_5599_5970_3725	4	0.000376491	0.021459965	0.001072998
3801	hsa-mir-1282	hsa04912	GnRH signaling pathway	5594_5599_468_3725	4	0.000463895	0.026442009	0.001259143
3802	hsa-mir-1282	hsa05221	Acute myeloid leukemia	5594_5970_6688	3	0.001037831	0.059156385	0.002688927
3803	hsa-mir-1282	hsa04115	p53 signaling pathway	7157_10912_4616	3	0.001599371	0.091164157	0.003963659
3804	hsa-mir-1282	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5970_3725	3	0.001730415	0.098633676	0.004109736
3805	hsa-mir-1282	hsa04662	B cell receptor signaling pathway	5594_5970_3725	3	0.002012193	0.114695008	0.0045878
3806	hsa-mir-1282	hsa04210	Apoptosis	823_5970_7157	3	0.003216517	0.183341471	0.007051595
3807	hsa-mir-1282	hsa05016	Huntington's disease	10891_1387_7157_2033	4	0.003376981	0.192487898	0.007129181
3808	hsa-mir-1282	hsa04916	Melanogenesis	5594_1387_2033	3	0.004912128	0.27999128	0.009999689
3809	hsa-mir-1282	hsa04660	T cell receptor signaling pathway	5594_5970_3725	3	0.005715439	0.325780011	0.011233793
3810	hsa-mir-1282	hsa05219	Bladder cancer	5594_7157	2	0.008730632	0.497646033	0.016588201
3811	hsa-mir-1282	hsa04930	Type II diabetes mellitus	5594_5599	2	0.00991499	0.565154406	0.018230787
3812	hsa-mir-1282	hsa04910	Insulin signaling pathway	10891_5594_5599	3	0.010472329	0.596922758	0.018653836
3813	hsa-mir-1282	hsa05213	Endometrial cancer	5594_7157	2	0.012937248	0.737423156	0.022346156
3814	hsa-mir-1282	hsa04630	Jak-STAT signaling pathway	1387_2033_8554	3	0.014209208	0.809924842	0.023821319
3815	hsa-mir-1282	hsa05214	Glioma	5594_7157	2	0.019461934	1	0.03169515
3816	hsa-mir-1282	hsa05010	Alzheimer's disease	5594_823_9451	3	0.020033854	1	0.031720269
3817	hsa-mir-1282	hsa05218	Melanoma	5594_7157	2	0.022849625	1	0.035200773
3818	hsa-mir-1282	hsa04664	Fc epsilon RI signaling pathway	5594_5599	2	0.027713186	1	0.041569779
3819	hsa-mir-1282	hsa04510	Focal adhesion	5594_5599_3725	3	0.029440396	1	0.04302827
3820	hsa-mir-128-2	hsa05200	Pathways in cancer	2249_367_3725_6776_6777_2353_5914_5970_6256	9	2.14E-09	8.14E-08	8.14E-08
3821	hsa-mir-128-2	hsa05221	Acute myeloid leukemia	6776_6777_5914_5970	4	2.68E-06	0.00010185	5.09E-05
3822	hsa-mir-128-2	hsa05220	Chronic myeloid leukemia	6776_6777_5970	3	0.000235738	0.008958042	0.002239511
3823	hsa-mir-128-2	hsa04662	B cell receptor signaling pathway	3725_2353_5970	3	0.000235738	0.008958042	0.002239511
3824	hsa-mir-128-2	hsa04012	ErbB signaling pathway	3725_6776_6777	3	0.000359393	0.013656919	0.002731384
3825	hsa-mir-128-2	hsa04620	Toll-like receptor signaling pathway	3725_2353_5970	3	0.000564349	0.021445249	0.003574208
3826	hsa-mir-128-2	hsa04660	T cell receptor signaling pathway	3725_2353_5970	3	0.000698866	0.026556897	0.003793842
3827	hsa-mir-128-2	hsa04010	MAPK signaling pathway	2249_3725_2353_5970	4	0.000850712	0.032327066	0.004040883
3828	hsa-mir-128-2	hsa03410	Base excision repair	3146_142	2	0.001556398	0.059143125	0.006571458
3829	hsa-mir-128-2	hsa04630	Jak-STAT signaling pathway	3977_6776_6777	3	0.001834826	0.069723391	0.006972339
3830	hsa-mir-128-2	hsa04920	Adipocytokine signaling pathway	5970_6256	2	0.00503974	0.191510122	0.017410011
3831	hsa-mir-128-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.005623673	0.213699557	0.017808296
3832	hsa-mir-128-2	hsa05210	Colorectal cancer	3725_2353	2	0.007723408	0.293489501	0.02045201
3833	hsa-mir-128-2	hsa05222	Small cell lung cancer	5970_6256	2	0.00807332	0.306786146	0.02045201
3834	hsa-mir-128-2	hsa05215	Prostate cancer	367_5970	2	0.008430271	0.320350298	0.02045201
3835	hsa-mir-128-2	hsa05212	Pancreatic cancer	367_5970	2	0.008611373	0.327232161	0.02045201
3836	hsa-mir-128-2	hsa03450	Non-homologous end-joining	2547	1	0.02272554	0.863570507	0.050798265
3837	hsa-mir-128-2	hsa05016	Huntington's disease	6908_6667	2	0.034322921	1	0.071429355
3838	hsa-mir-128-2	hsa04062	Chemokine signaling pathway	6777_5970	2	0.03598526	1	0.071429355
3839	hsa-mir-128-2	hsa04950	Maturity onset diabetes of the young	6927	1	0.037594397	1	0.071429355
3840	hsa-mir-128-2	hsa05216	Thyroid cancer	6256	1	0.044945606	1	0.081330144
3841	hsa-mir-1284	hsa05200	Pathways in cancer	3716_3320_3326_5371_2249_5747_3480_1956_1499_4233_1488_2261_5595_5594_5599_5914_1387_6256_5159_862_595_5156_1487_1019_367_1017_3815_6774_2064_6776_6777_6772_5879_6688_4088_836_4089_4087_8772_4609_3725_1026_2353_10401_3066_3065_5979_5925_2033_1441_6502_207_8554_4286_4790_5970_7046	57	3.32E-42	2.56E-40	2.56E-40
3842	hsa-mir-1284	hsa04630	Jak-STAT signaling pathway	3717_3716_3718_3559_3570_3977_85480_3560_149233_1387_595_3575_3572_3953_6778_6774_6776_6777_6772_1439_58985_3454_3455_3459_5781_4609_3561_2690_10401_6773_7297_2033_1441_207_8554_10379	36	6.60E-31	5.08E-29	2.54E-29
3843	hsa-mir-1284	hsa04010	MAPK signaling pathway	3925_6722_2249_1956_2261_5595_5594_5599_5598_1386_5159_9261_5156_4208_7132_2264_9252_7867_1432_1649_5879_836_468_6885_4609_3725_1845_2353_207_4790_51701_5970_7046	33	1.82E-20	1.40E-18	4.68E-19
3844	hsa-mir-1284	hsa04060	Cytokine-cytokine receptor interaction	3556_2321_3559_3570_3977_85480_1956_4233_3560_149233_90_5159_5156_7132_3575_3572_1234_1230_3815_3953_1439_3791_7852_58985_3454_3455_3459_3561_2690_7133_1441_7046	32	5.32E-20	4.10E-18	1.02E-18
3845	hsa-mir-1284	hsa05215	Prostate cancer	3320_3326_3480_1956_1499_5595_5594_1387_5159_595_5156_367_1017_2064_468_1026_5925_2033_207_4790_5970	21	9.97E-19	7.68E-17	1.34E-17
3846	hsa-mir-1284	hsa05220	Chronic myeloid leukemia	1488_5595_5594_595_1487_1019_6776_6777_4088_5781_4089_4609_1026_3066_3065_5925_207_4790_5970_7046	20	1.05E-18	8.06E-17	1.34E-17
3847	hsa-mir-1284	hsa05212	Pancreatic cancer	3320_3326_3480_1956_1499_5595_5594_1387_5159_595_5156_367_1017_2064_468_1026_5925_2033_207_4790_5970	21	1.22E-18	9.38E-17	1.34E-17
3848	hsa-mir-1284	hsa04520	Adherens junction	2241_3480_1956_1499_6714_4233_5595_5594_1387_2064_5879_4088_4089_4087_6885_1460_2033_51701_7046_2534	20	3.09E-18	2.38E-16	2.97E-17
3849	hsa-mir-1284	hsa05210	Colorectal cancer	3480_1956_1499_4233_5595_5594_5599_5159_595_5156_5879_4088_836_4089_4087_4609_3725_2353_207_7046	20	7.01E-18	5.40E-16	6.00E-17
3850	hsa-mir-1284	hsa04350	TGF-beta signaling pathway	5595_5594_1387_90_6667_7027_3397_1874_4088_4089_4087_4609_4086_3398_2033_3399_7046_5933_57154	19	1.89E-16	1.45E-14	1.45E-15
3851	hsa-mir-1284	hsa05214	Glioma	818_817_3480_1956_5595_5594_5159_595_5156_1019_1026_5925_808_207_805_801	16	9.23E-15	7.11E-13	6.46E-14
3852	hsa-mir-1284	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_862_595_3815_6774_6776_6777_6688_4609_207_4790_5970	15	4.25E-14	3.28E-12	2.73E-13
3853	hsa-mir-1284	hsa04110	Cell cycle	7533_1387_595_1019_1017_7027_4088_4089_4087_4174_1026_4172_3066_3065_5925_2033_6502_5933	18	3.22E-13	2.48E-11	1.90E-12
3854	hsa-mir-1284	hsa04620	Toll-like receptor signaling pathway	3654_5595_5594_5599_1432_6772_5879_3454_3455_8772_6885_3725_2353_207_4790_5970	16	4.11E-12	3.17E-10	2.26E-11
3855	hsa-mir-1284	hsa04012	ErbB signaling pathway	818_817_5747_1956_6714_5595_5594_5599_2064_6776_6777_4609_3725_1026_207	15	5.83E-12	4.49E-10	2.91E-11
3856	hsa-mir-1284	hsa05218	Melanoma	2249_3480_1956_4233_5595_5594_5159_595_5156_1019_1026_5925_207_4286	14	6.06E-12	4.66E-10	2.91E-11
3857	hsa-mir-1284	hsa04912	GnRH signaling pathway	5580_818_817_1956_6714_5595_5594_5599_5598_1432_468_2185_3725_808_805_801	16	8.93E-12	6.88E-10	3.85E-11
3858	hsa-mir-1284	hsa04062	Chemokine signaling pathway	3717_3718_5580_5747_5590_5595_5594_1234_1230_6774_6777_6772_5879_7852_2185_6773_207_3055_4790_5970	20	8.99E-12	6.92E-10	3.85E-11
3859	hsa-mir-1284	hsa04310	Wnt signaling pathway	818_817_1499_1488_5599_1387_595_1487_5879_4088_4089_4087_6885_4609_3725_1460_2033_51701	18	1.33E-11	1.03E-09	5.40E-11
3860	hsa-mir-1284	hsa04510	Focal adhesion	2321_5747_3480_1956_1499_6714_4233_5595_5594_5599_5159_595_5156_1729_2064_5879_3791_3725_207_2534	20	2.66E-11	2.05E-09	1.02E-10
3861	hsa-mir-1284	hsa05219	Bladder cancer	1956_2261_5595_5594_595_1019_9252_2064_4609_1026_5925	11	8.29E-11	6.38E-09	3.04E-10
3862	hsa-mir-1284	hsa04920	Adipocytokine signaling pathway	3717_8717_5599_6256_7132_3953_6774_5781_7133_207_4790_5970	12	5.29E-10	4.08E-08	1.85E-09
3863	hsa-mir-1284	hsa05222	Small cell lung cancer	5747_6256_595_1019_1017_4609_10401_5925_6502_207_8554_4790_5970	13	6.50E-10	5.00E-08	2.17E-09
3864	hsa-mir-1284	hsa04330	Notch signaling pathway	1488_1387_1487_388585_9612_8850_3280_3066_3065_2033	10	3.46E-09	2.67E-07	1.11E-08
3865	hsa-mir-1284	hsa04660	T cell receptor signaling pathway	3932_5595_5594_1019_1432_1739_6885_3725_2353_207_4790_5970_2534	13	9.70E-09	7.47E-07	2.99E-08
3866	hsa-mir-1284	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_4233_5599_1432_5879_836_5781_3725_4790_5970	11	1.08E-08	8.34E-07	3.21E-08
3867	hsa-mir-1284	hsa04916	Melanogenesis	818_817_1499_5595_5594_1387_3815_808_2033_4286_805_801	12	4.59E-08	3.54E-06	1.31E-07
3868	hsa-mir-1284	hsa04210	Apoptosis	3654_3556_8717_7132_1439_836_8772_840_207_4790_5970	11	8.86E-08	6.83E-06	2.44E-07
3869	hsa-mir-1284	hsa05223	Non-small cell lung cancer	1956_5595_5594_6256_595_1019_2064_5925_207	9	1.37E-07	1.05E-05	3.63E-07
3870	hsa-mir-1284	hsa04720	Long-term potentiation	818_817_5595_5594_1387_468_808_2033_805_801	10	1.81E-07	1.39E-05	4.64E-07
3871	hsa-mir-1284	hsa04370	VEGF signaling pathway	5747_6714_5595_5594_9261_7867_1432_5879_3791_207	10	2.26E-07	1.74E-05	5.61E-07
3872	hsa-mir-1284	hsa05216	Thyroid cancer	1499_5595_5594_6256_595_4609_5979	7	3.89E-07	3.00E-05	9.37E-07
3873	hsa-mir-1284	hsa04650	Natural killer cell mediated cytotoxicity	3932_5595_5594_5879_6850_3454_3455_3459_836_5781_2185_2534	12	7.71E-07	5.94E-05	1.80E-06
3874	hsa-mir-1284	hsa05213	Endometrial cancer	1956_1499_5595_5594_595_2064_4609_207	8	1.18E-06	9.08E-05	2.67E-06
3875	hsa-mir-1284	hsa05211	Renal cell carcinoma	4233_5595_5594_1387_5879_5781_3725_2033_207	9	1.22E-06	9.41E-05	2.69E-06
3876	hsa-mir-1284	hsa04662	B cell receptor signaling pathway	5595_5594_5879_6850_3725_2353_207_4790_5970	9	1.67E-06	0.000128321	3.56E-06
3877	hsa-mir-1284	hsa04664	Fc epsilon RI signaling pathway	5580_5595_5594_5599_1432_5879_6850_207_2534	9	2.47E-06	0.000190156	5.14E-06
3878	hsa-mir-1284	hsa04360	Axon guidance	2242_5747_4233_5998_5595_5594_5879_7852_1020_2534	10	1.86E-05	0.001432321	3.77E-05
3879	hsa-mir-1284	hsa04950	Maturity onset diabetes of the young	168620_6927_3172_3280_3651	5	3.52E-05	0.002711479	6.95E-05
3880	hsa-mir-1284	hsa05010	Alzheimer's disease	5595_5594_7132_836_8772_1020_840_808_4716_805_801	11	4.31E-05	0.003317422	8.29E-05
3881	hsa-mir-1284	hsa04930	Type II diabetes mellitus	5580_5590_5595_5594_5599_3651	6	5.46E-05	0.004203656	0.000102528
3882	hsa-mir-1284	hsa04020	Calcium signaling pathway	818_817_1956_5159_5156_2064_2185_808_147_805_801	11	6.00E-05	0.004620954	0.000110023
3883	hsa-mir-1284	hsa04810	Regulation of actin cytoskeleton	2249_5747_1956_2261_5595_5594_5159_5156_2264_1729_5879	11	0.000256585	0.019757076	0.000459467
3884	hsa-mir-1284	hsa04540	Gap junction	1956_6714_5595_5594_5598_5159_5156	7	0.000363014	0.027952102	0.000635275
3885	hsa-mir-1284	hsa04530	Tight junction	5580_10207_1499_6714_5590_1019_1460_207	8	0.000697199	0.053684296	0.001192984
3886	hsa-mir-1284	hsa04910	Insulin signaling pathway	5590_5595_5594_5599_808_207_805_801	8	0.000729318	0.056157488	0.001220815
3887	hsa-mir-1284	hsa04120	Ubiquitin mediated proteolysis	11059_5371_672_7329_10401_6502_8554_57154	8	0.000762618	0.058721571	0.001249395
3888	hsa-mir-1284	hsa05014	Amyotrophic lateral sclerosis (ALS)	7132_1432_5879_836_7133	5	0.001250246	0.096268945	0.002005603
3889	hsa-mir-1284	hsa04270	Vascular smooth muscle contraction	5580_5595_5594_808_147_805_801	7	0.001367744	0.105316324	0.002149313
3890	hsa-mir-1284	hsa04670	Leukocyte transendothelial migration	5747_1499_1432_5879_7852_5781_2185	7	0.001639681	0.126255441	0.002525109
3891	hsa-mir-1284	hsa05340	Primary immunodeficiency	3718_3932_3575_3561	4	0.001687855	0.129964858	0.002548331
3892	hsa-mir-1284	hsa03030	DNA replication	5981_4174_6118_4172	4	0.001856143	0.142922973	0.002748519
3893	hsa-mir-1284	hsa04115	p53 signaling pathway	595_1019_1017_836_1026	5	0.002946503	0.226880707	0.004280768
3894	hsa-mir-1284	hsa05016	Huntington's disease	1387_6908_6667_836_3066_3065_2033_4716	8	0.004607406	0.35477028	0.00656982
3895	hsa-mir-1284	hsa04640	Hematopoietic cell lineage	3559_3570_3575_3815_1441	5	0.007429679	0.572085321	0.010401551
3896	hsa-mir-1284	hsa03022	Basal transcription factors	2969_6908_2959	3	0.015587664	1	0.021433037
3897	hsa-mir-1284	hsa03420	Nucleotide excision repair	5981_4331_6118	3	0.023922874	1	0.032316865
3898	hsa-mir-1284	hsa04612	Antigen processing and presentation	3320_3326_4800_2923	4	0.034562682	1	0.04588494
3899	hsa-mir-1284	hsa04150	mTOR signaling pathway	5595_5594_207	3	0.035864846	1	0.046806664
3900	hsa-mir-1284	hsa03430	Mismatch repair	5981_6118	2	0.042452649	1	0.054480899
3901	hsa-mir-1285-1	hsa04010	MAPK signaling pathway	6722_8986_5595_5594_5599_5604_5606_5601_5600_3303_6195_6197_9252_3312_1432_9261_2885_7157_6196_2353_9344_1616_207_2005	24	7.81E-22	4.92E-20	4.92E-20
3902	hsa-mir-1285-1	hsa05200	Pathways in cancer	3320_5371_5595_5594_5599_1387_5604_5601_9915_2932_6772_3091_2885_7157_2113_861_2353_2736_9063_5925_2034_2033_207	23	8.46E-19	5.33E-17	2.67E-17
3903	hsa-mir-1285-1	hsa05211	Renal cell carcinoma	5595_5594_1387_5604_9915_3091_2885_2113_2034_2033_207	11	5.43E-13	3.42E-11	1.14E-11
3904	hsa-mir-1285-1	hsa05215	Prostate cancer	3320_5595_5594_1387_5604_2932_2885_7157_5925_2033_207	11	3.95E-12	2.49E-10	5.57E-11
3905	hsa-mir-1285-1	hsa05212	Pancreatic cancer	3320_5595_5594_1387_5604_2932_2885_7157_5925_2033_207	11	4.42E-12	2.78E-10	5.57E-11
3906	hsa-mir-1285-1	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5604_5606_5601_5600_1432_6772_2353_207	11	1.71E-11	1.08E-09	1.80E-10
3907	hsa-mir-1285-1	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5604_5606_5601_5600_1432_2885_207	10	3.45E-11	2.17E-09	3.10E-10
3908	hsa-mir-1285-1	hsa05210	Colorectal cancer	5595_5594_5599_5604_5601_2932_2885_7157_2353_207	10	6.00E-11	3.78E-09	4.72E-10
3909	hsa-mir-1285-1	hsa04720	Long-term potentiation	815_5595_5594_1387_5604_6195_6197_6196_2033	9	5.25E-10	3.31E-08	3.67E-09
3910	hsa-mir-1285-1	hsa04912	GnRH signaling pathway	815_5595_5594_5599_5604_5606_5601_5600_1432_2885	10	5.82E-10	3.67E-08	3.67E-09
3911	hsa-mir-1285-1	hsa04660	T cell receptor signaling pathway	5595_5594_5604_5601_5600_2932_1432_2885_2353_207	10	6.87E-10	4.33E-08	3.94E-09
3912	hsa-mir-1285-1	hsa04350	TGF-beta signaling pathway	5518_5595_5594_1387_3397_3399_3398_2033_4093	9	1.76E-09	1.11E-07	8.51E-09
3913	hsa-mir-1285-1	hsa04012	ErbB signaling pathway	815_5595_5594_5599_5604_5601_2932_2885_207	9	1.76E-09	1.11E-07	8.51E-09
3914	hsa-mir-1285-1	hsa03022	Basal transcription factors	2963_6879_6908_6872_2958_2959_6880	7	2.70E-09	1.70E-07	1.22E-08
3915	hsa-mir-1285-1	hsa05214	Glioma	815_5595_5594_5604_2885_7157_5925_207	8	4.12E-09	2.59E-07	1.73E-08
3916	hsa-mir-1285-1	hsa05220	Chronic myeloid leukemia	5595_5594_5604_2885_7157_861_5925_207	8	1.16E-08	7.28E-07	4.55E-08
3917	hsa-mir-1285-1	hsa05213	Endometrial cancer	5595_5594_5604_2932_2885_7157_207	7	2.26E-08	1.42E-06	7.89E-08
3918	hsa-mir-1285-1	hsa04150	mTOR signaling pathway	5595_5594_6195_6197_3091_6196_207	7	2.26E-08	1.42E-06	7.89E-08
3919	hsa-mir-1285-1	hsa05223	Non-small cell lung cancer	5595_5594_5604_2885_7157_5925_207	7	2.86E-08	1.80E-06	9.48E-08
3920	hsa-mir-1285-1	hsa05221	Acute myeloid leukemia	5371_5595_5594_5604_2885_861_207	7	5.00E-08	3.15E-06	1.57E-07
3921	hsa-mir-1285-1	hsa04310	Wnt signaling pathway	815_5518_5599_1387_5601_2932_7157_1457_2033	9	1.63E-07	1.02E-05	4.88E-07
3922	hsa-mir-1285-1	hsa05219	Bladder cancer	5595_5594_5604_9252_7157_5925	6	1.72E-07	1.08E-05	4.92E-07
3923	hsa-mir-1285-1	hsa04662	B cell receptor signaling pathway	5595_5594_5604_2932_2885_2353_207	7	2.28E-07	1.43E-05	6.24E-07
3924	hsa-mir-1285-1	hsa04370	VEGF signaling pathway	5595_5594_5604_5600_1432_9261_207	7	2.69E-07	1.69E-05	7.06E-07
3925	hsa-mir-1285-1	hsa04110	Cell cycle	5591_1387_7534_7531_2932_7157_5925_2033	8	3.25E-07	2.05E-05	8.18E-07
3926	hsa-mir-1285-1	hsa04910	Insulin signaling pathway	5595_5594_5599_5604_5601_2932_2885_207	8	9.40E-07	5.92E-05	2.28E-06
3927	hsa-mir-1285-1	hsa04916	Melanogenesis	815_5595_5594_1387_5604_2932_2033	7	1.80E-06	0.000113179	4.19E-06
3928	hsa-mir-1285-1	hsa05218	Melanoma	5595_5594_5604_7157_5925_207	6	2.94E-06	0.000184996	6.61E-06
3929	hsa-mir-1285-1	hsa04930	Type II diabetes mellitus	3651_5595_5594_5599_5601	5	5.91E-06	0.000372482	1.28E-05
3930	hsa-mir-1285-1	hsa04062	Chemokine signaling pathway	5595_5594_5604_2932_2931_6772_2885_207	8	1.01E-05	0.000635965	2.12E-05
3931	hsa-mir-1285-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	5606_5600_1432_7157_1616	5	1.59E-05	0.000999365	3.13E-05
3932	hsa-mir-1285-1	hsa04510	Focal adhesion	5595_5594_5599_5604_5601_2932_2885_207	8	1.59E-05	0.001001292	3.13E-05
3933	hsa-mir-1285-1	hsa05216	Thyroid cancer	5595_5594_5604_7157	4	2.45E-05	0.001541174	4.67E-05
3934	hsa-mir-1285-1	hsa04730	Long-term depression	5518_5592_5595_5594_5604	5	4.63E-05	0.002917068	8.58E-05
3935	hsa-mir-1285-1	hsa04520	Adherens junction	5595_5594_1387_1457_2033	5	7.92E-05	0.004990417	0.000142583
3936	hsa-mir-1285-1	hsa03450	Non-homologous end-joining	5591_7520_2547	3	8.59E-05	0.005412041	0.000150334
3937	hsa-mir-1285-1	hsa04540	Gap junction	5592_5595_5594_5604_2885	5	0.000155446	0.009793083	0.000264678
3938	hsa-mir-1285-1	hsa04630	Jak-STAT signaling pathway	1387_6772_2885_9063_2033_207	6	0.000191362	0.012055807	0.000317258
3939	hsa-mir-1285-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_5600_1432	4	0.000614625	0.038721354	0.000992855
3940	hsa-mir-1285-1	hsa04120	Ubiquitin mediated proteolysis	7329_5371_672_10273_9063	5	0.000911445	0.057421052	0.001435526
3941	hsa-mir-1285-1	hsa05222	Small cell lung cancer	7157_9063_5925_207	4	0.001217428	0.076697942	0.001870682
3942	hsa-mir-1285-1	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.002187032	0.137782985	0.003280547
3943	hsa-mir-1285-1	hsa05016	Huntington's disease	1387_6908_7157_3064_2033	5	0.003285054	0.206958409	0.004784323
3944	hsa-mir-1285-1	hsa05217	Basal cell carcinoma	2932_7157_2736	3	0.003341432	0.210510201	0.004784323
3945	hsa-mir-1285-1	hsa04270	Vascular smooth muscle contraction	5592_5595_5594_5604	4	0.003687513	0.232313327	0.005162518
3946	hsa-mir-1285-1	hsa04920	Adipocytokine signaling pathway	5599_5601_207	3	0.005668084	0.357089279	0.00776281
3947	hsa-mir-1285-1	hsa04530	Tight junction	5518_8189_1457_207	4	0.006146253	0.387213959	0.008238595
3948	hsa-mir-1285-1	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_5604_2885	4	0.006299593	0.396874379	0.008268216
3949	hsa-mir-1285-1	hsa04612	Antigen processing and presentation	3320_3303_3312	3	0.011981818	0.754854513	0.015405194
3950	hsa-mir-1285-1	hsa05010	Alzheimer's disease	5595_5594_2932_6622	4	0.014405618	0.907553925	0.018151079
3951	hsa-mir-1285-1	hsa04360	Axon guidance	5595_5594_2932	3	0.032041025	1	0.03958009
3952	hsa-mir-1285-1	hsa04340	Hedgehog signaling pathway	2932_2736	2	0.037108299	1	0.044958132
3953	hsa-mir-1286	hsa04350	TGF-beta signaling pathway	4086_4089_4093_3398_3399_1387	6	5.52E-09	1.93E-07	1.93E-07
3954	hsa-mir-1286	hsa05220	Chronic myeloid leukemia	4089_25_7157_5925_861	5	1.33E-07	4.64E-06	2.32E-06
3955	hsa-mir-1286	hsa05200	Pathways in cancer	4089_25_7157_5925_2113_861_1387	7	6.87E-07	2.41E-05	8.02E-06
3956	hsa-mir-1286	hsa04110	Cell cycle	4089_25_7157_5925_1387	5	1.18E-06	4.14E-05	1.03E-05
3957	hsa-mir-1286	hsa05215	Prostate cancer	7157_5925_90993_1387	4	1.11E-05	0.000389926	6.78E-05
3958	hsa-mir-1286	hsa05212	Pancreatic cancer	7157_5925_90993_1387	4	1.16E-05	0.000407006	6.78E-05
3959	hsa-mir-1286	hsa05016	Huntington's disease	6908_7157_90993_1387	4	0.000196192	0.006866727	0.000980961
3960	hsa-mir-1286	hsa04120	Ubiquitin mediated proteolysis	11059_7329_4734	3	0.001268263	0.044389189	0.005548649
3961	hsa-mir-1286	hsa04310	Wnt signaling pathway	4089_7157_1387	3	0.001630172	0.057056009	0.006339557
3962	hsa-mir-1286	hsa05219	Bladder cancer	7157_5925	2	0.001993642	0.069777476	0.006977748
3963	hsa-mir-1286	hsa05223	Non-small cell lung cancer	7157_5925	2	0.003208663	0.112303221	0.010026243
3964	hsa-mir-1286	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157_1616	2	0.003437569	0.120314914	0.010026243
3965	hsa-mir-1286	hsa05214	Glioma	7157_5925	2	0.004558871	0.159560495	0.012273884
3966	hsa-mir-1286	hsa05218	Melanoma	7157_5925	2	0.005387936	0.188577762	0.012908824
3967	hsa-mir-1286	hsa05211	Renal cell carcinoma	2113_1387	2	0.005532353	0.193632353	0.012908824
3968	hsa-mir-1286	hsa04520	Adherens junction	4089_1387	2	0.006750896	0.236281345	0.014767584
3969	hsa-mir-1286	hsa05210	Colorectal cancer	4089_7157	2	0.007401751	0.259061287	0.015044997
3970	hsa-mir-1286	hsa05222	Small cell lung cancer	7157_5925	2	0.007737427	0.270809939	0.015044997
3971	hsa-mir-1286	hsa04916	Melanogenesis	90993_1387	2	0.011058466	0.387046293	0.020370858
3972	hsa-mir-1286	hsa05216	Thyroid cancer	7157	1	0.043991061	1	0.076984356
3973	hsa-mir-1287	hsa04110	Cell cycle	10971_7534_1387	3	1.30E-06	3.25E-05	3.25E-05
3974	hsa-mir-1287	hsa05131	Shigellosis	10971_7534	2	5.48E-05	0.001370156	0.000456719
3975	hsa-mir-1287	hsa05130	Pathogenic Escherichia coli infection	10971_7534	2	5.48E-05	0.001370156	0.000456719
3976	hsa-mir-1287	hsa04310	Wnt signaling pathway	1452_1387	2	0.000387283	0.009682071	0.002420518
3977	hsa-mir-1287	hsa04330	Notch signaling pathway	1387	1	0.009560571	0.239014273	0.027491398
3978	hsa-mir-1287	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432	1	0.01134467	0.283616744	0.027491398
3979	hsa-mir-1287	hsa04340	Hedgehog signaling pathway	1452	1	0.011542738	0.288568439	0.027491398
3980	hsa-mir-1287	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432	1	0.014312216	0.357805407	0.027491398
3981	hsa-mir-1287	hsa05211	Renal cell carcinoma	1387	1	0.014509789	0.362744713	0.027491398
3982	hsa-mir-1287	hsa04720	Long-term potentiation	1387	1	0.015102307	0.377557679	0.027491398
3983	hsa-mir-1287	hsa04370	VEGF signaling pathway	1432	1	0.015497155	0.387428866	0.027491398
3984	hsa-mir-1287	hsa04664	Fc epsilon RI signaling pathway	1432	1	0.01589187	0.397296755	0.027491398
3985	hsa-mir-1287	hsa04520	Adherens junction	1387	1	0.016089179	0.402229463	0.027491398
3986	hsa-mir-1287	hsa04350	TGF-beta signaling pathway	1387	1	0.017469414	0.436735348	0.027491398
3987	hsa-mir-1287	hsa05215	Prostate cancer	1387	1	0.017666459	0.441661466	0.027491398
3988	hsa-mir-1287	hsa05212	Pancreatic cancer	1387	1	0.01786347	0.44658676	0.027491398
3989	hsa-mir-1287	hsa04620	Toll-like receptor signaling pathway	1432	1	0.020421629	0.510540716	0.027491398
3990	hsa-mir-1287	hsa04916	Melanogenesis	1387	1	0.020814698	0.520367454	0.027491398
3991	hsa-mir-1287	hsa04912	GnRH signaling pathway	1432	1	0.021600443	0.540011072	0.027491398
3992	hsa-mir-1287	hsa04660	T cell receptor signaling pathway	1432	1	0.021993118	0.549827954	0.027491398
3993	hsa-mir-1287	hsa04670	Leukocyte transendothelial migration	1432	1	0.024346413	0.608660324	0.028983825
3994	hsa-mir-1287	hsa04630	Jak-STAT signaling pathway	1387	1	0.030793655	0.769841385	0.03499279
3995	hsa-mir-1287	hsa05016	Huntington's disease	1387	1	0.037205355	0.930133879	0.040440603
3996	hsa-mir-1288	hsa05200	Pathways in cancer	3716_3066_1870_1871_7157_4790_6688_5925_2033_2113_207_4193_4609_5595_7704_1387_5594_861_6774_1029_5970_4792	22	5.00E-24	2.85E-22	2.85E-22
3997	hsa-mir-1288	hsa05220	Chronic myeloid leukemia	3066_1870_1871_7157_4790_5925_207_4193_4609_5595_5594_861_1029_5970_4792	15	3.42E-23	1.95E-21	9.76E-22
3998	hsa-mir-1288	hsa05215	Prostate cancer	1870_1871_7157_4790_5925_2033_207_4193_5595_1387_5594_5970_4792_1385	14	1.91E-20	1.09E-18	3.14E-19
3999	hsa-mir-1288	hsa05212	Pancreatic cancer	1870_1871_7157_4790_5925_2033_207_4193_5595_1387_5594_5970_4792_1385	14	2.21E-20	1.26E-18	3.14E-19
4000	hsa-mir-1288	hsa05221	Acute myeloid leukemia	4790_6688_207_4609_5595_7704_5594_861_6774_5970	10	3.83E-15	2.18E-13	4.37E-14
4001	hsa-mir-1288	hsa05219	Bladder cancer	1870_1871_7157_5925_4193_4609_5595_5594_1029	9	1.46E-14	8.35E-13	1.39E-13
4002	hsa-mir-1288	hsa05214	Glioma	1870_1871_7157_5925_207_4193_5595_5594_1029	9	5.06E-13	2.88E-11	4.12E-12
4003	hsa-mir-1288	hsa05218	Melanoma	1870_1871_7157_5925_207_4193_5595_5594_1029	9	1.05E-12	5.97E-11	7.47E-12
4004	hsa-mir-1288	hsa05222	Small cell lung cancer	1870_1871_7157_4790_5925_207_4609_5970_4792	9	5.14E-12	2.93E-10	3.25E-11
4005	hsa-mir-1288	hsa05223	Non-small cell lung cancer	1870_1871_7157_5925_207_5595_5594_1029	8	6.44E-12	3.67E-10	3.67E-11
4006	hsa-mir-1288	hsa04110	Cell cycle	3066_1870_1871_7157_5925_2033_4193_1387_1029	9	7.75E-11	4.42E-09	4.02E-10
4007	hsa-mir-1288	hsa04350	TGF-beta signaling pathway	6667_2033_4609_5595_1387_5594_3398_3399	8	2.15E-10	1.23E-08	1.02E-09
4008	hsa-mir-1288	hsa04630	Jak-STAT signaling pathway	3716_2033_207_5777_4609_1387_3566_6774_6773	9	7.11E-10	4.05E-08	3.12E-09
4009	hsa-mir-1288	hsa04662	B cell receptor signaling pathway	4790_207_5777_5595_5594_5970_4792	7	2.78E-09	1.58E-07	1.13E-08
4010	hsa-mir-1288	hsa04062	Chemokine signaling pathway	4790_207_5595_5590_5594_6774_5970_6773_4792	9	4.46E-09	2.54E-07	1.69E-08
4011	hsa-mir-1288	hsa04660	T cell receptor signaling pathway	4790_207_5777_5595_5594_5970_4792	7	3.35E-08	1.91E-06	1.20E-07
4012	hsa-mir-1288	hsa05211	Renal cell carcinoma	2033_2113_207_5595_1387_5594	6	7.48E-08	4.26E-06	2.51E-07
4013	hsa-mir-1288	hsa04010	MAPK signaling pathway	7157_4790_207_1616_4609_5595_1386_5594_5970	9	7.93E-08	4.52E-06	2.51E-07
4014	hsa-mir-1288	hsa04520	Adherens junction	2033_5777_5595_6714_1387_5594	6	1.35E-07	7.67E-06	4.04E-07
4015	hsa-mir-1288	hsa05213	Endometrial cancer	7157_207_4609_5595_5594	5	4.98E-07	2.84E-05	1.42E-06
4016	hsa-mir-1288	hsa04620	Toll-like receptor signaling pathway	4790_207_5595_5594_5970_4792	6	5.22E-07	2.98E-05	1.42E-06
4017	hsa-mir-1288	hsa05016	Huntington's disease	6667_3066_6908_7157_2033_1387_1385	7	1.09E-06	6.20E-05	2.82E-06
4018	hsa-mir-1288	hsa04920	Adipocytokine signaling pathway	4790_207_6774_5970_4792	5	1.61E-06	9.19E-05	4.00E-06
4019	hsa-mir-1288	hsa05216	Thyroid cancer	7157_4609_5595_5594	4	1.98E-06	0.000112604	4.69E-06
4020	hsa-mir-1288	hsa05210	Colorectal cancer	7157_207_4609_5595_5594	5	4.61E-06	0.000262979	1.05E-05
4021	hsa-mir-1288	hsa04012	ErbB signaling pathway	207_4609_5595_6714_5594	5	5.43E-06	0.000309586	1.19E-05
4022	hsa-mir-1288	hsa04210	Apoptosis	7157_4790_207_5970_4792	5	6.04E-06	0.000344089	1.27E-05
4023	hsa-mir-1288	hsa04330	Notch signaling pathway	3066_2033_1387_4851	4	1.16E-05	0.000662498	2.37E-05
4024	hsa-mir-1288	hsa04916	Melanogenesis	2033_5595_1387_5594_1385	5	1.24E-05	0.000709333	2.45E-05
4025	hsa-mir-1288	hsa04910	Insulin signaling pathway	6720_207_5595_5590_5594	5	4.60E-05	0.002622427	8.74E-05
4026	hsa-mir-1288	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	4790_6714_5970_4792	4	5.38E-05	0.003066096	9.89E-05
4027	hsa-mir-1288	hsa04720	Long-term potentiation	2033_5595_1387_5594	4	6.59E-05	0.003758994	0.000117469
4028	hsa-mir-1288	hsa04370	VEGF signaling pathway	207_5595_6714_5594	4	7.27E-05	0.004145212	0.000125612
4029	hsa-mir-1288	hsa04930	Type II diabetes mellitus	5595_5590_5594	3	0.000309039	0.01761522	0.000518095
4030	hsa-mir-1288	hsa04150	mTOR signaling pathway	207_5595_5594	3	0.000462365	0.026354813	0.000752995
4031	hsa-mir-1288	hsa04310	Wnt signaling pathway	7157_2033_4609_1387	4	0.000888949	0.050670085	0.001407502
4032	hsa-mir-1288	hsa04115	p53 signaling pathway	7157_4193_1029	3	0.001016665	0.057949908	0.001566214
4033	hsa-mir-1288	hsa04664	Fc epsilon RI signaling pathway	207_5595_5594	3	0.001480412	0.084383464	0.002220617
4034	hsa-mir-1288	hsa04540	Gap junction	5595_6714_5594	3	0.002324014	0.132468805	0.003396636
4035	hsa-mir-1288	hsa04510	Focal adhesion	207_5595_6714_5594	4	0.0026391	0.150428689	0.003760717
4036	hsa-mir-1288	hsa04912	GnRH signaling pathway	5595_6714_5594	3	0.003503912	0.199722956	0.004871292
4037	hsa-mir-1288	hsa03022	Basal transcription factors	2969_6908	2	0.005094526	0.290387961	0.006913999
4038	hsa-mir-1288	hsa04530	Tight junction	207_6714_5590	3	0.006682388	0.380896095	0.008800774
4039	hsa-mir-1288	hsa04650	Natural killer cell mediated cytotoxicity	5777_5595_5594	3	0.006814411	0.388421399	0.008800774
4040	hsa-mir-1288	hsa04120	Ubiquitin mediated proteolysis	7329_4193_672	3	0.00694798	0.396034839	0.008800774
4041	hsa-mir-1288	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157_1616	2	0.010991309	0.626504597	0.013619665
4042	hsa-mir-1288	hsa05010	Alzheimer's disease	22926_5595_5594	3	0.013206783	0.752786615	0.016016736
4043	hsa-mir-1288	hsa04730	Long-term depression	5595_5594	2	0.017021088	0.97020199	0.020212541
4044	hsa-mir-1288	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.042611339	1	0.049568293
4045	hsa-mir-1289-2	hsa05200	Pathways in cancer	5371_5595_5594_5599_5914_1387_6256_595_5601_836_367_1017_4149_7704_3091_5970_7428_1870_1871_7157_4087_6688_2113_4609_1869_3725_2353_4088_4089_3066_3065_1050_5925_2034_2033_4846_4286	37	1.12E-34	6.96E-33	6.96E-33
4046	hsa-mir-1289-2	hsa04110	Cell cycle	5591_1387_595_1017_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933_890_5934	18	2.15E-19	1.33E-17	6.65E-18
4047	hsa-mir-1289-2	hsa05220	Chronic myeloid leukemia	5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464	15	5.72E-18	3.55E-16	1.18E-16
4048	hsa-mir-1289-2	hsa04350	TGF-beta signaling pathway	5518_5595_5594_1387_6667_1874_1875_4087_4609_4088_4089_2033_5933_5934	14	1.11E-15	6.91E-14	1.73E-14
4049	hsa-mir-1289-2	hsa05210	Colorectal cancer	5595_5594_5599_595_5601_836_7157_4087_4609_3725_2353_4088_4089	13	1.89E-14	1.17E-12	2.35E-13
4050	hsa-mir-1289-2	hsa05215	Prostate cancer	5595_5594_1387_595_367_1017_5970_1870_1871_7157_1869_5925_2033	13	3.24E-14	2.01E-12	3.28E-13
4051	hsa-mir-1289-2	hsa05212	Pancreatic cancer	5595_5594_1387_595_367_1017_5970_1870_1871_7157_1869_5925_2033	13	3.70E-14	2.29E-12	3.28E-13
4052	hsa-mir-1289-2	hsa04310	Wnt signaling pathway	5518_5599_1387_595_5601_7157_4087_4773_4609_3725_1457_4088_4089_2033_8061	15	7.42E-14	4.60E-12	5.75E-13
4053	hsa-mir-1289-2	hsa05222	Small cell lung cancer	6256_595_1017_4149_5970_1870_1871_7157_4609_1869_5925_4846	12	5.97E-13	3.70E-11	4.11E-12
4054	hsa-mir-1289-2	hsa04010	MAPK signaling pathway	5595_5594_5599_4208_5601_836_4149_3312_1649_5970_7157_4773_4609_3725_1386_2353_4763	17	1.67E-12	1.04E-10	1.04E-11
4055	hsa-mir-1289-2	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_5970_6688_4609_1050	10	9.41E-12	5.83E-10	5.30E-11
4056	hsa-mir-1289-2	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_4609_1869_5925	9	1.65E-11	1.02E-09	8.52E-11
4057	hsa-mir-1289-2	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_7157_1869_5925	9	1.21E-10	7.49E-09	5.76E-10
4058	hsa-mir-1289-2	hsa05214	Glioma	5595_5594_595_1870_1871_7157_1869_5925_6464	9	5.33E-10	3.31E-08	2.36E-09
4059	hsa-mir-1289-2	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5925_4286	9	1.09E-09	6.73E-08	4.49E-09
4060	hsa-mir-1289-2	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_7428_2113_3725_2034_2033	9	1.22E-09	7.54E-08	4.71E-09
4061	hsa-mir-1289-2	hsa05016	Huntington's disease	6874_1387_2902_6908_836_6667_7157_3066_3065_3064_2033	11	2.92E-08	1.81E-06	1.07E-07
4062	hsa-mir-1289-2	hsa04520	Adherens junction	5595_5594_1387_4087_1457_4088_4089_2033	8	5.15E-08	3.19E-06	1.72E-07
4063	hsa-mir-1289-2	hsa05216	Thyroid cancer	5595_5594_6256_595_7157_4609	6	5.27E-08	3.27E-06	1.72E-07
4064	hsa-mir-1289-2	hsa04012	ErbB signaling pathway	5595_5594_5599_5601_4609_3725_6464	7	1.41E-06	8.76E-05	4.38E-06
4065	hsa-mir-1289-2	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5601_5970_3725_2353	7	3.82E-06	0.000236811	1.13E-05
4066	hsa-mir-1289-2	hsa04660	T cell receptor signaling pathway	5595_5594_5601_5970_4773_3725_2353	7	6.11E-06	0.00037896	1.72E-05
4067	hsa-mir-1289-2	hsa04662	B cell receptor signaling pathway	5595_5594_5970_4773_3725_2353	6	8.43E-06	0.000522744	2.27E-05
4068	hsa-mir-1289-2	hsa04330	Notch signaling pathway	1387_9612_3066_3065_2033	5	1.36E-05	0.000845518	3.52E-05
4069	hsa-mir-1289-2	hsa05213	Endometrial cancer	5595_5594_595_7157_4609	5	2.15E-05	0.001330313	5.32E-05
4070	hsa-mir-1289-2	hsa04115	p53 signaling pathway	595_836_1017_7157_64326	5	7.62E-05	0.00472262	0.000181639
4071	hsa-mir-1289-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_836_5970_3725	5	8.65E-05	0.005365349	0.000198717
4072	hsa-mir-1289-2	hsa04720	Long-term potentiation	5595_5594_1387_2902_2033	5	0.000110498	0.006850907	0.000244675
4073	hsa-mir-1289-2	hsa04930	Type II diabetes mellitus	5595_5594_5599_5601	4	0.000197251	0.012229589	0.00042171
4074	hsa-mir-1289-2	hsa04910	Insulin signaling pathway	6720_5595_5594_5599_5601_6464	6	0.000213559	0.013240631	0.000441354
4075	hsa-mir-1289-2	hsa04510	Focal adhesion	5595_5594_5599_595_5601_3725_6464	7	0.000275094	0.017055848	0.000550189
4076	hsa-mir-1289-2	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_7157_4846	4	0.000431775	0.026770025	0.000836563
4077	hsa-mir-1289-2	hsa04916	Melanogenesis	5595_5594_1387_2033_4286	5	0.000468393	0.029040356	0.000880011
4078	hsa-mir-1289-2	hsa04912	GnRH signaling pathway	5595_5594_5599_5601_3725	5	0.000552267	0.034240544	0.001007075
4079	hsa-mir-1289-2	hsa04920	Adipocytokine signaling pathway	5599_6256_5601_5970	4	0.000818336	0.050736862	0.001449625
4080	hsa-mir-1289-2	hsa04730	Long-term depression	5518_5595_5594_4846	4	0.001005249	0.062325416	0.001731262
4081	hsa-mir-1289-2	hsa04370	VEGF signaling pathway	5595_5594_4773_4846	4	0.001339042	0.083020588	0.0022438
4082	hsa-mir-1289-2	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5601	4	0.001465631	0.090869131	0.002391293
4083	hsa-mir-1289-2	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_4773_6464	5	0.001586901	0.09838784	0.002522765
4084	hsa-mir-1289-2	hsa04120	Ubiquitin mediated proteolysis	5371_672_7428_7329_64326	5	0.001636301	0.10145069	0.002536267
4085	hsa-mir-1289-2	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.004161105	0.257988484	0.006292402
4086	hsa-mir-1289-2	hsa05010	Alzheimer's disease	5595_5594_2902_836_4846	5	0.004484676	0.27804989	0.006620235
4087	hsa-mir-1289-2	hsa04630	Jak-STAT signaling pathway	1387_595_4609_2033	4	0.014522429	0.900390599	0.020939316
4088	hsa-mir-1289-2	hsa04612	Antigen processing and presentation	4800_4801_3312	3	0.017019271	1	0.023448773
4089	hsa-mir-1289-2	hsa04210	Apoptosis	836_5970_7157	3	0.017019271	1	0.023448773
4090	hsa-mir-1289-2	hsa03022	Basal transcription factors	6874_6908	2	0.021990781	1	0.029639749
4091	hsa-mir-1289-2	hsa04062	Chemokine signaling pathway	5595_5594_5970_6464	4	0.029111992	1	0.038403053
4092	hsa-mir-1289-2	hsa03050	Proteasome	5684_5705	2	0.034867246	1	0.045036859
4093	hsa-mir-1289-2	hsa04360	Axon guidance	5595_5594_4773	3	0.04454249	1	0.056359885
4094	hsa-mir-1290	hsa05200	Pathways in cancer	3320_9063_1499_5594_5599_367_2932_4193_7704_1387_6774_6776_6777_5970_7157_2113_5894_3725_2353_4088_4089_1050_207_4790_4791	25	1.46E-22	1.02E-20	1.02E-20
4095	hsa-mir-1290	hsa05215	Prostate cancer	3320_1499_5594_1385_367_2932_4193_1387_5970_7157_5894_207_4790	13	1.15E-15	8.04E-14	3.06E-14
4096	hsa-mir-1290	hsa05212	Pancreatic cancer	3320_1499_5594_1385_367_2932_4193_1387_5970_7157_5894_207_4790	13	1.31E-15	9.18E-14	3.06E-14
4097	hsa-mir-1290	hsa04660	T cell receptor signaling pathway	3932_5594_920_915_2932_1432_5970_5894_3725_2353_5058_207_4790	13	1.59E-14	1.11E-12	2.78E-13
4098	hsa-mir-1290	hsa05220	Chronic myeloid leukemia	5594_4193_6776_6777_5970_7157_5894_4088_4089_207_4790	11	2.08E-13	1.46E-11	2.92E-12
4099	hsa-mir-1290	hsa04010	MAPK signaling pathway	5594_5599_5608_5566_1432_5970_7157_5894_3725_2353_5058_3303_207_5536_4790_4791	16	3.53E-13	2.47E-11	4.12E-12
4100	hsa-mir-1290	hsa05210	Colorectal cancer	1499_5594_5599_2932_7157_5894_3725_2353_4088_4089_207	11	6.43E-13	4.50E-11	6.40E-12
4101	hsa-mir-1290	hsa05221	Acute myeloid leukemia	5594_7704_6774_6776_6777_5970_5894_1050_207_4790	10	7.31E-13	5.12E-11	6.40E-12
4102	hsa-mir-1290	hsa04912	GnRH signaling pathway	6714_5594_5599_5608_5566_1432_5894_3725_808_801_805	11	7.91E-12	5.54E-10	6.16E-11
4103	hsa-mir-1290	hsa04110	Cell cycle	7534_5591_7533_7532_2932_4193_1387_7157_2810_4088_4089	11	2.09E-11	1.46E-09	1.46E-10
4104	hsa-mir-1290	hsa04012	ErbB signaling pathway	6714_5594_5599_2932_6776_6777_5894_3725_5058_207	10	2.43E-11	1.70E-09	1.55E-10
4105	hsa-mir-1290	hsa04910	Insulin signaling pathway	10891_5594_5599_5566_2932_5894_207_2538_808_801_805	11	9.23E-11	6.46E-09	5.38E-10
4106	hsa-mir-1290	hsa04916	Melanogenesis	1499_5594_1385_5566_2932_1387_5894_808_801_805	10	1.23E-10	8.62E-09	6.63E-10
4107	hsa-mir-1290	hsa05214	Glioma	5594_4193_7157_5894_207_808_801_805	8	1.56E-09	1.09E-07	7.78E-09
4108	hsa-mir-1290	hsa04620	Toll-like receptor signaling pathway	5594_5599_5608_1432_5970_3725_2353_207_4790	9	2.17E-09	1.52E-07	1.01E-08
4109	hsa-mir-1290	hsa04310	Wnt signaling pathway	1499_5599_5566_2932_1387_7157_8061_3725_4088_4089	10	3.89E-09	2.72E-07	1.70E-08
4110	hsa-mir-1290	hsa04662	B cell receptor signaling pathway	5594_2932_5970_5894_3725_2353_207_4790	8	4.39E-09	3.08E-07	1.81E-08
4111	hsa-mir-1290	hsa04062	Chemokine signaling pathway	5594_5566_2932_6774_6777_5970_5894_5058_207_4790	10	3.36E-08	2.35E-06	1.31E-07
4112	hsa-mir-1290	hsa04920	Adipocytokine signaling pathway	10891_5599_6774_5970_207_4790_2538	7	4.80E-08	3.36E-06	1.77E-07
4113	hsa-mir-1290	hsa04630	Jak-STAT signaling pathway	9063_1387_3460_6774_6776_6777_3595_3594_207	9	6.63E-08	4.64E-06	2.31E-07
4114	hsa-mir-1290	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_5599_1432_5970_3725_5058_4790	7	6.94E-08	4.86E-06	2.31E-07
4115	hsa-mir-1290	hsa05211	Renal cell carcinoma	5594_1387_2113_5894_3725_5058_207	7	7.59E-08	5.31E-06	2.41E-07
4116	hsa-mir-1290	hsa04720	Long-term potentiation	5594_5566_1387_5894_808_801_805	7	9.84E-08	6.89E-06	2.99E-07
4117	hsa-mir-1290	hsa05213	Endometrial cancer	1499_5594_2932_7157_5894_207	6	2.63E-07	1.84E-05	7.68E-07
4118	hsa-mir-1290	hsa04510	Focal adhesion	1499_6714_5594_5599_2932_5894_3725_5058_207	9	6.59E-07	4.61E-05	1.84E-06
4119	hsa-mir-1290	hsa04664	Fc epsilon RI signaling pathway	5594_5599_5608_1432_5894_207	6	2.57E-06	0.000180231	6.93E-06
4120	hsa-mir-1290	hsa04520	Adherens junction	1499_6714_5594_1387_4088_4089	6	2.76E-06	0.000193029	7.15E-06
4121	hsa-mir-1290	hsa04612	Antigen processing and presentation	3320_811_920_1385_4800_3303	6	4.93E-06	0.000345084	1.23E-05
4122	hsa-mir-1290	hsa04270	Vascular smooth muscle contraction	5594_5566_5894_808_801_805	6	2.27E-05	0.001592027	5.49E-05
4123	hsa-mir-1290	hsa05218	Melanoma	5594_4193_7157_5894_207	5	2.57E-05	0.001800571	6.00E-05
4124	hsa-mir-1290	hsa05340	Primary immunodeficiency	3932_920_915_100	4	2.97E-05	0.002079541	6.71E-05
4125	hsa-mir-1290	hsa05016	Huntington's disease	10891_1385_291_6908_5481_1387_7157	7	3.23E-05	0.002258167	7.06E-05
4126	hsa-mir-1290	hsa04370	VEGF signaling pathway	6714_5594_1432_5894_207	5	3.72E-05	0.002601865	7.88E-05
4127	hsa-mir-1290	hsa05219	Bladder cancer	5594_4193_7157_5894	4	5.75E-05	0.004025345	0.000118393
4128	hsa-mir-1290	hsa05222	Small cell lung cancer	9063_5970_7157_207_4790	5	6.13E-05	0.004291882	0.000122625
4129	hsa-mir-1290	hsa04210	Apoptosis	5566_5970_7157_207_4790	5	7.16E-05	0.005010981	0.000139194
4130	hsa-mir-1290	hsa05223	Non-small cell lung cancer	5594_7157_5894_207	4	0.000143331	0.010033181	0.000271167
4131	hsa-mir-1290	hsa05010	Alzheimer's disease	5594_3416_2932_808_801_805	6	0.000196558	0.013759085	0.000362081
4132	hsa-mir-1290	hsa04020	Calcium signaling pathway	291_5566_5481_808_801_805	6	0.000240662	0.016846309	0.000431957
4133	hsa-mir-1290	hsa05216	Thyroid cancer	1499_5594_7157	3	0.000413867	0.028970691	0.000724267
4134	hsa-mir-1290	hsa04650	Natural killer cell mediated cytotoxicity	3932_5594_3460_5894_5058	5	0.000507012	0.035490871	0.000865631
4135	hsa-mir-1290	hsa04350	TGF-beta signaling pathway	5594_1387_4088_4089	4	0.000804252	0.056297607	0.001340419
4136	hsa-mir-1290	hsa04540	Gap junction	6714_5594_5566_5894	4	0.001020978	0.071468485	0.001662058
4137	hsa-mir-1290	hsa05217	Basal cell carcinoma	1499_2932_7157	3	0.002362172	0.165352068	0.003694376
4138	hsa-mir-1290	hsa05014	Amyotrophic lateral sclerosis (ALS)	5608_1432_7157	3	0.002480509	0.173635655	0.003694376
4139	hsa-mir-1290	hsa05131	Shigellosis	7534_1499_4691	3	0.002480509	0.173635655	0.003694376
4140	hsa-mir-1290	hsa05130	Pathogenic Escherichia coli infection	7534_1499_4691	3	0.002480509	0.173635655	0.003694376
4141	hsa-mir-1290	hsa04340	Hedgehog signaling pathway	5566_2932_53944	3	0.002602453	0.182171695	0.003795244
4142	hsa-mir-1290	hsa04115	p53 signaling pathway	4193_7157_2810	3	0.004359646	0.305175219	0.006228066
4143	hsa-mir-1290	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.005648953	0.395426685	0.007908534
4144	hsa-mir-1290	hsa04950	Maturity onset diabetes of the young	3172_3175	2	0.006207371	0.434516	0.008519922
4145	hsa-mir-1290	hsa03022	Basal transcription factors	2969_6908	2	0.013618682	0.953307757	0.018332841
4146	hsa-mir-1290	hsa04930	Type II diabetes mellitus	5594_5599	2	0.0194044	1	0.025628453
4147	hsa-mir-1290	hsa04330	Notch signaling pathway	1387_9612	2	0.020985821	1	0.027203842
4148	hsa-mir-1290	hsa04360	Axon guidance	5594_2932_5058	3	0.023398713	1	0.02978018
4149	hsa-mir-1290	hsa04150	mTOR signaling pathway	5594_207	2	0.025163832	1	0.031454789
4150	hsa-mir-1290	hsa05012	Parkinson's disease	7314_291_5481	3	0.025717236	1	0.03158257
4151	hsa-mir-1290	hsa04530	Tight junction	1499_6714_207	3	0.026195239	1	0.031614944
4152	hsa-mir-1290	hsa04120	Ubiquitin mediated proteolysis	9063_4193_7329	3	0.027165528	1	0.032230287
4153	hsa-mir-1290	hsa04730	Long-term depression	5594_5894	2	0.043714023	1	0.050999694
4154	hsa-mir-1291	hsa05210	Colorectal cancer	4087_4088_4609	3	3.82E-06	7.25E-05	4.02E-05
4155	hsa-mir-1291	hsa04350	TGF-beta signaling pathway	4087_4088_4609	3	4.23E-06	8.04E-05	4.02E-05
4156	hsa-mir-1291	hsa04310	Wnt signaling pathway	4087_4088_4609	3	2.16E-05	0.000410932	0.000136977
4157	hsa-mir-1291	hsa03022	Basal transcription factors	2959_6908	2	8.98E-05	0.001706887	0.000426722
4158	hsa-mir-1291	hsa05200	Pathways in cancer	4087_4088_4609	3	0.000212827	0.004043706	0.000808741
4159	hsa-mir-1291	hsa05220	Chronic myeloid leukemia	4088_4609	2	0.000352053	0.006688998	0.001083486
4160	hsa-mir-1291	hsa04520	Adherens junction	4087_4088	2	0.000399179	0.007584403	0.001083486
4161	hsa-mir-1291	hsa04612	Antigen processing and presentation	4800_4801	2	0.000491328	0.009335227	0.001166903
4162	hsa-mir-1291	hsa04110	Cell cycle	4087_4088	2	0.000865862	0.016451381	0.001827931
4163	hsa-mir-1291	hsa05216	Thyroid cancer	4609	1	0.010942987	0.207916755	0.020791676
4164	hsa-mir-1291	hsa05219	Bladder cancer	4609	1	0.015651049	0.297369932	0.02703363
4165	hsa-mir-1291	hsa05213	Endometrial cancer	4609	1	0.019258761	0.365916464	0.030493039
4166	hsa-mir-1291	hsa05221	Acute myeloid leukemia	4609	1	0.021777003	0.413763058	0.031827928
4167	hsa-mir-1291	hsa05222	Small cell lung cancer	4609	1	0.031435255	0.597269847	0.040268977
4168	hsa-mir-1291	hsa04012	ErbB signaling pathway	4609	1	0.031791298	0.604034653	0.040268977
4169	hsa-mir-129-2	hsa05200	Pathways in cancer	3716_3320_3326_675_1956_367_1499_5594_5595_1387_5159_5156_4286_1399_1398_1147_8517_3815_2932_7704_3551_6774_6777_6772_6256_5970_8554_6688_2113_4609_1869_862_867_6502_2353_4087_4088_7175_3065_5925_2033_207_4791_4792	44	9.32E-33	7.09E-31	7.09E-31
4170	hsa-mir-129-2	hsa05215	Prostate cancer	3320_3326_1956_367_1499_5594_5595_1387_5159_5156_1147_8517_2932_3551_5970_1869_5925_2033_207_4792	20	1.71E-19	1.30E-17	4.58E-18
4171	hsa-mir-129-2	hsa05212	Pancreatic cancer	3320_3326_1956_367_1499_5594_5595_1387_5159_5156_1147_8517_2932_3551_5970_1869_5925_2033_207_4792	20	2.08E-19	1.58E-17	4.58E-18
4172	hsa-mir-129-2	hsa05220	Chronic myeloid leukemia	5594_5595_1399_1398_1147_8517_3551_6777_5970_5781_4609_1869_867_4088_3065_5925_207_4792_6464	19	2.41E-19	1.83E-17	4.58E-18
4173	hsa-mir-129-2	hsa04010	MAPK signaling pathway	1956_5594_5595_6722_5159_1326_5156_4208_3305_3303_5566_1399_1398_1147_8517_7867_3312_1432_3551_5971_5970_9261_3310_4609_2353_207_4791	27	1.79E-17	1.36E-15	2.72E-16
4174	hsa-mir-129-2	hsa04630	Jak-STAT signaling pathway	3717_3716_3718_85480_3560_3561_1387_3575_6774_6777_6772_8554_3559_2057_5781_4609_867_2690_6778_2033_207	21	2.47E-16	1.88E-14	3.13E-15
4175	hsa-mir-129-2	hsa04660	T cell receptor signaling pathway	3932_5594_5595_1326_919_1147_8517_2932_4794_1432_3551_5970_867_2353_207_4792_4793_1493	18	1.85E-15	1.41E-13	2.01E-14
4176	hsa-mir-129-2	hsa04062	Chemokine signaling pathway	3717_3718_5594_5595_5566_1399_1398_1147_1234_8517_2932_3551_6774_6777_6772_5970_653361_207_4792_4793_6464	21	1.32E-14	1.00E-12	1.25E-13
4177	hsa-mir-129-2	hsa05221	Acute myeloid leukemia	5594_5595_1147_8517_3815_7704_3551_6774_6777_5970_6688_4609_862_207	14	2.98E-14	2.26E-12	2.51E-13
4178	hsa-mir-129-2	hsa04662	B cell receptor signaling pathway	5594_5595_6850_695_1147_8517_2932_4794_3551_5970_2353_207_4792_4793	14	5.29E-13	4.02E-11	4.02E-12
4179	hsa-mir-129-2	hsa05214	Glioma	1956_5594_5595_5159_5156_1869_5925_808_207_6464_801_805	12	2.78E-11	2.11E-09	1.92E-10
4180	hsa-mir-129-2	hsa04920	Adipocytokine signaling pathway	3717_1147_8517_4794_3551_6774_6256_5970_5781_207_4792_4793	12	3.80E-11	2.89E-09	2.39E-10
4181	hsa-mir-129-2	hsa04350	TGF-beta signaling pathway	5515_5594_5595_1387_6500_8454_3397_3398_4609_3399_4087_4088_2033	13	4.40E-11	3.34E-09	2.39E-10
4182	hsa-mir-129-2	hsa04012	ErbB signaling pathway	1956_6714_5594_5595_2066_1399_1398_2932_6777_4609_867_207_6464	13	4.40E-11	3.34E-09	2.39E-10
4183	hsa-mir-129-2	hsa04910	Insulin signaling pathway	3643_5594_5595_5566_1399_1398_2932_5770_3551_867_808_207_6464_801_805	15	8.50E-11	6.46E-09	4.31E-10
4184	hsa-mir-129-2	hsa04520	Adherens junction	1956_1499_6714_3643_5594_5595_1387_5770_4087_4088_2033_71	12	2.39E-10	1.81E-08	1.13E-09
4185	hsa-mir-129-2	hsa05210	Colorectal cancer	1956_1499_5594_5595_5159_5156_2932_4609_2353_4087_4088_207	12	3.96E-10	3.01E-08	1.77E-09
4186	hsa-mir-129-2	hsa05222	Small cell lung cancer	1147_8517_3551_6256_5970_8554_4609_1869_6502_5925_207_4792	12	5.05E-10	3.84E-08	2.13E-09
4187	hsa-mir-129-2	hsa04540	Gap junction	203068_1956_6714_5594_5595_5159_5156_5566_347733_10382_84617_7278	12	1.14E-09	8.64E-08	4.55E-09
4188	hsa-mir-129-2	hsa04310	Wnt signaling pathway	5515_23291_1499_1387_8607_6500_5566_2932_8454_8945_4609_4087_4088_2033	14	2.65E-09	2.02E-07	1.01E-08
4189	hsa-mir-129-2	hsa04620	Toll-like receptor signaling pathway	5594_5595_1326_1147_8517_1432_3551_6772_5970_2353_207_4792	12	2.96E-09	2.25E-07	1.07E-08
4190	hsa-mir-129-2	hsa04916	Melanogenesis	1499_5594_5595_1387_4286_5566_3815_2932_808_2033_801_805	12	3.62E-09	2.75E-07	1.25E-08
4191	hsa-mir-129-2	hsa04110	Cell cycle	5591_1387_6500_2932_8454_1869_6502_4087_4088_3065_5925_2033	12	1.45E-08	1.10E-06	4.80E-08
4192	hsa-mir-129-2	hsa04120	Ubiquitin mediated proteolysis	23291_672_6500_8454_3093_8554_10273_8945_7329_867_6502_7323	12	7.11E-08	5.41E-06	2.25E-07
4193	hsa-mir-129-2	hsa04612	Antigen processing and presentation	3320_3326_3308_3309_3305_3303_4800_4801_3312_3310	10	9.29E-08	7.06E-06	2.78E-07
4194	hsa-mir-129-2	hsa04510	Focal adhesion	1956_1499_6714_5594_5595_5159_5156_1399_1398_2932_10627_207_71_6464	14	9.52E-08	7.23E-06	2.78E-07
4195	hsa-mir-129-2	hsa05218	Melanoma	1956_5594_5595_5159_5156_4286_1869_5925_207	9	1.61E-07	1.23E-05	4.38E-07
4196	hsa-mir-129-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_1147_8517_1432_3551_5970_5781_4792	9	1.61E-07	1.23E-05	4.38E-07
4197	hsa-mir-129-2	hsa05211	Renal cell carcinoma	5594_5595_1387_1399_1398_5781_2113_2033_207	9	1.80E-07	1.37E-05	4.71E-07
4198	hsa-mir-129-2	hsa04330	Notch signaling pathway	388585_1387_4851_9612_3065_2033_8850	7	1.49E-06	0.000112975	3.72E-06
4199	hsa-mir-129-2	hsa03020	RNA polymerase	5437_64425_25885_51082_84172_5441	6	1.57E-06	0.000119111	3.72E-06
4200	hsa-mir-129-2	hsa05216	Thyroid cancer	1499_5594_5595_6256_4609_7175	6	1.57E-06	0.000119111	3.72E-06
4201	hsa-mir-129-2	hsa04720	Long-term potentiation	5594_5595_1387_5566_808_2033_801_805	8	2.61E-06	0.000198595	6.02E-06
4202	hsa-mir-129-2	hsa05213	Endometrial cancer	1956_1499_5594_5595_2932_4609_207	7	2.74E-06	0.000208115	6.12E-06
4203	hsa-mir-129-2	hsa05223	Non-small cell lung cancer	1956_5594_5595_6256_1869_5925_207	7	3.44E-06	0.000261431	7.47E-06
4204	hsa-mir-129-2	hsa04912	GnRH signaling pathway	1956_6714_5594_5595_5566_1432_808_801_805	9	4.10E-06	0.000311507	8.35E-06
4205	hsa-mir-129-2	hsa05340	Primary immunodeficiency	3718_3932_3561_3575_695_8517	6	4.12E-06	0.000313008	8.35E-06
4206	hsa-mir-129-2	hsa05131	Shigellosis	203068_1499_347733_10382_84617_7278_71	7	4.29E-06	0.000325673	8.35E-06
4207	hsa-mir-129-2	hsa05130	Pathogenic Escherichia coli infection	203068_1499_347733_10382_84617_7278_71	7	4.29E-06	0.000325673	8.35E-06
4208	hsa-mir-129-2	hsa04810	Regulation of actin cytoskeleton	1956_5594_5595_5159_5156_1399_1398_4628_10788_4627_10627_71	12	6.52E-06	0.00049521	1.24E-05
4209	hsa-mir-129-2	hsa04060	Cytokine-cytokine receptor interaction	85480_1956_3560_3561_5159_8600_5156_3575_1234_3815_3559_2057_2690	13	7.50E-06	0.000569865	1.39E-05
4210	hsa-mir-129-2	hsa04210	Apoptosis	5566_1147_8517_8837_3551_5970_207_4792	8	8.44E-06	0.000641198	1.53E-05
4211	hsa-mir-129-2	hsa05219	Bladder cancer	1956_5594_5595_4609_1869_5925	6	1.06E-05	0.000803345	1.87E-05
4212	hsa-mir-129-2	hsa04370	VEGF signaling pathway	6714_5594_5595_7867_1432_9261_207	7	2.91E-05	0.002210856	5.02E-05
4213	hsa-mir-129-2	hsa04020	Calcium signaling pathway	1956_292_293_2066_5159_5156_5566_808_801_805	10	4.10E-05	0.003112869	6.92E-05
4214	hsa-mir-129-2	hsa05016	Huntington's disease	1387_292_293_6908_1213_5437_3065_2033_5441_4724	10	4.87E-05	0.003698307	8.04E-05
4215	hsa-mir-129-2	hsa04530	Tight junction	5515_1499_6714_4628_4627_10627_207_71	8	0.000150871	0.011466171	0.000242629
4216	hsa-mir-129-2	hsa03010	Ribosome	6124_6156_6143_6129_6207_6202_6128	7	0.000153239	0.011646198	0.000242629
4217	hsa-mir-129-2	hsa04930	Type II diabetes mellitus	3651_3643_5594_5595_3551	5	0.000174506	0.013262437	0.000270662
4218	hsa-mir-129-2	hsa04664	Fc epsilon RI signaling pathway	5594_5595_6850_695_1432_207	6	0.000272586	0.020716502	0.00041433
4219	hsa-mir-129-2	hsa04270	Vascular smooth muscle contraction	5594_5595_4637_5566_808_801_805	7	0.000355874	0.027046396	0.000530321
4220	hsa-mir-129-2	hsa05010	Alzheimer's disease	22926_5594_5595_2932_808_4724_801_805	8	0.00077285	0.058736592	0.00112955
4221	hsa-mir-129-2	hsa04650	Natural killer cell mediated cytotoxicity	3932_5594_5595_6850_919_5781_6464	7	0.000863231	0.065605526	0.00123784
4222	hsa-mir-129-2	hsa04670	Leukocyte transendothelial migration	1499_1432_5781_653361_10627_71	6	0.002327412	0.176883296	0.003275617
4223	hsa-mir-129-2	hsa04950	Maturity onset diabetes of the young	3651_168620_5080	3	0.002750104	0.209007938	0.003800144
4224	hsa-mir-129-2	hsa04340	Hedgehog signaling pathway	23291_5566_2932_8945	4	0.003832291	0.291254088	0.005200966
4225	hsa-mir-129-2	hsa03022	Basal transcription factors	2969_6908_2959	3	0.008406682	0.638907819	0.011208909
4226	hsa-mir-129-2	hsa04640	Hematopoietic cell lineage	3575_3815_3559_2057	4	0.015397563	1	0.020176117
4227	hsa-mir-129-2	hsa04150	mTOR signaling pathway	5594_5595_207	3	0.019911427	1	0.025648618
4228	hsa-mir-129-2	hsa04730	Long-term depression	5515_5594_5595	3	0.042625757	1	0.053992625
4229	hsa-mir-1293	hsa04010	MAPK signaling pathway	468_1649_3725_3727	4	2.23E-06	5.12E-05	5.12E-05
4230	hsa-mir-1293	hsa05211	Renal cell carcinoma	1387_3725	2	0.000325176	0.007479044	0.002260107
4231	hsa-mir-1293	hsa04720	Long-term potentiation	1387_468	2	0.000352053	0.008097208	0.002260107
4232	hsa-mir-1293	hsa05215	Prostate cancer	1387_468	2	0.000480625	0.011054384	0.002260107
4233	hsa-mir-1293	hsa05212	Pancreatic cancer	1387_468	2	0.000491328	0.011300537	0.002260107
4234	hsa-mir-1293	hsa04912	GnRH signaling pathway	468_3725	2	0.000716567	0.016481032	0.002746839
4235	hsa-mir-1293	hsa04310	Wnt signaling pathway	1387_3725	2	0.001395817	0.0321038	0.004586257
4236	hsa-mir-1293	hsa04710	Circadian rhythm - mammal	406	1	0.005120351	0.117768066	0.014721008
4237	hsa-mir-1293	hsa05200	Pathways in cancer	1387_3725	2	0.006355899	0.146185677	0.016242853
4238	hsa-mir-1293	hsa04330	Notch signaling pathway	1387	1	0.01745641	0.401497441	0.040149744
4239	hsa-mir-1293	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725	1	0.026080317	0.599847284	0.04569999
4240	hsa-mir-1293	hsa04662	B cell receptor signaling pathway	3725	1	0.027510926	0.632751289	0.04569999
4241	hsa-mir-1293	hsa04520	Adherens junction	1387	1	0.0292965	0.673819503	0.04569999
4242	hsa-mir-1293	hsa05210	Colorectal cancer	3725	1	0.030722813	0.706624705	0.04569999
4243	hsa-mir-1293	hsa04350	TGF-beta signaling pathway	1387	1	0.031791298	0.731199843	0.04569999
4244	hsa-mir-1293	hsa04012	ErbB signaling pathway	3725	1	0.031791298	0.731199843	0.04569999
4245	hsa-mir-1293	hsa04620	Toll-like receptor signaling pathway	3725	1	0.037117675	0.853706523	0.048333021
4246	hsa-mir-1293	hsa04916	Melanogenesis	1387	1	0.037825842	0.869994372	0.048333021
4247	hsa-mir-1293	hsa04660	T cell receptor signaling pathway	3725	1	0.039947504	0.918792601	0.048357505
4248	hsa-mir-1293	hsa04110	Cell cycle	1387	1	0.043122024	0.991806549	0.049590327
4249	hsa-mir-1294	hsa04115	p53 signaling pathway	891_7157	2	0.000823484	0.024704509	0.01754219
4250	hsa-mir-1294	hsa05210	Colorectal cancer	7157_2353	2	0.00120477	0.03614309	0.01754219
4251	hsa-mir-1294	hsa03010	Ribosome	6222_6231	2	0.001754219	0.052626569	0.01754219
4252	hsa-mir-1294	hsa04110	Cell cycle	891_7157	2	0.002363532	0.070905954	0.017726488
4253	hsa-mir-1294	hsa04120	Ubiquitin mediated proteolysis	7325_7329	2	0.003190529	0.095715862	0.019143172
4254	hsa-mir-1294	hsa05016	Huntington's disease	7157_1537	2	0.005704163	0.171124897	0.028520816
4255	hsa-mir-1294	hsa04010	MAPK signaling pathway	7157_2353	2	0.011614496	0.348434866	0.049776409
4256	hsa-mir-1294	hsa05200	Pathways in cancer	7157_2353	2	0.016790244	0.503707326	0.059474038
4257	hsa-mir-1294	hsa05216	Thyroid cancer	7157	1	0.017842211	0.535266341	0.059474038
4258	hsa-mir-1294	hsa04130	SNARE interactions in vesicular transport	9342	1	0.023135969	0.694079072	0.06578568
4259	hsa-mir-1294	hsa05219	Bladder cancer	7157	1	0.02548009	0.764402702	0.06578568
4260	hsa-mir-1294	hsa05213	Endometrial cancer	7157	1	0.031317172	0.939515157	0.06578568
4261	hsa-mir-1294	hsa05223	Non-small cell lung cancer	7157	1	0.032480619	0.974418567	0.06578568
4262	hsa-mir-1294	hsa05217	Basal cell carcinoma	7157	1	0.033061847	0.991855421	0.06578568
4263	hsa-mir-1294	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157	1	0.033642746	1	0.06578568
4264	hsa-mir-1294	hsa05214	Glioma	7157	1	0.038856023	1	0.06578568
4265	hsa-mir-1294	hsa05218	Melanoma	7157	1	0.042316772	1	0.06578568
4266	hsa-mir-1294	hsa05220	Chronic myeloid leukemia	7157	1	0.044617397	1	0.06578568
4267	hsa-mir-1294	hsa04662	B cell receptor signaling pathway	2353	1	0.044617397	1	0.06578568
4268	hsa-mir-1294	hsa04260	Cardiac muscle contraction	1537	1	0.049202995	1	0.06578568
4269	hsa-mir-1295	hsa04350	TGF-beta signaling pathway	5518_1387_2033	3	5.63E-06	9.00E-05	9.00E-05
4270	hsa-mir-1295	hsa04310	Wnt signaling pathway	5518_1387_2033	3	2.87E-05	0.000459602	0.000229801
4271	hsa-mir-1295	hsa04330	Notch signaling pathway	1387_2033	2	0.000170558	0.002728922	0.000909641
4272	hsa-mir-1295	hsa05211	Renal cell carcinoma	1387_2033	2	0.000389562	0.006232993	0.001176782
4273	hsa-mir-1295	hsa04720	Long-term potentiation	1387_2033	2	0.000421732	0.006747719	0.001176782
4274	hsa-mir-1295	hsa04520	Adherens junction	1387_2033	2	0.000478134	0.007650137	0.001176782
4275	hsa-mir-1295	hsa05215	Prostate cancer	1387_2033	2	0.000575587	0.009209395	0.001176782
4276	hsa-mir-1295	hsa05212	Pancreatic cancer	1387_2033	2	0.000588391	0.009414257	0.001176782
4277	hsa-mir-1295	hsa04916	Melanogenesis	1387_2033	2	0.000796949	0.01275118	0.001416798
4278	hsa-mir-1295	hsa04110	Cell cycle	1387_2033	2	0.001036227	0.016579635	0.001657964
4279	hsa-mir-1295	hsa04630	Jak-STAT signaling pathway	1387_2033	2	0.001733966	0.027743449	0.002522132
4280	hsa-mir-1295	hsa05016	Huntington's disease	1387_2033	2	0.002523767	0.040380264	0.003365022
4281	hsa-mir-1295	hsa05200	Pathways in cancer	1387_2033	2	0.007570799	0.121132791	0.009317907
4282	hsa-mir-1295	hsa04730	Long-term depression	5518	1	0.028416789	0.45466863	0.032476331
4283	hsa-mir-1296	hsa03022	Basal transcription factors	2967_2961_2960_2963_6881_54457_2968_6878_6877_6874_6872_2957_6879_6873_2958_6884_2959_6880_6882_138474_6883	21	5.13E-34	3.44E-32	3.44E-32
4284	hsa-mir-1296	hsa05200	Pathways in cancer	3326_5925_5594_6256_4193_2353_1387_5970_7157_6688_3725_10401_4609_2033_8554_7184	16	3.55E-11	2.38E-09	1.19E-09
4285	hsa-mir-1296	hsa05215	Prostate cancer	3326_5925_5594_4193_1387_5970_7157_2033_7184	9	1.82E-09	1.22E-07	3.34E-08
4286	hsa-mir-1296	hsa05212	Pancreatic cancer	3326_5925_5594_4193_1387_5970_7157_2033_7184	9	2.00E-09	1.34E-07	3.34E-08
4287	hsa-mir-1296	hsa04110	Cell cycle	5925_993_983_4193_1387_7157_4171_4085_2033	9	2.12E-08	1.42E-06	2.84E-07
4288	hsa-mir-1296	hsa05222	Small cell lung cancer	5925_6256_5970_7157_10401_4609_8554	7	5.18E-07	3.47E-05	5.79E-06
4289	hsa-mir-1296	hsa05220	Chronic myeloid leukemia	5925_5594_4193_5970_7157_4609	6	3.81E-06	0.000255132	3.52E-05
4290	hsa-mir-1296	hsa05219	Bladder cancer	5925_5594_4193_7157_4609	5	4.20E-06	0.000281378	3.52E-05
4291	hsa-mir-1296	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	7.67E-06	0.000513579	5.71E-05
4292	hsa-mir-1296	hsa04310	Wnt signaling pathway	1460_8607_1387_7157_3725_4609_2033	7	1.84E-05	0.001234135	0.000123414
4293	hsa-mir-1296	hsa05216	Thyroid cancer	5594_6256_7157_4609	4	2.39E-05	0.001598163	0.000145288
4294	hsa-mir-1296	hsa05016	Huntington's disease	6874_9001_1387_5430_7157_3064_2033	7	6.76E-05	0.004532442	0.000377703
4295	hsa-mir-1296	hsa05210	Colorectal cancer	5594_2353_7157_3725_4609	5	9.57E-05	0.006408762	0.000492982
4296	hsa-mir-1296	hsa04010	MAPK signaling pathway	3727_5594_2353_3312_5970_7157_3725_4609	8	0.000103866	0.006958999	0.000497071
4297	hsa-mir-1296	hsa05223	Non-small cell lung cancer	5925_5594_6256_7157	4	0.000223979	0.015006569	0.001000438
4298	hsa-mir-1296	hsa05221	Acute myeloid leukemia	5594_5970_6688_4609	4	0.000308302	0.020656225	0.001291014
4299	hsa-mir-1296	hsa05214	Glioma	5925_5594_4193_7157	4	0.000436958	0.029276196	0.001722129
4300	hsa-mir-1296	hsa05218	Melanoma	5925_5594_4193_7157	4	0.000599958	0.040197205	0.002224381
4301	hsa-mir-1296	hsa05211	Renal cell carcinoma	5594_1387_3725_2033	4	0.000630795	0.042263241	0.002224381
4302	hsa-mir-1296	hsa04662	B cell receptor signaling pathway	5594_2353_5970_3725	4	0.000730035	0.048912346	0.002445617
4303	hsa-mir-1296	hsa04520	Adherens junction	1460_5594_1387_2033	4	0.000919202	0.061586547	0.002932693
4304	hsa-mir-1296	hsa04350	TGF-beta signaling pathway	5594_1387_4609_2033	4	0.00123861	0.082986846	0.003772129
4305	hsa-mir-1296	hsa04612	Antigen processing and presentation	3326_4801_3312_1514	4	0.001342496	0.089947225	0.003910749
4306	hsa-mir-1296	hsa04630	Jak-STAT signaling pathway	1387_10401_4609_2033_8554	5	0.001415158	0.094815603	0.00395065
4307	hsa-mir-1296	hsa03420	Nucleotide excision repair	2967_2968_5887	3	0.001796489	0.120364739	0.00481459
4308	hsa-mir-1296	hsa04330	Notch signaling pathway	1387_2033_8850	3	0.002147393	0.143875324	0.005385597
4309	hsa-mir-1296	hsa04620	Toll-like receptor signaling pathway	5594_2353_5970_3725	4	0.002170315	0.145411124	0.005385597
4310	hsa-mir-1296	hsa05213	Endometrial cancer	5594_7157_4609	3	0.002821353	0.189030656	0.006527075
4311	hsa-mir-1296	hsa04660	T cell receptor signaling pathway	5594_2353_5970_3725	4	0.002825152	0.189285189	0.006527075
4312	hsa-mir-1296	hsa04115	p53 signaling pathway	983_4193_7157	3	0.006021686	0.403452968	0.013448432
4313	hsa-mir-1296	hsa04720	Long-term potentiation	5594_1387_2033	3	0.007512529	0.503339468	0.016236757
4314	hsa-mir-1296	hsa04012	ErbB signaling pathway	5594_3725_4609	3	0.01109843	0.743594836	0.023237339
4315	hsa-mir-1296	hsa04540	Gap junction	5594_983_10382	3	0.01320293	0.884596298	0.026805948
4316	hsa-mir-1296	hsa04916	Melanogenesis	5594_1387_2033	3	0.017614356	1	0.034710643
4317	hsa-mir-1296	hsa04120	Ubiquitin mediated proteolysis	4193_10401_8554	3	0.0364824	1	0.069837737
4318	hsa-mir-1296	hsa05322	Systemic lupus erythematosus	3014_3015_8340	3	0.039773496	1	0.074022895
4319	hsa-mir-1296	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.048665044	1	0.088123187
4320	hsa-mir-1297	hsa05200	Pathways in cancer	2249_367_3725_6776_6777_2353_5914_5970_6256	9	9.03E-10	3.43E-08	3.43E-08
4321	hsa-mir-1297	hsa05221	Acute myeloid leukemia	6776_6777_5914_5970	4	1.85E-06	7.03E-05	3.52E-05
4322	hsa-mir-1297	hsa05220	Chronic myeloid leukemia	6776_6777_5970	3	0.000179685	0.006828022	0.001707005
4323	hsa-mir-1297	hsa04662	B cell receptor signaling pathway	3725_2353_5970	3	0.000179685	0.006828022	0.001707005
4324	hsa-mir-1297	hsa04012	ErbB signaling pathway	3725_6776_6777	3	0.000274263	0.010421976	0.002084395
4325	hsa-mir-1297	hsa04620	Toll-like receptor signaling pathway	3725_2353_5970	3	0.000431309	0.016389732	0.002731622
4326	hsa-mir-1297	hsa04660	T cell receptor signaling pathway	3725_2353_5970	3	0.000534536	0.020312379	0.002854227
4327	hsa-mir-1297	hsa04010	MAPK signaling pathway	2249_3725_2353_5970	4	0.00060089	0.022833818	0.002854227
4328	hsa-mir-1297	hsa04630	Jak-STAT signaling pathway	3977_6776_6777	3	0.001409613	0.053565292	0.005951699
4329	hsa-mir-1297	hsa04920	Adipocytokine signaling pathway	5970_6256	2	0.004218425	0.160300136	0.016030014
4330	hsa-mir-1297	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.004708842	0.178935979	0.016266907
4331	hsa-mir-1297	hsa05210	Colorectal cancer	3725_2353	2	0.006474344	0.246025068	0.018295347
4332	hsa-mir-1297	hsa05222	Small cell lung cancer	5970_6256	2	0.006768846	0.257216139	0.018295347
4333	hsa-mir-1297	hsa05215	Prostate cancer	367_5970	2	0.007069353	0.268635406	0.018295347
4334	hsa-mir-1297	hsa05212	Pancreatic cancer	367_5970	2	0.007221848	0.274430206	0.018295347
4335	hsa-mir-1297	hsa03450	Non-homologous end-joining	2547	1	0.020771447	0.789314997	0.049332187
4336	hsa-mir-1297	hsa05016	Huntington's disease	6908_6667	2	0.029030978	1	0.064283255
4337	hsa-mir-1297	hsa04062	Chemokine signaling pathway	6777_5970	2	0.030449963	1	0.064283255
4338	hsa-mir-1297	hsa04950	Maturity onset diabetes of the young	6927	1	0.034384455	1	0.068768911
4339	hsa-mir-1297	hsa05216	Thyroid cancer	6256	1	0.041121505	1	0.07813086
4340	hsa-mir-1301	hsa05200	Pathways in cancer	3320_3326_3725_1147_4087_4149_5371_405_3480_1956_1499_5595_5594_10401_6258_1387_2064_6256_595_1487_6502_2308_836_208_367_1017_4193_5914_7704_842_841_6776_5970_6654_8503_1870_1871_2885_7157_4824_2113_5295_1869_861_862_4088_4089_1050_5925_2033_207_8554_4286_4790	54	1.79E-43	1.32E-41	1.32E-41
4341	hsa-mir-1301	hsa05215	Prostate cancer	3320_3326_1147_3480_1956_1499_5595_5594_1385_1387_2064_595_2308_208_367_1017_4193_842_5970_6654_8503_1870_1871_2885_7157_4824_5295_1869_5925_2033_207_4790_90993	33	6.16E-37	4.55E-35	2.06E-35
4342	hsa-mir-1301	hsa05212	Pancreatic cancer	3320_3326_1147_3480_1956_1499_5595_5594_1385_1387_2064_595_2308_208_367_1017_4193_842_5970_6654_8503_1870_1871_2885_7157_4824_5295_1869_5925_2033_207_4790_90993	33	8.36E-37	6.18E-35	2.06E-35
4343	hsa-mir-1301	hsa05220	Chronic myeloid leukemia	1147_5595_5594_595_1487_208_4193_6776_5970_6654_8503_1870_1871_2885_7157_5295_1869_861_4088_4089_5925_207_4790_6464	24	8.81E-26	6.52E-24	1.63E-24
4344	hsa-mir-1301	hsa05214	Glioma	815_3480_1956_5595_5594_595_208_4193_6654_8503_1870_1871_2885_7157_5295_1869_5925_808_207_6464_801_805	22	3.55E-24	2.63E-22	5.26E-23
4345	hsa-mir-1301	hsa04010	MAPK signaling pathway	6722_3725_1147_4149_994_1956_5595_5594_9261_4208_836_5566_208_4214_7867_1432_5970_6654_627_2885_7157_10912_3727_6195_5058_4616_1616_6197_2872_207_4790_2002_2005	33	4.29E-23	3.17E-21	5.29E-22
4346	hsa-mir-1301	hsa05223	Non-small cell lung cancer	1956_5595_5594_6258_2064_6256_595_208_842_6654_8503_1870_1871_2885_7157_5295_1869_5925_2309_207	20	9.88E-23	7.31E-21	1.04E-21
4347	hsa-mir-1301	hsa04110	Cell cycle	4087_994_5591_1387_595_6502_1017_7533_4193_1870_1871_7157_10912_902_1869_4088_4089_1022_4616_5925_2033_890_5934_5933	24	1.06E-21	7.81E-20	9.77E-21
4348	hsa-mir-1301	hsa05221	Acute myeloid leukemia	1147_5371_5595_5594_595_208_5914_7704_6776_5970_6654_8503_2885_5295_861_862_1050_207_4790	19	1.05E-20	7.76E-19	8.62E-20
4349	hsa-mir-1301	hsa05222	Small cell lung cancer	1147_4149_10401_6258_6256_595_6502_208_1017_842_5970_8503_1870_1871_7157_5295_1869_5925_207_8554_4790	21	1.24E-20	9.18E-19	9.18E-20
4350	hsa-mir-1301	hsa05210	Colorectal cancer	3725_4087_3480_1956_1499_5595_5594_595_836_208_842_6654_8503_2885_7157_5295_4088_4089_207	19	3.00E-18	2.22E-16	2.02E-17
4351	hsa-mir-1301	hsa05213	Endometrial cancer	1956_1499_5595_5594_2064_595_208_842_6654_8503_2885_7157_5295_2309_207_2002	16	2.25E-17	1.67E-15	1.39E-16
4352	hsa-mir-1301	hsa04012	ErbB signaling pathway	3725_815_1956_6714_5595_5594_2064_208_6776_6654_8503_2885_5295_5058_56924_207_6464_2002	18	9.28E-17	6.86E-15	5.28E-16
4353	hsa-mir-1301	hsa04910	Insulin signaling pathway	6720_7249_10891_5595_5594_2308_5566_208_5770_6654_8503_2885_5295_808_2872_207_6464_2002_801_805	20	8.13E-16	6.02E-14	4.30E-15
4354	hsa-mir-1301	hsa05218	Melanoma	3480_1956_5595_5594_595_208_4193_8503_1870_1871_7157_5295_1869_5925_207_4286	16	1.51E-15	1.12E-13	7.44E-15
4355	hsa-mir-1301	hsa04520	Adherens junction	4087_3480_1956_1499_6714_5595_5594_1387_2064_5770_5777_1457_4088_4089_2033_1460	16	7.73E-15	5.72E-13	3.57E-14
4356	hsa-mir-1301	hsa05211	Renal cell carcinoma	3725_405_5595_5594_1387_208_6654_8503_2885_2113_5295_5058_56924_2033_207	15	3.21E-14	2.37E-12	1.40E-13
4357	hsa-mir-1301	hsa04660	T cell receptor signaling pathway	3725_1147_3932_5595_5594_208_5777_1432_5970_6654_8503_2885_5295_5058_56924_207_4790	17	4.79E-14	3.55E-12	1.97E-13
4358	hsa-mir-1301	hsa04510	Focal adhesion	3725_9564_3480_1956_1499_6714_5595_5594_2064_595_208_6654_8503_2885_857_5295_5058_56924_207_6464_2002	21	8.76E-14	6.49E-12	3.41E-13
4359	hsa-mir-1301	hsa04350	TGF-beta signaling pathway	4087_5595_5594_1387_3399_3398_1874_1875_4088_4089_2033_3397_6667_5934_5933	15	3.67E-13	2.72E-11	1.36E-12
4360	hsa-mir-1301	hsa04912	GnRH signaling pathway	3725_815_1956_6714_5595_5594_5566_4214_1432_6654_2885_808_2002_801_805	15	6.02E-12	4.45E-10	2.12E-11
4361	hsa-mir-1301	hsa04210	Apoptosis	1147_836_5566_839_208_842_841_840_5970_8503_7157_5295_207_4790	14	6.85E-12	5.07E-10	2.30E-11
4362	hsa-mir-1301	hsa05219	Bladder cancer	1956_5595_5594_2064_595_4193_1870_1871_7157_1869_5925	11	1.05E-11	7.79E-10	3.39E-11
4363	hsa-mir-1301	hsa04662	B cell receptor signaling pathway	3725_1147_5595_5594_208_5777_5970_6654_8503_2885_5295_207_4790	13	1.32E-11	9.73E-10	4.06E-11
4364	hsa-mir-1301	hsa04916	Melanogenesis	815_1499_5595_5594_1385_1387_2770_5566_808_2033_4286_90993_801_805	14	4.49E-11	3.32E-09	1.33E-10
4365	hsa-mir-1301	hsa04062	Chemokine signaling pathway	1147_9564_5595_5594_2770_5566_208_5970_6654_8503_2885_5295_5058_2309_207_4790_6464	17	1.73E-10	1.28E-08	4.94E-10
4366	hsa-mir-1301	hsa04720	Long-term potentiation	815_5595_5594_1387_5566_6195_6197_808_2033_801_805	11	2.46E-09	1.82E-07	6.73E-09
4367	hsa-mir-1301	hsa04370	VEGF signaling pathway	6714_5595_5594_9261_208_7867_1432_842_8503_5295_207	11	3.15E-09	2.33E-07	8.33E-09
4368	hsa-mir-1301	hsa04310	Wnt signaling pathway	3725_4087_815_1499_1387_595_1487_5566_7157_1457_4088_4089_2033_1460	14	4.25E-09	3.14E-07	1.08E-08
4369	hsa-mir-1301	hsa04620	Toll-like receptor signaling pathway	3725_1147_5595_5594_208_1432_841_5970_8503_5295_207_4790	12	4.47E-09	3.31E-07	1.10E-08
4370	hsa-mir-1301	hsa04115	p53 signaling pathway	7249_595_836_1017_4193_842_841_7157_10912_4616	10	1.46E-08	1.08E-06	3.49E-08
4371	hsa-mir-1301	hsa04150	mTOR signaling pathway	7249_5595_5594_208_8503_5295_6195_6197_207	9	1.97E-08	1.46E-06	4.56E-08
4372	hsa-mir-1301	hsa04630	Jak-STAT signaling pathway	10401_1387_595_208_5777_6776_6654_8503_2885_5295_2033_207_8554	13	4.27E-08	3.16E-06	9.58E-08
4373	hsa-mir-1301	hsa05216	Thyroid cancer	1499_5595_5594_6258_6256_595_7157	7	1.06E-07	7.82E-06	2.30E-07
4374	hsa-mir-1301	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_1147_1956_6714_836_1432_5970_5058_4790	9	2.20E-07	1.63E-05	4.65E-07
4375	hsa-mir-1301	hsa04664	Fc epsilon RI signaling pathway	5595_5594_208_1432_6654_8503_2885_5295_207	9	5.02E-07	3.72E-05	1.03E-06
4376	hsa-mir-1301	hsa04650	Natural killer cell mediated cytotoxicity	3932_5595_5594_836_5777_6654_8503_2885_5295_5058_6464	11	7.56E-07	5.59E-05	1.51E-06
4377	hsa-mir-1301	hsa04120	Ubiquitin mediated proteolysis	11059_5371_672_4734_10401_6502_4214_4193_10273_7329_8554	11	8.08E-07	5.98E-05	1.57E-06
4378	hsa-mir-1301	hsa04920	Adipocytokine signaling pathway	1147_10891_6258_6256_208_5970_207_4790	8	1.58E-06	0.000116941	3.00E-06
4379	hsa-mir-1301	hsa05016	Huntington's disease	10891_1385_1387_6908_836_842_841_627_7157_2033_6667_90993	12	2.15E-06	0.000159404	3.99E-06
4380	hsa-mir-1301	hsa03022	Basal transcription factors	2965_2962_2969_6908_2959_6881	6	6.77E-06	0.000500838	1.22E-05
4381	hsa-mir-1301	hsa04540	Gap junction	1956_6714_5595_5594_2770_5566_6654_2885	8	1.48E-05	0.00109761	2.61E-05
4382	hsa-mir-1301	hsa04330	Notch signaling pathway	388585_1387_1487_9612_2033_8850	6	2.33E-05	0.001721842	4.00E-05
4383	hsa-mir-1301	hsa05010	Alzheimer's disease	22926_5595_5594_836_842_841_840_808_801_805	10	4.09E-05	0.003023961	6.87E-05
4384	hsa-mir-1301	hsa04930	Type II diabetes mellitus	3651_5595_5594_8503_5295	5	0.000206906	0.01531108	0.000340246
4385	hsa-mir-1301	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432_842_7157_1616	5	0.000527155	0.039009435	0.000848031
4386	hsa-mir-1301	hsa04810	Regulation of actin cytoskeleton	9564_1956_5595_5594_6654_8503_5295_5058_56924	9	0.000918212	0.06794768	0.001445695
4387	hsa-mir-1301	hsa04530	Tight junction	1499_6714_2770_208_1457_207_1460	7	0.001025959	0.075920988	0.001581687
4388	hsa-mir-1301	hsa03420	Nucleotide excision repair	2965_902_1022_4331	4	0.001816616	0.134429595	0.002743461
4389	hsa-mir-1301	hsa04070	Phosphatidylinositol signaling system	8503_5295_808_801_805	5	0.001903962	0.14089321	0.002817864
4390	hsa-mir-1301	hsa04270	Vascular smooth muscle contraction	5595_5594_5566_808_801_805	6	0.002382634	0.176314926	0.003457155
4391	hsa-mir-1301	hsa04670	Leukocyte transendothelial migration	9564_1499_2770_1432_8503_5295	6	0.002791898	0.206600479	0.003973086
4392	hsa-mir-1301	hsa04950	Maturity onset diabetes of the young	3651_3172_168620	3	0.003050327	0.225724184	0.004258947
4393	hsa-mir-1301	hsa04612	Antigen processing and presentation	3320_3326_1385_4800_6890	5	0.003639958	0.269356912	0.004988091
4394	hsa-mir-1301	hsa04360	Axon guidance	5998_5595_5594_2770_5058_56924	6	0.003903012	0.288822861	0.005251325
4395	hsa-mir-1301	hsa04020	Calcium signaling pathway	815_1956_2064_5566_808_801_805	7	0.005007853	0.370581112	0.00661752
4396	hsa-mir-1301	hsa04730	Long-term depression	3480_5595_5594_2770	4	0.009036028	0.66866608	0.011730984
4397	hsa-mir-1301	hsa03050	Proteasome	5698_5705_5710	3	0.017948863	1	0.022900274
4398	hsa-mir-1302-1	hsa05200	Pathways in cancer	3716_5747_3725_675_1956_1499_5595_5594_1387_5159_5156_836_1019_1399_1398_1017_3815_6774_2064_6777_6772_2261_5879_7046_5970_6688_4089_8772_4609_1026_867_6776_4087_5925_2033_207_8554_2353	38	9.83E-33	7.28E-31	7.28E-31
4399	hsa-mir-1302-1	hsa04630	Jak-STAT signaling pathway	3717_3716_3718_85480_3560_3561_1387_3575_6774_6777_6772_6773_58985_2057_3455_3459_5781_7297_4609_867_6776_2690_1439_2033_207_8554_10379	27	8.25E-28	6.10E-26	3.05E-26
4400	hsa-mir-1302-1	hsa04012	ErbB signaling pathway	5747_3725_818_817_1956_6714_5595_5594_2066_1399_1398_2064_6777_4609_1026_867_6776_207_6464	19	1.65E-21	1.22E-19	4.06E-20
4401	hsa-mir-1302-1	hsa05220	Chronic myeloid leukemia	5595_5594_1019_1399_1398_6777_7046_5970_5781_4089_4609_1026_867_6776_5925_207_6464	17	1.32E-19	9.75E-18	1.96E-18
4402	hsa-mir-1302-1	hsa04010	MAPK signaling pathway	3725_1956_5595_5594_5598_1386_5159_5156_7132_836_1399_1398_2264_9252_1432_1649_2261_5879_7046_5970_468_4609_1845_207_2353	25	1.33E-19	9.82E-18	1.96E-18
4403	hsa-mir-1302-1	hsa04060	Cytokine-cytokine receptor interaction	2321_3791_85480_1956_90_3560_3561_5159_5156_7133_7132_3575_1234_1230_3815_7046_7852_58985_2057_3455_3459_2690_1439	23	9.66E-18	7.15E-16	1.19E-16
4404	hsa-mir-1302-1	hsa04520	Adherens junction	1956_1499_6714_3643_5595_5594_1387_5770_2064_5879_7046_4089_4087_2033_2534	15	2.31E-16	1.71E-14	2.44E-15
4405	hsa-mir-1302-1	hsa05210	Colorectal cancer	3725_1956_1499_5595_5594_5159_5156_836_5879_7046_4089_4609_4087_207_2353	15	4.40E-16	3.26E-14	4.07E-15
4406	hsa-mir-1302-1	hsa05215	Prostate cancer	1956_1499_5595_5594_1387_5159_5156_1017_2064_5970_468_1026_5925_2033_207	15	8.14E-16	6.02E-14	6.69E-15
4407	hsa-mir-1302-1	hsa05212	Pancreatic cancer	1956_1499_5595_5594_1387_5159_5156_1017_2064_5970_468_1026_5925_2033_207	15	9.45E-16	6.99E-14	6.99E-15
4408	hsa-mir-1302-1	hsa04062	Chemokine signaling pathway	3717_3718_5747_5580_5595_5594_1399_1398_1234_1230_6774_6777_6772_6773_5879_7852_5970_207_6464	19	1.09E-15	8.05E-14	7.32E-15
4409	hsa-mir-1302-1	hsa04350	TGF-beta signaling pathway	5515_90_5595_5594_1387_7027_7046_1874_4089_4609_4087_2033_57154_5933	14	1.55E-14	1.15E-12	9.58E-14
4410	hsa-mir-1302-1	hsa04510	Focal adhesion	5747_3725_2321_3791_1956_1499_6714_5595_5594_5159_5156_1399_1398_2064_5879_207_6464_2534	18	4.24E-14	3.14E-12	2.41E-13
4411	hsa-mir-1302-1	hsa05214	Glioma	818_817_1956_5595_5594_5159_5156_1019_1026_5925_207_6464	12	2.87E-13	2.12E-11	1.52E-12
4412	hsa-mir-1302-1	hsa04110	Cell cycle	1387_983_1019_1017_7027_4089_4174_1026_4172_4087_993_5925_2033_5933	14	7.60E-13	5.62E-11	3.75E-12
4413	hsa-mir-1302-1	hsa05219	Bladder cancer	1956_5595_5594_1019_9252_2064_2261_4609_1026_5925	10	3.14E-12	2.32E-10	1.45E-11
4414	hsa-mir-1302-1	hsa04660	T cell receptor signaling pathway	3725_3932_5595_5594_919_1019_1432_5970_867_207_2353_1493_2534	13	4.85E-12	3.59E-10	2.11E-11
4415	hsa-mir-1302-1	hsa05221	Acute myeloid leukemia	5595_5594_3815_6774_6777_5970_6688_4609_6776_207	10	6.08E-11	4.50E-09	2.50E-10
4416	hsa-mir-1302-1	hsa05211	Renal cell carcinoma	3725_5595_5594_1387_1399_1398_5879_5781_2033_207	10	3.53E-10	2.61E-08	1.38E-09
4417	hsa-mir-1302-1	hsa04620	Toll-like receptor signaling pathway	3725_5595_5594_1432_6772_5879_5970_3455_8772_207_2353	11	5.38E-10	3.98E-08	1.99E-09
4418	hsa-mir-1302-1	hsa04650	Natural killer cell mediated cytotoxicity	3932_5595_5594_836_919_5879_6850_3455_3459_5781_6464_2534	12	8.56E-10	6.34E-08	3.02E-09
4419	hsa-mir-1302-1	hsa04912	GnRH signaling pathway	3725_5580_818_817_1956_6714_5595_5594_5598_1432_468	11	9.39E-10	6.95E-08	3.16E-09
4420	hsa-mir-1302-1	hsa05218	Melanoma	1956_5595_5594_5159_5156_1019_1026_5925_207	9	5.69E-09	4.21E-07	1.83E-08
4421	hsa-mir-1302-1	hsa04662	B cell receptor signaling pathway	3725_695_5595_5594_5879_5970_6850_207_2353	9	8.81E-09	6.52E-07	2.72E-08
4422	hsa-mir-1302-1	hsa04664	Fc epsilon RI signaling pathway	5580_695_5595_5594_1432_5879_6850_207_2534	9	1.33E-08	9.87E-07	3.95E-08
4423	hsa-mir-1302-1	hsa04310	Wnt signaling pathway	3725_5515_818_817_1499_1387_5879_4089_4609_4087_2033	11	2.60E-08	1.92E-06	7.40E-08
4424	hsa-mir-1302-1	hsa04920	Adipocytokine signaling pathway	3717_8717_7133_7132_6774_5970_5781_207	8	6.24E-08	4.62E-06	1.71E-07
4425	hsa-mir-1302-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_1956_6714_836_1432_5879_5970_5781	8	9.42E-08	6.97E-06	2.49E-07
4426	hsa-mir-1302-1	hsa04370	VEGF signaling pathway	5747_3791_6714_5595_5594_1432_5879_207	8	1.67E-07	1.24E-05	4.27E-07
4427	hsa-mir-1302-1	hsa05213	Endometrial cancer	1956_1499_5595_5594_2064_4609_207	7	2.02E-07	1.50E-05	4.99E-07
4428	hsa-mir-1302-1	hsa05223	Non-small cell lung cancer	1956_5595_5594_1019_2064_5925_207	7	2.56E-07	1.89E-05	6.10E-07
4429	hsa-mir-1302-1	hsa05222	Small cell lung cancer	5747_1019_1017_5970_4609_5925_207_8554	8	3.67E-07	2.71E-05	8.48E-07
4430	hsa-mir-1302-1	hsa04210	Apoptosis	8717_7132_836_840_5970_8772_1439_207	8	4.68E-07	3.46E-05	1.05E-06
4431	hsa-mir-1302-1	hsa04540	Gap junction	1956_6714_5595_5594_5598_5159_983_5156	8	6.38E-07	4.72E-05	1.39E-06
4432	hsa-mir-1302-1	hsa04810	Regulation of actin cytoskeleton	5747_1956_5595_5594_5159_5156_1399_1398_2264_2261_5879	11	8.42E-07	6.23E-05	1.78E-06
4433	hsa-mir-1302-1	hsa04910	Insulin signaling pathway	3643_5595_5594_1399_1398_5770_867_207_6464	9	1.12E-06	8.30E-05	2.30E-06
4434	hsa-mir-1302-1	hsa04916	Melanogenesis	818_817_1499_5595_5594_1387_3815_2033	8	1.41E-06	0.000103989	2.81E-06
4435	hsa-mir-1302-1	hsa04720	Long-term potentiation	818_817_5595_5594_1387_468_2033	7	1.96E-06	0.000145382	3.83E-06
4436	hsa-mir-1302-1	hsa05340	Primary immunodeficiency	3718_695_3932_3561_3575	5	9.15E-06	0.000676888	1.74E-05
4437	hsa-mir-1302-1	hsa05010	Alzheimer's disease	5595_5594_7132_836_840_8772_1020_4724	8	5.55E-05	0.004108809	0.00010272
4438	hsa-mir-1302-1	hsa04360	Axon guidance	5747_5595_5594_5879_7852_1020_2534	7	5.99E-05	0.00443526	0.000108177
4439	hsa-mir-1302-1	hsa04020	Calcium signaling pathway	818_817_1956_2066_5159_5156_2064_147	8	7.21E-05	0.005332256	0.000126147
4440	hsa-mir-1302-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	7133_7132_836_1432_5879	5	7.33E-05	0.005424316	0.000126147
4441	hsa-mir-1302-1	hsa05216	Thyroid cancer	1499_5595_5594_4609	4	8.52E-05	0.006306714	0.000143334
4442	hsa-mir-1302-1	hsa04115	p53 signaling pathway	983_836_1019_1017_1026	5	0.000184234	0.01363328	0.000302962
4443	hsa-mir-1302-1	hsa04670	Leukocyte transendothelial migration	5747_1499_1432_5879_7852_5781	6	0.000311402	0.023043777	0.000500952
4444	hsa-mir-1302-1	hsa04930	Type II diabetes mellitus	5580_3643_5595_5594	4	0.000403893	0.029888117	0.000635917
4445	hsa-mir-1302-1	hsa04330	Notch signaling pathway	1387_9612_2033_8850	4	0.000471145	0.034864724	0.000726348
4446	hsa-mir-1302-1	hsa04530	Tight junction	5580_5515_1499_6714_1019_207	6	0.000561732	0.041568151	0.00084833
4447	hsa-mir-1302-1	hsa03030	DNA replication	5981_4174_4172	3	0.002653443	0.196354761	0.003927095
4448	hsa-mir-1302-1	hsa04120	Ubiquitin mediated proteolysis	672_7329_867_8554_57154	5	0.003693206	0.27329726	0.00535877
4449	hsa-mir-1302-1	hsa04150	mTOR signaling pathway	5595_5594_207	3	0.007011812	0.518874086	0.009978348
4450	hsa-mir-1302-1	hsa04270	Vascular smooth muscle contraction	5580_5595_5594_147	4	0.011225232	0.830667162	0.015672965
4451	hsa-mir-1302-1	hsa04730	Long-term depression	5515_5595_5594	3	0.015712497	1	0.021531941
4452	hsa-mir-1302-1	hsa04640	Hematopoietic cell lineage	3575_3815_2057	3	0.026239926	1	0.035304628
4453	hsa-mir-1302-1	hsa03010	Ribosome	6124_6129_6143	3	0.038798005	1	0.051268793
4454	hsa-mir-1302-1	hsa05016	Huntington's disease	1387_836_2033_4724	4	0.048118522	1	0.06246966
4455	hsa-mir-1302-4	hsa04950	Maturity onset diabetes of the young	3651_5080	2	0.001275693	0.030616621	0.030616621
4456	hsa-mir-1302-4	hsa03022	Basal transcription factors	6908_2959	2	0.002859692	0.068632608	0.034316304
4457	hsa-mir-1302-4	hsa05016	Huntington's disease	2033_6908_10476	3	0.006934609	0.166430607	0.055476869
4458	hsa-mir-1302-4	hsa05215	Prostate cancer	2033_367	2	0.014466222	0.347189324	0.070906519
4459	hsa-mir-1302-4	hsa05212	Pancreatic cancer	2033_367	2	0.014772191	0.354532596	0.070906519
4460	hsa-mir-1302-4	hsa04530	Tight junction	60412_4628	2	0.032523426	0.780562215	0.130093703
4461	hsa-mir-1302-5	hsa03022	Basal transcription factors	2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_2957_6908_6873_6872_2958_6884_2959_6880_6882_138474_6883	22	3.03E-35	2.00E-33	2.00E-33
4462	hsa-mir-1302-5	hsa05200	Pathways in cancer	5925_5595_5594_5599_6256_3326_5601_4193_5970_7157_6688_3725_4609_2353_10401_4088_4089_2033_8554_7184	20	7.64E-15	5.04E-13	2.52E-13
4463	hsa-mir-1302-5	hsa05210	Colorectal cancer	5595_5594_5599_5601_7157_3725_4609_2353_4088_4089	10	1.11E-10	7.32E-09	2.44E-09
4464	hsa-mir-1302-5	hsa05220	Chronic myeloid leukemia	5925_5595_5594_4193_5970_7157_4609_4088_4089	9	9.12E-10	6.02E-08	1.50E-08
4465	hsa-mir-1302-5	hsa04310	Wnt signaling pathway	1460_5599_8607_5601_7157_3725_8061_4609_4088_4089_2033	11	1.75E-09	1.16E-07	2.32E-08
4466	hsa-mir-1302-5	hsa05215	Prostate cancer	5925_5595_5594_3326_4193_5970_7157_2033_7184	9	3.33E-09	2.20E-07	3.44E-08
4467	hsa-mir-1302-5	hsa05212	Pancreatic cancer	5925_5595_5594_3326_4193_5970_7157_2033_7184	9	3.65E-09	2.41E-07	3.44E-08
4468	hsa-mir-1302-5	hsa04010	MAPK signaling pathway	3727_5595_5594_5599_1386_5601_3312_1649_5970_7157_3725_4609_2353	13	7.01E-09	4.63E-07	5.78E-08
4469	hsa-mir-1302-5	hsa05219	Bladder cancer	5925_5595_5594_4193_7157_4609	6	2.48E-07	1.64E-05	1.82E-06
4470	hsa-mir-1302-5	hsa04110	Cell cycle	5925_4193_7157_4171_4085_4088_4089_2033	8	5.22E-07	3.44E-05	3.44E-06
4471	hsa-mir-1302-5	hsa05222	Small cell lung cancer	5925_6256_5970_7157_4609_10401_8554	7	8.23E-07	5.43E-05	4.94E-06
4472	hsa-mir-1302-5	hsa05216	Thyroid cancer	5595_5594_6256_7157_4609	5	1.13E-06	7.44E-05	6.20E-06
4473	hsa-mir-1302-5	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5601_5970_3725_2353	7	2.41E-06	0.000158782	1.22E-05
4474	hsa-mir-1302-5	hsa04520	Adherens junction	1460_5595_5594_4088_4089_2033	6	8.01E-06	0.000528473	3.77E-05
4475	hsa-mir-1302-5	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	1.07E-05	0.000705859	4.71E-05
4476	hsa-mir-1302-5	hsa04350	TGF-beta signaling pathway	5595_5594_4609_4088_4089_2033	6	1.26E-05	0.000830208	4.88E-05
4477	hsa-mir-1302-5	hsa04012	ErbB signaling pathway	5595_5594_5599_5601_3725_4609	6	1.26E-05	0.000830208	4.88E-05
4478	hsa-mir-1302-5	hsa05223	Non-small cell lung cancer	5925_5595_5594_6256_7157	5	1.82E-05	0.001199285	6.66E-05
4479	hsa-mir-1302-5	hsa05221	Acute myeloid leukemia	5595_5594_5970_6688_4609	5	2.71E-05	0.001786669	9.40E-05
4480	hsa-mir-1302-5	hsa05214	Glioma	5925_5595_5594_4193_7157	5	4.19E-05	0.002762188	0.000138109
4481	hsa-mir-1302-5	hsa04660	T cell receptor signaling pathway	5595_5594_5601_5970_3725_2353	6	4.42E-05	0.002914144	0.000138769
4482	hsa-mir-1302-5	hsa05218	Melanoma	5925_5595_5594_4193_7157	5	6.22E-05	0.004106534	0.000186661
4483	hsa-mir-1302-5	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725_2353	5	7.96E-05	0.005250376	0.000228277
4484	hsa-mir-1302-5	hsa05016	Huntington's disease	6874_6908_9001_5430_7157_3064_2033	7	0.000104041	0.006866739	0.000286114
4485	hsa-mir-1302-5	hsa04930	Type II diabetes mellitus	5595_5594_5599_5601	4	0.00015095	0.009962682	0.000398507
4486	hsa-mir-1302-5	hsa05213	Endometrial cancer	5595_5594_7157_4609	4	0.000254008	0.01676451	0.000644789
4487	hsa-mir-1302-5	hsa04912	GnRH signaling pathway	5595_5594_5599_5601_3725	5	0.000401861	0.026522801	0.000982326
4488	hsa-mir-1302-5	hsa04920	Adipocytokine signaling pathway	5599_6256_5601_5970	4	0.000630551	0.041616377	0.001486299
4489	hsa-mir-1302-5	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_5970_3725	4	0.000775533	0.051185183	0.001765006
4490	hsa-mir-1302-5	hsa05211	Renal cell carcinoma	5595_5594_3725_2033	4	0.000815162	0.053800663	0.001793355
4491	hsa-mir-1302-5	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5601	4	0.001133511	0.074811727	0.002404622
4492	hsa-mir-1302-5	hsa04910	Insulin signaling pathway	5595_5594_5599_5601_5211	5	0.001165877	0.076947904	0.002404622
4493	hsa-mir-1302-5	hsa04120	Ubiquitin mediated proteolysis	672_4193_10401_64326_8554	5	0.001202555	0.07936864	0.00240511
4494	hsa-mir-1302-5	hsa03420	Nucleotide excision repair	2967_2968_5887	3	0.002183961	0.144141451	0.004239454
4495	hsa-mir-1302-5	hsa04510	Focal adhesion	5595_5594_5599_5601_3725	5	0.006208428	0.409756215	0.01170732
4496	hsa-mir-1302-5	hsa04115	p53 signaling pathway	4193_7157_64326	3	0.007272072	0.479956739	0.013332132
4497	hsa-mir-1302-5	hsa04720	Long-term potentiation	5595_5594_2033	3	0.009058179	0.597839838	0.016157833
4498	hsa-mir-1302-5	hsa04630	Jak-STAT signaling pathway	4609_10401_2033_8554	4	0.01149388	0.758596063	0.019963054
4499	hsa-mir-1302-5	hsa04612	Antigen processing and presentation	3326_4801_3312	3	0.014147568	0.93373947	0.023942038
4500	hsa-mir-1302-5	hsa04540	Gap junction	5595_5594_10382	3	0.015844675	1	0.026143714
4501	hsa-mir-1302-5	hsa04916	Melanogenesis	5595_5594_2033	3	0.021078649	1	0.033931483
4502	hsa-mir-1302-5	hsa04330	Notch signaling pathway	2033_8850	2	0.029567046	1	0.046462501
4503	hsa-mir-1302-5	hsa04150	mTOR signaling pathway	5595_5594	2	0.035348487	1	0.054255817
4504	hsa-mir-1302-5	hsa05322	Systemic lupus erythematosus	3014_3015_8340	3	0.047113112	1	0.070669669
4505	hsa-mir-1305	hsa05200	Pathways in cancer	2249_367_3725_6776_6777_2353_5914_5970_6256	9	2.03E-10	7.70E-09	7.70E-09
4506	hsa-mir-1305	hsa05221	Acute myeloid leukemia	6776_6777_5914_5970	4	9.84E-07	3.74E-05	1.87E-05
4507	hsa-mir-1305	hsa05220	Chronic myeloid leukemia	6776_6777_5970	3	0.000113081	0.004297074	0.001074269
4508	hsa-mir-1305	hsa04662	B cell receptor signaling pathway	3725_2353_5970	3	0.000113081	0.004297074	0.001074269
4509	hsa-mir-1305	hsa04012	ErbB signaling pathway	3725_6776_6777	3	0.00017291	0.006570564	0.001314113
4510	hsa-mir-1305	hsa04620	Toll-like receptor signaling pathway	3725_2353_5970	3	0.000272526	0.010355982	0.001606221
4511	hsa-mir-1305	hsa04010	MAPK signaling pathway	2249_3725_2353_5970	4	0.000330487	0.012558499	0.001606221
4512	hsa-mir-1305	hsa04660	T cell receptor signaling pathway	3725_2353_5970	3	0.000338152	0.012849769	0.001606221
4513	hsa-mir-1305	hsa04630	Jak-STAT signaling pathway	3977_6776_6777	3	0.000897685	0.03411204	0.003790227
4514	hsa-mir-1305	hsa04920	Adipocytokine signaling pathway	5970_6256	2	0.003115381	0.11838449	0.011838449
4515	hsa-mir-1305	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.003479392	0.132216888	0.012019717
4516	hsa-mir-1305	hsa05210	Colorectal cancer	3725_2353	2	0.004792101	0.18209983	0.0135505
4517	hsa-mir-1305	hsa05222	Small cell lung cancer	5970_6256	2	0.005011395	0.190433006	0.0135505
4518	hsa-mir-1305	hsa05215	Prostate cancer	367_5970	2	0.00523525	0.198939509	0.0135505
4519	hsa-mir-1305	hsa05212	Pancreatic cancer	367_5970	2	0.005348882	0.203257498	0.0135505
4520	hsa-mir-1305	hsa03450	Non-homologous end-joining	2547	1	0.01783249	0.677634628	0.042352164
4521	hsa-mir-1305	hsa05016	Huntington's disease	6908_6667	2	0.021779742	0.827630199	0.048257818
4522	hsa-mir-1305	hsa04062	Chemokine signaling pathway	6777_5970	2	0.022858967	0.868640727	0.048257818
4523	hsa-mir-1305	hsa04950	Maturity onset diabetes of the young	6927	1	0.02954865	1	0.0590973
4524	hsa-mir-1305	hsa05216	Thyroid cancer	6256	1	0.035355663	1	0.067175759
4525	hsa-mir-1305	hsa04080	Neuroactive ligand-receptor interaction	2908_7067	2	0.038234048	1	0.06918542
4526	hsa-mir-1305	hsa03410	Base excision repair	142	1	0.043428758	1	0.073648431
4527	hsa-mir-1305	hsa03022	Basal transcription factors	6908	1	0.044576682	1	0.073648431
4528	hsa-mir-1306	hsa05200	Pathways in cancer	2113_7157_861_5925_1387	5	1.32E-06	3.95E-05	3.95E-05
4529	hsa-mir-1306	hsa05220	Chronic myeloid leukemia	7157_861_5925	3	1.34E-05	0.000401696	0.000131923
4530	hsa-mir-1306	hsa04350	TGF-beta signaling pathway	3398_3399_1387	3	2.06E-05	0.000617532	0.000131923
4531	hsa-mir-1306	hsa05215	Prostate cancer	7157_5925_1387	3	2.13E-05	0.000638345	0.000131923
4532	hsa-mir-1306	hsa05212	Pancreatic cancer	7157_5925_1387	3	2.20E-05	0.000659615	0.000131923
4533	hsa-mir-1306	hsa04110	Cell cycle	7157_5925_1387	3	5.11E-05	0.001533416	0.000255569
4534	hsa-mir-1306	hsa05016	Huntington's disease	7157_1387_6908	3	0.000192852	0.005785569	0.00082651
4535	hsa-mir-1306	hsa05219	Bladder cancer	7157_5925	2	0.000316507	0.009495202	0.0011869
4536	hsa-mir-1306	hsa05223	Non-small cell lung cancer	7157_5925	2	0.000513053	0.01539158	0.001650923
4537	hsa-mir-1306	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157_1616	2	0.000550308	0.016509235	0.001650923
4538	hsa-mir-1306	hsa05214	Glioma	7157_5925	2	0.000733726	0.022011783	0.002001071
4539	hsa-mir-1306	hsa05218	Melanoma	7157_5925	2	0.000870253	0.026107597	0.00206333
4540	hsa-mir-1306	hsa05211	Renal cell carcinoma	2113_1387	2	0.00089411	0.026823286	0.00206333
4541	hsa-mir-1306	hsa05222	Small cell lung cancer	7157_5925	2	0.001260899	0.037826976	0.002701927
4542	hsa-mir-1306	hsa04310	Wnt signaling pathway	7157_1387	2	0.003790764	0.11372293	0.007581529
4543	hsa-mir-1306	hsa04010	MAPK signaling pathway	7157_1616	2	0.011614496	0.348434866	0.021777179
4544	hsa-mir-1306	hsa05216	Thyroid cancer	7157	1	0.017842211	0.535266341	0.031486255
4545	hsa-mir-1306	hsa03022	Basal transcription factors	6908	1	0.022549107	0.676473219	0.037581845
4546	hsa-mir-1306	hsa04330	Notch signaling pathway	1387	1	0.028402771	0.852083127	0.04484648
4547	hsa-mir-1306	hsa05213	Endometrial cancer	7157	1	0.031317172	0.939515157	0.046975758
4548	hsa-mir-1306	hsa05217	Basal cell carcinoma	7157	1	0.033061847	0.991855421	0.047231211
4549	hsa-mir-1306	hsa05221	Acute myeloid leukemia	861	1	0.035383465	1	0.04825018
4550	hsa-mir-1306	hsa04115	p53 signaling pathway	7157	1	0.041164499	1	0.053692825
4551	hsa-mir-1306	hsa04720	Long-term potentiation	1387	1	0.044617397	1	0.055771746
4552	hsa-mir-1306	hsa04520	Adherens junction	1387	1	0.047485837	1	0.056983005
4553	hsa-mir-1306	hsa05210	Colorectal cancer	7157	1	0.049774731	1	0.057432382
4554	hsa-mir-1307	hsa05200	Pathways in cancer	4088_9915_4087_5371_2034_2033_3091_4609	8	5.70E-09	1.60E-07	1.60E-07
4555	hsa-mir-1307	hsa04350	TGF-beta signaling pathway	4088_4087_2033_4093_4609	5	8.45E-08	2.37E-06	1.18E-06
4556	hsa-mir-1307	hsa04310	Wnt signaling pathway	4088_4087_2033_4609_1457	5	1.21E-06	3.39E-05	1.13E-05
4557	hsa-mir-1307	hsa05211	Renal cell carcinoma	9915_2034_2033_3091	4	2.10E-06	5.87E-05	1.47E-05
4558	hsa-mir-1307	hsa04520	Adherens junction	4088_4087_2033_1457	4	3.13E-06	8.77E-05	1.75E-05
4559	hsa-mir-1307	hsa05210	Colorectal cancer	4088_4087_4609	3	0.000156391	0.00437895	0.000729825
4560	hsa-mir-1307	hsa04110	Cell cycle	4088_4087_2033	3	0.00042326	0.011851275	0.001693039
4561	hsa-mir-1307	hsa04330	Notch signaling pathway	9612_2033	2	0.001585339	0.044389503	0.005548688
4562	hsa-mir-1307	hsa05221	Acute myeloid leukemia	5371_4609	2	0.002444814	0.068454799	0.007606089
4563	hsa-mir-1307	hsa05220	Chronic myeloid leukemia	4088_4609	2	0.003862313	0.108144758	0.010814476
4564	hsa-mir-1307	hsa04612	Antigen processing and presentation	4800_4801	2	0.005348882	0.149768683	0.013615335
4565	hsa-mir-1307	hsa04120	Ubiquitin mediated proteolysis	5371_7329	2	0.012418347	0.347713705	0.028976142
4566	hsa-mir-1307	hsa04630	Jak-STAT signaling pathway	2033_4609	2	0.015224725	0.426292297	0.032791715
4567	hsa-mir-1307	hsa05216	Thyroid cancer	4609	1	0.035355663	0.989958551	0.070711325
4568	hsa-mir-1307	hsa03022	Basal transcription factors	2963	1	0.044576682	1	0.083209806
4569	hsa-mir-130a	hsa05200	Pathways in cancer	1499_595_598_1019_1017_4193_5578_3091_4087_3065_1050_5925_5747_25_1956_2308_6789_613_4436_596_861_1147_998_1026_367_5595_5594_5599_5743_1387_9915_2932_6776_5970_6688_1869_3725_4088_4089_5888_5728_2034_2033_3910_4790_4792_3320_3326_5371_675_5601_5602_1856_841_51588_4609_2353_8554	58	1.66E-39	1.43E-37	1.43E-37
4570	hsa-mir-130a	hsa04110	Cell cycle	595_1019_1017_4193_902_4087_3065_5925_25_9232_5933_545_995_1026_5591_1387_11200_7534_7532_2932_7027_1031_1869_4088_4089_2033_890_894_896_983_5347_1022_472_1111_8556_8555	36	5.38E-32	4.63E-30	2.31E-30
4571	hsa-mir-130a	hsa05215	Prostate cancer	1499_595_1017_4193_5925_1956_2308_596_1147_1026_367_5595_5594_1385_1387_2932_5970_1869_5728_2033_4790_4792_3320_3326_468	25	5.12E-22	4.41E-20	1.39E-20
4572	hsa-mir-130a	hsa05212	Pancreatic cancer	1499_595_1017_4193_5925_1956_2308_596_1147_1026_367_5595_5594_1385_1387_2932_5970_1869_5728_2033_4790_4792_3320_3326_468	25	6.47E-22	5.56E-20	1.39E-20
4573	hsa-mir-130a	hsa04115	p53 signaling pathway	595_1019_1017_4194_4193_900_50484_6241_51246_545_1026_11200_64326_5728_894_896_27113_25898_983_841_7161_472_1111	23	1.14E-21	9.82E-20	1.96E-20
4574	hsa-mir-130a	hsa05220	Chronic myeloid leukemia	595_598_1019_4193_3065_5925_25_613_861_1147_1026_5595_5594_6776_5970_1869_4088_4089_4790_4792_4609	21	1.36E-18	1.17E-16	1.95E-17
4575	hsa-mir-130a	hsa04310	Wnt signaling pathway	815_1499_595_5578_4087_1460_5599_1387_2932_3725_1457_1452_4088_4089_2033_894_896_5518_5515_5601_5602_5566_1856_4609_5527	25	4.62E-17	3.97E-15	5.68E-16
4576	hsa-mir-130a	hsa04010	MAPK signaling pathway	6722_6195_9252_5578_5923_1956_3304_3305_3303_6789_1616_1147_998_5595_5594_5599_1386_3315_1649_5970_3164_3725_6196_4790_5601_5602_5566_4609_2353_468_2002	31	1.05E-16	9.01E-15	1.13E-15
4577	hsa-mir-130a	hsa05210	Colorectal cancer	1499_595_4087_1956_4436_596_5595_5594_5599_2932_3725_4088_4089_5601_5602_1856_4609_2353	18	2.19E-14	1.88E-12	2.09E-13
4578	hsa-mir-130a	hsa05222	Small cell lung cancer	595_598_1019_1017_5925_5747_596_1147_5743_5970_1869_5728_3910_4790_4792_51588_4609_8554	18	3.12E-14	2.68E-12	2.68E-13
4579	hsa-mir-130a	hsa04012	ErbB signaling pathway	815_5578_5747_25_1956_1026_5595_5594_5599_2932_6776_3725_5601_5602_4609_2002	16	4.76E-12	4.10E-10	3.73E-11
4580	hsa-mir-130a	hsa04350	TGF-beta signaling pathway	4087_6667_1874_5933_5595_5594_1387_7027_4088_4089_2033_5518_5515_4609_4093	15	5.00E-11	4.30E-09	3.58E-10
4581	hsa-mir-130a	hsa04510	Focal adhesion	1499_595_5578_5923_5747_1956_5499_596_998_5595_5594_5599_2932_3725_5728_894_896_3910_5601_5602_2002	21	6.22E-11	5.35E-09	4.12E-10
4582	hsa-mir-130a	hsa05219	Bladder cancer	595_1019_9252_4193_5925_1956_1026_5595_5594_1869_4609	11	4.17E-10	3.58E-08	2.56E-09
4583	hsa-mir-130a	hsa05221	Acute myeloid leukemia	595_1050_861_1147_5595_5594_6776_5970_6688_4790_5371_4609	12	8.26E-10	7.10E-08	4.74E-09
4584	hsa-mir-130a	hsa05214	Glioma	815_595_1019_4193_5578_5925_1956_1026_5595_5594_1869_5728	12	2.18E-09	1.88E-07	1.17E-08
4585	hsa-mir-130a	hsa04520	Adherens junction	1499_4087_1956_1460_998_5595_5594_1387_1457_4088_4089_2033	12	1.75E-08	1.51E-06	8.86E-08
4586	hsa-mir-130a	hsa04620	Toll-like receptor signaling pathway	1147_5595_5594_5599_5970_3725_4790_4792_5601_5602_841_2353_6348	13	2.58E-08	2.22E-06	1.23E-07
4587	hsa-mir-130a	hsa04912	GnRH signaling pathway	815_5578_1956_998_5595_5594_5599_3725_5601_5602_5566_468_2002	13	4.77E-08	4.11E-06	2.16E-07
4588	hsa-mir-130a	hsa04660	T cell receptor signaling pathway	1019_1147_998_5595_5594_2932_5970_3725_4790_4792_5601_2353_959	13	5.81E-08	5.00E-06	2.50E-07
4589	hsa-mir-130a	hsa04720	Long-term potentiation	815_6195_5578_5499_5595_5594_1387_6196_2033_5566_468	11	8.50E-08	7.31E-06	3.48E-07
4590	hsa-mir-130a	hsa04120	Ubiquitin mediated proteolysis	4193_3093_7319_84447_7329_10055_64326_7337_5371_672_25898_51588_10075_8554	14	1.12E-07	9.65E-06	4.38E-07
4591	hsa-mir-130a	hsa05213	Endometrial cancer	1499_595_1956_5595_5594_2932_5728_4609_2002	9	3.70E-07	3.18E-05	1.38E-06
4592	hsa-mir-130a	hsa05218	Melanoma	595_1019_4193_5925_1956_1026_5595_5594_1869_5728	10	4.62E-07	3.98E-05	1.59E-06
4593	hsa-mir-130a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_1147_998_5599_5970_3725_4790_4792_5601_5602	10	4.62E-07	3.98E-05	1.59E-06
4594	hsa-mir-130a	hsa05223	Non-small cell lung cancer	595_1019_5578_5925_1956_6789_5595_5594_1869	9	4.92E-07	4.23E-05	1.63E-06
4595	hsa-mir-130a	hsa04662	B cell receptor signaling pathway	1380_1147_5595_5594_2932_5970_3725_4790_4792_2353	10	7.29E-07	6.27E-05	2.32E-06
4596	hsa-mir-130a	hsa03420	Nucleotide excision repair	5981_902_6117_2965_4331_2071_2074_1022	8	1.20E-06	0.000102864	3.67E-06
4597	hsa-mir-130a	hsa04916	Melanogenesis	815_1499_5578_5595_5594_1385_1387_2932_2033_5566_1856	11	1.66E-06	0.000142723	4.92E-06
4598	hsa-mir-130a	hsa04920	Adipocytokine signaling pathway	6794_1147_5599_5970_4790_4792_5601_5602_5563	9	2.48E-06	0.000213535	7.12E-06
4599	hsa-mir-130a	hsa04210	Apoptosis	598_823_596_1147_5970_4790_4792_5566_841_472	10	3.00E-06	0.000258064	8.32E-06
4600	hsa-mir-130a	hsa05211	Renal cell carcinoma	3091_998_5595_5594_1387_9915_3725_2034_2033	9	4.25E-06	0.000365483	1.14E-05
4601	hsa-mir-130a	hsa03022	Basal transcription factors	51616_2957_2965_2963_6908_2958_6880	7	4.46E-06	0.00038371	1.16E-05
4602	hsa-mir-130a	hsa04910	Insulin signaling pathway	5499_2308_5595_5594_5599_2932_5601_5602_5566_5563_2002	11	2.02E-05	0.001737377	5.01E-05
4603	hsa-mir-130a	hsa04612	Antigen processing and presentation	3309_3304_3305_3303_1385_3320_3326_4800_4801	9	2.04E-05	0.001752714	5.01E-05
4604	hsa-mir-130a	hsa04150	mTOR signaling pathway	6794_6195_3091_5595_5594_6196_5563	7	3.26E-05	0.002802911	7.79E-05
4605	hsa-mir-130a	hsa04630	Jak-STAT signaling pathway	595_598_1387_6778_6776_2033_894_896_51588_4609_8554	11	5.47E-05	0.004703583	0.000127124
4606	hsa-mir-130a	hsa04062	Chemokine signaling pathway	5747_6362_1147_998_5595_5594_2932_5970_4790_4792_5566_6348	12	8.44E-05	0.007257638	0.00019099
4607	hsa-mir-130a	hsa04530	Tight junction	1499_1019_5578_1460_998_1457_5728_5518_5515_5520	10	9.53E-05	0.008196186	0.000210159
4608	hsa-mir-130a	hsa04330	Notch signaling pathway	3065_1387_9612_2033_8850_1856	6	0.000156718	0.013477766	0.000334963
4609	hsa-mir-130a	hsa05216	Thyroid cancer	1499_595_5595_5594_4609	5	0.000159692	0.013733498	0.000334963
4610	hsa-mir-130a	hsa04370	VEGF signaling pathway	5578_5747_998_5595_5594_5743_3315	7	0.000311635	0.026800638	0.00063811
4611	hsa-mir-130a	hsa05131	Shigellosis	1499_5578_25_998_7534_4691	6	0.000373719	0.032139869	0.000730452
4612	hsa-mir-130a	hsa05130	Pathogenic Escherichia coli infection	1499_5578_25_998_7534_4691	6	0.000373719	0.032139869	0.000730452
4613	hsa-mir-130a	hsa04540	Gap junction	5578_1956_5595_5594_1453_983_5566	7	0.000893567	0.076846759	0.001707706
4614	hsa-mir-130a	hsa04930	Type II diabetes mellitus	5595_5594_5599_5601_5602	5	0.000994702	0.085544373	0.00185966
4615	hsa-mir-130a	hsa05016	Huntington's disease	3065_3064_25942_6667_1385_1387_2033_27113_6908_841	10	0.001021631	0.087860282	0.001869368
4616	hsa-mir-130a	hsa03440	Homologous recombination	641_6117_5888_675	4	0.001394773	0.11995049	0.002498969
4617	hsa-mir-130a	hsa04664	Fc epsilon RI signaling pathway	5578_5595_5594_5599_5601_5602	6	0.001979859	0.170267863	0.003474854
4618	hsa-mir-130a	hsa03030	DNA replication	5981_6117_5557_5422	4	0.00321931	0.27686062	0.00542864
4619	hsa-mir-130a	hsa03410	Base excision repair	3146_142_4913_328	4	0.00321931	0.27686062	0.00542864
4620	hsa-mir-130a	hsa04360	Axon guidance	5747_25_998_5595_5594_2932_1020	7	0.005522672	0.474949821	0.00913365
4621	hsa-mir-130a	hsa04730	Long-term depression	5578_5595_5594_5518_5515	5	0.00627512	0.539660309	0.01018227
4622	hsa-mir-130a	hsa03430	Mismatch repair	5981_4436_6117	3	0.007159526	0.615719272	0.011402209
4623	hsa-mir-130a	hsa05014	Amyotrophic lateral sclerosis (ALS)	598_596_1616_834	4	0.013527617	1	0.021152274
4624	hsa-mir-130a	hsa04340	Hedgehog signaling pathway	2932_1452_1453_5566	4	0.01430608	1	0.021970052
4625	hsa-mir-130a	hsa05010	Alzheimer's disease	823_22926_5595_5594_2932_841_1020	7	0.02384292	1	0.035973529
4626	hsa-mir-130a	hsa03450	Non-homologous end-joining	2547_5591	2	0.0244101	1	0.036194286
4627	hsa-mir-130a	hsa04270	Vascular smooth muscle contraction	5578_5499_5595_5594_5566	5	0.041260709	1	0.060142728
4628	hsa-mir-130b	hsa05200	Pathways in cancer	1956_5595_5594_5599_6258_1387_6257_6256_8031_2308_836_841_6776_5970_6688_4609_4088_861_4087_4089_1050_5925_2033_8554_4790	25	7.02E-24	4.35E-22	4.35E-22
4629	hsa-mir-130b	hsa04010	MAPK signaling pathway	6722_1956_5595_5594_5599_5598_1386_836_5566_9252_1432_1649_5970_10912_468_4609_6195_6196_4616_4790_2002	21	2.48E-20	1.54E-18	7.69E-19
4630	hsa-mir-130b	hsa05215	Prostate cancer	1956_5595_5594_1385_1387_2308_5970_468_5925_2033_4790	11	2.83E-13	1.76E-11	4.92E-12
4631	hsa-mir-130b	hsa05212	Pancreatic cancer	1956_5595_5594_1385_1387_2308_5970_468_5925_2033_4790	11	3.17E-13	1.97E-11	4.92E-12
4632	hsa-mir-130b	hsa05220	Chronic myeloid leukemia	5595_5594_6776_5970_4609_4088_861_4089_5925_4790	10	1.98E-12	1.23E-10	2.45E-11
4633	hsa-mir-130b	hsa05221	Acute myeloid leukemia	5595_5594_6776_5970_6688_4609_861_1050_4790	9	8.76E-12	5.43E-10	9.05E-11
4634	hsa-mir-130b	hsa04912	GnRH signaling pathway	815_1956_5595_5594_5599_5598_5566_1432_468_2002	10	5.51E-11	3.41E-09	4.81E-10
4635	hsa-mir-130b	hsa04720	Long-term potentiation	815_5595_5594_1387_5566_468_6195_6196_2033	9	6.20E-11	3.84E-09	4.81E-10
4636	hsa-mir-130b	hsa05216	Thyroid cancer	5595_5594_6258_6257_6256_8031_4609	7	1.14E-10	7.05E-09	7.84E-10
4637	hsa-mir-130b	hsa05210	Colorectal cancer	1956_5595_5594_5599_836_4609_4088_4087_4089	9	1.57E-10	9.74E-09	9.74E-10
4638	hsa-mir-130b	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_4609_4088_4087_4089_2033	9	2.10E-10	1.30E-08	1.18E-09
4639	hsa-mir-130b	hsa04520	Adherens junction	1956_5595_5594_1387_4088_4087_4089_2033	8	2.81E-09	1.75E-07	1.45E-08
4640	hsa-mir-130b	hsa05222	Small cell lung cancer	6258_6257_6256_5970_4609_5925_8554_4790	8	4.78E-09	2.96E-07	2.26E-08
4641	hsa-mir-130b	hsa04012	ErbB signaling pathway	815_1956_5595_5594_5599_6776_4609_2002	8	5.20E-09	3.22E-07	2.26E-08
4642	hsa-mir-130b	hsa05223	Non-small cell lung cancer	1956_5595_5594_6258_6257_6256_5925	7	5.47E-09	3.39E-07	2.26E-08
4643	hsa-mir-130b	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_1432_841_5970_6348_4790	8	1.67E-08	1.03E-06	6.46E-08
4644	hsa-mir-130b	hsa04310	Wnt signaling pathway	815_5599_1387_5566_4609_4088_4087_4089_2033	9	2.07E-08	1.28E-06	7.44E-08
4645	hsa-mir-130b	hsa04920	Adipocytokine signaling pathway	5599_6258_6257_6256_5970_10891_4790	7	2.16E-08	1.34E-06	7.44E-08
4646	hsa-mir-130b	hsa05219	Bladder cancer	1956_5595_5594_9252_4609_5925	6	4.16E-08	2.58E-06	1.36E-07
4647	hsa-mir-130b	hsa04110	Cell cycle	1387_10912_4088_4087_4089_4616_5925_2033	8	5.15E-08	3.19E-06	1.60E-07
4648	hsa-mir-130b	hsa04916	Melanogenesis	815_5595_5594_1385_1387_5566_2033	7	3.60E-07	2.23E-05	1.06E-06
4649	hsa-mir-130b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_5599_836_1432_5970_4790	6	7.31E-07	4.53E-05	2.06E-06
4650	hsa-mir-130b	hsa04910	Insulin signaling pathway	5595_5594_5599_2308_5566_10891_2002	7	2.19E-06	0.000135504	5.89E-06
4651	hsa-mir-130b	hsa04210	Apoptosis	836_5566_841_840_5970_4790	6	2.53E-06	0.000156578	6.52E-06
4652	hsa-mir-130b	hsa05213	Endometrial cancer	1956_5595_5594_4609_2002	5	3.55E-06	0.00022013	8.81E-06
4653	hsa-mir-130b	hsa05214	Glioma	815_1956_5595_5594_5925	5	9.84E-06	0.00061013	2.35E-05
4654	hsa-mir-130b	hsa05010	Alzheimer's disease	22926_5595_5594_836_841_840_1020	7	1.05E-05	0.000650652	2.41E-05
4655	hsa-mir-130b	hsa05016	Huntington's disease	1385_1387_836_6667_841_10891_2033	7	1.53E-05	0.000948022	3.39E-05
4656	hsa-mir-130b	hsa04540	Gap junction	1956_5595_5594_5598_5566	5	5.04E-05	0.003127848	0.000106399
4657	hsa-mir-130b	hsa04630	Jak-STAT signaling pathway	1387_6776_4609_6778_2033_8554	6	5.15E-05	0.003191972	0.000106399
4658	hsa-mir-130b	hsa04150	mTOR signaling pathway	5595_5594_6195_6196	4	7.99E-05	0.004955882	0.000159867
4659	hsa-mir-130b	hsa04660	T cell receptor signaling pathway	5595_5594_1432_5970_4790	5	0.000107939	0.006692245	0.000209133
4660	hsa-mir-130b	hsa04062	Chemokine signaling pathway	5595_5594_5566_5970_6348_4790	6	0.000165032	0.010231965	0.00031006
4661	hsa-mir-130b	hsa04115	p53 signaling pathway	836_841_10912_4616	4	0.000224642	0.013927832	0.000409642
4662	hsa-mir-130b	hsa03320	PPAR signaling pathway	6258_6257_6256_2168	4	0.00023674	0.0146779	0.000419369
4663	hsa-mir-130b	hsa05218	Melanoma	1956_5595_5594_5925	4	0.0002493	0.01545659	0.00042935
4664	hsa-mir-130b	hsa05211	Renal cell carcinoma	5595_5594_1387_2033	4	0.000262331	0.016264541	0.000439582
4665	hsa-mir-130b	hsa04662	B cell receptor signaling pathway	5595_5594_5970_4790	4	0.000304361	0.018870367	0.000496589
4666	hsa-mir-130b	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_1432	4	0.000367639	0.022793589	0.000584451
4667	hsa-mir-130b	hsa04930	Type II diabetes mellitus	5595_5594_5599	3	0.000981496	0.060852771	0.001521319
4668	hsa-mir-130b	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.001105712	0.068554134	0.001672052
4669	hsa-mir-130b	hsa04510	Focal adhesion	1956_5595_5594_5599_2002	5	0.001717708	0.106497878	0.002535664
4670	hsa-mir-130b	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_834_1432	3	0.001786052	0.110735198	0.002575237
4671	hsa-mir-130b	hsa04370	VEGF signaling pathway	5595_5594_1432	3	0.004244255	0.263143829	0.005980542
4672	hsa-mir-130b	hsa04612	Antigen processing and presentation	1385_4800_4801	3	0.006263585	0.388342294	0.008629829
4673	hsa-mir-130b	hsa04270	Vascular smooth muscle contraction	5595_5594_5566	3	0.013200225	0.818413934	0.017791607
4674	hsa-mir-130b	hsa04360	Axon guidance	5595_5594_1020	3	0.017306946	1	0.022830439
4675	hsa-mir-130b	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836	3	0.019781106	1	0.025550596
4676	hsa-mir-130b	hsa04730	Long-term depression	5595_5594	2	0.035473897	1	0.044885339
4677	hsa-mir-130b	hsa04020	Calcium signaling pathway	815_1956_5566	3	0.040633489	1	0.050385526
4678	hsa-mir-132	hsa05200	Pathways in cancer	595_2261_4193_6934_3091_3066_3065_1050_5925_7184_25_1956_1487_1488_1870_1871_2113_861_10401_207_3716_1026_4233_5595_5594_5599_1387_2064_6256_3326_367_2932_6774_6776_6777_6772_5979_5879_7157_6688_3725_2736_4087_4088_4089_2033_4790_5970_3320_5371_3480_5159_5156_5601_5602_4609_1029_2353_1441_8554	60	2.11E-36	1.66E-34	1.66E-34
4679	hsa-mir-132	hsa03022	Basal transcription factors	54457_6879_2958_138474_6883_6880_6881_2967_2961_2960_2963_2969_2968_6878_6877_6874_6873_6872_6908_6884_6882_2959_2957	23	1.68E-24	1.32E-22	6.62E-23
4680	hsa-mir-132	hsa05215	Prostate cancer	595_4193_6934_5925_7184_1956_1870_1871_9586_207_1026_5595_5594_1385_1387_2064_3326_367_2932_7157_468_2033_4790_5970_3320_3480_5159_5156	28	3.37E-23	2.66E-21	8.59E-22
4681	hsa-mir-132	hsa05212	Pancreatic cancer	595_4193_6934_5925_7184_1956_1870_1871_9586_207_1026_5595_5594_1385_1387_2064_3326_367_2932_7157_468_2033_4790_5970_3320_3480_5159_5156	28	4.35E-23	3.43E-21	8.59E-22
4682	hsa-mir-132	hsa04010	MAPK signaling pathway	3925_6722_6197_2261_2264_9252_4773_8986_1956_1432_1616_207_5595_5594_5599_1386_3312_1649_5879_7157_468_3725_3727_6195_6196_4790_51701_5970_5159_9261_5156_5601_5600_5603_5602_9479_6885_4609_2353_8550	40	1.37E-21	1.08E-19	2.16E-20
4683	hsa-mir-132	hsa05220	Chronic myeloid leukemia	595_4193_3066_3065_5925_25_1487_1488_1870_1871_861_207_1026_5595_5594_6776_6777_7157_4088_4089_4790_5970_5781_4609_1029	25	2.92E-21	2.31E-19	3.85E-20
4684	hsa-mir-132	hsa04630	Jak-STAT signaling pathway	3559_595_3454_3455_3560_1439_2690_10401_207_3717_3716_3718_85480_1387_3575_3570_3572_6774_6775_6776_6777_6772_2033_149233_3953_5781_4609_1441_8554	29	1.64E-18	1.30E-16	1.85E-17
4685	hsa-mir-132	hsa05210	Colorectal cancer	595_6934_1956_207_4233_5595_5594_5599_2932_5879_7157_3725_4087_4088_4089_3480_5159_5156_5601_5602_4609_2353	22	5.34E-17	4.22E-15	5.28E-16
4686	hsa-mir-132	hsa04310	Wnt signaling pathway	595_8607_6934_1459_4773_1460_1487_1488_5599_1387_2932_5879_7157_8061_3725_1457_4087_4088_4089_2033_51701_5601_5602_6423_6885_4609	26	6.66E-16	5.26E-14	5.85E-15
4687	hsa-mir-132	hsa04520	Adherens junction	6934_1459_1460_1956_6714_2241_4233_5595_5594_1387_2064_5879_1457_4087_4088_4089_2033_51701_3480_6885	20	3.02E-15	2.39E-13	2.39E-14
4688	hsa-mir-132	hsa05219	Bladder cancer	595_2261_9252_4193_5925_1956_1870_1871_1026_5595_5594_2064_7157_4609_1029	15	1.19E-13	9.38E-12	8.53E-13
4689	hsa-mir-132	hsa04110	Cell cycle	595_4193_4171_3066_3065_5925_25_1870_1871_1026_5591_1387_7533_2932_7157_4085_4087_4088_4089_2033_1029	21	2.45E-13	1.94E-11	1.61E-12
4690	hsa-mir-132	hsa04620	Toll-like receptor signaling pathway	3454_3455_1432_207_3654_5595_5594_5599_6772_5879_3725_4790_5970_5601_5600_5603_5602_6885_2353	19	1.46E-12	1.15E-10	8.88E-12
4691	hsa-mir-132	hsa05218	Melanoma	595_4193_5925_1956_1870_1871_207_1026_4233_5595_5594_7157_3480_5159_5156_1029	16	7.06E-12	5.58E-10	3.85E-11
4692	hsa-mir-132	hsa05221	Acute myeloid leukemia	595_6934_1050_861_207_5595_5594_6774_6776_6777_6688_4790_5970_5371_4609	15	7.31E-12	5.78E-10	3.85E-11
4693	hsa-mir-132	hsa05214	Glioma	595_4193_5925_1956_1870_1871_207_1026_5595_5594_7157_3480_5159_5156_1029	15	2.40E-11	1.89E-09	1.18E-10
4694	hsa-mir-132	hsa04012	ErbB signaling pathway	25_1956_6714_207_1026_5595_5594_5599_2064_2932_6776_6777_3725_5601_5602_4609	16	1.01E-10	8.01E-09	4.71E-10
4695	hsa-mir-132	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_1432_4233_5599_5879_3725_4790_5970_5601_5600_5603_5602_5781	14	6.75E-10	5.34E-08	2.96E-09
4696	hsa-mir-132	hsa05223	Non-small cell lung cancer	595_5925_1956_1870_1871_207_5595_5594_2064_6256_7157_1029	12	3.48E-09	2.75E-07	1.45E-08
4697	hsa-mir-132	hsa04330	Notch signaling pathway	3066_3065_1487_1488_3280_388585_1387_9612_2033_8850_4851	11	9.86E-09	7.79E-07	3.89E-08
4698	hsa-mir-132	hsa04660	T cell receptor signaling pathway	4773_3932_1432_207_5595_5594_2932_3725_4790_5970_5601_5600_5603_6885_2353	15	1.50E-08	1.19E-06	5.66E-08
4699	hsa-mir-132	hsa04062	Chemokine signaling pathway	1234_1230_5580_7852_207_3055_3717_3718_5590_5595_5594_2932_6774_6777_6772_5879_4790_5970_2185	19	2.46E-08	1.94E-06	8.83E-08
4700	hsa-mir-132	hsa04060	Cytokine-cytokine receptor interaction	3556_3559_1234_1230_3454_3455_1956_3560_1439_7852_2690_85480_4233_3575_3570_3572_2321_149233_5159_5156_3953_1441	22	2.81E-08	2.22E-06	9.65E-08
4701	hsa-mir-132	hsa04912	GnRH signaling pathway	5580_1956_6714_1432_5595_5594_5599_468_3725_5601_5600_5603_5602_2185	14	8.04E-08	6.35E-06	2.65E-07
4702	hsa-mir-132	hsa04664	Fc epsilon RI signaling pathway	5580_6850_1432_207_5595_5594_5599_5879_5601_5600_5603_5602	12	1.45E-07	1.15E-05	4.60E-07
4703	hsa-mir-132	hsa05213	Endometrial cancer	595_6934_1956_207_5595_5594_2064_2932_7157_4609	10	2.32E-07	1.84E-05	7.01E-07
4704	hsa-mir-132	hsa04920	Adipocytokine signaling pathway	207_3717_5599_6256_6774_4790_5970_5601_5602_3953_5781	11	2.40E-07	1.89E-05	7.01E-07
4705	hsa-mir-132	hsa04510	Focal adhesion	595_1956_6714_207_4233_5595_5594_5599_2064_2932_5879_3725_2321_3480_5159_5156_5601_5602	18	2.97E-07	2.35E-05	8.38E-07
4706	hsa-mir-132	hsa05222	Small cell lung cancer	595_5925_1870_1871_10401_207_6256_7157_4790_5970_4609_8554	12	3.32E-07	2.63E-05	9.05E-07
4707	hsa-mir-132	hsa05216	Thyroid cancer	595_6934_5595_5594_6256_5979_7157_4609	8	3.61E-07	2.85E-05	9.47E-07
4708	hsa-mir-132	hsa04350	TGF-beta signaling pathway	6667_3399_3398_5595_5594_1387_4086_4087_4088_4089_2033_4609	12	3.72E-07	2.94E-05	9.47E-07
4709	hsa-mir-132	hsa05211	Renal cell carcinoma	3091_2113_207_4233_5595_5594_1387_5879_3725_2033_5781	11	4.57E-07	3.61E-05	1.13E-06
4710	hsa-mir-132	hsa04662	B cell receptor signaling pathway	4773_6850_207_5595_5594_2932_5879_3725_4790_5970_2353	11	6.58E-07	5.20E-05	1.58E-06
4711	hsa-mir-132	hsa04370	VEGF signaling pathway	4773_6714_1432_207_5595_5594_5879_9261_5600_5603	10	5.68E-06	0.000448372	1.32E-05
4712	hsa-mir-132	hsa04930	Type II diabetes mellitus	5580_3651_5590_5595_5594_5599_5601_5602	8	6.35E-06	0.000501909	1.43E-05
4713	hsa-mir-132	hsa04150	mTOR signaling pathway	6197_3091_207_5595_5594_6195_6196	7	0.00011862	0.009371014	0.000260306
4714	hsa-mir-132	hsa05016	Huntington's disease	3066_3065_3064_6667_9586_1385_1387_9001_5430_7157_2033_6874_6908	13	0.000124015	0.009797202	0.000264789
4715	hsa-mir-132	hsa04720	Long-term potentiation	6197_5595_5594_1387_468_6195_6196_2033	8	0.000172576	0.013633506	0.000358776
4716	hsa-mir-132	hsa04950	Maturity onset diabetes of the young	6927_3087_3280_3651_5080	5	0.00019044	0.015044759	0.000385763
4717	hsa-mir-132	hsa04612	Antigen processing and presentation	4801_1385_3326_3312_3320_4800_4802_2923	8	0.000502796	0.039720847	0.00095651
4718	hsa-mir-132	hsa04210	Apoptosis	3556_823_1439_207_3654_7157_4790_5970	8	0.000502796	0.039720847	0.00095651
4719	hsa-mir-132	hsa04910	Insulin signaling pathway	6720_5211_207_5590_5595_5594_5599_2932_5601_5602	10	0.000520632	0.041129925	0.00095651
4720	hsa-mir-132	hsa04650	Natural killer cell mediated cytotoxicity	3454_3455_4773_3932_6850_5595_5594_5879_5781_2185	10	0.000520632	0.041129925	0.00095651
4721	hsa-mir-132	hsa04540	Gap junction	10382_1956_6714_5592_5595_5594_5159_5156	8	0.000658628	0.052031621	0.001182537
4722	hsa-mir-132	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_1616_5879_7157_5600_5603	6	0.001095378	0.086534844	0.001922997
4723	hsa-mir-132	hsa04360	Axon guidance	4773_25_7852_2242_4233_5595_5594_2932_5879	9	0.001388186	0.109666692	0.002384059
4724	hsa-mir-132	hsa04120	Ubiquitin mediated proteolysis	55294_4193_10401_7329_83737_64326_5371_672_8554	9	0.002036321	0.16086938	0.003422753
4725	hsa-mir-132	hsa04115	p53 signaling pathway	595_4193_1026_7157_64326_1029	6	0.002923062	0.23092193	0.004810874
4726	hsa-mir-132	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	0.003177395	0.251014203	0.005122739
4727	hsa-mir-132	hsa04916	Melanogenesis	6934_5595_5594_1385_1387_2932_2033	7	0.005118492	0.404360901	0.008087218
4728	hsa-mir-132	hsa04670	Leukocyte transendothelial migration	1432_7852_5879_5600_5603_5781_2185	7	0.011315077	0.893891121	0.017527277
4729	hsa-mir-132	hsa04740	Olfactory transduction	5592	1	0.012314715	0.972862523	0.018708895
4730	hsa-mir-132	hsa03420	Nucleotide excision repair	5887_2967_2968_6118	4	0.012606856	0.995941585	0.018791351
4731	hsa-mir-132	hsa04530	Tight junction	1459_1460_5580_6714_207_5590_1457	7	0.019622248	1	0.028706621
4732	hsa-mir-132	hsa05217	Basal cell carcinoma	6934_2932_7157_2736	4	0.025115276	1	0.036074669
4733	hsa-mir-132	hsa05340	Primary immunodeficiency	3932_3718_3575	3	0.034466037	1	0.048621731
4734	hsa-mir-1321	hsa05200	Pathways in cancer	2249_367_3725_6776_6777_2353_5914_5970_6256	9	2.03E-10	7.70E-09	7.70E-09
4735	hsa-mir-1321	hsa05221	Acute myeloid leukemia	6776_6777_5914_5970	4	9.84E-07	3.74E-05	1.87E-05
4736	hsa-mir-1321	hsa05220	Chronic myeloid leukemia	6776_6777_5970	3	0.000113081	0.004297074	0.001074269
4737	hsa-mir-1321	hsa04662	B cell receptor signaling pathway	3725_2353_5970	3	0.000113081	0.004297074	0.001074269
4738	hsa-mir-1321	hsa04012	ErbB signaling pathway	3725_6776_6777	3	0.00017291	0.006570564	0.001314113
4739	hsa-mir-1321	hsa04620	Toll-like receptor signaling pathway	3725_2353_5970	3	0.000272526	0.010355982	0.001606221
4740	hsa-mir-1321	hsa04010	MAPK signaling pathway	2249_3725_2353_5970	4	0.000330487	0.012558499	0.001606221
4741	hsa-mir-1321	hsa04660	T cell receptor signaling pathway	3725_2353_5970	3	0.000338152	0.012849769	0.001606221
4742	hsa-mir-1321	hsa04630	Jak-STAT signaling pathway	3977_6776_6777	3	0.000897685	0.03411204	0.003790227
4743	hsa-mir-1321	hsa04920	Adipocytokine signaling pathway	5970_6256	2	0.003115381	0.11838449	0.011838449
4744	hsa-mir-1321	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.003479392	0.132216888	0.012019717
4745	hsa-mir-1321	hsa05210	Colorectal cancer	3725_2353	2	0.004792101	0.18209983	0.0135505
4746	hsa-mir-1321	hsa05222	Small cell lung cancer	5970_6256	2	0.005011395	0.190433006	0.0135505
4747	hsa-mir-1321	hsa05215	Prostate cancer	367_5970	2	0.00523525	0.198939509	0.0135505
4748	hsa-mir-1321	hsa05212	Pancreatic cancer	367_5970	2	0.005348882	0.203257498	0.0135505
4749	hsa-mir-1321	hsa03450	Non-homologous end-joining	2547	1	0.01783249	0.677634628	0.042352164
4750	hsa-mir-1321	hsa05016	Huntington's disease	6908_6667	2	0.021779742	0.827630199	0.048257818
4751	hsa-mir-1321	hsa04062	Chemokine signaling pathway	6777_5970	2	0.022858967	0.868640727	0.048257818
4752	hsa-mir-1321	hsa04950	Maturity onset diabetes of the young	6927	1	0.02954865	1	0.0590973
4753	hsa-mir-1321	hsa05216	Thyroid cancer	6256	1	0.035355663	1	0.067175759
4754	hsa-mir-1321	hsa04080	Neuroactive ligand-receptor interaction	2908_7067	2	0.038234048	1	0.06918542
4755	hsa-mir-1321	hsa03410	Base excision repair	142	1	0.043428758	1	0.073648431
4756	hsa-mir-1321	hsa03022	Basal transcription factors	6908	1	0.044576682	1	0.073648431
4757	hsa-mir-1322	hsa05200	Pathways in cancer	25_5371_5595_5599_861_1387_5601_5602_367_6934_6774_6772_3091_5970_6688_2113_4609_3725_2353_4087_4088_4089_5925_2033_1050_8554	26	2.62E-19	1.70E-17	1.70E-17
4758	hsa-mir-1322	hsa04310	Wnt signaling pathway	5599_1387_5601_5602_6934_8061_4773_4609_3725_1457_1459_4087_4088_4089_2033	15	5.89E-13	3.83E-11	1.91E-11
4759	hsa-mir-1322	hsa04010	MAPK signaling pathway	5595_5599_1386_5601_5600_5603_5602_9252_1432_1649_5970_468_4773_4609_3725_3727_2353_8550	18	1.64E-12	1.06E-10	3.55E-11
4760	hsa-mir-1322	hsa05210	Colorectal cancer	5595_5599_5601_5602_6934_4609_3725_2353_4087_4088_4089	11	4.84E-11	3.15E-09	7.87E-10
4761	hsa-mir-1322	hsa04620	Toll-like receptor signaling pathway	5595_5599_5601_5600_5603_5602_1432_6772_5970_3725_2353	11	3.24E-10	2.11E-08	4.22E-09
4762	hsa-mir-1322	hsa05221	Acute myeloid leukemia	5371_5595_861_6934_6774_5970_6688_4609_1050	9	8.56E-10	5.56E-08	9.27E-09
4763	hsa-mir-1322	hsa04520	Adherens junction	5595_1387_6934_1457_1459_4087_4088_4089_2033	9	9.77E-09	6.35E-07	9.07E-08
4764	hsa-mir-1322	hsa05215	Prostate cancer	5595_1387_367_6934_5970_468_9586_5925_2033	9	2.10E-08	1.36E-06	1.66E-07
4765	hsa-mir-1322	hsa05212	Pancreatic cancer	5595_1387_367_6934_5970_468_9586_5925_2033	9	2.30E-08	1.49E-06	1.66E-07
4766	hsa-mir-1322	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_5600_5603_5602_1432_5970_3725	8	6.53E-08	4.24E-06	4.24E-07
4767	hsa-mir-1322	hsa05220	Chronic myeloid leukemia	25_5595_861_5970_4609_4088_4089_5925	8	9.65E-08	6.27E-06	5.70E-07
4768	hsa-mir-1322	hsa04912	GnRH signaling pathway	5595_5599_5601_5600_5603_5602_1432_468_3725	9	1.08E-07	7.01E-06	5.84E-07
4769	hsa-mir-1322	hsa04660	T cell receptor signaling pathway	5595_5601_5600_5603_1432_5970_4773_3725_2353	9	1.25E-07	8.12E-06	6.24E-07
4770	hsa-mir-1322	hsa04110	Cell cycle	25_5591_1387_7533_4087_4088_4089_5925_2033	9	2.34E-07	1.52E-05	1.08E-06
4771	hsa-mir-1322	hsa04350	TGF-beta signaling pathway	5595_1387_6667_4609_4087_4088_4089_2033	8	2.77E-07	1.80E-05	1.20E-06
4772	hsa-mir-1322	hsa03022	Basal transcription factors	2963_6874_6872_6908_6883_2959	6	4.37E-07	2.84E-05	1.77E-06
4773	hsa-mir-1322	hsa04664	Fc epsilon RI signaling pathway	5595_5599_5601_5600_5603_5602_1432	7	1.98E-06	0.000128619	7.57E-06
4774	hsa-mir-1322	hsa04012	ErbB signaling pathway	25_5595_5599_5601_5602_4609_3725	7	3.60E-06	0.000234107	1.30E-05
4775	hsa-mir-1322	hsa05211	Renal cell carcinoma	5595_1387_3091_2113_3725_2033	6	1.51E-05	0.000982492	5.17E-05
4776	hsa-mir-1322	hsa04120	Ubiquitin mediated proteolysis	5371_83737_672_55294_7329_64326_8554	7	6.35E-05	0.00412686	0.000206343
4777	hsa-mir-1322	hsa04630	Jak-STAT signaling pathway	1387_6774_6775_6772_4609_2033_8554	7	0.000121848	0.00792012	0.000377149
4778	hsa-mir-1322	hsa04920	Adipocytokine signaling pathway	5599_5601_5602_6774_5970	5	0.00012968	0.008429211	0.000383146
4779	hsa-mir-1322	hsa04662	B cell receptor signaling pathway	5595_5970_4773_3725_2353	5	0.000213302	0.013864653	0.000602811
4780	hsa-mir-1322	hsa04370	VEGF signaling pathway	5595_5600_5603_1432_4773	5	0.000239473	0.015565757	0.000648573
4781	hsa-mir-1322	hsa05219	Bladder cancer	5595_9252_4609_5925	4	0.000264048	0.017163099	0.000686524
4782	hsa-mir-1322	hsa04930	Type II diabetes mellitus	5595_5599_5601_5602	4	0.00033746	0.021934917	0.000843651
4783	hsa-mir-1322	hsa05216	Thyroid cancer	5595_6934_4609	3	0.00130335	0.084717731	0.003137694
4784	hsa-mir-1322	hsa04720	Long-term potentiation	5595_1387_468_2033	4	0.002044482	0.132891298	0.004737465
4785	hsa-mir-1322	hsa05016	Huntington's disease	6874_1387_6908_6667_9586_2033	6	0.002113638	0.137386495	0.004737465
4786	hsa-mir-1322	hsa05222	Small cell lung cancer	5970_4609_5925_8554	4	0.003282716	0.213376561	0.007112552
4787	hsa-mir-1322	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.004711741	0.306263195	0.009879458
4788	hsa-mir-1322	hsa05213	Endometrial cancer	5595_6934_4609	3	0.006153327	0.399966271	0.012347897
4789	hsa-mir-1322	hsa04916	Melanogenesis	5595_1387_6934_2033	4	0.006268932	0.407480606	0.012347897
4790	hsa-mir-1322	hsa05014	Amyotrophic lateral sclerosis (ALS)	5600_5603_1432	3	0.007476327	0.485961279	0.014292979
4791	hsa-mir-1322	hsa04510	Focal adhesion	5595_5599_5601_5602_3725	5	0.014542964	0.945292663	0.027008362
4792	hsa-mir-1322	hsa04910	Insulin signaling pathway	5595_5599_5601_5602	4	0.015926157	1	0.028755561
4793	hsa-mir-1322	hsa04062	Chemokine signaling pathway	5595_6774_6772_5970	4	0.045053212	1	0.079147535
4794	hsa-mir-133a-1	hsa05200	Pathways in cancer	5371_7046_1499_5595_5594_6258_1387_6256_836_7704_842_841_6774_6772_5970_4824_6688_862_6502_4087_5925_2033_207	23	6.13E-18	3.98E-16	3.98E-16
4795	hsa-mir-133a-1	hsa05215	Prostate cancer	1499_5595_5594_1385_1387_842_5970_4824_5925_2033_207	11	1.01E-11	6.57E-10	2.45E-10
4796	hsa-mir-133a-1	hsa05212	Pancreatic cancer	1499_5595_5594_1385_1387_842_5970_4824_5925_2033_207	11	1.13E-11	7.35E-10	2.45E-10
4797	hsa-mir-133a-1	hsa04520	Adherens junction	4301_7046_1499_6714_5595_5594_1387_1457_4087_2033	10	9.05E-11	5.88E-09	1.47E-09
4798	hsa-mir-133a-1	hsa05221	Acute myeloid leukemia	5371_5595_5594_7704_6774_5970_6688_862_207	9	1.63E-10	1.06E-08	2.08E-09
4799	hsa-mir-133a-1	hsa04350	TGF-beta signaling pathway	3399_3400_7046_5595_5594_1387_3398_4087_2033_3397	10	1.92E-10	1.25E-08	2.08E-09
4800	hsa-mir-133a-1	hsa04916	Melanogenesis	815_1499_5595_5594_1385_1387_2033_808_801_805	10	9.60E-10	6.24E-08	8.06E-09
4801	hsa-mir-133a-1	hsa04010	MAPK signaling pathway	6722_7046_5595_5594_4208_836_7867_1432_5970_9261_6195_207_2002_2005	14	9.93E-10	6.45E-08	8.06E-09
4802	hsa-mir-133a-1	hsa04720	Long-term potentiation	815_5595_5594_1387_6195_2033_808_801_805	9	1.13E-09	7.32E-08	8.13E-09
4803	hsa-mir-133a-1	hsa05214	Glioma	815_5595_5594_5925_207_808_801_805	8	8.10E-09	5.26E-07	5.26E-08
4804	hsa-mir-133a-1	hsa04912	GnRH signaling pathway	815_6714_5595_5594_1432_2002_808_801_805	9	2.16E-08	1.40E-06	1.28E-07
4805	hsa-mir-133a-1	hsa04370	VEGF signaling pathway	6714_5595_5594_7867_1432_842_9261_207	8	2.74E-08	1.78E-06	1.48E-07
4806	hsa-mir-133a-1	hsa05210	Colorectal cancer	7046_1499_5595_5594_836_842_4087_207	8	5.12E-08	3.33E-06	2.40E-07
4807	hsa-mir-133a-1	hsa05223	Non-small cell lung cancer	5595_5594_6258_6256_842_5925_207	7	5.17E-08	3.36E-06	2.40E-07
4808	hsa-mir-133a-1	hsa05010	Alzheimer's disease	22926_5595_5594_836_842_841_840_808_801_805	10	1.12E-07	7.28E-06	4.86E-07
4809	hsa-mir-133a-1	hsa05213	Endometrial cancer	1499_5595_5594_842_207_2002	6	8.99E-07	5.84E-05	3.65E-06
4810	hsa-mir-133a-1	hsa05222	Small cell lung cancer	6258_6256_842_5970_6502_5925_207	7	9.66E-07	6.28E-05	3.69E-06
4811	hsa-mir-133a-1	hsa04210	Apoptosis	836_839_842_841_840_5970_207	7	1.20E-06	7.79E-05	4.33E-06
4812	hsa-mir-133a-1	hsa05216	Thyroid cancer	1499_5595_5594_6258_6256	5	1.27E-06	8.24E-05	4.34E-06
4813	hsa-mir-133a-1	hsa04620	Toll-like receptor signaling pathway	5595_5594_1432_841_6772_5970_207	7	2.82E-06	0.000183158	9.16E-06
4814	hsa-mir-133a-1	hsa05220	Chronic myeloid leukemia	7046_5595_5594_5970_5925_207	6	6.48E-06	0.000421261	2.01E-05
4815	hsa-mir-133a-1	hsa04330	Notch signaling pathway	388585_1387_9612_2033_8850	5	1.09E-05	0.000709719	3.23E-05
4816	hsa-mir-133a-1	hsa04012	ErbB signaling pathway	815_6714_5595_5594_207_2002	6	1.44E-05	0.000936101	4.07E-05
4817	hsa-mir-133a-1	hsa04910	Insulin signaling pathway	5595_5594_207_2002_808_801_805	7	1.84E-05	0.001198763	4.99E-05
4818	hsa-mir-133a-1	hsa04920	Adipocytokine signaling pathway	6258_6256_6774_5970_207	5	5.37E-05	0.003490961	0.000139638
4819	hsa-mir-133a-1	hsa05211	Renal cell carcinoma	5595_5594_1387_2033_207	5	7.42E-05	0.004819811	0.000184101
4820	hsa-mir-133a-1	hsa04110	Cell cycle	5591_1387_6502_4087_5925_2033	6	7.65E-05	0.004970738	0.000184101
4821	hsa-mir-133a-1	hsa03022	Basal transcription factors	2962_2969_6908_2959	4	8.19E-05	0.005320928	0.000190033
4822	hsa-mir-133a-1	hsa05016	Huntington's disease	1385_1387_6908_836_842_841_2033	7	0.000120674	0.007843826	0.000270477
4823	hsa-mir-133a-1	hsa04310	Wnt signaling pathway	815_1499_1387_1457_4087_2033	6	0.000274982	0.017873829	0.000583158
4824	hsa-mir-133a-1	hsa04150	mTOR signaling pathway	5595_5594_6195_207	4	0.000278121	0.018077895	0.000583158
4825	hsa-mir-133a-1	hsa04950	Maturity onset diabetes of the young	3651_168620_4760	3	0.000457527	0.029739287	0.000929353
4826	hsa-mir-133a-1	hsa04660	T cell receptor signaling pathway	5595_5594_1432_5970_207	5	0.000485524	0.031559036	0.000956334
4827	hsa-mir-133a-1	hsa04270	Vascular smooth muscle contraction	5595_5594_808_801_805	5	0.000659456	0.042864663	0.001260725
4828	hsa-mir-133a-1	hsa05218	Melanoma	5595_5594_5925_207	4	0.000847485	0.055086556	0.001530182
4829	hsa-mir-133a-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_836_1432_5970	4	0.000847485	0.055086556	0.001530182
4830	hsa-mir-133a-1	hsa04062	Chemokine signaling pathway	5595_5594_6774_6772_5970_207	6	0.00092807	0.060324577	0.001630394
4831	hsa-mir-133a-1	hsa04662	B cell receptor signaling pathway	5595_5594_5970_207	4	0.001029631	0.066926004	0.001761211
4832	hsa-mir-133a-1	hsa04664	Fc epsilon RI signaling pathway	5595_5594_1432_207	4	0.001237654	0.080447516	0.002036328
4833	hsa-mir-133a-1	hsa04530	Tight junction	4301_1499_6714_1457_207	5	0.00125601	0.081640645	0.002036328
4834	hsa-mir-133a-1	hsa04510	Focal adhesion	1499_6714_5595_5594_207_2002	6	0.001284453	0.083489452	0.002036328
4835	hsa-mir-133a-1	hsa05219	Bladder cancer	5595_5594_5925	3	0.002061634	0.13400623	0.003190625
4836	hsa-mir-133a-1	hsa04630	Jak-STAT signaling pathway	1387_6774_6772_2033_207	5	0.002121986	0.137929088	0.003207653
4837	hsa-mir-133a-1	hsa04930	Type II diabetes mellitus	3651_5595_5594	3	0.002482253	0.161346423	0.003666964
4838	hsa-mir-133a-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432_842	3	0.004460679	0.289944164	0.006443204
4839	hsa-mir-133a-1	hsa04115	p53 signaling pathway	836_842_841	3	0.007761771	0.504515124	0.01096772
4840	hsa-mir-133a-1	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.010003398	0.650220845	0.013834486
4841	hsa-mir-133a-1	hsa04540	Gap junction	6714_5595_5594	3	0.016873183	1	0.022849102
4842	hsa-mir-133a-1	hsa04020	Calcium signaling pathway	815_808_801_805	4	0.02164118	1	0.028707688
4843	hsa-mir-133a-1	hsa04670	Leukocyte transendothelial migration	4301_1499_1432	3	0.033396856	1	0.043415913
4844	hsa-mir-133a-1	hsa05012	Parkinson's disease	7314_836_842	3	0.043531799	1	0.055481704
4845	hsa-mir-133a-1	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836	3	0.045091462	1	0.056269911
4846	hsa-mir-133a-1	hsa04120	Ubiquitin mediated proteolysis	7329_5371_6502	3	0.04588162	1	0.056269911
4847	hsa-mir-133b	hsa05200	Pathways in cancer	4087_836_2033_2249_4089_367_3725_6776_6777_2353_5914_5970_6256	13	3.71E-13	1.96E-11	1.96E-11
4848	hsa-mir-133b	hsa05210	Colorectal cancer	4087_836_4089_3725_2353	5	1.35E-06	7.15E-05	3.57E-05
4849	hsa-mir-133b	hsa04010	MAPK signaling pathway	836_2249_3725_1432_2353_5598_5970	7	2.23E-06	0.000117981	3.93E-05
4850	hsa-mir-133b	hsa05221	Acute myeloid leukemia	6776_6777_5914_5970	4	1.01E-05	0.000536436	0.000134109
4851	hsa-mir-133b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_3725_1432_5970	4	2.03E-05	0.001073857	0.000214771
4852	hsa-mir-133b	hsa05220	Chronic myeloid leukemia	4089_6776_6777_5970	4	2.49E-05	0.001319034	0.000219839
4853	hsa-mir-133b	hsa04350	TGF-beta signaling pathway	4087_6667_2033_4089	4	4.34E-05	0.002301892	0.000328842
4854	hsa-mir-133b	hsa04620	Toll-like receptor signaling pathway	3725_1432_2353_5970	4	7.88E-05	0.004177564	0.000522195
4855	hsa-mir-133b	hsa04660	T cell receptor signaling pathway	3725_1432_2353_5970	4	0.000104539	0.005540553	0.000615617
4856	hsa-mir-133b	hsa04310	Wnt signaling pathway	4087_2033_4089_3725	4	0.000347879	0.018437568	0.001801574
4857	hsa-mir-133b	hsa04630	Jak-STAT signaling pathway	2033_3977_6776_6777	4	0.000373912	0.01981731	0.001801574
4858	hsa-mir-133b	hsa04662	B cell receptor signaling pathway	3725_2353_5970	3	0.000624588	0.033103147	0.002758596
4859	hsa-mir-133b	hsa04520	Adherens junction	4087_2033_4089	3	0.000748658	0.039678899	0.002875067
4860	hsa-mir-133b	hsa05016	Huntington's disease	6908_836_6667_2033	4	0.000759452	0.040250942	0.002875067
4861	hsa-mir-133b	hsa04012	ErbB signaling pathway	3725_6776_6777	3	0.000947156	0.050199248	0.002972126
4862	hsa-mir-133b	hsa05215	Prostate cancer	2033_367_5970	3	0.000977964	0.051832112	0.002972126
4863	hsa-mir-133b	hsa04210	Apoptosis	836_840_5970	3	0.001009401	0.053498273	0.002972126
4864	hsa-mir-133b	hsa05212	Pancreatic cancer	2033_367_5970	3	0.001009401	0.053498273	0.002972126
4865	hsa-mir-133b	hsa04912	GnRH signaling pathway	3725_1432_5598	3	0.001732455	0.091820096	0.004832637
4866	hsa-mir-133b	hsa04110	Cell cycle	4087_2033_4089	3	0.002267953	0.120201494	0.006010075
4867	hsa-mir-133b	hsa04330	Notch signaling pathway	9612_2033	2	0.004918812	0.26069705	0.012414145
4868	hsa-mir-133b	hsa05010	Alzheimer's disease	836_1020_840	3	0.006728729	0.356622623	0.015737539
4869	hsa-mir-133b	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432	2	0.006829498	0.361963397	0.015737539
4870	hsa-mir-133b	hsa04920	Adipocytokine signaling pathway	5970_6256	2	0.009548406	0.506065508	0.021086063
4871	hsa-mir-133b	hsa05211	Renal cell carcinoma	2033_3725	2	0.010918691	0.578690629	0.023147625
4872	hsa-mir-133b	hsa05222	Small cell lung cancer	5970_6256	2	0.015182762	0.804686404	0.030949477
4873	hsa-mir-133b	hsa03450	Non-homologous end-joining	2547	1	0.031467625	1	0.061769782
4874	hsa-mir-134	hsa05200	Pathways in cancer	3716_675_1956_5595_5594_5599_5914_1387_6257_6256_5159_595_5156_1488_1487_6258_1399_1398_367_3815_6774_6777_6772_5970_4436_4087_2113_4609_3725_867_2353_6776_4088_4089_5925_8031_2033_8554	38	1.69E-32	1.14E-30	1.14E-30
4875	hsa-mir-134	hsa04630	Jak-STAT signaling pathway	3717_3716_3718_85480_3560_3561_1387_595_3575_5777_6774_6777_6772_3559_2057_5781_4609_867_6776_2690_2033_894_896_8554	24	1.38E-23	9.23E-22	4.62E-22
4876	hsa-mir-134	hsa05220	Chronic myeloid leukemia	5595_5594_595_1488_1487_1399_1398_6777_5970_5781_4609_867_6776_4088_4089_5925_6464	17	1.67E-19	1.12E-17	3.73E-18
4877	hsa-mir-134	hsa05210	Colorectal cancer	1956_5595_5594_5599_5159_595_5156_4436_4087_4609_3725_2353_4088_4089	14	1.22E-14	8.17E-13	2.04E-13
4878	hsa-mir-134	hsa04012	ErbB signaling pathway	1956_5595_6714_5594_5599_2066_1399_1398_6777_4609_3725_867_6776_6464	14	1.88E-14	1.26E-12	2.52E-13
4879	hsa-mir-134	hsa04110	Cell cycle	1387_595_983_7027_4087_10912_8379_4088_4089_4616_993_5925_2033_894_896	15	5.51E-14	3.69E-12	6.15E-13
4880	hsa-mir-134	hsa04310	Wnt signaling pathway	5515_5599_1387_595_1488_1487_4087_4609_3725_1457_4088_4089_2033_894_896_8061	16	1.01E-13	6.76E-12	9.66E-13
4881	hsa-mir-134	hsa04520	Adherens junction	1956_5595_6714_3643_5594_1387_5770_5777_4087_1457_4088_4089_2033	13	1.47E-13	9.87E-12	1.23E-12
4882	hsa-mir-134	hsa05221	Acute myeloid leukemia	5595_5594_5914_595_3815_6774_6777_5970_4609_6776	10	6.96E-11	4.67E-09	5.18E-10
4883	hsa-mir-134	hsa05215	Prostate cancer	1956_5595_5594_1387_5159_595_5156_367_5970_5925_2033	11	1.47E-10	9.87E-09	9.87E-10
4884	hsa-mir-134	hsa05212	Pancreatic cancer	1956_5595_5594_1387_5159_595_5156_367_5970_5925_2033	11	1.64E-10	1.10E-08	1.00E-09
4885	hsa-mir-134	hsa05216	Thyroid cancer	5595_5594_6257_6256_595_6258_4609_8031	8	2.01E-10	1.34E-08	1.12E-09
4886	hsa-mir-134	hsa04510	Focal adhesion	1956_5595_6714_5594_5599_5159_595_5156_1399_1398_3725_894_896_6464	14	8.11E-10	5.44E-08	4.18E-09
4887	hsa-mir-134	hsa04660	T cell receptor signaling pathway	3932_5595_5594_919_5777_1432_5970_3725_867_2353_1493	11	1.30E-09	8.71E-08	6.22E-09
4888	hsa-mir-134	hsa04350	TGF-beta signaling pathway	5515_5595_5594_1387_7027_4087_4609_4088_4089_2033	10	2.16E-09	1.45E-07	9.66E-09
4889	hsa-mir-134	hsa04010	MAPK signaling pathway	1956_5595_5594_5599_5159_5156_1399_1398_1432_5970_10912_4609_3725_2353_4616	15	3.14E-09	2.10E-07	1.31E-08
4890	hsa-mir-134	hsa04062	Chemokine signaling pathway	3717_3718_5595_7852_5594_1399_1398_1234_6774_6777_6772_5970_6464	13	3.66E-09	2.45E-07	1.44E-08
4891	hsa-mir-134	hsa04920	Adipocytokine signaling pathway	3717_10891_5599_6257_6256_6258_6774_5970_5781	9	4.04E-09	2.71E-07	1.50E-08
4892	hsa-mir-134	hsa05211	Renal cell carcinoma	5595_5594_1387_1399_1398_5781_2113_3725_2033	9	7.17E-09	4.81E-07	2.53E-08
4893	hsa-mir-134	hsa05223	Non-small cell lung cancer	1956_5595_5594_6257_6256_595_6258_5925	8	1.51E-08	1.01E-06	5.05E-08
4894	hsa-mir-134	hsa05214	Glioma	1956_5595_5594_5159_595_5156_5925_6464	8	5.60E-08	3.75E-06	1.79E-07
4895	hsa-mir-134	hsa04060	Cytokine-cytokine receptor interaction	85480_1956_7852_3560_3561_5159_5156_3575_1234_3815_3559_2057_2690	13	1.12E-07	7.50E-06	3.41E-07
4896	hsa-mir-134	hsa04910	Insulin signaling pathway	10891_5595_3643_5594_5599_1399_1398_5770_867_6464	10	1.27E-07	8.54E-06	3.71E-07
4897	hsa-mir-134	hsa04662	B cell receptor signaling pathway	695_5595_5594_6850_5777_5970_3725_2353	8	1.54E-07	1.03E-05	4.31E-07
4898	hsa-mir-134	hsa05222	Small cell lung cancer	6257_6256_595_6258_5970_4609_5925_8554	8	4.07E-07	2.73E-05	1.09E-06
4899	hsa-mir-134	hsa05219	Bladder cancer	1956_5595_5594_595_4609_5925	6	1.22E-06	8.18E-05	3.15E-06
4900	hsa-mir-134	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_1432_6772_5970_3725_2353	8	1.36E-06	9.11E-05	3.37E-06
4901	hsa-mir-134	hsa05218	Melanoma	1956_5595_5594_5159_595_5156_5925	7	1.53E-06	0.000102716	3.54E-06
4902	hsa-mir-134	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_5599_1432_5970_5781_3725	7	1.53E-06	0.000102716	3.54E-06
4903	hsa-mir-134	hsa04330	Notch signaling pathway	1387_1488_1487_9612_2033_8850	6	2.22E-06	0.000148561	4.95E-06
4904	hsa-mir-134	hsa04540	Gap junction	1956_5595_6714_5594_5159_983_5156	7	8.13E-06	0.00054463	1.76E-05
4905	hsa-mir-134	hsa05340	Primary immunodeficiency	3718_695_3932_3561_3575	5	9.78E-06	0.000655253	2.05E-05
4906	hsa-mir-134	hsa04650	Natural killer cell mediated cytotoxicity	3932_5595_5594_6850_919_5777_5781_6464	8	1.12E-05	0.000750936	2.28E-05
4907	hsa-mir-134	hsa04115	p53 signaling pathway	595_983_10912_4616_894_896	6	1.71E-05	0.001142664	3.36E-05
4908	hsa-mir-134	hsa04912	GnRH signaling pathway	1956_5595_6714_5594_5599_1432_3725	7	2.03E-05	0.001361246	3.89E-05
4909	hsa-mir-134	hsa04664	Fc epsilon RI signaling pathway	695_5595_5594_5599_6850_1432	6	3.49E-05	0.002338293	6.50E-05
4910	hsa-mir-134	hsa05213	Endometrial cancer	1956_5595_5594_595_4609	5	5.64E-05	0.003776261	0.000102061
4911	hsa-mir-134	hsa04930	Type II diabetes mellitus	5595_3643_5594_5599	4	0.000425514	0.028509425	0.000750248
4912	hsa-mir-134	hsa04916	Melanogenesis	5595_5594_1387_3815_2033	5	0.001163342	0.077943918	0.001998562
4913	hsa-mir-134	hsa04810	Regulation of actin cytoskeleton	1956_5595_5594_5159_5156_1399_1398	7	0.001292657	0.086608015	0.0021652
4914	hsa-mir-134	hsa03320	PPAR signaling pathway	6257_6256_6258_2168	4	0.002009661	0.134647319	0.003284081
4915	hsa-mir-134	hsa04720	Long-term potentiation	5595_5594_1387_2033	4	0.002552215	0.170998383	0.00407139
4916	hsa-mir-134	hsa04370	VEGF signaling pathway	5595_6714_5594_1432	4	0.002794843	0.187254467	0.004354755
4917	hsa-mir-134	hsa04640	Hematopoietic cell lineage	3575_3815_3559_2057	4	0.004247168	0.284560246	0.006467278
4918	hsa-mir-134	hsa05016	Huntington's disease	10891_25942_1387_2033_4724	5	0.013032833	0.873199814	0.01940444
4919	hsa-mir-134	hsa04730	Long-term depression	5515_5595_5594	3	0.01629685	1	0.023736716
4920	hsa-mir-134	hsa03010	Ribosome	6124_6143_6129	3	0.040154192	1	0.057241082
4921	hsa-mir-134	hsa05010	Alzheimer's disease	5595_5594_840_4724	4	0.041960172	1	0.058569407
4922	hsa-mir-134	hsa04020	Calcium signaling pathway	1956_2066_5159_5156	4	0.047080778	1	0.064375757
4923	hsa-mir-135a-2	hsa05200	Pathways in cancer	25_2249_5595_5594_5914_1387_6256_1487_1488_367_7704_6774_6776_6777_5970_6688_3725_2353_4087_4088_4089_5925_2033_207	24	8.50E-24	5.35E-22	5.35E-22
4924	hsa-mir-135a-2	hsa05220	Chronic myeloid leukemia	25_5595_5594_1487_1488_6776_6777_5970_4088_4089_5925_207	12	3.84E-16	2.42E-14	1.21E-14
4925	hsa-mir-135a-2	hsa05221	Acute myeloid leukemia	5595_5594_5914_7704_6774_6776_6777_5970_6688_207	10	7.21E-14	4.54E-12	1.51E-12
4926	hsa-mir-135a-2	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_4086_4087_4088_4089_2033_4093	10	2.45E-12	1.55E-10	3.86E-11
4927	hsa-mir-135a-2	hsa04110	Cell cycle	25_993_1387_983_4087_4088_4089_5925_2033	9	1.02E-09	6.41E-08	1.28E-08
4928	hsa-mir-135a-2	hsa05210	Colorectal cancer	5595_5594_3725_2353_4087_4088_4089_207	8	1.64E-09	1.04E-07	1.73E-08
4929	hsa-mir-135a-2	hsa05215	Prostate cancer	5595_5594_1387_367_5970_5925_2033_207	8	2.31E-09	1.46E-07	1.98E-08
4930	hsa-mir-135a-2	hsa05212	Pancreatic cancer	5595_5594_1387_367_5970_5925_2033_207	8	2.52E-09	1.58E-07	1.98E-08
4931	hsa-mir-135a-2	hsa04520	Adherens junction	5595_5594_1387_4087_4088_4089_2033	7	3.09E-08	1.95E-06	2.16E-07
4932	hsa-mir-135a-2	hsa04330	Notch signaling pathway	1387_1487_1488_9612_2033_8850	6	3.92E-08	2.47E-06	2.47E-07
4933	hsa-mir-135a-2	hsa04012	ErbB signaling pathway	25_5595_5594_6776_6777_3725_207	7	5.30E-08	3.34E-06	3.03E-07
4934	hsa-mir-135a-2	hsa04310	Wnt signaling pathway	1387_1487_1488_3725_4087_4088_4089_2033	8	1.29E-07	8.10E-06	6.75E-07
4935	hsa-mir-135a-2	hsa05211	Renal cell carcinoma	5595_5594_1387_3725_2033_207	6	4.07E-07	2.57E-05	1.97E-06
4936	hsa-mir-135a-2	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725_2353_207	6	5.10E-07	3.21E-05	2.29E-06
4937	hsa-mir-135a-2	hsa04630	Jak-STAT signaling pathway	1387_6774_6776_6777_2033_3977_207	7	2.16E-06	0.000135798	9.05E-06
4938	hsa-mir-135a-2	hsa05223	Non-small cell lung cancer	5595_5594_6256_5925_207	5	2.43E-06	0.000153018	9.56E-06
4939	hsa-mir-135a-2	hsa04620	Toll-like receptor signaling pathway	5595_5594_5970_3725_2353_207	6	2.78E-06	0.000175023	1.03E-05
4940	hsa-mir-135a-2	hsa04660	T cell receptor signaling pathway	5595_5594_5970_3725_2353_207	6	4.21E-06	0.000265116	1.47E-05
4941	hsa-mir-135a-2	hsa05218	Melanoma	2249_5595_5594_5925_207	5	8.54E-06	0.000537758	2.83E-05
4942	hsa-mir-135a-2	hsa04010	MAPK signaling pathway	2249_5595_5594_5970_3725_2353_207	7	7.41E-05	0.004668216	0.000233411
4943	hsa-mir-135a-2	hsa04062	Chemokine signaling pathway	5595_5594_6774_6777_5970_207	6	8.90E-05	0.005604394	0.000266876
4944	hsa-mir-135a-2	hsa05214	Glioma	5595_5594_5925_207	4	0.000117209	0.007384149	0.000335643
4945	hsa-mir-135a-2	hsa04920	Adipocytokine signaling pathway	6256_6774_5970_207	4	0.000131004	0.008253264	0.000358838
4946	hsa-mir-135a-2	hsa04720	Long-term potentiation	5595_5594_1387_2033	4	0.000198131	0.01248224	0.000520093
4947	hsa-mir-135a-2	hsa05216	Thyroid cancer	5595_5594_6256	3	0.00021205	0.013359157	0.000534366
4948	hsa-mir-135a-2	hsa05222	Small cell lung cancer	6256_5970_5925_207	4	0.000326822	0.020589768	0.000791914
4949	hsa-mir-135a-2	hsa05219	Bladder cancer	5595_5594_5925	3	0.00058626	0.036934386	0.00136794
4950	hsa-mir-135a-2	hsa04916	Melanogenesis	5595_5594_1387_2033	4	0.000652122	0.041083675	0.001467274
4951	hsa-mir-135a-2	hsa05213	Endometrial cancer	5595_5594_207	3	0.001055814	0.066516261	0.002217209
4952	hsa-mir-135a-2	hsa04150	mTOR signaling pathway	5595_5594_207	3	0.001055814	0.066516261	0.002217209
4953	hsa-mir-135a-2	hsa04370	VEGF signaling pathway	5595_5594_207	3	0.003097001	0.195111053	0.006293905
4954	hsa-mir-135a-2	hsa04664	Fc epsilon RI signaling pathway	5595_5594_207	3	0.003320851	0.209213617	0.006537926
4955	hsa-mir-135a-2	hsa04950	Maturity onset diabetes of the young	6927_5080	2	0.003987569	0.251216845	0.007612632
4956	hsa-mir-135a-2	hsa04540	Gap junction	5595_5594_983	3	0.005165593	0.325432351	0.009535274
4957	hsa-mir-135a-2	hsa05016	Huntington's disease	1387_6908_6667_2033	4	0.005297374	0.333734584	0.009535274
4958	hsa-mir-135a-2	hsa04510	Focal adhesion	5595_5594_3725_207	4	0.007235797	0.455855227	0.012662645
4959	hsa-mir-135a-2	hsa04912	GnRH signaling pathway	5595_5594_3725	3	0.007712301	0.485874933	0.013131755
4960	hsa-mir-135a-2	hsa03410	Base excision repair	3146_142	2	0.008385287	0.528273063	0.013901923
4961	hsa-mir-135a-2	hsa04930	Type II diabetes mellitus	5595_5594	2	0.012624631	0.795351726	0.020227226
4962	hsa-mir-135a-2	hsa04360	Axon guidance	25_5595_5594	3	0.012842683	0.809089041	0.020227226
4963	hsa-mir-135a-2	hsa04910	Insulin signaling pathway	5595_5594_207	3	0.01471024	0.926745151	0.02260354
4964	hsa-mir-135a-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5970_3725	2	0.028884178	1	0.04231868
4965	hsa-mir-135a-2	hsa04730	Long-term depression	5595_5594	2	0.028884178	1	0.04231868
4966	hsa-mir-135a-2	hsa04612	Antigen processing and presentation	4800_1514	2	0.043167439	1	0.060434414
4967	hsa-mir-135a-2	hsa04210	Apoptosis	5970_207	2	0.043167439	1	0.060434414
4968	hsa-mir-135a-2	hsa04810	Regulation of actin cytoskeleton	2249_5595_5594	3	0.046998685	1	0.064367765
4969	hsa-mir-135b	hsa05200	Pathways in cancer	3066_1499_25_5371_405_2034_2249_9063_5467_5468_5595_5594_5599_5914_1387_6256_595_861_5601_1488_1487_6258_367_1017_2956_1871_51176_4193_6934_7704_842_6776_6772_2885_3065_5970_1870_7157_4824_4087_6688_5604_2113_10401_4089_7849_4609_3725_6774_4286_1029_841_2353_6777_4088_1050_5925_3091_2033_207_836	61	1.62E-47	1.16E-45	1.16E-45
4970	hsa-mir-135b	hsa05220	Chronic myeloid leukemia	3066_25_5595_5594_595_861_1488_1487_1871_4193_6776_2885_3065_5970_1870_7157_5604_4089_4609_1029_6777_4088_5925_207	24	4.38E-24	3.15E-22	1.58E-22
4971	hsa-mir-135b	hsa05221	Acute myeloid leukemia	5371_5467_5595_5594_5914_595_861_51176_6934_7704_6776_2885_5970_6688_5604_4609_6774_6777_1050_207	20	1.08E-20	7.80E-19	2.60E-19
4972	hsa-mir-135b	hsa05215	Prostate cancer	1499_5595_5594_1387_595_367_1017_1871_51176_4193_6934_1385_842_2885_5970_1870_7157_4824_5604_5925_2033_207	22	3.26E-20	2.35E-18	5.79E-19
4973	hsa-mir-135b	hsa05212	Pancreatic cancer	1499_5595_5594_1387_595_367_1017_1871_51176_4193_6934_1385_842_2885_5970_1870_7157_4824_5604_5925_2033_207	22	4.02E-20	2.89E-18	5.79E-19
4974	hsa-mir-135b	hsa05210	Colorectal cancer	1499_5595_5594_5599_595_5601_2956_51176_6934_842_2885_7157_4087_5604_4089_4609_3725_2353_4088_207_836	21	2.37E-19	1.70E-17	2.84E-18
4975	hsa-mir-135b	hsa04010	MAPK signaling pathway	6722_2249_5595_5594_5599_1386_9261_4208_5606_5601_5600_3164_6195_9252_1432_2885_5970_9344_7157_5604_4609_3725_2353_207_836_2002_2005_4773	28	3.37E-16	2.43E-14	3.47E-15
4976	hsa-mir-135b	hsa04310	Wnt signaling pathway	1499_4772_815_5467_5599_1387_595_5601_1488_1487_51176_1457_6934_7157_4087_4089_4609_3725_4088_5527_2033_4773	22	8.87E-16	6.39E-14	7.99E-15
4977	hsa-mir-135b	hsa05216	Thyroid cancer	1499_5468_5595_5594_6256_595_6258_51176_6934_7157_5604_7849_4609	13	3.58E-15	2.58E-13	2.87E-14
4978	hsa-mir-135b	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_6258_1871_842_2885_1870_7157_5604_1029_5925_2309_207	15	9.05E-15	6.51E-13	6.51E-14
4979	hsa-mir-135b	hsa04110	Cell cycle	3066_25_5591_1387_595_5111_1017_1871_4193_3065_5934_1870_7157_4087_4089_1029_4088_5925_2033	19	1.71E-14	1.23E-12	1.12E-13
4980	hsa-mir-135b	hsa05213	Endometrial cancer	1499_5595_5594_595_51176_6934_842_2885_7157_5604_4609_2309_207_2002	14	1.03E-13	7.40E-12	6.17E-13
4981	hsa-mir-135b	hsa04350	TGF-beta signaling pathway	5595_5594_1387_4092_6667_3397_3399_3398_5934_4087_4089_4609_4088_4086_2033_1875	16	3.00E-13	2.16E-11	1.66E-12
4982	hsa-mir-135b	hsa04330	Notch signaling pathway	3066_22938_1387_2648_1488_1487_9794_3065_9612_2033_1840_8850_4851	13	5.90E-13	4.25E-11	3.03E-12
4983	hsa-mir-135b	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5606_5601_5600_3665_3661_1432_6772_5970_5604_3725_841_2353_207	16	2.61E-12	1.88E-10	1.26E-11
4984	hsa-mir-135b	hsa05219	Bladder cancer	5595_5594_595_1871_9252_4193_1870_7157_5604_4609_1029_5925	12	3.36E-12	2.42E-10	1.51E-11
4985	hsa-mir-135b	hsa04012	ErbB signaling pathway	25_815_6714_5595_5594_5599_5601_6776_2885_5604_4609_3725_6777_207_2002	15	3.80E-12	2.74E-10	1.61E-11
4986	hsa-mir-135b	hsa05214	Glioma	815_5595_5594_595_1871_4193_2885_1870_7157_5604_1029_5925_207	13	2.05E-11	1.47E-09	8.18E-11
4987	hsa-mir-135b	hsa05222	Small cell lung cancer	9063_6256_595_6258_1017_1871_842_5970_1870_7157_10401_4609_5925_207	14	3.96E-11	2.85E-09	1.50E-10
4988	hsa-mir-135b	hsa05218	Melanoma	2249_5595_5594_595_1871_4193_1870_7157_5604_4286_1029_5925_207	13	5.42E-11	3.90E-09	1.95E-10
4989	hsa-mir-135b	hsa04912	GnRH signaling pathway	5580_815_6714_5595_5594_5599_5606_5601_5600_1432_2885_5604_3725_2002	14	5.95E-10	4.29E-08	2.04E-09
4990	hsa-mir-135b	hsa05211	Renal cell carcinoma	405_2034_5595_5594_1387_2885_5604_2113_3725_3091_2033_207	12	7.84E-10	5.64E-08	2.56E-09
4991	hsa-mir-135b	hsa05322	Systemic lupus erythematosus	3020_8363_8365_3021_8359_8362_8294_8368_8370_121504_8361_8360_8364_8367_8366	15	2.29E-09	1.65E-07	6.89E-09
4992	hsa-mir-135b	hsa04520	Adherens junction	1499_6714_5595_5594_1387_51176_1457_6934_4087_4089_4088_2033	12	2.30E-09	1.65E-07	6.89E-09
4993	hsa-mir-135b	hsa04660	T cell receptor signaling pathway	4772_5595_5594_5601_5600_1432_2885_5970_5604_3725_2353_207_4773	13	6.79E-09	4.89E-07	1.96E-08
4994	hsa-mir-135b	hsa04370	VEGF signaling pathway	4772_6714_5595_5594_9261_5600_1432_842_5604_207_4773	11	1.70E-08	1.22E-06	4.70E-08
4995	hsa-mir-135b	hsa04664	Fc epsilon RI signaling pathway	5580_5595_5594_5599_5606_5601_5600_1432_2885_5604_207	11	2.16E-08	1.55E-06	5.75E-08
4996	hsa-mir-135b	hsa04630	Jak-STAT signaling pathway	9063_1387_595_6776_6772_2885_10401_4609_6774_6777_2033_3977_207_6778	14	4.14E-08	2.98E-06	1.06E-07
4997	hsa-mir-135b	hsa04115	p53 signaling pathway	595_1017_4194_4193_842_7157_7161_1029_841_836	10	6.75E-08	4.86E-06	1.68E-07
4998	hsa-mir-135b	hsa04662	B cell receptor signaling pathway	4772_5595_5594_2885_5970_5604_3725_2353_207_4773	10	1.37E-07	9.87E-06	3.29E-07
4999	hsa-mir-135b	hsa04916	Melanogenesis	1499_815_5595_5594_1387_51176_6934_1385_5604_4286_2033	11	2.77E-07	2.00E-05	6.44E-07
5000	hsa-mir-135b	hsa04920	Adipocytokine signaling pathway	10891_5599_6256_5601_6258_5970_6774_207_5465	9	5.51E-07	3.97E-05	1.24E-06
5001	hsa-mir-135b	hsa03410	Base excision repair	6996_252969_5111_4350_328_142_2237	7	1.14E-06	8.19E-05	2.48E-06
5002	hsa-mir-135b	hsa05016	Huntington's disease	3066_10891_5468_1387_6908_6667_1385_842_3065_7157_841_2033_836	13	2.13E-06	0.000153701	4.52E-06
5003	hsa-mir-135b	hsa03450	Non-homologous end-joining	10111_5591_2547_4361_2237	5	3.32E-06	0.000238946	6.83E-06
5004	hsa-mir-135b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_5599_5601_5600_1432_5970_3725_836	8	7.78E-06	0.000560206	1.56E-05
5005	hsa-mir-135b	hsa04910	Insulin signaling pathway	10891_5595_5594_6720_5599_5601_2885_5604_207_2002	10	2.19E-05	0.001577572	4.26E-05
5006	hsa-mir-135b	hsa04510	Focal adhesion	1499_6714_5595_5594_5599_595_5601_2885_5604_3725_207_2002	12	2.65E-05	0.001911152	5.03E-05
5007	hsa-mir-135b	hsa04210	Apoptosis	839_842_840_5970_7157_841_207_836	8	3.53E-05	0.002542578	6.52E-05
5008	hsa-mir-135b	hsa04062	Chemokine signaling pathway	5580_5595_5594_6772_2885_5970_5604_6774_6777_2309_207	11	6.89E-05	0.004960346	0.000124009
5009	hsa-mir-135b	hsa04720	Long-term potentiation	815_5595_5594_1387_6195_5604_2033	7	8.75E-05	0.006303456	0.000153743
5010	hsa-mir-135b	hsa05014	Amyotrophic lateral sclerosis (ALS)	5606_5600_1432_842_7157_836	6	0.000140217	0.010095654	0.000240373
5011	hsa-mir-135b	hsa04930	Type II diabetes mellitus	5580_5595_5594_5599_5601	5	0.000437073	0.031469282	0.000731844
5012	hsa-mir-135b	hsa04150	mTOR signaling pathway	5595_5594_6195_3091_207	5	0.000803035	0.057818514	0.001314057
5013	hsa-mir-135b	hsa03022	Basal transcription factors	2962_2969_6908_2959	4	0.001825017	0.131401189	0.002920026
5014	hsa-mir-135b	hsa04650	Natural killer cell mediated cytotoxicity	4772_5595_5594_2885_5604_836_4773	7	0.002685729	0.193372485	0.004100724
5015	hsa-mir-135b	hsa05010	Alzheimer's disease	22926_5595_5594_842_840_841_6622_836	8	0.002712753	0.195318238	0.004100724
5016	hsa-mir-135b	hsa03320	PPAR signaling pathway	5467_5468_6256_6258_5465	5	0.002746509	0.197748679	0.004100724
5017	hsa-mir-135b	hsa04120	Ubiquitin mediated proteolysis	5371_9063_672_4193_10401_7329_8925	7	0.00279077	0.200935453	0.004100724
5018	hsa-mir-135b	hsa04950	Maturity onset diabetes of the young	5080_6927_4760	3	0.004812662	0.346511676	0.006930234
5019	hsa-mir-135b	hsa05217	Basal cell carcinoma	1499_51176_6934_7157	4	0.006854992	0.493559426	0.009677636
5020	hsa-mir-135b	hsa03440	Homologous recombination	10111_4361_4683	3	0.007123115	0.512864299	0.009862775
5021	hsa-mir-135b	hsa04540	Gap junction	6714_5595_5594_2885_5604	5	0.008527514	0.61398103	0.011584548
5022	hsa-mir-135b	hsa04270	Vascular smooth muscle contraction	5580_5595_5594_59_5604	5	0.021019116	1	0.028025488
5023	hsa-mir-135b	hsa03420	Nucleotide excision repair	4331_5111_5886	3	0.022131914	1	0.028972688
5024	hsa-mir-135b	hsa04360	Axon guidance	25_4772_5595_5594_4773	5	0.030690163	1	0.039458781
5025	hsa-mir-135b	hsa04530	Tight junction	1499_5580_6714_1457_207	5	0.035958792	1	0.045421631
5026	hsa-mir-135b	hsa03430	Mismatch repair	5111_2956	2	0.040207958	1	0.049913327
5027	hsa-mir-136	hsa05200	Pathways in cancer	4149_7046_596_598_1017_4193_7704_5578_6502_3091_3066_3065_1050_5925_613_5743_5747_25_6789_4436_1870_1871_2113_5894_207_1147_998_5595_5594_5599_1387_2932_6774_6772_5970_7157_6688_1869_3725_2736_4087_4088_4089_5888_5728_2033_3910_4792_3320_3326_5371_675_5604_5601_5602_1856_4292_51588_4609_1026_1029_2353_8554	63	2.30E-42	1.95E-40	1.95E-40
5028	hsa-mir-136	hsa04110	Cell cycle	1017_4193_902_6502_6500_3066_3065_990_5925_25_1870_1871_9232_5933_545_995_5347_5591_1387_11200_7534_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_1031_983_8454_1026_1022_1029_1111_8556_8555_472	41	1.35E-36	1.15E-34	5.73E-35
5029	hsa-mir-136	hsa05220	Chronic myeloid leukemia	7046_598_4193_3066_3065_5925_613_25_1870_1871_5894_207_1147_5595_5594_5970_7157_1869_4088_4089_4792_5604_4609_1026_1029	25	1.76E-22	1.50E-20	4.99E-21
5030	hsa-mir-136	hsa04010	MAPK signaling pathway	6722_4149_7046_6195_6197_9252_5578_5923_3304_3305_3303_6789_1432_5894_1616_207_1147_998_5595_5594_5599_5598_8986_1386_3315_1649_5970_3164_7157_3725_6196_9261_5604_5601_5602_4609_2353	37	9.99E-21	8.49E-19	2.12E-19
5031	hsa-mir-136	hsa05215	Prostate cancer	596_1017_4193_5925_1870_1871_5894_207_1147_5595_5594_1385_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_5604_1026	24	6.37E-20	5.41E-18	1.08E-18
5032	hsa-mir-136	hsa05212	Pancreatic cancer	596_1017_4193_5925_1870_1871_5894_207_1147_5595_5594_1385_1387_2932_5970_7157_1869_5728_2033_4792_3320_3326_5604_1026	24	7.96E-20	6.76E-18	1.13E-18
5033	hsa-mir-136	hsa04115	p53 signaling pathway	1017_4194_4193_50484_6241_51246_545_7161_11200_7157_900_64326_5728_27113_25898_983_1026_1029_1111_472	20	2.95E-17	2.51E-15	3.58E-16
5034	hsa-mir-136	hsa05210	Colorectal cancer	7046_596_4436_5894_207_5595_5594_5599_2932_7157_3725_4087_4088_4089_5604_5601_5602_1856_4292_4609_2353	21	6.07E-17	5.16E-15	6.45E-16
5035	hsa-mir-136	hsa05222	Small cell lung cancer	4149_596_598_1017_6502_5925_5743_5747_1870_1871_207_1147_5970_7157_1869_5728_3910_4792_51588_4609_8554	21	9.14E-17	7.77E-15	8.63E-16
5036	hsa-mir-136	hsa04310	Wnt signaling pathway	5578_6500_1460_5599_1387_2932_7157_3725_1457_1452_1459_4087_4088_4089_8061_2033_5518_5515_5601_5602_1856_8454_4609_5527	24	3.35E-15	2.85E-13	2.85E-14
5037	hsa-mir-136	hsa05219	Bladder cancer	9252_4193_5925_1870_1871_5894_5595_5594_7157_1869_5604_4609_1026_1029	14	3.59E-13	3.05E-11	2.77E-12
5038	hsa-mir-136	hsa05214	Glioma	4193_5578_5925_1870_1871_5894_207_5595_5594_7157_1869_5728_5604_1026_1029	15	4.69E-12	3.99E-10	3.32E-11
5039	hsa-mir-136	hsa04350	TGF-beta signaling pathway	7046_6500_6667_5933_5595_5594_1387_7027_4087_4088_4089_2033_5518_5515_8454_4609	16	1.84E-11	1.56E-09	1.20E-10
5040	hsa-mir-136	hsa05223	Non-small cell lung cancer	5578_5925_6789_1870_1871_5894_207_5595_5594_7157_1869_5604_1029	13	7.99E-11	6.79E-09	4.85E-10
5041	hsa-mir-136	hsa05218	Melanoma	4193_5925_1870_1871_5894_207_5595_5594_7157_1869_5728_5604_1026_1029	14	1.50E-10	1.28E-08	8.53E-10
5042	hsa-mir-136	hsa04012	ErbB signaling pathway	5578_5747_25_5894_207_5595_5594_5599_2932_3725_5604_5601_5602_4609_1026	15	1.76E-10	1.50E-08	9.20E-10
5043	hsa-mir-136	hsa04120	Ubiquitin mediated proteolysis	55294_4193_6502_6500_3093_7319_84447_7329_10055_64326_7337_5371_672_25898_8454_51588_10075_8554	18	1.84E-10	1.56E-08	9.20E-10
5044	hsa-mir-136	hsa05221	Acute myeloid leukemia	7704_1050_5894_207_1147_5595_5594_6774_5970_6688_5371_5604_4609	13	2.07E-10	1.76E-08	9.77E-10
5045	hsa-mir-136	hsa04520	Adherens junction	7046_4301_1460_998_5595_5594_1387_1457_1459_4087_4088_4089_2033_71	14	6.01E-10	5.11E-08	2.69E-09
5046	hsa-mir-136	hsa04660	T cell receptor signaling pathway	1432_5894_207_1147_998_5595_5594_2932_5970_3725_959_4792_5604_5601_2353	15	3.21E-09	2.73E-07	1.37E-08
5047	hsa-mir-136	hsa04540	Gap junction	5578_51807_5894_5592_5595_5594_5598_7846_1453_983_5604_7277_7278_10376	14	3.44E-09	2.92E-07	1.39E-08
5048	hsa-mir-136	hsa04620	Toll-like receptor signaling pathway	1432_207_1147_5595_5594_5599_6772_5970_3725_4792_5604_5601_5602_2353	14	9.98E-09	8.48E-07	3.79E-08
5049	hsa-mir-136	hsa04510	Focal adhesion	596_5578_5923_5747_5499_5894_207_998_5595_5594_5599_2932_3725_5728_3910_5604_5601_5602_71	19	1.02E-08	8.71E-07	3.79E-08
5050	hsa-mir-136	hsa05131	Shigellosis	5578_51807_25_998_7534_7846_7277_7278_71_4691_10376	11	1.47E-08	1.25E-06	5.00E-08
5051	hsa-mir-136	hsa05130	Pathogenic Escherichia coli infection	5578_51807_25_998_7534_7846_7277_7278_71_4691_10376	11	1.47E-08	1.25E-06	5.00E-08
5052	hsa-mir-136	hsa04662	B cell receptor signaling pathway	5894_207_1147_5595_5594_1380_2932_5970_3725_4792_5604_2353	12	2.49E-08	2.11E-06	8.13E-08
5053	hsa-mir-136	hsa04370	VEGF signaling pathway	5578_5743_5747_1432_5894_207_998_5595_5594_3315_9261_5604	12	3.23E-08	2.74E-06	1.02E-07
5054	hsa-mir-136	hsa03022	Basal transcription factors	51616_2965_2963_2962_2969_6908_2958_6880_2957	9	6.24E-08	5.31E-06	1.90E-07
5055	hsa-mir-136	hsa05213	Endometrial cancer	5894_207_5595_5594_2932_7157_5728_5604_4292_4609	10	7.98E-08	6.79E-06	2.34E-07
5056	hsa-mir-136	hsa05211	Renal cell carcinoma	3091_2113_5894_207_998_5595_5594_1387_3725_2033_5604	11	1.45E-07	1.23E-05	4.11E-07
5057	hsa-mir-136	hsa04720	Long-term potentiation	6195_6197_5578_5499_5894_5595_5594_1387_6196_2033_5604	11	2.10E-07	1.79E-05	5.76E-07
5058	hsa-mir-136	hsa04920	Adipocytokine signaling pathway	6794_207_1147_5599_6774_5970_4792_5601_5602_5563	10	6.51E-07	5.53E-05	1.73E-06
5059	hsa-mir-136	hsa04150	mTOR signaling pathway	6794_6195_6197_3091_207_5595_5594_6196_5563	9	7.86E-07	6.68E-05	2.03E-06
5060	hsa-mir-136	hsa04912	GnRH signaling pathway	5578_1432_5894_998_5595_5594_5599_5598_3725_5604_5601_5602	12	8.96E-07	7.62E-05	2.24E-06
5061	hsa-mir-136	hsa04664	Fc epsilon RI signaling pathway	5578_1432_5894_207_5595_5594_5599_5604_5601_5602	10	2.52E-06	0.000214215	6.12E-06
5062	hsa-mir-136	hsa04062	Chemokine signaling pathway	7074_5747_6362_5894_207_1147_998_5595_5594_2932_6774_6772_5970_4792_5604	15	2.68E-06	0.000227581	6.32E-06
5063	hsa-mir-136	hsa04330	Notch signaling pathway	3066_3065_1387_2033_8850_1856_2648_4851	8	3.63E-06	0.000308306	8.33E-06
5064	hsa-mir-136	hsa04612	Antigen processing and presentation	3308_3309_3304_3305_3303_1385_3320_3326_4801_4802	10	6.65E-06	0.000565245	1.49E-05
5065	hsa-mir-136	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_1147_998_5599_5970_3725_4792_5601_5602	9	7.93E-06	0.000674211	1.73E-05
5066	hsa-mir-136	hsa04530	Tight junction	5578_207_4301_1460_998_1457_1459_5728_5518_5515_71_5520	12	8.70E-06	0.000739681	1.85E-05
5067	hsa-mir-136	hsa04910	Insulin signaling pathway	6720_5499_5894_207_5595_5594_5599_2932_5604_5601_5602_5563	12	9.32E-06	0.00079196	1.93E-05
5068	hsa-mir-136	hsa03420	Nucleotide excision repair	902_2965_4331_2071_2074_1022_6117	7	2.20E-05	0.001868541	4.45E-05
5069	hsa-mir-136	hsa04916	Melanogenesis	5578_5894_5595_5594_1385_1387_2932_2033_5604_1856	10	2.32E-05	0.00197436	4.59E-05
5070	hsa-mir-136	hsa04210	Apoptosis	596_598_823_207_1147_5970_7157_4792_472	9	4.12E-05	0.003505977	7.97E-05
5071	hsa-mir-136	hsa04730	Long-term depression	5578_5894_5592_5595_5594_5518_5515_5604	8	5.47E-05	0.004648206	0.000103293
5072	hsa-mir-136	hsa04930	Type II diabetes mellitus	3651_5595_5594_5599_5601_5602	6	0.0002059	0.017501497	0.000380467
5073	hsa-mir-136	hsa05216	Thyroid cancer	5595_5594_7157_5604_4609	5	0.000242875	0.020644361	0.000439242
5074	hsa-mir-136	hsa05016	Huntington's disease	3066_3065_3064_25942_6667_1385_1387_7157_2033_27113_6908	11	0.000579082	0.049221958	0.001025457
5075	hsa-mir-136	hsa04630	Jak-STAT signaling pathway	598_207_1387_6774_6772_2033_51588_4609_8554	9	0.001881212	0.15990304	0.003263327
5076	hsa-mir-136	hsa03440	Homologous recombination	641_5888_675_6117	4	0.00194153	0.165030064	0.003300601
5077	hsa-mir-136	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_598_1432_1616_7157	5	0.003586098	0.30481832	0.00597683
5078	hsa-mir-136	hsa03410	Base excision repair	3146_142_4913_328	4	0.004440786	0.377466849	0.007258978
5079	hsa-mir-136	hsa04270	Vascular smooth muscle contraction	5578_5499_5894_5592_5595_5594_5604	7	0.005248979	0.446163202	0.008418174
5080	hsa-mir-136	hsa04360	Axon guidance	5747_25_998_5595_5594_2932_1020	7	0.008874196	0.754306646	0.013968642
5081	hsa-mir-136	hsa03430	Mismatch repair	4436_4292_6117	3	0.00916756	0.779242627	0.014168048
5082	hsa-mir-136	hsa04810	Regulation of actin cytoskeleton	7074_5747_5499_5894_998_5595_5594_5604_71	9	0.015379823	1	0.023344374
5083	hsa-mir-136	hsa05217	Basal cell carcinoma	2932_7157_2736_1856	4	0.017254881	1	0.025730963
5084	hsa-mir-136	hsa04340	Hedgehog signaling pathway	2932_1452_1453_2736	4	0.019277966	1	0.028252191
5085	hsa-mir-136	hsa04670	Leukocyte transendothelial migration	5578_5747_1432_4301_998_71	6	0.021187854	1	0.030524875
5086	hsa-mir-136	hsa04740	Olfactory transduction	5592	1	0.025061796	1	0.035504211
5087	hsa-mir-136	hsa03030	DNA replication	5557_6117_5422	3	0.027470092	1	0.038277996
5088	hsa-mir-136	hsa03450	Non-homologous end-joining	2547_5591	2	0.028868931	1	0.039578372
5089	hsa-mir-137	hsa05200	Pathways in cancer	3725_5371_7046_367_1499_5595_5594_5914_6256_595_1488_836_1487_2932_5599_1387_51588_3091_5970_7428_1870_1871_7157_4087_2113_7704_4609_1869_2353_3065_4088_4089_3066_1050_5925_2034_2033_4846_207_208_5601_7189_7186	43	1.36E-31	9.82E-30	9.82E-30
5090	hsa-mir-137	hsa05220	Chronic myeloid leukemia	7046_5595_5594_595_1488_1487_5970_1870_1871_7157_4609_1869_3065_4088_4089_3066_5925_207_208_6464	20	1.20E-20	8.64E-19	4.32E-19
5091	hsa-mir-137	hsa04010	MAPK signaling pathway	6722_3725_3727_7046_5595_5594_1386_4208_5600_3303_836_9252_5599_1432_1649_5970_3312_7157_468_4609_2353_4763_5058_207_208_5601_5603_8550_7189_7186	30	1.95E-20	1.40E-18	4.68E-19
5092	hsa-mir-137	hsa04110	Cell cycle	993_5591_595_983_896_894_7534_2932_1387_1870_1871_7157_4087_1869_3065_4088_4089_7532_3066_5925_2033_5933	22	1.36E-19	9.76E-18	2.44E-18
5093	hsa-mir-137	hsa05210	Colorectal cancer	3725_7046_1499_5595_5594_595_836_2932_5599_7157_4087_4609_2353_4088_4089_207_208_5601	18	2.98E-17	2.15E-15	4.30E-16
5094	hsa-mir-137	hsa05215	Prostate cancer	367_1499_5595_5594_595_2932_1387_5970_1870_1871_7157_468_9586_1869_5925_2033_207_208	18	6.12E-17	4.41E-15	7.34E-16
5095	hsa-mir-137	hsa05212	Pancreatic cancer	367_1499_5595_5594_595_2932_1387_5970_1870_1871_7157_468_9586_1869_5925_2033_207_208	18	7.29E-17	5.25E-15	7.50E-16
5096	hsa-mir-137	hsa04620	Toll-like receptor signaling pathway	3725_3654_5595_5594_5600_3661_353376_148022_5599_1432_5970_2353_4615_207_208_5601_5603_7189	18	6.04E-16	4.35E-14	5.43E-15
5097	hsa-mir-137	hsa04310	Wnt signaling pathway	3725_1499_595_1488_896_894_1487_2932_5599_1387_7157_4087_8061_4609_1459_4088_4089_2033_5601_1457	20	2.27E-15	1.63E-13	1.82E-14
5098	hsa-mir-137	hsa05222	Small cell lung cancer	6256_595_51588_5970_1870_1871_7157_4609_1869_5925_4846_207_208_7189_7186	15	1.94E-13	1.40E-11	1.40E-12
5099	hsa-mir-137	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_7157_1869_5925_207_208	11	7.69E-11	5.54E-09	4.98E-10
5100	hsa-mir-137	hsa05211	Renal cell carcinoma	3725_5595_5594_1387_3091_7428_2113_5058_2034_2033_207_208	12	8.30E-11	5.97E-09	4.98E-10
5101	hsa-mir-137	hsa05219	Bladder cancer	5595_5594_595_9252_1870_1871_7157_4609_1869_5925	10	1.50E-10	1.08E-08	8.30E-10
5102	hsa-mir-137	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_5970_7704_4609_1050_207_208	11	1.78E-10	1.28E-08	9.13E-10
5103	hsa-mir-137	hsa04520	Adherens junction	7046_1499_6714_5595_5594_1387_4087_1459_4088_4089_2033_1457	12	2.47E-10	1.78E-08	1.19E-09
5104	hsa-mir-137	hsa05214	Glioma	5595_5594_595_1870_1871_7157_1869_5925_207_208_6464	11	4.44E-10	3.20E-08	2.00E-09
5105	hsa-mir-137	hsa04012	ErbB signaling pathway	3725_6714_5595_5594_2932_5599_4609_5058_207_208_5601_6464	12	5.90E-10	4.25E-08	2.50E-09
5106	hsa-mir-137	hsa04660	T cell receptor signaling pathway	3725_5595_5594_5600_2932_1432_5970_2353_5058_207_208_5601_5603	13	6.36E-10	4.58E-08	2.55E-09
5107	hsa-mir-137	hsa04330	Notch signaling pathway	1488_1487_1387_9612_3065_3066_2033_2648_8850	9	6.75E-09	4.86E-07	2.55E-08
5108	hsa-mir-137	hsa04350	TGF-beta signaling pathway	7046_5595_5594_1387_4087_658_4609_4088_4089_2033_5933	11	7.08E-09	5.10E-07	2.55E-08
5109	hsa-mir-137	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5925_207_208	10	1.36E-08	9.80E-07	4.42E-08
5110	hsa-mir-137	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_6714_5600_836_5599_1432_5970_5058_5601_5603	10	1.36E-08	9.80E-07	4.42E-08
5111	hsa-mir-137	hsa04510	Focal adhesion	3725_1499_6714_5595_5594_595_896_894_2932_5599_5058_207_208_5601_6464	15	1.46E-08	1.05E-06	4.42E-08
5112	hsa-mir-137	hsa05213	Endometrial cancer	1499_5595_5594_595_2932_7157_4609_207_208	9	1.47E-08	1.06E-06	4.42E-08
5113	hsa-mir-137	hsa05216	Thyroid cancer	1499_5595_5594_6256_595_7157_4609	7	8.41E-08	6.05E-06	2.42E-07
5114	hsa-mir-137	hsa04370	VEGF signaling pathway	6714_5595_5594_5600_1432_4846_207_208_5603	9	3.11E-07	2.24E-05	8.61E-07
5115	hsa-mir-137	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5600_5599_1432_207_208_5601_5603	9	3.79E-07	2.73E-05	1.01E-06
5116	hsa-mir-137	hsa04912	GnRH signaling pathway	3725_6714_5595_5594_5600_5599_1432_468_5601_5603	10	5.02E-07	3.61E-05	1.29E-06
5117	hsa-mir-137	hsa04920	Adipocytokine signaling pathway	6256_5599_5970_207_208_5601_2538_7186	8	1.23E-06	8.85E-05	3.05E-06
5118	hsa-mir-137	hsa05016	Huntington's disease	6874_25942_2902_836_1387_7157_9586_3065_10476_3066_3064_2033	12	1.52E-06	0.000109459	3.65E-06
5119	hsa-mir-137	hsa04662	B cell receptor signaling pathway	3725_5595_5594_2932_5970_2353_207_208	8	2.67E-06	0.000192527	6.21E-06
5120	hsa-mir-137	hsa04910	Insulin signaling pathway	5595_5594_6720_2932_5599_207_208_5601_6464_2538	10	3.98E-06	0.000286295	8.95E-06
5121	hsa-mir-137	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_5600_836_1432_7157_4846_5603	7	4.37E-06	0.000314899	9.54E-06
5122	hsa-mir-137	hsa04210	Apoptosis	3654_836_5970_7157_4615_207_208_7186	8	8.63E-06	0.000621356	1.83E-05
5123	hsa-mir-137	hsa04630	Jak-STAT signaling pathway	595_896_894_1387_51588_4609_2033_207_208	9	6.27E-05	0.004513395	0.000128954
5124	hsa-mir-137	hsa04115	p53 signaling pathway	595_983_836_896_894_7157	6	0.000139277	0.010027943	0.000278554
5125	hsa-mir-137	hsa04530	Tight junction	1499_6714_4628_60412_1459_207_208_1457	8	0.000154113	0.011096147	0.000299896
5126	hsa-mir-137	hsa04930	Type II diabetes mellitus	3651_5595_5594_5599_5601	5	0.000177048	0.012747437	0.000335459
5127	hsa-mir-137	hsa04720	Long-term potentiation	5595_5594_2902_1387_468_2033	6	0.000212992	0.015335453	0.000393217
5128	hsa-mir-137	hsa04150	mTOR signaling pathway	5595_5594_3091_207_208	5	0.000329567	0.023728793	0.00059322
5129	hsa-mir-137	hsa04916	Melanogenesis	1499_5595_5594_2932_1387_2033	6	0.001091424	0.07858251	0.001916647
5130	hsa-mir-137	hsa04062	Chemokine signaling pathway	5595_5594_2932_5970_5058_207_208_6464	8	0.001343285	0.096716488	0.002302774
5131	hsa-mir-137	hsa04950	Maturity onset diabetes of the young	3651_5080_3172	3	0.002774397	0.199756619	0.004645503
5132	hsa-mir-137	hsa04612	Antigen processing and presentation	3303_4800_1514_3312_4801	5	0.003154831	0.227147852	0.005162451
5133	hsa-mir-137	hsa05010	Alzheimer's disease	5595_5594_2902_836_2932_10476_4846	7	0.003406939	0.245299624	0.005451103
5134	hsa-mir-137	hsa04120	Ubiquitin mediated proteolysis	5371_672_51588_7428_7329_7189	6	0.004373094	0.314862772	0.006844843
5135	hsa-mir-137	hsa04710	Circadian rhythm - mammal	8863_406	2	0.010522564	0.757624624	0.016119673
5136	hsa-mir-137	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_5058_6464	5	0.017682648	1	0.026523971
5137	hsa-mir-137	hsa04540	Gap junction	6714_5595_5594_983	4	0.019216217	1	0.028236075
5138	hsa-mir-137	hsa05217	Basal cell carcinoma	1499_2932_7157	3	0.023077179	1	0.033231138
5139	hsa-mir-137	hsa04730	Long-term depression	5595_5594_4846	3	0.042955021	1	0.060642383
5140	hsa-mir-137	hsa04670	Leukocyte transendothelial migration	1499_5600_1432_5603	4	0.044015821	1	0.060944983
5141	hsa-mir-139	hsa05200	Pathways in cancer	3320_1869_4149_5371_4292_1499_5595_5594_5599_861_5914_1387_6256_595_2308_836_1019_367_1017_2932_7704_3091_5970_7428_1870_1871_7157_6688_2113_5894_4609_3725_1026_5604_1029_6502_2353_4087_4088_4089_3066_3065_1050_5925_2034_2033_4846_5601_8554_4286	50	1.80E-39	1.35E-37	1.35E-37
5142	hsa-mir-139	hsa04110	Cell cycle	1869_990_5591_1387_595_983_1019_1017_2932_8454_7027_6500_1870_1871_7157_1026_1029_6502_4087_4088_4089_3066_3065_5925_2033_891_5933	27	8.19E-26	6.14E-24	3.07E-24
5143	hsa-mir-139	hsa05215	Prostate cancer	3320_1869_1499_5595_5594_1387_595_2308_367_1017_2932_5970_1870_1871_7157_468_5894_1026_5604_5925_2033_90993	22	4.88E-22	3.66E-20	9.05E-21
5144	hsa-mir-139	hsa05220	Chronic myeloid leukemia	1869_5595_5594_861_595_1019_5970_1870_1871_7157_5894_4609_1026_5604_1029_4088_4089_3066_3065_5925_6464	21	5.76E-22	4.32E-20	9.05E-21
5145	hsa-mir-139	hsa05212	Pancreatic cancer	3320_1869_1499_5595_5594_1387_595_2308_367_1017_2932_5970_1870_1871_7157_468_5894_1026_5604_5925_2033_90993	22	6.03E-22	4.53E-20	9.05E-21
5146	hsa-mir-139	hsa05210	Colorectal cancer	4292_1499_5595_5594_5599_595_836_2932_7157_5894_4609_3725_5604_2353_4087_4088_4089_5601	18	3.15E-17	2.36E-15	3.94E-16
5147	hsa-mir-139	hsa05219	Bladder cancer	1869_5595_5594_595_1019_1870_1871_7157_5894_4609_1026_5604_1029_5925	14	5.98E-16	4.48E-14	6.40E-15
5148	hsa-mir-139	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_8454_7027_3399_3398_6500_1874_4609_4087_4088_4089_2033_5933	16	1.52E-14	1.14E-12	1.43E-13
5149	hsa-mir-139	hsa05214	Glioma	1869_5595_5594_595_1019_1870_1871_7157_5894_1026_5604_1029_5925_6464	14	1.03E-13	7.73E-12	8.59E-13
5150	hsa-mir-139	hsa04010	MAPK signaling pathway	3727_4149_5595_5594_5599_5598_4208_836_1386_1432_1649_5970_3312_7157_468_5894_4609_3725_5604_2353_4763_1616_5601	23	1.22E-13	9.17E-12	9.17E-13
5151	hsa-mir-139	hsa05222	Small cell lung cancer	1869_4149_6256_595_1019_1017_5970_1870_1871_7157_4609_6502_5925_4846_8554	15	2.03E-13	1.52E-11	1.39E-12
5152	hsa-mir-139	hsa05223	Non-small cell lung cancer	1869_5595_5594_6256_595_1019_1870_1871_7157_5894_5604_1029_5925	13	2.31E-13	1.73E-11	1.45E-12
5153	hsa-mir-139	hsa05218	Melanoma	1869_5595_5594_595_1019_1870_1871_7157_5894_1026_5604_1029_5925_4286	14	2.98E-13	2.23E-11	1.69E-12
5154	hsa-mir-139	hsa04310	Wnt signaling pathway	1499_5599_1387_595_2932_8454_6500_7157_8061_4609_3725_1457_1459_4087_4088_4089_2033_5601	18	3.16E-13	2.37E-11	1.69E-12
5155	hsa-mir-139	hsa05221	Acute myeloid leukemia	5371_5595_5594_861_5914_595_7704_5970_6688_5894_4609_5604_1050	13	6.17E-13	4.62E-11	3.08E-12
5156	hsa-mir-139	hsa04115	p53 signaling pathway	7161_595_983_836_1019_1017_7157_1026_1029_64326_891	11	8.09E-10	6.07E-08	3.79E-09
5157	hsa-mir-139	hsa05213	Endometrial cancer	4292_1499_5595_5594_595_2932_7157_5894_4609_5604	10	9.57E-10	7.18E-08	4.22E-09
5158	hsa-mir-139	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_7428_2113_5894_3725_5604_2034_2033	11	1.21E-09	9.09E-08	5.05E-09
5159	hsa-mir-139	hsa05216	Thyroid cancer	1499_5595_5594_6256_595_7157_4609_5604	8	4.07E-09	3.06E-07	1.61E-08
5160	hsa-mir-139	hsa04012	ErbB signaling pathway	5595_5594_5599_2932_5894_4609_3725_1026_5604_5601_6464	11	7.32E-09	5.49E-07	2.74E-08
5161	hsa-mir-139	hsa04540	Gap junction	5595_5594_5598_983_7277_7278_5894_7846_5604_51807_10376	11	1.38E-08	1.03E-06	4.92E-08
5162	hsa-mir-139	hsa05016	Huntington's disease	10891_1387_2902_6908_6874_836_6667_1537_7157_3066_3065_3064_2033_90993	14	3.54E-08	2.66E-06	1.21E-07
5163	hsa-mir-139	hsa04520	Adherens junction	1499_5595_5594_1387_1457_1459_4087_4088_4089_2033	10	3.93E-08	2.95E-06	1.28E-07
5164	hsa-mir-139	hsa04660	T cell receptor signaling pathway	5595_5594_1019_2932_1432_5970_5894_3725_5604_2353_5601	11	6.73E-08	5.05E-06	2.10E-07
5165	hsa-mir-139	hsa04910	Insulin signaling pathway	6720_10891_5595_5594_5599_2308_5563_2932_5894_5604_5601_6464	12	7.07E-08	5.30E-06	2.12E-07
5166	hsa-mir-139	hsa04120	Ubiquitin mediated proteolysis	7325_11059_5371_672_4734_8454_55294_6500_7428_6502_64326_8554	12	7.61E-08	5.71E-06	2.20E-07
5167	hsa-mir-139	hsa04916	Melanogenesis	1499_5595_5594_1387_2932_5894_5604_2033_4286_90993	10	3.74E-07	2.81E-05	1.04E-06
5168	hsa-mir-139	hsa04912	GnRH signaling pathway	5595_5594_5599_5598_1432_468_5894_3725_5604_5601	10	5.16E-07	3.87E-05	1.38E-06
5169	hsa-mir-139	hsa04720	Long-term potentiation	5595_5594_1387_2902_468_5894_5604_2033	8	2.74E-06	0.000205205	6.74E-06
5170	hsa-mir-139	hsa04662	B cell receptor signaling pathway	5595_5594_2932_5970_5894_3725_5604_2353	8	2.74E-06	0.000205205	6.74E-06
5171	hsa-mir-139	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_1432_5970_3725_5604_2353_5601	9	2.79E-06	0.000208999	6.74E-06
5172	hsa-mir-139	hsa05131	Shigellosis	1499_4691_7277_7278_7846_51807_10376	7	4.46E-06	0.000334765	1.01E-05
5173	hsa-mir-139	hsa05130	Pathogenic Escherichia coli infection	1499_4691_7277_7278_7846_51807_10376	7	4.46E-06	0.000334765	1.01E-05
5174	hsa-mir-139	hsa04330	Notch signaling pathway	1387_9612_3066_3065_2033_2648	6	1.96E-05	0.001470064	4.32E-05
5175	hsa-mir-139	hsa04510	Focal adhesion	1499_5595_5594_5599_595_2932_5894_3725_5604_5601_6464	11	2.10E-05	0.001575009	4.50E-05
5176	hsa-mir-139	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_1432_5894_5604_5601	7	3.53E-05	0.002644944	7.35E-05
5177	hsa-mir-139	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_1432_7157_1616_4846	6	4.85E-05	0.00363626	9.83E-05
5178	hsa-mir-139	hsa04920	Adipocytokine signaling pathway	10891_5599_6256_5563_5970_5601	6	0.000121872	0.009140372	0.000240536
5179	hsa-mir-139	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_836_1432_5970_3725_5601	6	0.000163878	0.012290879	0.000314019
5180	hsa-mir-139	hsa05010	Alzheimer's disease	5595_5594_823_2902_836_2932_1537_9451_4846	9	0.000167477	0.01256074	0.000314019
5181	hsa-mir-139	hsa04370	VEGF signaling pathway	5595_5594_1432_5894_5604_4846	6	0.000247504	0.018562835	0.000452752
5182	hsa-mir-139	hsa03022	Basal transcription factors	2969_2962_6908_6874	4	0.000896059	0.067204403	0.001600105
5183	hsa-mir-139	hsa04730	Long-term depression	5595_5594_5894_5604_4846	5	0.001253955	0.09404662	0.002187131
5184	hsa-mir-139	hsa04062	Chemokine signaling pathway	5595_5594_2932_5970_5894_5604_6464_7074	8	0.001369889	0.102741641	0.002335037
5185	hsa-mir-139	hsa04930	Type II diabetes mellitus	5595_5594_5599_5601	4	0.001755218	0.131641313	0.002925363
5186	hsa-mir-139	hsa04150	mTOR signaling pathway	5595_5594_5563_3091	4	0.00287273	0.215454783	0.0046838
5187	hsa-mir-139	hsa04612	Antigen processing and presentation	3320_4800_4802_3312_4801	5	0.003196898	0.239767383	0.005101434
5188	hsa-mir-139	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_5894_5604_6464	6	0.004292412	0.321930915	0.006706894
5189	hsa-mir-139	hsa04210	Apoptosis	823_836_5970_7157	4	0.016895044	1	0.025859762
5190	hsa-mir-139	hsa05217	Basal cell carcinoma	1499_2932_7157	3	0.023263292	1	0.034894939
5191	hsa-mir-139	hsa04630	Jak-STAT signaling pathway	1387_595_4609_2033_8554	5	0.027439175	1	0.040351728
5192	hsa-mir-139	hsa03430	Mismatch repair	5981_4292	2	0.028230269	1	0.040716734
5193	hsa-mir-139	hsa04270	Vascular smooth muscle contraction	5595_5594_5894_5604	4	0.040256411	1	0.05696662
5194	hsa-mir-140	hsa05200	Pathways in cancer	1147_3320_3326_405_3480_1956_5595_5594_5599_6654_5914_2064_6256_595_5601_1488_2308_1487_208_367_4193_7704_1387_5970_8503_2885_7157_4087_10401_3725_2353_6776_4088_4089_5295_2033_207_8554_4790	39	7.01E-33	5.26E-31	5.26E-31
5195	hsa-mir-140	hsa05215	Prostate cancer	1147_3320_3326_3480_1956_5595_5594_6654_2064_595_2308_208_367_4193_1387_5970_8503_2885_7157_468_5295_2033_207_4790	24	3.20E-28	2.40E-26	1.01E-26
5196	hsa-mir-140	hsa05212	Pancreatic cancer	1147_3320_3326_3480_1956_5595_5594_6654_2064_595_2308_208_367_4193_1387_5970_8503_2885_7157_468_5295_2033_207_4790	24	4.04E-28	3.03E-26	1.01E-26
5197	hsa-mir-140	hsa04010	MAPK signaling pathway	1147_994_1956_5595_5594_5599_6654_5601_5566_208_4214_1386_1432_1649_5970_627_2885_7157_10912_468_3725_3727_6195_6197_2353_5058_4616_2872_207_4790	30	1.21E-24	9.07E-23	2.27E-23
5198	hsa-mir-140	hsa05220	Chronic myeloid leukemia	1147_5595_5594_6654_595_1488_1487_208_4193_5970_8503_2885_7157_6776_4088_4089_5295_207_4790_6464	20	1.58E-23	1.19E-21	2.37E-22
5199	hsa-mir-140	hsa05210	Colorectal cancer	3480_1956_5595_5594_5599_6654_595_5601_208_8503_2885_7157_4087_3725_2353_4088_4089_5295_207	19	3.09E-21	2.32E-19	3.86E-20
5200	hsa-mir-140	hsa04910	Insulin signaling pathway	6720_10891_5595_5594_5599_6654_5601_2308_5566_7249_208_5770_8503_2885_5295_2872_207_801_6464_808_805	21	3.51E-20	2.63E-18	3.76E-19
5201	hsa-mir-140	hsa05214	Glioma	3480_1956_5595_5594_6654_595_208_4193_8503_2885_7157_5295_207_801_6464_808_805	17	4.75E-20	3.57E-18	4.46E-19
5202	hsa-mir-140	hsa04012	ErbB signaling pathway	1956_6714_5595_5594_5599_6654_56924_2064_5601_208_8503_2885_3725_6776_5295_5058_207_6464	18	1.42E-19	1.07E-17	1.18E-18
5203	hsa-mir-140	hsa04660	T cell receptor signaling pathway	1147_3932_5595_5594_6654_56924_5601_208_5777_1432_5970_8503_2885_3725_2353_5295_5058_207_4790	19	2.73E-19	2.05E-17	2.05E-18
5204	hsa-mir-140	hsa05221	Acute myeloid leukemia	1147_5595_5594_6654_5914_595_208_7704_5970_8503_2885_6776_5295_207_4790	15	1.12E-17	8.44E-16	7.67E-17
5205	hsa-mir-140	hsa04510	Focal adhesion	9564_3480_1956_6714_5595_5594_5599_6654_56924_2064_595_5601_208_8503_857_2885_3725_5295_5058_207_6464	21	6.08E-17	4.56E-15	3.80E-16
5206	hsa-mir-140	hsa05223	Non-small cell lung cancer	1956_5595_5594_6654_2064_6256_595_208_8503_2885_7157_5295_2309_207	14	1.11E-16	8.32E-15	6.40E-16
5207	hsa-mir-140	hsa04912	GnRH signaling pathway	1956_6714_5595_5594_5599_6654_5601_5566_4214_1432_2885_468_3725_801_808_805	16	1.71E-15	1.28E-13	9.15E-15
5208	hsa-mir-140	hsa05213	Endometrial cancer	1956_5595_5594_6654_2064_595_208_8503_2885_7157_5295_2309_207	13	2.11E-15	1.58E-13	1.05E-14
5209	hsa-mir-140	hsa05211	Renal cell carcinoma	405_5595_5594_6654_56924_208_1387_8503_2885_3725_5295_5058_2033_207	14	3.62E-15	2.72E-13	1.70E-14
5210	hsa-mir-140	hsa04662	B cell receptor signaling pathway	1147_5595_5594_6654_208_5777_5970_8503_2885_3725_2353_5295_207_4790	14	5.98E-15	4.48E-13	2.64E-14
5211	hsa-mir-140	hsa04520	Adherens junction	1460_3480_1956_6714_5595_5594_2064_5770_5777_1387_4087_4088_4089_2033	14	1.32E-14	9.90E-13	5.50E-14
5212	hsa-mir-140	hsa04110	Cell cycle	994_891_595_7533_4193_902_1387_7157_4087_10912_1022_4088_4089_4616_2033	15	1.13E-13	8.49E-12	4.47E-13
5213	hsa-mir-140	hsa04620	Toll-like receptor signaling pathway	1147_5595_5594_5599_5601_208_1432_5970_8503_3725_2353_5295_207_4790	14	2.65E-13	1.99E-11	9.94E-13
5214	hsa-mir-140	hsa04062	Chemokine signaling pathway	1147_9564_5595_5594_6654_2770_5566_208_5970_8503_2885_5295_5058_2309_207_4790_6464	17	5.46E-13	4.09E-11	1.95E-12
5215	hsa-mir-140	hsa04310	Wnt signaling pathway	1460_5599_595_5601_1488_5566_1487_1387_7157_4087_8061_3725_4088_4089_2033	15	2.92E-12	2.19E-10	9.95E-12
5216	hsa-mir-140	hsa05222	Small cell lung cancer	1147_6256_595_208_5970_8503_7157_10401_5295_207_8554_4790	12	1.16E-11	8.73E-10	3.80E-11
5217	hsa-mir-140	hsa05218	Melanoma	3480_1956_5595_5594_595_208_4193_8503_7157_5295_207	11	3.09E-11	2.32E-09	9.65E-11
5218	hsa-mir-140	hsa04720	Long-term potentiation	5595_5594_5566_1387_468_6195_6197_2033_801_808_805	11	5.26E-11	3.94E-09	1.58E-10
5219	hsa-mir-140	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_6654_5601_208_1432_8503_2885_5295_207	11	8.71E-11	6.53E-09	2.51E-10
5220	hsa-mir-140	hsa04630	Jak-STAT signaling pathway	6654_595_208_5777_1387_8503_2885_10401_6776_5295_2033_207_8554	13	5.49E-10	4.12E-08	1.52E-09
5221	hsa-mir-140	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_1956_6714_5599_5601_1432_5970_3725_5058_4790	10	5.76E-10	4.32E-08	1.54E-09
5222	hsa-mir-140	hsa04150	mTOR signaling pathway	5595_5594_7249_208_8503_6195_6197_5295_207	9	8.32E-10	6.24E-08	2.15E-09
5223	hsa-mir-140	hsa04210	Apoptosis	1147_5566_208_5970_8503_823_7157_5295_207_4790	10	4.24E-09	3.18E-07	1.06E-08
5224	hsa-mir-140	hsa04920	Adipocytokine signaling pathway	1147_10891_5599_6256_5601_208_5970_207_4790	9	6.20E-09	4.65E-07	1.50E-08
5225	hsa-mir-140	hsa05219	Bladder cancer	1956_5595_5594_2064_595_4193_7157	7	8.31E-08	6.23E-06	1.95E-07
5226	hsa-mir-140	hsa04115	p53 signaling pathway	891_595_7249_4193_7157_10912_64326_4616	8	1.25E-07	9.35E-06	2.83E-07
5227	hsa-mir-140	hsa04650	Natural killer cell mediated cytotoxicity	3932_5595_5594_6654_5777_8503_2885_5295_5058_6464	10	2.01E-07	1.51E-05	4.37E-07
5228	hsa-mir-140	hsa04916	Melanogenesis	5595_5594_2770_5566_1387_2033_801_808_805	9	2.04E-07	1.53E-05	4.37E-07
5229	hsa-mir-140	hsa04370	VEGF signaling pathway	6714_5595_5594_208_1432_8503_5295_207	8	2.71E-07	2.03E-05	5.64E-07
5230	hsa-mir-140	hsa04350	TGF-beta signaling pathway	5595_5594_6667_1387_4087_4088_4089_2033	8	6.41E-07	4.81E-05	1.30E-06
5231	hsa-mir-140	hsa04540	Gap junction	1956_6714_5595_5594_6654_2770_5566_2885	8	1.02E-06	7.69E-05	2.02E-06
5232	hsa-mir-140	hsa04120	Ubiquitin mediated proteolysis	672_4214_4193_10401_10273_64326_7329_7325_8554	9	1.99E-06	0.000149554	3.83E-06
5233	hsa-mir-140	hsa04930	Type II diabetes mellitus	5595_5594_5599_5601_8503_5295	6	2.34E-06	0.000175378	4.38E-06
5234	hsa-mir-140	hsa05216	Thyroid cancer	5595_5594_6256_595_7157	5	5.44E-06	0.000407931	9.95E-06
5235	hsa-mir-140	hsa04330	Notch signaling pathway	1488_1487_1387_9612_2033	5	4.55E-05	0.003411964	8.12E-05
5236	hsa-mir-140	hsa04810	Regulation of actin cytoskeleton	9564_1956_5595_5594_6654_56924_8503_5295_5058	9	6.33E-05	0.004748459	0.000110429
5237	hsa-mir-140	hsa05010	Alzheimer's disease	5595_5594_1537_823_9451_801_808_805	8	8.62E-05	0.006463121	0.000146889
5238	hsa-mir-140	hsa05016	Huntington's disease	10891_6908_6667_1387_1537_627_7157_2033	8	0.000128581	0.009643557	0.000214301
5239	hsa-mir-140	hsa03022	Basal transcription factors	2965_6908_2959_6881	4	0.000256456	0.019234175	0.000418134
5240	hsa-mir-140	hsa04270	Vascular smooth muscle contraction	5595_5594_5566_801_808_805	6	0.000367146	0.027535916	0.000585871
5241	hsa-mir-140	hsa04070	Phosphatidylinositol signaling system	8503_5295_801_808_805	5	0.000375675	0.028175601	0.000586992
5242	hsa-mir-140	hsa03420	Nucleotide excision repair	2965_902_4331_1022	4	0.000472843	0.035463199	0.000723739
5243	hsa-mir-140	hsa04360	Axon guidance	5998_5595_5594_56924_2770_5058	6	0.000623173	0.04673799	0.00093476
5244	hsa-mir-140	hsa04730	Long-term depression	3480_5595_5594_2770	4	0.002520845	0.189063408	0.003707126
5245	hsa-mir-140	hsa04670	Leukocyte transendothelial migration	9564_2770_1432_8503_5295	5	0.002819548	0.211466065	0.004066655
5246	hsa-mir-140	hsa04020	Calcium signaling pathway	1956_2064_5566_801_808_805	6	0.00329379	0.247034269	0.004661024
5247	hsa-mir-140	hsa04530	Tight junction	1460_6714_2770_208_207	5	0.004539158	0.340436887	0.006304387
5248	hsa-mir-140	hsa05340	Primary immunodeficiency	3932_6890	2	0.031729325	1	0.043267261
5249	hsa-mir-140	hsa04612	Antigen processing and presentation	3320_3326_6890	3	0.032573473	1	0.043625188
5250	hsa-mir-140	hsa03410	Base excision repair	6996_4350	2	0.033328701	1	0.043853553
5251	hsa-mir-141	hsa05200	Pathways in cancer	5914_595_596_598_2261_4193_6934_7704_5578_3091_3066_3065_5925_613_5747_25_1956_1487_1488_6789_4824_4436_1870_1871_2885_2113_861_10401_207_836_3716_1147_2249_998_4233_5595_5594_5599_6258_1387_2064_6256_3326_4286_367_2932_6774_6776_6777_6772_5979_5879_7157_6688_1869_3725_2736_4087_4088_4089_9063_5888_5728_2034_2033_675_4846_3910_4790_4792_5970_1017_3320_5371_3480_5159_5156_5604_5601_5602_1856_842_841_51588_7428_4609_1026_2353_1441_5743_8554	91	6.86E-57	5.97E-55	5.97E-55
5252	hsa-mir-141	hsa04010	MAPK signaling pathway	3925_6722_6197_2261_2264_9252_5578_4773_5923_8986_1956_3304_3303_6789_1432_2885_3305_4763_207_836_1147_2249_998_5595_5594_5599_1386_3312_3315_1649_5879_3164_7157_468_3725_3727_6195_6196_9344_4790_51701_5970_1616_5159_9261_5156_5604_4208_5601_5600_5602_6885_4609_5606_2353_8550_2002_2005	58	2.48E-31	2.16E-29	1.08E-29
5253	hsa-mir-141	hsa05215	Prostate cancer	595_596_4193_6934_5925_1956_4824_1870_1871_2885_9586_207_1147_5595_5594_1385_1387_2064_3326_367_2932_7157_468_1869_5728_2033_4790_4792_5970_1017_3320_3480_5159_5156_5604_842_1026	37	4.64E-29	4.03E-27	1.34E-27
5254	hsa-mir-141	hsa05212	Pancreatic cancer	595_596_4193_6934_5925_1956_4824_1870_1871_2885_9586_207_1147_5595_5594_1385_1387_2064_3326_367_2932_7157_468_1869_5728_2033_4790_4792_5970_1017_3320_3480_5159_5156_5604_842_1026	37	6.41E-29	5.57E-27	1.39E-27
5255	hsa-mir-141	hsa04110	Cell cycle	595_4193_902_5347_1022_3066_3065_5925_25_1870_1871_5933_545_995_7534_5591_1387_11200_7533_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_1017_1031_983_9232_1026_472_1111_8556_8555	38	2.93E-26	2.55E-24	5.10E-25
5256	hsa-mir-141	hsa05220	Chronic myeloid leukemia	595_598_4193_3066_3065_5925_613_25_1487_1488_1870_1871_2885_861_207_1147_5595_5594_6776_6777_7157_1869_4088_4089_4790_4792_5970_5604_5781_4609_1026_6464	32	1.83E-25	1.59E-23	2.65E-24
5257	hsa-mir-141	hsa05210	Colorectal cancer	595_596_6934_1956_4436_2885_207_836_4233_5595_5594_5599_2932_5879_7157_3725_4087_4088_4089_3480_5159_5156_5604_5601_5602_1856_842_4609_2353	29	3.99E-21	3.48E-19	4.96E-20
5258	hsa-mir-141	hsa04630	Jak-STAT signaling pathway	3559_595_598_3454_3455_3560_1439_2885_2690_10401_3977_207_3717_3716_3718_85480_1387_3575_3570_3572_6774_6775_6776_6777_6772_9063_2033_149233_3953_51588_5781_4609_1441_8554	34	3.07E-19	2.67E-17	3.34E-18
5259	hsa-mir-141	hsa05222	Small cell lung cancer	595_596_598_5925_5747_1870_1871_10401_207_1147_6258_6256_7157_1869_9063_5728_4846_3910_4790_4792_5970_1017_842_51588_4609_5743_8554	27	6.94E-19	6.03E-17	6.71E-18
5260	hsa-mir-141	hsa04115	p53 signaling pathway	595_4194_4193_50484_27113_51246_836_545_11200_7157_900_6241_64326_5728_1017_25898_983_842_841_1026_7161_472_1111	23	9.23E-17	8.03E-15	8.03E-16
5261	hsa-mir-141	hsa04310	Wnt signaling pathway	815_595_6934_5578_4773_1460_1487_1488_5599_1387_2932_5879_7157_8061_3725_1457_1452_4087_4088_4089_2033_51701_5518_5515_5601_5602_1856_6885_4609_5527	30	4.77E-16	4.15E-14	3.77E-15
5262	hsa-mir-141	hsa05214	Glioma	815_595_4193_5578_5925_1956_1870_1871_2885_207_5595_5594_7157_1869_5728_3480_5159_5156_5604_1026_6464	21	3.36E-15	2.93E-13	2.44E-14
5263	hsa-mir-141	hsa04012	ErbB signaling pathway	815_5578_5747_25_1956_6714_2885_207_5595_5594_5599_2064_2932_6776_6777_3725_5604_5601_5602_4609_1026_6464_2002	23	6.20E-15	5.40E-13	4.15E-14
5264	hsa-mir-141	hsa05221	Acute myeloid leukemia	5914_595_6934_7704_2885_861_207_1147_5595_5594_6774_6776_6777_6688_4790_5970_5371_5604_4609	19	7.32E-14	6.37E-12	4.55E-13
5265	hsa-mir-141	hsa04620	Toll-like receptor signaling pathway	3454_3455_1432_207_1147_3654_5595_5594_5599_6772_5879_3725_4790_4792_5970_5604_5601_5600_5602_841_6885_5606_2353	23	1.12E-13	9.78E-12	6.52E-13
5266	hsa-mir-141	hsa05218	Melanoma	595_4193_5925_1956_1870_1871_207_2249_4233_5595_5594_4286_7157_1869_5728_3480_5159_5156_5604_1026	20	1.33E-13	1.16E-11	7.24E-13
5267	hsa-mir-141	hsa05223	Non-small cell lung cancer	595_5578_5925_1956_6789_1870_1871_2885_207_5595_5594_6258_2064_6256_7157_1869_5604_842	18	2.04E-13	1.78E-11	1.04E-12
5268	hsa-mir-141	hsa04510	Focal adhesion	595_596_5578_5923_5747_1956_6714_5499_2885_207_998_4233_5595_5594_5599_2064_2932_5879_3725_5728_3910_2321_3480_5159_5156_5604_5601_5602_6464_2002	30	5.77E-13	5.02E-11	2.79E-12
5269	hsa-mir-141	hsa05219	Bladder cancer	595_2261_9252_4193_5925_1956_1870_1871_5595_5594_2064_7157_1869_5604_4609_1026	16	8.41E-13	7.32E-11	3.83E-12
5270	hsa-mir-141	hsa04520	Adherens junction	6934_1460_1956_6714_2241_998_4233_5595_5594_1387_2064_5879_1457_4087_4088_4089_2033_51701_3480_6885	20	8.80E-13	7.65E-11	3.83E-12
5271	hsa-mir-141	hsa04062	Chemokine signaling pathway	1234_1230_5747_5580_7852_2885_6362_207_3055_3717_1147_3718_998_5590_5595_5594_2932_6774_6777_6772_5879_4790_4792_5970_5604_2185_6464	27	1.91E-11	1.66E-09	7.89E-11
5272	hsa-mir-141	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_1432_836_1147_998_4233_5599_5879_3725_4790_4792_5970_5601_5600_5602_5781	17	8.07E-11	7.02E-09	3.19E-10
5273	hsa-mir-141	hsa04912	GnRH signaling pathway	815_5578_5580_1956_6714_1432_2885_998_5595_5594_5599_468_3725_5604_5601_5600_5602_2185_5606_2002	20	1.00E-10	8.74E-09	3.80E-10
5274	hsa-mir-141	hsa05213	Endometrial cancer	595_6934_1956_2885_207_5595_5594_2064_2932_7157_5728_5604_842_4609_2002	15	1.15E-10	9.98E-09	4.16E-10
5275	hsa-mir-141	hsa04660	T cell receptor signaling pathway	4773_3932_1432_2885_207_1147_998_5595_5594_2932_3725_4790_4792_5970_5604_5601_5600_6885_2353_959	20	1.34E-10	1.16E-08	4.66E-10
5276	hsa-mir-141	hsa04370	VEGF signaling pathway	5578_4773_5747_6714_1432_207_998_5595_5594_3315_5879_4846_9261_5604_5600_842_5743	17	2.40E-10	2.09E-08	7.99E-10
5277	hsa-mir-141	hsa04210	Apoptosis	3556_596_598_823_1439_207_836_1147_3654_839_7157_4790_4792_5970_842_841_840_472	18	2.48E-10	2.16E-08	7.99E-10
5278	hsa-mir-141	hsa04920	Adipocytokine signaling pathway	5563_6794_207_3717_1147_5599_6258_6256_6774_4790_4792_5970_5601_5602_3953_5781	16	3.00E-10	2.61E-08	9.32E-10
5279	hsa-mir-141	hsa05211	Renal cell carcinoma	3091_2885_2113_207_998_4233_5595_5594_1387_5879_3725_2034_2033_5604_7428_5781	16	7.46E-10	6.49E-08	2.24E-09
5280	hsa-mir-141	hsa04350	TGF-beta signaling pathway	6667_3397_3399_3398_5933_5595_5594_1387_7027_4086_4087_4088_4089_2033_5518_5515_4609	17	1.24E-09	1.07E-07	3.51E-09
5281	hsa-mir-141	hsa04662	B cell receptor signaling pathway	4773_6850_2885_207_1147_5595_5594_2932_5879_3725_4790_4792_5970_5604_2353_1380	16	1.25E-09	1.09E-07	3.51E-09
5282	hsa-mir-141	hsa03022	Basal transcription factors	6880_51616_2957_2965_2963_2962_2969_6874_6872_6908_2958_2959	12	2.78E-09	2.42E-07	7.55E-09
5283	hsa-mir-141	hsa04664	Fc epsilon RI signaling pathway	5578_5580_6850_1432_2885_207_5595_5594_5599_5879_5604_5601_5600_5602_5606	15	1.63E-08	1.41E-06	4.29E-08
5284	hsa-mir-141	hsa04120	Ubiquitin mediated proteolysis	55294_4193_3093_7319_84447_10401_7329_83737_10055_9063_64326_7337_5371_672_25898_10075_51588_7428_8554	19	2.55E-08	2.22E-06	6.53E-08
5285	hsa-mir-141	hsa05216	Thyroid cancer	595_6934_5595_5594_6258_6256_5979_7157_5604_4609	10	3.66E-08	3.18E-06	9.09E-08
5286	hsa-mir-141	hsa04060	Cytokine-cytokine receptor interaction	3556_3559_1234_1230_3454_3455_1956_3560_1439_7852_6362_2690_3977_85480_4233_3575_3570_3572_2321_149233_5159_5156_3953_959_1441	25	1.19E-07	1.04E-05	2.89E-07
5287	hsa-mir-141	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_598_2902_1432_836_5879_7157_4846_1616_5600_842_5606	12	1.41E-07	1.22E-05	3.30E-07
5288	hsa-mir-141	hsa04330	Notch signaling pathway	9612_3066_3065_1487_1488_3280_1387_2033_8850_388585_1856	11	2.17E-07	1.88E-05	4.96E-07
5289	hsa-mir-141	hsa04720	Long-term potentiation	815_6197_5578_2902_5499_5595_5594_1387_468_6195_6196_2033_5604	13	3.71E-07	3.23E-05	8.28E-07
5290	hsa-mir-141	hsa04910	Insulin signaling pathway	6720_5563_5499_2885_207_5590_5595_5594_5599_23265_2932_5604_5601_5602_6464_2002	16	2.30E-06	0.000200301	5.01E-06
5291	hsa-mir-141	hsa04650	Natural killer cell mediated cytotoxicity	5578_3454_3455_4773_3932_6850_2885_836_5595_5594_5879_5604_5781_2185_6464	15	9.65E-06	0.000839245	2.05E-05
5292	hsa-mir-141	hsa04540	Gap junction	5578_1956_6714_2885_5592_5595_5594_1453_5159_983_5156_5604	12	1.59E-05	0.001384023	3.30E-05
5293	hsa-mir-141	hsa05016	Huntington's disease	6667_3066_3065_3064_25942_2902_27113_9586_836_1385_1387_7157_2033_6874_6908_842_841	17	2.32E-05	0.0020208	4.65E-05
5294	hsa-mir-141	hsa04150	mTOR signaling pathway	5563_6794_6197_3091_207_5595_5594_6195_6196	9	2.35E-05	0.002045971	4.65E-05
5295	hsa-mir-141	hsa04916	Melanogenesis	815_6934_5578_5595_5594_1385_1387_4286_2932_2033_5604_1856	12	4.34E-05	0.003778811	8.40E-05
5296	hsa-mir-141	hsa03420	Nucleotide excision repair	2074_902_1022_6117_2965_4331_2071_6118	8	4.90E-05	0.004261741	9.26E-05
5297	hsa-mir-141	hsa04612	Antigen processing and presentation	3309_3304_3303_3305_1385_3326_3312_3320_4800_4801_2923	11	5.10E-05	0.00443517	9.44E-05
5298	hsa-mir-141	hsa04930	Type II diabetes mellitus	5580_3651_5590_5595_5594_5599_5601_5602	8	5.64E-05	0.004907869	0.000102247
5299	hsa-mir-141	hsa04730	Long-term depression	5578_5592_5595_5594_4846_3480_5518_5515_5604	9	0.000204377	0.017780779	0.000362873
5300	hsa-mir-141	hsa04360	Axon guidance	4773_5747_25_7852_2242_998_4233_5595_5594_2932_5879_1020	12	0.000321239	0.027947768	0.000558955
5301	hsa-mir-141	hsa04530	Tight junction	5578_1460_5580_6714_207_998_5590_1457_5728_5518_5515_5520	12	0.000467165	0.040643393	0.000796929
5302	hsa-mir-141	hsa04950	Maturity onset diabetes of the young	6927_3087_3280_3651_3172	5	0.000768873	0.066891941	0.001286383
5303	hsa-mir-141	hsa05010	Alzheimer's disease	22926_823_2902_836_5595_5594_2932_6622_4846_842_841_840_1020	13	0.001277191	0.111115643	0.002096522
5304	hsa-mir-141	hsa03440	Homologous recombination	641_6117_5888_675_6118	5	0.001412516	0.122888867	0.00227572
5305	hsa-mir-141	hsa03410	Base excision repair	3146_4913_142_328_6996	5	0.00377137	0.328109159	0.005965621
5306	hsa-mir-141	hsa04740	Olfactory transduction	815_5592	2	0.005204647	0.452804325	0.008085792
5307	hsa-mir-141	hsa04670	Leukocyte transendothelial migration	5578_5747_1432_7852_998_5879_5600_5781_2185	9	0.006631239	0.576917801	0.010121365
5308	hsa-mir-141	hsa04710	Circadian rhythm - mammal	8863_1453_8553	3	0.007267165	0.632243314	0.010900747
5309	hsa-mir-141	hsa04810	Regulation of actin cytoskeleton	2261_2264_5747_1956_5499_2249_998_5595_5594_5879_5159_5156_5604	13	0.009454857	0.822572538	0.013941907
5310	hsa-mir-141	hsa05340	Primary immunodeficiency	3932_3718_3575_959	4	0.017162359	1	0.02488542
5311	hsa-mir-141	hsa05217	Basal cell carcinoma	6934_2932_7157_2736_1856	5	0.018526433	1	0.026231304
5312	hsa-mir-141	hsa03030	DNA replication	6117_6118_5422_5557	4	0.018693573	1	0.026231304
5313	hsa-mir-141	hsa05131	Shigellosis	5578_25_998_7534_4691	5	0.01976907	1	0.026873579
5314	hsa-mir-141	hsa05130	Pathogenic Escherichia coli infection	5578_25_998_7534_4691	5	0.01976907	1	0.026873579
5315	hsa-mir-141	hsa03430	Mismatch repair	4436_6117_6118	3	0.027947857	1	0.037407131
5316	hsa-mir-141	hsa04640	Hematopoietic cell lineage	3559_3575_3570_914_1380_1441	6	0.032118253	1	0.042337697
5317	hsa-mir-141	hsa04270	Vascular smooth muscle contraction	5578_5580_5499_5592_5595_5594_5604	7	0.041811249	1	0.054292219
5318	hsa-mir-142	hsa05200	Pathways in cancer	3320_4149_5371_9063_1871_5595_5594_5599_6258_1387_6257_6256_8031_1870_5604_1488_9915_1487_1017_2932_2353_6502_4292_3091_5970_2885_7157_5894_1869_1029_5601_4087_4088_4089_5925_2034_2033_1050_8554_4286	40	9.44E-35	5.67E-33	5.67E-33
5319	hsa-mir-142	hsa04110	Cell cycle	890_990_1871_1387_1870_983_1017_2932_8454_6502_6500_7157_10912_1869_1029_4087_4088_4089_5925_2033_4616_5934_5933	23	1.83E-24	1.10E-22	5.49E-23
5320	hsa-mir-142	hsa04350	TGF-beta signaling pathway	5595_5594_1387_4093_6667_8454_3399_6500_1874_1875_3397_3398_4087_4088_4089_2033_5934_5933	18	7.48E-20	4.49E-18	1.50E-18
5321	hsa-mir-142	hsa05220	Chronic myeloid leukemia	1871_5595_5594_1870_5604_1488_1487_5970_2885_7157_5894_1869_1029_4088_4089_5925	16	5.77E-18	3.46E-16	8.65E-17
5322	hsa-mir-142	hsa05215	Prostate cancer	3320_1871_5595_5594_1387_1870_5604_1017_2932_5970_2885_7157_5894_1869_5925_2033	16	5.41E-17	3.25E-15	5.78E-16
5323	hsa-mir-142	hsa05212	Pancreatic cancer	3320_1871_5595_5594_1387_1870_5604_1017_2932_5970_2885_7157_5894_1869_5925_2033	16	6.34E-17	3.81E-15	5.78E-16
5324	hsa-mir-142	hsa05223	Non-small cell lung cancer	1871_5595_5594_6258_6257_6256_1870_5604_2885_7157_5894_1869_1029_5925	14	6.74E-17	4.04E-15	5.78E-16
5325	hsa-mir-142	hsa04010	MAPK signaling pathway	6722_4149_5595_5594_5599_5598_1386_5604_5606_5600_2353_1432_5970_9344_2885_7157_10912_5894_5601_4616_2005	21	5.48E-15	3.29E-13	4.11E-14
5326	hsa-mir-142	hsa05210	Colorectal cancer	5595_5594_5599_5604_2932_2353_4292_2885_7157_5894_5601_4087_4088_4089	14	1.47E-14	8.84E-13	9.82E-14
5327	hsa-mir-142	hsa05222	Small cell lung cancer	4149_9063_1871_6258_6257_6256_1870_1017_6502_5970_7157_1869_5925_8554	14	1.97E-14	1.18E-12	1.18E-13
5328	hsa-mir-142	hsa04310	Wnt signaling pathway	5599_1387_1488_1487_2932_8454_6500_7157_8061_1457_5601_1459_4087_4088_4089_2033	16	1.25E-13	7.48E-12	6.80E-13
5329	hsa-mir-142	hsa05219	Bladder cancer	1871_5595_5594_1870_5604_7157_5894_1869_1029_5925	10	4.12E-12	2.47E-10	2.06E-11
5330	hsa-mir-142	hsa05214	Glioma	1871_5595_5594_1870_5604_2885_7157_5894_1869_1029_5925	11	8.96E-12	5.38E-10	4.14E-11
5331	hsa-mir-142	hsa04540	Gap junction	5595_5594_5598_983_5604_7277_7278_10376_2885_5894_7846_51807	12	1.77E-11	1.06E-09	7.57E-11
5332	hsa-mir-142	hsa05218	Melanoma	1871_5595_5594_1870_5604_7157_5894_1869_1029_5925_4286	11	2.11E-11	1.27E-09	8.43E-11
5333	hsa-mir-142	hsa05216	Thyroid cancer	5595_5594_6258_6257_6256_8031_5604_7157	8	2.24E-10	1.34E-08	8.38E-10
5334	hsa-mir-142	hsa05211	Renal cell carcinoma	5595_5594_1387_5604_9915_3091_2885_5894_2034_2033	10	4.61E-10	2.77E-08	1.63E-09
5335	hsa-mir-142	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5604_5606_5600_1432_2885_5894_5601	10	1.05E-09	6.29E-08	3.50E-09
5336	hsa-mir-142	hsa04912	GnRH signaling pathway	5595_5594_5599_5598_5604_5606_5600_1432_2885_5894_5601	11	1.26E-09	7.53E-08	3.96E-09
5337	hsa-mir-142	hsa04660	T cell receptor signaling pathway	5595_5594_5604_5600_2932_2353_1432_5970_2885_5894_5601	11	1.50E-09	9.00E-08	4.50E-09
5338	hsa-mir-142	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5604_5606_5600_2353_1432_5970_5601	10	1.01E-08	6.06E-07	2.88E-08
5339	hsa-mir-142	hsa05213	Endometrial cancer	5595_5594_5604_2932_4292_2885_7157_5894	8	1.28E-08	7.70E-07	3.50E-08
5340	hsa-mir-142	hsa04520	Adherens junction	5595_5594_1387_1457_1459_4087_4088_4089_2033	9	1.87E-08	1.12E-06	4.88E-08
5341	hsa-mir-142	hsa05221	Acute myeloid leukemia	5371_5595_5594_5604_5970_2885_5894_1050	8	3.13E-08	1.88E-06	7.83E-08
5342	hsa-mir-142	hsa04910	Insulin signaling pathway	10891_5595_5594_5599_5604_2932_2885_5894_23265_5601	10	1.45E-07	8.68E-06	3.47E-07
5343	hsa-mir-142	hsa04662	B cell receptor signaling pathway	5595_5594_5604_2932_2353_5970_2885_5894	8	1.71E-07	1.03E-05	3.96E-07
5344	hsa-mir-142	hsa04012	ErbB signaling pathway	5595_5594_5599_5604_2932_2885_5894_5601	8	4.90E-07	2.94E-05	1.09E-06
5345	hsa-mir-142	hsa04920	Adipocytokine signaling pathway	10891_5599_6258_6257_6256_5970_5601	7	1.17E-06	7.03E-05	2.51E-06
5346	hsa-mir-142	hsa04115	p53 signaling pathway	983_1017_7157_10912_7161_1029_4616	7	1.41E-06	8.44E-05	2.91E-06
5347	hsa-mir-142	hsa04120	Ubiquitin mediated proteolysis	55294_5371_9063_672_8454_6502_6500_7329_8554	9	1.49E-06	8.93E-05	2.98E-06
5348	hsa-mir-142	hsa04916	Melanogenesis	5595_5594_1387_5604_2932_5894_2033_4286	8	1.73E-06	0.000103505	3.34E-06
5349	hsa-mir-142	hsa04330	Notch signaling pathway	1387_1488_9612_1487_2033_2648	6	2.40E-06	0.000143943	4.50E-06
5350	hsa-mir-142	hsa05131	Shigellosis	7277_7278_10376_7846_51807_4691	6	6.08E-06	0.000364993	1.07E-05
5351	hsa-mir-142	hsa05130	Pathogenic Escherichia coli infection	7277_7278_10376_7846_51807_4691	6	6.08E-06	0.000364993	1.07E-05
5352	hsa-mir-142	hsa04720	Long-term potentiation	5595_5594_1387_5604_5894_2033	6	2.86E-05	0.001717711	4.91E-05
5353	hsa-mir-142	hsa04370	VEGF signaling pathway	5595_5594_5604_5600_1432_5894	6	3.29E-05	0.001973742	5.48E-05
5354	hsa-mir-142	hsa04062	Chemokine signaling pathway	5595_5594_5604_2932_5970_2885_5894_7074	8	0.000119843	0.007190578	0.00019434
5355	hsa-mir-142	hsa04510	Focal adhesion	5595_5594_5599_5604_2932_2885_5894_5601	8	0.000184165	0.011049875	0.000290786
5356	hsa-mir-142	hsa03022	Basal transcription factors	2963_2962_2969_6908	4	0.000224064	0.013443854	0.000344714
5357	hsa-mir-142	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5600_1432_5970_5601	5	0.000237165	0.014229915	0.000355748
5358	hsa-mir-142	hsa04930	Type II diabetes mellitus	5595_5594_5599_5601	4	0.000447944	0.026876669	0.000655529
5359	hsa-mir-142	hsa05014	Amyotrophic lateral sclerosis (ALS)	5606_5600_1432_7157	4	0.000968593	0.058115579	0.001383704
5360	hsa-mir-142	hsa03320	PPAR signaling pathway	6258_6257_6256_2168	4	0.002111523	0.126691362	0.002946311
5361	hsa-mir-142	hsa04730	Long-term depression	5595_5594_5604_5894	4	0.002217926	0.133075541	0.003024444
5362	hsa-mir-142	hsa05016	Huntington's disease	10891_1387_6908_6667_7157_2033	6	0.003066125	0.183967476	0.004088166
5363	hsa-mir-142	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_5604_2885_5894	5	0.004027286	0.241637164	0.005252982
5364	hsa-mir-142	hsa04612	Antigen processing and presentation	3320_4800_4801_4802	4	0.004814205	0.288852297	0.006145794
5365	hsa-mir-142	hsa04630	Jak-STAT signaling pathway	9063_1387_2885_2033_8554	5	0.006446743	0.38680455	0.008058428
5366	hsa-mir-142	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.007559082	0.453544929	0.009256019
5367	hsa-mir-142	hsa04270	Vascular smooth muscle contraction	5595_5594_5604_5894	4	0.012311818	0.738709092	0.014774182
5368	hsa-mir-142	hsa04810	Regulation of actin cytoskeleton	5595_5594_5604_5894_7074	5	0.024414797	1	0.02872329
5369	hsa-mir-142	hsa05010	Alzheimer's disease	5595_5594_2932_6622	4	0.043737883	1	0.050466789
5370	hsa-mir-143	hsa05200	Pathways in cancer	3320_1147_4149_5371_2249_1499_5595_5594_5599_5914_1387_6256_3326_5604_367_8517_2932_7704_6774_6502_6776_6777_5970_6688_2113_5894_4609_1869_3725_1029_2353_4087_4088_7175_3065_4292_3551_5925_2033_1050_207_4791_4792	43	6.09E-32	4.57E-30	4.57E-30
5371	hsa-mir-143	hsa05221	Acute myeloid leukemia	1147_5371_5595_5594_5914_5604_8517_7704_6774_6776_6777_5970_6688_5894_4609_3551_1050_207	18	9.72E-20	7.29E-18	3.65E-18
5372	hsa-mir-143	hsa05215	Prostate cancer	3320_1147_1499_5595_5594_1387_3326_5604_367_8517_2932_5970_5894_1869_3551_5925_2033_207_4792	19	2.40E-18	1.80E-16	5.41E-17
5373	hsa-mir-143	hsa05212	Pancreatic cancer	3320_1147_1499_5595_5594_1387_3326_5604_367_8517_2932_5970_5894_1869_3551_5925_2033_207_4792	19	2.89E-18	2.16E-16	5.41E-17
5374	hsa-mir-143	hsa05220	Chronic myeloid leukemia	1147_5595_5594_5604_8517_6776_6777_5970_5894_4609_1869_1029_4088_3065_3551_5925_207_4792	18	3.73E-18	2.80E-16	5.60E-17
5375	hsa-mir-143	hsa04010	MAPK signaling pathway	6722_1147_4149_2249_5595_5594_5599_5598_1326_5604_3305_3303_5566_8517_3310_3312_1386_5971_5970_51701_5894_4609_3725_2353_3551_207_4791	27	1.20E-17	8.98E-16	1.50E-16
5376	hsa-mir-143	hsa04310	Wnt signaling pathway	23291_1499_5599_1387_8607_5566_2932_8454_1459_51701_8061_4609_3725_1457_6500_4087_4088_2033_8945	19	1.90E-14	1.43E-12	2.04E-13
5377	hsa-mir-143	hsa04662	B cell receptor signaling pathway	1147_5595_5594_5604_4794_8517_2932_5970_5894_3725_2353_3551_207_4792_4793	15	2.52E-14	1.89E-12	2.27E-13
5378	hsa-mir-143	hsa04540	Gap junction	5595_5594_5598_983_5604_5566_347733_7277_10382_84617_5894_7846_7278_51807_203068_10376	16	2.72E-14	2.04E-12	2.27E-13
5379	hsa-mir-143	hsa04660	T cell receptor signaling pathway	1147_5595_5594_1326_5604_4794_8517_2932_5970_5894_3725_2353_3551_207_4792_4793	16	2.79E-13	2.09E-11	2.09E-12
5380	hsa-mir-143	hsa04110	Cell cycle	990_5591_1387_983_2932_8454_6502_1869_1029_6500_4087_4088_3065_5925_2033_5933	16	8.28E-13	6.21E-11	5.65E-12
5381	hsa-mir-143	hsa05210	Colorectal cancer	1499_5595_5594_5599_5604_2932_5894_4609_3725_2353_4087_4088_4292_207	14	1.68E-12	1.26E-10	1.05E-11
5382	hsa-mir-143	hsa05131	Shigellosis	1499_347733_7277_10382_84617_7846_7278_51807_4691_203068_71_10376	12	4.98E-12	3.74E-10	2.67E-11
5383	hsa-mir-143	hsa05130	Pathogenic Escherichia coli infection	1499_347733_7277_10382_84617_7846_7278_51807_4691_203068_71_10376	12	4.98E-12	3.74E-10	2.67E-11
5384	hsa-mir-143	hsa04062	Chemokine signaling pathway	1147_5595_5594_5604_5566_8517_2932_6774_6777_5970_653361_5894_3551_207_4792_4793_7074	17	7.69E-11	5.76E-09	3.84E-10
5385	hsa-mir-143	hsa04620	Toll-like receptor signaling pathway	1147_5595_5594_5599_1326_5604_8517_5970_3725_2353_3551_207_4792	13	2.17E-10	1.62E-08	1.02E-09
5386	hsa-mir-143	hsa05214	Glioma	5595_5594_5604_5894_1869_1029_5925_207_808_801_805	11	3.64E-10	2.73E-08	1.61E-09
5387	hsa-mir-143	hsa05222	Small cell lung cancer	1147_4149_6256_8517_6502_5970_4609_1869_3551_5925_207_4792	12	4.22E-10	3.17E-08	1.76E-09
5388	hsa-mir-143	hsa04920	Adipocytokine signaling pathway	1147_5599_6256_4794_8517_6774_5970_3551_207_4792_4793	11	4.86E-10	3.64E-08	1.92E-09
5389	hsa-mir-143	hsa04520	Adherens junction	1499_5595_5594_1387_1459_51701_1457_4087_4088_2033_71	11	2.62E-09	1.97E-07	9.84E-09
5390	hsa-mir-143	hsa04916	Melanogenesis	1499_5595_5594_1387_5604_5566_2932_5894_2033_808_801_805	12	3.03E-09	2.27E-07	1.08E-08
5391	hsa-mir-143	hsa04350	TGF-beta signaling pathway	5595_5594_1387_8454_4609_6500_4087_4088_2033_6667_5933	11	5.83E-09	4.37E-07	1.90E-08
5392	hsa-mir-143	hsa04012	ErbB signaling pathway	5595_5594_5599_5604_2932_6776_6777_5894_4609_3725_207	11	5.83E-09	4.37E-07	1.90E-08
5393	hsa-mir-143	hsa05213	Endometrial cancer	1499_5595_5594_5604_2932_5894_4609_4292_207	9	1.25E-08	9.40E-07	3.92E-08
5394	hsa-mir-143	hsa05223	Non-small cell lung cancer	5595_5594_6256_5604_5894_1869_1029_5925_207	9	1.68E-08	1.26E-06	5.04E-08
5395	hsa-mir-143	hsa04720	Long-term potentiation	5595_5594_1387_5604_5566_5894_2033_808_801_805	10	1.83E-08	1.37E-06	5.28E-08
5396	hsa-mir-143	hsa05219	Bladder cancer	5595_5594_5604_5894_4609_1869_1029_5925	8	4.25E-08	3.19E-06	1.18E-07
5397	hsa-mir-143	hsa04912	GnRH signaling pathway	5595_5594_5599_5598_5604_5566_5894_3725_808_801_805	11	4.53E-08	3.40E-06	1.21E-07
5398	hsa-mir-143	hsa04910	Insulin signaling pathway	5595_5594_5599_5604_5566_2932_5894_3551_207_808_801_805	12	5.57E-08	4.18E-06	1.44E-07
5399	hsa-mir-143	hsa04120	Ubiquitin mediated proteolysis	55294_5371_23291_672_8454_6502_3093_10273_6500_7323_7329_8945	12	5.99E-08	4.50E-06	1.50E-07
5400	hsa-mir-143	hsa05216	Thyroid cancer	1499_5595_5594_6256_5604_4609_7175	7	7.40E-08	5.55E-06	1.79E-07
5401	hsa-mir-143	hsa04612	Antigen processing and presentation	3320_3326_3309_3305_3303_4800_4801_4802_3310_3312	10	8.02E-08	6.02E-06	1.88E-07
5402	hsa-mir-143	hsa05218	Melanoma	2249_5595_5594_5604_5894_1869_1029_5925_207	9	1.41E-07	1.06E-05	3.21E-07
5403	hsa-mir-143	hsa05211	Renal cell carcinoma	5595_5594_1387_5604_2113_5894_3725_2033_207	9	1.57E-07	1.18E-05	3.47E-07
5404	hsa-mir-143	hsa05016	Huntington's disease	1387_292_6908_5437_1213_23186_3065_3064_293_2033_6667_5441	12	1.25E-06	9.37E-05	2.68E-06
5405	hsa-mir-143	hsa03020	RNA polymerase	64425_5437_25885_51082_84172_5441	6	1.43E-06	0.00010731	2.98E-06
5406	hsa-mir-143	hsa04270	Vascular smooth muscle contraction	5595_5594_4637_5604_5566_5894_808_801_805	9	7.08E-06	0.000530831	1.43E-05
5407	hsa-mir-143	hsa04210	Apoptosis	1147_5566_8517_5970_8837_3551_207_4792	8	7.52E-06	0.000564364	1.49E-05
5408	hsa-mir-143	hsa04630	Jak-STAT signaling pathway	3559_1387_6778_6774_6776_6777_4609_2033_3977_207	10	8.85E-06	0.000663573	1.70E-05
5409	hsa-mir-143	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_5599_8517_5970_3725_3551_4792	7	1.62E-05	0.001213397	3.03E-05
5410	hsa-mir-143	hsa04510	Focal adhesion	1499_5595_5594_5599_5604_2932_5894_3725_10627_207_71	11	1.72E-05	0.001286367	3.09E-05
5411	hsa-mir-143	hsa04330	Notch signaling pathway	1387_9612_3065_2033_2648_4851	6	1.73E-05	0.001299151	3.09E-05
5412	hsa-mir-143	hsa04810	Regulation of actin cytoskeleton	2249_5595_5594_5604_4627_4628_10788_5894_10627_71_7074	11	2.93E-05	0.002200776	5.12E-05
5413	hsa-mir-143	hsa04530	Tight junction	1499_4627_4628_1459_1457_10627_207_71	8	0.000135487	0.010161536	0.000230944
5414	hsa-mir-143	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5604_5894_207	6	0.00025058	0.018793501	0.000417633
5415	hsa-mir-143	hsa04370	VEGF signaling pathway	5595_5594_5604_5894_207	5	0.001598644	0.119898314	0.00258532
5416	hsa-mir-143	hsa04930	Type II diabetes mellitus	5595_5594_5599_3551	4	0.001620134	0.121510042	0.00258532
5417	hsa-mir-143	hsa05010	Alzheimer's disease	22926_5595_5594_2932_808_801_805	7	0.00307215	0.230411252	0.004800234
5418	hsa-mir-143	hsa04340	Hedgehog signaling pathway	23291_5566_2932_8945	4	0.003624011	0.271800815	0.005546955
5419	hsa-mir-143	hsa04730	Long-term depression	5595_5594_5604_5894	4	0.007547507	0.566063051	0.011321261
5420	hsa-mir-143	hsa03022	Basal transcription factors	2962_2969_6908	3	0.00805387	0.604040262	0.011843927
5421	hsa-mir-143	hsa03450	Non-homologous end-joining	5591_2547	2	0.011521526	0.864114432	0.016617585
5422	hsa-mir-143	hsa04020	Calcium signaling pathway	292_5566_293_808_801_805	6	0.014175041	1	0.02005902
5423	hsa-mir-143	hsa04150	mTOR signaling pathway	5595_5594_207	3	0.019109446	1	0.026540897
5424	hsa-mir-143	hsa03010	Ribosome	6156_6128_6207_6202	4	0.02413081	1	0.032905651
5425	hsa-mir-143	hsa04115	p53 signaling pathway	983_7161_1029	3	0.038281996	1	0.051270531
5426	hsa-mir-143	hsa04670	Leukocyte transendothelial migration	1499_653361_10627_71	4	0.041562113	1	0.05468699
5427	hsa-mir-143	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.048201684	1	0.062329764
5428	hsa-mir-144	hsa05200	Pathways in cancer	5371_5595_5594_6256_595_4286_367_5914_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846_836	29	4.64E-33	2.87E-31	2.87E-31
5429	hsa-mir-144	hsa05220	Chronic myeloid leukemia	5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464	15	3.09E-22	1.91E-20	9.57E-21
5430	hsa-mir-144	hsa04110	Cell cycle	5591_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933	14	6.94E-18	4.30E-16	1.43E-16
5431	hsa-mir-144	hsa05215	Prostate cancer	5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033	11	1.52E-14	9.42E-13	2.11E-13
5432	hsa-mir-144	hsa05212	Pancreatic cancer	5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033	11	1.70E-14	1.06E-12	2.11E-13
5433	hsa-mir-144	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_4609_1869_5925	9	5.22E-14	3.24E-12	5.39E-13
5434	hsa-mir-144	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_7157_1869_5925	9	3.94E-13	2.44E-11	3.05E-12
5435	hsa-mir-144	hsa05210	Colorectal cancer	5595_5594_595_7157_4087_4609_3725_4088_4089_836	10	3.94E-13	2.44E-11	3.05E-12
5436	hsa-mir-144	hsa05222	Small cell lung cancer	6256_595_5970_1870_1871_7157_4609_1869_5925_4846	10	4.89E-13	3.03E-11	3.37E-12
5437	hsa-mir-144	hsa05214	Glioma	5595_5594_595_1870_1871_7157_1869_5925_6464	9	1.79E-12	1.11E-10	1.11E-11
5438	hsa-mir-144	hsa05218	Melanoma	5595_5594_595_4286_1870_1871_7157_1869_5925	9	3.69E-12	2.29E-10	2.08E-11
5439	hsa-mir-144	hsa05221	Acute myeloid leukemia	5371_5595_5594_595_5914_7704_5970_4609	8	3.75E-11	2.32E-09	1.94E-10
5440	hsa-mir-144	hsa05211	Renal cell carcinoma	5595_5594_3091_7428_2113_3725_2034_2033	8	1.61E-10	9.99E-09	7.69E-10
5441	hsa-mir-144	hsa04350	TGF-beta signaling pathway	5595_5594_4087_4609_4088_4089_2033_5933	8	6.51E-10	4.03E-08	2.88E-09
5442	hsa-mir-144	hsa05216	Thyroid cancer	5595_5594_6256_595_7157_4609	6	1.19E-09	7.39E-08	4.93E-09
5443	hsa-mir-144	hsa04310	Wnt signaling pathway	595_7157_4087_4609_3725_1457_4088_4089_2033	9	2.07E-09	1.28E-07	8.01E-09
5444	hsa-mir-144	hsa04520	Adherens junction	5595_5594_4087_1457_4088_4089_2033	7	1.10E-08	6.83E-07	4.02E-08
5445	hsa-mir-144	hsa04010	MAPK signaling pathway	5595_5594_4208_3312_5970_7157_4609_3725_4763_836	10	2.08E-08	1.29E-06	7.17E-08
5446	hsa-mir-144	hsa05016	Huntington's disease	6874_2902_7157_3066_3065_3064_2033_836	8	1.93E-07	1.20E-05	6.31E-07
5447	hsa-mir-144	hsa05213	Endometrial cancer	5595_5594_595_7157_4609	5	9.83E-07	6.10E-05	3.05E-06
5448	hsa-mir-144	hsa04012	ErbB signaling pathway	5595_5594_4609_3725_6464	5	1.06E-05	0.000656913	3.13E-05
5449	hsa-mir-144	hsa04330	Notch signaling pathway	9612_3066_3065_2033	4	1.99E-05	0.001235796	5.62E-05
5450	hsa-mir-144	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_7157_4846_836	4	3.81E-05	0.00236019	0.000102617
5451	hsa-mir-144	hsa04720	Long-term potentiation	5595_5594_2902_2033	4	0.000112099	0.006950151	0.000278006
5452	hsa-mir-144	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725	4	0.000112099	0.006950151	0.000278006
5453	hsa-mir-144	hsa05010	Alzheimer's disease	5595_5594_2902_4846_836	5	0.000272005	0.016864338	0.000648628
5454	hsa-mir-144	hsa04620	Toll-like receptor signaling pathway	5595_5594_5970_3725	4	0.000347565	0.021549049	0.000798113
5455	hsa-mir-144	hsa04916	Melanogenesis	5595_5594_4286_2033	4	0.000373172	0.023136643	0.000826309
5456	hsa-mir-144	hsa04660	T cell receptor signaling pathway	5595_5594_5970_3725	4	0.000458077	0.028400745	0.000979336
5457	hsa-mir-144	hsa04510	Focal adhesion	5595_5594_595_3725_6464	5	0.000534758	0.033154988	0.001105166
5458	hsa-mir-144	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.000688286	0.042673748	0.001376573
5459	hsa-mir-144	hsa04910	Insulin signaling pathway	6720_5595_5594_6464	4	0.001042813	0.064654432	0.001959225
5460	hsa-mir-144	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_6464	4	0.001042813	0.064654432	0.001959225
5461	hsa-mir-144	hsa04115	p53 signaling pathway	595_7157_836	3	0.001505878	0.093364444	0.002746013
5462	hsa-mir-144	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5970_3725_836	3	0.001629421	0.101024104	0.002806225
5463	hsa-mir-144	hsa04730	Long-term depression	5595_5594_4846	3	0.001629421	0.101024104	0.002806225
5464	hsa-mir-144	hsa04370	VEGF signaling pathway	5595_5594_4846	3	0.002037497	0.126324804	0.003414184
5465	hsa-mir-144	hsa04612	Antigen processing and presentation	4800_4801_3312	3	0.003031441	0.18794936	0.004819214
5466	hsa-mir-144	hsa04210	Apoptosis	5970_7157_836	3	0.003031441	0.18794936	0.004819214
5467	hsa-mir-144	hsa04062	Chemokine signaling pathway	5595_5594_5970_6464	4	0.003432618	0.212822338	0.005320558
5468	hsa-mir-144	hsa04912	GnRH signaling pathway	5595_5594_3725	3	0.005131225	0.318135948	0.007759413
5469	hsa-mir-144	hsa04930	Type II diabetes mellitus	5595_5594	2	0.009524046	0.590490858	0.014059306
5470	hsa-mir-144	hsa04120	Ubiquitin mediated proteolysis	5371_672_7428	3	0.010084082	0.625213079	0.014539839
5471	hsa-mir-144	hsa04630	Jak-STAT signaling pathway	595_4609_2033	3	0.01343412	0.832915445	0.018929896
5472	hsa-mir-144	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.019773498	1	0.027243487
5473	hsa-mir-144	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.026659315	1	0.035932121
5474	hsa-mir-144	hsa04540	Gap junction	5595_5594	2	0.035724885	1	0.047126445
5475	hsa-mir-144	hsa04710	Circadian rhythm - mammal	8863	1	0.042861871	1	0.055363251
5476	hsa-mir-144	hsa03450	Non-homologous end-joining	5591	1	0.045852928	1	0.058017991
5477	hsa-mir-145	hsa05200	Pathways in cancer	3320_1147_4149_5371_2249_1499_5595_5594_5599_5914_1387_6256_3326_5604_367_8517_2932_7704_6774_6502_6776_6777_5970_6688_2113_5894_4609_1869_3725_1029_2353_4087_4088_7175_3065_4292_3551_5925_2033_1050_207_4791_4792	43	6.09E-32	4.57E-30	4.57E-30
5478	hsa-mir-145	hsa05221	Acute myeloid leukemia	1147_5371_5595_5594_5914_5604_8517_7704_6774_6776_6777_5970_6688_5894_4609_3551_1050_207	18	9.72E-20	7.29E-18	3.65E-18
5479	hsa-mir-145	hsa05215	Prostate cancer	3320_1147_1499_5595_5594_1387_3326_5604_367_8517_2932_5970_5894_1869_3551_5925_2033_207_4792	19	2.40E-18	1.80E-16	5.41E-17
5480	hsa-mir-145	hsa05212	Pancreatic cancer	3320_1147_1499_5595_5594_1387_3326_5604_367_8517_2932_5970_5894_1869_3551_5925_2033_207_4792	19	2.89E-18	2.16E-16	5.41E-17
5481	hsa-mir-145	hsa05220	Chronic myeloid leukemia	1147_5595_5594_5604_8517_6776_6777_5970_5894_4609_1869_1029_4088_3065_3551_5925_207_4792	18	3.73E-18	2.80E-16	5.60E-17
5482	hsa-mir-145	hsa04010	MAPK signaling pathway	6722_1147_4149_2249_5595_5594_5599_5598_1326_5604_3305_3303_5566_8517_3310_3312_1386_5971_5970_51701_5894_4609_3725_2353_3551_207_4791	27	1.20E-17	8.98E-16	1.50E-16
5483	hsa-mir-145	hsa04310	Wnt signaling pathway	23291_1499_5599_1387_8607_5566_2932_8454_1459_51701_8061_4609_3725_1457_6500_4087_4088_2033_8945	19	1.90E-14	1.43E-12	2.04E-13
5484	hsa-mir-145	hsa04662	B cell receptor signaling pathway	1147_5595_5594_5604_4794_8517_2932_5970_5894_3725_2353_3551_207_4792_4793	15	2.52E-14	1.89E-12	2.27E-13
5485	hsa-mir-145	hsa04540	Gap junction	5595_5594_5598_983_5604_5566_347733_7277_10382_84617_5894_7846_7278_51807_203068_10376	16	2.72E-14	2.04E-12	2.27E-13
5486	hsa-mir-145	hsa04660	T cell receptor signaling pathway	1147_5595_5594_1326_5604_4794_8517_2932_5970_5894_3725_2353_3551_207_4792_4793	16	2.79E-13	2.09E-11	2.09E-12
5487	hsa-mir-145	hsa04110	Cell cycle	990_5591_1387_983_2932_8454_6502_1869_1029_6500_4087_4088_3065_5925_2033_5933	16	8.28E-13	6.21E-11	5.65E-12
5488	hsa-mir-145	hsa05210	Colorectal cancer	1499_5595_5594_5599_5604_2932_5894_4609_3725_2353_4087_4088_4292_207	14	1.68E-12	1.26E-10	1.05E-11
5489	hsa-mir-145	hsa05131	Shigellosis	1499_347733_7277_10382_84617_7846_7278_51807_4691_203068_71_10376	12	4.98E-12	3.74E-10	2.67E-11
5490	hsa-mir-145	hsa05130	Pathogenic Escherichia coli infection	1499_347733_7277_10382_84617_7846_7278_51807_4691_203068_71_10376	12	4.98E-12	3.74E-10	2.67E-11
5491	hsa-mir-145	hsa04062	Chemokine signaling pathway	1147_5595_5594_5604_5566_8517_2932_6774_6777_5970_653361_5894_3551_207_4792_4793_7074	17	7.69E-11	5.76E-09	3.84E-10
5492	hsa-mir-145	hsa04620	Toll-like receptor signaling pathway	1147_5595_5594_5599_1326_5604_8517_5970_3725_2353_3551_207_4792	13	2.17E-10	1.62E-08	1.02E-09
5493	hsa-mir-145	hsa05214	Glioma	5595_5594_5604_5894_1869_1029_5925_207_808_801_805	11	3.64E-10	2.73E-08	1.61E-09
5494	hsa-mir-145	hsa05222	Small cell lung cancer	1147_4149_6256_8517_6502_5970_4609_1869_3551_5925_207_4792	12	4.22E-10	3.17E-08	1.76E-09
5495	hsa-mir-145	hsa04920	Adipocytokine signaling pathway	1147_5599_6256_4794_8517_6774_5970_3551_207_4792_4793	11	4.86E-10	3.64E-08	1.92E-09
5496	hsa-mir-145	hsa04520	Adherens junction	1499_5595_5594_1387_1459_51701_1457_4087_4088_2033_71	11	2.62E-09	1.97E-07	9.84E-09
5497	hsa-mir-145	hsa04916	Melanogenesis	1499_5595_5594_1387_5604_5566_2932_5894_2033_808_801_805	12	3.03E-09	2.27E-07	1.08E-08
5498	hsa-mir-145	hsa04350	TGF-beta signaling pathway	5595_5594_1387_8454_4609_6500_4087_4088_2033_6667_5933	11	5.83E-09	4.37E-07	1.90E-08
5499	hsa-mir-145	hsa04012	ErbB signaling pathway	5595_5594_5599_5604_2932_6776_6777_5894_4609_3725_207	11	5.83E-09	4.37E-07	1.90E-08
5500	hsa-mir-145	hsa05213	Endometrial cancer	1499_5595_5594_5604_2932_5894_4609_4292_207	9	1.25E-08	9.40E-07	3.92E-08
5501	hsa-mir-145	hsa05223	Non-small cell lung cancer	5595_5594_6256_5604_5894_1869_1029_5925_207	9	1.68E-08	1.26E-06	5.04E-08
5502	hsa-mir-145	hsa04720	Long-term potentiation	5595_5594_1387_5604_5566_5894_2033_808_801_805	10	1.83E-08	1.37E-06	5.28E-08
5503	hsa-mir-145	hsa05219	Bladder cancer	5595_5594_5604_5894_4609_1869_1029_5925	8	4.25E-08	3.19E-06	1.18E-07
5504	hsa-mir-145	hsa04912	GnRH signaling pathway	5595_5594_5599_5598_5604_5566_5894_3725_808_801_805	11	4.53E-08	3.40E-06	1.21E-07
5505	hsa-mir-145	hsa04910	Insulin signaling pathway	5595_5594_5599_5604_5566_2932_5894_3551_207_808_801_805	12	5.57E-08	4.18E-06	1.44E-07
5506	hsa-mir-145	hsa04120	Ubiquitin mediated proteolysis	55294_5371_23291_672_8454_6502_3093_10273_6500_7323_7329_8945	12	5.99E-08	4.50E-06	1.50E-07
5507	hsa-mir-145	hsa05216	Thyroid cancer	1499_5595_5594_6256_5604_4609_7175	7	7.40E-08	5.55E-06	1.79E-07
5508	hsa-mir-145	hsa04612	Antigen processing and presentation	3320_3326_3309_3305_3303_4800_4801_4802_3310_3312	10	8.02E-08	6.02E-06	1.88E-07
5509	hsa-mir-145	hsa05218	Melanoma	2249_5595_5594_5604_5894_1869_1029_5925_207	9	1.41E-07	1.06E-05	3.21E-07
5510	hsa-mir-145	hsa05211	Renal cell carcinoma	5595_5594_1387_5604_2113_5894_3725_2033_207	9	1.57E-07	1.18E-05	3.47E-07
5511	hsa-mir-145	hsa05016	Huntington's disease	1387_292_6908_5437_1213_23186_3065_3064_293_2033_6667_5441	12	1.25E-06	9.37E-05	2.68E-06
5512	hsa-mir-145	hsa03020	RNA polymerase	64425_5437_25885_51082_84172_5441	6	1.43E-06	0.00010731	2.98E-06
5513	hsa-mir-145	hsa04270	Vascular smooth muscle contraction	5595_5594_4637_5604_5566_5894_808_801_805	9	7.08E-06	0.000530831	1.43E-05
5514	hsa-mir-145	hsa04210	Apoptosis	1147_5566_8517_5970_8837_3551_207_4792	8	7.52E-06	0.000564364	1.49E-05
5515	hsa-mir-145	hsa04630	Jak-STAT signaling pathway	3559_1387_6778_6774_6776_6777_4609_2033_3977_207	10	8.85E-06	0.000663573	1.70E-05
5516	hsa-mir-145	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_5599_8517_5970_3725_3551_4792	7	1.62E-05	0.001213397	3.03E-05
5517	hsa-mir-145	hsa04510	Focal adhesion	1499_5595_5594_5599_5604_2932_5894_3725_10627_207_71	11	1.72E-05	0.001286367	3.09E-05
5518	hsa-mir-145	hsa04330	Notch signaling pathway	1387_9612_3065_2033_2648_4851	6	1.73E-05	0.001299151	3.09E-05
5519	hsa-mir-145	hsa04810	Regulation of actin cytoskeleton	2249_5595_5594_5604_4627_4628_10788_5894_10627_71_7074	11	2.93E-05	0.002200776	5.12E-05
5520	hsa-mir-145	hsa04530	Tight junction	1499_4627_4628_1459_1457_10627_207_71	8	0.000135487	0.010161536	0.000230944
5521	hsa-mir-145	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5604_5894_207	6	0.00025058	0.018793501	0.000417633
5522	hsa-mir-145	hsa04370	VEGF signaling pathway	5595_5594_5604_5894_207	5	0.001598644	0.119898314	0.00258532
5523	hsa-mir-145	hsa04930	Type II diabetes mellitus	5595_5594_5599_3551	4	0.001620134	0.121510042	0.00258532
5524	hsa-mir-145	hsa05010	Alzheimer's disease	22926_5595_5594_2932_808_801_805	7	0.00307215	0.230411252	0.004800234
5525	hsa-mir-145	hsa04340	Hedgehog signaling pathway	23291_5566_2932_8945	4	0.003624011	0.271800815	0.005546955
5526	hsa-mir-145	hsa04730	Long-term depression	5595_5594_5604_5894	4	0.007547507	0.566063051	0.011321261
5527	hsa-mir-145	hsa03022	Basal transcription factors	2962_2969_6908	3	0.00805387	0.604040262	0.011843927
5528	hsa-mir-145	hsa03450	Non-homologous end-joining	5591_2547	2	0.011521526	0.864114432	0.016617585
5529	hsa-mir-145	hsa04020	Calcium signaling pathway	292_5566_293_808_801_805	6	0.014175041	1	0.02005902
5530	hsa-mir-145	hsa04150	mTOR signaling pathway	5595_5594_207	3	0.019109446	1	0.026540897
5531	hsa-mir-145	hsa03010	Ribosome	6156_6128_6207_6202	4	0.02413081	1	0.032905651
5532	hsa-mir-145	hsa04115	p53 signaling pathway	983_7161_1029	3	0.038281996	1	0.051270531
5533	hsa-mir-145	hsa04670	Leukocyte transendothelial migration	1499_653361_10627_71	4	0.041562113	1	0.05468699
5534	hsa-mir-145	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.048201684	1	0.062329764
5535	hsa-mir-1468	hsa05215	Prostate cancer	1147_3551_2033_207_208_2932_367_1499_1387	9	4.81E-14	2.45E-12	1.35E-12
5536	hsa-mir-1468	hsa05212	Pancreatic cancer	1147_3551_2033_207_208_2932_367_1499_1387	9	5.28E-14	2.70E-12	1.35E-12
5537	hsa-mir-1468	hsa05200	Pathways in cancer	1147_4087_4088_4089_3551_2033_207_208_2932_367_1499_1387	12	2.64E-13	1.35E-11	4.49E-12
5538	hsa-mir-1468	hsa04110	Cell cycle	4087_4088_4089_2033_7534_7532_2932_1387	8	3.18E-11	1.62E-09	4.05E-10
5539	hsa-mir-1468	hsa04520	Adherens junction	4087_4088_4089_2033_1499_6714_1387	7	1.04E-10	5.29E-09	1.06E-09
5540	hsa-mir-1468	hsa05210	Colorectal cancer	4087_4088_4089_207_208_2932_1499	7	1.43E-10	7.29E-09	1.22E-09
5541	hsa-mir-1468	hsa05220	Chronic myeloid leukemia	1147_4088_4089_3551_207_208	6	4.05E-09	2.07E-07	2.95E-08
5542	hsa-mir-1468	hsa04310	Wnt signaling pathway	4087_4088_4089_2033_2932_1499_1387	7	7.25E-09	3.70E-07	4.62E-08
5543	hsa-mir-1468	hsa04660	T cell receptor signaling pathway	1147_5058_3551_207_208_2932	6	3.55E-08	1.81E-06	2.01E-07
5544	hsa-mir-1468	hsa04920	Adipocytokine signaling pathway	1147_3551_207_208_2538	5	1.20E-07	6.14E-06	6.14E-07
5545	hsa-mir-1468	hsa05211	Renal cell carcinoma	5058_2033_207_208_1387	5	1.69E-07	8.62E-06	7.84E-07
5546	hsa-mir-1468	hsa04662	B cell receptor signaling pathway	1147_3551_207_208_2932	5	2.05E-07	1.05E-05	8.71E-07
5547	hsa-mir-1468	hsa04350	TGF-beta signaling pathway	4087_4088_4089_2033_1387	5	4.13E-07	2.11E-05	1.51E-06
5548	hsa-mir-1468	hsa04012	ErbB signaling pathway	5058_207_208_2932_6714	5	4.13E-07	2.11E-05	1.51E-06
5549	hsa-mir-1468	hsa04062	Chemokine signaling pathway	1147_5058_3551_207_208_2932	6	8.63E-07	4.40E-05	2.93E-06
5550	hsa-mir-1468	hsa04510	Focal adhesion	5058_207_208_2932_1499_6714	6	1.25E-06	6.36E-05	3.98E-06
5551	hsa-mir-1468	hsa05213	Endometrial cancer	207_208_2932_1499	4	2.15E-06	0.000109794	6.46E-06
5552	hsa-mir-1468	hsa05221	Acute myeloid leukemia	1147_3551_207_208	4	3.46E-06	0.000176576	9.81E-06
5553	hsa-mir-1468	hsa04910	Insulin signaling pathway	3551_207_208_2932_2538	5	3.67E-06	0.000186948	9.84E-06
5554	hsa-mir-1468	hsa04010	MAPK signaling pathway	1147_6722_5058_3551_207_208	6	6.07E-06	0.00030971	1.55E-05
5555	hsa-mir-1468	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_5058_3551_6714	4	6.96E-06	0.000355163	1.69E-05
5556	hsa-mir-1468	hsa05222	Small cell lung cancer	1147_3551_207_208	4	1.44E-05	0.00073336	3.33E-05
5557	hsa-mir-1468	hsa04210	Apoptosis	1147_3551_207_208	4	1.64E-05	0.000834985	3.63E-05
5558	hsa-mir-1468	hsa04620	Toll-like receptor signaling pathway	1147_3551_207_208	4	2.74E-05	0.001398736	5.83E-05
5559	hsa-mir-1468	hsa04916	Melanogenesis	2033_2932_1499_1387	4	2.95E-05	0.001505338	6.02E-05
5560	hsa-mir-1468	hsa04530	Tight junction	207_208_1499_6714	4	8.35E-05	0.004260277	0.000163857
5561	hsa-mir-1468	hsa04630	Jak-STAT signaling pathway	2033_207_208_1387	4	0.000132851	0.006775404	0.000250941
5562	hsa-mir-1468	hsa04370	VEGF signaling pathway	207_208_6714	3	0.000306481	0.015630512	0.000558233
5563	hsa-mir-1468	hsa04330	Notch signaling pathway	2033_1387	2	0.00291712	0.148773115	0.005130107
5564	hsa-mir-1468	hsa04150	mTOR signaling pathway	207_208	2	0.003531285	0.180095551	0.006003185
5565	hsa-mir-1468	hsa05223	Non-small cell lung cancer	207_208	2	0.003792388	0.19341177	0.006093336
5566	hsa-mir-1468	hsa05217	Basal cell carcinoma	2932_1499	2	0.003926218	0.200237103	0.006093336
5567	hsa-mir-1468	hsa05131	Shigellosis	7534_1499	2	0.004062224	0.20717343	0.006093336
5568	hsa-mir-1468	hsa05130	Pathogenic Escherichia coli infection	7534_1499	2	0.004062224	0.20717343	0.006093336
5569	hsa-mir-1468	hsa04340	Hedgehog signaling pathway	2932_53944	2	0.0042004	0.214220386	0.006120582
5570	hsa-mir-1468	hsa05214	Glioma	207_208	2	0.005383042	0.27453516	0.007625977
5571	hsa-mir-1468	hsa05218	Melanoma	207_208	2	0.006358656	0.324291439	0.008764633
5572	hsa-mir-1468	hsa04720	Long-term potentiation	2033_1387	2	0.007050434	0.359572129	0.009462424
5573	hsa-mir-1468	hsa04664	Fc epsilon RI signaling pathway	207_208	2	0.007774794	0.396514501	0.010167038
5574	hsa-mir-1468	hsa04360	Axon guidance	5058_2932	2	0.019963764	1	0.0254538
5575	hsa-mir-1468	hsa05016	Huntington's disease	2033_1387	2	0.038516907	1	0.047911274
5576	hsa-mir-1468	hsa04950	Maturity onset diabetes of the young	3172	1	0.03999457	1	0.048564835
5577	hsa-mir-1468	hsa05216	Thyroid cancer	1499	1	0.047803337	1	0.056696981
5578	hsa-mir-1469	hsa05200	Pathways in cancer	3320_4149_5371_9063_367_1499_5594_5595_5599_6258_6256_1488_4286_1487_2932_1387_842_6502_6772_5970_8554_4824_5604_5894_3725_1029_841_4087_4088_4089_5601_4292_1050_5925_2033_207_836	37	1.27E-25	8.99E-24	8.99E-24
5579	hsa-mir-1469	hsa04110	Cell cycle	993_5591_7532_983_7531_2932_8454_7534_1387_6502_6500_1029_4087_4088_4089_990_5925_2033_5933	19	2.84E-16	2.01E-14	1.01E-14
5580	hsa-mir-1469	hsa04010	MAPK signaling pathway	9479_6722_4149_5594_5595_5599_5598_9261_5608_6195_3312_1386_1432_5970_5604_5894_3725_5601_5058_3303_207_836_51701_2002_2005	25	8.30E-16	5.90E-14	1.97E-14
5581	hsa-mir-1469	hsa04310	Wnt signaling pathway	815_1499_5599_1488_1487_5518_2932_8454_1387_6500_6423_3725_1457_1459_4087_4088_4089_5601_2033_51701	20	1.32E-15	9.36E-14	2.34E-14
5582	hsa-mir-1469	hsa05210	Colorectal cancer	1499_5594_5595_5599_2932_842_5604_5894_3725_4087_4088_4089_5601_4292_207_836	16	5.75E-15	4.08E-13	8.17E-14
5583	hsa-mir-1469	hsa05215	Prostate cancer	3320_367_1499_5594_5595_1385_2932_1387_842_5970_4824_5604_5894_5925_2033_207	16	1.09E-14	7.76E-13	1.29E-13
5584	hsa-mir-1469	hsa05212	Pancreatic cancer	3320_367_1499_5594_5595_1385_2932_1387_842_5970_4824_5604_5894_5925_2033_207	16	1.28E-14	9.07E-13	1.30E-13
5585	hsa-mir-1469	hsa04520	Adherens junction	1499_6714_5594_5595_1387_1457_1459_4087_4088_4089_2033_71_51701	13	1.25E-11	8.87E-10	1.11E-10
5586	hsa-mir-1469	hsa04350	TGF-beta signaling pathway	5594_5595_6667_5518_8454_1387_6500_3398_4087_4088_4089_2033_5933	13	3.21E-11	2.28E-09	2.28E-10
5587	hsa-mir-1469	hsa04012	ErbB signaling pathway	815_6714_5594_5595_5599_2932_5604_5894_3725_5601_5058_207_2002	13	3.21E-11	2.28E-09	2.28E-10
5588	hsa-mir-1469	hsa05220	Chronic myeloid leukemia	5594_5595_1488_1487_5970_5604_5894_1029_4088_4089_5925_207	12	9.14E-11	6.49E-09	5.90E-10
5589	hsa-mir-1469	hsa04912	GnRH signaling pathway	815_6714_5594_5595_5599_5598_5608_1432_5604_5894_3725_5601_2002	13	3.66E-10	2.60E-08	2.17E-09
5590	hsa-mir-1469	hsa05213	Endometrial cancer	1499_5594_5595_2932_842_5604_5894_4292_207_2002	10	7.06E-10	5.01E-08	3.86E-09
5591	hsa-mir-1469	hsa04540	Gap junction	7846_7277_6714_5594_5595_5598_983_7278_5604_5894_51807_10376	12	8.54E-10	6.06E-08	4.33E-09
5592	hsa-mir-1469	hsa05223	Non-small cell lung cancer	5594_5595_6258_6256_842_5604_5894_1029_5925_207	10	9.77E-10	6.94E-08	4.62E-09
5593	hsa-mir-1469	hsa04620	Toll-like receptor signaling pathway	5594_5595_5599_5608_1432_6772_5970_5604_3725_841_5601_207	12	2.23E-09	1.58E-07	9.88E-09
5594	hsa-mir-1469	hsa03022	Basal transcription factors	2962_2969_6879_6908_6872_2959_6880_2958	8	1.66E-08	1.18E-06	6.92E-08
5595	hsa-mir-1469	hsa05131	Shigellosis	7846_7277_1499_7534_7278_51807_4691_71_10376	9	2.05E-08	1.46E-06	7.67E-08
5596	hsa-mir-1469	hsa05130	Pathogenic Escherichia coli infection	7846_7277_1499_7534_7278_51807_4691_71_10376	9	2.05E-08	1.46E-06	7.67E-08
5597	hsa-mir-1469	hsa04916	Melanogenesis	815_1499_5594_5595_1385_4286_2932_1387_5604_5894_2033	11	2.88E-08	2.04E-06	1.02E-07
5598	hsa-mir-1469	hsa04660	T cell receptor signaling pathway	5594_5595_2932_1432_5970_5604_5894_3725_5601_5058_207	11	4.89E-08	3.47E-06	1.65E-07
5599	hsa-mir-1469	hsa05222	Small cell lung cancer	4149_9063_6258_6256_842_6502_5970_8554_5925_207	10	5.46E-08	3.88E-06	1.76E-07
5600	hsa-mir-1469	hsa04510	Focal adhesion	1499_6714_5594_5595_5599_2932_5604_5894_3725_5601_5058_207_71_2002	14	6.97E-08	4.95E-06	2.15E-07
5601	hsa-mir-1469	hsa05211	Renal cell carcinoma	5594_5595_1387_5604_5894_3725_5058_2033_207	9	1.45E-07	1.03E-05	4.30E-07
5602	hsa-mir-1469	hsa04370	VEGF signaling pathway	6714_5594_5595_9261_1432_842_5604_5894_207	9	2.45E-07	1.74E-05	6.95E-07
5603	hsa-mir-1469	hsa04664	Fc epsilon RI signaling pathway	5594_5595_5599_5608_1432_5604_5894_5601_207	9	2.99E-07	2.12E-05	8.16E-07
5604	hsa-mir-1469	hsa05221	Acute myeloid leukemia	5371_5594_5595_5970_5604_5894_1050_207	8	4.13E-07	2.93E-05	1.08E-06
5605	hsa-mir-1469	hsa04612	Antigen processing and presentation	3320_1385_3308_4800_4802_3312_1514_3303_4801	9	7.53E-07	5.35E-05	1.91E-06
5606	hsa-mir-1469	hsa05214	Glioma	815_5594_5595_5604_5894_1029_5925_207	8	8.07E-07	5.73E-05	1.97E-06
5607	hsa-mir-1469	hsa04330	Notch signaling pathway	1488_1487_1387_9612_2033_2648_8850	7	1.26E-06	8.92E-05	2.97E-06
5608	hsa-mir-1469	hsa05216	Thyroid cancer	1499_5594_5595_6258_6256_5604	6	1.35E-06	9.61E-05	3.10E-06
5609	hsa-mir-1469	hsa05218	Melanoma	5594_5595_4286_5604_5894_1029_5925_207	8	1.48E-06	0.000105409	3.19E-06
5610	hsa-mir-1469	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_5599_1432_5970_3725_5601_5058_836	8	1.48E-06	0.000105409	3.19E-06
5611	hsa-mir-1469	hsa04720	Long-term potentiation	815_5594_5595_6195_1387_5604_5894_2033	8	2.17E-06	0.000153847	4.40E-06
5612	hsa-mir-1469	hsa04662	B cell receptor signaling pathway	5594_5595_2932_5970_5604_5894_3725_207	8	2.17E-06	0.000153847	4.40E-06
5613	hsa-mir-1469	hsa04910	Insulin signaling pathway	5594_5595_5599_2932_5604_5894_5601_207_2002_2538	10	3.09E-06	0.000219547	6.10E-06
5614	hsa-mir-1469	hsa04120	Ubiquitin mediated proteolysis	55294_5371_9063_672_8454_6502_6500_8554_10273_7329	10	3.29E-06	0.000233246	6.30E-06
5615	hsa-mir-1469	hsa04062	Chemokine signaling pathway	5594_5595_2932_2931_6772_5970_5604_5894_5058_7074_207	11	8.79E-06	0.000624381	1.64E-05
5616	hsa-mir-1469	hsa05219	Bladder cancer	5594_5595_5604_5894_1029_5925	6	9.16E-06	0.000650104	1.67E-05
5617	hsa-mir-1469	hsa04920	Adipocytokine signaling pathway	5599_6258_6256_5970_5601_207_2538	7	1.07E-05	0.000761778	1.90E-05
5618	hsa-mir-1469	hsa04210	Apoptosis	839_842_840_5970_841_207_836	7	5.87E-05	0.004168674	0.000101675
5619	hsa-mir-1469	hsa04115	p53 signaling pathway	983_842_7161_1029_841_836	6	0.000119333	0.008472633	0.000201729
5620	hsa-mir-1469	hsa04530	Tight junction	1499_6714_5518_8189_1457_1459_207_71	8	0.000126894	0.009009449	0.000209522
5621	hsa-mir-1469	hsa05010	Alzheimer's disease	22926_5594_5595_2932_842_840_1020_841_836	9	0.000132305	0.009393683	0.000213493
5622	hsa-mir-1469	hsa04630	Jak-STAT signaling pathway	9063_1387_6772_8554_3595_3594_2033_207	8	0.000282621	0.020066091	0.000445913
5623	hsa-mir-1469	hsa03450	Non-homologous end-joining	5591_7520_2547	3	0.000641819	0.045569164	0.000990634
5624	hsa-mir-1469	hsa05016	Huntington's disease	1385_6908_6667_1387_842_841_2033_836	8	0.00095435	0.067758877	0.001441678
5625	hsa-mir-1469	hsa04730	Long-term depression	5594_5595_5518_5604_5894	5	0.001090708	0.077440264	0.001613339
5626	hsa-mir-1469	hsa04930	Type II diabetes mellitus	5594_5595_5599_5601	4	0.001564508	0.111080097	0.002266941
5627	hsa-mir-1469	hsa04150	mTOR signaling pathway	5594_5595_6195_207	4	0.002565164	0.182126671	0.003642533
5628	hsa-mir-1469	hsa05014	Amyotrophic lateral sclerosis (ALS)	5608_1432_842_836	4	0.00329917	0.234241076	0.004592962
5629	hsa-mir-1469	hsa04650	Natural killer cell mediated cytotoxicity	5594_5595_5604_5894_5058_836	6	0.00368447	0.261597392	0.005030719
5630	hsa-mir-1469	hsa04810	Regulation of actin cytoskeleton	5594_5595_5604_5894_5058_7074_71	7	0.008781047	0.623454322	0.011763289
5631	hsa-mir-1469	hsa04360	Axon guidance	5594_5595_2932_1020_5058	5	0.012996191	0.922729594	0.017087585
5632	hsa-mir-1469	hsa04270	Vascular smooth muscle contraction	5594_5595_5604_5894	4	0.036536277	1	0.047165012
5633	hsa-mir-146b	hsa05200	Pathways in cancer	3716_3320_3326_5925_5371_3480_1956_4233_5595_5594_5599_1387_2064_6256_5159_595_5156_367_2261_4193_6776_6777_6772_5979_5879_7157_6688_2113_4609_3725_1026_2353_10401_3066_3065_2033_1441_8554_4790_4792_5970_7184	42	4.02E-33	2.98E-31	2.98E-31
5634	hsa-mir-146b	hsa03022	Basal transcription factors	2961_2960_2963_6881_2969_6874_6878_2957_6879_6877_6873_2958_6872_2968_54457_6884_2959_6882_6880_138474_2967_6883	22	3.42E-30	2.53E-28	1.26E-28
5635	hsa-mir-146b	hsa04630	Jak-STAT signaling pathway	3717_3716_3718_3559_85480_3566_3560_149233_1387_595_3575_3570_3572_3953_5777_6776_6777_6772_1439_3454_3455_5781_4609_2690_10401_6773_2033_1441_8554	29	2.09E-27	1.54E-25	5.15E-26
5636	hsa-mir-146b	hsa05215	Prostate cancer	3320_3326_5925_3480_1956_5595_5594_1387_2064_5159_595_5156_367_4193_7157_468_1026_2033_4790_4792_5970_7184	22	1.93E-23	1.43E-21	3.53E-22
5637	hsa-mir-146b	hsa05212	Pancreatic cancer	3320_3326_5925_3480_1956_5595_5594_1387_2064_5159_595_5156_367_4193_7157_468_1026_2033_4790_4792_5970_7184	22	2.38E-23	1.76E-21	3.53E-22
5638	hsa-mir-146b	hsa05220	Chronic myeloid leukemia	5925_5595_5594_595_4193_6776_6777_7157_5781_4609_1026_3066_3065_4790_4792_5970	16	1.96E-16	1.45E-14	2.42E-15
5639	hsa-mir-146b	hsa04060	Cytokine-cytokine receptor interaction	3556_2321_3559_85480_1956_3566_4233_3560_149233_5159_5156_3575_3570_3572_1234_1230_3953_1439_7852_3454_3455_2690_1441	23	2.35E-15	1.74E-13	2.49E-14
5640	hsa-mir-146b	hsa04010	MAPK signaling pathway	3925_1956_5595_5594_5599_5159_5156_2261_2264_9252_3312_1649_5879_7157_468_6885_4609_3725_3727_2353_4790_51701_5970	23	5.32E-15	3.94E-13	4.92E-14
5641	hsa-mir-146b	hsa04520	Adherens junction	2241_3480_1956_6714_4233_5595_5594_1387_2064_5777_5879_6885_1460_2033_51701	15	9.30E-15	6.88E-13	7.64E-14
5642	hsa-mir-146b	hsa05219	Bladder cancer	5925_1956_5595_5594_2064_595_2261_9252_4193_7157_4609_1026	12	6.06E-14	4.49E-12	4.49E-13
5643	hsa-mir-146b	hsa05210	Colorectal cancer	3480_1956_4233_5595_5594_5599_5159_595_5156_5879_7157_4609_3725_2353	14	3.09E-13	2.28E-11	2.08E-12
5644	hsa-mir-146b	hsa04062	Chemokine signaling pathway	3717_3718_5580_5590_5595_5594_1234_1230_6777_6772_5879_7852_3055_2185_6773_4790_4792_5970	18	1.08E-12	7.98E-11	6.65E-12
5645	hsa-mir-146b	hsa04620	Toll-like receptor signaling pathway	3654_5595_5594_5599_6772_5879_3454_3455_6885_3725_2353_4790_4792_5970	14	3.31E-12	2.45E-10	1.88E-11
5646	hsa-mir-146b	hsa05218	Melanoma	5925_3480_1956_4233_5595_5594_5159_595_5156_4193_7157_1026	12	1.36E-11	1.00E-09	7.17E-11
5647	hsa-mir-146b	hsa05214	Glioma	5925_3480_1956_5595_5594_5159_595_5156_4193_7157_1026	11	9.66E-11	7.15E-09	4.77E-10
5648	hsa-mir-146b	hsa05221	Acute myeloid leukemia	5371_5595_5594_595_6776_6777_6688_4609_4790_5970	10	6.89E-10	5.10E-08	3.19E-09
5649	hsa-mir-146b	hsa04012	ErbB signaling pathway	1956_6714_5595_5594_5599_2064_6776_6777_4609_3725_1026	11	1.58E-09	1.17E-07	6.90E-09
5650	hsa-mir-146b	hsa04110	Cell cycle	5925_7533_1387_595_4193_7157_1026_4171_4085_3066_3065_2033	12	3.02E-09	2.23E-07	1.24E-08
5651	hsa-mir-146b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_4233_5599_5879_5781_3725_4790_4792_5970	10	3.46E-09	2.56E-07	1.35E-08
5652	hsa-mir-146b	hsa04662	B cell receptor signaling pathway	5595_5594_5777_5879_6850_3725_2353_4790_4792_5970	10	5.58E-09	4.13E-07	2.07E-08
5653	hsa-mir-146b	hsa04510	Focal adhesion	2321_3480_1956_6714_4233_5595_5594_5599_2064_5159_595_5156_5879_3725	14	1.65E-08	1.22E-06	5.82E-08
5654	hsa-mir-146b	hsa05222	Small cell lung cancer	5925_6256_595_7157_4609_10401_8554_4790_4792_5970	10	1.84E-08	1.36E-06	6.20E-08
5655	hsa-mir-146b	hsa05216	Thyroid cancer	5595_5594_6256_595_5979_7157_4609	7	3.15E-08	2.33E-06	1.01E-07
5656	hsa-mir-146b	hsa04330	Notch signaling pathway	1387_388585_3280_9612_3066_3065_2033_8850	8	3.52E-08	2.61E-06	1.09E-07
5657	hsa-mir-146b	hsa04310	Wnt signaling pathway	5599_1387_595_8607_5879_7157_6885_4609_3725_1460_2033_51701	12	3.82E-08	2.83E-06	1.13E-07
5658	hsa-mir-146b	hsa05211	Renal cell carcinoma	4233_5595_5594_1387_5879_5781_2113_3725_2033	9	5.44E-08	4.03E-06	1.55E-07
5659	hsa-mir-146b	hsa05223	Non-small cell lung cancer	5925_1956_5595_5594_2064_6256_595_7157	8	9.26E-08	6.85E-06	2.54E-07
5660	hsa-mir-146b	hsa04660	T cell receptor signaling pathway	3932_5595_5594_5777_6885_3725_2353_4790_4792_5970	10	1.57E-07	1.16E-05	4.14E-07
5661	hsa-mir-146b	hsa04920	Adipocytokine signaling pathway	3717_5599_6256_3953_5781_4790_4792_5970	8	4.17E-07	3.09E-05	1.06E-06
5662	hsa-mir-146b	hsa05213	Endometrial cancer	1956_5595_5594_2064_595_7157_4609	7	1.08E-06	7.97E-05	2.63E-06
5663	hsa-mir-146b	hsa04650	Natural killer cell mediated cytotoxicity	3932_5595_5594_5777_5879_6850_3454_3455_5781_2185	10	1.10E-06	8.14E-05	2.63E-06
5664	hsa-mir-146b	hsa04912	GnRH signaling pathway	5580_1956_6714_5595_5594_5599_468_2185_3725	9	1.30E-06	9.60E-05	3.00E-06
5665	hsa-mir-146b	hsa04210	Apoptosis	3654_3556_1439_7157_4790_4792_5970	7	2.83E-05	0.002093138	6.34E-05
5666	hsa-mir-146b	hsa04540	Gap junction	1956_6714_5595_5594_5159_5156_10382	7	3.68E-05	0.002725786	8.02E-05
5667	hsa-mir-146b	hsa05016	Huntington's disease	6874_1387_9001_5430_7157_3064_3066_3065_2033	9	8.56E-05	0.006332271	0.000180922
5668	hsa-mir-146b	hsa04930	Type II diabetes mellitus	5580_5590_5595_5594_5599	5	9.04E-05	0.006693064	0.000185918
5669	hsa-mir-146b	hsa03050	Proteasome	5710_5705_5701_5702_5719	5	0.000119815	0.008866327	0.00023963
5670	hsa-mir-146b	hsa04664	Fc epsilon RI signaling pathway	5580_5595_5594_5599_5879_6850	6	0.000127572	0.009440347	0.00024843
5671	hsa-mir-146b	hsa04350	TGF-beta signaling pathway	5595_5594_1387_4609_4086_2033	6	0.000209297	0.015487985	0.000397128
5672	hsa-mir-146b	hsa04720	Long-term potentiation	5595_5594_1387_468_2033	5	0.000822584	0.060871215	0.00152178
5673	hsa-mir-146b	hsa03420	Nucleotide excision repair	2968_6118_5887_2967	4	0.000946548	0.070044567	0.001708404
5674	hsa-mir-146b	hsa04810	Regulation of actin cytoskeleton	1956_5595_5594_5159_5156_2261_2264_5879	8	0.001169773	0.086563176	0.002061028
5675	hsa-mir-146b	hsa04640	Hematopoietic cell lineage	3559_3566_3575_3570_1441	5	0.001540831	0.114021459	0.002651662
5676	hsa-mir-146b	hsa04360	Axon guidance	2242_4233_5595_5594_5879_7852	6	0.001620525	0.119918872	0.002725429
5677	hsa-mir-146b	hsa04612	Antigen processing and presentation	3320_3326_4801_3312_2923	5	0.001694834	0.125417729	0.002787061
5678	hsa-mir-146b	hsa04950	Maturity onset diabetes of the young	6927_3280_5080	3	0.001845166	0.136542267	0.00296831
5679	hsa-mir-146b	hsa04115	p53 signaling pathway	595_4193_7157_1026	4	0.00443676	0.328320227	0.006985537
5680	hsa-mir-146b	hsa05340	Primary immunodeficiency	3718_3932_3575	3	0.00494486	0.365919623	0.007623325
5681	hsa-mir-146b	hsa04370	VEGF signaling pathway	6714_5595_5594_5879	4	0.006410736	0.474394465	0.00968152
5682	hsa-mir-146b	hsa04710	Circadian rhythm - mammal	406_8553	2	0.007984069	0.590821074	0.011816421
5683	hsa-mir-146b	hsa04910	Insulin signaling pathway	5590_5595_5594_5599_5211	5	0.010031868	0.742358219	0.014556044
5684	hsa-mir-146b	hsa04120	Ubiquitin mediated proteolysis	5371_672_4193_10401_8554	5	0.010317727	0.763511826	0.01468292
5685	hsa-mir-146b	hsa05322	Systemic lupus erythematosus	333932_3014_3015_8340_126961	5	0.011830978	0.875492359	0.016518724
5686	hsa-mir-146b	hsa04916	Melanogenesis	5595_5594_1387_2033	4	0.017095705	1	0.023427448
5687	hsa-mir-146b	hsa04670	Leukocyte transendothelial migration	5879_7852_5781_2185	4	0.02817868	1	0.037913133
5688	hsa-mir-146b	hsa04020	Calcium signaling pathway	1956_2064_5159_5156_2185	5	0.029557949	1	0.038893386
5689	hsa-mir-146b	hsa04730	Long-term depression	3480_5595_5594	3	0.029958419	1	0.038893386
5690	hsa-mir-146b	hsa04530	Tight junction	5580_6714_5590_1460	4	0.040048823	1	0.051096774
5691	hsa-mir-146b	hsa03030	DNA replication	6118_4171	2	0.046648205	1	0.058507918
5692	hsa-mir-1470	hsa05200	Pathways in cancer	25_5371_2034_7046_5595_5594_5599_861_5914_1387_6256_595_3326_10401_5601_4286_367_2932_4193_6688_7704_6772_3091_5970_7428_1870_1871_8554_7157_2113_4609_1869_3725_4088_2353_2736_4087_4089_3066_3065_1050_5925_2033_4846_207_836_7184	47	3.68E-31	2.80E-29	2.80E-29
5693	hsa-mir-1470	hsa03022	Basal transcription factors	2961_2960_2963_6881_2967_6879_6878_6877_2957_54457_2968_6908_6874_2958_6873_6872_6884_2959_6882_138474_6880_6883	22	1.97E-26	1.50E-24	7.49E-25
5694	hsa-mir-1470	hsa05220	Chronic myeloid leukemia	25_7046_5595_5594_861_595_4193_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_207_6464	20	1.46E-18	1.11E-16	3.70E-17
5695	hsa-mir-1470	hsa04010	MAPK signaling pathway	6722_7046_5595_5594_5599_5598_9261_4208_5601_5600_6197_9252_1432_5970_3312_7157_4609_3725_3727_6195_6196_2353_5603_8986_4763_1616_207_1649_8550_836	30	1.85E-17	1.41E-15	3.52E-16
5696	hsa-mir-1470	hsa04110	Cell cycle	25_4171_5591_1387_595_2932_4193_4085_1870_1871_7157_1869_4088_4087_4089_3066_3065_5925_2033_5933	20	3.54E-15	2.69E-13	5.38E-14
5697	hsa-mir-1470	hsa05215	Prostate cancer	5595_5594_1387_595_3326_367_2932_4193_5970_1870_1871_7157_9586_1869_5925_2033_207_7184	18	4.31E-15	3.27E-13	5.46E-14
5698	hsa-mir-1470	hsa05212	Pancreatic cancer	5595_5594_1387_595_3326_367_2932_4193_5970_1870_1871_7157_9586_1869_5925_2033_207_7184	18	5.11E-15	3.89E-13	5.55E-14
5699	hsa-mir-1470	hsa05210	Colorectal cancer	7046_5595_5594_5599_595_5601_2932_7157_4609_3725_4088_2353_4087_4089_207_836	16	3.83E-13	2.91E-11	3.63E-12
5700	hsa-mir-1470	hsa04350	TGF-beta signaling pathway	7046_5595_5594_1387_3399_3398_4609_4088_4086_4087_4089_2033_4093_5933	14	8.47E-11	6.43E-09	7.15E-10
5701	hsa-mir-1470	hsa05219	Bladder cancer	5595_5594_595_9252_4193_1870_1871_7157_4609_1869_5925	11	9.95E-11	7.56E-09	7.56E-10
5702	hsa-mir-1470	hsa04310	Wnt signaling pathway	1460_5599_1387_595_8607_5601_1459_2932_7157_8061_4609_3725_4088_1457_4087_4089_2033	17	1.46E-10	1.11E-08	1.01E-09
5703	hsa-mir-1470	hsa05221	Acute myeloid leukemia	5371_5595_5594_861_5914_595_6688_7704_5970_4609_1050_207	12	1.77E-10	1.34E-08	1.12E-09
5704	hsa-mir-1470	hsa05222	Small cell lung cancer	6256_595_10401_5970_1870_1871_8554_7157_4609_1869_5925_4846_207	13	8.00E-10	6.08E-08	4.67E-09
5705	hsa-mir-1470	hsa04520	Adherens junction	4301_1460_7046_5595_5594_1387_1459_4088_1457_4087_4089_2033	12	3.89E-09	2.96E-07	2.11E-08
5706	hsa-mir-1470	hsa05214	Glioma	5595_5594_595_4193_1870_1871_7157_1869_5925_207_6464	11	5.67E-09	4.31E-07	2.87E-08
5707	hsa-mir-1470	hsa05218	Melanoma	5595_5594_595_4286_4193_1870_1871_7157_1869_5925_207	11	1.29E-08	9.81E-07	5.88E-08
5708	hsa-mir-1470	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_7157_1869_5925_207	10	1.32E-08	1.00E-06	5.88E-08
5709	hsa-mir-1470	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5601_5600_1432_6772_5970_3725_2353_5603_207	12	4.55E-08	3.46E-06	1.92E-07
5710	hsa-mir-1470	hsa04660	T cell receptor signaling pathway	5595_5594_5601_5600_2932_1432_5970_1739_3725_2353_5603_207	12	9.72E-08	7.38E-06	3.89E-07
5711	hsa-mir-1470	hsa05211	Renal cell carcinoma	2034_5595_5594_1387_3091_7428_2113_3725_2033_207	10	1.50E-07	1.14E-05	5.70E-07
5712	hsa-mir-1470	hsa05016	Huntington's disease	1387_2902_6908_6874_9001_5430_7157_9586_3066_3065_3064_2033_836_4716	14	6.63E-07	5.04E-05	2.40E-06
5713	hsa-mir-1470	hsa04012	ErbB signaling pathway	25_5595_5594_5599_5601_2932_4609_3725_207_6464	10	7.38E-07	5.61E-05	2.55E-06
5714	hsa-mir-1470	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_5600_1432_7157_5603_1616_4846_836	8	2.21E-06	0.000168153	7.31E-06
5715	hsa-mir-1470	hsa05216	Thyroid cancer	5595_5594_6256_595_7157_4609	6	6.48E-06	0.000492337	2.05E-05
5716	hsa-mir-1470	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_5600_1432_5970_3725_5603_836	8	1.10E-05	0.000832334	3.33E-05
5717	hsa-mir-1470	hsa05213	Endometrial cancer	5595_5594_595_2932_7157_4609_207	7	1.37E-05	0.001041002	3.86E-05
5718	hsa-mir-1470	hsa04150	mTOR signaling pathway	5595_5594_6197_3091_6195_6196_207	7	1.37E-05	0.001041002	3.86E-05
5719	hsa-mir-1470	hsa04720	Long-term potentiation	5595_5594_1387_2902_6197_6195_6196_2033	8	1.58E-05	0.001201217	4.29E-05
5720	hsa-mir-1470	hsa04370	VEGF signaling pathway	5595_5594_9261_5600_1432_5603_4846_207	8	1.88E-05	0.001431932	4.94E-05
5721	hsa-mir-1470	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5601_5600_1432_5603_207	8	2.24E-05	0.001698746	5.66E-05
5722	hsa-mir-1470	hsa04912	GnRH signaling pathway	5595_5594_5599_5598_5601_5600_1432_3725_5603	9	2.92E-05	0.002218913	7.16E-05
5723	hsa-mir-1470	hsa04330	Notch signaling pathway	1387_9612_3066_3065_2033_8850	6	7.48E-05	0.005684294	0.000177634
5724	hsa-mir-1470	hsa04662	B cell receptor signaling pathway	5595_5594_2932_5970_3725_2353_207	7	0.000117286	0.008913704	0.000270112
5725	hsa-mir-1470	hsa04910	Insulin signaling pathway	5595_5594_5599_5601_5211_6720_2932_207_6464	9	0.00017124	0.013014272	0.000382773
5726	hsa-mir-1470	hsa04930	Type II diabetes mellitus	5595_5594_5599_5601_3651	5	0.000541401	0.041146467	0.001175613
5727	hsa-mir-1470	hsa03050	Proteasome	5719_5710_5705_5701_5702	5	0.000709644	0.05393296	0.00146101
5728	hsa-mir-1470	hsa04510	Focal adhesion	5595_5594_5599_595_5601_2932_1729_3725_207_6464	10	0.000711281	0.054057361	0.00146101
5729	hsa-mir-1470	hsa04120	Ubiquitin mediated proteolysis	11059_5371_672_10401_4193_7428_8554_7329	8	0.000851601	0.064721711	0.001703203
5730	hsa-mir-1470	hsa05010	Alzheimer's disease	5595_5594_2902_840_2932_1020_4846_836_4716	9	0.000953264	0.072448045	0.001857642
5731	hsa-mir-1470	hsa04630	Jak-STAT signaling pathway	1387_595_10401_6772_8554_4609_2033_207	8	0.001651022	0.125477646	0.003136941
5732	hsa-mir-1470	hsa04920	Adipocytokine signaling pathway	5599_6256_5601_5970_207	5	0.00281371	0.213841942	0.005215657
5733	hsa-mir-1470	hsa04916	Melanogenesis	5595_5594_1387_4286_2932_2033	6	0.003691247	0.280534774	0.006679399
5734	hsa-mir-1470	hsa04210	Apoptosis	840_5970_7157_207_836	5	0.008703518	0.661467377	0.015382962
5735	hsa-mir-1470	hsa04540	Gap junction	5592_5595_5594_5598_10382	5	0.010314669	0.783914816	0.017752831
5736	hsa-mir-1470	hsa04360	Axon guidance	25_5998_5595_5594_2932_1020	6	0.010511544	0.798877376	0.017752831
5737	hsa-mir-1470	hsa04530	Tight junction	4301_1460_10207_1459_1457_207	6	0.012787	0.971811983	0.021126347
5738	hsa-mir-1470	hsa04115	p53 signaling pathway	595_4193_7157_836	4	0.016685169	1	0.026980273
5739	hsa-mir-1470	hsa04730	Long-term depression	5592_5595_5594_4846	4	0.018251698	1	0.028840903
5740	hsa-mir-1470	hsa04062	Chemokine signaling pathway	5595_5594_2932_6772_5970_207_6464	7	0.018594792	1	0.028840903
5741	hsa-mir-1470	hsa03420	Nucleotide excision repair	2967_5887_2968	3	0.025002393	1	0.038003638
5742	hsa-mir-1470	hsa04612	Antigen processing and presentation	3326_4800_4801_3312	4	0.036446619	1	0.054312609
5743	hsa-mir-1470	hsa05217	Basal cell carcinoma	2932_7157_2736	3	0.042772595	1	0.062513793
5744	hsa-mir-1470	hsa04950	Maturity onset diabetes of the young	3651_5080	2	0.047021031	1	0.067426384
5745	hsa-mir-148b	hsa04350	TGF-beta signaling pathway	4087_4088_6667_2033_4093_4609_5594_1387_5595_3399	10	7.93E-14	4.44E-12	4.44E-12
5746	hsa-mir-148b	hsa05200	Pathways in cancer	4087_4088_9915_5371_2034_2033_2932_4609_367_5594_3091_1387_5595_2353	14	2.88E-13	1.61E-11	8.07E-12
5747	hsa-mir-148b	hsa05211	Renal cell carcinoma	9915_2034_2033_5594_3091_1387_5595	7	1.49E-09	8.37E-08	2.79E-08
5748	hsa-mir-148b	hsa04520	Adherens junction	4087_4088_2033_5594_1387_5595_1457	7	2.96E-09	1.66E-07	4.15E-08
5749	hsa-mir-148b	hsa05210	Colorectal cancer	4087_4088_2932_4609_5594_5595_2353	7	4.07E-09	2.28E-07	4.56E-08
5750	hsa-mir-148b	hsa04310	Wnt signaling pathway	4087_4088_2033_2932_8061_4609_1387_1457	8	9.19E-09	5.15E-07	8.58E-08
5751	hsa-mir-148b	hsa05215	Prostate cancer	2033_2932_367_5594_1387_5595	6	1.70E-07	9.51E-06	1.27E-06
5752	hsa-mir-148b	hsa05212	Pancreatic cancer	2033_2932_367_5594_1387_5595	6	1.81E-07	1.01E-05	1.27E-06
5753	hsa-mir-148b	hsa04110	Cell cycle	4087_4088_2033_891_2932_1387	6	9.18E-07	5.14E-05	5.71E-06
5754	hsa-mir-148b	hsa03022	Basal transcription factors	2963_2969_2959_6908	4	3.94E-06	0.000220592	2.21E-05
5755	hsa-mir-148b	hsa04916	Melanogenesis	2033_2932_5594_1387_5595	5	9.75E-06	0.000545774	4.96E-05
5756	hsa-mir-148b	hsa05213	Endometrial cancer	2932_4609_5594_5595	4	1.39E-05	0.000776806	6.47E-05
5757	hsa-mir-148b	hsa05221	Acute myeloid leukemia	5371_4609_5594_5595	4	2.22E-05	0.001242606	9.56E-05
5758	hsa-mir-148b	hsa04720	Long-term potentiation	2033_5594_1387_5595	4	5.42E-05	0.003037423	0.000189839
5759	hsa-mir-148b	hsa05220	Chronic myeloid leukemia	4088_4609_5594_5595	4	5.42E-05	0.003037423	0.000189839
5760	hsa-mir-148b	hsa04662	B cell receptor signaling pathway	2932_5594_5595_2353	4	5.42E-05	0.003037423	0.000189839
5761	hsa-mir-148b	hsa05216	Thyroid cancer	4609_5594_5595	3	7.88E-05	0.004413873	0.00025964
5762	hsa-mir-148b	hsa04012	ErbB signaling pathway	2932_4609_5594_5595	4	9.42E-05	0.005277322	0.000293185
5763	hsa-mir-148b	hsa05010	Alzheimer's disease	2932_22926_5594_5595_1537	5	0.000113365	0.006348447	0.000334129
5764	hsa-mir-148b	hsa05016	Huntington's disease	6667_2033_6908_1387_1537	5	0.000149168	0.008353389	0.000417669
5765	hsa-mir-148b	hsa05219	Bladder cancer	4609_5594_5595	3	0.00022009	0.01232503	0.000572514
5766	hsa-mir-148b	hsa04660	T cell receptor signaling pathway	2932_5594_5595_2353	4	0.000224916	0.012595305	0.000572514
5767	hsa-mir-148b	hsa04330	Notch signaling pathway	9612_2033_1387	3	0.00030118	0.016866088	0.000733308
5768	hsa-mir-148b	hsa04150	mTOR signaling pathway	5594_3091_5595	3	0.000399398	0.022366299	0.000931929
5769	hsa-mir-148b	hsa04910	Insulin signaling pathway	23265_2932_5594_5595	4	0.000518031	0.029009726	0.001145625
5770	hsa-mir-148b	hsa04120	Ubiquitin mediated proteolysis	7325_55294_5371_7329	4	0.000531897	0.029786257	0.001145625
5771	hsa-mir-148b	hsa04620	Toll-like receptor signaling pathway	5594_5595_2353	3	0.002600737	0.145641247	0.00539412
5772	hsa-mir-148b	hsa04360	Axon guidance	2932_5594_5595	3	0.005155477	0.288706713	0.010310954
5773	hsa-mir-148b	hsa04010	MAPK signaling pathway	4609_5594_5595_2353	4	0.005889246	0.329797764	0.011372337
5774	hsa-mir-148b	hsa04930	Type II diabetes mellitus	5594_5595	2	0.006654459	0.372649706	0.012421657
5775	hsa-mir-148b	hsa04630	Jak-STAT signaling pathway	2033_4609_1387	3	0.008113236	0.454341226	0.014656169
5776	hsa-mir-148b	hsa05223	Non-small cell lung cancer	5594_5595	2	0.009338529	0.522957644	0.016342426
5777	hsa-mir-148b	hsa05214	Glioma	5594_5595	2	0.013163812	0.737173458	0.02233859
5778	hsa-mir-148b	hsa04062	Chemokine signaling pathway	2932_5594_5595	3	0.0144967	0.811815173	0.023876917
5779	hsa-mir-148b	hsa05218	Melanoma	5594_5595	2	0.015491055	0.867499069	0.024097196
5780	hsa-mir-148b	hsa04730	Long-term depression	5594_5595	2	0.015491055	0.867499069	0.024097196
5781	hsa-mir-148b	hsa04510	Focal adhesion	2932_5594_5595	3	0.017179419	0.96204748	0.026001283
5782	hsa-mir-148b	hsa04370	VEGF signaling pathway	5594_5595	2	0.017981053	1	0.026498394
5783	hsa-mir-148b	hsa04664	Fc epsilon RI signaling pathway	5594_5595	2	0.018846274	1	0.027061316
5784	hsa-mir-148b	hsa04612	Antigen processing and presentation	4800_4801	2	0.023427622	1	0.032798671
5785	hsa-mir-148b	hsa04540	Gap junction	5594_5595	2	0.025375656	1	0.034659432
5786	hsa-mir-148b	hsa03010	Ribosome	6222_6231	2	0.029989424	1	0.039985899
5787	hsa-mir-148b	hsa04912	GnRH signaling pathway	5594_5595	2	0.033236173	1	0.043284319
5788	hsa-mir-148b	hsa04270	Vascular smooth muscle contraction	5594_5595	2	0.038936358	1	0.049555364
5789	hsa-mir-151	hsa05200	Pathways in cancer	4087_4088_4089_836_2033_367	6	1.25E-07	4.00E-06	4.00E-06
5790	hsa-mir-151	hsa04520	Adherens junction	4087_4088_4089_2033	4	4.01E-07	1.28E-05	4.43E-06
5791	hsa-mir-151	hsa05210	Colorectal cancer	4087_4088_4089_836	4	4.84E-07	1.55E-05	4.43E-06
5792	hsa-mir-151	hsa04350	TGF-beta signaling pathway	4087_4088_4089_2033	4	5.54E-07	1.77E-05	4.43E-06
5793	hsa-mir-151	hsa04110	Cell cycle	4087_4088_4089_2033	4	1.85E-06	5.93E-05	1.19E-05
5794	hsa-mir-151	hsa04310	Wnt signaling pathway	4087_4088_4089_2033	4	4.77E-06	0.00015264	2.54E-05
5795	hsa-mir-151	hsa05010	Alzheimer's disease	836_1020_840	3	0.00030013	0.009604155	0.001372022
5796	hsa-mir-151	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432	2	0.000826523	0.026448733	0.003306092
5797	hsa-mir-151	hsa04010	MAPK signaling pathway	836_1432_5598	3	0.001039885	0.033276327	0.00369737
5798	hsa-mir-151	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_1432	2	0.001305326	0.041770435	0.004177043
5799	hsa-mir-151	hsa05220	Chronic myeloid leukemia	4088_4089	2	0.001450768	0.046424576	0.004220416
5800	hsa-mir-151	hsa05215	Prostate cancer	2033_367	2	0.001974351	0.063179226	0.004612169
5801	hsa-mir-151	hsa04210	Apoptosis	836_840	2	0.002017824	0.064570371	0.004612169
5802	hsa-mir-151	hsa05212	Pancreatic cancer	2033_367	2	0.002017824	0.064570371	0.004612169
5803	hsa-mir-151	hsa04912	GnRH signaling pathway	1432_5598	2	0.002929301	0.093737632	0.006249175
5804	hsa-mir-151	hsa05016	Huntington's disease	836_2033	2	0.008468312	0.270985989	0.016936624
5805	hsa-mir-151	hsa04330	Notch signaling pathway	2033	1	0.034601859	1	0.065132912
5806	hsa-mir-152	hsa05200	Pathways in cancer	1488_5595_4087_1487_3065_367_3725_5594	8	3.06E-13	1.32E-11	1.32E-11
5807	hsa-mir-152	hsa05220	Chronic myeloid leukemia	1488_5595_1487_3065_5594	5	1.50E-10	6.45E-09	3.22E-09
5808	hsa-mir-152	hsa05210	Colorectal cancer	5595_4087_3725_5594	4	4.83E-08	2.08E-06	6.93E-07
5809	hsa-mir-152	hsa04310	Wnt signaling pathway	1488_4087_1487_3725	4	4.84E-07	2.08E-05	5.20E-06
5810	hsa-mir-152	hsa04330	Notch signaling pathway	1488_1487_3065	3	1.23E-06	5.29E-05	1.06E-05
5811	hsa-mir-152	hsa05211	Renal cell carcinoma	5595_3725_5594	3	4.21E-06	0.000181029	2.79E-05
5812	hsa-mir-152	hsa04662	B cell receptor signaling pathway	5595_3725_5594	3	4.74E-06	0.0002038	2.79E-05
5813	hsa-mir-152	hsa04520	Adherens junction	5595_4087_5594	3	5.72E-06	0.000245832	2.79E-05
5814	hsa-mir-152	hsa04350	TGF-beta signaling pathway	5595_4087_5594	3	7.30E-06	0.000313774	2.79E-05
5815	hsa-mir-152	hsa04012	ErbB signaling pathway	5595_3725_5594	3	7.30E-06	0.000313774	2.79E-05
5816	hsa-mir-152	hsa05215	Prostate cancer	5595_367_5594	3	7.54E-06	0.00032439	2.79E-05
5817	hsa-mir-152	hsa05212	Pancreatic cancer	5595_367_5594	3	7.80E-06	0.00033524	2.79E-05
5818	hsa-mir-152	hsa04620	Toll-like receptor signaling pathway	5595_3725_5594	3	1.16E-05	0.000498806	3.84E-05
5819	hsa-mir-152	hsa04912	GnRH signaling pathway	5595_3725_5594	3	1.37E-05	0.000589335	4.15E-05
5820	hsa-mir-152	hsa04660	T cell receptor signaling pathway	5595_3725_5594	3	1.45E-05	0.000621759	4.15E-05
5821	hsa-mir-152	hsa05216	Thyroid cancer	5595_5594	2	8.00E-05	0.00343846	0.000214904
5822	hsa-mir-152	hsa04510	Focal adhesion	5595_3725_5594	3	9.04E-05	0.003888172	0.000228716
5823	hsa-mir-152	hsa05219	Bladder cancer	5595_5594	2	0.000162164	0.006973049	0.000387392
5824	hsa-mir-152	hsa04930	Type II diabetes mellitus	5595_5594	2	0.00018517	0.007962307	0.000419069
5825	hsa-mir-152	hsa04010	MAPK signaling pathway	5595_3725_5594	3	0.000205494	0.008836249	0.000441812
5826	hsa-mir-152	hsa05213	Endometrial cancer	5595_5594	2	0.000244704	0.010522286	0.000478286
5827	hsa-mir-152	hsa04150	mTOR signaling pathway	5595_5594	2	0.000244704	0.010522286	0.000478286
5828	hsa-mir-152	hsa05223	Non-small cell lung cancer	5595_5594	2	0.000263215	0.011318243	0.000492098
5829	hsa-mir-152	hsa05221	Acute myeloid leukemia	5595_5594	2	0.0003124	0.013433181	0.000559716
5830	hsa-mir-152	hsa05214	Glioma	5595_5594	2	0.000376887	0.016206153	0.000648246
5831	hsa-mir-152	hsa05218	Melanoma	5595_5594	2	0.000447313	0.019234459	0.000712387
5832	hsa-mir-152	hsa04730	Long-term depression	5595_5594	2	0.000447313	0.019234459	0.000712387
5833	hsa-mir-152	hsa04720	Long-term potentiation	5595_5594	2	0.000497549	0.02139462	0.000764094
5834	hsa-mir-152	hsa04370	VEGF signaling pathway	5595_5594	2	0.00052365	0.022516961	0.000776447
5835	hsa-mir-152	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.000550405	0.02366742	0.000788914
5836	hsa-mir-152	hsa04540	Gap junction	5595_5594	2	0.000755916	0.032504404	0.001048529
5837	hsa-mir-152	hsa04916	Melanogenesis	5595_5594	2	0.000939616	0.040403509	0.00126261
5838	hsa-mir-152	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.001201431	0.05166152	0.001544616
5839	hsa-mir-152	hsa04110	Cell cycle	4087_3065	2	0.001221325	0.052516954	0.001544616
5840	hsa-mir-152	hsa04360	Axon guidance	5595_5594	2	0.001472371	0.063311964	0.001808913
5841	hsa-mir-152	hsa04910	Insulin signaling pathway	5595_5594	2	0.001629267	0.070058476	0.001893472
5842	hsa-mir-152	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.001629267	0.070058476	0.001893472
5843	hsa-mir-152	hsa05010	Alzheimer's disease	5595_5594	2	0.00264233	0.113620169	0.002990004
5844	hsa-mir-152	hsa05016	Huntington's disease	3065_25942	2	0.002970046	0.127711962	0.003274666
5845	hsa-mir-152	hsa04062	Chemokine signaling pathway	5595_5594	2	0.003125028	0.134376225	0.003359406
5846	hsa-mir-152	hsa04810	Regulation of actin cytoskeleton	5595_5594	2	0.003990952	0.17161092	0.004185632
5847	hsa-mir-152	hsa03410	Base excision repair	3146	1	0.015911537	0.684196071	0.016290383
5848	hsa-mir-152	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725	1	0.030747579	1	0.030747579
5849	hsa-mir-153-1	hsa04630	Jak-STAT signaling pathway	3717_867_2057_3559_5781_2033_5777_3560_6774_6772_3575_6776_2690	13	2.95E-18	1.74E-16	1.74E-16
5850	hsa-mir-153-1	hsa05200	Pathways in cancer	5159_5156_867_7157_1399_1398_2033_2113_3815_5594_6774_6772_1956_5914_6776	15	3.68E-17	2.17E-15	1.08E-15
5851	hsa-mir-153-1	hsa04012	ErbB signaling pathway	867_1399_1398_6714_5594_6464_1956_6776_2066	9	1.11E-13	6.57E-12	2.19E-12
5852	hsa-mir-153-1	hsa05220	Chronic myeloid leukemia	867_7157_5781_1399_1398_5594_6464_6776	8	2.25E-12	1.33E-10	3.31E-11
5853	hsa-mir-153-1	hsa04060	Cytokine-cytokine receptor interaction	5159_5156_7852_2057_3559_3815_3560_3575_1956_2690	10	5.27E-11	3.11E-09	6.22E-10
5854	hsa-mir-153-1	hsa04520	Adherens junction	2033_5777_5770_6714_3643_5594_1956	7	2.11E-10	1.25E-08	2.08E-09
5855	hsa-mir-153-1	hsa04062	Chemokine signaling pathway	3717_7852_1399_1398_5594_6774_6464_6772	8	2.78E-09	1.64E-07	2.35E-08
5856	hsa-mir-153-1	hsa05214	Glioma	5159_5156_7157_5594_6464_1956	6	3.31E-09	1.95E-07	2.44E-08
5857	hsa-mir-153-1	hsa04510	Focal adhesion	5159_5156_1399_1398_6714_5594_6464_1956	8	4.55E-09	2.69E-07	2.98E-08
5858	hsa-mir-153-1	hsa05211	Renal cell carcinoma	5781_1399_1398_2033_2113_5594	6	5.88E-09	3.47E-07	3.47E-08
5859	hsa-mir-153-1	hsa04910	Insulin signaling pathway	867_1399_1398_5770_3643_5594_6464	7	7.71E-09	4.55E-07	4.13E-08
5860	hsa-mir-153-1	hsa05215	Prostate cancer	5159_5156_7157_2033_5594_1956	6	1.82E-08	1.08E-06	8.82E-08
5861	hsa-mir-153-1	hsa05212	Pancreatic cancer	5159_5156_7157_2033_5594_1956	6	1.94E-08	1.15E-06	8.82E-08
5862	hsa-mir-153-1	hsa05221	Acute myeloid leukemia	3815_5594_6774_5914_6776	5	1.09E-07	6.43E-06	4.59E-07
5863	hsa-mir-153-1	hsa05218	Melanoma	5159_5156_7157_5594_1956	5	2.60E-07	1.53E-05	1.02E-06
5864	hsa-mir-153-1	hsa05210	Colorectal cancer	5159_5156_7157_5594_1956	5	5.73E-07	3.38E-05	2.11E-06
5865	hsa-mir-153-1	hsa04010	MAPK signaling pathway	5159_5156_7157_1399_1398_5594_1956	7	6.89E-07	4.06E-05	2.39E-06
5866	hsa-mir-153-1	hsa04540	Gap junction	5159_5156_6714_5594_1956	5	9.27E-07	5.47E-05	3.04E-06
5867	hsa-mir-153-1	hsa04660	T cell receptor signaling pathway	867_919_5777_1493_5594	5	2.05E-06	0.00012073	6.35E-06
5868	hsa-mir-153-1	hsa04810	Regulation of actin cytoskeleton	5159_5156_1399_1398_5594_1956	6	3.15E-06	0.000185917	9.30E-06
5869	hsa-mir-153-1	hsa04650	Natural killer cell mediated cytotoxicity	919_5781_5777_5594_6464	5	5.96E-06	0.000351615	1.67E-05
5870	hsa-mir-153-1	hsa04640	Hematopoietic cell lineage	2057_3559_3815_3575	4	2.22E-05	0.001306929	5.94E-05
5871	hsa-mir-153-1	hsa05219	Bladder cancer	7157_5594_1956	3	7.38E-05	0.004351511	0.000189196
5872	hsa-mir-153-1	hsa05213	Endometrial cancer	7157_5594_1956	3	0.000134639	0.007943696	0.000330987
5873	hsa-mir-153-1	hsa05223	Non-small cell lung cancer	7157_5594_1956	3	0.000149782	0.008837167	0.000353487
5874	hsa-mir-153-1	hsa04920	Adipocytokine signaling pathway	3717_5781_6774	3	0.00027563	0.016262165	0.000625468
5875	hsa-mir-153-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5781_6714_1956	3	0.000324754	0.019160457	0.000709647
5876	hsa-mir-153-1	hsa04020	Calcium signaling pathway	5159_5156_1956_2066	4	0.000367314	0.021671528	0.000773983
5877	hsa-mir-153-1	hsa04350	TGF-beta signaling pathway	2033_5594_5515	3	0.000576731	0.034027125	0.001173349
5878	hsa-mir-153-1	hsa04916	Melanogenesis	2033_3815_5594	3	0.000953646	0.056265122	0.001875504
5879	hsa-mir-153-1	hsa04912	GnRH signaling pathway	6714_5594_1956	3	0.001060357	0.062561043	0.002018098
5880	hsa-mir-153-1	hsa05216	Thyroid cancer	7157_5594	2	0.001425017	0.084075991	0.002627375
5881	hsa-mir-153-1	hsa04310	Wnt signaling pathway	7157_2033_5515	3	0.002752369	0.162389757	0.004920902
5882	hsa-mir-153-1	hsa04930	Type II diabetes mellitus	3643_5594	2	0.003252427	0.191893215	0.005643918
5883	hsa-mir-153-1	hsa04330	Notch signaling pathway	9612_2033	2	0.003530142	0.208278385	0.005950811
5884	hsa-mir-153-1	hsa04730	Long-term depression	5594_5515	2	0.00767476	0.452810835	0.012578079
5885	hsa-mir-153-1	hsa04720	Long-term potentiation	2033_5594	2	0.008506018	0.501855059	0.013206712
5886	hsa-mir-153-1	hsa04662	B cell receptor signaling pathway	5777_5594	2	0.008506018	0.501855059	0.013206712
5887	hsa-mir-153-1	hsa04370	VEGF signaling pathway	6714_5594	2	0.008936147	0.52723268	0.013518787
5888	hsa-mir-153-1	hsa04620	Toll-like receptor signaling pathway	5594_6772	2	0.015097431	0.890748452	0.022268711
5889	hsa-mir-153-1	hsa04110	Cell cycle	7157_2033	2	0.020072063	1	0.028884188
5890	hsa-mir-153-1	hsa04670	Leukocyte transendothelial migration	7852_5781	2	0.021012148	1	0.029517065
5891	hsa-mir-153-1	hsa04360	Axon guidance	7852_5594	2	0.023940182	1	0.032848156
5892	hsa-mir-153-1	hsa04530	Tight junction	6714_5515	2	0.025979895	1	0.034836678
5893	hsa-mir-153-1	hsa04120	Ubiquitin mediated proteolysis	867_7329	2	0.026675038	1	0.034973939
5894	hsa-mir-153-1	hsa05016	Huntington's disease	7157_2033	2	0.045909789	1	0.058884295
5895	hsa-mir-153-2	hsa05218	Melanoma	4286	1	0.009564701	0.028694103	0.020888276
5896	hsa-mir-153-2	hsa04916	Melanogenesis	4286	1	0.013925517	0.041776551	0.020888276
5897	hsa-mir-153-2	hsa05200	Pathways in cancer	4286	1	0.043662618	0.130987853	0.043662618
5898	hsa-mir-1537	hsa05200	Pathways in cancer	5371_9063_5595_5594_5599_5914_1387_6256_595_1871_5601_1488_836_367_2353_7704_3091_5970_7428_1870_2885_7157_4087_2113_4609_1869_3725_5604_1487_4088_4089_3066_3065_5925_2034_2033_4846	37	9.15E-39	5.76E-37	5.76E-37
5899	hsa-mir-1537	hsa05220	Chronic myeloid leukemia	5595_5594_595_1871_1488_5970_1870_2885_7157_4609_1869_5604_1487_4088_4089_3066_3065_5925_6464	19	3.56E-26	2.24E-24	1.12E-24
5900	hsa-mir-1537	hsa04010	MAPK signaling pathway	6722_5595_5594_5599_4208_5606_5601_5600_836_2353_3312_1432_5970_2885_7157_4773_4609_3725_5604_9344_4763_2005	22	2.57E-20	1.62E-18	5.41E-19
5901	hsa-mir-1537	hsa05210	Colorectal cancer	5595_5594_5599_595_5601_836_2353_2885_7157_4087_4609_3725_5604_4088_4089	15	7.24E-19	4.56E-17	1.14E-17
5902	hsa-mir-1537	hsa05215	Prostate cancer	5595_5594_1387_595_1871_367_5970_1870_2885_7157_1869_5604_5925_2033	14	4.70E-17	2.96E-15	5.69E-16
5903	hsa-mir-1537	hsa05212	Pancreatic cancer	5595_5594_1387_595_1871_367_5970_1870_2885_7157_1869_5604_5925_2033	14	5.42E-17	3.41E-15	5.69E-16
5904	hsa-mir-1537	hsa04110	Cell cycle	5591_1387_595_1871_1870_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933	15	8.01E-17	5.05E-15	7.21E-16
5905	hsa-mir-1537	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_3397_3399_3398_4087_4609_4088_4089_2033_5933	13	1.34E-15	8.42E-14	1.05E-14
5906	hsa-mir-1537	hsa04310	Wnt signaling pathway	5599_1387_595_5601_1488_7157_4087_4773_4609_3725_1457_1487_4088_4089_2033	15	2.26E-15	1.42E-13	1.58E-14
5907	hsa-mir-1537	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1871_1870_2885_7157_1869_5604_5925	11	1.05E-14	6.63E-13	6.63E-14
5908	hsa-mir-1537	hsa05219	Bladder cancer	5595_5594_595_1871_1870_7157_4609_1869_5604_5925	10	4.52E-14	2.85E-12	2.59E-13
5909	hsa-mir-1537	hsa05214	Glioma	5595_5594_595_1871_1870_2885_7157_1869_5604_5925_6464	11	6.45E-14	4.06E-12	3.39E-13
5910	hsa-mir-1537	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_7428_2885_2113_3725_5604_2034_2033	11	1.77E-13	1.11E-11	8.57E-13
5911	hsa-mir-1537	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_5970_2885_4609_5604	10	9.09E-13	5.73E-11	4.09E-12
5912	hsa-mir-1537	hsa05222	Small cell lung cancer	9063_6256_595_1871_5970_1870_7157_4609_1869_5925_4846	11	1.03E-12	6.50E-11	4.33E-12
5913	hsa-mir-1537	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5606_5601_5600_2353_1432_5970_3725_5604	11	5.66E-12	3.57E-10	2.23E-11
5914	hsa-mir-1537	hsa04660	T cell receptor signaling pathway	5595_5594_5601_5600_2353_1432_5970_2885_4773_3725_5604	11	1.20E-11	7.59E-10	4.46E-11
5915	hsa-mir-1537	hsa05218	Melanoma	5595_5594_595_1871_1870_7157_1869_5604_5925	9	1.36E-10	8.57E-09	4.76E-10
5916	hsa-mir-1537	hsa04912	GnRH signaling pathway	5595_5594_5599_5606_5601_5600_1432_2885_3725_5604	10	2.15E-10	1.35E-08	7.12E-10
5917	hsa-mir-1537	hsa05216	Thyroid cancer	5595_5594_6256_595_7157_4609_5604	7	2.99E-10	1.88E-08	9.42E-10
5918	hsa-mir-1537	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5606_5601_5600_1432_2885_5604	9	3.25E-10	2.05E-08	9.75E-10
5919	hsa-mir-1537	hsa04012	ErbB signaling pathway	5595_5594_5599_5601_2885_4609_3725_5604_6464	9	7.15E-10	4.50E-08	2.05E-09
5920	hsa-mir-1537	hsa04662	B cell receptor signaling pathway	5595_5594_2353_5970_2885_4773_3725_5604	8	5.21E-09	3.28E-07	1.43E-08
5921	hsa-mir-1537	hsa04330	Notch signaling pathway	1387_1488_9612_1487_3066_3065_2033	7	5.92E-09	3.73E-07	1.55E-08
5922	hsa-mir-1537	hsa04520	Adherens junction	5595_5594_1387_4087_1457_4088_4089_2033	8	8.33E-09	5.25E-07	2.10E-08
5923	hsa-mir-1537	hsa05213	Endometrial cancer	5595_5594_595_2885_7157_4609_5604	7	1.12E-08	7.05E-07	2.71E-08
5924	hsa-mir-1537	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_5606_5600_836_1432_7157_4846	7	1.79E-08	1.13E-06	4.17E-08
5925	hsa-mir-1537	hsa05016	Huntington's disease	6874_1387_2902_836_6667_7157_3066_3065_3064_2033	10	3.26E-08	2.05E-06	7.34E-08
5926	hsa-mir-1537	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_5600_836_1432_5970_3725	7	8.05E-08	5.07E-06	1.75E-07
5927	hsa-mir-1537	hsa04370	VEGF signaling pathway	5595_5594_5600_1432_4773_5604_4846	7	1.35E-07	8.49E-06	2.83E-07
5928	hsa-mir-1537	hsa04910	Insulin signaling pathway	6720_5595_5594_5599_5601_2885_5604_6464	8	4.35E-07	2.74E-05	8.85E-07
5929	hsa-mir-1537	hsa04510	Focal adhesion	5595_5594_5599_595_5601_2885_3725_5604_6464	9	7.90E-07	4.98E-05	1.55E-06
5930	hsa-mir-1537	hsa04720	Long-term potentiation	5595_5594_1387_2902_5604_2033	6	2.20E-06	0.000138495	4.20E-06
5931	hsa-mir-1537	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_2885_4773_5604_6464	7	5.43E-06	0.000342202	1.01E-05
5932	hsa-mir-1537	hsa04930	Type II diabetes mellitus	5595_5594_5599_5601	4	8.03E-05	0.005060446	0.000144584
5933	hsa-mir-1537	hsa04630	Jak-STAT signaling pathway	9063_1387_595_2885_4609_2033	6	0.000110071	0.00693446	0.000192624
5934	hsa-mir-1537	hsa04916	Melanogenesis	5595_5594_1387_5604_2033	5	0.000159602	0.010054956	0.000271756
5935	hsa-mir-1537	hsa05010	Alzheimer's disease	5595_5594_2902_836_6622_4846	6	0.000220927	0.013918411	0.000366274
5936	hsa-mir-1537	hsa04920	Adipocytokine signaling pathway	5599_6256_5601_5970	4	0.000340375	0.021443596	0.000545261
5937	hsa-mir-1537	hsa04062	Chemokine signaling pathway	5595_5594_5970_2885_5604_6464	6	0.000346198	0.021810443	0.000545261
5938	hsa-mir-1537	hsa04730	Long-term depression	5595_5594_5604_4846	4	0.000419723	0.026442571	0.000644941
5939	hsa-mir-1537	hsa04120	Ubiquitin mediated proteolysis	5371_9063_672_7428_7329	5	0.000577265	0.036367678	0.000865897
5940	hsa-mir-1537	hsa04540	Gap junction	5595_5594_2885_5604	4	0.001105901	0.069671754	0.001620273
5941	hsa-mir-1537	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.002156713	0.135872941	0.003088021
5942	hsa-mir-1537	hsa04115	p53 signaling pathway	595_836_7157	3	0.004629656	0.291668324	0.006481518
5943	hsa-mir-1537	hsa04612	Antigen processing and presentation	4800_4801_3312	3	0.009114978	0.574243626	0.012217949
5944	hsa-mir-1537	hsa04210	Apoptosis	836_5970_7157	3	0.009114978	0.574243626	0.012217949
5945	hsa-mir-1537	hsa04270	Vascular smooth muscle contraction	5595_5594_5604	3	0.018972507	1	0.024901415
5946	hsa-mir-1537	hsa03050	Proteasome	5684_5705	2	0.022689099	1	0.029171699
5947	hsa-mir-1537	hsa04360	Axon guidance	5595_5594_4773	3	0.02473844	1	0.031170434
5948	hsa-mir-1538	hsa05200	Pathways in cancer	3551_5467_1499_595_1017_8517_4193_6934_7704_3091_4087_3065_1050_5925_7187_5468_25_405_9063_1487_1488_2885_4824_2113_10401_861_207_836_1147_3320_5595_5594_5599_6258_1387_6256_10342_4286_367_2932_6774_6776_6777_6772_5970_7157_7849_3725_4088_4089_2034_2033_4790_4792_3326_51176_5371_5604_5601_842_841_4609_2956_2736_2353	65	1.10E-38	8.72E-37	8.72E-37
5949	hsa-mir-1538	hsa05215	Prostate cancer	3551_1499_595_1017_8517_4193_6934_5925_2885_4824_207_1147_3320_5595_5594_1385_1387_367_2932_5970_7157_2033_4790_4792_3326_51176_5604_842	28	4.42E-22	3.49E-20	1.50E-20
5950	hsa-mir-1538	hsa05212	Pancreatic cancer	3551_1499_595_1017_8517_4193_6934_5925_2885_4824_207_1147_3320_5595_5594_1385_1387_367_2932_5970_7157_2033_4790_4792_3326_51176_5604_842	28	5.70E-22	4.50E-20	1.50E-20
5951	hsa-mir-1538	hsa04010	MAPK signaling pathway	6722_3551_6197_8517_9252_4773_9020_3303_9344_1432_2885_3305_1616_207_836_1147_5595_5594_5599_1386_3310_3312_5971_5970_3164_7157_3725_6195_6196_4790_9261_1326_5604_4208_5606_5601_5600_4609_2353_8986_2002_2005	42	9.36E-22	7.39E-20	1.85E-20
5952	hsa-mir-1538	hsa04310	Wnt signaling pathway	815_5467_1499_595_8607_6934_4087_4772_4773_23291_1487_1488_5599_1387_2932_7157_3725_1457_4088_4089_2033_894_896_51176_5519_5518_5601_6500_8454_8945_4609_5527	32	2.12E-20	1.68E-18	3.36E-19
5953	hsa-mir-1538	hsa05220	Chronic myeloid leukemia	3551_595_8517_4193_3065_5925_25_1487_1488_2885_861_207_1147_5595_5594_6776_6777_5970_7157_4088_4089_4790_4792_5604_4609	25	2.92E-20	2.30E-18	3.84E-19
5954	hsa-mir-1538	hsa05221	Acute myeloid leukemia	3551_5467_595_8517_6934_7704_1050_2885_861_207_1147_5595_5594_6774_6776_6777_5970_4790_51176_5371_5604_4609	22	7.63E-19	6.03E-17	8.61E-18
5955	hsa-mir-1538	hsa04620	Toll-like receptor signaling pathway	3551_8517_7187_3665_3661_1432_207_1147_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5606_5601_5600_9641_841_2353	24	1.42E-16	1.12E-14	1.40E-15
5956	hsa-mir-1538	hsa05210	Colorectal cancer	1499_595_6934_4087_2885_207_836_5595_5594_5599_2932_7157_3725_4088_4089_51176_5604_5601_842_4609_2956_2353	22	3.90E-16	3.08E-14	3.42E-15
5957	hsa-mir-1538	hsa04660	T cell receptor signaling pathway	3551_8517_4772_4773_9020_1432_2885_4794_207_1147_5595_5594_2932_5970_3725_4790_4792_4793_1326_5604_5601_5600_2353	23	5.55E-15	4.38E-13	4.38E-14
5958	hsa-mir-1538	hsa03010	Ribosome	6204_6205_6207_6202_6156_6141_6217_6130_6137_6135_6210_6191_6193_6222_6223_6229_6129_6128_6181_6189_6188_6232	22	1.25E-14	9.84E-13	8.95E-14
5959	hsa-mir-1538	hsa04350	TGF-beta signaling pathway	4086_4087_6667_3397_3399_3398_1875_5934_5595_5594_1387_4088_4089_2033_5519_5518_6500_8454_4609_4092	20	7.11E-14	5.62E-12	4.68E-13
5960	hsa-mir-1538	hsa05216	Thyroid cancer	1499_595_6934_5468_5595_5594_6258_6256_10342_7157_7849_51176_5604_4609	14	1.06E-13	8.35E-12	6.42E-13
5961	hsa-mir-1538	hsa04662	B cell receptor signaling pathway	3551_8517_4772_4773_2885_4794_207_1147_5595_5594_2932_5970_3725_4790_4792_4793_5604_2353	18	6.75E-13	5.34E-11	3.81E-12
5962	hsa-mir-1538	hsa05222	Small cell lung cancer	3551_595_1017_8517_5925_7187_9063_10401_207_1147_6258_6256_5970_7157_4790_4792_842_4609	18	4.98E-12	3.94E-10	2.62E-11
5963	hsa-mir-1538	hsa05213	Endometrial cancer	1499_595_6934_2309_2885_207_5595_5594_2932_7157_51176_5604_842_4609_2002	15	6.08E-12	4.80E-10	3.00E-11
5964	hsa-mir-1538	hsa04110	Cell cycle	595_1017_4193_5111_4087_3065_5925_25_5934_5591_1387_2932_7157_4088_4089_2033_894_896_6500_8454	20	1.14E-11	8.98E-10	5.28E-11
5965	hsa-mir-1538	hsa04920	Adipocytokine signaling pathway	3551_10891_5465_8517_4794_207_1147_5599_6258_6256_6774_5970_4790_4792_4793_5601	16	1.38E-11	1.09E-09	6.05E-11
5966	hsa-mir-1538	hsa04012	ErbB signaling pathway	815_25_6714_2885_207_5595_5594_5599_2932_6776_6777_3725_5604_5601_4609_2002	16	4.08E-10	3.22E-08	1.70E-09
5967	hsa-mir-1538	hsa04912	GnRH signaling pathway	815_5580_6714_1432_2885_5595_5594_5599_3725_808_801_805_5604_5606_5601_5600_2002	17	9.77E-10	7.72E-08	3.86E-09
5968	hsa-mir-1538	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3551_8517_9020_6714_1432_836_1147_5599_5970_3725_4790_4792_5601_5600	14	2.30E-09	1.82E-07	8.66E-09
5969	hsa-mir-1538	hsa04330	Notch signaling pathway	1840_3065_22938_1487_1488_9612_1387_2033_8850_2648_4851_9794	12	2.61E-09	2.06E-07	9.38E-09
5970	hsa-mir-1538	hsa03050	Proteasome	5708_5705_5700_5693_5719_5684_5717_5713_5687_5709_5706_5707	12	3.20E-09	2.53E-07	1.10E-08
5971	hsa-mir-1538	hsa04210	Apoptosis	3551_8517_9020_207_836_1147_839_5970_7157_9131_4790_4792_842_841_840	15	4.14E-09	3.27E-07	1.36E-08
5972	hsa-mir-1538	hsa05214	Glioma	815_595_4193_5925_2885_207_5595_5594_7157_808_801_805_5604	13	7.41E-09	5.85E-07	2.34E-08
5973	hsa-mir-1538	hsa04520	Adherens junction	1499_6934_4087_6714_71_5595_5594_1387_1457_4088_4089_2033_51176_8826	14	8.90E-09	7.03E-07	2.70E-08
5974	hsa-mir-1538	hsa05223	Non-small cell lung cancer	595_5925_2309_2885_207_5595_5594_6258_6256_7157_5604_842	12	1.01E-08	7.95E-07	2.95E-08
5975	hsa-mir-1538	hsa04916	Melanogenesis	815_1499_6934_5595_5594_1385_1387_4286_2932_2033_808_801_805_51176_5604	15	2.70E-08	2.13E-06	7.61E-08
5976	hsa-mir-1538	hsa04910	Insulin signaling pathway	3551_10891_2885_5211_207_5595_5594_5599_2932_2194_808_801_805_5604_5601_2002	16	1.46E-07	1.16E-05	3.99E-07
5977	hsa-mir-1538	hsa05211	Renal cell carcinoma	3091_405_2885_2113_207_5595_5594_1387_3725_2034_2033_5604	12	1.65E-07	1.30E-05	4.33E-07
5978	hsa-mir-1538	hsa04720	Long-term potentiation	815_6197_5595_5594_1387_6195_6196_2033_808_801_805_5604	12	2.44E-07	1.93E-05	6.13E-07
5979	hsa-mir-1538	hsa05322	Systemic lupus erythematosus	3020_8368_3018_8294_8370_121504_8361_8360_8363_8362_8365_8364_8367_8366_8359_3021	16	2.48E-07	1.96E-05	6.13E-07
5980	hsa-mir-1538	hsa04062	Chemokine signaling pathway	3551_8517_5580_2309_2885_207_1147_5595_5594_2932_6774_6777_6772_5970_4790_4792_4793_5604	18	4.90E-07	3.87E-05	1.17E-06
5981	hsa-mir-1538	hsa04115	p53 signaling pathway	595_1017_4194_4193_836_7157_894_896_842_841_7161	11	7.99E-07	6.31E-05	1.86E-06
5982	hsa-mir-1538	hsa05219	Bladder cancer	595_9252_4193_5925_5595_5594_7157_5604_4609	9	9.34E-07	7.38E-05	2.11E-06
5983	hsa-mir-1538	hsa05131	Shigellosis	7846_1499_10382_25_203068_71_347733_7278_84617_4691	10	1.01E-06	8.01E-05	2.16E-06
5984	hsa-mir-1538	hsa05130	Pathogenic Escherichia coli infection	7846_1499_10382_25_203068_71_347733_7278_84617_4691	10	1.01E-06	8.01E-05	2.16E-06
5985	hsa-mir-1538	hsa05016	Huntington's disease	10891_3065_3064_5468_25942_6667_836_1385_1387_5437_7157_2033_6908_842_841_5441_1213	17	1.50E-06	0.00011854	3.12E-06
5986	hsa-mir-1538	hsa04540	Gap junction	7846_10382_203068_6714_2885_5592_5595_5594_347733_5604_7278_84617	12	1.92E-06	0.000151296	3.88E-06
5987	hsa-mir-1538	hsa04370	VEGF signaling pathway	4772_4773_6714_1432_207_5595_5594_9261_5604_5600_842	11	2.10E-06	0.000166007	4.15E-06
5988	hsa-mir-1538	hsa04664	Fc epsilon RI signaling pathway	5580_1432_2885_207_5595_5594_5599_5604_5606_5601_5600	11	2.63E-06	0.000207879	5.07E-06
5989	hsa-mir-1538	hsa04630	Jak-STAT signaling pathway	595_9063_2885_10401_207_1387_6778_6774_6776_6777_6772_2033_894_896_4609	15	2.86E-06	0.000226183	5.39E-06
5990	hsa-mir-1538	hsa04510	Focal adhesion	1499_595_6714_2885_207_71_5595_5594_5599_2932_3725_894_896_5604_5601_85366_2002	17	4.71E-06	0.00037204	8.65E-06
5991	hsa-mir-1538	hsa04612	Antigen processing and presentation	3309_3303_3305_3320_1385_3310_3312_3326_4800_4801_4802	11	7.43E-06	0.00058716	1.33E-05
5992	hsa-mir-1538	hsa03410	Base excision repair	4350_5111_142_252969_328_2237_6996	7	2.68E-05	0.002117855	4.71E-05
5993	hsa-mir-1538	hsa03450	Non-homologous end-joining	10111_7520_2237_5591_4361	5	3.44E-05	0.002719003	5.91E-05
5994	hsa-mir-1538	hsa05218	Melanoma	595_4193_5925_207_5595_5594_4286_7157_5604	9	4.18E-05	0.003301308	7.02E-05
5995	hsa-mir-1538	hsa03020	RNA polymerase	64425_25885_51082_5437_84172_5441	6	7.53E-05	0.005952592	0.000124012
5996	hsa-mir-1538	hsa04120	Ubiquitin mediated proteolysis	4193_55294_23291_9063_10401_7329_8925_5371_672_6500_8454_8945	12	7.76E-05	0.006134259	0.000125189
5997	hsa-mir-1538	hsa04930	Type II diabetes mellitus	3551_5580_3651_5595_5594_5599_5601	7	9.47E-05	0.007484453	0.000149689
5998	hsa-mir-1538	hsa04150	mTOR signaling pathway	6197_3091_207_5595_5594_6195_6196	7	0.000213203	0.016843024	0.000330255
5999	hsa-mir-1538	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_1616_836_7157_5606_5600_842	7	0.000321976	0.025436141	0.000489157
6000	hsa-mir-1538	hsa04270	Vascular smooth muscle contraction	5580_5592_5595_5594_808_801_805_59_5604_85366	10	0.000346399	0.02736551	0.00051633
6001	hsa-mir-1538	hsa05010	Alzheimer's disease	6622_836_22926_5595_5594_2932_808_801_805_842_841_840	12	0.000620246	0.04899941	0.000907396
6002	hsa-mir-1538	hsa05217	Basal cell carcinoma	1499_6934_2932_7157_51176_2736	6	0.001636105	0.129252286	0.002350042
6003	hsa-mir-1538	hsa03022	Basal transcription factors	2963_2962_2969_6908_2959	5	0.001700189	0.134314899	0.00239848
6004	hsa-mir-1538	hsa04950	Maturity onset diabetes of the young	6927_4760_3651_5080	4	0.00252118	0.199173199	0.003494267
6005	hsa-mir-1538	hsa04530	Tight junction	1499_5580_6714_4627_207_71_1457_5519_5518	9	0.003503142	0.276748249	0.004771522
6006	hsa-mir-1538	hsa04730	Long-term depression	5592_5595_5594_5519_5518_5604	6	0.005294816	0.418290429	0.007089668
6007	hsa-mir-1538	hsa03320	PPAR signaling pathway	5465_5467_5468_6258_6256	5	0.019810281	1	0.026083537
6008	hsa-mir-1538	hsa03440	Homologous recombination	10111_4683_4361	3	0.025909961	1	0.033555524
6009	hsa-mir-1538	hsa04650	Natural killer cell mediated cytotoxicity	4772_4773_2885_836_5595_5594_5604	7	0.031859092	1	0.040594649
6010	hsa-mir-1538	hsa04340	Hedgehog signaling pathway	23291_2932_8945_2736	4	0.037735241	1	0.047318794
6011	hsa-mir-154	hsa05200	Pathways in cancer	7046_5468_595_2261_8517_3551_4089_3066_3065_5925_7187_5747_10342_1956_207_3716_1147_4233_5595_5594_5599_1387_2064_6256_367_10401_2932_6774_6776_6777_6772_5979_5879_3725_2033_898_4790_4791_4792_5970_3320_3326_5371_3480_5159_5156_3815_3265_8772_4609_1026_2353_1441_8554	54	2.14E-28	1.80E-26	1.80E-26
6012	hsa-mir-154	hsa04630	Jak-STAT signaling pathway	3559_595_58985_3454_3455_3560_3561_1439_2690_207_3717_3716_3718_8651_85480_1387_3575_3570_3572_10401_6778_6774_6776_6777_6772_6773_7297_2033_149233_3953_3459_5781_4609_1441_8554_10379	36	8.14E-24	6.84E-22	3.42E-22
6013	hsa-mir-154	hsa04010	MAPK signaling pathway	3925_6722_7046_2261_2264_8517_3551_1845_9020_1956_7132_3303_1432_22800_207_1147_5595_5594_5599_9252_3310_3312_5971_5879_3725_4790_4791_51701_5970_5159_1326_5156_5608_5566_3265_6885_4609_2353_3305	39	4.73E-19	3.97E-17	1.32E-17
6014	hsa-mir-154	hsa05215	Prostate cancer	595_8517_3551_5925_1956_207_1147_5595_5594_1387_2064_367_2932_2033_898_4790_4792_5970_3320_3326_3480_5159_5156_3265_1026	25	1.04E-18	8.75E-17	2.19E-17
6015	hsa-mir-154	hsa05212	Pancreatic cancer	595_8517_3551_5925_1956_207_1147_5595_5594_1387_2064_367_2932_2033_898_4790_4792_5970_3320_3326_3480_5159_5156_3265_1026	25	1.31E-18	1.10E-16	2.20E-17
6016	hsa-mir-154	hsa04620	Toll-like receptor signaling pathway	8517_3551_3454_3455_7187_3661_1432_207_1147_3654_29110_5595_5594_5599_6772_5879_3725_4790_4792_5970_1326_5608_9641_8772_6885_2353	26	2.05E-18	1.73E-16	2.88E-17
6017	hsa-mir-154	hsa03010	Ribosome	6155_6156_6128_6193_6204_6205_6207_6202_6141_6217_6137_6135_6210_6191_9349_6222_6223_6229_6129_6181_6130_6189_6188_6232	24	2.00E-16	1.68E-14	2.40E-15
6018	hsa-mir-154	hsa05220	Chronic myeloid leukemia	7046_595_8517_3551_4089_3066_3065_5925_207_1147_5595_5594_6776_6777_4790_4792_5970_3265_5781_4609_1026	21	7.96E-16	6.69E-14	8.36E-15
6019	hsa-mir-154	hsa04920	Adipocytokine signaling pathway	5465_8517_3551_7133_7132_8471_207_3717_1147_8717_5599_6256_6774_4794_4790_4792_4793_5970_3953_5781	20	1.39E-15	1.17E-13	1.30E-14
6020	hsa-mir-154	hsa04062	Chemokine signaling pathway	8517_1230_3551_653361_5747_5580_7852_207_3055_3717_1147_3718_5590_5595_5594_1234_2932_6774_6777_6772_6773_5879_4790_4792_4793_5970_5566_3265_2185	29	5.26E-15	4.42E-13	4.42E-14
6021	hsa-mir-154	hsa04060	Cytokine-cytokine receptor interaction	3556_3559_7046_1230_58985_3454_3455_90_3791_1956_3560_3561_7133_7132_1439_7852_2690_85480_4233_1234_3575_3570_3572_2321_149233_5159_5156_3815_3953_3459_1441	31	2.07E-13	1.74E-11	1.58E-12
6022	hsa-mir-154	hsa04520	Adherens junction	7046_4089_2534_1956_6714_71_2241_4233_5595_5594_1387_2064_5879_1457_2033_51701_3480_8826_6885	19	2.38E-13	2.00E-11	1.67E-12
6023	hsa-mir-154	hsa04660	T cell receptor signaling pathway	8517_3551_9020_2534_3932_1432_207_1147_5595_5594_2932_3725_4794_4790_4792_4793_5970_1326_3265_6885_2353	21	5.35E-13	4.49E-11	3.46E-12
6024	hsa-mir-154	hsa04662	B cell receptor signaling pathway	8517_3551_6850_207_1147_695_5595_5594_2932_5879_3725_4794_4790_4792_4793_5970_3265_2353	18	8.73E-13	7.33E-11	5.24E-12
6025	hsa-mir-154	hsa04310	Wnt signaling pathway	818_817_595_8607_6500_4089_23291_8945_5599_1387_2932_5879_3725_1457_2033_51701_5519_5518_5515_5566_8454_6885_4609	23	3.08E-12	2.59E-10	1.72E-11
6026	hsa-mir-154	hsa05221	Acute myeloid leukemia	595_8517_3551_207_1147_5595_5594_6774_6776_6777_4790_5970_5371_3815_3265_4609	16	3.34E-12	2.81E-10	1.75E-11
6027	hsa-mir-154	hsa05214	Glioma	818_817_595_5925_1956_207_5595_5594_808_801_805_3480_5159_5156_3265_1026	16	1.17E-11	9.81E-10	5.77E-11
6028	hsa-mir-154	hsa05210	Colorectal cancer	7046_595_4089_1956_207_4233_5595_5594_5599_2932_5879_3725_3480_5159_5156_4609_2353	17	3.93E-11	3.30E-09	1.83E-10
6029	hsa-mir-154	hsa04012	ErbB signaling pathway	818_817_5747_1956_6714_207_5595_5594_5599_2064_2932_6776_6777_3725_3265_4609_1026	17	6.37E-11	5.35E-09	2.82E-10
6030	hsa-mir-154	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	8517_3551_9020_1956_6714_1432_1147_4233_5599_5879_3725_4790_4792_5970_5781	15	3.29E-10	2.76E-08	1.38E-09
6031	hsa-mir-154	hsa05222	Small cell lung cancer	595_8517_3551_5925_7187_5747_207_1147_6256_10401_898_4790_4792_5970_4609_8554	16	4.38E-10	3.68E-08	1.75E-09
6032	hsa-mir-154	hsa04350	TGF-beta signaling pathway	7046_6500_4089_90_57154_6667_5595_5594_1387_4086_2033_5519_5518_5515_8454_4609	16	5.09E-10	4.28E-08	1.94E-09
6033	hsa-mir-154	hsa04210	Apoptosis	3556_8517_3551_9020_7132_1439_207_1147_3654_8717_9131_4790_4792_5970_5566_8772	16	6.83E-10	5.73E-08	2.49E-09
6034	hsa-mir-154	hsa04912	GnRH signaling pathway	818_817_5580_1956_6714_1432_5595_5594_5599_3725_808_801_805_5608_5566_3265_2185	17	1.23E-09	1.03E-07	4.31E-09
6035	hsa-mir-154	hsa04510	Focal adhesion	595_2534_5747_3791_1956_6714_207_71_4233_5595_5594_5599_2064_2932_5879_3725_2321_3480_5159_5156_3265_85366	22	3.71E-09	3.12E-07	1.23E-08
6036	hsa-mir-154	hsa03050	Proteasome	5709_5705_5706_5700_5693_5719_5717_5713_5684_5707_5687_5708	12	3.80E-09	3.19E-07	1.23E-08
6037	hsa-mir-154	hsa04110	Cell cycle	595_6500_4089_4174_4172_3066_3065_5925_5591_1387_2932_5111_2033_898_8454_1026_1111	17	4.59E-09	3.85E-07	1.43E-08
6038	hsa-mir-154	hsa04720	Long-term potentiation	818_814_817_2902_5595_5594_1387_2033_808_801_805_5566_3265_2906	14	5.20E-09	4.37E-07	1.56E-08
6039	hsa-mir-154	hsa05219	Bladder cancer	595_2261_5925_1956_5595_5594_2064_9252_3265_4609_1026	11	1.13E-08	9.47E-07	3.27E-08
6040	hsa-mir-154	hsa04540	Gap junction	10382_1956_6714_5595_5594_7846_203068_347733_5159_5156_5566_3265_7278_84617	14	5.86E-08	4.92E-06	1.64E-07
6041	hsa-mir-154	hsa05216	Thyroid cancer	5468_595_10342_5595_5594_6256_5979_3265_4609	9	7.25E-08	6.09E-06	1.96E-07
6042	hsa-mir-154	hsa05218	Melanoma	595_5925_1956_207_4233_5595_5594_3480_5159_5156_3265_1026	12	1.69E-07	1.42E-05	4.45E-07
6043	hsa-mir-154	hsa04910	Insulin signaling pathway	3551_8471_5211_207_8651_5590_5595_5594_5599_2932_2194_808_801_805_5566_3265	16	1.80E-07	1.51E-05	4.58E-07
6044	hsa-mir-154	hsa04020	Calcium signaling pathway	818_814_817_292_293_147_1956_2902_2064_808_801_805_5159_5156_5566_2906_2185_85366	18	3.21E-07	2.70E-05	7.93E-07
6045	hsa-mir-154	hsa04664	Fc epsilon RI signaling pathway	2534_5580_6850_1432_207_695_5595_5594_5599_5879_5608_3265	12	4.73E-07	3.98E-05	1.14E-06
6046	hsa-mir-154	hsa04916	Melanogenesis	818_817_5595_5594_1387_2932_2033_808_801_805_5566_3815_3265	13	1.18E-06	9.90E-05	2.75E-06
6047	hsa-mir-154	hsa04330	Notch signaling pathway	9612_3066_3065_3280_1387_2033_8850_388585_4851	9	2.40E-06	0.000201946	5.46E-06
6048	hsa-mir-154	hsa04530	Tight junction	5580_6714_4627_4628_22800_8573_207_71_5590_1457_5519_5518_5515_3265	14	4.07E-06	0.000342177	9.00E-06
6049	hsa-mir-154	hsa05213	Endometrial cancer	595_1956_207_5595_5594_2064_2932_3265_4609	9	5.01E-06	0.000421011	1.08E-05
6050	hsa-mir-154	hsa05223	Non-small cell lung cancer	595_5925_1956_207_5595_5594_2064_6256_3265	9	6.59E-06	0.000553514	1.38E-05
6051	hsa-mir-154	hsa05131	Shigellosis	10382_2534_71_7846_203068_347733_7278_84617_4691	9	8.57E-06	0.000720195	1.70E-05
6052	hsa-mir-154	hsa05130	Pathogenic Escherichia coli infection	10382_2534_71_7846_203068_347733_7278_84617_4691	9	8.57E-06	0.000720195	1.70E-05
6053	hsa-mir-154	hsa05211	Renal cell carcinoma	207_4233_5595_5594_1387_5879_3725_2033_3265_5781	10	8.72E-06	0.00073266	1.70E-05
6054	hsa-mir-154	hsa04810	Regulation of actin cytoskeleton	2261_2264_5747_1956_4627_4628_22800_71_5595_5594_5879_5159_5156_3265_10788_8826_85366	17	1.21E-05	0.001020421	2.32E-05
6055	hsa-mir-154	hsa04930	Type II diabetes mellitus	3551_5580_8471_8651_5590_5595_5594_5599	8	1.42E-05	0.001191594	2.65E-05
6056	hsa-mir-154	hsa04120	Ubiquitin mediated proteolysis	55294_6500_57154_23291_8945_7329_8651_51366_10401_5371_672_8454_8554	13	2.13E-05	0.001792643	3.90E-05
6057	hsa-mir-154	hsa05016	Huntington's disease	5468_292_293_3066_3065_498_2902_6667_5441_1387_5437_2033_6908_1213_9519	15	2.90E-05	0.002439545	5.19E-05
6058	hsa-mir-154	hsa03022	Basal transcription factors	2969_6878_6872_6908_6882_2959_9519	7	3.45E-05	0.002898825	6.04E-05
6059	hsa-mir-154	hsa03020	RNA polymerase	64425_25885_51082_5441_5437_84172	6	8.20E-05	0.006885071	0.000138582
6060	hsa-mir-154	hsa04370	VEGF signaling pathway	5747_3791_6714_1432_207_5595_5594_5879_3265	9	8.34E-05	0.007005792	0.000138582
6061	hsa-mir-154	hsa04650	Natural killer cell mediated cytotoxicity	3454_3455_2534_3932_6850_5595_5594_5879_3265_3459_5781_2185	12	8.41E-05	0.007067678	0.000138582
6062	hsa-mir-154	hsa05340	Primary immunodeficiency	8517_3932_3561_3718_695_3575	6	0.000204025	0.01713812	0.000329579
6063	hsa-mir-154	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_7133_7132_1432_5879_5608_2906	7	0.000352978	0.029650165	0.000559437
6064	hsa-mir-154	hsa05010	Alzheimer's disease	498_2902_7132_5595_5594_2932_808_351_801_805_2906_8772	12	0.000708616	0.059523758	0.001102292
6065	hsa-mir-154	hsa04360	Axon guidance	2534_5747_7852_2242_4233_5595_5594_2932_5879_3265	10	0.000834214	0.070073944	0.001274072
6066	hsa-mir-154	hsa04612	Antigen processing and presentation	3309_3303_3310_3312_3320_3326_2923_3305	8	0.001031092	0.086611735	0.001546638
6067	hsa-mir-154	hsa04730	Long-term depression	5595_5594_3480_5519_5518_5515_3265	7	0.001285898	0.108015411	0.001895007
6068	hsa-mir-154	hsa04270	Vascular smooth muscle contraction	147_5580_5595_5594_808_801_805_5566_85366	9	0.001505277	0.126443302	0.002180057
6069	hsa-mir-154	hsa03030	DNA replication	5981_4174_4172_5111_6118	5	0.001629255	0.136857415	0.002319617
6070	hsa-mir-154	hsa04670	Leukocyte transendothelial migration	653361_5747_1432_7852_71_5879_5781_2185	8	0.00636397	0.534573475	0.008909558
6071	hsa-mir-154	hsa03430	Mismatch repair	5981_5111_6118	3	0.016836633	1	0.023184871
6072	hsa-mir-154	hsa04340	Hedgehog signaling pathway	23291_8945_2932_5566	4	0.039557697	1	0.0535943
6073	hsa-mir-154	hsa03450	Non-homologous end-joining	5591_7520	2	0.043677528	1	0.058236704
6074	hsa-mir-154	hsa04640	Hematopoietic cell lineage	3559_3575_3570_3815_1441	5	0.044983891	1	0.059041356
6075	hsa-mir-154	hsa03410	Base excision repair	142_3146_5111	3	0.048486075	1	0.062658928
6076	hsa-mir-15a	hsa05200	Pathways in cancer	4149_1499_595_2261_8517_4193_3551_3091_3066_3065_1050_5925_7184_1956_4436_1487_1488_1870_1871_10401_207_208_836_3716_1147_4233_5595_5594_5599_1387_2064_6256_9915_367_2932_6776_6777_6772_5979_5879_7157_6688_1869_3725_4286_2736_4087_4088_4089_2034_2033_898_4790_4791_4792_5970_1017_3320_3326_5371_3480_5159_5156_3265_4609_1026_2353_1441_8554	69	1.20E-46	9.71E-45	9.71E-45
6077	hsa-mir-15a	hsa05215	Prostate cancer	1499_595_8517_4193_3551_5925_7184_1956_1870_1871_207_208_1147_5595_5594_1387_2064_367_2932_7157_1869_2033_898_4790_4792_5970_1017_3320_3326_3480_5159_5156_3265_1026	34	6.83E-31	5.53E-29	2.51E-29
6078	hsa-mir-15a	hsa05212	Pancreatic cancer	1499_595_8517_4193_3551_5925_7184_1956_1870_1871_207_208_1147_5595_5594_1387_2064_367_2932_7157_1869_2033_898_4790_4792_5970_1017_3320_3326_3480_5159_5156_3265_1026	34	9.28E-31	7.52E-29	2.51E-29
6079	hsa-mir-15a	hsa05220	Chronic myeloid leukemia	595_8517_4193_3551_3066_3065_5925_1487_1488_1870_1871_207_208_1147_5595_5594_6776_6777_7157_1869_4088_4089_4790_4792_5970_3265_5781_4609_1026	29	1.56E-26	1.26E-24	3.15E-25
6080	hsa-mir-15a	hsa03022	Basal transcription factors	6880_54457_2958_138474_6883_6881_2957_6879_2967_2961_2960_2963_2969_2968_6878_6877_6874_6873_6872_6908_6884_6882_2959_9519	24	2.50E-26	2.03E-24	4.06E-25
6081	hsa-mir-15a	hsa04010	MAPK signaling pathway	3925_6722_4149_2261_2264_8517_9252_3551_9020_8986_1956_1432_22800_207_208_836_1147_5595_5594_5599_5598_3312_5971_5879_7157_3725_3727_6195_6196_6197_5058_4790_4791_51701_5970_5159_9261_1326_5156_3265_6885_4609_2353	43	4.86E-25	3.94E-23	6.57E-24
6082	hsa-mir-15a	hsa04110	Cell cycle	4171_595_4193_6500_3066_3065_5925_1870_1871_8379_5934_5933_7534_1387_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_898_1017_8454_4085_1026	29	8.27E-22	6.70E-20	9.57E-21
6083	hsa-mir-15a	hsa04630	Jak-STAT signaling pathway	3559_595_3454_3455_3560_1439_10401_2690_207_208_3717_3716_3718_85480_1387_3575_3570_3572_6778_6776_6777_6772_7297_2033_149233_3953_5781_4609_1441_8554_10379	31	4.96E-21	4.02E-19	5.02E-20
6084	hsa-mir-15a	hsa05210	Colorectal cancer	1499_595_1956_4436_207_208_836_4233_5595_5594_5599_2932_5879_7157_3725_4087_4088_4089_3480_5159_5156_4609_2353	23	1.60E-18	1.30E-16	1.44E-17
6085	hsa-mir-15a	hsa05214	Glioma	595_4193_5925_1956_1870_1871_207_208_5595_5594_7157_1869_808_801_805_3480_5159_5156_3265_1026	20	4.17E-17	3.38E-15	3.38E-16
6086	hsa-mir-15a	hsa05222	Small cell lung cancer	4149_595_8517_3551_5925_1870_1871_10401_207_208_1147_6256_7157_1869_898_4790_4792_5970_1017_4609_8554	21	3.59E-16	2.91E-14	2.64E-15
6087	hsa-mir-15a	hsa04620	Toll-like receptor signaling pathway	8517_3551_3454_3455_1432_207_208_1147_3654_5595_5594_5599_6772_5879_3725_4790_4792_5970_1326_9641_6885_2353	22	6.69E-16	5.42E-14	4.52E-15
6088	hsa-mir-15a	hsa04520	Adherens junction	1499_1457_1460_1956_6714_71_2241_4233_5595_5594_1387_2064_5879_4087_4088_4089_2033_51701_3480_6885	20	1.24E-15	1.00E-13	7.72E-15
6089	hsa-mir-15a	hsa05218	Melanoma	595_4193_5925_1956_1870_1871_207_208_4233_5595_5594_7157_1869_4286_3480_5159_5156_3265_1026	19	2.22E-15	1.80E-13	1.29E-14
6090	hsa-mir-15a	hsa04660	T cell receptor signaling pathway	8517_3551_9020_3932_1432_207_208_1147_5595_5594_2932_3725_5058_4794_4790_4792_4793_5970_1326_3265_6885_2353	22	2.63E-15	2.13E-13	1.42E-14
6091	hsa-mir-15a	hsa05219	Bladder cancer	595_2261_9252_4193_5925_1956_1870_1871_5595_5594_2064_7157_1869_3265_4609_1026	16	3.80E-15	3.08E-13	1.92E-14
6092	hsa-mir-15a	hsa05221	Acute myeloid leukemia	595_8517_3551_1050_207_208_1147_5595_5594_6776_6777_6688_4790_5970_5371_3265_4609	17	2.39E-14	1.94E-12	1.14E-13
6093	hsa-mir-15a	hsa04062	Chemokine signaling pathway	8517_1230_3551_7852_207_208_3055_3717_1147_3718_5590_5595_5594_1234_2932_5580_6777_6772_5879_5058_4790_4792_4793_5970_3265_2185	26	3.48E-14	2.82E-12	1.57E-13
6094	hsa-mir-15a	hsa04662	B cell receptor signaling pathway	8517_3551_6850_207_208_1147_5595_5594_2932_5879_3725_4794_4790_4792_4793_5970_3265_2353	18	6.08E-14	4.92E-12	2.59E-13
6095	hsa-mir-15a	hsa04310	Wnt signaling pathway	1499_595_8607_1457_6500_1460_23291_1487_1488_5599_1387_2932_5879_7157_3725_4087_4088_4089_2033_51701_8454_6885_4609	23	1.20E-13	9.68E-12	4.84E-13
6096	hsa-mir-15a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	8517_3551_9020_1956_6714_1432_836_1147_4233_5599_5879_3725_5058_4790_4792_5970_5781	17	3.14E-13	2.55E-11	1.21E-12
6097	hsa-mir-15a	hsa04350	TGF-beta signaling pathway	6500_6667_1874_1875_5934_5933_5595_5594_1387_7027_4086_4087_4088_4089_2033_8454_4609_4093	18	5.48E-13	4.44E-11	2.02E-12
6098	hsa-mir-15a	hsa04920	Adipocytokine signaling pathway	8517_3551_2538_207_208_3717_1147_5599_6256_4794_4790_4792_4793_5970_3953_5781	16	1.63E-12	1.32E-10	5.73E-12
6099	hsa-mir-15a	hsa05223	Non-small cell lung cancer	595_5925_1956_1870_1871_207_208_5595_5594_2064_6256_7157_1869_3265	14	1.58E-11	1.28E-09	5.32E-11
6100	hsa-mir-15a	hsa05211	Renal cell carcinoma	3091_207_208_4233_5595_5594_1387_9915_5879_3725_5058_2034_2033_3265_5781	15	4.37E-11	3.54E-09	1.42E-10
6101	hsa-mir-15a	hsa04012	ErbB signaling pathway	1956_6714_207_208_5595_5594_5599_2064_2932_6776_6777_3725_5058_3265_4609_1026	16	5.07E-11	4.11E-09	1.58E-10
6102	hsa-mir-15a	hsa04210	Apoptosis	3556_8517_3551_9020_1439_207_208_836_1147_3654_7157_4790_4792_5970_840	15	5.98E-10	4.85E-08	1.80E-09
6103	hsa-mir-15a	hsa04510	Focal adhesion	1499_595_1956_6714_207_208_71_4233_5595_5594_5599_2064_2932_5879_3725_5058_2321_3480_5159_5156_3265	21	1.11E-09	9.01E-08	3.22E-09
6104	hsa-mir-15a	hsa05213	Endometrial cancer	1499_595_1956_207_208_5595_5594_2064_2932_7157_3265_4609	12	1.42E-09	1.15E-07	3.95E-09
6105	hsa-mir-15a	hsa04330	Notch signaling pathway	3066_3065_1487_1488_3280_1387_9612_2033_8850_388585_4851	11	6.07E-09	4.91E-07	1.62E-08
6106	hsa-mir-15a	hsa04720	Long-term potentiation	2902_5595_5594_1387_6195_6196_6197_2033_808_801_805_3265_2906	13	6.22E-09	5.04E-07	1.62E-08
6107	hsa-mir-15a	hsa04060	Cytokine-cytokine receptor interaction	3556_3559_1230_3454_3455_1956_7852_3560_1439_2690_85480_4233_1234_3575_3570_3572_2321_149233_5159_5156_3953_1441	22	1.22E-08	9.85E-07	3.08E-08
6108	hsa-mir-15a	hsa05216	Thyroid cancer	1499_595_5595_5594_6256_5979_7157_3265_4609	9	1.88E-08	1.52E-06	4.61E-08
6109	hsa-mir-15a	hsa04912	GnRH signaling pathway	1956_6714_1432_5595_5594_5599_5598_5580_3725_808_801_805_3265_2185	14	4.50E-08	3.65E-06	1.07E-07
6110	hsa-mir-15a	hsa04910	Insulin signaling pathway	3551_2538_5211_207_208_5590_5595_5594_5599_2932_808_801_805_3265	14	7.00E-07	5.67E-05	1.62E-06
6111	hsa-mir-15a	hsa05016	Huntington's disease	3066_3065_3064_2902_6667_836_5441_1387_9001_5430_5437_7157_2033_6874_6908_9519	16	1.00E-06	8.14E-05	2.26E-06
6112	hsa-mir-15a	hsa03020	RNA polymerase	64425_25885_51082_5441_5430_5437_84172	7	3.10E-06	0.000250745	6.78E-06
6113	hsa-mir-15a	hsa04664	Fc epsilon RI signaling pathway	6850_1432_207_208_5595_5594_5599_5580_5879_3265	10	4.62E-06	0.000374035	9.84E-06
6114	hsa-mir-15a	hsa04916	Melanogenesis	1499_5595_5594_1387_2932_4286_2033_808_801_805_3265	11	7.55E-06	0.000611263	1.57E-05
6115	hsa-mir-15a	hsa04150	mTOR signaling pathway	3091_207_208_5595_5594_6195_6196_6197	8	1.16E-05	0.000942928	2.36E-05
6116	hsa-mir-15a	hsa04540	Gap junction	10382_1956_6714_5592_5595_5594_5598_5159_5156_3265	10	1.71E-05	0.001386912	3.31E-05
6117	hsa-mir-15a	hsa04530	Tight junction	1499_1457_1460_6714_22800_8573_207_208_71_5590_5580_3265	12	1.72E-05	0.001391949	3.31E-05
6118	hsa-mir-15a	hsa04650	Natural killer cell mediated cytotoxicity	3454_3455_3932_6850_836_5595_5594_5879_5058_3265_5781_2185	12	1.84E-05	0.001488712	3.46E-05
6119	hsa-mir-15a	hsa04370	VEGF signaling pathway	6714_1432_207_208_5595_5594_5879_9261_3265	9	2.47E-05	0.001998491	4.54E-05
6120	hsa-mir-15a	hsa04930	Type II diabetes mellitus	3551_3651_5590_5595_5594_5599_5580	7	3.87E-05	0.00313521	6.97E-05
6121	hsa-mir-15a	hsa04950	Maturity onset diabetes of the young	6927_3280_3651_5080_3172	5	0.000152977	0.012391103	0.000269372
6122	hsa-mir-15a	hsa05010	Alzheimer's disease	2902_836_5595_5594_2932_808_351_801_805_840_2906_1020	12	0.00017248	0.013970854	0.000297252
6123	hsa-mir-15a	hsa04360	Axon guidance	7852_2242_4233_5595_5594_2932_5879_5058_3265_1020	10	0.00024449	0.01980365	0.000412576
6124	hsa-mir-15a	hsa04810	Regulation of actin cytoskeleton	2261_2264_1956_22800_71_5595_5594_5879_5058_5159_5156_3265_10788	13	0.000320354	0.025948701	0.000529565
6125	hsa-mir-15a	hsa04120	Ubiquitin mediated proteolysis	55294_4193_6500_23291_10401_7329_5371_672_8454_8554	10	0.000380639	0.030831791	0.000616636
6126	hsa-mir-15a	hsa04115	p53 signaling pathway	595_4193_836_7157_898_1017_1026	7	0.000436716	0.035374001	0.000693608
6127	hsa-mir-15a	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_1432_836_5879_7157_2906	6	0.000859454	0.069615793	0.001338765
6128	hsa-mir-15a	hsa04612	Antigen processing and presentation	3308_3312_3320_3326_4802_2923_4801	7	0.001751982	0.141910549	0.002677558
6129	hsa-mir-15a	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	0.002596161	0.210289076	0.003894242
6130	hsa-mir-15a	hsa04020	Calcium signaling pathway	1956_2902_2064_808_801_805_5159_5156_2906_2185	10	0.002813104	0.227861426	0.004142935
6131	hsa-mir-15a	hsa05340	Primary immunodeficiency	8517_3932_3718_3575	4	0.005157931	0.417792427	0.007460579
6132	hsa-mir-15a	hsa04270	Vascular smooth muscle contraction	5592_5595_5594_5580_808_801_805	7	0.007537347	0.610525123	0.010710967
6133	hsa-mir-15a	hsa04670	Leukocyte transendothelial migration	1499_7852_1432_71_5879_5781_2185	7	0.008892269	0.720273797	0.012418514
6134	hsa-mir-15a	hsa03420	Nucleotide excision repair	5887_2967_2968_6118	4	0.010754591	0.871121876	0.014764778
6135	hsa-mir-15a	hsa04730	Long-term depression	5592_5595_5594_3480_3265	5	0.011957968	0.968595402	0.016143257
6136	hsa-mir-15a	hsa05217	Basal cell carcinoma	1499_2932_7157_2736	4	0.021580514	1	0.028656093
6137	hsa-mir-15a	hsa05131	Shigellosis	1499_10382_71_7534	4	0.022803379	1	0.029318631
6138	hsa-mir-15a	hsa05130	Pathogenic Escherichia coli infection	1499_10382_71_7534	4	0.022803379	1	0.029318631
6139	hsa-mir-15a	hsa04340	Hedgehog signaling pathway	23291_53944_2932_2736	4	0.024067596	1	0.030460552
6140	hsa-mir-15a	hsa03010	Ribosome	6156_6128_6207_9349_6229	5	0.044099579	1	0.054954859
6141	hsa-mir-15b	hsa05200	Pathways in cancer	4088_4089_5925_1870_1871_3725_1050_5599_4149_7157_2249_1017_367_1869_6776_6777_2353_5914_5970_6256	20	8.14E-22	4.15E-20	4.15E-20
6142	hsa-mir-15b	hsa05220	Chronic myeloid leukemia	4088_4089_5925_1870_1871_7157_1869_6776_6777_5970	10	1.54E-14	7.87E-13	3.93E-13
6143	hsa-mir-15b	hsa04110	Cell cycle	4088_4089_5925_1870_1871_7157_1017_890_1869_5934_5933	11	2.89E-14	1.47E-12	4.90E-13
6144	hsa-mir-15b	hsa05222	Small cell lung cancer	5925_1870_1871_4149_7157_1017_1869_5970_6256	9	2.54E-12	1.30E-10	2.88E-11
6145	hsa-mir-15b	hsa05215	Prostate cancer	5925_1870_1871_7157_1017_468_367_1869_5970	9	3.08E-12	1.57E-10	2.88E-11
6146	hsa-mir-15b	hsa05212	Pancreatic cancer	5925_1870_1871_7157_1017_468_367_1869_5970	9	3.38E-12	1.73E-10	2.88E-11
6147	hsa-mir-15b	hsa04350	TGF-beta signaling pathway	4088_4089_1874_1875_6667_5934_5933_3398	8	1.16E-10	5.91E-09	8.45E-10
6148	hsa-mir-15b	hsa04010	MAPK signaling pathway	3725_5599_4149_7157_2249_9479_468_3727_2353_5970	10	2.56E-09	1.31E-07	1.63E-08
6149	hsa-mir-15b	hsa05223	Non-small cell lung cancer	5925_1870_1871_7157_1869_6256	6	9.56E-09	4.88E-07	5.42E-08
6150	hsa-mir-15b	hsa05218	Melanoma	5925_1870_1871_7157_2249_1869	6	4.38E-08	2.23E-06	2.23E-07
6151	hsa-mir-15b	hsa05210	Colorectal cancer	4088_4089_3725_5599_7157_2353	6	1.12E-07	5.71E-06	5.19E-07
6152	hsa-mir-15b	hsa05219	Bladder cancer	5925_1870_1871_7157_1869	5	1.27E-07	6.49E-06	5.41E-07
6153	hsa-mir-15b	hsa05221	Acute myeloid leukemia	1050_6776_6777_5914_5970	5	6.12E-07	3.12E-05	2.40E-06
6154	hsa-mir-15b	hsa05214	Glioma	5925_1870_1871_7157_1869	5	9.60E-07	4.89E-05	3.50E-06
6155	hsa-mir-15b	hsa04310	Wnt signaling pathway	4088_4089_3725_5599_7157_6423	6	3.08E-06	0.000157277	1.05E-05
6156	hsa-mir-15b	hsa04012	ErbB signaling pathway	3725_5599_6776_6777	4	8.52E-05	0.00434388	0.000271492
6157	hsa-mir-15b	hsa04620	Toll-like receptor signaling pathway	3725_5599_2353_5970	4	0.000153848	0.00784623	0.000461543
6158	hsa-mir-15b	hsa04920	Adipocytokine signaling pathway	5599_5970_6256	3	0.00075152	0.038327521	0.002129307
6159	hsa-mir-15b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5599_5970	3	0.000883542	0.045060636	0.002371612
6160	hsa-mir-15b	hsa04662	B cell receptor signaling pathway	3725_2353_5970	3	0.001029428	0.052500806	0.00262504
6161	hsa-mir-15b	hsa04210	Apoptosis	7157_5970_823	3	0.001656828	0.084498231	0.004023725
6162	hsa-mir-15b	hsa05216	Thyroid cancer	7157_6256	2	0.002794329	0.142510797	0.006270449
6163	hsa-mir-15b	hsa04912	GnRH signaling pathway	3725_5599_468	3	0.00282785	0.144220333	0.006270449
6164	hsa-mir-15b	hsa04660	T cell receptor signaling pathway	3725_2353_5970	3	0.002974183	0.151683358	0.00632014
6165	hsa-mir-15b	hsa04630	Jak-STAT signaling pathway	3977_6776_6777	3	0.00755587	0.385349355	0.015413974
6166	hsa-mir-15b	hsa05016	Huntington's disease	7157_6667_6908	3	0.012623667	0.643807022	0.024761809
6167	hsa-mir-15b	hsa04115	p53 signaling pathway	7157_1017	2	0.013992134	0.713598848	0.026429587
6168	hsa-mir-15b	hsa04520	Adherens junction	4088_4089	2	0.018369197	0.936829049	0.03345818
6169	hsa-mir-15b	hsa03450	Non-homologous end-joining	2547	1	0.037249315	1	0.065507416
6170	hsa-mir-16-1	hsa05200	Pathways in cancer	4149_1499_595_2261_8517_4193_3551_3091_3066_3065_1050_5925_7184_1956_4436_1487_1488_1870_1871_10401_207_208_836_3716_1147_4233_5595_5594_5599_1387_2064_6256_9915_367_2932_6776_6777_6772_5979_5879_7157_6688_1869_3725_4286_2736_4087_4088_4089_2034_2033_898_4790_4791_4792_5970_1017_3320_3326_5371_3480_5159_5156_3265_4609_1026_2353_1441_8554	69	1.20E-46	9.71E-45	9.71E-45
6171	hsa-mir-16-1	hsa05215	Prostate cancer	1499_595_8517_4193_3551_5925_7184_1956_1870_1871_207_208_1147_5595_5594_1387_2064_367_2932_7157_1869_2033_898_4790_4792_5970_1017_3320_3326_3480_5159_5156_3265_1026	34	6.83E-31	5.53E-29	2.51E-29
6172	hsa-mir-16-1	hsa05212	Pancreatic cancer	1499_595_8517_4193_3551_5925_7184_1956_1870_1871_207_208_1147_5595_5594_1387_2064_367_2932_7157_1869_2033_898_4790_4792_5970_1017_3320_3326_3480_5159_5156_3265_1026	34	9.28E-31	7.52E-29	2.51E-29
6173	hsa-mir-16-1	hsa05220	Chronic myeloid leukemia	595_8517_4193_3551_3066_3065_5925_1487_1488_1870_1871_207_208_1147_5595_5594_6776_6777_7157_1869_4088_4089_4790_4792_5970_3265_5781_4609_1026	29	1.56E-26	1.26E-24	3.15E-25
6174	hsa-mir-16-1	hsa03022	Basal transcription factors	6880_54457_2958_138474_6883_6881_2957_6879_2967_2961_2960_2963_2969_2968_6878_6877_6874_6873_6872_6908_6884_6882_2959_9519	24	2.50E-26	2.03E-24	4.06E-25
6175	hsa-mir-16-1	hsa04010	MAPK signaling pathway	3925_6722_4149_2261_2264_8517_9252_3551_9020_8986_1956_1432_22800_207_208_836_1147_5595_5594_5599_5598_3312_5971_5879_7157_3725_3727_6195_6196_6197_5058_4790_4791_51701_5970_5159_9261_1326_5156_3265_6885_4609_2353	43	4.86E-25	3.94E-23	6.57E-24
6176	hsa-mir-16-1	hsa04110	Cell cycle	4171_595_4193_6500_3066_3065_5925_1870_1871_8379_5934_5933_7534_1387_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_898_1017_8454_4085_1026	29	8.27E-22	6.70E-20	9.57E-21
6177	hsa-mir-16-1	hsa04630	Jak-STAT signaling pathway	3559_595_3454_3455_3560_1439_10401_2690_207_208_3717_3716_3718_85480_1387_3575_3570_3572_6778_6776_6777_6772_7297_2033_149233_3953_5781_4609_1441_8554_10379	31	4.96E-21	4.02E-19	5.02E-20
6178	hsa-mir-16-1	hsa05210	Colorectal cancer	1499_595_1956_4436_207_208_836_4233_5595_5594_5599_2932_5879_7157_3725_4087_4088_4089_3480_5159_5156_4609_2353	23	1.60E-18	1.30E-16	1.44E-17
6179	hsa-mir-16-1	hsa05214	Glioma	595_4193_5925_1956_1870_1871_207_208_5595_5594_7157_1869_808_801_805_3480_5159_5156_3265_1026	20	4.17E-17	3.38E-15	3.38E-16
6180	hsa-mir-16-1	hsa05222	Small cell lung cancer	4149_595_8517_3551_5925_1870_1871_10401_207_208_1147_6256_7157_1869_898_4790_4792_5970_1017_4609_8554	21	3.59E-16	2.91E-14	2.64E-15
6181	hsa-mir-16-1	hsa04620	Toll-like receptor signaling pathway	8517_3551_3454_3455_1432_207_208_1147_3654_5595_5594_5599_6772_5879_3725_4790_4792_5970_1326_9641_6885_2353	22	6.69E-16	5.42E-14	4.52E-15
6182	hsa-mir-16-1	hsa04520	Adherens junction	1499_1457_1460_1956_6714_71_2241_4233_5595_5594_1387_2064_5879_4087_4088_4089_2033_51701_3480_6885	20	1.24E-15	1.00E-13	7.72E-15
6183	hsa-mir-16-1	hsa05218	Melanoma	595_4193_5925_1956_1870_1871_207_208_4233_5595_5594_7157_1869_4286_3480_5159_5156_3265_1026	19	2.22E-15	1.80E-13	1.29E-14
6184	hsa-mir-16-1	hsa04660	T cell receptor signaling pathway	8517_3551_9020_3932_1432_207_208_1147_5595_5594_2932_3725_5058_4794_4790_4792_4793_5970_1326_3265_6885_2353	22	2.63E-15	2.13E-13	1.42E-14
6185	hsa-mir-16-1	hsa05219	Bladder cancer	595_2261_9252_4193_5925_1956_1870_1871_5595_5594_2064_7157_1869_3265_4609_1026	16	3.80E-15	3.08E-13	1.92E-14
6186	hsa-mir-16-1	hsa05221	Acute myeloid leukemia	595_8517_3551_1050_207_208_1147_5595_5594_6776_6777_6688_4790_5970_5371_3265_4609	17	2.39E-14	1.94E-12	1.14E-13
6187	hsa-mir-16-1	hsa04062	Chemokine signaling pathway	8517_1230_3551_7852_207_208_3055_3717_1147_3718_5590_5595_5594_1234_2932_5580_6777_6772_5879_5058_4790_4792_4793_5970_3265_2185	26	3.48E-14	2.82E-12	1.57E-13
6188	hsa-mir-16-1	hsa04662	B cell receptor signaling pathway	8517_3551_6850_207_208_1147_5595_5594_2932_5879_3725_4794_4790_4792_4793_5970_3265_2353	18	6.08E-14	4.92E-12	2.59E-13
6189	hsa-mir-16-1	hsa04310	Wnt signaling pathway	1499_595_8607_1457_6500_1460_23291_1487_1488_5599_1387_2932_5879_7157_3725_4087_4088_4089_2033_51701_8454_6885_4609	23	1.20E-13	9.68E-12	4.84E-13
6190	hsa-mir-16-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	8517_3551_9020_1956_6714_1432_836_1147_4233_5599_5879_3725_5058_4790_4792_5970_5781	17	3.14E-13	2.55E-11	1.21E-12
6191	hsa-mir-16-1	hsa04350	TGF-beta signaling pathway	6500_6667_1874_1875_5934_5933_5595_5594_1387_7027_4086_4087_4088_4089_2033_8454_4609_4093	18	5.48E-13	4.44E-11	2.02E-12
6192	hsa-mir-16-1	hsa04920	Adipocytokine signaling pathway	8517_3551_2538_207_208_3717_1147_5599_6256_4794_4790_4792_4793_5970_3953_5781	16	1.63E-12	1.32E-10	5.73E-12
6193	hsa-mir-16-1	hsa05223	Non-small cell lung cancer	595_5925_1956_1870_1871_207_208_5595_5594_2064_6256_7157_1869_3265	14	1.58E-11	1.28E-09	5.32E-11
6194	hsa-mir-16-1	hsa05211	Renal cell carcinoma	3091_207_208_4233_5595_5594_1387_9915_5879_3725_5058_2034_2033_3265_5781	15	4.37E-11	3.54E-09	1.42E-10
6195	hsa-mir-16-1	hsa04012	ErbB signaling pathway	1956_6714_207_208_5595_5594_5599_2064_2932_6776_6777_3725_5058_3265_4609_1026	16	5.07E-11	4.11E-09	1.58E-10
6196	hsa-mir-16-1	hsa04210	Apoptosis	3556_8517_3551_9020_1439_207_208_836_1147_3654_7157_4790_4792_5970_840	15	5.98E-10	4.85E-08	1.80E-09
6197	hsa-mir-16-1	hsa04510	Focal adhesion	1499_595_1956_6714_207_208_71_4233_5595_5594_5599_2064_2932_5879_3725_5058_2321_3480_5159_5156_3265	21	1.11E-09	9.01E-08	3.22E-09
6198	hsa-mir-16-1	hsa05213	Endometrial cancer	1499_595_1956_207_208_5595_5594_2064_2932_7157_3265_4609	12	1.42E-09	1.15E-07	3.95E-09
6199	hsa-mir-16-1	hsa04330	Notch signaling pathway	3066_3065_1487_1488_3280_1387_9612_2033_8850_388585_4851	11	6.07E-09	4.91E-07	1.62E-08
6200	hsa-mir-16-1	hsa04720	Long-term potentiation	2902_5595_5594_1387_6195_6196_6197_2033_808_801_805_3265_2906	13	6.22E-09	5.04E-07	1.62E-08
6201	hsa-mir-16-1	hsa04060	Cytokine-cytokine receptor interaction	3556_3559_1230_3454_3455_1956_7852_3560_1439_2690_85480_4233_1234_3575_3570_3572_2321_149233_5159_5156_3953_1441	22	1.22E-08	9.85E-07	3.08E-08
6202	hsa-mir-16-1	hsa05216	Thyroid cancer	1499_595_5595_5594_6256_5979_7157_3265_4609	9	1.88E-08	1.52E-06	4.61E-08
6203	hsa-mir-16-1	hsa04912	GnRH signaling pathway	1956_6714_1432_5595_5594_5599_5598_5580_3725_808_801_805_3265_2185	14	4.50E-08	3.65E-06	1.07E-07
6204	hsa-mir-16-1	hsa04910	Insulin signaling pathway	3551_2538_5211_207_208_5590_5595_5594_5599_2932_808_801_805_3265	14	7.00E-07	5.67E-05	1.62E-06
6205	hsa-mir-16-1	hsa05016	Huntington's disease	3066_3065_3064_2902_6667_836_5441_1387_9001_5430_5437_7157_2033_6874_6908_9519	16	1.00E-06	8.14E-05	2.26E-06
6206	hsa-mir-16-1	hsa03020	RNA polymerase	64425_25885_51082_5441_5430_5437_84172	7	3.10E-06	0.000250745	6.78E-06
6207	hsa-mir-16-1	hsa04664	Fc epsilon RI signaling pathway	6850_1432_207_208_5595_5594_5599_5580_5879_3265	10	4.62E-06	0.000374035	9.84E-06
6208	hsa-mir-16-1	hsa04916	Melanogenesis	1499_5595_5594_1387_2932_4286_2033_808_801_805_3265	11	7.55E-06	0.000611263	1.57E-05
6209	hsa-mir-16-1	hsa04150	mTOR signaling pathway	3091_207_208_5595_5594_6195_6196_6197	8	1.16E-05	0.000942928	2.36E-05
6210	hsa-mir-16-1	hsa04540	Gap junction	10382_1956_6714_5592_5595_5594_5598_5159_5156_3265	10	1.71E-05	0.001386912	3.31E-05
6211	hsa-mir-16-1	hsa04530	Tight junction	1499_1457_1460_6714_22800_8573_207_208_71_5590_5580_3265	12	1.72E-05	0.001391949	3.31E-05
6212	hsa-mir-16-1	hsa04650	Natural killer cell mediated cytotoxicity	3454_3455_3932_6850_836_5595_5594_5879_5058_3265_5781_2185	12	1.84E-05	0.001488712	3.46E-05
6213	hsa-mir-16-1	hsa04370	VEGF signaling pathway	6714_1432_207_208_5595_5594_5879_9261_3265	9	2.47E-05	0.001998491	4.54E-05
6214	hsa-mir-16-1	hsa04930	Type II diabetes mellitus	3551_3651_5590_5595_5594_5599_5580	7	3.87E-05	0.00313521	6.97E-05
6215	hsa-mir-16-1	hsa04950	Maturity onset diabetes of the young	6927_3280_3651_5080_3172	5	0.000152977	0.012391103	0.000269372
6216	hsa-mir-16-1	hsa05010	Alzheimer's disease	2902_836_5595_5594_2932_808_351_801_805_840_2906_1020	12	0.00017248	0.013970854	0.000297252
6217	hsa-mir-16-1	hsa04360	Axon guidance	7852_2242_4233_5595_5594_2932_5879_5058_3265_1020	10	0.00024449	0.01980365	0.000412576
6218	hsa-mir-16-1	hsa04810	Regulation of actin cytoskeleton	2261_2264_1956_22800_71_5595_5594_5879_5058_5159_5156_3265_10788	13	0.000320354	0.025948701	0.000529565
6219	hsa-mir-16-1	hsa04120	Ubiquitin mediated proteolysis	55294_4193_6500_23291_10401_7329_5371_672_8454_8554	10	0.000380639	0.030831791	0.000616636
6220	hsa-mir-16-1	hsa04115	p53 signaling pathway	595_4193_836_7157_898_1017_1026	7	0.000436716	0.035374001	0.000693608
6221	hsa-mir-16-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_1432_836_5879_7157_2906	6	0.000859454	0.069615793	0.001338765
6222	hsa-mir-16-1	hsa04612	Antigen processing and presentation	3308_3312_3320_3326_4802_2923_4801	7	0.001751982	0.141910549	0.002677558
6223	hsa-mir-16-1	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	0.002596161	0.210289076	0.003894242
6224	hsa-mir-16-1	hsa04020	Calcium signaling pathway	1956_2902_2064_808_801_805_5159_5156_2906_2185	10	0.002813104	0.227861426	0.004142935
6225	hsa-mir-16-1	hsa05340	Primary immunodeficiency	8517_3932_3718_3575	4	0.005157931	0.417792427	0.007460579
6226	hsa-mir-16-1	hsa04270	Vascular smooth muscle contraction	5592_5595_5594_5580_808_801_805	7	0.007537347	0.610525123	0.010710967
6227	hsa-mir-16-1	hsa04670	Leukocyte transendothelial migration	1499_7852_1432_71_5879_5781_2185	7	0.008892269	0.720273797	0.012418514
6228	hsa-mir-16-1	hsa03420	Nucleotide excision repair	5887_2967_2968_6118	4	0.010754591	0.871121876	0.014764778
6229	hsa-mir-16-1	hsa04730	Long-term depression	5592_5595_5594_3480_3265	5	0.011957968	0.968595402	0.016143257
6230	hsa-mir-16-1	hsa05217	Basal cell carcinoma	1499_2932_7157_2736	4	0.021580514	1	0.028656093
6231	hsa-mir-16-1	hsa05131	Shigellosis	1499_10382_71_7534	4	0.022803379	1	0.029318631
6232	hsa-mir-16-1	hsa05130	Pathogenic Escherichia coli infection	1499_10382_71_7534	4	0.022803379	1	0.029318631
6233	hsa-mir-16-1	hsa04340	Hedgehog signaling pathway	23291_53944_2932_2736	4	0.024067596	1	0.030460552
6234	hsa-mir-16-1	hsa03010	Ribosome	6156_6128_6207_9349_6229	5	0.044099579	1	0.054954859
6235	hsa-mir-16-2	hsa05200	Pathways in cancer	4088_4089_5925_1870_1871_3725_1050_5599_4149_7157_2249_1017_367_1869_6776_6777_2353_5914_5970_6256	20	8.14E-22	4.15E-20	4.15E-20
6236	hsa-mir-16-2	hsa05220	Chronic myeloid leukemia	4088_4089_5925_1870_1871_7157_1869_6776_6777_5970	10	1.54E-14	7.87E-13	3.93E-13
6237	hsa-mir-16-2	hsa04110	Cell cycle	4088_4089_5925_1870_1871_7157_1017_890_1869_5934_5933	11	2.89E-14	1.47E-12	4.90E-13
6238	hsa-mir-16-2	hsa05222	Small cell lung cancer	5925_1870_1871_4149_7157_1017_1869_5970_6256	9	2.54E-12	1.30E-10	2.88E-11
6239	hsa-mir-16-2	hsa05215	Prostate cancer	5925_1870_1871_7157_1017_468_367_1869_5970	9	3.08E-12	1.57E-10	2.88E-11
6240	hsa-mir-16-2	hsa05212	Pancreatic cancer	5925_1870_1871_7157_1017_468_367_1869_5970	9	3.38E-12	1.73E-10	2.88E-11
6241	hsa-mir-16-2	hsa04350	TGF-beta signaling pathway	4088_4089_1874_1875_6667_5934_5933_3398	8	1.16E-10	5.91E-09	8.45E-10
6242	hsa-mir-16-2	hsa04010	MAPK signaling pathway	3725_5599_4149_7157_2249_9479_468_3727_2353_5970	10	2.56E-09	1.31E-07	1.63E-08
6243	hsa-mir-16-2	hsa05223	Non-small cell lung cancer	5925_1870_1871_7157_1869_6256	6	9.56E-09	4.88E-07	5.42E-08
6244	hsa-mir-16-2	hsa05218	Melanoma	5925_1870_1871_7157_2249_1869	6	4.38E-08	2.23E-06	2.23E-07
6245	hsa-mir-16-2	hsa05210	Colorectal cancer	4088_4089_3725_5599_7157_2353	6	1.12E-07	5.71E-06	5.19E-07
6246	hsa-mir-16-2	hsa05219	Bladder cancer	5925_1870_1871_7157_1869	5	1.27E-07	6.49E-06	5.41E-07
6247	hsa-mir-16-2	hsa05221	Acute myeloid leukemia	1050_6776_6777_5914_5970	5	6.12E-07	3.12E-05	2.40E-06
6248	hsa-mir-16-2	hsa05214	Glioma	5925_1870_1871_7157_1869	5	9.60E-07	4.89E-05	3.50E-06
6249	hsa-mir-16-2	hsa04310	Wnt signaling pathway	4088_4089_3725_5599_7157_6423	6	3.08E-06	0.000157277	1.05E-05
6250	hsa-mir-16-2	hsa04012	ErbB signaling pathway	3725_5599_6776_6777	4	8.52E-05	0.00434388	0.000271492
6251	hsa-mir-16-2	hsa04620	Toll-like receptor signaling pathway	3725_5599_2353_5970	4	0.000153848	0.00784623	0.000461543
6252	hsa-mir-16-2	hsa04920	Adipocytokine signaling pathway	5599_5970_6256	3	0.00075152	0.038327521	0.002129307
6253	hsa-mir-16-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5599_5970	3	0.000883542	0.045060636	0.002371612
6254	hsa-mir-16-2	hsa04662	B cell receptor signaling pathway	3725_2353_5970	3	0.001029428	0.052500806	0.00262504
6255	hsa-mir-16-2	hsa04210	Apoptosis	7157_5970_823	3	0.001656828	0.084498231	0.004023725
6256	hsa-mir-16-2	hsa05216	Thyroid cancer	7157_6256	2	0.002794329	0.142510797	0.006270449
6257	hsa-mir-16-2	hsa04912	GnRH signaling pathway	3725_5599_468	3	0.00282785	0.144220333	0.006270449
6258	hsa-mir-16-2	hsa04660	T cell receptor signaling pathway	3725_2353_5970	3	0.002974183	0.151683358	0.00632014
6259	hsa-mir-16-2	hsa04630	Jak-STAT signaling pathway	3977_6776_6777	3	0.00755587	0.385349355	0.015413974
6260	hsa-mir-16-2	hsa05016	Huntington's disease	7157_6667_6908	3	0.012623667	0.643807022	0.024761809
6261	hsa-mir-16-2	hsa04115	p53 signaling pathway	7157_1017	2	0.013992134	0.713598848	0.026429587
6262	hsa-mir-16-2	hsa04520	Adherens junction	4088_4089	2	0.018369197	0.936829049	0.03345818
6263	hsa-mir-16-2	hsa03450	Non-homologous end-joining	2547	1	0.037249315	1	0.065507416
6264	hsa-mir-17	hsa05200	Pathways in cancer	4149_3551_1398_1499_5914_595_596_598_3815_1017_8517_4193_6934_5578_3091_2735_2064_3066_3065_5925_1050_613_5743_5747_10342_25_405_9063_1956_1487_6789_7046_4436_1870_1871_2113_6774_867_10401_207_208_9915_7187_4286_3716_1147_5879_2249_998_1488_2261_5595_5594_5599_861_1387_6256_836_367_2932_6777_6772_5970_7157_7849_1869_3725_5467_6776_4087_4088_4089_5888_5728_2034_2033_5468_4846_3910_898_4790_4791_4792_3320_3326_51176_5371_675_5159_5156_5604_5601_5602_1856_1399_3265_51588_7428_8772_4609_2956_1026_2736_2353_7704_2737_8554	107	1.09E-45	9.69E-44	9.69E-44
6265	hsa-mir-17	hsa04010	MAPK signaling pathway	6722_4149_3551_1398_6195_6197_2264_8517_9252_5578_1845_7132_4773_9020_5923_1956_3304_3305_3303_6789_1432_7046_22800_4763_1616_207_208_1147_5879_2249_998_3727_2261_5595_5594_5599_5598_8986_1386_1649_836_3310_3312_3315_5971_5970_3164_7157_3725_6196_5058_4790_4791_5159_9261_1326_5156_5604_4208_5601_5600_5603_5602_5608_1399_3265_6885_4609_2353_2002_8550_5566	72	1.47E-26	1.31E-24	6.54E-25
6266	hsa-mir-17	hsa05220	Chronic myeloid leukemia	3551_1398_595_598_8517_4193_3066_3065_5925_613_25_1487_7046_1870_1871_867_207_208_1147_1488_5595_5594_861_6777_5970_7157_1869_6776_4088_4089_4790_4792_5604_1399_3265_5781_4609_1026_6464	39	2.88E-23	2.56E-21	8.53E-22
6267	hsa-mir-17	hsa04110	Cell cycle	4174_4172_595_1017_4193_902_6500_3066_3065_5925_25_1870_1871_5111_9232_5934_5933_545_995_5347_7534_5591_1387_11200_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_898_1031_983_8454_1026_1022_1111_8556_8555_472	44	2.18E-21	1.94E-19	4.85E-20
6268	hsa-mir-17	hsa05215	Prostate cancer	3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026	38	1.64E-20	1.46E-18	2.92E-19
6269	hsa-mir-17	hsa05212	Pancreatic cancer	3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026	38	2.24E-20	1.99E-18	3.32E-19
6270	hsa-mir-17	hsa04310	Wnt signaling pathway	818_817_1499_595_8607_6934_5578_6500_4772_4773_23291_1487_5879_1460_1488_5599_1387_1459_2932_7157_8061_3725_5467_1457_1452_4087_4088_4089_2033_51176_5519_5518_5515_5601_5602_1856_8454_8945_6885_4609_5527_5566	42	1.16E-16	1.03E-14	1.48E-15
6271	hsa-mir-17	hsa04660	T cell receptor signaling pathway	3551_1493_8517_5777_4772_4773_9020_2534_3932_4794_1432_867_207_208_1147_998_5595_5594_2932_5970_3725_5058_959_4790_4792_4793_1326_5604_5601_5600_5603_919_3265_6885_2353	35	1.17E-15	1.04E-13	1.30E-14
6272	hsa-mir-17	hsa05222	Small cell lung cancer	4149_3551_595_596_598_1017_8517_5925_5743_5747_9063_1870_1871_10401_207_208_7187_1147_6256_5970_7157_1869_5728_4846_3910_898_4790_4792_51588_4609_8554	31	3.05E-15	2.72E-13	3.02E-14
6273	hsa-mir-17	hsa05210	Colorectal cancer	1499_595_596_6934_1956_7046_4436_207_208_5879_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_51176_5159_5156_5604_5601_5602_1856_4609_2956_2353	30	1.04E-14	9.26E-13	9.26E-14
6274	hsa-mir-17	hsa04012	ErbB signaling pathway	818_817_1398_5578_2064_5747_25_1956_6714_867_207_208_5595_5594_5599_2066_2932_6777_3725_6776_5058_5604_5601_5602_1399_3265_4609_1026_2002_6464	30	2.22E-14	1.98E-12	1.80E-13
6275	hsa-mir-17	hsa05221	Acute myeloid leukemia	3551_5914_595_3815_8517_6934_1050_6774_207_208_1147_5595_5594_861_6777_5970_5467_6776_4790_51176_5371_5604_3265_4609_7704	25	7.83E-14	6.97E-12	5.61E-13
6276	hsa-mir-17	hsa04630	Jak-STAT signaling pathway	3559_595_598_5777_3455_3594_9063_3560_3561_6773_1439_3595_2057_6774_867_2690_10401_3459_3977_207_208_3717_3716_8651_1387_6778_6777_6772_7297_6776_2033_51588_10379_5781_58985_4609_3575_8554	38	8.19E-14	7.29E-12	5.61E-13
6277	hsa-mir-17	hsa04920	Adipocytokine signaling pathway	3551_10891_5465_6794_8517_7132_8717_2538_4794_8471_6774_207_208_3717_1147_5599_6256_5970_4790_4792_4793_5601_5602_5563_5781_7133	26	1.29E-13	1.15E-11	8.15E-13
6278	hsa-mir-17	hsa04620	Toll-like receptor signaling pathway	3551_8517_3455_3665_3661_1432_207_208_7187_1147_5879_29110_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5601_5600_5603_5602_5608_9641_8772_6885_2353	31	1.37E-13	1.22E-11	8.15E-13
6279	hsa-mir-17	hsa05214	Glioma	818_817_595_4193_5578_5925_1956_1870_1871_207_208_5595_5594_7157_1869_5728_808_801_805_5159_5156_5604_3265_1026_6464	25	4.48E-13	3.98E-11	2.49E-12
6280	hsa-mir-17	hsa04520	Adherens junction	1499_6934_5770_5777_2064_2534_1956_6714_7046_5879_1460_998_5595_5594_1387_1459_1457_4087_4088_4089_2033_51176_3643_71_8826_6885	26	3.59E-12	3.20E-10	1.88E-11
6281	hsa-mir-17	hsa04910	Insulin signaling pathway	3551_10891_1398_6720_5770_2538_5590_5499_8471_867_5211_207_208_8651_5595_5594_5599_2932_2194_808_801_805_3643_5604_5601_5602_5563_1399_3265_2002_6464_5566	32	2.57E-11	2.28E-09	1.27E-10
6282	hsa-mir-17	hsa04662	B cell receptor signaling pathway	3551_8517_5777_4772_4773_4794_207_208_1147_5879_695_5595_5594_1380_2932_6850_5970_3725_4790_4792_4793_5604_3265_2353	24	3.15E-11	2.80E-09	1.48E-10
6283	hsa-mir-17	hsa04350	TGF-beta signaling pathway	6500_90_4086_1875_6667_7046_1874_57154_5934_5933_5595_5594_1387_7027_4087_4088_4089_2033_5519_5518_5515_8454_4609_4093_4092	25	8.45E-11	7.52E-09	3.76E-10
6284	hsa-mir-17	hsa04115	p53 signaling pathway	595_1017_4194_4193_900_50484_51246_545_7161_11200_836_7157_6241_64326_5728_898_27113_25898_983_1026_1111_472	22	2.19E-10	1.95E-08	9.29E-10
6285	hsa-mir-17	hsa04510	Focal adhesion	1398_1499_595_596_5578_2064_5923_2534_5747_3791_1956_6714_5499_207_208_5879_998_5595_5594_5599_2932_3725_5058_5728_3910_2321_5159_5156_5604_5601_5602_1399_3265_71_2002_85366_6464	37	4.52E-10	4.03E-08	1.83E-09
6286	hsa-mir-17	hsa04062	Chemokine signaling pathway	3551_1398_8517_653361_5747_5580_5590_6773_2309_6362_6774_207_208_3717_1147_5879_998_5595_5594_1234_2932_6777_6772_5970_5058_4790_4792_4793_1230_5604_1399_3265_7852_6464_5566	35	1.06E-09	9.45E-08	4.11E-09
6287	hsa-mir-17	hsa05219	Bladder cancer	595_9252_4193_2064_5925_1956_1870_1871_2261_5595_5594_7157_1869_5604_3265_4609_1026	17	1.31E-09	1.16E-07	4.85E-09
6288	hsa-mir-17	hsa03010	Ribosome	6193_6204_6205_6207_6202_6141_9349_6217_6137_6135_6210_6155_6156_6191_6222_6223_6229_6129_6128_6125_6130_6181_6189_6188_6232	25	1.42E-09	1.26E-07	5.05E-09
6289	hsa-mir-17	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3551_8517_9020_1956_6714_1432_1147_5879_998_5599_836_5970_3725_5058_4790_4792_5601_5600_5603_5602_5781	21	1.74E-09	1.55E-07	5.96E-09
6290	hsa-mir-17	hsa05211	Renal cell carcinoma	1398_3091_405_2113_207_208_9915_5879_998_5595_5594_1387_3725_5058_2034_2033_5604_1399_3265_7428_5781	21	2.15E-09	1.91E-07	7.08E-09
6291	hsa-mir-17	hsa05213	Endometrial cancer	1499_595_6934_2064_1956_2309_207_208_5595_5594_2932_7157_5728_51176_5604_3265_4609_2002	18	3.26E-09	2.90E-07	1.04E-08
6292	hsa-mir-17	hsa04912	GnRH signaling pathway	818_817_5578_5580_1956_6714_1432_998_5595_5594_5599_5598_3725_808_801_805_5604_5601_5600_5603_5602_5608_3265_2002_5566	25	3.86E-09	3.43E-07	1.18E-08
6293	hsa-mir-17	hsa05223	Non-small cell lung cancer	595_5578_2064_5925_1956_2309_6789_1870_1871_207_208_5595_5594_6256_7157_1869_5604_3265	18	5.31E-09	4.73E-07	1.58E-08
6294	hsa-mir-17	hsa04370	VEGF signaling pathway	5578_4772_4773_5743_5747_3791_6714_1432_207_208_5879_998_5595_5594_3315_4846_9261_5604_5600_5603_3265	21	5.87E-09	5.23E-07	1.69E-08
6295	hsa-mir-17	hsa05216	Thyroid cancer	1499_595_6934_10342_5595_5594_6256_7157_7849_5468_51176_5604_3265_4609	14	6.40E-09	5.70E-07	1.78E-08
6296	hsa-mir-17	hsa05218	Melanoma	595_4193_5925_1956_1870_1871_207_208_4286_2249_5595_5594_7157_1869_5728_5159_5156_5604_3265_1026	20	8.48E-09	7.55E-07	2.29E-08
6297	hsa-mir-17	hsa04210	Apoptosis	3551_596_598_8517_7132_8717_9020_823_1439_207_208_1147_836_5970_7157_9131_4790_4792_840_8772_472_5566	22	1.19E-08	1.06E-06	3.10E-08
6298	hsa-mir-17	hsa04720	Long-term potentiation	818_814_817_6195_6197_5578_2902_2906_5499_5595_5594_1387_6196_2033_808_801_805_5604_3265_5566	20	1.85E-08	1.65E-06	4.71E-08
6299	hsa-mir-17	hsa04120	Ubiquitin mediated proteolysis	4193_55294_6500_3093_23291_9063_7319_84447_867_10401_7329_8925_57154_8651_10055_51366_64326_7337_5371_672_25898_8454_8945_51588_7428_10075_8554	27	2.40E-08	2.13E-06	5.93E-08
6300	hsa-mir-17	hsa03022	Basal transcription factors	51616_6872_2965_2963_2969_6878_6874_6908_2958_2959_6880_2957_6882_9519	14	7.37E-08	6.56E-06	1.77E-07
6301	hsa-mir-17	hsa04664	Fc epsilon RI signaling pathway	5578_2534_5580_1432_207_208_5879_695_5595_5594_5599_6850_5604_5601_5600_5603_5602_5608_3265	19	1.67E-07	1.49E-05	3.91E-07
6302	hsa-mir-17	hsa04540	Gap junction	5592_5578_10382_1956_6714_5595_5594_5598_7846_1453_347733_5159_983_5156_5604_3265_7278_84617_203068_5566	20	3.78E-07	3.36E-05	8.62E-07
6303	hsa-mir-17	hsa04330	Notch signaling pathway	3066_3065_1840_9794_1487_2648_1488_1387_22938_9612_2033_8850_1856_4851	14	8.20E-07	7.30E-05	1.83E-06
6304	hsa-mir-17	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_598_7132_2902_2906_1432_1616_5879_836_7157_4846_5600_5603_5608_7133	15	1.04E-06	9.28E-05	2.26E-06
6305	hsa-mir-17	hsa04916	Melanogenesis	818_817_1499_3815_6934_5578_4286_5595_5594_1387_2932_2033_808_801_805_51176_5604_1856_3265_5566	20	1.74E-06	0.000154611	3.68E-06
6306	hsa-mir-17	hsa05131	Shigellosis	1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068	14	4.71E-06	0.00041917	9.53E-06
6307	hsa-mir-17	hsa05130	Pathogenic Escherichia coli infection	1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068	14	4.71E-06	0.00041917	9.53E-06
6308	hsa-mir-17	hsa04530	Tight junction	1499_5578_5580_5590_6714_4627_4628_22800_8573_207_208_1460_998_1459_1457_5728_5519_5518_5515_3265_71_5520	22	7.30E-06	0.000649919	1.44E-05
6309	hsa-mir-17	hsa04930	Type II diabetes mellitus	3551_5580_5590_8471_3651_8651_5595_5594_5599_3643_5601_5602	12	1.29E-05	0.001144695	2.49E-05
6310	hsa-mir-17	hsa03050	Proteasome	5708_5709_5705_5706_5700_5684_5719_5717_5713_5687_5693_5707	12	2.23E-05	0.001983967	4.22E-05
6311	hsa-mir-17	hsa05322	Systemic lupus erythematosus	3021_3020_8366_9555_8349_8362_8365_8368_3018_8294_8370_6628_121504_8360_8363_8364_8367_959_8359_8361	20	0.000114962	0.010231574	0.000213158
6312	hsa-mir-17	hsa04650	Natural killer cell mediated cytotoxicity	5777_5578_3455_4772_4773_2534_3932_3459_5879_5595_5594_836_6850_5058_5604_919_3265_5781_6464	19	0.00018639	0.016588666	0.000338544
6313	hsa-mir-17	hsa03420	Nucleotide excision repair	5981_902_5111_5886_2965_4331_2071_2074_1022_6117	10	0.000208973	0.018598561	0.000371971
6314	hsa-mir-17	hsa03410	Base excision repair	4350_142_4913_252969_5111_3146_328_2237_6996	9	0.000234704	0.020888642	0.000404365
6315	hsa-mir-17	hsa05016	Huntington's disease	10891_293_292_3066_3065_3064_498_25942_2902_6667_9586_1387_836_5437_7157_1213_2033_5468_27113_6874_6908_5441_9519	23	0.000236258	0.021026969	0.000404365
6316	hsa-mir-17	hsa03450	Non-homologous end-joining	2547_10111_7520_2237_5591_4361	6	0.000254676	0.022666203	0.000427664
6317	hsa-mir-17	hsa04060	Cytokine-cytokine receptor interaction	3559_3815_7132_3455_90_3594_3791_1956_3560_3561_1439_7046_3595_2057_6362_2690_3459_3977_1234_959_2321_1230_5159_5156_7852_58985_3575_7133	28	0.000428557	0.038141597	0.000706326
6318	hsa-mir-17	hsa04150	mTOR signaling pathway	6794_6195_6197_3091_207_208_5595_5594_6196_5563	10	0.000664511	0.059141519	0.0010753
6319	hsa-mir-17	hsa04810	Regulation of actin cytoskeleton	10788_1398_2264_5747_1956_5499_4627_4628_22800_5879_2249_998_2261_5595_5594_5058_5159_5156_5604_1399_3265_71_8826_85366	24	0.000734187	0.065342612	0.001166832
6320	hsa-mir-17	hsa03030	DNA replication	5981_4174_4172_5111_2237_5557_6117_5422	8	0.001009998	0.089889789	0.001577014
6321	hsa-mir-17	hsa03440	Homologous recombination	641_10111_4361_4683_5888_675_6117	7	0.001154958	0.102791261	0.001772263
6322	hsa-mir-17	hsa04340	Hedgehog signaling pathway	2735_23291_53944_2932_1452_1453_8945_2736_2737_5566	10	0.001235803	0.10998646	0.001864177
6323	hsa-mir-17	hsa04020	Calcium signaling pathway	818_814_817_293_5578_292_2064_1956_2902_2906_147_2066_4846_808_801_805_5159_5156_85366_5566	20	0.002418527	0.215248871	0.003587481
6324	hsa-mir-17	hsa04740	Olfactory transduction	818_817_5592_808_801_805_5566	7	0.002690948	0.239494361	0.003926137
6325	hsa-mir-17	hsa05217	Basal cell carcinoma	1499_6934_2735_2932_7157_51176_1856_2736_2737	9	0.003243108	0.288636595	0.004655429
6326	hsa-mir-17	hsa04730	Long-term depression	5592_5578_5595_5594_4846_5519_5518_5515_5604_3265	10	0.005138341	0.457312374	0.007258927
6327	hsa-mir-17	hsa03020	RNA polymerase	64425_25885_51082_5437_84172_5441	6	0.005784676	0.514836197	0.008007755
6328	hsa-mir-17	hsa04270	Vascular smooth muscle contraction	5592_5578_5580_147_5499_59_5595_5594_808_801_805_5604_85366_5566	14	0.005848361	0.520504088	0.008007755
6329	hsa-mir-17	hsa03430	Mismatch repair	5981_4436_5111_2956_6117	5	0.00967112	0.860729705	0.013041359
6330	hsa-mir-17	hsa04360	Axon guidance	4772_4773_2534_5747_25_5879_998_5595_5594_2932_5058_3265_7852_1020	14	0.010520257	0.936302834	0.013974669
6331	hsa-mir-17	hsa04950	Maturity onset diabetes of the young	5080_6927_4760_3651_3172	5	0.011235995	1	0.014705934
6332	hsa-mir-17	hsa05340	Primary immunodeficiency	8517_3932_3561_695_959_3575	6	0.012581327	1	0.016228089
6333	hsa-mir-17	hsa05010	Alzheimer's disease	7132_498_823_2902_2906_5595_5594_836_2932_4846_808_351_801_805_840_8772_1020	17	0.016210182	1	0.020610088
6334	hsa-mir-17	hsa04612	Antigen processing and presentation	3309_3304_3305_3303_3310_3312_3320_3326_4800_4801	10	0.027680759	1	0.034698417
6335	hsa-mir-17	hsa04670	Leukocyte transendothelial migration	1499_5578_653361_5747_1432_5879_998_5600_5603_7852_71_5781	12	0.037827534	1	0.046535049
6336	hsa-mir-17	hsa04710	Circadian rhythm - mammal	8863_4862_1453	3	0.038169197	1	0.046535049
6337	hsa-mir-181a-1	hsa05200	Pathways in cancer	4087_5925_6688_2249_207_7046_367_3725_7704_5970_5595_5594_6774_6776_6777_6772_2353_5914_1387_6256	20	3.31E-21	1.95E-19	1.95E-19
6338	hsa-mir-181a-1	hsa05221	Acute myeloid leukemia	6688_207_7704_5970_5595_5594_6774_6776_6777_5914	10	3.37E-15	1.99E-13	9.94E-14
6339	hsa-mir-181a-1	hsa05220	Chronic myeloid leukemia	5925_207_7046_5970_5595_5594_6776_6777	8	6.49E-11	3.83E-09	1.28E-09
6340	hsa-mir-181a-1	hsa05210	Colorectal cancer	4087_207_7046_3725_5595_5594_2353	7	5.31E-09	3.14E-07	7.61E-08
6341	hsa-mir-181a-1	hsa05215	Prostate cancer	5925_207_367_5970_5595_5594_1387	7	7.19E-09	4.24E-07	7.61E-08
6342	hsa-mir-181a-1	hsa05212	Pancreatic cancer	5925_207_367_5970_5595_5594_1387	7	7.74E-09	4.57E-07	7.61E-08
6343	hsa-mir-181a-1	hsa04620	Toll-like receptor signaling pathway	207_3725_5970_5595_5594_6772_2353	7	1.88E-08	1.11E-06	1.59E-07
6344	hsa-mir-181a-1	hsa04662	B cell receptor signaling pathway	207_3725_5970_5595_5594_2353	6	8.72E-08	5.15E-06	6.43E-07
6345	hsa-mir-181a-1	hsa04520	Adherens junction	4087_4301_7046_5595_5594_1387	6	1.25E-07	7.38E-06	8.20E-07
6346	hsa-mir-181a-1	hsa04350	TGF-beta signaling pathway	4087_6667_7046_5595_5594_1387	6	2.00E-07	1.18E-05	1.07E-06
6347	hsa-mir-181a-1	hsa04012	ErbB signaling pathway	207_3725_5595_5594_6776_6777	6	2.00E-07	1.18E-05	1.07E-06
6348	hsa-mir-181a-1	hsa04630	Jak-STAT signaling pathway	3977_207_6774_6776_6777_6772_1387	7	2.87E-07	1.69E-05	1.41E-06
6349	hsa-mir-181a-1	hsa05223	Non-small cell lung cancer	5925_207_5595_5594_6256	5	5.58E-07	3.29E-05	2.53E-06
6350	hsa-mir-181a-1	hsa04660	T cell receptor signaling pathway	207_3725_5970_5595_5594_2353	6	7.40E-07	4.37E-05	3.12E-06
6351	hsa-mir-181a-1	hsa04010	MAPK signaling pathway	2249_207_7046_3725_5970_5595_5594_2353	8	9.36E-07	5.52E-05	3.68E-06
6352	hsa-mir-181a-1	hsa04062	Chemokine signaling pathway	207_5970_5595_5594_6774_6777_6772	7	1.19E-06	7.00E-05	4.37E-06
6353	hsa-mir-181a-1	hsa05218	Melanoma	5925_2249_207_5595_5594	5	1.99E-06	0.000117213	6.89E-06
6354	hsa-mir-181a-1	hsa05211	Renal cell carcinoma	207_3725_5595_5594_1387	5	2.12E-06	0.00012509	6.95E-06
6355	hsa-mir-181a-1	hsa05214	Glioma	5925_207_5595_5594	4	3.69E-05	0.002178041	0.000114634
6356	hsa-mir-181a-1	hsa04920	Adipocytokine signaling pathway	207_5970_6774_6256	4	4.13E-05	0.002437979	0.000121899
6357	hsa-mir-181a-1	hsa05216	Thyroid cancer	5595_5594_6256	3	8.82E-05	0.005202577	0.000247742
6358	hsa-mir-181a-1	hsa05222	Small cell lung cancer	5925_207_5970_6256	4	0.000104534	0.006167505	0.000280341
6359	hsa-mir-181a-1	hsa05219	Bladder cancer	5925_5595_5594	3	0.000245989	0.014513361	0.000631016
6360	hsa-mir-181a-1	hsa05213	Endometrial cancer	207_5595_5594	3	0.000446068	0.026318005	0.00105272
6361	hsa-mir-181a-1	hsa04150	mTOR signaling pathway	207_5595_5594	3	0.000446068	0.026318005	0.00105272
6362	hsa-mir-181a-1	hsa04720	Long-term potentiation	5595_5594_1387	3	0.00123723	0.072996587	0.002807561
6363	hsa-mir-181a-1	hsa04370	VEGF signaling pathway	207_5595_5594	3	0.001331024	0.07853041	0.002908534
6364	hsa-mir-181a-1	hsa04664	Fc epsilon RI signaling pathway	207_5595_5594	3	0.001429177	0.08432143	0.00301148
6365	hsa-mir-181a-1	hsa04510	Focal adhesion	207_3725_5595_5594	4	0.002524265	0.148931661	0.005135575
6366	hsa-mir-181a-1	hsa04916	Melanogenesis	5595_5594_1387	3	0.003052417	0.180092576	0.006003086
6367	hsa-mir-181a-1	hsa04912	GnRH signaling pathway	3725_5595_5594	3	0.003385036	0.199717116	0.006442488
6368	hsa-mir-181a-1	hsa04110	Cell cycle	4087_5925_1387	3	0.004411233	0.260262772	0.008133212
6369	hsa-mir-181a-1	hsa03410	Base excision repair	3146_142	2	0.004727752	0.278937394	0.008452648
6370	hsa-mir-181a-1	hsa04910	Insulin signaling pathway	207_5595_5594	3	0.006587995	0.388691678	0.011432108
6371	hsa-mir-181a-1	hsa04930	Type II diabetes mellitus	5595_5594	2	0.007156968	0.42226114	0.012064604
6372	hsa-mir-181a-1	hsa04330	Notch signaling pathway	9612_1387	2	0.007758936	0.45777723	0.012716034
6373	hsa-mir-181a-1	hsa04310	Wnt signaling pathway	4087_3725_1387	3	0.008536581	0.503658301	0.013612387
6374	hsa-mir-181a-1	hsa05016	Huntington's disease	6667_6908_1387	3	0.014966365	0.883015554	0.023237251
6375	hsa-mir-181a-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.016632786	0.981334366	0.024533359
6376	hsa-mir-181a-1	hsa04730	Long-term depression	5595_5594	2	0.016632786	0.981334366	0.024533359
6377	hsa-mir-181a-1	hsa04810	Regulation of actin cytoskeleton	2249_5595_5594	3	0.022203153	1	0.031950879
6378	hsa-mir-181a-1	hsa04210	Apoptosis	207_5970	2	0.02512523	1	0.035294966
6379	hsa-mir-181a-1	hsa04540	Gap junction	5595_5594	2	0.027207464	1	0.037331172
6380	hsa-mir-181a-1	hsa03450	Non-homologous end-joining	2547	1	0.039647477	1	0.053163663
6381	hsa-mir-181a-1	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.041680852	1	0.054648228
6382	hsa-mir-181b-1	hsa05200	Pathways in cancer	2249_7046_5595_5594_5914_1387_6256_367_7704_6774_6776_6777_6772_5970_6688_3725_2353_4087_5925_207	20	2.00E-19	1.24E-17	1.24E-17
6383	hsa-mir-181b-1	hsa05221	Acute myeloid leukemia	5595_5594_5914_7704_6774_6776_6777_5970_6688_207	10	2.42E-14	1.50E-12	7.52E-13
6384	hsa-mir-181b-1	hsa05220	Chronic myeloid leukemia	7046_5595_5594_6776_6777_5970_5925_207	8	3.05E-10	1.89E-08	6.30E-09
6385	hsa-mir-181b-1	hsa05210	Colorectal cancer	7046_5595_5594_3725_2353_4087_207	7	2.02E-08	1.25E-06	3.03E-07
6386	hsa-mir-181b-1	hsa05215	Prostate cancer	5595_5594_1387_367_5970_5925_207	7	2.73E-08	1.69E-06	3.03E-07
6387	hsa-mir-181b-1	hsa05212	Pancreatic cancer	5595_5594_1387_367_5970_5925_207	7	2.94E-08	1.82E-06	3.03E-07
6388	hsa-mir-181b-1	hsa04620	Toll-like receptor signaling pathway	5595_5594_6772_5970_3725_2353_207	7	7.09E-08	4.40E-06	6.28E-07
6389	hsa-mir-181b-1	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725_2353_207	6	2.72E-07	1.69E-05	2.11E-06
6390	hsa-mir-181b-1	hsa04520	Adherens junction	4301_7046_5595_5594_1387_4087	6	3.89E-07	2.41E-05	2.68E-06
6391	hsa-mir-181b-1	hsa04350	TGF-beta signaling pathway	7046_5595_5594_1387_6667_4087	6	6.19E-07	3.84E-05	3.49E-06
6392	hsa-mir-181b-1	hsa04012	ErbB signaling pathway	5595_5594_6776_6777_3725_207	6	6.19E-07	3.84E-05	3.49E-06
6393	hsa-mir-181b-1	hsa04630	Jak-STAT signaling pathway	1387_6774_6776_6777_6772_3977_207	7	1.05E-06	6.54E-05	5.45E-06
6394	hsa-mir-181b-1	hsa05223	Non-small cell lung cancer	5595_5594_6256_5925_207	5	1.44E-06	8.91E-05	6.86E-06
6395	hsa-mir-181b-1	hsa04660	T cell receptor signaling pathway	5595_5594_5970_3725_2353_207	6	2.27E-06	0.000140658	1.00E-05
6396	hsa-mir-181b-1	hsa04010	MAPK signaling pathway	2249_7046_5595_5594_5970_3725_2353_207	8	3.98E-06	0.000246587	1.64E-05
6397	hsa-mir-181b-1	hsa04062	Chemokine signaling pathway	5595_5594_6774_6777_6772_5970_207	7	4.27E-06	0.000264979	1.66E-05
6398	hsa-mir-181b-1	hsa05218	Melanoma	2249_5595_5594_5925_207	5	5.08E-06	0.000314895	1.85E-05
6399	hsa-mir-181b-1	hsa05211	Renal cell carcinoma	5595_5594_1387_3725_207	5	5.42E-06	0.000335898	1.87E-05
6400	hsa-mir-181b-1	hsa04110	Cell cycle	993_1387_983_4087_5925	5	5.47E-05	0.003392683	0.000178562
6401	hsa-mir-181b-1	hsa05214	Glioma	5595_5594_5925_207	4	7.77E-05	0.004815423	0.000240771
6402	hsa-mir-181b-1	hsa04920	Adipocytokine signaling pathway	6256_6774_5970_207	4	8.69E-05	0.005385303	0.000256443
6403	hsa-mir-181b-1	hsa05216	Thyroid cancer	5595_5594_6256	3	0.000155019	0.009611149	0.00043687
6404	hsa-mir-181b-1	hsa05222	Small cell lung cancer	6256_5970_5925_207	4	0.00021788	0.01350858	0.00058733
6405	hsa-mir-181b-1	hsa05219	Bladder cancer	5595_5594_5925	3	0.000430095	0.026665898	0.001111079
6406	hsa-mir-181b-1	hsa04330	Notch signaling pathway	1387_9612_8850	3	0.000587113	0.036400989	0.00145604
6407	hsa-mir-181b-1	hsa05213	Endometrial cancer	5595_5594_207	3	0.000776664	0.048153181	0.001783451
6408	hsa-mir-181b-1	hsa04150	mTOR signaling pathway	5595_5594_207	3	0.000776664	0.048153181	0.001783451
6409	hsa-mir-181b-1	hsa04720	Long-term potentiation	5595_5594_1387	3	0.002133658	0.132286808	0.004724529
6410	hsa-mir-181b-1	hsa04370	VEGF signaling pathway	5595_5594_207	3	0.002293506	0.142197368	0.004903358
6411	hsa-mir-181b-1	hsa04664	Fc epsilon RI signaling pathway	5595_5594_207	3	0.002460594	0.152556801	0.005085227
6412	hsa-mir-181b-1	hsa04540	Gap junction	5595_5594_983	3	0.003841756	0.23818886	0.007683512
6413	hsa-mir-181b-1	hsa04510	Focal adhesion	5595_5594_3725_207	4	0.004990594	0.309416807	0.009669275
6414	hsa-mir-181b-1	hsa04916	Melanogenesis	5595_5594_1387	3	0.005201329	0.322482393	0.009772194
6415	hsa-mir-181b-1	hsa04912	GnRH signaling pathway	5595_5594_3725	3	0.005758634	0.357035327	0.010501039
6416	hsa-mir-181b-1	hsa03410	Base excision repair	3146_142	2	0.0068352	0.423782387	0.012108068
6417	hsa-mir-181b-1	hsa04930	Type II diabetes mellitus	5595_5594	2	0.010312935	0.63940195	0.017761165
6418	hsa-mir-181b-1	hsa04910	Insulin signaling pathway	5595_5594_207	3	0.011070813	0.686390421	0.018551092
6419	hsa-mir-181b-1	hsa04310	Wnt signaling pathway	1387_3725_4087	3	0.014263946	0.884364642	0.023272754
6420	hsa-mir-181b-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5970_3725	2	0.023740186	1	0.036797289
6421	hsa-mir-181b-1	hsa04730	Long-term depression	5595_5594	2	0.023740186	1	0.036797289
6422	hsa-mir-181b-1	hsa05016	Huntington's disease	1387_6908_6667	3	0.02464728	1	0.037271496
6423	hsa-mir-181b-1	hsa04612	Antigen processing and presentation	4800_1514	2	0.035628577	1	0.050890603
6424	hsa-mir-181b-1	hsa04210	Apoptosis	5970_207	2	0.035628577	1	0.050890603
6425	hsa-mir-181b-1	hsa04810	Regulation of actin cytoskeleton	2249_5595_5594	3	0.036115911	1	0.050890603
6426	hsa-mir-181b-1	hsa03450	Non-homologous end-joining	2547	1	0.047753682	1	0.065793962
6427	hsa-mir-181b-2	hsa03022	Basal transcription factors	6879_6872_6908_2959_6880_2958	6	4.67E-11	2.47E-09	2.47E-09
6428	hsa-mir-181b-2	hsa05200	Pathways in cancer	4088_3320_5601_5595_367_5599_6772_1387	8	3.71E-08	1.97E-06	9.83E-07
6429	hsa-mir-181b-2	hsa04310	Wnt signaling pathway	4088_5601_815_5599_1457_1387	6	1.32E-07	7.01E-06	2.34E-06
6430	hsa-mir-181b-2	hsa04110	Cell cycle	4088_7534_7531_5591_1387	5	1.18E-06	6.26E-05	1.57E-05
6431	hsa-mir-181b-2	hsa03450	Non-homologous end-joining	2547_5591_7520	3	2.10E-06	0.000111498	2.23E-05
6432	hsa-mir-181b-2	hsa04010	MAPK signaling pathway	6722_5601_3303_5595_3312_5599	6	3.65E-06	0.000193538	3.23E-05
6433	hsa-mir-181b-2	hsa04520	Adherens junction	4088_5595_1457_1387	4	7.76E-06	0.000411314	5.60E-05
6434	hsa-mir-181b-2	hsa05210	Colorectal cancer	4088_5601_5595_5599	4	9.34E-06	0.000494928	5.60E-05
6435	hsa-mir-181b-2	hsa04012	ErbB signaling pathway	5601_815_5595_5599	4	1.07E-05	0.000565403	5.60E-05
6436	hsa-mir-181b-2	hsa05215	Prostate cancer	3320_5595_367_1387	4	1.11E-05	0.000590459	5.60E-05
6437	hsa-mir-181b-2	hsa05212	Pancreatic cancer	3320_5595_367_1387	4	1.16E-05	0.000616324	5.60E-05
6438	hsa-mir-181b-2	hsa04620	Toll-like receptor signaling pathway	5601_5595_5599_6772	4	1.95E-05	0.001033863	8.62E-05
6439	hsa-mir-181b-2	hsa04912	GnRH signaling pathway	5601_815_5595_5599	4	2.42E-05	0.001284152	9.88E-05
6440	hsa-mir-181b-2	hsa04930	Type II diabetes mellitus	5601_5595_5599	3	5.18E-05	0.002745359	0.000196097
6441	hsa-mir-181b-2	hsa04720	Long-term potentiation	815_5595_1387	3	0.000220797	0.011702232	0.000780149
6442	hsa-mir-181b-2	hsa04664	Fc epsilon RI signaling pathway	5601_5595_5599	3	0.000255957	0.013565706	0.000847857
6443	hsa-mir-181b-2	hsa04350	TGF-beta signaling pathway	4088_5595_1387	3	0.000336714	0.017845848	0.001049756
6444	hsa-mir-181b-2	hsa04612	Antigen processing and presentation	3320_3303_3312	3	0.000359178	0.019036453	0.001057581
6445	hsa-mir-181b-2	hsa04916	Melanogenesis	815_5595_1387	3	0.000558872	0.029620222	0.001558959
6446	hsa-mir-181b-2	hsa04910	Insulin signaling pathway	5601_5595_5599	3	0.001242763	0.065866451	0.003293323
6447	hsa-mir-181b-2	hsa04062	Chemokine signaling pathway	5595_2931_6772	3	0.003171378	0.168083027	0.008003954
6448	hsa-mir-181b-2	hsa04510	Focal adhesion	5601_5595_5599	3	0.003797227	0.201253046	0.009147866
6449	hsa-mir-181b-2	hsa05214	Glioma	815_5595	2	0.004558871	0.241620178	0.010505225
6450	hsa-mir-181b-2	hsa04920	Adipocytokine signaling pathway	5601_5599	2	0.004828059	0.255887143	0.010661964
6451	hsa-mir-181b-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5601_5599	2	0.005387936	0.285560611	0.011277489
6452	hsa-mir-181b-2	hsa05211	Renal cell carcinoma	5595_1387	2	0.005532353	0.293214706	0.011277489
6453	hsa-mir-181b-2	hsa05220	Chronic myeloid leukemia	4088_5595	2	0.005976192	0.316738161	0.011731043
6454	hsa-mir-181b-2	hsa04660	T cell receptor signaling pathway	5601_5595	2	0.01228227	0.650960333	0.023248583
6455	hsa-mir-181b-2	hsa04530	Tight junction	8189_1457	2	0.018474408	0.979143622	0.033763573
6456	hsa-mir-181b-2	hsa04630	Jak-STAT signaling pathway	6772_1387	2	0.023192285	1	0.040973037
6457	hsa-mir-181b-2	hsa05016	Huntington's disease	6908_1387	2	0.032967131	1	0.056363159
6458	hsa-mir-181b-2	hsa05216	Thyroid cancer	5595	1	0.043991061	1	0.072860194
6459	hsa-mir-181c	hsa05200	Pathways in cancer	1147_4087_4088_4089_3551_2033_207_2932_367_1499_1387	11	1.20E-13	6.12E-12	3.28E-12
6460	hsa-mir-181c	hsa05215	Prostate cancer	1147_3551_2033_207_2932_367_1499_1387	8	1.77E-13	9.04E-12	3.28E-12
6461	hsa-mir-181c	hsa05212	Pancreatic cancer	1147_3551_2033_207_2932_367_1499_1387	8	1.93E-13	9.84E-12	3.28E-12
6462	hsa-mir-181c	hsa04110	Cell cycle	4087_4088_4089_2033_7534_7532_2932_1387	8	1.75E-12	8.91E-11	2.23E-11
6463	hsa-mir-181c	hsa04520	Adherens junction	4087_4088_4089_2033_1499_6714_1387	7	8.42E-12	4.29E-10	8.59E-11
6464	hsa-mir-181c	hsa04310	Wnt signaling pathway	4087_4088_4089_2033_2932_1499_1387	7	6.06E-10	3.09E-08	5.15E-09
6465	hsa-mir-181c	hsa05210	Colorectal cancer	4087_4088_4089_207_2932_1499	6	9.25E-10	4.72E-08	6.74E-09
6466	hsa-mir-181c	hsa05220	Chronic myeloid leukemia	1147_4088_4089_3551_207	5	3.60E-08	1.84E-06	2.30E-07
6467	hsa-mir-181c	hsa04350	TGF-beta signaling pathway	4087_4088_4089_2033_1387	5	7.29E-08	3.72E-06	4.13E-07
6468	hsa-mir-181c	hsa04660	T cell receptor signaling pathway	1147_5058_3551_207_2932	5	2.23E-07	1.14E-05	1.14E-06
6469	hsa-mir-181c	hsa04920	Adipocytokine signaling pathway	1147_3551_207_2538	4	1.42E-06	7.24E-05	6.58E-06
6470	hsa-mir-181c	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_5058_3551_6714	4	1.77E-06	9.03E-05	7.32E-06
6471	hsa-mir-181c	hsa05211	Renal cell carcinoma	5058_2033_207_1387	4	1.87E-06	9.52E-05	7.32E-06
6472	hsa-mir-181c	hsa04662	B cell receptor signaling pathway	1147_3551_207_2932	4	2.18E-06	0.000111242	7.95E-06
6473	hsa-mir-181c	hsa04062	Chemokine signaling pathway	1147_5058_3551_207_2932	5	3.27E-06	0.000166861	1.11E-05
6474	hsa-mir-181c	hsa04012	ErbB signaling pathway	5058_207_2932_6714	4	3.84E-06	0.000195928	1.22E-05
6475	hsa-mir-181c	hsa04510	Focal adhesion	5058_207_2932_1499_6714	5	4.46E-06	0.000227565	1.34E-05
6476	hsa-mir-181c	hsa04916	Melanogenesis	2033_2932_1499_1387	4	7.60E-06	0.000387389	2.15E-05
6477	hsa-mir-181c	hsa04910	Insulin signaling pathway	3551_207_2932_2538	4	2.24E-05	0.001141056	6.01E-05
6478	hsa-mir-181c	hsa05213	Endometrial cancer	207_2932_1499	3	3.65E-05	0.001860503	9.30E-05
6479	hsa-mir-181c	hsa05221	Acute myeloid leukemia	1147_3551_207	3	5.23E-05	0.002667129	0.000127006
6480	hsa-mir-181c	hsa05222	Small cell lung cancer	1147_3551_207	3	0.000153687	0.007838033	0.000356274
6481	hsa-mir-181c	hsa04210	Apoptosis	1147_3551_207	3	0.000169542	0.008646648	0.000375941
6482	hsa-mir-181c	hsa04620	Toll-like receptor signaling pathway	1147_3551_207	3	0.000250475	0.012774208	0.000532259
6483	hsa-mir-181c	hsa04010	MAPK signaling pathway	1147_5058_3551_207	4	0.000295936	0.015092739	0.00060371
6484	hsa-mir-181c	hsa04530	Tight junction	207_1499_6714	3	0.000581586	0.029660866	0.001140803
6485	hsa-mir-181c	hsa04630	Jak-STAT signaling pathway	2033_207_1387	3	0.000826131	0.042132657	0.001560469
6486	hsa-mir-181c	hsa04330	Notch signaling pathway	2033_1387	2	0.001498921	0.076444984	0.002730178
6487	hsa-mir-181c	hsa05217	Basal cell carcinoma	2932_1499	2	0.0020224	0.103142396	0.003443487
6488	hsa-mir-181c	hsa05131	Shigellosis	7534_1499	2	0.0020931	0.106748089	0.003443487
6489	hsa-mir-181c	hsa05130	Pathogenic Escherichia coli infection	7534_1499	2	0.0020931	0.106748089	0.003443487
6490	hsa-mir-181c	hsa04340	Hedgehog signaling pathway	2932_53944	2	0.002164961	0.110413002	0.003450406
6491	hsa-mir-181c	hsa04720	Long-term potentiation	2033_1387	2	0.003654022	0.186355128	0.005647125
6492	hsa-mir-181c	hsa04370	VEGF signaling pathway	207_6714	2	0.003841982	0.195941069	0.005762973
6493	hsa-mir-181c	hsa04360	Axon guidance	5058_2932	2	0.010524331	0.536740874	0.015335454
6494	hsa-mir-181c	hsa05016	Huntington's disease	2033_1387	2	0.020655789	1	0.029262368
6495	hsa-mir-181c	hsa04950	Maturity onset diabetes of the young	3172	1	0.028740237	1	0.039614921
6496	hsa-mir-181c	hsa05216	Thyroid cancer	1499	1	0.034391211	1	0.046156625
6497	hsa-mir-181d	hsa05200	Pathways in cancer	1147_3320_1499_3551_2249_367_5595_5599_5914_1387_6256_5601_2932_6776_6777_6772_5970_3725_2353_4087_4088_4089_5925_2033_207	25	1.64E-23	1.10E-21	1.10E-21
6498	hsa-mir-181d	hsa05215	Prostate cancer	1147_3320_1499_3551_367_5595_1387_2932_5970_5925_2033_207	12	1.29E-14	8.65E-13	2.45E-13
6499	hsa-mir-181d	hsa04110	Cell cycle	993_5591_1387_983_7534_7531_7532_2932_4087_4088_4089_5925_2033	13	1.35E-14	9.02E-13	2.45E-13
6500	hsa-mir-181d	hsa05212	Pancreatic cancer	1147_3320_1499_3551_367_5595_1387_2932_5970_5925_2033_207	12	1.46E-14	9.78E-13	2.45E-13
6501	hsa-mir-181d	hsa05210	Colorectal cancer	1499_5595_5599_5601_2932_3725_2353_4087_4088_4089_207	11	2.55E-13	1.71E-11	3.41E-12
6502	hsa-mir-181d	hsa04012	ErbB signaling pathway	815_6714_5595_5599_5601_2932_6776_6777_3725_5058_207	11	3.62E-13	2.42E-11	4.04E-12
6503	hsa-mir-181d	hsa05220	Chronic myeloid leukemia	1147_3551_5595_6776_6777_5970_4088_4089_5925_207	10	2.73E-12	1.83E-10	2.62E-11
6504	hsa-mir-181d	hsa04310	Wnt signaling pathway	1499_815_5599_1387_5601_2932_3725_1457_4087_4088_4089_2033	12	5.14E-12	3.44E-10	4.30E-11
6505	hsa-mir-181d	hsa04620	Toll-like receptor signaling pathway	1147_3551_5595_5599_5601_6772_5970_3725_2353_207	10	4.50E-11	3.01E-09	3.35E-10
6506	hsa-mir-181d	hsa04660	T cell receptor signaling pathway	1147_3551_5595_5601_2932_5970_3725_2353_5058_207	10	8.97E-11	6.01E-09	6.01E-10
6507	hsa-mir-181d	hsa04520	Adherens junction	1499_6714_5595_1387_1457_4087_4088_4089_2033	9	1.41E-10	9.42E-09	8.56E-10
6508	hsa-mir-181d	hsa04010	MAPK signaling pathway	1147_3551_2249_5595_5599_5601_3303_3312_5970_3725_2353_5058_207	13	2.54E-10	1.70E-08	1.42E-09
6509	hsa-mir-181d	hsa05221	Acute myeloid leukemia	1147_3551_5595_5914_6776_6777_5970_207	8	3.97E-10	2.66E-08	2.04E-09
6510	hsa-mir-181d	hsa04920	Adipocytokine signaling pathway	1147_3551_5599_6256_5601_5970_207_2538	8	9.98E-10	6.69E-08	4.78E-09
6511	hsa-mir-181d	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_6714_5599_5601_5970_3725_5058	8	1.52E-09	1.02E-07	6.80E-09
6512	hsa-mir-181d	hsa04662	B cell receptor signaling pathway	1147_3551_5595_2932_5970_3725_2353_207	8	2.27E-09	1.52E-07	9.50E-09
6513	hsa-mir-181d	hsa04062	Chemokine signaling pathway	1147_3551_5595_2932_2931_6777_6772_5970_5058_207	10	1.51E-08	1.01E-06	5.95E-08
6514	hsa-mir-181d	hsa03022	Basal transcription factors	6879_6872_6908_2958_2959_6880	6	2.55E-08	1.71E-06	9.49E-08
6515	hsa-mir-181d	hsa04350	TGF-beta signaling pathway	6667_5595_1387_4087_4088_4089_2033	7	1.43E-07	9.60E-06	5.05E-07
6516	hsa-mir-181d	hsa04510	Focal adhesion	1499_6714_5595_5599_5601_2932_3725_5058_207	9	3.25E-07	2.18E-05	1.09E-06
6517	hsa-mir-181d	hsa05211	Renal cell carcinoma	5595_1387_3725_5058_2033_207	6	9.53E-07	6.39E-05	3.04E-06
6518	hsa-mir-181d	hsa05222	Small cell lung cancer	1147_3551_6256_5970_5925_207	6	2.52E-06	0.000169045	7.68E-06
6519	hsa-mir-181d	hsa04910	Insulin signaling pathway	3551_5595_5599_5601_2932_207_2538	7	2.71E-06	0.000181487	7.89E-06
6520	hsa-mir-181d	hsa04630	Jak-STAT signaling pathway	1387_6776_6777_6772_2033_3977_207	7	5.64E-06	0.000377751	1.57E-05
6521	hsa-mir-181d	hsa04916	Melanogenesis	1499_815_5595_1387_2932_2033	6	7.13E-06	0.000477565	1.91E-05
6522	hsa-mir-181d	hsa04912	GnRH signaling pathway	815_6714_5595_5599_5601_3725	6	8.76E-06	0.000586598	2.26E-05
6523	hsa-mir-181d	hsa03450	Non-homologous end-joining	5591_7520_2547	3	4.65E-05	0.003118013	0.000115242
6524	hsa-mir-181d	hsa04612	Antigen processing and presentation	3320_3303_4800_1514_3312	5	4.82E-05	0.003226779	0.000115242
6525	hsa-mir-181d	hsa04930	Type II diabetes mellitus	3551_5595_5599_5601	4	5.34E-05	0.00357941	0.000123428
6526	hsa-mir-181d	hsa04330	Notch signaling pathway	1387_9612_2033_8850	4	6.26E-05	0.004194606	0.00013982
6527	hsa-mir-181d	hsa05213	Endometrial cancer	1499_5595_2932_207	4	9.05E-05	0.006066314	0.000195688
6528	hsa-mir-181d	hsa05223	Non-small cell lung cancer	5595_6256_5925_207	4	0.000103916	0.006962346	0.000217573
6529	hsa-mir-181d	hsa05214	Glioma	815_5595_5925_207	4	0.000204363	0.013692301	0.000414918
6530	hsa-mir-181d	hsa05218	Melanoma	2249_5595_5925_207	4	0.000281825	0.018882306	0.000555362
6531	hsa-mir-181d	hsa05216	Thyroid cancer	1499_5595_6256	3	0.000324243	0.021724293	0.000620694
6532	hsa-mir-181d	hsa04530	Tight junction	1499_6714_8189_1457_207	5	0.000335125	0.022453372	0.000622786
6533	hsa-mir-181d	hsa04720	Long-term potentiation	815_5595_1387_2033	4	0.000343927	0.023043086	0.000622786
6534	hsa-mir-181d	hsa04664	Fc epsilon RI signaling pathway	5595_5599_5601_207	4	0.000415257	0.027822242	0.000732164
6535	hsa-mir-181d	hsa04210	Apoptosis	1147_3551_5970_207	4	0.000638915	0.042807296	0.001097623
6536	hsa-mir-181d	hsa04370	VEGF signaling pathway	6714_5595_207	3	0.004642225	0.311029095	0.007775727
6537	hsa-mir-181d	hsa04950	Maturity onset diabetes of the young	6927_3172	2	0.005281518	0.353861704	0.008630773
6538	hsa-mir-181d	hsa04540	Gap junction	6714_5595_983	3	0.007692343	0.515386948	0.012271118
6539	hsa-mir-181d	hsa05016	Huntington's disease	6667_1387_6908_2033	4	0.008752636	0.586426624	0.013637828
6540	hsa-mir-181d	hsa03410	Base excision repair	3146_142	2	0.011057219	0.740833645	0.016837128
6541	hsa-mir-181d	hsa05219	Bladder cancer	5595_5925	2	0.014638965	0.980810636	0.021795792
6542	hsa-mir-181d	hsa04360	Axon guidance	5595_2932_5058	3	0.018832535	1	0.027429996
6543	hsa-mir-181d	hsa04150	mTOR signaling pathway	5595_207	2	0.02155285	1	0.030724276
6544	hsa-mir-181d	hsa05217	Basal cell carcinoma	1499_2932	2	0.023844016	1	0.0330029
6545	hsa-mir-181d	hsa05131	Shigellosis	1499_7534	2	0.02462903	1	0.0330029
6546	hsa-mir-181d	hsa05130	Pathogenic Escherichia coli infection	1499_7534	2	0.02462903	1	0.0330029
6547	hsa-mir-181d	hsa04340	Hedgehog signaling pathway	53944_2932	2	0.025424522	1	0.033400843
6548	hsa-mir-181d	hsa03320	PPAR signaling pathway	10062_6256	2	0.036674834	1	0.047254113
6549	hsa-mir-182	hsa05200	Pathways in cancer	1147_3320_3326_5371_405_3480_1956_5595_5594_6654_5914_2064_6256_595_2308_9915_208_367_4193_7704_1387_6776_3091_5970_8503_2885_7157_10401_4087_3725_4088_4089_5295_2034_2033_207_8554_4790	38	1.01E-33	7.10E-32	7.10E-32
6550	hsa-mir-182	hsa05215	Prostate cancer	1147_3320_3326_3480_1956_5595_5594_6654_2064_595_2308_208_367_4193_1387_5970_8503_2885_7157_5295_2033_207_4790	23	5.86E-28	4.10E-26	1.71E-26
6551	hsa-mir-182	hsa05212	Pancreatic cancer	1147_3320_3326_3480_1956_5595_5594_6654_2064_595_2308_208_367_4193_1387_5970_8503_2885_7157_5295_2033_207_4790	23	7.33E-28	5.13E-26	1.71E-26
6552	hsa-mir-182	hsa05220	Chronic myeloid leukemia	1147_5595_5594_6654_595_208_4193_6776_5970_8503_2885_7157_4088_4089_5295_207_4790_6464	18	1.56E-21	1.09E-19	2.73E-20
6553	hsa-mir-182	hsa05214	Glioma	3480_1956_5595_5594_6654_595_208_4193_8503_2885_7157_5295_207_801_6464_808_805	17	5.99E-21	4.19E-19	8.38E-20
6554	hsa-mir-182	hsa05211	Renal cell carcinoma	405_5595_5594_6654_56924_9915_208_1387_3091_8503_2885_3725_5295_5058_2034_2033_207	17	2.69E-20	1.88E-18	3.14E-19
6555	hsa-mir-182	hsa05221	Acute myeloid leukemia	1147_5371_5595_5594_6654_5914_595_208_7704_6776_5970_8503_2885_5295_207_4790	16	5.31E-20	3.71E-18	5.31E-19
6556	hsa-mir-182	hsa04010	MAPK signaling pathway	1147_994_1956_5595_5594_6654_5566_6197_208_4214_1432_5970_627_2885_7157_10912_3725_3727_6195_5058_4616_2872_207_4790	24	4.54E-19	3.18E-17	3.97E-18
6557	hsa-mir-182	hsa04910	Insulin signaling pathway	6720_10891_5595_5594_6654_2308_5566_7249_208_5770_8503_2885_5295_2872_207_801_6464_808_805	19	1.26E-18	8.85E-17	9.83E-18
6558	hsa-mir-182	hsa05210	Colorectal cancer	3480_1956_5595_5594_6654_595_208_8503_2885_7157_4087_3725_4088_4089_5295_207	16	7.22E-18	5.06E-16	5.06E-17
6559	hsa-mir-182	hsa04012	ErbB signaling pathway	1956_6714_5595_5594_6654_56924_2064_208_6776_8503_2885_3725_5295_5058_207_6464	16	1.18E-17	8.29E-16	7.54E-17
6560	hsa-mir-182	hsa04660	T cell receptor signaling pathway	1147_5595_5594_6654_56924_208_5777_1432_5970_8503_2885_3725_5295_5058_207_3932_4790	17	1.52E-17	1.06E-15	8.85E-17
6561	hsa-mir-182	hsa05223	Non-small cell lung cancer	1956_5595_5594_6654_2064_6256_595_2309_208_8503_2885_7157_5295_207	14	2.04E-17	1.43E-15	1.10E-16
6562	hsa-mir-182	hsa04520	Adherens junction	1460_3480_1956_6714_5595_5594_2064_5770_5777_1387_4087_1457_4088_4089_2033	15	9.78E-17	6.85E-15	4.89E-16
6563	hsa-mir-182	hsa05213	Endometrial cancer	1956_5595_5594_6654_2064_595_2309_208_8503_2885_7157_5295_207	13	4.39E-16	3.07E-14	2.05E-15
6564	hsa-mir-182	hsa04510	Focal adhesion	9564_3480_1956_6714_5595_5594_6654_56924_2064_595_208_8503_857_2885_3725_5295_5058_207_6464	19	1.13E-15	7.91E-14	4.95E-15
6565	hsa-mir-182	hsa04662	B cell receptor signaling pathway	1147_5595_5594_6654_208_5777_5970_8503_2885_3725_5295_207_4790	13	2.81E-14	1.97E-12	1.16E-13
6566	hsa-mir-182	hsa04062	Chemokine signaling pathway	1147_9564_5595_5594_6654_2770_2309_5566_208_5970_8503_2885_5295_5058_207_4790_6464	17	7.62E-14	5.34E-12	2.96E-13
6567	hsa-mir-182	hsa04110	Cell cycle	994_595_7533_4193_902_1387_7157_10912_4087_1022_4088_4089_2033_4616	14	3.47E-13	2.43E-11	1.28E-12
6568	hsa-mir-182	hsa04912	GnRH signaling pathway	1956_6714_5595_5594_6654_5566_4214_1432_2885_3725_801_808_805	13	1.89E-12	1.33E-10	6.63E-12
6569	hsa-mir-182	hsa05222	Small cell lung cancer	1147_6256_595_208_5970_8503_7157_10401_5295_207_8554_4790	12	2.83E-12	1.98E-10	9.44E-12
6570	hsa-mir-182	hsa05218	Melanoma	3480_1956_5595_5594_595_208_4193_8503_7157_5295_207	11	8.43E-12	5.90E-10	2.68E-11
6571	hsa-mir-182	hsa04150	mTOR signaling pathway	5595_5594_7249_6197_208_3091_8503_6195_5295_207	10	1.14E-11	7.97E-10	3.46E-11
6572	hsa-mir-182	hsa04630	Jak-STAT signaling pathway	6654_595_208_5777_1387_6776_8503_2885_10401_5295_2033_207_8554	13	1.24E-10	8.70E-09	3.62E-10
6573	hsa-mir-182	hsa04720	Long-term potentiation	5595_5594_5566_6197_1387_6195_2033_801_808_805	10	2.90E-10	2.03E-08	7.87E-10
6574	hsa-mir-182	hsa04620	Toll-like receptor signaling pathway	1147_5595_5594_208_1432_5970_8503_3725_5295_207_4790	11	2.92E-10	2.05E-08	7.87E-10
6575	hsa-mir-182	hsa04664	Fc epsilon RI signaling pathway	5595_5594_6654_208_1432_8503_2885_5295_207	9	8.11E-09	5.68E-07	2.10E-08
6576	hsa-mir-182	hsa04310	Wnt signaling pathway	1460_595_5566_1387_7157_4087_3725_1457_4088_4089_2033	11	1.44E-08	1.01E-06	3.60E-08
6577	hsa-mir-182	hsa04350	TGF-beta signaling pathway	5595_5594_6667_1387_4087_4088_4089_2033_4093	9	1.76E-08	1.23E-06	4.24E-08
6578	hsa-mir-182	hsa04210	Apoptosis	1147_5566_208_5970_8503_7157_5295_207_4790	9	2.11E-08	1.48E-06	4.92E-08
6579	hsa-mir-182	hsa05219	Bladder cancer	1956_5595_5594_2064_595_4193_7157	7	3.65E-08	2.56E-06	8.25E-08
6580	hsa-mir-182	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_1956_6714_1432_5970_3725_5058_4790	8	6.05E-08	4.24E-06	1.32E-07
6581	hsa-mir-182	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_6654_5777_8503_2885_5295_5058_3932_6464	10	6.55E-08	4.59E-06	1.39E-07
6582	hsa-mir-182	hsa04916	Melanogenesis	5595_5594_2770_5566_1387_2033_801_808_805	9	7.34E-08	5.14E-06	1.51E-07
6583	hsa-mir-182	hsa04370	VEGF signaling pathway	6714_5595_5594_208_1432_8503_5295_207	8	1.08E-07	7.55E-06	2.16E-07
6584	hsa-mir-182	hsa04540	Gap junction	1956_6714_5595_5594_6654_2770_5566_2885	8	4.14E-07	2.90E-05	8.04E-07
6585	hsa-mir-182	hsa04920	Adipocytokine signaling pathway	1147_10891_6256_208_5970_207_4790	7	6.64E-07	4.65E-05	1.26E-06
6586	hsa-mir-182	hsa05216	Thyroid cancer	5595_5594_6256_595_7157	5	3.03E-06	0.000211871	5.58E-06
6587	hsa-mir-182	hsa04120	Ubiquitin mediated proteolysis	5371_672_4214_4193_10273_10401_7329_8554	8	7.02E-06	0.000491195	1.26E-05
6588	hsa-mir-182	hsa03022	Basal transcription factors	2965_2963_6881_6908_2959	5	8.86E-06	0.000620194	1.55E-05
6589	hsa-mir-182	hsa04115	p53 signaling pathway	595_7249_4193_7157_10912_4616	6	1.14E-05	0.000797927	1.95E-05
6590	hsa-mir-182	hsa04810	Regulation of actin cytoskeleton	9564_1956_5595_5594_6654_56924_8503_5295_5058	9	2.48E-05	0.001739312	4.14E-05
6591	hsa-mir-182	hsa04270	Vascular smooth muscle contraction	5595_5594_5566_801_808_805	6	0.000192787	0.013495073	0.000313839
6592	hsa-mir-182	hsa04070	Phosphatidylinositol signaling system	8503_5295_801_808_805	5	0.00021609	0.015126318	0.00034378
6593	hsa-mir-182	hsa03420	Nucleotide excision repair	2965_4331_902_1022	4	0.000300192	0.021013452	0.000466966
6594	hsa-mir-182	hsa04930	Type II diabetes mellitus	5595_5594_8503_5295	4	0.000325176	0.02276234	0.000491903
6595	hsa-mir-182	hsa04360	Axon guidance	5998_5595_5594_56924_2770_5058	6	0.000330278	0.023119436	0.000491903
6596	hsa-mir-182	hsa05016	Huntington's disease	10891_6908_6667_1387_627_7157_2033	7	0.000356966	0.024987608	0.000520575
6597	hsa-mir-182	hsa04530	Tight junction	1460_6714_2770_208_1457_207	6	0.000415214	0.029064982	0.000593163
6598	hsa-mir-182	hsa04730	Long-term depression	3480_5595_5594_2770	4	0.001629577	0.114070377	0.002281408
6599	hsa-mir-182	hsa04670	Leukocyte transendothelial migration	9564_2770_1432_8503_5295	5	0.001674308	0.117201546	0.00229807
6600	hsa-mir-182	hsa04020	Calcium signaling pathway	1956_2064_5566_801_808_805	6	0.001812334	0.126863414	0.002439681
6601	hsa-mir-182	hsa03410	Base excision repair	6996_3146_4350	3	0.002256167	0.1579317	0.002979843
6602	hsa-mir-182	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.004585264	0.320968483	0.005943861
6603	hsa-mir-182	hsa05010	Alzheimer's disease	5595_5594_801_808_805	5	0.007731947	0.541236316	0.00984066
6604	hsa-mir-182	hsa04612	Antigen processing and presentation	3320_3326_6890	3	0.023966593	1	0.029958242
6605	hsa-mir-182	hsa05340	Primary immunodeficiency	6890_3932	2	0.02542847	1	0.031227945
6606	hsa-mir-182	hsa03050	Proteasome	5698_5705	2	0.044213542	1	0.053361171
6607	hsa-mir-1825	hsa05200	Pathways in cancer	4149_7046_1499_5914_595_3815_1019_1017_4193_7704_5578_6502_3091_2736_4089_3066_3065_1050_5925_7184_3716_1956_2308_1870_1871_2113_10401_6774_861_862_867_207_208_9915_4609_3725_5595_5594_5599_1387_6256_3326_836_367_2932_6776_6777_6772_5970_7157_6688_1869_2735_2737_4088_2034_2033_4846_4790_3320_5371_675_5159_5156_5601_1399_1398_841_7428_4087_2353_8554	72	3.34E-42	2.77E-40	2.77E-40
6608	hsa-mir-1825	hsa05220	Chronic myeloid leukemia	7046_595_1019_4193_4089_3066_3065_5925_1870_1871_861_867_207_208_4609_5595_5594_6776_6777_5970_7157_1869_4088_4790_1399_1398_5781_6464	28	2.27E-22	1.89E-20	9.43E-21
6609	hsa-mir-1825	hsa03022	Basal transcription factors	54457_138474_6882_6883_2967_2961_2960_2963_2968_6879_6878_6877_6874_6873_6872_6884_2958_2959_6880_6881_2957_6908	22	2.88E-21	2.39E-19	7.97E-20
6610	hsa-mir-1825	hsa05215	Prostate cancer	1499_595_1017_4193_5925_7184_1956_2308_1870_1871_207_208_5595_5594_1385_1387_3326_367_2932_5970_7157_468_1869_2033_4790_3320_5159_5156	28	7.86E-21	6.52E-19	1.40E-19
6611	hsa-mir-1825	hsa04010	MAPK signaling pathway	6722_4149_7046_6197_9252_7867_5578_4773_1956_1432_4342_4763_207_208_9479_4609_3725_5595_5594_5599_5598_8986_1386_836_3312_1649_5970_7157_468_3727_6195_6196_4790_5159_9261_5156_4208_5601_5566_1399_1398_2353_2002	43	8.47E-21	7.03E-19	1.40E-19
6612	hsa-mir-1825	hsa05212	Pancreatic cancer	1499_595_1017_4193_5925_7184_1956_2308_1870_1871_207_208_5595_5594_1385_1387_3326_367_2932_5970_7157_468_1869_2033_4790_3320_5159_5156	28	1.01E-20	8.39E-19	1.40E-19
6613	hsa-mir-1825	hsa04110	Cell cycle	595_1019_1017_4193_6502_4089_4171_3066_3065_5925_1870_1871_5934_5933_7534_5591_1387_2932_7157_1869_4085_4088_2033_890_891_4087_1028_10971	28	6.80E-18	5.64E-16	8.06E-17
6614	hsa-mir-1825	hsa05214	Glioma	815_595_1019_4193_5578_5925_1956_1870_1871_207_208_5595_5594_7157_1869_808_801_805_5159_5156_6464	21	4.50E-16	3.74E-14	4.67E-15
6615	hsa-mir-1825	hsa05221	Acute myeloid leukemia	5914_595_3815_7704_1050_6774_861_862_207_208_4609_5595_5594_6776_6777_5970_6688_4790_5371	19	1.19E-14	9.87E-13	1.10E-13
6616	hsa-mir-1825	hsa05210	Colorectal cancer	7046_1499_595_4089_1956_207_208_4609_3725_5595_5594_5599_836_2932_7157_4088_5159_5156_5601_4087_2353	21	3.32E-14	2.75E-12	2.75E-13
6617	hsa-mir-1825	hsa04350	TGF-beta signaling pathway	7046_4089_6667_3397_3399_3398_1874_1875_5934_5933_4609_3400_5595_5594_1387_4088_2033_5515_4087_4093_4092	21	5.99E-14	4.97E-12	4.14E-13
6618	hsa-mir-1825	hsa04012	ErbB signaling pathway	815_5578_1956_6714_867_207_208_4609_3725_5595_5594_5599_2066_2932_6776_6777_5601_1399_1398_6464_2002	21	5.99E-14	4.97E-12	4.14E-13
6619	hsa-mir-1825	hsa04310	Wnt signaling pathway	815_1499_595_8607_5578_4089_4773_4609_3725_1460_5599_1387_2932_7157_8061_1457_1452_4088_2033_5515_5601_5566_6423_4087	24	3.24E-12	2.69E-10	2.07E-11
6620	hsa-mir-1825	hsa05222	Small cell lung cancer	4149_595_1019_1017_6502_5925_1870_1871_10401_207_208_4609_6256_5970_7157_1869_4846_4790_8554	19	3.63E-12	3.01E-10	2.15E-11
6621	hsa-mir-1825	hsa04630	Jak-STAT signaling pathway	3717_595_3716_3560_3561_2057_10401_6774_867_2690_207_208_3575_4609_3718_85480_1387_6778_6776_6777_6772_2033_5781_8554	24	4.69E-12	3.89E-10	2.60E-11
6622	hsa-mir-1825	hsa04910	Insulin signaling pathway	6720_5770_2308_867_5211_207_208_5595_5594_5599_2932_808_801_805_3643_5601_5566_1399_1398_6464_2002	21	1.35E-10	1.12E-08	7.00E-10
6623	hsa-mir-1825	hsa05219	Bladder cancer	595_1019_9252_4193_5925_1956_1870_1871_4609_5595_5594_7157_1869	13	2.83E-10	2.35E-08	1.38E-09
6624	hsa-mir-1825	hsa05223	Non-small cell lung cancer	595_1019_5578_5925_1956_1870_1871_207_208_5595_5594_6256_7157_1869	14	4.20E-10	3.49E-08	1.94E-09
6625	hsa-mir-1825	hsa04520	Adherens junction	7046_1499_5770_4089_1956_6714_4301_1460_5595_5594_1387_1457_4088_2033_3643_4087	16	6.58E-10	5.46E-08	2.87E-09
6626	hsa-mir-1825	hsa05218	Melanoma	595_1019_4193_5925_1956_1870_1871_207_208_5595_5594_7157_1869_5159_5156	15	1.16E-09	9.67E-08	4.83E-09
6627	hsa-mir-1825	hsa05211	Renal cell carcinoma	3091_2113_207_208_9915_3725_5595_5594_1387_2034_2033_1399_1398_7428_5781	15	1.38E-09	1.14E-07	5.45E-09
6628	hsa-mir-1825	hsa04720	Long-term potentiation	815_6197_5578_2902_5595_5594_1387_468_6195_6196_2033_808_801_805_5566	15	2.25E-09	1.87E-07	8.48E-09
6629	hsa-mir-1825	hsa04912	GnRH signaling pathway	815_5578_1956_6714_1432_3725_5595_5594_5599_5598_468_808_801_805_5601_5566_2002	17	4.90E-09	4.06E-07	1.77E-08
6630	hsa-mir-1825	hsa04660	T cell receptor signaling pathway	1019_4773_1493_3932_1432_867_207_208_3725_5595_5594_2932_5970_4790_5601_919_2353	17	6.26E-09	5.20E-07	2.16E-08
6631	hsa-mir-1825	hsa05213	Endometrial cancer	1499_595_1956_207_208_4609_5595_5594_2932_7157_2002	11	1.90E-07	1.58E-05	6.32E-07
6632	hsa-mir-1825	hsa04620	Toll-like receptor signaling pathway	1432_207_208_3725_5595_5594_5599_6772_5970_4790_5601_841_2353_6348	14	4.98E-07	4.13E-05	1.59E-06
6633	hsa-mir-1825	hsa04916	Melanogenesis	815_1499_3815_5578_5595_5594_1385_1387_2932_2033_808_801_805_5566	14	6.15E-07	5.11E-05	1.89E-06
6634	hsa-mir-1825	hsa04662	B cell receptor signaling pathway	4773_6850_207_208_3725_695_5595_5594_2932_5970_4790_2353	12	7.63E-07	6.33E-05	2.26E-06
6635	hsa-mir-1825	hsa04510	Focal adhesion	1499_595_5578_1956_6714_207_208_3725_5595_5594_5599_2932_5159_5156_5601_1399_1398_6464_2002	19	1.39E-06	0.000115308	3.98E-06
6636	hsa-mir-1825	hsa04062	Chemokine signaling pathway	3717_1234_6774_207_208_3718_5595_5594_2932_6777_6772_5970_4790_5566_1399_1398_6348_6464	18	2.26E-06	0.000187926	6.26E-06
6637	hsa-mir-1825	hsa04370	VEGF signaling pathway	7867_5578_4773_6714_1432_207_208_5595_5594_4846_9261	11	5.87E-06	0.000487057	1.57E-05
6638	hsa-mir-1825	hsa05016	Huntington's disease	1537_3066_3065_3064_2902_6667_1385_1387_836_9001_5430_7157_2033_6874_841_6908_4724	17	6.29E-06	0.000521825	1.63E-05
6639	hsa-mir-1825	hsa04920	Adipocytokine signaling pathway	3717_6774_207_208_5599_6256_5970_4790_5601_5781	10	1.10E-05	0.000913331	2.77E-05
6640	hsa-mir-1825	hsa05216	Thyroid cancer	1499_595_4609_5595_5594_6256_7157	7	1.58E-05	0.001313022	3.86E-05
6641	hsa-mir-1825	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_1432_3725_5599_836_5970_4790_5601_5781	10	1.73E-05	0.001439768	4.11E-05
6642	hsa-mir-1825	hsa04540	Gap junction	5578_10382_1956_6714_5592_5595_5594_5598_5159_5156_5566	11	2.93E-05	0.002432846	6.76E-05
6643	hsa-mir-1825	hsa04664	Fc epsilon RI signaling pathway	5578_6850_1432_207_208_695_5595_5594_5599_5601	10	3.98E-05	0.003304047	8.93E-05
6644	hsa-mir-1825	hsa05010	Alzheimer's disease	1537_840_2902_22926_5595_5594_836_2932_4846_808_801_805_841_1020_4724	15	4.36E-05	0.003620937	9.53E-05
6645	hsa-mir-1825	hsa04150	mTOR signaling pathway	6197_3091_207_208_5595_5594_6195_6196	8	6.89E-05	0.005717017	0.00014659
6646	hsa-mir-1825	hsa04115	p53 signaling pathway	595_1019_1017_4193_836_7157_64326_891_841	9	7.81E-05	0.006481966	0.000162049
6647	hsa-mir-1825	hsa04120	Ubiquitin mediated proteolysis	4193_6502_10401_867_7325_7329_997_64326_5371_672_7428_8554	12	0.00021135	0.017542016	0.000427854
6648	hsa-mir-1825	hsa04330	Notch signaling pathway	3066_3065_1387_9612_2033_8850_388585	7	0.000234297	0.01944665	0.000463015
6649	hsa-mir-1825	hsa04210	Apoptosis	840_207_208_836_5970_7157_4790_5566_841	9	0.000448254	0.037205069	0.000865234
6650	hsa-mir-1825	hsa04930	Type II diabetes mellitus	3651_5595_5594_5599_3643_5601	6	0.001103998	0.091631823	0.002082541
6651	hsa-mir-1825	hsa03050	Proteasome	5705_5701_5702_5684_5719_5710	6	0.001493591	0.123968058	0.002754846
6652	hsa-mir-1825	hsa04020	Calcium signaling pathway	815_5578_1956_2902_2066_4846_808_801_805_5159_5156_5566	12	0.002112984	0.175377702	0.003812559
6653	hsa-mir-1825	hsa05340	Primary immunodeficiency	3932_3561_3575_3718_695	5	0.002181121	0.181033062	0.003851767
6654	hsa-mir-1825	hsa04530	Tight junction	1499_1019_5578_6714_207_208_4301_1460_1457_5515	10	0.002262662	0.187800987	0.003912521
6655	hsa-mir-1825	hsa04650	Natural killer cell mediated cytotoxicity	5578_4773_3932_6850_5595_5594_836_919_5781_6464	10	0.002377701	0.197349151	0.004027534
6656	hsa-mir-1825	hsa05217	Basal cell carcinoma	1499_2736_2932_7157_2735_2737	6	0.002803675	0.232704997	0.0046541
6657	hsa-mir-1825	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_1432_836_834_7157_4846	6	0.003044605	0.252702232	0.004954946
6658	hsa-mir-1825	hsa04340	Hedgehog signaling pathway	2736_2932_1452_2735_2737_5566	6	0.003300659	0.273954664	0.005268359
6659	hsa-mir-1825	hsa04730	Long-term depression	5578_5592_5595_5594_4846_5515	6	0.008795641	0.730038233	0.013774306
6660	hsa-mir-1825	hsa04270	Vascular smooth muscle contraction	5578_5592_5595_5594_808_801_805_5566	8	0.009016334	0.74835572	0.013858439
6661	hsa-mir-1825	hsa05131	Shigellosis	1499_5578_10382_7534_10971	5	0.013292367	1	0.01943703
6662	hsa-mir-1825	hsa05130	Pathogenic Escherichia coli infection	1499_5578_10382_7534_10971	5	0.013292367	1	0.01943703
6663	hsa-mir-1825	hsa03010	Ribosome	6129_9349_6222_6229_6124_6143_6231	7	0.013348322	1	0.01943703
6664	hsa-mir-1825	hsa04060	Cytokine-cytokine receptor interaction	7046_3815_1234_1956_3560_3561_2057_2690_3575_85480_5159_5156_6348	13	0.013690574	1	0.019591683
6665	hsa-mir-1825	hsa04612	Antigen processing and presentation	1385_3326_3312_3320_4800_4801	6	0.022864931	1	0.03216592
6666	hsa-mir-1825	hsa04950	Maturity onset diabetes of the young	3651_168620_5080	3	0.023748852	1	0.032852578
6667	hsa-mir-1825	hsa04710	Circadian rhythm - mammal	8863_79365	2	0.0458192	1	0.062344158
6668	hsa-mir-183	hsa04010	MAPK signaling pathway	468_2353_3725_3727_1432_1386	6	6.85E-06	0.000232769	0.000232769
6669	hsa-mir-183	hsa04310	Wnt signaling pathway	4089_8061_3725_1457	4	0.000133635	0.004543574	0.002271787
6670	hsa-mir-183	hsa05200	Pathways in cancer	4089_25_1050_2353_3725	5	0.000241208	0.008201056	0.002733685
6671	hsa-mir-183	hsa05210	Colorectal cancer	4089_2353_3725	3	0.000416364	0.014156372	0.003127073
6672	hsa-mir-183	hsa04350	TGF-beta signaling pathway	4086_4089_4093	3	0.000459864	0.015635364	0.003127073
6673	hsa-mir-183	hsa04620	Toll-like receptor signaling pathway	2353_3725_1432	3	0.000721049	0.024515677	0.00379191
6674	hsa-mir-183	hsa04912	GnRH signaling pathway	468_3725_1432	3	0.000847238	0.028806098	0.00379191
6675	hsa-mir-183	hsa04660	T cell receptor signaling pathway	2353_3725_1432	3	0.000892214	0.030335281	0.00379191
6676	hsa-mir-183	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_1432	2	0.006612827	0.224836126	0.022661367
6677	hsa-mir-183	hsa05220	Chronic myeloid leukemia	4089_25	2	0.007331619	0.249275037	0.022661367
6678	hsa-mir-183	hsa04662	B cell receptor signaling pathway	2353_3725	2	0.007331619	0.249275037	0.022661367
6679	hsa-mir-183	hsa04520	Adherens junction	4089_1457	2	0.00827752	0.28143569	0.022916416
6680	hsa-mir-183	hsa04012	ErbB signaling pathway	25_3725	2	0.009688675	0.329414955	0.022916416
6681	hsa-mir-183	hsa05215	Prostate cancer	10488_468	2	0.009898421	0.336546309	0.022916416
6682	hsa-mir-183	hsa05212	Pancreatic cancer	10488_468	2	0.010110183	0.343746237	0.022916416
6683	hsa-mir-183	hsa04110	Cell cycle	4089_25	2	0.017366729	0.590468783	0.036904299
6684	hsa-mir-184	hsa05200	Pathways in cancer	2249_1499_5914_1387_6256_1019_367_1017_4193_6776_6777_5970_1870_1871_7157_6688_4609_3725_1026_1029_2353_3066_5925_2033_8554	25	2.51E-26	1.41E-24	1.41E-24
6685	hsa-mir-184	hsa05215	Prostate cancer	1499_1387_367_1017_4193_1385_5970_1870_1871_7157_468_1026_5925_2033	14	3.13E-19	1.75E-17	6.74E-18
6686	hsa-mir-184	hsa05212	Pancreatic cancer	1499_1387_367_1017_4193_1385_5970_1870_1871_7157_468_1026_5925_2033	14	3.61E-19	2.02E-17	6.74E-18
6687	hsa-mir-184	hsa05220	Chronic myeloid leukemia	1019_4193_6776_6777_5970_1870_1871_7157_4609_1026_1029_3066_5925	13	2.28E-18	1.28E-16	3.20E-17
6688	hsa-mir-184	hsa04110	Cell cycle	1387_1019_1017_4193_7027_1870_1871_7157_1026_1029_3066_5925_2033_5933	14	1.48E-17	8.30E-16	1.66E-16
6689	hsa-mir-184	hsa05219	Bladder cancer	1019_4193_1870_1871_7157_4609_1026_1029_5925	9	8.43E-14	4.72E-12	7.86E-13
6690	hsa-mir-184	hsa05222	Small cell lung cancer	6256_1019_1017_5970_1870_1871_7157_4609_5925_8554	10	8.30E-13	4.65E-11	6.64E-12
6691	hsa-mir-184	hsa05218	Melanoma	2249_1019_4193_1870_1871_7157_1026_1029_5925	9	5.94E-12	3.33E-10	4.16E-11
6692	hsa-mir-184	hsa05214	Glioma	1019_4193_1870_1871_7157_1026_1029_5925	8	1.16E-10	6.48E-09	7.20E-10
6693	hsa-mir-184	hsa05223	Non-small cell lung cancer	6256_1019_1870_1871_7157_1029_5925	7	1.27E-09	7.09E-08	7.09E-09
6694	hsa-mir-184	hsa04350	TGF-beta signaling pathway	1387_7027_1874_4609_2033_6667_5933	7	2.72E-08	1.52E-06	1.38E-07
6695	hsa-mir-184	hsa05221	Acute myeloid leukemia	5914_6776_6777_5970_6688_4609	6	7.67E-08	4.29E-06	3.58E-07
6696	hsa-mir-184	hsa04115	p53 signaling pathway	1019_1017_4193_7157_1026_1029	6	1.82E-07	1.02E-05	7.84E-07
6697	hsa-mir-184	hsa04010	MAPK signaling pathway	2249_1386_1649_5970_7157_468_4609_3725_2353	9	4.06E-07	2.27E-05	1.62E-06
6698	hsa-mir-184	hsa04330	Notch signaling pathway	1387_3066_9612_2033_4851	5	7.99E-07	4.48E-05	2.98E-06
6699	hsa-mir-184	hsa04630	Jak-STAT signaling pathway	1387_6776_6777_4609_2033_3977_8554	7	1.13E-06	6.32E-05	3.95E-06
6700	hsa-mir-184	hsa05016	Huntington's disease	1387_6908_1385_7157_3066_2033_6667	7	3.87E-06	0.000216754	1.28E-05
6701	hsa-mir-184	hsa05216	Thyroid cancer	1499_6256_7157_4609	4	4.19E-06	0.000234474	1.30E-05
6702	hsa-mir-184	hsa05210	Colorectal cancer	1499_7157_4609_3725_2353	5	1.16E-05	0.000649283	3.42E-05
6703	hsa-mir-184	hsa04012	ErbB signaling pathway	6776_6777_4609_3725_1026	5	1.36E-05	0.000763286	3.80E-05
6704	hsa-mir-184	hsa04310	Wnt signaling pathway	1499_1387_7157_4609_3725_2033	6	1.43E-05	0.000798024	3.80E-05
6705	hsa-mir-184	hsa04916	Melanogenesis	1499_1387_1385_2033	4	0.000454089	0.025429007	0.001155864
6706	hsa-mir-184	hsa04660	T cell receptor signaling pathway	1019_5970_3725_2353	4	0.00055697	0.031190302	0.0013561
6707	hsa-mir-184	hsa05213	Endometrial cancer	1499_7157_4609	3	0.000799827	0.044790294	0.001866262
6708	hsa-mir-184	hsa05211	Renal cell carcinoma	1387_3725_2033	3	0.001963133	0.109935459	0.004397418
6709	hsa-mir-184	hsa04720	Long-term potentiation	1387_468_2033	3	0.002196056	0.122979143	0.004554783
6710	hsa-mir-184	hsa04662	B cell receptor signaling pathway	5970_3725_2353	3	0.002196056	0.122979143	0.004554783
6711	hsa-mir-184	hsa04520	Adherens junction	1499_1387_2033	3	0.002621051	0.146778833	0.005242101
6712	hsa-mir-184	hsa04620	Toll-like receptor signaling pathway	5970_3725_2353	3	0.005076444	0.284280855	0.009802788
6713	hsa-mir-184	hsa03022	Basal transcription factors	2969_6908	2	0.007331284	0.41055191	0.013685064
6714	hsa-mir-184	hsa03420	Nucleotide excision repair	5981_4331	2	0.010088532	0.564957777	0.018224444
6715	hsa-mir-184	hsa04120	Ubiquitin mediated proteolysis	672_4193_8554	3	0.011595583	0.649352661	0.020292271
6716	hsa-mir-184	hsa05217	Basal cell carcinoma	1499_7157	2	0.015197422	0.85105563	0.025789565
6717	hsa-mir-184	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.021778312	1	0.035870161
6718	hsa-mir-184	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5970_3725	2	0.024190725	1	0.038705159
6719	hsa-mir-184	hsa04612	Antigen processing and presentation	4800_1385	2	0.036290881	1	0.054926739
6720	hsa-mir-184	hsa04210	Apoptosis	5970_7157	2	0.036290881	1	0.054926739
6721	hsa-mir-184	hsa03450	Non-homologous end-joining	2547	1	0.048228239	1	0.071073195
6722	hsa-mir-185	hsa05200	Pathways in cancer	5371_5595_5594_5914_1387_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846	29	9.48E-32	5.88E-30	5.88E-30
6723	hsa-mir-185	hsa05220	Chronic myeloid leukemia	5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464	15	1.32E-21	8.19E-20	4.10E-20
6724	hsa-mir-185	hsa04110	Cell cycle	5591_1387_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933	15	6.99E-19	4.33E-17	1.44E-17
6725	hsa-mir-185	hsa05215	Prostate cancer	5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033	12	1.09E-15	6.75E-14	1.53E-14
6726	hsa-mir-185	hsa05212	Pancreatic cancer	5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033	12	1.23E-15	7.64E-14	1.53E-14
6727	hsa-mir-185	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_4609_1869_5925	9	1.21E-13	7.53E-12	1.25E-12
6728	hsa-mir-185	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_7157_1869_5925	9	9.13E-13	5.66E-11	7.76E-12
6729	hsa-mir-185	hsa05210	Colorectal cancer	5595_5594_595_836_7157_4087_4609_3725_4088_4089	10	1.00E-12	6.21E-11	7.76E-12
6730	hsa-mir-185	hsa05222	Small cell lung cancer	6256_595_5970_1870_1871_7157_4609_1869_5925_4846	10	1.24E-12	7.70E-11	8.56E-12
6731	hsa-mir-185	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_4087_4609_4088_4089_2033_5933	10	1.38E-12	8.56E-11	8.56E-12
6732	hsa-mir-185	hsa05214	Glioma	5595_5594_595_1870_1871_7157_1869_5925_6464	9	4.13E-12	2.56E-10	2.33E-11
6733	hsa-mir-185	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_7428_2113_3725_2034_2033	9	9.57E-12	5.93E-10	4.94E-11
6734	hsa-mir-185	hsa04310	Wnt signaling pathway	1387_595_7157_4087_4773_4609_3725_1457_4088_4089_2033	11	1.08E-11	6.72E-10	5.17E-11
6735	hsa-mir-185	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_5970_4609	8	7.86E-11	4.88E-09	3.48E-10
6736	hsa-mir-185	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5925	8	3.04E-10	1.89E-08	1.26E-09
6737	hsa-mir-185	hsa04520	Adherens junction	5595_5594_1387_4087_1457_4088_4089_2033	8	7.31E-10	4.53E-08	2.83E-09
6738	hsa-mir-185	hsa05016	Huntington's disease	6874_1387_2902_836_6667_7157_3066_3065_3064_2033	10	1.67E-09	1.04E-07	6.11E-09
6739	hsa-mir-185	hsa05216	Thyroid cancer	5595_5594_6256_595_7157_4609	6	2.07E-09	1.29E-07	7.14E-09
6740	hsa-mir-185	hsa04010	MAPK signaling pathway	5595_5594_4208_836_3312_5970_7157_4773_4609_3725_4763	11	4.02E-09	2.49E-07	1.31E-08
6741	hsa-mir-185	hsa04330	Notch signaling pathway	1387_9612_3066_3065_2033	5	9.73E-07	6.03E-05	3.01E-06
6742	hsa-mir-185	hsa05213	Endometrial cancer	5595_5594_595_7157_4609	5	1.55E-06	9.58E-05	4.56E-06
6743	hsa-mir-185	hsa04720	Long-term potentiation	5595_5594_1387_2902_2033	5	8.34E-06	0.000516989	2.25E-05
6744	hsa-mir-185	hsa04662	B cell receptor signaling pathway	5595_5594_5970_4773_3725	5	8.34E-06	0.000516989	2.25E-05
6745	hsa-mir-185	hsa04012	ErbB signaling pathway	5595_5594_4609_3725_6464	5	1.65E-05	0.001023785	4.27E-05
6746	hsa-mir-185	hsa04660	T cell receptor signaling pathway	5595_5594_5970_4773_3725	5	4.84E-05	0.003002512	0.0001201
6747	hsa-mir-185	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_7157_4846	4	5.44E-05	0.003372571	0.000129714
6748	hsa-mir-185	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_4773_6464	5	0.000135841	0.008422164	0.000311932
6749	hsa-mir-185	hsa04370	VEGF signaling pathway	5595_5594_4773_4846	4	0.000175657	0.01089072	0.000388954
6750	hsa-mir-185	hsa05010	Alzheimer's disease	5595_5594_2902_836_4846	5	0.000414675	0.025709879	0.000886548
6751	hsa-mir-185	hsa04620	Toll-like receptor signaling pathway	5595_5594_5970_3725	4	0.000491299	0.030460516	0.001015351
6752	hsa-mir-185	hsa04916	Melanogenesis	5595_5594_1387_2033	4	0.000527247	0.032689323	0.001054494
6753	hsa-mir-185	hsa04510	Focal adhesion	5595_5594_595_3725_6464	5	0.000809526	0.050190623	0.001568457
6754	hsa-mir-185	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.000896844	0.055604329	0.00168498
6755	hsa-mir-185	hsa04910	Insulin signaling pathway	6720_5595_5594_6464	4	0.001461722	0.090626737	0.002665492
6756	hsa-mir-185	hsa04115	p53 signaling pathway	595_836_7157	3	0.001954848	0.12120056	0.003462873
6757	hsa-mir-185	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_5970_3725	3	0.002114296	0.131086374	0.003542875
6758	hsa-mir-185	hsa04730	Long-term depression	5595_5594_4846	3	0.002114296	0.131086374	0.003542875
6759	hsa-mir-185	hsa04630	Jak-STAT signaling pathway	1387_595_4609_2033	4	0.002208463	0.136924734	0.003603282
6760	hsa-mir-185	hsa04612	Antigen processing and presentation	4800_4801_3312	3	0.003918069	0.242920304	0.006073008
6761	hsa-mir-185	hsa04210	Apoptosis	836_5970_7157	3	0.003918069	0.242920304	0.006073008
6762	hsa-mir-185	hsa04062	Chemokine signaling pathway	5595_5594_5970_6464	4	0.004750734	0.294545482	0.007184036
6763	hsa-mir-185	hsa04912	GnRH signaling pathway	5595_5594_3725	3	0.006604658	0.409488823	0.009749734
6764	hsa-mir-185	hsa04360	Axon guidance	5595_5594_4773	3	0.011034538	0.684141361	0.015910264
6765	hsa-mir-185	hsa04930	Type II diabetes mellitus	5595_5594	2	0.011338112	0.702962923	0.01597643
6766	hsa-mir-185	hsa03050	Proteasome	5684_5705	2	0.012763454	0.791334124	0.017377911
6767	hsa-mir-185	hsa04120	Ubiquitin mediated proteolysis	5371_672_7428	3	0.012893289	0.799383912	0.017377911
6768	hsa-mir-185	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.023439873	1	0.030920683
6769	hsa-mir-185	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.03152989	1	0.040726108
6770	hsa-mir-185	hsa04540	Gap junction	5595_5594	2	0.042139387	1	0.053319224
6771	hsa-mir-185	hsa04710	Circadian rhythm - mammal	8863	1	0.046861183	1	0.058107867
6772	hsa-mir-186	hsa05200	Pathways in cancer	4087_5601_3065_1488_3725_2885_1487_2033_367_9063_5595_5594_5604_5599_2353_1387	16	5.90E-21	2.95E-19	2.95E-19
6773	hsa-mir-186	hsa04010	MAPK signaling pathway	9344_6722_5606_5601_5600_3725_2885_5595_1432_5594_5604_5599_2005_2353	14	1.07E-18	5.37E-17	2.68E-17
6774	hsa-mir-186	hsa04620	Toll-like receptor signaling pathway	5606_5601_5600_3725_5595_1432_5594_5604_5599_2353	10	3.50E-16	1.75E-14	5.83E-15
6775	hsa-mir-186	hsa04912	GnRH signaling pathway	5606_5601_5600_3725_2885_5595_1432_5594_5604_5599	10	5.99E-16	3.00E-14	7.49E-15
6776	hsa-mir-186	hsa04664	Fc epsilon RI signaling pathway	5606_5601_5600_2885_5595_1432_5594_5604_5599	9	3.38E-15	1.69E-13	3.38E-14
6777	hsa-mir-186	hsa05210	Colorectal cancer	4087_5601_3725_2885_5595_5594_5604_5599_2353	9	5.67E-15	2.83E-13	4.72E-14
6778	hsa-mir-186	hsa04660	T cell receptor signaling pathway	5601_5600_3725_2885_5595_1432_5594_5604_2353	9	5.56E-14	2.78E-12	3.97E-13
6779	hsa-mir-186	hsa04350	TGF-beta signaling pathway	4087_2033_5595_5594_3397_3399_3398_1387	8	6.49E-13	3.24E-11	4.06E-12
6780	hsa-mir-186	hsa05211	Renal cell carcinoma	3725_2885_2033_5595_5594_5604_1387	7	1.39E-11	6.93E-10	7.70E-11
6781	hsa-mir-186	hsa05220	Chronic myeloid leukemia	3065_1488_2885_1487_5595_5594_5604	7	1.81E-11	9.06E-10	9.06E-11
6782	hsa-mir-186	hsa04310	Wnt signaling pathway	4087_5601_1488_3725_1487_2033_5599_1387	8	4.47E-11	2.23E-09	2.00E-10
6783	hsa-mir-186	hsa04012	ErbB signaling pathway	5601_3725_2885_5595_5594_5604_5599	7	4.82E-11	2.41E-09	2.00E-10
6784	hsa-mir-186	hsa05215	Prostate cancer	2885_2033_367_5595_5594_5604_1387	7	5.20E-11	2.60E-09	2.00E-10
6785	hsa-mir-186	hsa05212	Pancreatic cancer	2885_2033_367_5595_5594_5604_1387	7	5.60E-11	2.80E-09	2.00E-10
6786	hsa-mir-186	hsa04662	B cell receptor signaling pathway	3725_2885_5595_5594_5604_2353	6	1.33E-09	6.63E-08	4.42E-09
6787	hsa-mir-186	hsa04330	Notch signaling pathway	3065_1488_1487_2033_1387	5	9.12E-09	4.56E-07	2.85E-08
6788	hsa-mir-186	hsa04510	Focal adhesion	5601_3725_2885_5595_5594_5604_5599	7	1.50E-08	7.48E-07	4.40E-08
6789	hsa-mir-186	hsa04910	Insulin signaling pathway	5601_2885_5595_5594_5604_5599	6	4.28E-08	2.14E-06	1.19E-07
6790	hsa-mir-186	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5601_5600_3725_1432_5599	5	6.33E-08	3.16E-06	1.67E-07
6791	hsa-mir-186	hsa04720	Long-term potentiation	2033_5595_5594_5604_1387	5	8.20E-08	4.10E-06	2.05E-07
6792	hsa-mir-186	hsa04370	VEGF signaling pathway	5600_5595_1432_5594_5604	5	9.29E-08	4.64E-06	2.21E-07
6793	hsa-mir-186	hsa04520	Adherens junction	4087_2033_5595_5594_1387	5	1.11E-07	5.57E-06	2.53E-07
6794	hsa-mir-186	hsa04916	Melanogenesis	2033_5595_5594_5604_1387	5	3.87E-07	1.94E-05	8.42E-07
6795	hsa-mir-186	hsa04930	Type II diabetes mellitus	5601_5595_5594_5599	4	6.05E-07	3.02E-05	1.26E-06
6796	hsa-mir-186	hsa05213	Endometrial cancer	2885_5595_5594_5604	4	1.04E-06	5.21E-05	2.08E-06
6797	hsa-mir-186	hsa05223	Non-small cell lung cancer	2885_5595_5594_5604	4	1.20E-06	6.00E-05	2.31E-06
6798	hsa-mir-186	hsa05221	Acute myeloid leukemia	2885_5595_5594_5604	4	1.68E-06	8.39E-05	3.11E-06
6799	hsa-mir-186	hsa05214	Glioma	2885_5595_5594_5604	4	2.42E-06	0.000121014	4.32E-06
6800	hsa-mir-186	hsa04540	Gap junction	2885_5595_5594_5604	4	9.44E-06	0.000471822	1.63E-05
6801	hsa-mir-186	hsa05216	Thyroid cancer	5595_5594_5604	3	1.14E-05	0.000569261	1.90E-05
6802	hsa-mir-186	hsa04110	Cell cycle	4087_3065_2033_1387	4	2.41E-05	0.001205033	3.89E-05
6803	hsa-mir-186	hsa05219	Bladder cancer	5595_5594_5604	3	3.22E-05	0.001608643	5.03E-05
6804	hsa-mir-186	hsa04650	Natural killer cell mediated cytotoxicity	2885_5595_5594_5604	4	4.23E-05	0.002114935	6.41E-05
6805	hsa-mir-186	hsa04630	Jak-STAT signaling pathway	2885_2033_9063_1387	4	6.57E-05	0.003284439	9.66E-05
6806	hsa-mir-186	hsa05014	Amyotrophic lateral sclerosis (ALS)	5606_5600_1432	3	7.27E-05	0.003636802	0.000103909
6807	hsa-mir-186	hsa05016	Huntington's disease	3065_2033_25942_1387	4	0.000136103	0.006805149	0.000188148
6808	hsa-mir-186	hsa05218	Melanoma	5595_5594_5604	3	0.000142992	0.007149614	0.000188148
6809	hsa-mir-186	hsa04730	Long-term depression	5595_5594_5604	3	0.000142992	0.007149614	0.000188148
6810	hsa-mir-186	hsa04062	Chemokine signaling pathway	2885_5595_5594_5604	4	0.000150225	0.007511234	0.000192596
6811	hsa-mir-186	hsa04270	Vascular smooth muscle contraction	5595_5594_5604	3	0.00060762	0.030380982	0.000759525
6812	hsa-mir-186	hsa04120	Ubiquitin mediated proteolysis	7329_9063_672	3	0.000966359	0.048317952	0.001178487
6813	hsa-mir-186	hsa05010	Alzheimer's disease	6622_5595_5594	3	0.001907557	0.095377839	0.002270901
6814	hsa-mir-186	hsa04150	mTOR signaling pathway	5595_5594	2	0.002486313	0.124315631	0.002891061
6815	hsa-mir-186	hsa04810	Regulation of actin cytoskeleton	5595_5594_5604	3	0.003450783	0.172539164	0.003921345
6816	hsa-mir-186	hsa04920	Adipocytokine signaling pathway	5601_5599	2	0.004023752	0.201187601	0.004470836
6817	hsa-mir-186	hsa04670	Leukocyte transendothelial migration	5600_1432	2	0.012476175	0.62380875	0.01356106
6818	hsa-mir-186	hsa04360	Axon guidance	5595_5594	2	0.014250563	0.712528162	0.015160174
6819	hsa-mir-186	hsa03410	Base excision repair	3146	1	0.049305461	1	0.051359855
6820	hsa-mir-187	hsa04350	TGF-beta signaling pathway	659	1	0.002933236	0.005866471	0.005866471
6821	hsa-mir-187	hsa04060	Cytokine-cytokine receptor interaction	659	1	0.008766374	0.017532749	0.008766374
6822	hsa-mir-18a	hsa05200	Pathways in cancer	4149_3551_1398_1499_5914_595_596_598_3815_1017_8517_4193_6934_5578_3091_2735_2064_3066_3065_5925_1050_613_5743_5747_10342_25_405_9063_1956_1487_6789_7046_4436_1870_1871_2113_6774_867_10401_207_208_9915_7187_4286_3716_1147_5879_2249_998_1488_2261_5595_5594_5599_861_1387_6256_836_367_2932_6777_6772_5970_7157_7849_1869_3725_5467_6776_4087_4088_4089_5888_5728_2034_2033_5468_4846_3910_898_4790_4791_4792_3320_3326_51176_5371_675_5159_5156_5604_5601_5602_1856_1399_3265_51588_7428_8772_4609_2956_1026_2736_2353_7704_2737_8554	107	1.09E-45	9.69E-44	9.69E-44
6823	hsa-mir-18a	hsa04010	MAPK signaling pathway	6722_4149_3551_1398_6195_6197_2264_8517_9252_5578_1845_7132_4773_9020_5923_1956_3304_3305_3303_6789_1432_7046_22800_4763_1616_207_208_1147_5879_2249_998_3727_2261_5595_5594_5599_5598_8986_1386_1649_836_3310_3312_3315_5971_5970_3164_7157_3725_6196_5058_4790_4791_5159_9261_1326_5156_5604_4208_5601_5600_5603_5602_5608_1399_3265_6885_4609_2353_2002_8550_5566	72	1.47E-26	1.31E-24	6.54E-25
6824	hsa-mir-18a	hsa05220	Chronic myeloid leukemia	3551_1398_595_598_8517_4193_3066_3065_5925_613_25_1487_7046_1870_1871_867_207_208_1147_1488_5595_5594_861_6777_5970_7157_1869_6776_4088_4089_4790_4792_5604_1399_3265_5781_4609_1026_6464	39	2.88E-23	2.56E-21	8.53E-22
6825	hsa-mir-18a	hsa04110	Cell cycle	4174_4172_595_1017_4193_902_6500_3066_3065_5925_25_1870_1871_5111_9232_5934_5933_545_995_5347_7534_5591_1387_11200_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_898_1031_983_8454_1026_1022_1111_8556_8555_472	44	2.18E-21	1.94E-19	4.85E-20
6826	hsa-mir-18a	hsa05215	Prostate cancer	3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026	38	1.64E-20	1.46E-18	2.92E-19
6827	hsa-mir-18a	hsa05212	Pancreatic cancer	3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026	38	2.24E-20	1.99E-18	3.32E-19
6828	hsa-mir-18a	hsa04310	Wnt signaling pathway	818_817_1499_595_8607_6934_5578_6500_4772_4773_23291_1487_5879_1460_1488_5599_1387_1459_2932_7157_8061_3725_5467_1457_1452_4087_4088_4089_2033_51176_5519_5518_5515_5601_5602_1856_8454_8945_6885_4609_5527_5566	42	1.16E-16	1.03E-14	1.48E-15
6829	hsa-mir-18a	hsa04660	T cell receptor signaling pathway	3551_1493_8517_5777_4772_4773_9020_2534_3932_4794_1432_867_207_208_1147_998_5595_5594_2932_5970_3725_5058_959_4790_4792_4793_1326_5604_5601_5600_5603_919_3265_6885_2353	35	1.17E-15	1.04E-13	1.30E-14
6830	hsa-mir-18a	hsa05222	Small cell lung cancer	4149_3551_595_596_598_1017_8517_5925_5743_5747_9063_1870_1871_10401_207_208_7187_1147_6256_5970_7157_1869_5728_4846_3910_898_4790_4792_51588_4609_8554	31	3.05E-15	2.72E-13	3.02E-14
6831	hsa-mir-18a	hsa05210	Colorectal cancer	1499_595_596_6934_1956_7046_4436_207_208_5879_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_51176_5159_5156_5604_5601_5602_1856_4609_2956_2353	30	1.04E-14	9.26E-13	9.26E-14
6832	hsa-mir-18a	hsa04012	ErbB signaling pathway	818_817_1398_5578_2064_5747_25_1956_6714_867_207_208_5595_5594_5599_2066_2932_6777_3725_6776_5058_5604_5601_5602_1399_3265_4609_1026_2002_6464	30	2.22E-14	1.98E-12	1.80E-13
6833	hsa-mir-18a	hsa05221	Acute myeloid leukemia	3551_5914_595_3815_8517_6934_1050_6774_207_208_1147_5595_5594_861_6777_5970_5467_6776_4790_51176_5371_5604_3265_4609_7704	25	7.83E-14	6.97E-12	5.61E-13
6834	hsa-mir-18a	hsa04630	Jak-STAT signaling pathway	3559_595_598_5777_3455_3594_9063_3560_3561_6773_1439_3595_2057_6774_867_2690_10401_3459_3977_207_208_3717_3716_8651_1387_6778_6777_6772_7297_6776_2033_51588_10379_5781_58985_4609_3575_8554	38	8.19E-14	7.29E-12	5.61E-13
6835	hsa-mir-18a	hsa04920	Adipocytokine signaling pathway	3551_10891_5465_6794_8517_7132_8717_2538_4794_8471_6774_207_208_3717_1147_5599_6256_5970_4790_4792_4793_5601_5602_5563_5781_7133	26	1.29E-13	1.15E-11	8.15E-13
6836	hsa-mir-18a	hsa04620	Toll-like receptor signaling pathway	3551_8517_3455_3665_3661_1432_207_208_7187_1147_5879_29110_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5601_5600_5603_5602_5608_9641_8772_6885_2353	31	1.37E-13	1.22E-11	8.15E-13
6837	hsa-mir-18a	hsa05214	Glioma	818_817_595_4193_5578_5925_1956_1870_1871_207_208_5595_5594_7157_1869_5728_808_801_805_5159_5156_5604_3265_1026_6464	25	4.48E-13	3.98E-11	2.49E-12
6838	hsa-mir-18a	hsa04520	Adherens junction	1499_6934_5770_5777_2064_2534_1956_6714_7046_5879_1460_998_5595_5594_1387_1459_1457_4087_4088_4089_2033_51176_3643_71_8826_6885	26	3.59E-12	3.20E-10	1.88E-11
6839	hsa-mir-18a	hsa04910	Insulin signaling pathway	3551_10891_1398_6720_5770_2538_5590_5499_8471_867_5211_207_208_8651_5595_5594_5599_2932_2194_808_801_805_3643_5604_5601_5602_5563_1399_3265_2002_6464_5566	32	2.57E-11	2.28E-09	1.27E-10
6840	hsa-mir-18a	hsa04662	B cell receptor signaling pathway	3551_8517_5777_4772_4773_4794_207_208_1147_5879_695_5595_5594_1380_2932_6850_5970_3725_4790_4792_4793_5604_3265_2353	24	3.15E-11	2.80E-09	1.48E-10
6841	hsa-mir-18a	hsa04350	TGF-beta signaling pathway	6500_90_4086_1875_6667_7046_1874_57154_5934_5933_5595_5594_1387_7027_4087_4088_4089_2033_5519_5518_5515_8454_4609_4093_4092	25	8.45E-11	7.52E-09	3.76E-10
6842	hsa-mir-18a	hsa04115	p53 signaling pathway	595_1017_4194_4193_900_50484_51246_545_7161_11200_836_7157_6241_64326_5728_898_27113_25898_983_1026_1111_472	22	2.19E-10	1.95E-08	9.29E-10
6843	hsa-mir-18a	hsa04510	Focal adhesion	1398_1499_595_596_5578_2064_5923_2534_5747_3791_1956_6714_5499_207_208_5879_998_5595_5594_5599_2932_3725_5058_5728_3910_2321_5159_5156_5604_5601_5602_1399_3265_71_2002_85366_6464	37	4.52E-10	4.03E-08	1.83E-09
6844	hsa-mir-18a	hsa04062	Chemokine signaling pathway	3551_1398_8517_653361_5747_5580_5590_6773_2309_6362_6774_207_208_3717_1147_5879_998_5595_5594_1234_2932_6777_6772_5970_5058_4790_4792_4793_1230_5604_1399_3265_7852_6464_5566	35	1.06E-09	9.45E-08	4.11E-09
6845	hsa-mir-18a	hsa05219	Bladder cancer	595_9252_4193_2064_5925_1956_1870_1871_2261_5595_5594_7157_1869_5604_3265_4609_1026	17	1.31E-09	1.16E-07	4.85E-09
6846	hsa-mir-18a	hsa03010	Ribosome	6193_6204_6205_6207_6202_6141_9349_6217_6137_6135_6210_6155_6156_6191_6222_6223_6229_6129_6128_6125_6130_6181_6189_6188_6232	25	1.42E-09	1.26E-07	5.05E-09
6847	hsa-mir-18a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3551_8517_9020_1956_6714_1432_1147_5879_998_5599_836_5970_3725_5058_4790_4792_5601_5600_5603_5602_5781	21	1.74E-09	1.55E-07	5.96E-09
6848	hsa-mir-18a	hsa05211	Renal cell carcinoma	1398_3091_405_2113_207_208_9915_5879_998_5595_5594_1387_3725_5058_2034_2033_5604_1399_3265_7428_5781	21	2.15E-09	1.91E-07	7.08E-09
6849	hsa-mir-18a	hsa05213	Endometrial cancer	1499_595_6934_2064_1956_2309_207_208_5595_5594_2932_7157_5728_51176_5604_3265_4609_2002	18	3.26E-09	2.90E-07	1.04E-08
6850	hsa-mir-18a	hsa04912	GnRH signaling pathway	818_817_5578_5580_1956_6714_1432_998_5595_5594_5599_5598_3725_808_801_805_5604_5601_5600_5603_5602_5608_3265_2002_5566	25	3.86E-09	3.43E-07	1.18E-08
6851	hsa-mir-18a	hsa05223	Non-small cell lung cancer	595_5578_2064_5925_1956_2309_6789_1870_1871_207_208_5595_5594_6256_7157_1869_5604_3265	18	5.31E-09	4.73E-07	1.58E-08
6852	hsa-mir-18a	hsa04370	VEGF signaling pathway	5578_4772_4773_5743_5747_3791_6714_1432_207_208_5879_998_5595_5594_3315_4846_9261_5604_5600_5603_3265	21	5.87E-09	5.23E-07	1.69E-08
6853	hsa-mir-18a	hsa05216	Thyroid cancer	1499_595_6934_10342_5595_5594_6256_7157_7849_5468_51176_5604_3265_4609	14	6.40E-09	5.70E-07	1.78E-08
6854	hsa-mir-18a	hsa05218	Melanoma	595_4193_5925_1956_1870_1871_207_208_4286_2249_5595_5594_7157_1869_5728_5159_5156_5604_3265_1026	20	8.48E-09	7.55E-07	2.29E-08
6855	hsa-mir-18a	hsa04210	Apoptosis	3551_596_598_8517_7132_8717_9020_823_1439_207_208_1147_836_5970_7157_9131_4790_4792_840_8772_472_5566	22	1.19E-08	1.06E-06	3.10E-08
6856	hsa-mir-18a	hsa04720	Long-term potentiation	818_814_817_6195_6197_5578_2902_2906_5499_5595_5594_1387_6196_2033_808_801_805_5604_3265_5566	20	1.85E-08	1.65E-06	4.71E-08
6857	hsa-mir-18a	hsa04120	Ubiquitin mediated proteolysis	4193_55294_6500_3093_23291_9063_7319_84447_867_10401_7329_8925_57154_8651_10055_51366_64326_7337_5371_672_25898_8454_8945_51588_7428_10075_8554	27	2.40E-08	2.13E-06	5.93E-08
6858	hsa-mir-18a	hsa03022	Basal transcription factors	51616_6872_2965_2963_2969_6878_6874_6908_2958_2959_6880_2957_6882_9519	14	7.37E-08	6.56E-06	1.77E-07
6859	hsa-mir-18a	hsa04664	Fc epsilon RI signaling pathway	5578_2534_5580_1432_207_208_5879_695_5595_5594_5599_6850_5604_5601_5600_5603_5602_5608_3265	19	1.67E-07	1.49E-05	3.91E-07
6860	hsa-mir-18a	hsa04540	Gap junction	5592_5578_10382_1956_6714_5595_5594_5598_7846_1453_347733_5159_983_5156_5604_3265_7278_84617_203068_5566	20	3.78E-07	3.36E-05	8.62E-07
6861	hsa-mir-18a	hsa04330	Notch signaling pathway	3066_3065_1840_9794_1487_2648_1488_1387_22938_9612_2033_8850_1856_4851	14	8.20E-07	7.30E-05	1.83E-06
6862	hsa-mir-18a	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_598_7132_2902_2906_1432_1616_5879_836_7157_4846_5600_5603_5608_7133	15	1.04E-06	9.28E-05	2.26E-06
6863	hsa-mir-18a	hsa04916	Melanogenesis	818_817_1499_3815_6934_5578_4286_5595_5594_1387_2932_2033_808_801_805_51176_5604_1856_3265_5566	20	1.74E-06	0.000154611	3.68E-06
6864	hsa-mir-18a	hsa05131	Shigellosis	1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068	14	4.71E-06	0.00041917	9.53E-06
6865	hsa-mir-18a	hsa05130	Pathogenic Escherichia coli infection	1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068	14	4.71E-06	0.00041917	9.53E-06
6866	hsa-mir-18a	hsa04530	Tight junction	1499_5578_5580_5590_6714_4627_4628_22800_8573_207_208_1460_998_1459_1457_5728_5519_5518_5515_3265_71_5520	22	7.30E-06	0.000649919	1.44E-05
6867	hsa-mir-18a	hsa04930	Type II diabetes mellitus	3551_5580_5590_8471_3651_8651_5595_5594_5599_3643_5601_5602	12	1.29E-05	0.001144695	2.49E-05
6868	hsa-mir-18a	hsa03050	Proteasome	5708_5709_5705_5706_5700_5684_5719_5717_5713_5687_5693_5707	12	2.23E-05	0.001983967	4.22E-05
6869	hsa-mir-18a	hsa05322	Systemic lupus erythematosus	3021_3020_8366_9555_8349_8362_8365_8368_3018_8294_8370_6628_121504_8360_8363_8364_8367_959_8359_8361	20	0.000114962	0.010231574	0.000213158
6870	hsa-mir-18a	hsa04650	Natural killer cell mediated cytotoxicity	5777_5578_3455_4772_4773_2534_3932_3459_5879_5595_5594_836_6850_5058_5604_919_3265_5781_6464	19	0.00018639	0.016588666	0.000338544
6871	hsa-mir-18a	hsa03420	Nucleotide excision repair	5981_902_5111_5886_2965_4331_2071_2074_1022_6117	10	0.000208973	0.018598561	0.000371971
6872	hsa-mir-18a	hsa03410	Base excision repair	4350_142_4913_252969_5111_3146_328_2237_6996	9	0.000234704	0.020888642	0.000404365
6873	hsa-mir-18a	hsa05016	Huntington's disease	10891_293_292_3066_3065_3064_498_25942_2902_6667_9586_1387_836_5437_7157_1213_2033_5468_27113_6874_6908_5441_9519	23	0.000236258	0.021026969	0.000404365
6874	hsa-mir-18a	hsa03450	Non-homologous end-joining	2547_10111_7520_2237_5591_4361	6	0.000254676	0.022666203	0.000427664
6875	hsa-mir-18a	hsa04060	Cytokine-cytokine receptor interaction	3559_3815_7132_3455_90_3594_3791_1956_3560_3561_1439_7046_3595_2057_6362_2690_3459_3977_1234_959_2321_1230_5159_5156_7852_58985_3575_7133	28	0.000428557	0.038141597	0.000706326
6876	hsa-mir-18a	hsa04150	mTOR signaling pathway	6794_6195_6197_3091_207_208_5595_5594_6196_5563	10	0.000664511	0.059141519	0.0010753
6877	hsa-mir-18a	hsa04810	Regulation of actin cytoskeleton	10788_1398_2264_5747_1956_5499_4627_4628_22800_5879_2249_998_2261_5595_5594_5058_5159_5156_5604_1399_3265_71_8826_85366	24	0.000734187	0.065342612	0.001166832
6878	hsa-mir-18a	hsa03030	DNA replication	5981_4174_4172_5111_2237_5557_6117_5422	8	0.001009998	0.089889789	0.001577014
6879	hsa-mir-18a	hsa03440	Homologous recombination	641_10111_4361_4683_5888_675_6117	7	0.001154958	0.102791261	0.001772263
6880	hsa-mir-18a	hsa04340	Hedgehog signaling pathway	2735_23291_53944_2932_1452_1453_8945_2736_2737_5566	10	0.001235803	0.10998646	0.001864177
6881	hsa-mir-18a	hsa04020	Calcium signaling pathway	818_814_817_293_5578_292_2064_1956_2902_2906_147_2066_4846_808_801_805_5159_5156_85366_5566	20	0.002418527	0.215248871	0.003587481
6882	hsa-mir-18a	hsa04740	Olfactory transduction	818_817_5592_808_801_805_5566	7	0.002690948	0.239494361	0.003926137
6883	hsa-mir-18a	hsa05217	Basal cell carcinoma	1499_6934_2735_2932_7157_51176_1856_2736_2737	9	0.003243108	0.288636595	0.004655429
6884	hsa-mir-18a	hsa04730	Long-term depression	5592_5578_5595_5594_4846_5519_5518_5515_5604_3265	10	0.005138341	0.457312374	0.007258927
6885	hsa-mir-18a	hsa03020	RNA polymerase	64425_25885_51082_5437_84172_5441	6	0.005784676	0.514836197	0.008007755
6886	hsa-mir-18a	hsa04270	Vascular smooth muscle contraction	5592_5578_5580_147_5499_59_5595_5594_808_801_805_5604_85366_5566	14	0.005848361	0.520504088	0.008007755
6887	hsa-mir-18a	hsa03430	Mismatch repair	5981_4436_5111_2956_6117	5	0.00967112	0.860729705	0.013041359
6888	hsa-mir-18a	hsa04360	Axon guidance	4772_4773_2534_5747_25_5879_998_5595_5594_2932_5058_3265_7852_1020	14	0.010520257	0.936302834	0.013974669
6889	hsa-mir-18a	hsa04950	Maturity onset diabetes of the young	5080_6927_4760_3651_3172	5	0.011235995	1	0.014705934
6890	hsa-mir-18a	hsa05340	Primary immunodeficiency	8517_3932_3561_695_959_3575	6	0.012581327	1	0.016228089
6891	hsa-mir-18a	hsa05010	Alzheimer's disease	7132_498_823_2902_2906_5595_5594_836_2932_4846_808_351_801_805_840_8772_1020	17	0.016210182	1	0.020610088
6892	hsa-mir-18a	hsa04612	Antigen processing and presentation	3309_3304_3305_3303_3310_3312_3320_3326_4800_4801	10	0.027680759	1	0.034698417
6893	hsa-mir-18a	hsa04670	Leukocyte transendothelial migration	1499_5578_653361_5747_1432_5879_998_5600_5603_7852_71_5781	12	0.037827534	1	0.046535049
6894	hsa-mir-18a	hsa04710	Circadian rhythm - mammal	8863_4862_1453	3	0.038169197	1	0.046535049
6895	hsa-mir-18b	hsa05200	Pathways in cancer	3320_5371_1488_1017_5595_5594_5599_861_5914_1387_6256_595_6502_836_6258_367_2932_4193_4149_7704_842_6774_3091_5970_7428_1870_1871_7157_4824_4087_6688_5604_2113_4609_1869_3725_841_1029_1487_4088_4089_3066_3065_4292_1050_5925_2034_2033_4846_207_9915_5894	52	7.62E-41	5.11E-39	5.11E-39
6896	hsa-mir-18b	hsa05220	Chronic myeloid leukemia	1488_5595_5594_861_595_4193_5970_1870_1871_7157_5604_4609_1869_1029_1487_4088_4089_3066_3065_5925_207_6464_5894	23	2.78E-24	1.86E-22	9.32E-23
6897	hsa-mir-18b	hsa04110	Cell cycle	890_5591_1017_1387_595_983_6502_2932_4193_8454_6500_1870_1871_7157_4087_1869_1029_4088_4089_3066_3065_5925_2033_5933_5934_990	26	4.68E-24	3.13E-22	1.04E-22
6898	hsa-mir-18b	hsa05215	Prostate cancer	3320_1017_5595_5594_1387_595_367_2932_4193_1385_842_5970_1870_1871_7157_4824_5604_1869_5925_2033_207_5894	22	1.24E-21	8.27E-20	2.04E-20
6899	hsa-mir-18b	hsa05212	Pancreatic cancer	3320_1017_5595_5594_1387_595_367_2932_4193_1385_842_5970_1870_1871_7157_4824_5604_1869_5925_2033_207_5894	22	1.53E-21	1.02E-19	2.04E-20
6900	hsa-mir-18b	hsa04350	TGF-beta signaling pathway	3399_5595_5594_1387_6667_8454_3398_6500_1874_1875_4087_4609_4088_4089_2033_5933_4093_5934	18	1.14E-16	7.67E-15	1.28E-15
6901	hsa-mir-18b	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_6258_842_1870_1871_7157_5604_1869_1029_5925_207_5894	15	9.82E-16	6.58E-14	9.40E-15
6902	hsa-mir-18b	hsa05210	Colorectal cancer	5595_5594_5599_595_836_2932_842_7157_4087_5604_4609_3725_4088_4089_4292_207_5894	17	1.13E-15	7.56E-14	9.45E-15
6903	hsa-mir-18b	hsa05221	Acute myeloid leukemia	5371_5595_5594_861_5914_595_7704_6774_5970_6688_5604_4609_1050_207_5894	15	3.01E-15	2.02E-13	2.24E-14
6904	hsa-mir-18b	hsa05214	Glioma	815_5595_5594_595_4193_1870_1871_7157_5604_1869_1029_5925_207_6464_5894	15	1.03E-14	6.91E-13	6.91E-14
6905	hsa-mir-18b	hsa05222	Small cell lung cancer	1017_6256_595_6502_6258_4149_842_5970_1870_1871_7157_4609_1869_5925_4846_207	16	2.51E-14	1.68E-12	1.43E-13
6906	hsa-mir-18b	hsa05219	Bladder cancer	5595_5594_595_4193_1870_1871_7157_5604_4609_1869_1029_5925_5894	13	2.55E-14	1.71E-12	1.43E-13
6907	hsa-mir-18b	hsa04310	Wnt signaling pathway	815_1488_5599_1387_595_2932_8454_6500_7157_4087_4609_3725_1457_1487_1459_4088_4089_2033	18	6.49E-13	4.35E-11	3.34E-12
6908	hsa-mir-18b	hsa04010	MAPK signaling pathway	5595_5594_5599_5598_4208_836_4149_3312_1386_5970_9261_7157_5604_4609_3725_6195_4763_1616_207_2002_2005_5894	22	2.25E-12	1.51E-10	1.08E-11
6909	hsa-mir-18b	hsa05213	Endometrial cancer	5595_5594_595_2932_842_7157_5604_4609_4292_207_2002_5894	12	4.95E-12	3.32E-10	2.21E-11
6910	hsa-mir-18b	hsa05218	Melanoma	5595_5594_595_4193_1870_1871_7157_5604_1869_1029_5925_207_5894	13	8.28E-12	5.55E-10	3.47E-11
6911	hsa-mir-18b	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_7428_5604_2113_3725_2034_2033_207_9915_5894	13	9.68E-12	6.48E-10	3.81E-11
6912	hsa-mir-18b	hsa04012	ErbB signaling pathway	815_6714_5595_5594_5599_2932_5604_4609_3725_207_6464_2002_5894	13	8.04E-11	5.38E-09	2.99E-10
6913	hsa-mir-18b	hsa04540	Gap junction	6714_5595_5594_5598_983_7277_7278_5604_7846_51807_10376_5894	12	1.97E-09	1.32E-07	6.95E-09
6914	hsa-mir-18b	hsa05216	Thyroid cancer	5595_5594_6256_595_6258_7157_5604_4609	8	5.68E-09	3.80E-07	1.90E-08
6915	hsa-mir-18b	hsa04330	Notch signaling pathway	1488_1387_2648_1487_9612_3066_3065_2033_4851	9	1.00E-08	6.71E-07	3.19E-08
6916	hsa-mir-18b	hsa04115	p53 signaling pathway	1017_595_983_836_4193_842_7157_841_7161_1029	10	1.64E-08	1.10E-06	4.99E-08
6917	hsa-mir-18b	hsa04520	Adherens junction	6714_5595_5594_1387_4087_1457_1459_4088_4089_2033	10	5.84E-08	3.92E-06	1.68E-07
6918	hsa-mir-18b	hsa05016	Huntington's disease	6874_1387_2902_6908_836_6667_1385_842_7157_841_3066_3065_3064_2033	14	6.00E-08	4.02E-06	1.68E-07
6919	hsa-mir-18b	hsa04720	Long-term potentiation	815_5595_5594_1387_2902_5604_6195_2033_5894	9	3.72E-07	2.49E-05	9.96E-07
6920	hsa-mir-18b	hsa04370	VEGF signaling pathway	6714_5595_5594_842_9261_5604_4846_207_5894	9	4.55E-07	3.05E-05	1.17E-06
6921	hsa-mir-18b	hsa04912	GnRH signaling pathway	815_6714_5595_5594_5599_5598_5604_3725_2002_5894	10	7.59E-07	5.09E-05	1.88E-06
6922	hsa-mir-18b	hsa04662	B cell receptor signaling pathway	5595_5594_2932_5970_5604_3725_207_5894	8	3.74E-06	0.000250732	8.95E-06
6923	hsa-mir-18b	hsa04916	Melanogenesis	815_5595_5594_1387_2932_1385_5604_2033_5894	9	4.56E-06	0.000305637	1.05E-05
6924	hsa-mir-18b	hsa04510	Focal adhesion	6714_5595_5594_5599_595_2932_5604_3725_207_6464_2002_5894	12	5.92E-06	0.000396333	1.28E-05
6925	hsa-mir-18b	hsa04910	Insulin signaling pathway	6720_5595_5594_5599_2932_5604_207_6464_2002_5894	10	5.94E-06	0.000397869	1.28E-05
6926	hsa-mir-18b	hsa04210	Apoptosis	836_839_842_840_5970_7157_841_207	8	1.20E-05	0.000804339	2.51E-05
6927	hsa-mir-18b	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5970_5604_3725_841_207	8	3.01E-05	0.002015855	6.11E-05
6928	hsa-mir-18b	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_6502_4193_8454_6500_7428_7329	9	4.00E-05	0.002682995	7.89E-05
6929	hsa-mir-18b	hsa05010	Alzheimer's disease	22926_5595_5594_2902_836_2932_842_840_841_4846	10	4.52E-05	0.003026732	8.65E-05
6930	hsa-mir-18b	hsa04660	T cell receptor signaling pathway	5595_5594_2932_5970_5604_3725_207_5894	8	4.98E-05	0.003336698	9.27E-05
6931	hsa-mir-18b	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_842_7157_1616_4846	6	6.13E-05	0.004109065	0.000105361
6932	hsa-mir-18b	hsa05131	Shigellosis	7277_7278_7846_51807_4691_10376	6	6.13E-05	0.004109065	0.000105361
6933	hsa-mir-18b	hsa05130	Pathogenic Escherichia coli infection	7277_7278_7846_51807_4691_10376	6	6.13E-05	0.004109065	0.000105361
6934	hsa-mir-18b	hsa04062	Chemokine signaling pathway	5595_5594_7074_2932_6774_5970_5604_207_6464_5894	10	8.98E-05	0.006014739	0.000150368
6935	hsa-mir-18b	hsa03022	Basal transcription factors	2963_2962_6874_2969_6908	5	9.43E-05	0.006319284	0.000154129
6936	hsa-mir-18b	hsa04920	Adipocytokine signaling pathway	5599_6256_6258_6774_5970_207	6	0.000153509	0.010285107	0.000244883
6937	hsa-mir-18b	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5604_207_5894	6	0.000353322	0.023672599	0.000550526
6938	hsa-mir-18b	hsa04150	mTOR signaling pathway	5595_5594_3091_6195_207	5	0.000405884	0.027194253	0.000618051
6939	hsa-mir-18b	hsa04612	Antigen processing and presentation	3320_4800_4801_4802_1385_3312	6	0.000640768	0.042931444	0.000954032
6940	hsa-mir-18b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_5599_836_5970_3725	5	0.001511809	0.101291179	0.002155131
6941	hsa-mir-18b	hsa04730	Long-term depression	5595_5594_5604_4846_5894	5	0.001511809	0.101291179	0.002155131
6942	hsa-mir-18b	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_5604_6464_5894	6	0.005263344	0.352644071	0.007346751
6943	hsa-mir-18b	hsa04630	Jak-STAT signaling pathway	1387_595_6774_4609_2033_207	6	0.008919457	0.597603604	0.012195992
6944	hsa-mir-18b	hsa04930	Type II diabetes mellitus	5595_5594_5599	3	0.015755146	1	0.021111895
6945	hsa-mir-18b	hsa04270	Vascular smooth muscle contraction	5595_5594_5604_5894	4	0.045810228	1	0.060182064
6946	hsa-mir-1909	hsa05216	Thyroid cancer	7157	1	0.004989512	0.104779753	0.020872303
6947	hsa-mir-1909	hsa05219	Bladder cancer	7157	1	0.007145439	0.150054223	0.020872303
6948	hsa-mir-1909	hsa05213	Endometrial cancer	7157	1	0.0088013	0.184827307	0.020872303
6949	hsa-mir-1909	hsa05223	Non-small cell lung cancer	7157	1	0.009132207	0.191776353	0.020872303
6950	hsa-mir-1909	hsa05217	Basal cell carcinoma	7157	1	0.009297628	0.19525018	0.020872303
6951	hsa-mir-1909	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157	1	0.009463026	0.198723543	0.020872303
6952	hsa-mir-1909	hsa05214	Glioma	7157	1	0.010950616	0.229962939	0.020872303
6953	hsa-mir-1909	hsa04115	p53 signaling pathway	7157	1	0.011611193	0.243835062	0.020872303
6954	hsa-mir-1909	hsa05218	Melanoma	7157	1	0.01194135	0.250768344	0.020872303
6955	hsa-mir-1909	hsa05220	Chronic myeloid leukemia	7157	1	0.012601398	0.264629348	0.020872303
6956	hsa-mir-1909	hsa05210	Colorectal cancer	7157	1	0.014085216	0.295789526	0.020872303
6957	hsa-mir-1909	hsa05222	Small cell lung cancer	7157	1	0.01441471	0.30270892	0.020872303
6958	hsa-mir-1909	hsa05215	Prostate cancer	7157	1	0.014744117	0.309626463	0.020872303
6959	hsa-mir-1909	hsa04210	Apoptosis	7157	1	0.014908788	0.313084542	0.020872303
6960	hsa-mir-1909	hsa05212	Pancreatic cancer	7157	1	0.014908788	0.313084542	0.020872303
6961	hsa-mir-1909	hsa04110	Cell cycle	7157	1	0.019838671	0.416612086	0.026038255
6962	hsa-mir-1909	hsa04120	Ubiquitin mediated proteolysis	7329	1	0.02311428	0.485399873	0.028552934
6963	hsa-mir-1909	hsa04310	Wnt signaling pathway	7157	1	0.025238725	0.530013226	0.029445179
6964	hsa-mir-1909	hsa05016	Huntington's disease	7157	1	0.031102522	0.653152954	0.034376471
6965	hsa-mir-1909	hsa04010	MAPK signaling pathway	7157	1	0.044835671	0.9415491	0.047077455
6966	hsa-mir-190b	hsa05200	Pathways in cancer	3716_5601_3065_1050_5925_2033_3326_2932_3265_8554_3725_6772_2353_1387_6256	15	1.56E-13	9.03E-12	9.03E-12
6967	hsa-mir-190b	hsa04630	Jak-STAT signaling pathway	3717_3716_3454_3455_7297_2033_8554_10379_6778_6772_1387	11	3.33E-12	1.93E-10	9.66E-11
6968	hsa-mir-190b	hsa05215	Prostate cancer	5925_2033_3326_468_2932_3265_1387	7	1.63E-08	9.44E-07	2.54E-07
6969	hsa-mir-190b	hsa05212	Pancreatic cancer	5925_2033_3326_468_2932_3265_1387	7	1.75E-08	1.02E-06	2.54E-07
6970	hsa-mir-190b	hsa04720	Long-term potentiation	2902_2906_2033_468_3265_1387	6	1.75E-07	1.02E-05	1.90E-06
6971	hsa-mir-190b	hsa04010	MAPK signaling pathway	5601_468_22800_3265_3725_3727_1649_2353_1386	9	1.97E-07	1.14E-05	1.90E-06
6972	hsa-mir-190b	hsa04620	Toll-like receptor signaling pathway	5601_3454_3455_3725_6772_2353	6	9.67E-07	5.61E-05	8.01E-06
6973	hsa-mir-190b	hsa05016	Huntington's disease	2902_3065_6874_2033_6667_1387_9519	7	2.20E-06	0.00012772	1.60E-05
6974	hsa-mir-190b	hsa03022	Basal transcription factors	6874_6883_2959_9519	4	7.27E-06	0.000421927	4.69E-05
6975	hsa-mir-190b	hsa04310	Wnt signaling pathway	5601_2033_2932_8061_3725_1387	6	8.79E-06	0.000509697	5.10E-05
6976	hsa-mir-190b	hsa04330	Notch signaling pathway	9612_3065_2033_1387	4	1.75E-05	0.001017405	9.25E-05
6977	hsa-mir-190b	hsa04660	T cell receptor signaling pathway	5601_2932_3265_3725_2353	5	2.67E-05	0.001550351	0.000129196
6978	hsa-mir-190b	hsa04110	Cell cycle	3065_5925_2033_2932_1387	5	3.84E-05	0.002226302	0.000171254
6979	hsa-mir-190b	hsa05211	Renal cell carcinoma	2033_3265_3725_1387	4	8.50E-05	0.004930663	0.00035219
6980	hsa-mir-190b	hsa04662	B cell receptor signaling pathway	2932_3265_3725_2353	4	9.89E-05	0.005734561	0.000382304
6981	hsa-mir-190b	hsa05210	Colorectal cancer	5601_2932_3725_2353	4	0.000150302	0.008717505	0.000544844
6982	hsa-mir-190b	hsa04012	ErbB signaling pathway	5601_2932_3265_3725	4	0.000171081	0.009922712	0.000583689
6983	hsa-mir-190b	hsa04916	Melanogenesis	2033_2932_3265_1387	4	0.000329888	0.019133502	0.001052615
6984	hsa-mir-190b	hsa04062	Chemokine signaling pathway	3717_7852_2932_3265_6772	5	0.000344822	0.019999687	0.001052615
6985	hsa-mir-190b	hsa04912	GnRH signaling pathway	5601_468_3265_3725	4	0.000378819	0.021971481	0.001098574
6986	hsa-mir-190b	hsa05223	Non-small cell lung cancer	5925_3265_6256	3	0.000695581	0.040343719	0.001921129
6987	hsa-mir-190b	hsa04920	Adipocytokine signaling pathway	3717_5601_6256	3	0.001264945	0.073366812	0.003334855
6988	hsa-mir-190b	hsa05220	Chronic myeloid leukemia	3065_5925_3265	3	0.001727632	0.100202653	0.004356637
6989	hsa-mir-190b	hsa05010	Alzheimer's disease	2902_2906_2932_351	4	0.002252256	0.130630871	0.005442953
6990	hsa-mir-190b	hsa05222	Small cell lung cancer	5925_8554_6256	3	0.002518009	0.146044545	0.00579818
6991	hsa-mir-190b	hsa04350	TGF-beta signaling pathway	2033_6667_1387	3	0.002599184	0.150752687	0.00579818
6992	hsa-mir-190b	hsa04510	Focal adhesion	5601_2932_3265_3725	4	0.003837441	0.222571572	0.008229354
6993	hsa-mir-190b	hsa05216	Thyroid cancer	3265_6256	2	0.003972791	0.230421903	0.008229354
6994	hsa-mir-190b	hsa05219	Bladder cancer	5925_3265	2	0.007879113	0.45698856	0.015246337
6995	hsa-mir-190b	hsa04360	Axon guidance	7852_2932_3265	3	0.007886036	0.457390109	0.015246337
6996	hsa-mir-190b	hsa04530	Tight junction	8573_22800_3265	3	0.008886372	0.51540955	0.015923603
6997	hsa-mir-190b	hsa04910	Insulin signaling pathway	5601_2932_3265	3	0.009059981	0.525478905	0.015923603
6998	hsa-mir-190b	hsa04650	Natural killer cell mediated cytotoxicity	3454_3455_3265	3	0.009059981	0.525478905	0.015923603
6999	hsa-mir-190b	hsa05213	Endometrial cancer	2932_3265	2	0.011688079	0.677908602	0.019938488
7000	hsa-mir-190b	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_2906	2	0.013396421	0.776992405	0.022199783
7001	hsa-mir-190b	hsa05221	Acute myeloid leukemia	1050_3265	2	0.014744443	0.855177722	0.023754937
7002	hsa-mir-190b	hsa05214	Glioma	5925_3265	2	0.017607354	1	0.027600717
7003	hsa-mir-190b	hsa05218	Melanoma	5925_3265	2	0.020685492	1	0.03076304
7004	hsa-mir-190b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5601_3725	2	0.020685492	1	0.03076304
7005	hsa-mir-190b	hsa04664	Fc epsilon RI signaling pathway	5601_3265	2	0.025109813	1	0.03633872
7006	hsa-mir-190b	hsa04520	Adherens junction	2033_1387	2	0.025687716	1	0.03633872
7007	hsa-mir-190b	hsa04512	ECM-receptor interaction	6383_9672	2	0.02805295	1	0.038739788
7008	hsa-mir-190b	hsa04080	Neuroactive ligand-receptor interaction	2902_2906_7067	3	0.044049387	1	0.059415453
7009	hsa-mir-190b	hsa04060	Cytokine-cytokine receptor interaction	7852_3454_3455	3	0.046597825	1	0.061424406
7010	hsa-mir-191	hsa05200	Pathways in cancer	1869_3725_4149_7046_5468_5914_595_2261_8517_7704_3551_6502_3091_3066_3065_1050_5925_5747_1956_1487_1488_1870_1871_2885_2113_10401_5894_861_207_3716_1147_5595_5594_5599_1387_2064_6256_836_367_2932_6774_6776_6777_6772_5879_7157_2736_4088_4089_9063_2034_2033_4846_4790_4791_4792_5970_3320_3326_5371_5159_5156_5604_5601_3815_4292_7428_4087_8772_4609_1029_2353_8554	73	2.51E-48	2.01E-46	2.01E-46
7011	hsa-mir-191	hsa04010	MAPK signaling pathway	6722_3725_4149_7046_6195_6197_2261_2264_8517_3551_1845_4773_9020_8986_1956_3303_1432_2885_5894_3305_4763_1616_207_1147_5595_5594_5599_5598_1386_836_9252_3312_5971_5879_7157_6196_9344_4790_4791_5970_5159_9261_1326_5156_5604_4208_5601_5600_5608_5566_6885_4609_5606_2353_7132_2005	56	8.86E-36	7.09E-34	3.55E-34
7012	hsa-mir-191	hsa05220	Chronic myeloid leukemia	1869_7046_595_8517_3551_3066_3065_5925_1487_1488_1870_1871_2885_5894_861_207_1147_5595_5594_6776_6777_7157_4088_4089_4790_4792_5970_5604_5781_4609_1029_6464	32	3.90E-29	3.12E-27	1.04E-27
7013	hsa-mir-191	hsa05215	Prostate cancer	1869_595_8517_3551_90993_5925_1956_1870_1871_2885_5894_207_1147_5595_5594_1387_2064_367_2932_7157_2033_4790_4792_5970_3320_3326_5159_5156_5604	29	6.24E-24	4.99E-22	1.25E-22
7014	hsa-mir-191	hsa05212	Pancreatic cancer	1869_595_8517_3551_90993_5925_1956_1870_1871_2885_5894_207_1147_5595_5594_1387_2064_367_2932_7157_2033_4790_4792_5970_3320_3326_5159_5156_5604	29	8.12E-24	6.50E-22	1.30E-22
7015	hsa-mir-191	hsa04620	Toll-like receptor signaling pathway	3725_8517_3551_3455_3661_1432_207_1147_29110_5595_5594_5599_6772_5879_4790_4792_5970_1326_5604_5601_5600_5608_9641_8772_6885_5606_2353	27	2.74E-20	2.19E-18	3.66E-19
7016	hsa-mir-191	hsa05221	Acute myeloid leukemia	5914_595_8517_7704_3551_1050_2885_5894_861_207_1147_5595_5594_6774_6776_6777_4790_5970_5371_5604_3815_4609	22	2.04E-19	1.63E-17	2.33E-18
7017	hsa-mir-191	hsa04310	Wnt signaling pathway	3725_818_817_595_8607_6500_4773_23291_1487_1488_8945_5599_1387_2932_5879_7157_8061_1457_1459_4088_4089_2033_5519_5515_5601_5566_8454_4087_6885_4609	30	2.86E-19	2.29E-17	2.86E-18
7018	hsa-mir-191	hsa05210	Colorectal cancer	3725_7046_595_1956_2885_5894_207_5595_5594_5599_836_2932_5879_7157_4088_4089_5159_5156_5604_5601_4292_4087_4609_2353	24	7.90E-19	6.32E-17	7.03E-18
7019	hsa-mir-191	hsa05214	Glioma	1869_818_817_595_5925_1956_1870_1871_2885_5894_207_5595_5594_7157_808_801_805_5159_5156_5604_1029_6464	22	1.12E-18	8.95E-17	8.95E-18
7020	hsa-mir-191	hsa04660	T cell receptor signaling pathway	3725_8517_3551_4773_9020_2534_3932_1432_4794_2885_5894_207_1147_5595_5594_2932_4790_4792_4793_5970_1326_5604_5601_5600_6885_2353	26	1.53E-18	1.22E-16	1.11E-17
7021	hsa-mir-191	hsa04110	Cell cycle	1869_595_6502_6500_4174_4172_3066_3065_5925_1870_1871_5933_990_5591_1387_2932_7157_5111_4088_4089_2033_983_8454_4087_1029_1111	26	8.14E-18	6.51E-16	5.43E-17
7022	hsa-mir-191	hsa04062	Chemokine signaling pathway	1234_8517_1230_3551_653361_7074_5747_5580_7852_2885_5894_207_3717_1147_5590_5595_5594_2932_6774_6777_6772_6773_5879_4790_4792_4793_5970_5604_5566_6464	30	9.82E-17	7.86E-15	6.05E-16
7023	hsa-mir-191	hsa05222	Small cell lung cancer	1869_4149_595_8517_3551_6502_5925_5747_1870_1871_10401_207_1147_6256_7157_9063_4846_4790_4792_5970_4609_8554	22	1.64E-16	1.31E-14	9.12E-16
7024	hsa-mir-191	hsa04662	B cell receptor signaling pathway	3725_8517_3551_4773_6850_4794_2885_5894_207_1147_695_5595_5594_2932_5879_4790_4792_4793_5970_5604_2353	21	1.71E-16	1.37E-14	9.12E-16
7025	hsa-mir-191	hsa04630	Jak-STAT signaling pathway	595_58985_3455_3459_3560_3561_1439_2885_10401_207_3717_3716_8651_1387_6778_6774_6776_6777_6772_6773_7297_9063_2033_5781_4609_8554_10379	27	2.80E-16	2.24E-14	1.40E-15
7026	hsa-mir-191	hsa04920	Adipocytokine signaling pathway	5465_8517_3551_7133_4794_8471_207_3717_1147_8717_5599_6256_6774_4790_4792_4793_5970_5601_5781_7132	20	3.19E-16	2.55E-14	1.50E-15
7027	hsa-mir-191	hsa04540	Gap junction	10382_51807_1956_6714_2885_5894_5592_5595_5594_5598_7846_347733_5159_983_5156_5604_5566_7277_7278_203068_10376	21	6.79E-15	5.43E-13	3.02E-14
7028	hsa-mir-191	hsa04912	GnRH signaling pathway	3725_818_817_5580_1956_6714_1432_2885_5894_5595_5594_5599_5598_808_801_805_5604_5601_5600_5608_5566_5606	22	9.81E-15	7.85E-13	4.13E-14
7029	hsa-mir-191	hsa05219	Bladder cancer	1869_595_2261_5925_1956_1870_1871_5894_5595_5594_2064_9252_7157_5604_4609_1029	16	1.32E-14	1.06E-12	5.29E-14
7030	hsa-mir-191	hsa04350	TGF-beta signaling pathway	7046_6500_90_57154_6667_3397_3399_3398_5933_5595_5594_1387_4088_4089_2033_5519_5515_8454_4087_4609	20	2.24E-14	1.79E-12	8.13E-14
7031	hsa-mir-191	hsa04012	ErbB signaling pathway	3725_818_817_5747_1956_6714_2885_5894_207_5595_5594_5599_2064_2932_6776_6777_5604_5601_4609_6464	20	2.24E-14	1.79E-12	8.13E-14
7032	hsa-mir-191	hsa05223	Non-small cell lung cancer	1869_595_5925_1956_1870_1871_2885_5894_207_5595_5594_2064_6256_7157_5604_1029	16	3.31E-13	2.64E-11	1.15E-12
7033	hsa-mir-191	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_8517_3551_9020_1956_6714_1432_1147_5599_836_5879_4790_4792_5970_5601_5600_5781	17	1.14E-12	9.11E-11	3.80E-12
7034	hsa-mir-191	hsa04720	Long-term potentiation	818_814_817_6195_6197_2902_5894_5595_5594_1387_6196_2033_808_801_805_5604_5566	17	2.44E-12	1.95E-10	7.80E-12
7035	hsa-mir-191	hsa04664	Fc epsilon RI signaling pathway	2534_5580_6850_1432_2885_5894_207_695_5595_5594_5599_5879_5604_5601_5600_5608_5606	17	5.01E-12	4.01E-10	1.54E-11
7036	hsa-mir-191	hsa04520	Adherens junction	7046_2534_1956_6714_71_5595_5594_1387_2064_5879_1457_1459_4088_4089_2033_4087_6885	17	5.97E-12	4.78E-10	1.77E-11
7037	hsa-mir-191	hsa04210	Apoptosis	8517_3551_9020_1439_207_1147_8717_836_7157_9131_4790_4792_5970_5566_840_8772_7132	17	2.62E-11	2.10E-09	7.49E-11
7038	hsa-mir-191	hsa05218	Melanoma	1869_595_5925_1956_1870_1871_5894_207_5595_5594_7157_5159_5156_5604_1029	15	1.13E-10	9.04E-09	3.12E-10
7039	hsa-mir-191	hsa05211	Renal cell carcinoma	3725_3091_2885_2113_5894_207_5595_5594_1387_5879_2034_2033_5604_7428_5781	15	1.34E-10	1.07E-08	3.58E-10
7040	hsa-mir-191	hsa04510	Focal adhesion	3725_595_2534_5747_3791_1956_6714_2885_5894_207_71_5595_5594_5599_2064_2932_5879_2321_5159_5156_5604_5601_6464	23	1.67E-10	1.34E-08	4.32E-10
7041	hsa-mir-191	hsa04910	Insulin signaling pathway	6720_3551_2885_5894_8471_207_8651_5590_5595_5594_5599_2932_808_801_805_5604_5601_5566_6464	19	2.75E-10	2.20E-08	6.89E-10
7042	hsa-mir-191	hsa05213	Endometrial cancer	595_1956_2885_5894_207_5595_5594_2064_2932_7157_5604_4292_4609	13	3.32E-10	2.66E-08	8.05E-10
7043	hsa-mir-191	hsa04120	Ubiquitin mediated proteolysis	55294_4734_6502_6500_57154_23291_10401_8945_51366_11059_8651_9063_7329_5371_672_8454_7428_8554	18	1.96E-09	1.57E-07	4.62E-09
7044	hsa-mir-191	hsa04370	VEGF signaling pathway	4773_5747_3791_6714_1432_5894_207_5595_5594_5879_4846_9261_5604_5600	14	2.63E-09	2.10E-07	6.00E-09
7045	hsa-mir-191	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_7133_1432_1616_836_5879_7157_4846_5600_5608_5606_7132	12	7.22E-09	5.77E-07	1.60E-08
7046	hsa-mir-191	hsa04916	Melanogenesis	818_817_90993_5894_5595_5594_1387_2932_2033_808_801_805_5604_5566_3815	15	1.19E-08	9.51E-07	2.57E-08
7047	hsa-mir-191	hsa05016	Huntington's disease	5468_292_293_90993_3066_3065_3064_498_2902_6667_1387_836_5437_7157_1213_2033_6874_6908_5441	19	2.84E-08	2.27E-06	5.97E-08
7048	hsa-mir-191	hsa05131	Shigellosis	10382_51807_2534_71_7846_347733_7277_7278_4691_203068_10376	11	6.70E-08	5.36E-06	1.34E-07
7049	hsa-mir-191	hsa05130	Pathogenic Escherichia coli infection	10382_51807_2534_71_7846_347733_7277_7278_4691_203068_10376	11	6.70E-08	5.36E-06	1.34E-07
7050	hsa-mir-191	hsa04930	Type II diabetes mellitus	3551_5580_8471_3651_8651_5590_5595_5594_5599_5601	10	9.71E-08	7.77E-06	1.89E-07
7051	hsa-mir-191	hsa04330	Notch signaling pathway	9612_3066_3065_1487_1488_1387_2033_8850_2648_4851	10	1.38E-07	1.11E-05	2.64E-07
7052	hsa-mir-191	hsa03022	Basal transcription factors	6872_2963_2962_2969_6878_6874_6908_6882_2959	9	2.20E-07	1.76E-05	4.10E-07
7053	hsa-mir-191	hsa04650	Natural killer cell mediated cytotoxicity	3455_3459_4773_2534_3932_6850_2885_5894_5595_5594_836_5879_5604_5781_6464	15	3.47E-07	2.78E-05	6.31E-07
7054	hsa-mir-191	hsa05216	Thyroid cancer	5468_595_5595_5594_6256_7157_5604_4609	8	4.64E-07	3.71E-05	8.25E-07
7055	hsa-mir-191	hsa04020	Calcium signaling pathway	818_814_817_292_293_147_1956_2902_2064_4846_808_801_805_5159_5156_5566	16	2.19E-06	0.000175471	3.81E-06
7056	hsa-mir-191	hsa04060	Cytokine-cytokine receptor interaction	7046_1234_1230_58985_3455_3459_90_3791_1956_3560_3561_7133_1439_7852_2321_5159_5156_3815_7132	19	3.14E-06	0.000250895	5.34E-06
7057	hsa-mir-191	hsa05010	Alzheimer's disease	498_2902_6622_1020_5595_5594_836_2932_4846_808_801_805_840_8772_7132	15	6.05E-06	0.000484262	1.01E-05
7058	hsa-mir-191	hsa04270	Vascular smooth muscle contraction	147_5580_5894_5592_5595_5594_808_801_805_5604_5566	11	4.68E-05	0.003742459	7.64E-05
7059	hsa-mir-191	hsa03020	RNA polymerase	25885_51082_64425_5437_84172_5441	6	5.35E-05	0.004277804	8.56E-05
7060	hsa-mir-191	hsa04810	Regulation of actin cytoskeleton	2261_2264_10788_7074_5747_1956_4628_5894_71_5595_5594_5879_5159_5156_5604	15	6.18E-05	0.00494795	9.70E-05
7061	hsa-mir-191	hsa04612	Antigen processing and presentation	3309_3303_3305_3312_3320_3326_4800_4801_4802	9	0.000128451	0.010276077	0.000197617
7062	hsa-mir-191	hsa04150	mTOR signaling pathway	6195_6197_3091_207_5595_5594_6196	7	0.000145802	0.011664158	0.000220078
7063	hsa-mir-191	hsa04730	Long-term depression	5894_5592_5595_5594_4846_5519_5515_5604	8	0.000153246	0.012259708	0.000227032
7064	hsa-mir-191	hsa04530	Tight junction	5580_6714_4628_207_71_5590_1457_1459_5519_5515	10	0.000638828	0.051106208	0.000929204
7065	hsa-mir-191	hsa04115	p53 signaling pathway	595_836_7157_983_7161_1029_1111	7	0.000703236	0.056258856	0.001004622
7066	hsa-mir-191	hsa03010	Ribosome	6155_6156_6207_9349_6141_6217_6128_6188	8	0.0014248	0.113984024	0.00199972
7067	hsa-mir-191	hsa04360	Axon guidance	4773_2534_5747_7852_1020_5595_5594_2932_5879	9	0.001744441	0.139555271	0.002406125
7068	hsa-mir-191	hsa04670	Leukocyte transendothelial migration	653361_5747_1432_7852_71_5879_5600_5781	8	0.004036849	0.322947912	0.005473693
7069	hsa-mir-191	hsa05340	Primary immunodeficiency	8517_3932_3561_695	4	0.006833899	0.546711925	0.009111865
7070	hsa-mir-191	hsa04340	Hedgehog signaling pathway	23291_8945_2932_2736_5566	5	0.007165751	0.573260049	0.009397706
7071	hsa-mir-191	hsa03030	DNA replication	5981_4174_4172_5111	4	0.007478417	0.598273336	0.00964957
7072	hsa-mir-191	hsa03430	Mismatch repair	5981_5111_4292	3	0.013705098	1	0.017403299
7073	hsa-mir-191	hsa03410	Base excision repair	3146_142_5111	3	0.040045578	1	0.050056972
7074	hsa-mir-1910	hsa05220	Chronic myeloid leukemia	3066_1870_1871_7157_4193_4609_1029	7	4.03E-13	1.37E-11	1.37E-11
7075	hsa-mir-1910	hsa05219	Bladder cancer	1870_1871_7157_4193_4609_1029	6	2.09E-12	7.10E-11	3.55E-11
7076	hsa-mir-1910	hsa04110	Cell cycle	3066_1870_1871_7157_2033_4193_1029	7	8.74E-12	2.97E-10	9.91E-11
7077	hsa-mir-1910	hsa05215	Prostate cancer	1870_1871_7157_2033_4193_1385	6	1.35E-10	4.60E-09	9.81E-10
7078	hsa-mir-1910	hsa05212	Pancreatic cancer	1870_1871_7157_2033_4193_1385	6	1.44E-10	4.90E-09	9.81E-10
7079	hsa-mir-1910	hsa05200	Pathways in cancer	3066_1870_1871_7157_2033_4193_4609_1029	8	2.28E-10	7.74E-09	1.29E-09
7080	hsa-mir-1910	hsa05214	Glioma	1870_1871_7157_4193_1029	5	3.05E-09	1.04E-07	1.48E-08
7081	hsa-mir-1910	hsa05218	Melanoma	1870_1871_7157_4193_1029	5	4.64E-09	1.58E-07	1.97E-08
7082	hsa-mir-1910	hsa05223	Non-small cell lung cancer	1870_1871_7157_1029	4	1.54E-07	5.23E-06	5.81E-07
7083	hsa-mir-1910	hsa05016	Huntington's disease	3066_7157_6667_2033_1385	5	4.99E-07	1.70E-05	1.70E-06
7084	hsa-mir-1910	hsa05222	Small cell lung cancer	1870_1871_7157_4609	4	9.10E-07	3.09E-05	2.81E-06
7085	hsa-mir-1910	hsa04330	Notch signaling pathway	3066_2033_4851	3	9.74E-06	0.000331123	2.76E-05
7086	hsa-mir-1910	hsa04115	p53 signaling pathway	7157_4193_1029	3	2.93E-05	0.000995455	7.66E-05
7087	hsa-mir-1910	hsa04350	TGF-beta signaling pathway	6667_2033_4609	3	5.71E-05	0.001941574	0.000138684
7088	hsa-mir-1910	hsa04310	Wnt signaling pathway	7157_2033_4609	3	0.000285499	0.009706957	0.00064713
7089	hsa-mir-1910	hsa05216	Thyroid cancer	7157_4609	2	0.000304946	0.010368147	0.000648009
7090	hsa-mir-1910	hsa05213	Endometrial cancer	7157_4609	2	0.0009275	0.031535016	0.001855001
7091	hsa-mir-1910	hsa04010	MAPK signaling pathway	7157_4609_1386	3	0.001521354	0.051726038	0.002873669
7092	hsa-mir-1910	hsa05210	Colorectal cancer	7157_4609	2	0.002330672	0.079242863	0.004170677
7093	hsa-mir-1910	hsa04916	Melanogenesis	2033_1385	2	0.003512677	0.119431022	0.005971551
7094	hsa-mir-1910	hsa04120	Ubiquitin mediated proteolysis	4193_672	2	0.006120155	0.208085273	0.009908823
7095	hsa-mir-1910	hsa04630	Jak-STAT signaling pathway	2033_4609	2	0.007532003	0.256088112	0.011640369
7096	hsa-mir-1910	hsa03022	Basal transcription factors	2969	1	0.031176672	1	0.046087254
7097	hsa-mir-1910	hsa05217	Basal cell carcinoma	7157	1	0.045616816	1	0.063121623
7098	hsa-mir-1910	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157	1	0.046412958	1	0.063121623
7099	hsa-mir-1910	hsa05221	Acute myeloid leukemia	4609	1	0.048797561	1	0.063812195
7100	hsa-mir-1915	hsa05200	Pathways in cancer	3551_1398_7046_1499_595_1019_1017_8517_6502_3091_2736_4087_1050_5925_7189_7186_25_1956_862_867_207_4286_3716_1147_5595_5594_5599_6258_1387_6257_6256_9915_367_2932_6774_6777_6772_5970_7157_6688_3725_4088_4089_5881_2034_2033_898_4790_4791_4792_5371_675_5159_5156_1399_3815_841_51588_8031_4609_1026_2353_8554	63	1.05E-41	8.47E-40	8.47E-40
7101	hsa-mir-1915	hsa04010	MAPK signaling pathway	6722_3551_1398_7046_6195_6197_8517_9252_7867_4773_9020_4616_7189_7186_1956_3303_1432_207_1147_5595_5594_5599_1386_3312_1649_5971_5970_7157_10912_468_3725_6196_5881_4790_4791_5159_9261_1326_5156_4208_1399_4609_2353_8986	44	9.62E-27	7.79E-25	3.90E-25
7102	hsa-mir-1915	hsa05220	Chronic myeloid leukemia	3551_1398_7046_595_1019_8517_5925_25_867_207_1147_5595_5594_6777_5970_7157_4088_4089_4790_4792_1399_5781_4609_1026_6464	25	3.21E-22	2.60E-20	8.67E-21
7103	hsa-mir-1915	hsa05215	Prostate cancer	3551_1499_595_1017_8517_5925_1956_207_1147_5595_5594_1387_367_2932_5970_7157_468_2033_898_4790_4792_5159_5156_1026	24	1.12E-19	9.11E-18	2.28E-18
7104	hsa-mir-1915	hsa05212	Pancreatic cancer	3551_1499_595_1017_8517_5925_1956_207_1147_5595_5594_1387_367_2932_5970_7157_468_2033_898_4790_4792_5159_5156_1026	24	1.41E-19	1.14E-17	2.28E-18
7105	hsa-mir-1915	hsa04110	Cell cycle	595_1019_1017_6502_6500_4087_4616_5925_25_5933_993_1387_2932_7027_7157_10912_4088_4089_2033_891_894_896_898_983_8454_1026	26	3.86E-19	3.13E-17	5.22E-18
7106	hsa-mir-1915	hsa04660	T cell receptor signaling pathway	3551_1019_8517_4773_9020_1493_3932_1432_867_207_1147_5595_5594_2932_5970_3725_4794_4790_4792_4793_1326_919_1739_2353	24	9.35E-18	7.57E-16	1.08E-16
7107	hsa-mir-1915	hsa05222	Small cell lung cancer	3551_595_1019_1017_8517_6502_5925_7189_7186_207_1147_6258_6257_6256_5970_7157_898_4790_4792_51588_4609_8554	22	1.21E-17	9.82E-16	1.23E-16
7108	hsa-mir-1915	hsa04350	TGF-beta signaling pathway	6667_7046_6500_4087_3397_3399_3398_1874_658_5933_5595_5594_1387_7027_4086_4088_4089_2033_5515_4093_8454_4609	22	1.50E-17	1.21E-15	1.35E-16
7109	hsa-mir-1915	hsa04620	Toll-like receptor signaling pathway	3551_8517_4615_7189_3661_1432_207_1147_3654_5595_5594_5599_6772_5970_3725_4790_4792_1326_353376_148022_9641_841_2353	23	2.41E-17	1.96E-15	1.96E-16
7110	hsa-mir-1915	hsa04920	Adipocytokine signaling pathway	3717_3551_10891_8517_7186_207_1147_5599_6258_6257_6256_6774_5970_4794_4790_4792_4793_5781	18	5.41E-15	4.38E-13	3.98E-14
7111	hsa-mir-1915	hsa05221	Acute myeloid leukemia	3551_595_8517_1050_862_207_1147_5595_5594_6774_6777_5970_6688_4790_5371_3815_4609	17	1.17E-14	9.48E-13	7.90E-14
7112	hsa-mir-1915	hsa05210	Colorectal cancer	7046_1499_595_4087_1956_207_5595_5594_5599_2932_7157_3725_4088_4089_5881_5159_5156_4609_2353	19	1.40E-14	1.13E-12	8.70E-14
7113	hsa-mir-1915	hsa04662	B cell receptor signaling pathway	3551_8517_4773_6850_207_1147_695_5595_5594_2932_5970_3725_5881_4794_4790_4792_4793_2353	18	2.88E-14	2.33E-12	1.66E-13
7114	hsa-mir-1915	hsa04630	Jak-STAT signaling pathway	3717_595_3560_3561_2057_867_2690_207_3716_3718_1387_3575_6774_6777_6772_2033_894_896_51588_5781_4609_85480_8554	23	6.91E-14	5.60E-12	3.73E-13
7115	hsa-mir-1915	hsa04310	Wnt signaling pathway	1499_595_6500_4087_4773_23291_1460_5599_1387_2932_7157_3725_1457_4088_4089_5881_2033_894_896_5515_8454_4609	22	3.81E-13	3.08E-11	1.93E-12
7116	hsa-mir-1915	hsa04520	Adherens junction	7046_1499_5770_4087_1956_6714_4301_1460_5595_5594_1387_1457_4088_4089_5881_2033_3643	17	8.30E-13	6.72E-11	3.95E-12
7117	hsa-mir-1915	hsa04012	ErbB signaling pathway	1398_25_1956_6714_867_207_5595_5594_5599_2066_2932_6777_3725_1399_4609_1026_6464	17	2.70E-12	2.19E-10	1.21E-11
7118	hsa-mir-1915	hsa05214	Glioma	595_1019_5925_1956_207_5595_5594_7157_808_801_805_5159_5156_1026_6464	15	6.65E-12	5.39E-10	2.84E-11
7119	hsa-mir-1915	hsa05216	Thyroid cancer	1499_595_5595_5594_6258_6257_6256_7157_8031_4609	10	8.45E-10	6.85E-08	3.42E-09
7120	hsa-mir-1915	hsa04062	Chemokine signaling pathway	3717_3551_1398_8517_207_1147_3718_5595_5594_1234_2932_6774_6777_6772_5970_4790_4792_4793_1399_6464	20	1.01E-09	8.18E-08	3.90E-09
7121	hsa-mir-1915	hsa04115	p53 signaling pathway	595_1019_1017_4616_7157_10912_891_894_896_898_983_841_1026	13	1.50E-09	1.22E-07	5.54E-09
7122	hsa-mir-1915	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3551_8517_9020_1956_6714_1432_1147_5599_5970_3725_4790_4792_5781	13	2.05E-09	1.66E-07	7.20E-09
7123	hsa-mir-1915	hsa04910	Insulin signaling pathway	3551_10891_1398_5770_867_207_5595_5594_5599_2932_808_801_805_3643_1399_6464	16	1.13E-08	9.13E-07	3.81E-08
7124	hsa-mir-1915	hsa05223	Non-small cell lung cancer	595_1019_5925_1956_207_5595_5594_6258_6257_6256_7157	11	1.36E-08	1.10E-06	4.40E-08
7125	hsa-mir-1915	hsa04510	Focal adhesion	1398_1499_595_1956_6714_207_5595_5594_5599_2932_1729_3725_5881_894_896_5159_5156_1399_6464	19	1.52E-08	1.23E-06	4.73E-08
7126	hsa-mir-1915	hsa05219	Bladder cancer	595_1019_9252_5925_1956_5595_5594_7157_4609_1026	10	1.72E-08	1.39E-06	5.17E-08
7127	hsa-mir-1915	hsa05218	Melanoma	595_1019_5925_1956_207_4286_5595_5594_7157_5159_5156_1026	12	1.89E-08	1.53E-06	5.47E-08
7128	hsa-mir-1915	hsa05211	Renal cell carcinoma	1398_3091_207_5595_5594_1387_9915_3725_2034_2033_1399_5781	12	2.17E-08	1.76E-06	6.07E-08
7129	hsa-mir-1915	hsa04210	Apoptosis	3551_8517_9020_4615_7186_207_1147_3654_5970_7157_4790_4792_841	13	2.31E-08	1.87E-06	6.23E-08
7130	hsa-mir-1915	hsa04720	Long-term potentiation	6195_6197_5595_5594_1387_468_6196_2033_808_801_805	11	2.68E-07	2.17E-05	7.01E-07
7131	hsa-mir-1915	hsa04120	Ubiquitin mediated proteolysis	55294_6502_6500_7189_23291_867_7325_7329_11059_5371_672_8454_51588_8554	14	4.50E-07	3.65E-05	1.14E-06
7132	hsa-mir-1915	hsa05213	Endometrial cancer	1499_595_1956_207_5595_5594_2932_7157_4609	9	9.64E-07	7.81E-05	2.37E-06
7133	hsa-mir-1915	hsa04916	Melanogenesis	1499_4286_5595_5594_1387_2932_2033_808_801_805_3815	11	4.99E-06	0.000404158	1.19E-05
7134	hsa-mir-1915	hsa04912	GnRH signaling pathway	1956_6714_1432_5595_5594_5599_468_3725_808_801_805	11	6.95E-06	0.000563061	1.61E-05
7135	hsa-mir-1915	hsa05016	Huntington's disease	6667_10891_1537_3064_25942_4716_5441_1387_5437_7157_2033_6908_841_4724	14	1.19E-05	0.000965821	2.68E-05
7136	hsa-mir-1915	hsa04370	VEGF signaling pathway	7867_4773_6714_1432_207_5595_5594_5881_9261	9	1.75E-05	0.001416014	3.83E-05
7137	hsa-mir-1915	hsa03020	RNA polymerase	64425_25885_51082_5441_5437_84172	6	2.67E-05	0.002164939	5.70E-05
7138	hsa-mir-1915	hsa04330	Notch signaling pathway	388585_1387_9612_2033_8850_2648_4851	7	3.76E-05	0.003049415	7.82E-05
7139	hsa-mir-1915	hsa04150	mTOR signaling pathway	6195_6197_3091_207_5595_5594_6196	7	6.73E-05	0.005455222	0.000134047
7140	hsa-mir-1915	hsa05340	Primary immunodeficiency	8517_3932_3561_3718_695_3575	6	6.79E-05	0.005495944	0.000134047
7141	hsa-mir-1915	hsa04950	Maturity onset diabetes of the young	6928_6927_3651_168620_3172	5	0.000124636	0.010095513	0.000240369
7142	hsa-mir-1915	hsa04664	Fc epsilon RI signaling pathway	6850_1432_207_695_5595_5594_5599_5881	8	0.000129064	0.010454159	0.000242217
7143	hsa-mir-1915	hsa03010	Ribosome	6156_6207_6143_6222_6124_6129_6128_6130_6231	9	0.000131575	0.010657556	0.000242217
7144	hsa-mir-1915	hsa04930	Type II diabetes mellitus	3551_3651_5595_5594_5599_3643	6	0.00023506	0.019039838	0.000423108
7145	hsa-mir-1915	hsa04540	Gap junction	1956_6714_5592_5595_5594_5159_983_5156	8	0.000362165	0.029335328	0.000637725
7146	hsa-mir-1915	hsa04530	Tight junction	1499_1019_10207_6714_207_4301_1460_1457_5515	9	0.000992989	0.080432113	0.001711322
7147	hsa-mir-1915	hsa04650	Natural killer cell mediated cytotoxicity	4773_3932_6850_5595_5594_5881_919_5781_6464	9	0.001041996	0.084401646	0.001724613
7148	hsa-mir-1915	hsa04060	Cytokine-cytokine receptor interaction	7046_1956_3560_3561_2057_658_2690_1234_3575_5159_5156_3815_85480	13	0.001043284	0.084506042	0.001724613
7149	hsa-mir-1915	hsa05010	Alzheimer's disease	1537_4716_5595_5594_2932_808_801_805_841_4724	10	0.001565386	0.126796306	0.002535926
7150	hsa-mir-1915	hsa03022	Basal transcription factors	2963_2969_6908_2959	4	0.005295905	0.428968268	0.008411143
7151	hsa-mir-1915	hsa04810	Regulation of actin cytoskeleton	1398_1956_5595_5594_1729_5881_5159_5156_1399_10788	10	0.006605582	0.535052146	0.010289464
7152	hsa-mir-1915	hsa04360	Axon guidance	4773_25_5998_5595_5594_2932_5881	7	0.0100713	0.81577532	0.015391987
7153	hsa-mir-1915	hsa05217	Basal cell carcinoma	1499_2736_2932_7157	4	0.018707275	1	0.028060913
7154	hsa-mir-1915	hsa04270	Vascular smooth muscle contraction	5592_5595_5594_808_801_805	6	0.020521057	1	0.03022192
7155	hsa-mir-1915	hsa04612	Antigen processing and presentation	3303_3312_1514_4800_4802	5	0.023251727	1	0.033631962
7156	hsa-mir-1915	hsa03320	PPAR signaling pathway	2168_6258_6257_6256	4	0.038781729	1	0.055110878
7157	hsa-mir-1915	hsa04730	Long-term depression	5592_5595_5594_5515	4	0.040431196	1	0.056464256
7158	hsa-mir-1915	hsa04020	Calcium signaling pathway	1956_2066_808_801_805_5159_5156	7	0.047895187	1	0.065754409
7159	hsa-mir-192	hsa05200	Pathways in cancer	3320_4149_5371_4292_7046_5595_5599_1387_5604_1487_2932_6502_6772_5970_4088_5894_1029_4087_1050_5925_2033	21	1.10E-20	6.50E-19	6.50E-19
7160	hsa-mir-192	hsa04110	Cell cycle	990_1387_983_2932_8454_6502_6500_4088_1029_4087_5925_2033_5933	13	5.45E-16	3.21E-14	1.61E-14
7161	hsa-mir-192	hsa04350	TGF-beta signaling pathway	7046_5595_1387_6667_8454_6500_4088_4087_2033_5933	10	9.23E-13	5.45E-11	1.82E-11
7162	hsa-mir-192	hsa04540	Gap junction	5595_5598_983_5604_7277_7278_10376_5894_7846_51807	10	1.70E-12	1.01E-10	2.51E-11
7163	hsa-mir-192	hsa04310	Wnt signaling pathway	5599_1387_1487_2932_8454_6500_4088_1457_1459_4087_2033	11	6.98E-12	4.12E-10	8.24E-11
7164	hsa-mir-192	hsa05220	Chronic myeloid leukemia	7046_5595_5604_1487_5970_4088_5894_1029_5925	9	9.33E-12	5.50E-10	9.17E-11
7165	hsa-mir-192	hsa04520	Adherens junction	4301_7046_5595_1387_4088_1457_1459_4087_2033	9	1.59E-11	9.38E-10	1.34E-10
7166	hsa-mir-192	hsa05210	Colorectal cancer	4292_7046_5595_5599_5604_2932_4088_5894_4087	9	2.38E-11	1.40E-09	1.75E-10
7167	hsa-mir-192	hsa05215	Prostate cancer	3320_5595_1387_5604_2932_5970_5894_5925_2033	9	3.50E-11	2.06E-09	2.27E-10
7168	hsa-mir-192	hsa05212	Pancreatic cancer	3320_5595_1387_5604_2932_5970_5894_5925_2033	9	3.84E-11	2.27E-09	2.27E-10
7169	hsa-mir-192	hsa05131	Shigellosis	7277_7278_10376_7846_51807_4691	6	5.75E-08	3.39E-06	2.83E-07
7170	hsa-mir-192	hsa05130	Pathogenic Escherichia coli infection	7277_7278_10376_7846_51807_4691	6	5.75E-08	3.39E-06	2.83E-07
7171	hsa-mir-192	hsa05221	Acute myeloid leukemia	5371_5595_5604_5970_5894_1050	6	7.67E-08	4.52E-06	3.48E-07
7172	hsa-mir-192	hsa04010	MAPK signaling pathway	4149_7046_5595_5599_5598_5604_1386_5970_5894	9	4.06E-07	2.39E-05	1.71E-06
7173	hsa-mir-192	hsa05219	Bladder cancer	5595_5604_5894_1029_5925	5	4.78E-07	2.82E-05	1.88E-06
7174	hsa-mir-192	hsa05213	Endometrial cancer	4292_5595_5604_2932_5894	5	1.27E-06	7.50E-05	4.69E-06
7175	hsa-mir-192	hsa05223	Non-small cell lung cancer	5595_5604_5894_1029_5925	5	1.51E-06	8.92E-05	5.25E-06
7176	hsa-mir-192	hsa04916	Melanogenesis	5595_1387_5604_2932_5894_2033	6	1.77E-06	0.000104152	5.79E-06
7177	hsa-mir-192	hsa05214	Glioma	5595_5604_5894_1029_5925	5	3.55E-06	0.000209553	1.10E-05
7178	hsa-mir-192	hsa04062	Chemokine signaling pathway	5595_5604_2932_6772_5970_5894_7074	7	4.57E-06	0.000269771	1.35E-05
7179	hsa-mir-192	hsa05218	Melanoma	5595_5604_5894_1029_5925	5	5.34E-06	0.000314928	1.50E-05
7180	hsa-mir-192	hsa05211	Renal cell carcinoma	5595_1387_5604_5894_2033	5	5.69E-06	0.000335924	1.53E-05
7181	hsa-mir-192	hsa04720	Long-term potentiation	5595_1387_5604_5894_2033	5	6.87E-06	0.000405558	1.69E-05
7182	hsa-mir-192	hsa04662	B cell receptor signaling pathway	5595_5604_2932_5970_5894	5	6.87E-06	0.000405558	1.69E-05
7183	hsa-mir-192	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_8454_6502_6500	6	8.73E-06	0.000515311	2.06E-05
7184	hsa-mir-192	hsa04012	ErbB signaling pathway	5595_5599_5604_2932_5894	5	1.36E-05	0.000804176	3.09E-05
7185	hsa-mir-192	hsa04330	Notch signaling pathway	1387_1487_2033_2648	4	2.44E-05	0.001441726	5.34E-05
7186	hsa-mir-192	hsa04620	Toll-like receptor signaling pathway	5595_5599_5604_6772_5970	5	2.83E-05	0.001672071	5.97E-05
7187	hsa-mir-192	hsa04912	GnRH signaling pathway	5595_5599_5598_5604_5894	5	3.68E-05	0.002173636	7.50E-05
7188	hsa-mir-192	hsa04660	T cell receptor signaling pathway	5595_5604_2932_5970_5894	5	4.01E-05	0.002364386	7.88E-05
7189	hsa-mir-192	hsa04910	Insulin signaling pathway	5595_5599_5604_2932_5894	5	0.000112753	0.006652447	0.000214595
7190	hsa-mir-192	hsa04664	Fc epsilon RI signaling pathway	5595_5599_5604_5894	4	0.000165789	0.009781558	0.000305674
7191	hsa-mir-192	hsa05222	Small cell lung cancer	4149_6502_5970_5925	4	0.00022651	0.013364096	0.000404973
7192	hsa-mir-192	hsa03022	Basal transcription factors	2962_2969_6908	3	0.000312163	0.01841764	0.000541695
7193	hsa-mir-192	hsa04510	Focal adhesion	5595_5599_5604_2932_5894	5	0.000676894	0.039936728	0.001141049
7194	hsa-mir-192	hsa04115	p53 signaling pathway	983_7161_1029	3	0.001746279	0.103030439	0.002861957
7195	hsa-mir-192	hsa04730	Long-term depression	5595_5604_5894	3	0.001889083	0.111455911	0.003012322
7196	hsa-mir-192	hsa04370	VEGF signaling pathway	5595_5604_5894	3	0.002360464	0.139267358	0.00366493
7197	hsa-mir-192	hsa04612	Antigen processing and presentation	3320_4801_4802	3	0.003506845	0.206903841	0.005305227
7198	hsa-mir-192	hsa05016	Huntington's disease	1387_6908_6667_2033	4	0.003769328	0.22239036	0.005559759
7199	hsa-mir-192	hsa05216	Thyroid cancer	5595_5604	2	0.004679807	0.27610859	0.006734356
7200	hsa-mir-192	hsa04810	Regulation of actin cytoskeleton	5595_5604_5894_7074	4	0.006378731	0.376345121	0.008960598
7201	hsa-mir-192	hsa04270	Vascular smooth muscle contraction	5595_5604_5894	3	0.007509714	0.443073125	0.010304026
7202	hsa-mir-192	hsa04930	Type II diabetes mellitus	5595_5599	2	0.010514518	0.620356541	0.014099012
7203	hsa-mir-192	hsa04530	Tight junction	4301_1457_1459	3	0.011161414	0.658523447	0.014592619
7204	hsa-mir-192	hsa04650	Natural killer cell mediated cytotoxicity	5595_5604_5894	3	0.011377297	0.671260497	0.014592619
7205	hsa-mir-192	hsa04630	Jak-STAT signaling pathway	1387_6772_2033	3	0.015418392	0.909685121	0.019355003
7206	hsa-mir-192	hsa04920	Adipocytokine signaling pathway	5599_5970	2	0.021778312	1	0.026769175
7207	hsa-mir-192	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5970	2	0.024190725	1	0.029127607
7208	hsa-mir-193a	hsa05200	Pathways in cancer	3320_3326_4149_5371_1499_5595_5594_5599_5914_1387_6257_6256_862_595_1870_5604_9915_6258_367_2932_861_7704_6502_4292_3091_3265_5970_7428_1871_7157_2113_5894_4609_1869_3725_4286_1029_4087_4088_4089_3066_3065_1050_5925_8031_2034_2033_4846_8554_836	50	2.09E-38	1.48E-36	1.48E-36
7209	hsa-mir-193a	hsa04110	Cell cycle	990_5591_1387_595_1870_983_2932_8454_6502_6500_4616_1871_7157_10912_1869_1029_4087_4088_4089_3066_3065_5925_2033_5933	24	1.61E-21	1.14E-19	5.72E-20
7210	hsa-mir-193a	hsa05220	Chronic myeloid leukemia	5595_5594_595_1870_5604_861_3265_5970_1871_7157_5894_4609_1869_1029_4088_4089_3066_3065_5925_6464	20	3.33E-20	2.37E-18	7.89E-19
7211	hsa-mir-193a	hsa05215	Prostate cancer	3320_3326_1499_5595_5594_1387_595_1870_5604_367_2932_3265_5970_1871_7157_5894_1869_5925_2033	19	8.92E-18	6.33E-16	1.52E-16
7212	hsa-mir-193a	hsa05212	Pancreatic cancer	3320_3326_1499_5595_5594_1387_595_1870_5604_367_2932_3265_5970_1871_7157_5894_1869_5925_2033	19	1.07E-17	7.61E-16	1.52E-16
7213	hsa-mir-193a	hsa05214	Glioma	5595_5594_595_1870_5604_3265_808_1871_7157_5894_1869_1029_5925_6464_801_805	16	6.01E-16	4.27E-14	7.11E-15
7214	hsa-mir-193a	hsa05223	Non-small cell lung cancer	5595_5594_6257_6256_595_1870_5604_6258_3265_1871_7157_5894_1869_1029_5925	15	1.07E-15	7.61E-14	1.09E-14
7215	hsa-mir-193a	hsa04350	TGF-beta signaling pathway	5518_5595_5594_1387_4093_6667_8454_3399_6500_4609_3397_3398_4087_4088_4089_2033_5933	17	2.08E-15	1.47E-13	1.84E-14
7216	hsa-mir-193a	hsa04010	MAPK signaling pathway	6722_4149_5595_5594_5599_5598_1386_5604_4208_7867_1432_4616_3265_5970_9261_3312_7157_10912_5894_4609_3725_4763_22800_836_1616	25	5.29E-15	3.76E-13	4.18E-14
7217	hsa-mir-193a	hsa05216	Thyroid cancer	1499_5595_5594_6257_6256_595_5604_6258_3265_7157_4609_8031	12	1.60E-14	1.14E-12	1.14E-13
7218	hsa-mir-193a	hsa05210	Colorectal cancer	1499_5595_5594_5599_595_5604_2932_4292_7157_5894_4609_3725_4087_4088_4089_836	16	1.99E-14	1.41E-12	1.29E-13
7219	hsa-mir-193a	hsa05219	Bladder cancer	5595_5594_595_1870_5604_3265_1871_7157_5894_4609_1869_1029_5925	13	2.75E-14	1.96E-12	1.63E-13
7220	hsa-mir-193a	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_862_595_5604_861_7704_3265_5970_5894_4609_1050	14	6.29E-14	4.47E-12	3.44E-13
7221	hsa-mir-193a	hsa05222	Small cell lung cancer	4149_6257_6256_595_1870_6258_6502_5970_1871_7157_4609_1869_5925_4846_8554	15	4.09E-13	2.91E-11	2.08E-12
7222	hsa-mir-193a	hsa04310	Wnt signaling pathway	5518_1499_5599_1387_595_2932_8454_6500_7157_4609_3725_1457_1459_4087_4088_4089_2033	17	7.24E-12	5.14E-10	3.43E-11
7223	hsa-mir-193a	hsa05218	Melanoma	5595_5594_595_1870_5604_3265_1871_7157_5894_1869_4286_1029_5925	13	8.92E-12	6.33E-10	3.96E-11
7224	hsa-mir-193a	hsa05211	Renal cell carcinoma	5595_5594_1387_5604_9915_3091_3265_7428_2113_5894_3725_2034_2033	13	1.04E-11	7.40E-10	4.35E-11
7225	hsa-mir-193a	hsa05213	Endometrial cancer	1499_5595_5594_595_5604_2932_4292_3265_7157_5894_4609	11	9.34E-11	6.63E-09	3.68E-10
7226	hsa-mir-193a	hsa04720	Long-term potentiation	5595_5594_1387_5604_3265_808_2902_2906_5894_2033_801_805	12	2.29E-10	1.62E-08	8.54E-10
7227	hsa-mir-193a	hsa04916	Melanogenesis	1499_5595_5594_1387_5604_2932_3265_808_5894_4286_2033_801_805	13	6.36E-10	4.52E-08	2.26E-09
7228	hsa-mir-193a	hsa04540	Gap junction	5595_5594_5598_983_5604_7277_7278_3265_10376_5894_7846_51807	12	2.11E-09	1.50E-07	7.12E-09
7229	hsa-mir-193a	hsa04912	GnRH signaling pathway	5595_5594_5599_5598_5604_1432_3265_808_5894_3725_801_805	12	9.81E-09	6.97E-07	3.17E-08
7230	hsa-mir-193a	hsa04910	Insulin signaling pathway	6720_10891_5595_5594_5599_5604_2932_3265_808_5894_6464_801_805	13	1.47E-08	1.04E-06	4.54E-08
7231	hsa-mir-193a	hsa04520	Adherens junction	1499_5595_5594_1387_1457_1459_4087_4088_4089_2033	10	6.18E-08	4.39E-06	1.83E-07
7232	hsa-mir-193a	hsa04012	ErbB signaling pathway	5595_5594_5599_5604_2932_3265_5894_4609_3725_6464	10	1.27E-07	9.01E-06	3.60E-07
7233	hsa-mir-193a	hsa04330	Notch signaling pathway	388585_1387_9612_8850_3066_3065_2033_2648	8	1.58E-07	1.12E-05	4.31E-07
7234	hsa-mir-193a	hsa05016	Huntington's disease	6874_10891_1387_6908_6667_2902_7157_3066_3065_3064_2033_836_9519	13	4.24E-07	3.01E-05	1.11E-06
7235	hsa-mir-193a	hsa04370	VEGF signaling pathway	5595_5594_5604_7867_1432_3265_9261_5894_4846	9	4.78E-07	3.40E-05	1.21E-06
7236	hsa-mir-193a	hsa04115	p53 signaling pathway	595_983_4616_7157_10912_7161_1029_836	8	2.21E-06	0.000156795	5.41E-06
7237	hsa-mir-193a	hsa04662	B cell receptor signaling pathway	5595_5594_5604_2932_3265_5970_5894_3725	8	3.91E-06	0.000277523	9.25E-06
7238	hsa-mir-193a	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_2902_2906_7157_4846_836_1616	7	6.13E-06	0.000434879	1.32E-05
7239	hsa-mir-193a	hsa05131	Shigellosis	1499_7277_7278_10376_7846_51807_4691	7	6.13E-06	0.000434879	1.32E-05
7240	hsa-mir-193a	hsa05130	Pathogenic Escherichia coli infection	1499_7277_7278_10376_7846_51807_4691	7	6.13E-06	0.000434879	1.32E-05
7241	hsa-mir-193a	hsa04660	T cell receptor signaling pathway	5595_5594_5604_2932_1432_3265_5970_5894_3725	9	7.32E-06	0.000519518	1.52E-05
7242	hsa-mir-193a	hsa03022	Basal transcription factors	2963_2962_2969_6874_6908_9519	6	7.49E-06	0.000532057	1.52E-05
7243	hsa-mir-193a	hsa05010	Alzheimer's disease	5595_5594_2932_808_2902_2906_4846_351_836_801_805	11	8.60E-06	0.000610384	1.70E-05
7244	hsa-mir-193a	hsa04730	Long-term depression	5518_5595_5594_5604_3265_5894_4846	7	2.54E-05	0.001802688	4.87E-05
7245	hsa-mir-193a	hsa04510	Focal adhesion	1499_5595_5594_5599_595_5604_2932_3265_5894_3725_6464	11	3.27E-05	0.002321282	6.11E-05
7246	hsa-mir-193a	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_8454_6502_6500_7428_7329_8554	9	4.19E-05	0.002976487	7.63E-05
7247	hsa-mir-193a	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5604_1432_3265_5894	7	4.79E-05	0.003400402	8.50E-05
7248	hsa-mir-193a	hsa04920	Adipocytokine signaling pathway	10891_5599_6257_6256_6258_5970	6	0.000158512	0.011254364	0.000274497
7249	hsa-mir-193a	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5604_1432_5970_3725	7	0.00021399	0.01519327	0.000361745
7250	hsa-mir-193a	hsa04062	Chemokine signaling pathway	5595_5594_5604_2932_3265_5970_5894_7074_6464	9	0.000439159	0.031180275	0.000725123
7251	hsa-mir-193a	hsa04270	Vascular smooth muscle contraction	5595_5594_5604_808_5894_801_805	7	0.000492989	0.03500219	0.000795504
7252	hsa-mir-193a	hsa04612	Antigen processing and presentation	3320_3326_4800_4801_4802_3312	6	0.000660857	0.046920813	0.001042685
7253	hsa-mir-193a	hsa04530	Tight junction	8573_5518_1499_3265_1457_1459_22800	7	0.001137381	0.080754048	0.001755523
7254	hsa-mir-193a	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_5604_3265_5894_836_6464	7	0.001183986	0.084062973	0.001788574
7255	hsa-mir-193a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_1432_5970_3725_836	5	0.001551584	0.110162468	0.002295051
7256	hsa-mir-193a	hsa04930	Type II diabetes mellitus	5595_5594_5599_3651	4	0.002092779	0.148587288	0.003032394
7257	hsa-mir-193a	hsa03320	PPAR signaling pathway	6257_6256_6258_2168	4	0.009169364	0.651024828	0.013020497
7258	hsa-mir-193a	hsa04810	Regulation of actin cytoskeleton	5595_5594_5604_3265_5894_22800_7074	7	0.013185906	0.936199315	0.018356849
7259	hsa-mir-193a	hsa04020	Calcium signaling pathway	808_2902_2906_4846_801_805	6	0.019339666	1	0.026406083
7260	hsa-mir-193a	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.02294898	1	0.030742973
7261	hsa-mir-193a	hsa05217	Basal cell carcinoma	1499_2932_7157	3	0.026351096	1	0.034646811
7262	hsa-mir-193a	hsa04630	Jak-STAT signaling pathway	1387_595_4609_2033_8554	5	0.032801447	1	0.042083198
7263	hsa-mir-193a	hsa04950	Maturity onset diabetes of the young	3651_168620	2	0.033192381	1	0.042083198
7264	hsa-mir-194-1	hsa05200	Pathways in cancer	1499_5595_5594_1387_4286_1019_1017_7704_6774_6688_4088_4609_1026_4087_5925_2033_207_8554	18	3.12E-16	1.90E-14	1.90E-14
7265	hsa-mir-194-1	hsa04350	TGF-beta signaling pathway	5595_5594_1387_7027_1874_4088_4609_4087_2033_5933	10	1.68E-12	1.02E-10	3.15E-11
7266	hsa-mir-194-1	hsa05215	Prostate cancer	1499_5595_5594_1387_1017_468_1026_5925_2033_207	10	1.86E-12	1.14E-10	3.15E-11
7267	hsa-mir-194-1	hsa05212	Pancreatic cancer	1499_5595_5594_1387_1017_468_1026_5925_2033_207	10	2.07E-12	1.26E-10	3.15E-11
7268	hsa-mir-194-1	hsa04110	Cell cycle	1387_1019_1017_7027_4088_1026_4087_5925_2033_5933	10	2.99E-11	1.83E-09	3.65E-10
7269	hsa-mir-194-1	hsa05220	Chronic myeloid leukemia	5595_5594_1019_4088_4609_1026_5925_207	8	5.31E-10	3.24E-08	5.39E-09
7270	hsa-mir-194-1	hsa04520	Adherens junction	1460_1499_5595_5594_1387_4088_4087_2033	8	8.52E-10	5.20E-08	7.43E-09
7271	hsa-mir-194-1	hsa05221	Acute myeloid leukemia	5595_5594_7704_6774_6688_4609_207	7	3.37E-09	2.06E-07	2.57E-08
7272	hsa-mir-194-1	hsa05218	Melanoma	5595_5594_4286_1019_1026_5925_207	7	1.11E-08	6.74E-07	7.49E-08
7273	hsa-mir-194-1	hsa05219	Bladder cancer	5595_5594_1019_4609_1026_5925	6	1.70E-08	1.04E-06	1.04E-07
7274	hsa-mir-194-1	hsa05210	Colorectal cancer	1499_5595_5594_4088_4609_4087_207	7	3.26E-08	1.99E-06	1.81E-07
7275	hsa-mir-194-1	hsa05214	Glioma	5595_5594_1019_1026_5925_207	6	1.86E-07	1.13E-05	9.44E-07
7276	hsa-mir-194-1	hsa05222	Small cell lung cancer	1019_1017_4609_5925_207_8554	6	8.71E-07	5.32E-05	4.09E-06
7277	hsa-mir-194-1	hsa04310	Wnt signaling pathway	1460_1499_1387_4088_4609_4087_2033	7	1.48E-06	9.03E-05	6.45E-06
7278	hsa-mir-194-1	hsa05213	Endometrial cancer	1499_5595_5594_4609_207	5	1.70E-06	0.000103669	6.91E-06
7279	hsa-mir-194-1	hsa05223	Non-small cell lung cancer	5595_5594_1019_5925_207	5	2.02E-06	0.00012327	7.70E-06
7280	hsa-mir-194-1	hsa04916	Melanogenesis	1499_5595_5594_1387_4286_2033	6	2.49E-06	0.000151766	8.93E-06
7281	hsa-mir-194-1	hsa05216	Thyroid cancer	1499_5595_5594_4609	4	5.29E-06	0.000322586	1.79E-05
7282	hsa-mir-194-1	hsa05211	Renal cell carcinoma	5595_5594_1387_2033_207	5	7.59E-06	0.000462883	2.44E-05
7283	hsa-mir-194-1	hsa04720	Long-term potentiation	5595_5594_1387_468_2033	5	9.16E-06	0.000558559	2.79E-05
7284	hsa-mir-194-1	hsa04012	ErbB signaling pathway	5595_5594_4609_1026_207	5	1.81E-05	0.001105379	5.26E-05
7285	hsa-mir-194-1	hsa04630	Jak-STAT signaling pathway	1387_6774_4609_2033_207_8554	6	2.22E-05	0.001351467	6.14E-05
7286	hsa-mir-194-1	hsa04660	T cell receptor signaling pathway	5595_5594_1019_1739_207	5	5.31E-05	0.003237737	0.000140771
7287	hsa-mir-194-1	hsa04010	MAPK signaling pathway	5595_5594_1386_468_4609_1649_207	7	5.85E-05	0.003566219	0.000148592
7288	hsa-mir-194-1	hsa04530	Tight junction	1460_10207_1499_1019_207	5	0.000143856	0.008775203	0.000351008
7289	hsa-mir-194-1	hsa04510	Focal adhesion	1499_5595_5594_1729_207	5	0.000882661	0.053842305	0.002070858
7290	hsa-mir-194-1	hsa04150	mTOR signaling pathway	5595_5594_207	3	0.000948017	0.057829031	0.002141816
7291	hsa-mir-194-1	hsa04115	p53 signaling pathway	1019_1017_1026	3	0.002064674	0.125945137	0.004498041
7292	hsa-mir-194-1	hsa04662	B cell receptor signaling pathway	5595_5594_207	3	0.002594185	0.158245298	0.005456734
7293	hsa-mir-194-1	hsa04370	VEGF signaling pathway	5595_5594_207	3	0.002787586	0.170042721	0.005668091
7294	hsa-mir-194-1	hsa04664	Fc epsilon RI signaling pathway	5595_5594_207	3	0.002989651	0.182368727	0.005882862
7295	hsa-mir-194-1	hsa05010	Alzheimer's disease	22926_5595_5594_4716	4	0.003768853	0.229900034	0.007184376
7296	hsa-mir-194-1	hsa05016	Huntington's disease	1387_6908_2033_4716	4	0.004644182	0.28329512	0.008584701
7297	hsa-mir-194-1	hsa04062	Chemokine signaling pathway	5595_5594_6774_207	4	0.005083743	0.310108294	0.009120832
7298	hsa-mir-194-1	hsa04620	Toll-like receptor signaling pathway	5595_5594_207	3	0.005973302	0.364371422	0.010410612
7299	hsa-mir-194-1	hsa04912	GnRH signaling pathway	5595_5594_468	3	0.006962574	0.424716999	0.011797694
7300	hsa-mir-194-1	hsa03022	Basal transcription factors	6908_2959	2	0.00820835	0.500709328	0.013532685
7301	hsa-mir-194-1	hsa04360	Axon guidance	5998_5595_5594	3	0.011619724	0.708803147	0.018394131
7302	hsa-mir-194-1	hsa04930	Type II diabetes mellitus	5595_5594	2	0.011760182	0.717371096	0.018394131
7303	hsa-mir-194-1	hsa04330	Notch signaling pathway	1387_2033	2	0.012736087	0.776901279	0.019422532
7304	hsa-mir-194-1	hsa04910	Insulin signaling pathway	5595_5594_207	3	0.013318293	0.812415846	0.019815021
7305	hsa-mir-194-1	hsa04920	Adipocytokine signaling pathway	6774_207	2	0.024289515	1	0.035277629
7306	hsa-mir-194-1	hsa04730	Long-term depression	5595_5594	2	0.02696631	1	0.038254533
7307	hsa-mir-194-1	hsa04612	Antigen processing and presentation	4800_4801	2	0.040362465	1	0.055957053
7308	hsa-mir-194-1	hsa04810	Regulation of actin cytoskeleton	5595_5594_1729	3	0.042874351	1	0.057842421
7309	hsa-mir-194-1	hsa04540	Gap junction	5595_5594	2	0.043618875	1	0.057842421
7310	hsa-mir-194-2	hsa05200	Pathways in cancer	3320_4149_5371_7046_5595_5599_1387_5604_2932_6502_6772_5970_5894_4088_1029_4087_4292_1050_5925_2033	20	1.61E-19	9.48E-18	9.48E-18
7311	hsa-mir-194-2	hsa04110	Cell cycle	990_1387_983_2932_8454_6502_6500_4088_1029_4087_5925_2033_5933	13	4.14E-16	2.44E-14	1.22E-14
7312	hsa-mir-194-2	hsa04350	TGF-beta signaling pathway	7046_5595_1387_6667_8454_6500_4088_4087_2033_5933	10	7.50E-13	4.42E-11	1.47E-11
7313	hsa-mir-194-2	hsa04540	Gap junction	5595_5598_983_5604_7277_7278_10376_5894_7846_51807	10	1.38E-12	8.17E-11	2.04E-11
7314	hsa-mir-194-2	hsa04520	Adherens junction	4301_7046_5595_1387_4088_1457_1459_4087_2033	9	1.32E-11	7.78E-10	1.56E-10
7315	hsa-mir-194-2	hsa05210	Colorectal cancer	7046_5595_5599_5604_2932_5894_4088_4087_4292	9	1.98E-11	1.17E-09	1.94E-10
7316	hsa-mir-194-2	hsa05215	Prostate cancer	3320_5595_1387_5604_2932_5970_5894_5925_2033	9	2.90E-11	1.71E-09	2.35E-10
7317	hsa-mir-194-2	hsa05212	Pancreatic cancer	3320_5595_1387_5604_2932_5970_5894_5925_2033	9	3.19E-11	1.88E-09	2.35E-10
7318	hsa-mir-194-2	hsa04310	Wnt signaling pathway	5599_1387_2932_8454_6500_4088_1457_1459_4087_2033	10	1.30E-10	7.66E-09	8.51E-10
7319	hsa-mir-194-2	hsa05220	Chronic myeloid leukemia	7046_5595_5604_5970_5894_4088_1029_5925	8	2.80E-10	1.65E-08	1.65E-09
7320	hsa-mir-194-2	hsa05131	Shigellosis	7277_7278_10376_7846_51807_4691	6	5.09E-08	3.00E-06	2.50E-07
7321	hsa-mir-194-2	hsa05130	Pathogenic Escherichia coli infection	7277_7278_10376_7846_51807_4691	6	5.09E-08	3.00E-06	2.50E-07
7322	hsa-mir-194-2	hsa05221	Acute myeloid leukemia	5371_5595_5604_5970_5894_1050	6	6.79E-08	4.01E-06	3.08E-07
7323	hsa-mir-194-2	hsa04010	MAPK signaling pathway	4149_7046_5595_5599_5598_5604_1386_5970_5894	9	3.41E-07	2.01E-05	1.44E-06
7324	hsa-mir-194-2	hsa05219	Bladder cancer	5595_5604_5894_1029_5925	5	4.32E-07	2.55E-05	1.70E-06
7325	hsa-mir-194-2	hsa05213	Endometrial cancer	5595_5604_2932_5894_4292	5	1.15E-06	6.78E-05	4.24E-06
7326	hsa-mir-194-2	hsa05223	Non-small cell lung cancer	5595_5604_5894_1029_5925	5	1.37E-06	8.06E-05	4.74E-06
7327	hsa-mir-194-2	hsa04916	Melanogenesis	5595_1387_5604_2932_5894_2033	6	1.57E-06	9.24E-05	5.13E-06
7328	hsa-mir-194-2	hsa05214	Glioma	5595_5604_5894_1029_5925	5	3.21E-06	0.000189559	9.98E-06
7329	hsa-mir-194-2	hsa04062	Chemokine signaling pathway	5595_5604_2932_6772_5970_5894_7074	7	3.99E-06	0.000235511	1.18E-05
7330	hsa-mir-194-2	hsa05218	Melanoma	5595_5604_5894_1029_5925	5	4.83E-06	0.000284973	1.36E-05
7331	hsa-mir-194-2	hsa05211	Renal cell carcinoma	5595_1387_5604_5894_2033	5	5.15E-06	0.000303989	1.38E-05
7332	hsa-mir-194-2	hsa04720	Long-term potentiation	5595_1387_5604_5894_2033	5	6.22E-06	0.000367064	1.53E-05
7333	hsa-mir-194-2	hsa04662	B cell receptor signaling pathway	5595_5604_2932_5970_5894	5	6.22E-06	0.000367064	1.53E-05
7334	hsa-mir-194-2	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_8454_6502_6500	6	7.77E-06	0.000458215	1.83E-05
7335	hsa-mir-194-2	hsa04012	ErbB signaling pathway	5595_5599_5604_2932_5894	5	1.23E-05	0.000728325	2.80E-05
7336	hsa-mir-194-2	hsa04620	Toll-like receptor signaling pathway	5595_5599_5604_6772_5970	5	2.57E-05	0.001515602	5.61E-05
7337	hsa-mir-194-2	hsa04912	GnRH signaling pathway	5595_5599_5598_5604_5894	5	3.34E-05	0.001970878	7.04E-05
7338	hsa-mir-194-2	hsa04660	T cell receptor signaling pathway	5595_5604_2932_5970_5894	5	3.63E-05	0.002144069	7.39E-05
7339	hsa-mir-194-2	hsa04910	Insulin signaling pathway	5595_5599_5604_2932_5894	5	0.000102403	0.006041771	0.000201392
7340	hsa-mir-194-2	hsa04664	Fc epsilon RI signaling pathway	5595_5599_5604_5894	4	0.000153275	0.009043226	0.000291717
7341	hsa-mir-194-2	hsa05222	Small cell lung cancer	4149_6502_5970_5925	4	0.000209489	0.012359871	0.000386246
7342	hsa-mir-194-2	hsa03022	Basal transcription factors	2962_2969_6908	3	0.000294034	0.01734803	0.000525698
7343	hsa-mir-194-2	hsa04330	Notch signaling pathway	1387_2033_2648	3	0.000569859	0.033621663	0.000988872
7344	hsa-mir-194-2	hsa04510	Focal adhesion	5595_5599_5604_2932_5894	5	0.000617023	0.036404341	0.001040124
7345	hsa-mir-194-2	hsa04115	p53 signaling pathway	983_7161_1029	3	0.001647445	0.097199274	0.00269998
7346	hsa-mir-194-2	hsa04730	Long-term depression	5595_5604_5894	3	0.001782342	0.105158149	0.002842112
7347	hsa-mir-194-2	hsa04370	VEGF signaling pathway	5595_5604_5894	3	0.002227738	0.131436524	0.003458856
7348	hsa-mir-194-2	hsa04612	Antigen processing and presentation	3320_4801_4802	3	0.003311588	0.195383709	0.005009839
7349	hsa-mir-194-2	hsa05016	Huntington's disease	1387_6908_6667_2033	4	0.003504524	0.206766911	0.005169173
7350	hsa-mir-194-2	hsa05216	Thyroid cancer	5595_5604	2	0.004498013	0.265382763	0.00647275
7351	hsa-mir-194-2	hsa04810	Regulation of actin cytoskeleton	5595_5604_5894_7074	4	0.005939985	0.350459098	0.008344264
7352	hsa-mir-194-2	hsa04270	Vascular smooth muscle contraction	5595_5604_5894	3	0.00710151	0.418989074	0.009743932
7353	hsa-mir-194-2	hsa04930	Type II diabetes mellitus	5595_5599	2	0.01011309	0.596672308	0.013560734
7354	hsa-mir-194-2	hsa04530	Tight junction	4301_1457_1459	3	0.010564315	0.623294577	0.01381262
7355	hsa-mir-194-2	hsa04650	Natural killer cell mediated cytotoxicity	5595_5604_5894	3	0.010769162	0.635380532	0.01381262
7356	hsa-mir-194-2	hsa04630	Jak-STAT signaling pathway	1387_6772_2033	3	0.014606052	0.861757064	0.018335257
7357	hsa-mir-194-2	hsa04920	Adipocytokine signaling pathway	5599_5970	2	0.020966666	1	0.025771526
7358	hsa-mir-194-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5970	2	0.023293146	1	0.02804685
7359	hsa-mir-195	hsa05200	Pathways in cancer	4149_1499_595_1019_1017_8517_4193_3551_5578_6502_3091_2736_2737_4087_7175_3066_3065_5925_1050_5468_2034_2308_1870_1871_2113_10401_5894_861_207_9915_1147_367_5595_5594_5599_6258_1387_6257_6256_4286_2932_6774_6772_5970_7157_6688_1869_3725_2735_4088_4089_2033_4790_4791_4792_3320_3326_5371_5604_5601_4292_8031_4609_1029_2353_8554	66	8.48E-34	7.12E-32	7.12E-32
7360	hsa-mir-195	hsa04010	MAPK signaling pathway	6722_4149_6195_6197_8517_9252_3551_5578_4773_9020_4616_3305_3303_1432_4342_5894_1616_207_1147_3727_5595_5594_5599_5598_1386_3312_1649_5971_5970_3310_7157_10912_3725_6196_5058_4790_4791_9261_1326_5604_5601_5600_5603_5608_5566_6885_4609_2353_8986_8550	50	1.92E-24	1.62E-22	8.08E-23
7361	hsa-mir-195	hsa04110	Cell cycle	595_1019_1017_4193_6502_6500_4087_3066_3065_4616_5925_1870_1871_5933_5591_1387_7533_7532_2932_7534_7157_5111_10912_1869_4088_4089_2033_891_894_896_983_8454_1029_1028_1111_990	36	3.77E-24	3.16E-22	1.05E-22
7362	hsa-mir-195	hsa05215	Prostate cancer	1499_595_1017_8517_4193_3551_5925_2308_1870_1871_5894_207_9586_1147_367_5595_5594_1385_1387_2932_5970_7157_1869_2033_4790_4792_3320_3326_5604	29	1.46E-20	1.23E-18	3.06E-19
7363	hsa-mir-195	hsa05212	Pancreatic cancer	1499_595_1017_8517_4193_3551_5925_2308_1870_1871_5894_207_9586_1147_367_5595_5594_1385_1387_2932_5970_7157_1869_2033_4790_4792_3320_3326_5604	29	1.89E-20	1.59E-18	3.17E-19
7364	hsa-mir-195	hsa05220	Chronic myeloid leukemia	595_1019_8517_4193_3551_3066_3065_5925_1870_1871_5894_861_207_1147_5595_5594_5970_7157_1869_4088_4089_4790_4792_5604_4609_1029	26	5.03E-19	4.23E-17	7.05E-18
7365	hsa-mir-195	hsa04660	T cell receptor signaling pathway	1019_8517_3551_4773_9020_1432_5894_207_1147_5595_5594_2932_5970_3725_5058_4794_4790_4792_4793_1326_5604_5601_5600_5603_6885_2353	26	1.30E-15	1.09E-13	1.56E-14
7366	hsa-mir-195	hsa04310	Wnt signaling pathway	1499_595_5578_6500_8945_4087_4773_23291_8607_5599_1387_2932_7157_8061_3725_1457_1459_4088_4089_2033_894_896_5519_5515_5601_5566_8454_6885_4609	29	3.98E-15	3.35E-13	4.18E-14
7367	hsa-mir-195	hsa05222	Small cell lung cancer	4149_595_1019_1017_8517_3551_6502_5925_1870_1871_10401_207_1147_6258_6257_6256_5970_7157_1869_4790_4792_4609_8554	23	6.03E-15	5.07E-13	5.63E-14
7368	hsa-mir-195	hsa04620	Toll-like receptor signaling pathway	8517_3551_3661_1432_207_1147_29110_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5601_5600_5603_5608_9641_6885_2353	24	1.77E-14	1.48E-12	1.48E-13
7369	hsa-mir-195	hsa04920	Adipocytokine signaling pathway	10891_5465_8517_3551_2538_8471_207_1147_5599_6258_6257_6256_6774_5970_4794_4790_4792_4793_5601_5563	20	6.25E-14	5.25E-12	4.77E-13
7370	hsa-mir-195	hsa05223	Non-small cell lung cancer	595_1019_5578_5925_1870_1871_5894_207_5595_5594_6258_6257_6256_7157_1869_5604_1029	17	2.34E-12	1.97E-10	1.64E-11
7371	hsa-mir-195	hsa05214	Glioma	595_1019_4193_5578_5925_1870_1871_5894_207_5595_5594_7157_1869_808_801_805_5604_1029	18	3.27E-12	2.74E-10	2.11E-11
7372	hsa-mir-195	hsa04350	TGF-beta signaling pathway	6500_4087_6667_3397_3399_3398_5933_3400_5595_5594_1387_4088_4089_2033_5519_5515_4093_8454_4609_4092	20	3.88E-12	3.26E-10	2.33E-11
7373	hsa-mir-195	hsa05221	Acute myeloid leukemia	595_8517_3551_1050_5894_861_207_1147_5595_5594_6774_5970_6688_4790_5371_5604_4609	17	7.67E-12	6.44E-10	4.30E-11
7374	hsa-mir-195	hsa05219	Bladder cancer	595_1019_9252_4193_5925_1870_1871_5894_5595_5594_7157_1869_5604_4609_1029	15	1.05E-11	8.80E-10	5.50E-11
7375	hsa-mir-195	hsa04662	B cell receptor signaling pathway	8517_3551_4773_5894_207_1147_695_5595_5594_2932_5970_3725_4794_4790_4792_4793_5604_2353	18	2.50E-11	2.10E-09	1.21E-10
7376	hsa-mir-195	hsa05216	Thyroid cancer	1499_595_7175_5468_5595_5594_6258_6257_6256_7157_5604_8031_4609	13	2.59E-11	2.17E-09	1.21E-10
7377	hsa-mir-195	hsa04540	Gap junction	5578_10382_51807_6714_5894_5592_5595_5594_5598_7846_203068_347733_983_5604_5566_7277_7278_84617_10376	19	7.84E-11	6.59E-09	3.47E-10
7378	hsa-mir-195	hsa05210	Colorectal cancer	1499_595_4087_5894_207_5595_5594_5599_2932_7157_3725_4088_4089_5604_5601_4292_4609_2353	18	1.25E-10	1.05E-08	5.26E-10
7379	hsa-mir-195	hsa04910	Insulin signaling pathway	10891_6720_3551_2538_2308_5894_8471_207_8651_5590_5595_5594_5599_2932_808_801_805_5604_5601_5566_5563	21	9.88E-10	8.30E-08	3.95E-09
7380	hsa-mir-195	hsa05131	Shigellosis	1499_5578_10382_51807_71_7534_7846_203068_347733_7277_7278_84617_4691_10376	14	2.60E-09	2.19E-07	9.51E-09
7381	hsa-mir-195	hsa05130	Pathogenic Escherichia coli infection	1499_5578_10382_51807_71_7534_7846_203068_347733_7277_7278_84617_4691_10376	14	2.60E-09	2.19E-07	9.51E-09
7382	hsa-mir-195	hsa04912	GnRH signaling pathway	5578_6714_1432_5894_5595_5594_5599_5598_3725_808_801_805_5604_5601_5600_5603_5608_5566	18	4.34E-09	3.65E-07	1.52E-08
7383	hsa-mir-195	hsa05218	Melanoma	595_1019_4193_5925_1870_1871_5894_207_5595_5594_4286_7157_1869_5604_1029	15	5.17E-09	4.34E-07	1.67E-08
7384	hsa-mir-195	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	8517_3551_9020_6714_1432_1147_5599_5970_3725_5058_4790_4792_5601_5600_5603	15	5.17E-09	4.34E-07	1.67E-08
7385	hsa-mir-195	hsa04720	Long-term potentiation	814_6195_6197_5578_5894_5595_5594_1387_6196_2033_808_801_805_5604_5566	15	9.88E-09	8.30E-07	3.07E-08
7386	hsa-mir-195	hsa04115	p53 signaling pathway	595_1019_1017_4193_4616_7157_10912_891_894_896_983_7161_1029_1111	14	2.61E-08	2.20E-06	7.84E-08
7387	hsa-mir-195	hsa04120	Ubiquitin mediated proteolysis	55294_4193_6502_6500_3093_8945_23291_10401_10273_7325_7323_7329_51366_8651_997_5371_672_8454_8554	19	2.92E-08	2.46E-06	8.47E-08
7388	hsa-mir-195	hsa05211	Renal cell carcinoma	3091_2034_2113_5894_207_9915_5595_5594_1387_3725_5058_2033_5604	13	2.70E-07	2.27E-05	7.56E-07
7389	hsa-mir-195	hsa04916	Melanogenesis	1499_5578_5894_5595_5594_1385_1387_4286_2932_2033_808_801_805_5604_5566	15	4.47E-07	3.76E-05	1.21E-06
7390	hsa-mir-195	hsa05016	Huntington's disease	10891_292_293_1537_3066_3065_3064_498_5468_6667_5441_9586_1385_1387_5437_7157_1213_25942_2033_6908	20	5.21E-07	4.38E-05	1.37E-06
7391	hsa-mir-195	hsa05213	Endometrial cancer	1499_595_5894_207_5595_5594_2932_7157_5604_4292_4609	11	5.68E-07	4.77E-05	1.45E-06
7392	hsa-mir-195	hsa04664	Fc epsilon RI signaling pathway	5578_1432_5894_207_695_5595_5594_5599_5604_5601_5600_5603_5608	13	6.92E-07	5.81E-05	1.71E-06
7393	hsa-mir-195	hsa04062	Chemokine signaling pathway	8517_3551_653361_7074_5894_207_1147_5590_5595_5594_2932_6774_6772_5970_5058_4790_4792_4793_5604_5566	20	7.61E-07	6.39E-05	1.83E-06
7394	hsa-mir-195	hsa04520	Adherens junction	1499_4087_6714_71_5595_5594_1387_1457_1459_4088_4089_2033_6885	13	7.85E-07	6.60E-05	1.83E-06
7395	hsa-mir-195	hsa04012	ErbB signaling pathway	5578_6714_5894_207_5595_5594_5599_2932_3725_5058_5604_5601_4609	13	1.82E-06	0.000153196	4.14E-06
7396	hsa-mir-195	hsa04370	VEGF signaling pathway	5578_4773_6714_1432_5894_207_5595_5594_9261_5604_5600_5603	12	3.07E-06	0.000257572	6.78E-06
7397	hsa-mir-195	hsa04930	Type II diabetes mellitus	3651_3551_8471_8651_5590_5595_5594_5599_5601	9	9.06E-06	0.000761119	1.95E-05
7398	hsa-mir-195	hsa04210	Apoptosis	8517_3551_9020_8837_207_1147_5970_7157_9131_4790_4792_5566	12	1.16E-05	0.000976014	2.44E-05
7399	hsa-mir-195	hsa03022	Basal transcription factors	6872_2963_2962_2969_6878_6908_6882_2959	8	1.75E-05	0.001467812	3.58E-05
7400	hsa-mir-195	hsa04510	Focal adhesion	1499_595_5578_6714_10627_5894_207_71_5595_5594_5599_2932_3725_5058_894_896_5604_5601	18	2.31E-05	0.001941568	4.62E-05
7401	hsa-mir-195	hsa04530	Tight junction	1499_1019_5578_6714_4627_4628_10627_207_71_5590_1457_1459_5519_5515	14	3.90E-05	0.003272058	7.61E-05
7402	hsa-mir-195	hsa04612	Antigen processing and presentation	3308_3309_3305_3303_1385_3312_3310_3320_3326_4802_4801	11	5.51E-05	0.004626425	0.000105146
7403	hsa-mir-195	hsa04330	Notch signaling pathway	9612_3066_3065_1387_2033_8850_2648_4851	8	7.87E-05	0.006608545	0.000146857
7404	hsa-mir-195	hsa04630	Jak-STAT signaling pathway	3559_595_10401_207_8651_1387_6778_6774_6772_2033_894_896_4609_8554	14	0.000132003	0.011088231	0.000241049
7405	hsa-mir-195	hsa04150	mTOR signaling pathway	6195_6197_3091_207_5595_5594_6196_5563	8	0.000147641	0.012401866	0.000263869
7406	hsa-mir-195	hsa03010	Ribosome	6155_6156_6207_6202_9349_6141_6217_6222_6128_6188_6231	11	0.000167183	0.014043403	0.000292571
7407	hsa-mir-195	hsa03020	RNA polymerase	25885_64425_51082_5441_5437_84172	6	0.000247121	0.020758154	0.000423636
7408	hsa-mir-195	hsa04340	Hedgehog signaling pathway	2736_2737_8945_23291_53944_2932_2735_5566	8	0.000260146	0.021852284	0.000437046
7409	hsa-mir-195	hsa04270	Vascular smooth muscle contraction	5578_5894_5592_5595_5594_4637_808_801_805_5604_5566	11	0.000528245	0.044372583	0.000870051
7410	hsa-mir-195	hsa04730	Long-term depression	5578_5894_5592_5595_5594_5519_5515_5604	8	0.000981101	0.082412502	0.001584856
7411	hsa-mir-195	hsa03320	PPAR signaling pathway	5465_2168_10062_5468_6258_6257_6256	7	0.003719801	0.312463285	0.005895534
7412	hsa-mir-195	hsa05217	Basal cell carcinoma	1499_2736_2737_2932_7157_2735	6	0.004804453	0.403574082	0.007473594
7413	hsa-mir-195	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_1616_7157_5600_5603_5608	6	0.005205713	0.437279877	0.007950543
7414	hsa-mir-195	hsa04950	Maturity onset diabetes of the young	3651_6927_168620_3172	4	0.005488683	0.461049387	0.008233025
7415	hsa-mir-195	hsa04670	Leukocyte transendothelial migration	1499_5578_653361_1432_10627_71_5600_5603	8	0.019651977	1	0.028485255
7416	hsa-mir-195	hsa04810	Regulation of actin cytoskeleton	7074_4627_4628_4342_10627_5894_71_5595_5594_5058_5604_10788	12	0.019668391	1	0.028485255
7417	hsa-mir-195	hsa03430	Mismatch repair	5981_5111_4292	3	0.02857349	1	0.0406809
7418	hsa-mir-196a-2	hsa05200	Pathways in cancer	4286_3716_5925_2249_675_1871_1956_5595_5594_861_5914_1387_6256_5159_595_1029_5156_1487_1488_836_207_1399_1398_367_1017_3815_2932_2353_6776_6777_6772_7157_2308_5970_7046_1870_2113_1869_3725_4088_1026_867_6774_2736_4087_4089_1050_2033_4149_898	50	2.50E-36	1.82E-34	1.82E-34
7419	hsa-mir-196a-2	hsa05220	Chronic myeloid leukemia	5925_1871_5595_5594_861_595_1029_1487_1488_207_1399_1398_6776_6777_7157_5970_7046_1870_5781_1869_4088_1026_867_4089_6464	25	6.10E-26	4.46E-24	2.23E-24
7420	hsa-mir-196a-2	hsa04110	Cell cycle	5925_1871_1387_595_1029_1017_7532_5001_2932_7157_1870_1869_4174_4088_1026_4172_4173_4087_4089_2033_5933_890_894_896_898_5934_4998_4999	28	2.29E-25	1.67E-23	5.58E-24
7421	hsa-mir-196a-2	hsa05215	Prostate cancer	5925_1871_1956_5595_5594_1387_5159_595_5156_207_367_1017_2932_7157_2308_5970_1870_1869_1026_2033_898	21	1.95E-19	1.42E-17	3.48E-18
7422	hsa-mir-196a-2	hsa05212	Pancreatic cancer	5925_1871_1956_5595_5594_1387_5159_595_5156_207_367_1017_2932_7157_2308_5970_1870_1869_1026_2033_898	21	2.38E-19	1.74E-17	3.48E-18
7423	hsa-mir-196a-2	hsa04630	Jak-STAT signaling pathway	3717_3716_3718_85480_3560_3561_1387_595_207_3575_6776_6777_6772_2057_5781_867_6774_2690_2033_3977_894_896	22	4.57E-16	3.33E-14	5.56E-15
7424	hsa-mir-196a-2	hsa04010	MAPK signaling pathway	2249_1956_5595_5594_5598_5159_9261_5156_836_207_1399_1398_9252_2353_1432_7157_5970_7046_6722_1616_3725_6195_6196_8986_4149_6197	26	6.14E-15	4.48E-13	6.40E-14
7425	hsa-mir-196a-2	hsa05218	Melanoma	4286_5925_2249_1871_1956_5595_5594_5159_595_1029_5156_207_7157_1870_1869_1026	16	8.84E-15	6.45E-13	8.06E-14
7426	hsa-mir-196a-2	hsa05214	Glioma	5925_1871_1956_5595_5594_5159_595_1029_5156_207_7157_1870_1869_1026_6464	15	4.54E-14	3.31E-12	3.68E-13
7427	hsa-mir-196a-2	hsa05210	Colorectal cancer	1956_5595_5594_5159_595_5156_836_207_2932_2353_7157_7046_3725_4088_4087_4089	16	8.70E-14	6.35E-12	6.35E-13
7428	hsa-mir-196a-2	hsa04350	TGF-beta signaling pathway	5515_5595_5594_1387_6667_3399_3398_7046_1874_1875_4088_4087_4089_2033_5933_5934	16	1.40E-13	1.03E-11	9.32E-13
7429	hsa-mir-196a-2	hsa04012	ErbB signaling pathway	1956_6714_5595_5594_2066_207_1399_1398_2932_6776_6777_3725_1026_867_6464	15	1.87E-12	1.37E-10	1.06E-11
7430	hsa-mir-196a-2	hsa05219	Bladder cancer	5925_1871_1956_5595_5594_595_1029_9252_7157_1870_1869_1026	12	1.88E-12	1.37E-10	1.06E-11
7431	hsa-mir-196a-2	hsa04520	Adherens junction	4301_1460_1956_6714_3643_5595_5594_1387_5770_7046_4088_4087_4089_2033	14	8.66E-12	6.32E-10	4.51E-11
7432	hsa-mir-196a-2	hsa05223	Non-small cell lung cancer	5925_1871_1956_5595_5594_6256_595_1029_207_7157_1870_1869	12	2.37E-11	1.73E-09	1.15E-10
7433	hsa-mir-196a-2	hsa05221	Acute myeloid leukemia	5595_5594_861_5914_595_207_3815_6776_6777_5970_6774_1050	12	5.83E-11	4.25E-09	2.66E-10
7434	hsa-mir-196a-2	hsa04910	Insulin signaling pathway	10891_3643_5595_5594_23265_5499_207_1399_1398_2932_5770_2308_5563_867_6464	15	6.81E-10	4.97E-08	2.92E-09
7435	hsa-mir-196a-2	hsa04310	Wnt signaling pathway	5515_1460_1387_595_1487_1488_2932_7157_3725_4088_4087_4089_2033_894_896	15	2.31E-09	1.68E-07	9.36E-09
7436	hsa-mir-196a-2	hsa04510	Focal adhesion	1956_6714_5595_5594_5159_595_5156_5499_207_1399_1398_2932_3725_1729_894_896_6464	17	2.46E-09	1.80E-07	9.46E-09
7437	hsa-mir-196a-2	hsa05222	Small cell lung cancer	5925_1871_6256_595_207_1017_7157_5970_1870_1869_4149_898	12	2.76E-09	2.01E-07	1.01E-08
7438	hsa-mir-196a-2	hsa04660	T cell receptor signaling pathway	5595_5594_207_919_2932_2353_1432_5970_1739_3725_867_3932_1493	13	3.76E-09	2.74E-07	1.31E-08
7439	hsa-mir-196a-2	hsa05211	Renal cell carcinoma	5595_5594_1387_207_1399_1398_5781_2113_3725_2033	10	6.11E-08	4.46E-06	2.03E-07
7440	hsa-mir-196a-2	hsa04062	Chemokine signaling pathway	3717_3718_5595_5594_207_1399_1398_1234_2932_6777_6772_5970_6774_6464	14	2.80E-07	2.04E-05	8.89E-07
7441	hsa-mir-196a-2	hsa04115	p53 signaling pathway	595_1029_836_1017_7157_1026_894_896_898	9	4.57E-07	3.33E-05	1.39E-06
7442	hsa-mir-196a-2	hsa04662	B cell receptor signaling pathway	695_5595_5594_6850_207_2932_2353_5970_3725	9	8.65E-07	6.31E-05	2.52E-06
7443	hsa-mir-196a-2	hsa05016	Huntington's disease	10891_25942_1387_6908_836_4724_6667_7157_23186_3064_4697_2033_4716	13	1.24E-06	9.02E-05	3.47E-06
7444	hsa-mir-196a-2	hsa04920	Adipocytokine signaling pathway	3717_10891_6256_207_5970_5781_5563_6774	8	3.66E-06	0.000266932	9.89E-06
7445	hsa-mir-196a-2	hsa05213	Endometrial cancer	1956_5595_5594_595_207_2932_7157	7	7.32E-06	0.000534456	1.84E-05
7446	hsa-mir-196a-2	hsa04150	mTOR signaling pathway	5595_5594_207_5563_6195_6196_6197	7	7.32E-06	0.000534456	1.84E-05
7447	hsa-mir-196a-2	hsa04720	Long-term potentiation	5595_5594_1387_5499_6195_6196_2033_6197	8	7.86E-06	0.000573601	1.91E-05
7448	hsa-mir-196a-2	hsa04540	Gap junction	5592_1956_6714_5595_5594_5598_5159_5156	8	3.33E-05	0.002431826	7.84E-05
7449	hsa-mir-196a-2	hsa04060	Cytokine-cytokine receptor interaction	85480_1956_3560_3561_5159_5156_3575_1234_3815_7046_2057_2690_3977	13	3.63E-05	0.002647666	8.27E-05
7450	hsa-mir-196a-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_836_1432_5970_5781_3725	7	4.65E-05	0.00339731	0.000102949
7451	hsa-mir-196a-2	hsa05216	Thyroid cancer	5595_5594_6256_595_7157	5	5.37E-05	0.003918268	0.000115243
7452	hsa-mir-196a-2	hsa04620	Toll-like receptor signaling pathway	5595_5594_207_2353_1432_6772_5970_3725	8	6.14E-05	0.004485275	0.000128151
7453	hsa-mir-196a-2	hsa05340	Primary immunodeficiency	3718_695_3561_3575_3932	5	0.000119569	0.008728548	0.00024246
7454	hsa-mir-196a-2	hsa04330	Notch signaling pathway	1387_1487_1488_9612_2033	5	0.000419222	0.030603206	0.000811093
7455	hsa-mir-196a-2	hsa04916	Melanogenesis	4286_5595_5594_1387_3815_2932_2033	7	0.000425229	0.031041742	0.000811093
7456	hsa-mir-196a-2	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_6850_836_919_5781_3932_6464	8	0.000433324	0.031632637	0.000811093
7457	hsa-mir-196a-2	hsa05010	Alzheimer's disease	5595_5594_836_4724_2932_840_1020_4697_4716	9	0.000480347	0.035065297	0.000876632
7458	hsa-mir-196a-2	hsa04912	GnRH signaling pathway	1956_6714_5595_5594_5598_1432_3725	7	0.000526385	0.03842612	0.000902094
7459	hsa-mir-196a-2	hsa04370	VEGF signaling pathway	6714_5595_5594_9261_207_1432	6	0.000530964	0.038760375	0.000902094
7460	hsa-mir-196a-2	hsa04810	Regulation of actin cytoskeleton	2249_1956_5595_5594_5159_5156_5499_1399_1398_1729	10	0.000531371	0.038790058	0.000902094
7461	hsa-mir-196a-2	hsa04664	Fc epsilon RI signaling pathway	695_5595_5594_6850_207_1432	6	0.000602889	0.044010924	0.001000248
7462	hsa-mir-196a-2	hsa03030	DNA replication	79621_4174_4172_4173	4	0.001387516	0.101288665	0.002250859
7463	hsa-mir-196a-2	hsa04930	Type II diabetes mellitus	3643_5595_5594_3651	4	0.002952922	0.215563274	0.004686158
7464	hsa-mir-196a-2	hsa04210	Apoptosis	836_207_840_7157_5970	5	0.005854878	0.427406116	0.009093747
7465	hsa-mir-196a-2	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432_7157_1616	4	0.006123928	0.447046714	0.009313473
7466	hsa-mir-196a-2	hsa04530	Tight junction	5515_4301_1460_10207_6714_207	6	0.008212079	0.599481733	0.012234321
7467	hsa-mir-196a-2	hsa03022	Basal transcription factors	2963_6908_2959	3	0.012609716	0.920509259	0.018410185
7468	hsa-mir-196a-2	hsa04730	Long-term depression	5515_5592_5595_5594	4	0.013253826	0.967529275	0.018971162
7469	hsa-mir-196a-2	hsa04360	Axon guidance	5998_5595_5594_2932_1020	5	0.025531577	1	0.035842407
7470	hsa-mir-196a-2	hsa04120	Ubiquitin mediated proteolysis	11059_55294_672_867_7329	5	0.031590971	1	0.043512092
7471	hsa-mir-196a-2	hsa05217	Basal cell carcinoma	2932_7157_2736	3	0.033595722	1	0.045416439
7472	hsa-mir-196a-2	hsa04950	Maturity onset diabetes of the young	6927_3651	2	0.039497441	1	0.052423877
7473	hsa-mir-196a-2	hsa03010	Ribosome	6124_6129_6143_6130	4	0.040583893	1	0.052904003
7474	hsa-mir-196b	hsa05200	Pathways in cancer	1869_3716_5371_1956_367_1499_5595_5594_1387_6256_4846_595_2308_836_1019_1017_2932_5914_7704_841_6776_51588_3091_5970_7428_1870_1871_7157_4087_6688_2113_4609_3725_4088_1026_861_4089_3066_3065_1050_5925_2034_2033_207_8554_4790_4792_7189_7046	49	6.39E-42	4.86E-40	4.86E-40
7475	hsa-mir-196b	hsa05220	Chronic myeloid leukemia	1869_5595_5594_595_1019_6776_5970_1870_1871_7157_4609_4088_1026_861_4089_3066_3065_5925_207_4790_4792_6464_7046	23	2.26E-26	1.72E-24	8.59E-25
7476	hsa-mir-196b	hsa05215	Prostate cancer	1869_1956_367_1499_5595_5594_1385_1387_595_2308_1017_2932_5970_1870_1871_7157_468_1026_5925_2033_207_4790_4792	23	5.10E-25	3.88E-23	1.21E-23
7477	hsa-mir-196b	hsa05212	Pancreatic cancer	1869_1956_367_1499_5595_5594_1385_1387_595_2308_1017_2932_5970_1870_1871_7157_468_1026_5925_2033_207_4790_4792	23	6.37E-25	4.84E-23	1.21E-23
7478	hsa-mir-196b	hsa04110	Cell cycle	1869_5591_1387_595_1019_7534_1017_7532_2932_7027_1870_1871_7157_4087_4088_1026_4089_3066_3065_5925_2033_5933	22	4.01E-21	3.05E-19	6.10E-20
7479	hsa-mir-196b	hsa05222	Small cell lung cancer	1869_6256_4846_595_1019_1017_51588_5970_1870_1871_7157_4609_5925_207_8554_4790_4792_7189	18	2.42E-18	1.84E-16	3.06E-17
7480	hsa-mir-196b	hsa04010	MAPK signaling pathway	6722_1956_5595_5594_1386_4208_836_5566_9252_1649_5970_3312_7157_468_4609_3725_6195_6196_4763_5058_207_4790_2002_7189_7046	25	3.55E-17	2.70E-15	3.86E-16
7481	hsa-mir-196b	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_5518_7027_3399_1874_4087_658_659_4609_4088_4089_2033_7046_5933	17	5.93E-17	4.50E-15	5.63E-16
7482	hsa-mir-196b	hsa05219	Bladder cancer	1869_1956_5595_5594_595_1019_9252_1870_1871_7157_4609_1026_5925	13	1.76E-15	1.34E-13	1.49E-14
7483	hsa-mir-196b	hsa05221	Acute myeloid leukemia	5371_5595_5594_595_5914_7704_6776_5970_6688_4609_861_1050_207_4790	14	3.33E-15	2.53E-13	2.53E-14
7484	hsa-mir-196b	hsa05214	Glioma	1869_815_1956_5595_5594_595_1019_1870_1871_7157_1026_5925_207_6464	14	1.07E-14	8.11E-13	7.38E-14
7485	hsa-mir-196b	hsa05210	Colorectal cancer	1956_1499_5595_5594_595_836_2932_7157_4087_4609_3725_4088_4089_207_7046	15	1.34E-14	1.02E-12	8.51E-14
7486	hsa-mir-196b	hsa04620	Toll-like receptor signaling pathway	3654_5595_5594_353376_3661_148022_841_5970_3725_4615_6348_207_4790_4792_7189	15	1.71E-13	1.30E-11	9.99E-13
7487	hsa-mir-196b	hsa04012	ErbB signaling pathway	815_1956_6714_5595_5594_2932_6776_4609_3725_1026_5058_207_6464_2002	14	3.70E-13	2.81E-11	2.01E-12
7488	hsa-mir-196b	hsa05223	Non-small cell lung cancer	1869_1956_5595_5594_6256_595_1019_1870_1871_7157_5925_207	12	6.37E-13	4.84E-11	3.23E-12
7489	hsa-mir-196b	hsa04520	Adherens junction	1956_1499_6714_5595_5594_1387_5777_4087_4088_1457_4089_2033_7046	13	2.33E-12	1.77E-10	1.11E-11
7490	hsa-mir-196b	hsa05218	Melanoma	1869_1956_5595_5594_595_1019_1870_1871_7157_1026_5925_207	12	1.10E-11	8.33E-10	4.90E-11
7491	hsa-mir-196b	hsa04310	Wnt signaling pathway	815_1499_1387_595_5566_5518_2932_7157_4087_4609_3725_4088_1457_4089_2033	15	3.19E-11	2.43E-09	1.35E-10
7492	hsa-mir-196b	hsa05213	Endometrial cancer	1956_1499_5595_5594_595_2932_7157_4609_207_2002	10	1.93E-10	1.47E-08	7.72E-10
7493	hsa-mir-196b	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_7428_2113_3725_5058_2034_2033_207	11	2.12E-10	1.61E-08	8.07E-10
7494	hsa-mir-196b	hsa04630	Jak-STAT signaling pathway	3716_3566_1387_595_5777_6778_6776_6773_51588_4609_2033_207_8554	13	4.20E-09	3.19E-07	1.52E-08
7495	hsa-mir-196b	hsa04720	Long-term potentiation	815_5595_5594_1387_2902_5566_468_6195_6196_2033	10	4.69E-09	3.57E-07	1.62E-08
7496	hsa-mir-196b	hsa04910	Insulin signaling pathway	6720_5590_5595_5594_2308_5566_2932_23265_207_6464_2002_2538	12	1.15E-08	8.75E-07	3.80E-08
7497	hsa-mir-196b	hsa04660	T cell receptor signaling pathway	5595_5594_1019_2932_5777_5970_3725_5058_207_4790_4792	11	1.25E-08	9.47E-07	3.94E-08
7498	hsa-mir-196b	hsa04210	Apoptosis	3654_836_5566_841_5970_7157_4615_207_4790_4792	10	2.09E-08	1.59E-06	6.36E-08
7499	hsa-mir-196b	hsa05216	Thyroid cancer	1499_5595_5594_6256_595_7157_4609	7	2.78E-08	2.11E-06	8.13E-08
7500	hsa-mir-196b	hsa04062	Chemokine signaling pathway	5590_5595_5594_5566_2932_6773_5970_5058_6348_207_4790_4792_6464	13	4.82E-08	3.67E-06	1.36E-07
7501	hsa-mir-196b	hsa04662	B cell receptor signaling pathway	5595_5594_2932_5777_5970_3725_207_4790_4792	9	6.42E-08	4.88E-06	1.74E-07
7502	hsa-mir-196b	hsa05016	Huntington's disease	6874_1385_1387_2902_836_6667_841_7157_3066_3065_3064_2033	12	2.75E-07	2.09E-05	7.21E-07
7503	hsa-mir-196b	hsa04330	Notch signaling pathway	1387_9612_3066_3065_2033_2648_8850	7	5.15E-07	3.91E-05	1.30E-06
7504	hsa-mir-196b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_836_5970_3725_5058_4790_4792	8	5.45E-07	4.14E-05	1.34E-06
7505	hsa-mir-196b	hsa04510	Focal adhesion	1956_1499_6714_5595_5594_595_2932_3725_5058_207_6464_2002	12	6.91E-07	5.25E-05	1.64E-06
7506	hsa-mir-196b	hsa04916	Melanogenesis	815_1499_5595_5594_1385_1387_5566_2932_2033	9	8.32E-07	6.32E-05	1.92E-06
7507	hsa-mir-196b	hsa04912	GnRH signaling pathway	815_1956_6714_5595_5594_5566_468_3725_2002	9	1.12E-06	8.48E-05	2.49E-06
7508	hsa-mir-196b	hsa04115	p53 signaling pathway	595_836_1019_1017_841_7157_1026	7	5.38E-06	0.000408528	1.17E-05
7509	hsa-mir-196b	hsa04150	mTOR signaling pathway	5595_5594_3091_6195_6196_207	6	1.31E-05	0.000993383	2.76E-05
7510	hsa-mir-196b	hsa04920	Adipocytokine signaling pathway	6256_5970_207_4790_4792_2538	6	4.92E-05	0.003736486	0.000100986
7511	hsa-mir-196b	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_51588_7428_7329_8554_7189	8	5.53E-05	0.004201751	0.000110572
7512	hsa-mir-196b	hsa05014	Amyotrophic lateral sclerosis (ALS)	4846_2902_836_834_7157	5	0.000215276	0.016360942	0.000419511
7513	hsa-mir-196b	hsa04530	Tight junction	5590_1499_6714_1019_5518_1457_207	7	0.000323193	0.024562661	0.000614067
7514	hsa-mir-196b	hsa04370	VEGF signaling pathway	6714_5595_5594_4846_207	5	0.000848268	0.064468346	0.001572399
7515	hsa-mir-196b	hsa05010	Alzheimer's disease	5595_5594_4846_2902_836_2932_841	7	0.001375404	0.104530703	0.002488826
7516	hsa-mir-196b	hsa04950	Maturity onset diabetes of the young	6927_3172_4760	3	0.001751986	0.133150958	0.003096534
7517	hsa-mir-196b	hsa04540	Gap junction	1956_6714_5595_5594_5566	5	0.001881491	0.142993353	0.003214847
7518	hsa-mir-196b	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_5777_5058_6464	6	0.001903528	0.144668104	0.003214847
7519	hsa-mir-196b	hsa04730	Long-term depression	5595_5594_4846_5518	4	0.004582488	0.348269111	0.007571068
7520	hsa-mir-196b	hsa04930	Type II diabetes mellitus	5590_5595_5594	3	0.009030201	0.686295282	0.014602027
7521	hsa-mir-196b	hsa04612	Antigen processing and presentation	1385_4800_3312_4801	4	0.00972331	0.738971571	0.015395241
7522	hsa-mir-196b	hsa05217	Basal cell carcinoma	1499_2932_7157	3	0.015096814	1	0.023415466
7523	hsa-mir-196b	hsa04340	Hedgehog signaling pathway	53944_5566_2932	3	0.016527236	1	0.025121398
7524	hsa-mir-196b	hsa04020	Calcium signaling pathway	815_1956_4846_2902_5566	5	0.027631821	1	0.041176831
7525	hsa-mir-196b	hsa04360	Axon guidance	5595_5594_2932_5058	4	0.033082473	1	0.048351306
7526	hsa-mir-196b	hsa04060	Cytokine-cytokine receptor interaction	1956_3566_658_659_6348_7046	6	0.033724864	1	0.048360182
7527	hsa-mir-196b	hsa04664	Fc epsilon RI signaling pathway	5595_5594_207	3	0.03712197	1	0.052245735
7528	hsa-mir-196b	hsa03022	Basal transcription factors	6874_6880	2	0.047319708	1	0.065387233
7529	hsa-mir-199a-1	hsa04630	Jak-STAT signaling pathway	3595_3594_9063_1387	4	6.20E-06	0.000179815	0.000179815
7530	hsa-mir-199a-1	hsa04620	Toll-like receptor signaling pathway	5608_3725_1432	3	7.00E-05	0.002028736	0.000797784
7531	hsa-mir-199a-1	hsa04912	GnRH signaling pathway	5608_3725_1432	3	8.25E-05	0.002393351	0.000797784
7532	hsa-mir-199a-1	hsa04120	Ubiquitin mediated proteolysis	11059_9063_4734	3	0.000171151	0.004963372	0.001240843
7533	hsa-mir-199a-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	5608_1432	2	0.000904057	0.026217656	0.005243531
7534	hsa-mir-199a-1	hsa04010	MAPK signaling pathway	5608_3725_1432	3	0.001187666	0.034442313	0.005315221
7535	hsa-mir-199a-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_1432	2	0.001427303	0.041391787	0.005315221
7536	hsa-mir-199a-1	hsa05211	Renal cell carcinoma	3725_1387	2	0.001466268	0.042521767	0.005315221
7537	hsa-mir-199a-1	hsa04664	Fc epsilon RI signaling pathway	5608_1432	2	0.001753151	0.050841375	0.005329972
7538	hsa-mir-199a-1	hsa05200	Pathways in cancer	9063_3725_1387	3	0.002066146	0.059918226	0.005329972
7539	hsa-mir-199a-1	hsa05215	Prostate cancer	90993_1387	2	0.002158036	0.062583051	0.005329972
7540	hsa-mir-199a-1	hsa05212	Pancreatic cancer	90993_1387	2	0.002205505	0.063959659	0.005329972
7541	hsa-mir-199a-1	hsa04916	Melanogenesis	90993_1387	2	0.002976396	0.086315471	0.006639652
7542	hsa-mir-199a-1	hsa04660	T cell receptor signaling pathway	3725_1432	2	0.00331532	0.096144272	0.006867448
7543	hsa-mir-199a-1	hsa04310	Wnt signaling pathway	3725_1387	2	0.006162064	0.178699856	0.011913324
7544	hsa-mir-199a-1	hsa05016	Huntington's disease	90993_1387	2	0.009235897	0.267841026	0.016740064
7545	hsa-mir-199a-1	hsa04060	Cytokine-cytokine receptor interaction	3595_3594	2	0.01725636	0.500434448	0.02943732
7546	hsa-mir-199a-1	hsa04330	Notch signaling pathway	1387	1	0.036145313	1	0.058234116
7547	hsa-mir-199a-2	hsa05200	Pathways in cancer	3725_3551_5468_5914_8517_6934_3091_4089_3066_3065_5925_25_4824_2113_10401_861_207_3716_1147_2249_5595_5599_6258_1387_6256_836_367_2932_6774_6776_6777_6772_5970_6688_2736_4087_4088_2033_4790_4791_4792_3320_3326_5371_5601_5602_842_841_4609_2353_8554	51	2.74E-29	2.14E-27	2.14E-27
7548	hsa-mir-199a-2	hsa04010	MAPK signaling pathway	6722_3725_3727_3551_6195_6197_8517_9252_4773_9020_8986_3305_3303_1432_1616_207_1147_2249_5595_5599_1386_1649_836_3312_5971_5970_468_6196_4790_4791_9261_1326_5601_5600_5602_5608_6885_4609_2353_8550_2002_2005_5566	43	3.16E-25	2.47E-23	1.23E-23
7549	hsa-mir-199a-2	hsa04620	Toll-like receptor signaling pathway	3725_3551_8517_3454_3455_3661_1432_207_1147_29110_5595_5599_6772_5970_4790_4792_1326_5601_5600_5602_5608_9641_841_6885_2353	25	3.84E-19	2.99E-17	9.98E-18
7550	hsa-mir-199a-2	hsa05215	Prostate cancer	3551_8517_6934_5925_4824_9586_207_1147_5595_1385_1387_367_2932_5970_468_2033_4790_4792_3320_3326_842	21	4.31E-16	3.36E-14	8.17E-15
7551	hsa-mir-199a-2	hsa05212	Pancreatic cancer	3551_8517_6934_5925_4824_9586_207_1147_5595_1385_1387_367_2932_5970_468_2033_4790_4792_3320_3326_842	21	5.24E-16	4.09E-14	8.17E-15
7552	hsa-mir-199a-2	hsa04310	Wnt signaling pathway	3725_815_8607_6934_6500_8945_4089_4773_23291_5599_1387_2932_1457_4087_4088_2033_5519_5515_5601_5602_8454_6885_4609_8061_5566	25	1.44E-15	1.12E-13	1.87E-14
7553	hsa-mir-199a-2	hsa04920	Adipocytokine signaling pathway	3551_5465_8517_8471_207_3717_1147_5599_6258_6256_6774_5970_4794_4790_4792_4793_5601_5602	18	9.55E-15	7.45E-13	1.06E-13
7554	hsa-mir-199a-2	hsa05220	Chronic myeloid leukemia	3551_8517_4089_3066_3065_5925_25_861_207_1147_5595_6776_6777_5970_4088_4790_4792_4609	18	5.06E-14	3.95E-12	4.93E-13
7555	hsa-mir-199a-2	hsa04660	T cell receptor signaling pathway	3725_3551_8517_4773_9020_1432_207_1147_5595_2932_5970_4794_4790_4792_4793_1326_5601_5600_6885_2353	20	1.93E-13	1.50E-11	1.67E-12
7556	hsa-mir-199a-2	hsa05221	Acute myeloid leukemia	3551_5914_8517_6934_861_207_1147_5595_6774_6776_6777_5970_6688_4790_5371_4609	16	2.60E-13	2.03E-11	2.03E-12
7557	hsa-mir-199a-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_3551_8517_9020_6714_1432_1147_5599_836_5970_4790_4792_5601_5600_5602	15	3.16E-11	2.47E-09	2.24E-10
7558	hsa-mir-199a-2	hsa04110	Cell cycle	6500_4089_3066_3065_5925_25_993_5591_1387_7533_2932_5111_4087_4088_2033_983_8454_1111	18	4.74E-11	3.70E-09	3.08E-10
7559	hsa-mir-199a-2	hsa04630	Jak-STAT signaling pathway	3454_3455_10401_3977_207_3717_3716_8651_1387_6778_6774_6775_6776_6777_6772_7297_2033_4609_8554_10379	20	5.30E-11	4.14E-09	3.18E-10
7560	hsa-mir-199a-2	hsa04210	Apoptosis	3551_8517_9020_823_207_1147_836_839_5970_9131_4790_4792_842_841_840_5566	16	5.84E-11	4.55E-09	3.24E-10
7561	hsa-mir-199a-2	hsa04662	B cell receptor signaling pathway	3725_3551_8517_4773_207_1147_695_5595_2932_5970_4794_4790_4792_4793_2353	15	6.23E-11	4.86E-09	3.24E-10
7562	hsa-mir-199a-2	hsa05210	Colorectal cancer	3725_6934_4089_207_5595_5599_836_2932_4087_4088_5601_5602_842_4609_2353	15	2.53E-10	1.97E-08	1.23E-09
7563	hsa-mir-199a-2	hsa04912	GnRH signaling pathway	3725_815_6714_1432_5595_5599_468_808_801_805_5601_5600_5602_5608_2002_5566	16	7.43E-10	5.80E-08	3.41E-09
7564	hsa-mir-199a-2	hsa05222	Small cell lung cancer	3551_8517_5925_10401_207_1147_6258_6256_5970_4790_4792_842_4609_8554	14	2.91E-09	2.27E-07	1.26E-08
7565	hsa-mir-199a-2	hsa04350	TGF-beta signaling pathway	6667_6500_4089_3399_3398_5595_1387_4087_4088_2033_5519_5515_8454_4609	14	3.32E-09	2.59E-07	1.30E-08
7566	hsa-mir-199a-2	hsa04012	ErbB signaling pathway	3725_815_25_6714_207_5595_5599_2932_6776_6777_5601_5602_4609_2002	14	3.32E-09	2.59E-07	1.30E-08
7567	hsa-mir-199a-2	hsa04720	Long-term potentiation	814_815_6195_6197_5595_1387_468_6196_2033_808_801_805_5566	13	5.47E-09	4.27E-07	2.03E-08
7568	hsa-mir-199a-2	hsa05016	Huntington's disease	6667_5468_292_293_3066_3065_3064_498_9586_5441_1385_1387_836_5437_1213_2033_6908_842_841	19	6.60E-09	5.15E-07	2.34E-08
7569	hsa-mir-199a-2	hsa04062	Chemokine signaling pathway	3551_8517_653361_7852_207_3717_1147_5590_5595_2932_6774_6777_6772_5970_4790_4792_4793_5566	18	5.12E-08	3.99E-06	1.73E-07
7570	hsa-mir-199a-2	hsa04910	Insulin signaling pathway	3551_8471_207_8651_5590_5595_5599_2932_808_801_805_5601_5602_2002_5566	15	1.08E-07	8.43E-06	3.51E-07
7571	hsa-mir-199a-2	hsa04930	Type II diabetes mellitus	3551_8471_3651_8651_5590_5595_5599_5601_5602	9	4.34E-07	3.38E-05	1.35E-06
7572	hsa-mir-199a-2	hsa04520	Adherens junction	6934_4089_6714_71_5595_1387_1457_4087_4088_2033_6885	11	6.65E-07	5.19E-05	1.93E-06
7573	hsa-mir-199a-2	hsa04120	Ubiquitin mediated proteolysis	55294_6500_8945_7329_23291_10401_51366_83737_8651_64326_5371_672_8454_8554	14	6.68E-07	5.21E-05	1.93E-06
7574	hsa-mir-199a-2	hsa03022	Basal transcription factors	2963_2962_2969_6878_6872_6908_6882_2959	8	1.15E-06	8.94E-05	3.19E-06
7575	hsa-mir-199a-2	hsa04916	Melanogenesis	815_6934_5595_1385_1387_2932_2033_808_801_805_5566	11	6.82E-06	0.000531886	1.83E-05
7576	hsa-mir-199a-2	hsa04540	Gap junction	10382_6714_5592_5595_7846_203068_347733_983_7278_5566	10	1.56E-05	0.001217587	4.06E-05
7577	hsa-mir-199a-2	hsa05131	Shigellosis	10382_25_71_7846_203068_347733_7278_4691	8	1.75E-05	0.001365407	4.27E-05
7578	hsa-mir-199a-2	hsa05130	Pathogenic Escherichia coli infection	10382_25_71_7846_203068_347733_7278_4691	8	1.75E-05	0.001365407	4.27E-05
7579	hsa-mir-199a-2	hsa04664	Fc epsilon RI signaling pathway	1432_207_695_5595_5599_5601_5600_5602_5608	9	2.73E-05	0.002129596	6.45E-05
7580	hsa-mir-199a-2	hsa03020	RNA polymerase	64425_25885_51082_5441_5437_84172	6	3.22E-05	0.002508901	7.17E-05
7581	hsa-mir-199a-2	hsa05216	Thyroid cancer	5468_6934_5595_6258_6256_4609	6	3.22E-05	0.002508901	7.17E-05
7582	hsa-mir-199a-2	hsa05010	Alzheimer's disease	498_823_22926_5595_836_2932_808_801_805_842_841_840_9451	13	3.91E-05	0.00304785	8.47E-05
7583	hsa-mir-199a-2	hsa04330	Notch signaling pathway	9612_3066_3065_1387_2033_8850_4851	7	4.64E-05	0.003620012	9.78E-05
7584	hsa-mir-199a-2	hsa04612	Antigen processing and presentation	3309_3305_3303_1385_3312_1514_3320_3326_4800	9	6.43E-05	0.005015054	0.000131975
7585	hsa-mir-199a-2	hsa05213	Endometrial cancer	6934_207_5595_2932_842_4609_2002	7	8.28E-05	0.006459759	0.000165635
7586	hsa-mir-199a-2	hsa04370	VEGF signaling pathway	4773_6714_1432_207_5595_9261_5600_842	8	0.000137445	0.010720683	0.000268017
7587	hsa-mir-199a-2	hsa03010	Ribosome	6155_6156_6207_6141_6217_6128_9349_6142_6188	9	0.000168485	0.013141804	0.000320532
7588	hsa-mir-199a-2	hsa05214	Glioma	815_5925_207_5595_808_801_805	7	0.000293258	0.022874104	0.000544622
7589	hsa-mir-199a-2	hsa05211	Renal cell carcinoma	3725_3091_2113_207_5595_1387_2033	7	0.000518748	0.04046235	0.000940985
7590	hsa-mir-199a-2	hsa04150	mTOR signaling pathway	6195_6197_3091_207_5595_6196	6	0.000568075	0.044309888	0.001007043
7591	hsa-mir-199a-2	hsa05223	Non-small cell lung cancer	5925_207_5595_6258_6256_842	6	0.000681974	0.053194009	0.001182089
7592	hsa-mir-199a-2	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_1616_836_5600_5608_842	6	0.000812787	0.063397352	0.001378203
7593	hsa-mir-199a-2	hsa04115	p53 signaling pathway	836_64326_983_842_841_1111	6	0.002193941	0.171127432	0.003641009
7594	hsa-mir-199a-2	hsa04530	Tight junction	6714_4628_207_71_5590_1457_5519_5515	8	0.004524847	0.352938097	0.007352877
7595	hsa-mir-199a-2	hsa04340	Hedgehog signaling pathway	8945_23291_2932_2736_5566	5	0.004906566	0.382712174	0.007810453
7596	hsa-mir-199a-2	hsa03410	Base excision repair	3146_142_5111_6996	4	0.005441472	0.424434851	0.008487837
7597	hsa-mir-199a-2	hsa04510	Focal adhesion	3725_6714_207_71_5595_5599_2932_5601_5602_2002	10	0.005549739	0.432879674	0.008487837
7598	hsa-mir-199a-2	hsa05219	Bladder cancer	9252_5925_5595_4609	4	0.008939516	0.697282284	0.013409275
7599	hsa-mir-199a-2	hsa03320	PPAR signaling pathway	5465_5468_10062_6258_6256	5	0.010855932	0.846762689	0.015976655
7600	hsa-mir-199a-2	hsa04950	Maturity onset diabetes of the young	6927_3087_3651	3	0.011904625	0.928560784	0.01719557
7601	hsa-mir-199a-2	hsa04020	Calcium signaling pathway	814_815_292_293_808_801_805_5566	8	0.022033862	1	0.031248023
7602	hsa-mir-199a-2	hsa04270	Vascular smooth muscle contraction	5592_5595_808_801_805_5566	6	0.023669132	1	0.03296772
7603	hsa-mir-199a-2	hsa03450	Non-homologous end-joining	2547_5591	2	0.032110193	1	0.043940264
7604	hsa-mir-199a-2	hsa05012	Parkinson's disease	292_293_498_7314_836_842	6	0.041773986	1	0.056178808
7605	hsa-mir-199a-2	hsa05218	Melanoma	5925_207_2249_5595	4	0.044728436	1	0.058146967
7606	hsa-mir-199a-2	hsa04730	Long-term depression	5592_5595_5519_5515	4	0.044728436	1	0.058146967
7607	hsa-mir-199b	hsa05200	Pathways in cancer	3320_3326_1147_5371_3551_1499_5595_5594_6258_1387_6256_836_367_8517_2932_7704_842_841_6774_5970_4824_6688_2113_1869_862_6502_2353_3065_7175_5925_2033_207_4791_4792	34	2.48E-23	1.86E-21	1.86E-21
7608	hsa-mir-199b	hsa05215	Prostate cancer	3320_3326_1147_3551_1499_5595_5594_1385_1387_367_8517_2932_842_5970_4824_1869_5925_2033_207_4792	20	3.42E-20	2.56E-18	1.04E-18
7609	hsa-mir-199b	hsa05212	Pancreatic cancer	3320_3326_1147_3551_1499_5595_5594_1385_1387_367_8517_2932_842_5970_4824_1869_5925_2033_207_4792	20	4.15E-20	3.11E-18	1.04E-18
7610	hsa-mir-199b	hsa04010	MAPK signaling pathway	6722_1147_3551_5595_5594_9261_1326_4208_3305_3303_836_5566_8517_7867_3310_3312_1432_5971_5970_6195_2353_207_4791_2002_2005	25	2.23E-16	1.68E-14	4.19E-15
7611	hsa-mir-199b	hsa05221	Acute myeloid leukemia	1147_5371_3551_5595_5594_8517_7704_6774_5970_6688_862_207	12	3.96E-12	2.97E-10	5.94E-11
7612	hsa-mir-199b	hsa04660	T cell receptor signaling pathway	1147_3551_5595_5594_1326_8517_2932_1432_5970_4794_2353_207_4792_4793	14	1.85E-11	1.38E-09	2.21E-10
7613	hsa-mir-199b	hsa04210	Apoptosis	1147_3551_836_5566_839_8517_842_841_840_5970_8837_207_4792	13	2.07E-11	1.55E-09	2.21E-10
7614	hsa-mir-199b	hsa04662	B cell receptor signaling pathway	1147_3551_5595_5594_8517_2932_5970_4794_2353_207_4792_4793	12	4.79E-11	3.59E-09	4.49E-10
7615	hsa-mir-199b	hsa05222	Small cell lung cancer	1147_3551_6258_6256_8517_842_5970_1869_6502_5925_207_4792	12	2.00E-10	1.50E-08	1.66E-09
7616	hsa-mir-199b	hsa04920	Adipocytokine signaling pathway	1147_3551_6258_6256_8517_6774_5970_4794_207_4792_4793	11	2.43E-10	1.82E-08	1.82E-09
7617	hsa-mir-199b	hsa05220	Chronic myeloid leukemia	1147_3551_5595_5594_8517_5970_1869_3065_5925_207_4792	11	7.13E-10	5.35E-08	4.86E-09
7618	hsa-mir-199b	hsa04620	Toll-like receptor signaling pathway	1147_3551_5595_5594_1326_8517_1432_841_5970_2353_207_4792	12	1.18E-09	8.87E-08	7.39E-09
7619	hsa-mir-199b	hsa04916	Melanogenesis	815_1499_5595_5594_1385_1387_5566_2932_2033_808_801_805	12	1.45E-09	1.09E-07	8.36E-09
7620	hsa-mir-199b	hsa04720	Long-term potentiation	815_5595_5594_1387_5566_6195_2033_808_801_805	10	9.83E-09	7.37E-07	5.27E-08
7621	hsa-mir-199b	hsa04120	Ubiquitin mediated proteolysis	55294_5371_23291_672_8454_3093_10273_8945_6502_6500_7323_7329	12	2.92E-08	2.19E-06	1.46E-07
7622	hsa-mir-199b	hsa04350	TGF-beta signaling pathway	3399_5595_5594_1387_6667_8454_3398_6500_2033_3397	10	3.57E-08	2.68E-06	1.67E-07
7623	hsa-mir-199b	hsa05214	Glioma	815_5595_5594_1869_5925_207_808_801_805	9	4.06E-08	3.04E-06	1.79E-07
7624	hsa-mir-199b	hsa04310	Wnt signaling pathway	815_23291_1499_1387_5566_1457_2932_8454_8945_8607_6500_2033	12	7.31E-08	5.48E-06	3.05E-07
7625	hsa-mir-199b	hsa05016	Huntington's disease	1385_1387_292_836_6667_842_841_293_1213_5437_3065_2033_5441	13	8.93E-08	6.70E-06	3.52E-07
7626	hsa-mir-199b	hsa04062	Chemokine signaling pathway	1147_3551_5595_5594_5566_8517_2932_6774_5970_653361_207_4792_4793	13	1.19E-07	8.92E-06	4.46E-07
7627	hsa-mir-199b	hsa05223	Non-small cell lung cancer	5595_5594_6258_6256_842_1869_5925_207	8	1.46E-07	1.09E-05	5.21E-07
7628	hsa-mir-199b	hsa04912	GnRH signaling pathway	815_6714_5595_5594_5566_1432_2002_808_801_805	10	2.31E-07	1.74E-05	7.67E-07
7629	hsa-mir-199b	hsa04910	Insulin signaling pathway	3551_5595_5594_5566_2932_23265_207_2002_808_801_805	11	2.35E-07	1.76E-05	7.67E-07
7630	hsa-mir-199b	hsa04612	Antigen processing and presentation	3320_3326_1385_3309_3305_3303_4800_3310_3312	9	4.72E-07	3.54E-05	1.48E-06
7631	hsa-mir-199b	hsa04110	Cell cycle	5591_1387_2932_8454_1869_6502_6500_3065_5925_2033	10	5.32E-07	3.99E-05	1.60E-06
7632	hsa-mir-199b	hsa04540	Gap junction	6714_5595_5594_5566_7278_347733_10382_84617_203068	9	6.65E-07	4.99E-05	1.92E-06
7633	hsa-mir-199b	hsa04330	Notch signaling pathway	388585_1387_4851_9612_3065_2033_8850	7	8.65E-07	6.49E-05	2.40E-06
7634	hsa-mir-199b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_6714_836_8517_1432_5970_4792	8	9.77E-07	7.33E-05	2.44E-06
7635	hsa-mir-199b	hsa03020	RNA polymerase	64425_5437_25885_51082_84172_5441	6	9.78E-07	7.33E-05	2.44E-06
7636	hsa-mir-199b	hsa05216	Thyroid cancer	1499_5595_5594_6258_6256_7175	6	9.78E-07	7.33E-05	2.44E-06
7637	hsa-mir-199b	hsa05213	Endometrial cancer	1499_5595_5594_2932_842_207_2002	7	1.60E-06	0.000119951	3.87E-06
7638	hsa-mir-199b	hsa04370	VEGF signaling pathway	6714_5595_5594_9261_7867_1432_842_207	8	1.71E-06	0.000128583	4.02E-06
7639	hsa-mir-199b	hsa04520	Adherens junction	1499_6714_5595_5594_1387_1457_2033_71	8	2.23E-06	0.000167508	5.08E-06
7640	hsa-mir-199b	hsa05010	Alzheimer's disease	22926_5595_5594_836_2932_842_841_840_808_801_805	11	2.36E-06	0.000177029	5.21E-06
7641	hsa-mir-199b	hsa05131	Shigellosis	1499_7278_347733_10382_84617_203068_71	7	2.51E-06	0.000188242	5.23E-06
7642	hsa-mir-199b	hsa05130	Pathogenic Escherichia coli infection	1499_7278_347733_10382_84617_203068_71	7	2.51E-06	0.000188242	5.23E-06
7643	hsa-mir-199b	hsa05210	Colorectal cancer	1499_5595_5594_836_2932_842_2353_207	8	3.13E-06	0.000234638	6.34E-06
7644	hsa-mir-199b	hsa04012	ErbB signaling pathway	815_6714_5595_5594_2932_207_2002	7	3.60E-05	0.002700591	7.11E-05
7645	hsa-mir-199b	hsa04530	Tight junction	1499_6714_1457_4627_4628_10627_207_71	8	8.62E-05	0.006467493	0.000165833
7646	hsa-mir-199b	hsa05211	Renal cell carcinoma	5595_5594_1387_2113_2033_207	6	0.000109392	0.008204377	0.000205109
7647	hsa-mir-199b	hsa04270	Vascular smooth muscle contraction	5595_5594_4637_5566_808_801_805	7	0.000217736	0.016330169	0.000398297
7648	hsa-mir-199b	hsa04510	Focal adhesion	1499_6714_5595_5594_2932_10627_207_71_2002	9	0.000257518	0.019313847	0.000459853
7649	hsa-mir-199b	hsa05218	Melanoma	5595_5594_1869_5925_207	5	0.000849922	0.063744155	0.001482422
7650	hsa-mir-199b	hsa05219	Bladder cancer	5595_5594_1869_5925	4	0.001003692	0.075276877	0.001710838
7651	hsa-mir-199b	hsa04930	Type II diabetes mellitus	3651_3551_5595_5594	4	0.001274041	0.095553101	0.002123402
7652	hsa-mir-199b	hsa04150	mTOR signaling pathway	5595_5594_6195_207	4	0.002095263	0.157144704	0.003416189
7653	hsa-mir-199b	hsa04950	Maturity onset diabetes of the young	3651_168620_4760	3	0.002184742	0.163855667	0.003486291
7654	hsa-mir-199b	hsa04020	Calcium signaling pathway	815_292_5566_293_808_801_805	7	0.002630469	0.197285182	0.004110108
7655	hsa-mir-199b	hsa04340	Hedgehog signaling pathway	23291_5566_2932_8945	4	0.002867305	0.215047877	0.004388732
7656	hsa-mir-199b	hsa04630	Jak-STAT signaling pathway	3559_1387_6774_6778_2033_207	6	0.004834055	0.362554113	0.007251082
7657	hsa-mir-199b	hsa04810	Regulation of actin cytoskeleton	5595_5594_4627_4628_10788_10627_71	7	0.006555641	0.491673087	0.009640649
7658	hsa-mir-199b	hsa04670	Leukocyte transendothelial migration	1499_1432_653361_10627_71	5	0.007872998	0.590474825	0.011355285
7659	hsa-mir-199b	hsa04664	Fc epsilon RI signaling pathway	5595_5594_1432_207	4	0.008565655	0.642424134	0.01212121
7660	hsa-mir-199b	hsa05012	Parkinson's disease	7314_292_836_842_293	5	0.012019639	0.901472943	0.016693943
7661	hsa-mir-199b	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432_842	3	0.019379084	1	0.026148668
7662	hsa-mir-199b	hsa03010	Ribosome	6156_6128_6207_6202	4	0.019524339	1	0.026148668
7663	hsa-mir-199b	hsa04115	p53 signaling pathway	836_842_841	3	0.032473573	1	0.042728386
7664	hsa-mir-199b	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.041018859	1	0.053041627
7665	hsa-mir-19a	hsa05200	Pathways in cancer	4149_3551_1398_1499_5914_595_596_598_3815_1017_8517_4193_6934_5578_3091_2735_2064_3066_3065_5925_1050_613_5743_5747_10342_25_405_9063_1956_1487_6789_7046_4436_1870_1871_2113_6774_867_10401_207_208_9915_7187_4286_3716_1147_5879_2249_998_1488_2261_5595_5594_5599_861_1387_6256_836_367_2932_6777_6772_5970_7157_7849_1869_3725_5467_6776_4087_4088_4089_5888_5728_2034_2033_5468_4846_3910_898_4790_4791_4792_3320_3326_51176_5371_675_5159_5156_5604_5601_5602_1856_1399_3265_51588_7428_8772_4609_2956_1026_2736_2353_7704_2737_8554	107	1.09E-45	9.69E-44	9.69E-44
7666	hsa-mir-19a	hsa04010	MAPK signaling pathway	6722_4149_3551_1398_6195_6197_2264_8517_9252_5578_1845_7132_4773_9020_5923_1956_3304_3305_3303_6789_1432_7046_22800_4763_1616_207_208_1147_5879_2249_998_3727_2261_5595_5594_5599_5598_8986_1386_1649_836_3310_3312_3315_5971_5970_3164_7157_3725_6196_5058_4790_4791_5159_9261_1326_5156_5604_4208_5601_5600_5603_5602_5608_1399_3265_6885_4609_2353_2002_8550_5566	72	1.47E-26	1.31E-24	6.54E-25
7667	hsa-mir-19a	hsa05220	Chronic myeloid leukemia	3551_1398_595_598_8517_4193_3066_3065_5925_613_25_1487_7046_1870_1871_867_207_208_1147_1488_5595_5594_861_6777_5970_7157_1869_6776_4088_4089_4790_4792_5604_1399_3265_5781_4609_1026_6464	39	2.88E-23	2.56E-21	8.53E-22
7668	hsa-mir-19a	hsa04110	Cell cycle	4174_4172_595_1017_4193_902_6500_3066_3065_5925_25_1870_1871_5111_9232_5934_5933_545_995_5347_7534_5591_1387_11200_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_898_1031_983_8454_1026_1022_1111_8556_8555_472	44	2.18E-21	1.94E-19	4.85E-20
7669	hsa-mir-19a	hsa05215	Prostate cancer	3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026	38	1.64E-20	1.46E-18	2.92E-19
7670	hsa-mir-19a	hsa05212	Pancreatic cancer	3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026	38	2.24E-20	1.99E-18	3.32E-19
7671	hsa-mir-19a	hsa04310	Wnt signaling pathway	818_817_1499_595_8607_6934_5578_6500_4772_4773_23291_1487_5879_1460_1488_5599_1387_1459_2932_7157_8061_3725_5467_1457_1452_4087_4088_4089_2033_51176_5519_5518_5515_5601_5602_1856_8454_8945_6885_4609_5527_5566	42	1.16E-16	1.03E-14	1.48E-15
7672	hsa-mir-19a	hsa04660	T cell receptor signaling pathway	3551_1493_8517_5777_4772_4773_9020_2534_3932_4794_1432_867_207_208_1147_998_5595_5594_2932_5970_3725_5058_959_4790_4792_4793_1326_5604_5601_5600_5603_919_3265_6885_2353	35	1.17E-15	1.04E-13	1.30E-14
7673	hsa-mir-19a	hsa05222	Small cell lung cancer	4149_3551_595_596_598_1017_8517_5925_5743_5747_9063_1870_1871_10401_207_208_7187_1147_6256_5970_7157_1869_5728_4846_3910_898_4790_4792_51588_4609_8554	31	3.05E-15	2.72E-13	3.02E-14
7674	hsa-mir-19a	hsa05210	Colorectal cancer	1499_595_596_6934_1956_7046_4436_207_208_5879_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_51176_5159_5156_5604_5601_5602_1856_4609_2956_2353	30	1.04E-14	9.26E-13	9.26E-14
7675	hsa-mir-19a	hsa04012	ErbB signaling pathway	818_817_1398_5578_2064_5747_25_1956_6714_867_207_208_5595_5594_5599_2066_2932_6777_3725_6776_5058_5604_5601_5602_1399_3265_4609_1026_2002_6464	30	2.22E-14	1.98E-12	1.80E-13
7676	hsa-mir-19a	hsa05221	Acute myeloid leukemia	3551_5914_595_3815_8517_6934_1050_6774_207_208_1147_5595_5594_861_6777_5970_5467_6776_4790_51176_5371_5604_3265_4609_7704	25	7.83E-14	6.97E-12	5.61E-13
7677	hsa-mir-19a	hsa04630	Jak-STAT signaling pathway	3559_595_598_5777_3455_3594_9063_3560_3561_6773_1439_3595_2057_6774_867_2690_10401_3459_3977_207_208_3717_3716_8651_1387_6778_6777_6772_7297_6776_2033_51588_10379_5781_58985_4609_3575_8554	38	8.19E-14	7.29E-12	5.61E-13
7678	hsa-mir-19a	hsa04920	Adipocytokine signaling pathway	3551_10891_5465_6794_8517_7132_8717_2538_4794_8471_6774_207_208_3717_1147_5599_6256_5970_4790_4792_4793_5601_5602_5563_5781_7133	26	1.29E-13	1.15E-11	8.15E-13
7679	hsa-mir-19a	hsa04620	Toll-like receptor signaling pathway	3551_8517_3455_3665_3661_1432_207_208_7187_1147_5879_29110_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5601_5600_5603_5602_5608_9641_8772_6885_2353	31	1.37E-13	1.22E-11	8.15E-13
7680	hsa-mir-19a	hsa05214	Glioma	818_817_595_4193_5578_5925_1956_1870_1871_207_208_5595_5594_7157_1869_5728_808_801_805_5159_5156_5604_3265_1026_6464	25	4.48E-13	3.98E-11	2.49E-12
7681	hsa-mir-19a	hsa04520	Adherens junction	1499_6934_5770_5777_2064_2534_1956_6714_7046_5879_1460_998_5595_5594_1387_1459_1457_4087_4088_4089_2033_51176_3643_71_8826_6885	26	3.59E-12	3.20E-10	1.88E-11
7682	hsa-mir-19a	hsa04910	Insulin signaling pathway	3551_10891_1398_6720_5770_2538_5590_5499_8471_867_5211_207_208_8651_5595_5594_5599_2932_2194_808_801_805_3643_5604_5601_5602_5563_1399_3265_2002_6464_5566	32	2.57E-11	2.28E-09	1.27E-10
7683	hsa-mir-19a	hsa04662	B cell receptor signaling pathway	3551_8517_5777_4772_4773_4794_207_208_1147_5879_695_5595_5594_1380_2932_6850_5970_3725_4790_4792_4793_5604_3265_2353	24	3.15E-11	2.80E-09	1.48E-10
7684	hsa-mir-19a	hsa04350	TGF-beta signaling pathway	6500_90_4086_1875_6667_7046_1874_57154_5934_5933_5595_5594_1387_7027_4087_4088_4089_2033_5519_5518_5515_8454_4609_4093_4092	25	8.45E-11	7.52E-09	3.76E-10
7685	hsa-mir-19a	hsa04115	p53 signaling pathway	595_1017_4194_4193_900_50484_51246_545_7161_11200_836_7157_6241_64326_5728_898_27113_25898_983_1026_1111_472	22	2.19E-10	1.95E-08	9.29E-10
7686	hsa-mir-19a	hsa04510	Focal adhesion	1398_1499_595_596_5578_2064_5923_2534_5747_3791_1956_6714_5499_207_208_5879_998_5595_5594_5599_2932_3725_5058_5728_3910_2321_5159_5156_5604_5601_5602_1399_3265_71_2002_85366_6464	37	4.52E-10	4.03E-08	1.83E-09
7687	hsa-mir-19a	hsa04062	Chemokine signaling pathway	3551_1398_8517_653361_5747_5580_5590_6773_2309_6362_6774_207_208_3717_1147_5879_998_5595_5594_1234_2932_6777_6772_5970_5058_4790_4792_4793_1230_5604_1399_3265_7852_6464_5566	35	1.06E-09	9.45E-08	4.11E-09
7688	hsa-mir-19a	hsa05219	Bladder cancer	595_9252_4193_2064_5925_1956_1870_1871_2261_5595_5594_7157_1869_5604_3265_4609_1026	17	1.31E-09	1.16E-07	4.85E-09
7689	hsa-mir-19a	hsa03010	Ribosome	6193_6204_6205_6207_6202_6141_9349_6217_6137_6135_6210_6155_6156_6191_6222_6223_6229_6129_6128_6125_6130_6181_6189_6188_6232	25	1.42E-09	1.26E-07	5.05E-09
7690	hsa-mir-19a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3551_8517_9020_1956_6714_1432_1147_5879_998_5599_836_5970_3725_5058_4790_4792_5601_5600_5603_5602_5781	21	1.74E-09	1.55E-07	5.96E-09
7691	hsa-mir-19a	hsa05211	Renal cell carcinoma	1398_3091_405_2113_207_208_9915_5879_998_5595_5594_1387_3725_5058_2034_2033_5604_1399_3265_7428_5781	21	2.15E-09	1.91E-07	7.08E-09
7692	hsa-mir-19a	hsa05213	Endometrial cancer	1499_595_6934_2064_1956_2309_207_208_5595_5594_2932_7157_5728_51176_5604_3265_4609_2002	18	3.26E-09	2.90E-07	1.04E-08
7693	hsa-mir-19a	hsa04912	GnRH signaling pathway	818_817_5578_5580_1956_6714_1432_998_5595_5594_5599_5598_3725_808_801_805_5604_5601_5600_5603_5602_5608_3265_2002_5566	25	3.86E-09	3.43E-07	1.18E-08
7694	hsa-mir-19a	hsa05223	Non-small cell lung cancer	595_5578_2064_5925_1956_2309_6789_1870_1871_207_208_5595_5594_6256_7157_1869_5604_3265	18	5.31E-09	4.73E-07	1.58E-08
7695	hsa-mir-19a	hsa04370	VEGF signaling pathway	5578_4772_4773_5743_5747_3791_6714_1432_207_208_5879_998_5595_5594_3315_4846_9261_5604_5600_5603_3265	21	5.87E-09	5.23E-07	1.69E-08
7696	hsa-mir-19a	hsa05216	Thyroid cancer	1499_595_6934_10342_5595_5594_6256_7157_7849_5468_51176_5604_3265_4609	14	6.40E-09	5.70E-07	1.78E-08
7697	hsa-mir-19a	hsa05218	Melanoma	595_4193_5925_1956_1870_1871_207_208_4286_2249_5595_5594_7157_1869_5728_5159_5156_5604_3265_1026	20	8.48E-09	7.55E-07	2.29E-08
7698	hsa-mir-19a	hsa04210	Apoptosis	3551_596_598_8517_7132_8717_9020_823_1439_207_208_1147_836_5970_7157_9131_4790_4792_840_8772_472_5566	22	1.19E-08	1.06E-06	3.10E-08
7699	hsa-mir-19a	hsa04720	Long-term potentiation	818_814_817_6195_6197_5578_2902_2906_5499_5595_5594_1387_6196_2033_808_801_805_5604_3265_5566	20	1.85E-08	1.65E-06	4.71E-08
7700	hsa-mir-19a	hsa04120	Ubiquitin mediated proteolysis	4193_55294_6500_3093_23291_9063_7319_84447_867_10401_7329_8925_57154_8651_10055_51366_64326_7337_5371_672_25898_8454_8945_51588_7428_10075_8554	27	2.40E-08	2.13E-06	5.93E-08
7701	hsa-mir-19a	hsa03022	Basal transcription factors	51616_6872_2965_2963_2969_6878_6874_6908_2958_2959_6880_2957_6882_9519	14	7.37E-08	6.56E-06	1.77E-07
7702	hsa-mir-19a	hsa04664	Fc epsilon RI signaling pathway	5578_2534_5580_1432_207_208_5879_695_5595_5594_5599_6850_5604_5601_5600_5603_5602_5608_3265	19	1.67E-07	1.49E-05	3.91E-07
7703	hsa-mir-19a	hsa04540	Gap junction	5592_5578_10382_1956_6714_5595_5594_5598_7846_1453_347733_5159_983_5156_5604_3265_7278_84617_203068_5566	20	3.78E-07	3.36E-05	8.62E-07
7704	hsa-mir-19a	hsa04330	Notch signaling pathway	3066_3065_1840_9794_1487_2648_1488_1387_22938_9612_2033_8850_1856_4851	14	8.20E-07	7.30E-05	1.83E-06
7705	hsa-mir-19a	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_598_7132_2902_2906_1432_1616_5879_836_7157_4846_5600_5603_5608_7133	15	1.04E-06	9.28E-05	2.26E-06
7706	hsa-mir-19a	hsa04916	Melanogenesis	818_817_1499_3815_6934_5578_4286_5595_5594_1387_2932_2033_808_801_805_51176_5604_1856_3265_5566	20	1.74E-06	0.000154611	3.68E-06
7707	hsa-mir-19a	hsa05131	Shigellosis	1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068	14	4.71E-06	0.00041917	9.53E-06
7708	hsa-mir-19a	hsa05130	Pathogenic Escherichia coli infection	1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068	14	4.71E-06	0.00041917	9.53E-06
7709	hsa-mir-19a	hsa04530	Tight junction	1499_5578_5580_5590_6714_4627_4628_22800_8573_207_208_1460_998_1459_1457_5728_5519_5518_5515_3265_71_5520	22	7.30E-06	0.000649919	1.44E-05
7710	hsa-mir-19a	hsa04930	Type II diabetes mellitus	3551_5580_5590_8471_3651_8651_5595_5594_5599_3643_5601_5602	12	1.29E-05	0.001144695	2.49E-05
7711	hsa-mir-19a	hsa03050	Proteasome	5708_5709_5705_5706_5700_5684_5719_5717_5713_5687_5693_5707	12	2.23E-05	0.001983967	4.22E-05
7712	hsa-mir-19a	hsa05322	Systemic lupus erythematosus	3021_3020_8366_9555_8349_8362_8365_8368_3018_8294_8370_6628_121504_8360_8363_8364_8367_959_8359_8361	20	0.000114962	0.010231574	0.000213158
7713	hsa-mir-19a	hsa04650	Natural killer cell mediated cytotoxicity	5777_5578_3455_4772_4773_2534_3932_3459_5879_5595_5594_836_6850_5058_5604_919_3265_5781_6464	19	0.00018639	0.016588666	0.000338544
7714	hsa-mir-19a	hsa03420	Nucleotide excision repair	5981_902_5111_5886_2965_4331_2071_2074_1022_6117	10	0.000208973	0.018598561	0.000371971
7715	hsa-mir-19a	hsa03410	Base excision repair	4350_142_4913_252969_5111_3146_328_2237_6996	9	0.000234704	0.020888642	0.000404365
7716	hsa-mir-19a	hsa05016	Huntington's disease	10891_293_292_3066_3065_3064_498_25942_2902_6667_9586_1387_836_5437_7157_1213_2033_5468_27113_6874_6908_5441_9519	23	0.000236258	0.021026969	0.000404365
7717	hsa-mir-19a	hsa03450	Non-homologous end-joining	2547_10111_7520_2237_5591_4361	6	0.000254676	0.022666203	0.000427664
7718	hsa-mir-19a	hsa04060	Cytokine-cytokine receptor interaction	3559_3815_7132_3455_90_3594_3791_1956_3560_3561_1439_7046_3595_2057_6362_2690_3459_3977_1234_959_2321_1230_5159_5156_7852_58985_3575_7133	28	0.000428557	0.038141597	0.000706326
7719	hsa-mir-19a	hsa04150	mTOR signaling pathway	6794_6195_6197_3091_207_208_5595_5594_6196_5563	10	0.000664511	0.059141519	0.0010753
7720	hsa-mir-19a	hsa04810	Regulation of actin cytoskeleton	10788_1398_2264_5747_1956_5499_4627_4628_22800_5879_2249_998_2261_5595_5594_5058_5159_5156_5604_1399_3265_71_8826_85366	24	0.000734187	0.065342612	0.001166832
7721	hsa-mir-19a	hsa03030	DNA replication	5981_4174_4172_5111_2237_5557_6117_5422	8	0.001009998	0.089889789	0.001577014
7722	hsa-mir-19a	hsa03440	Homologous recombination	641_10111_4361_4683_5888_675_6117	7	0.001154958	0.102791261	0.001772263
7723	hsa-mir-19a	hsa04340	Hedgehog signaling pathway	2735_23291_53944_2932_1452_1453_8945_2736_2737_5566	10	0.001235803	0.10998646	0.001864177
7724	hsa-mir-19a	hsa04020	Calcium signaling pathway	818_814_817_293_5578_292_2064_1956_2902_2906_147_2066_4846_808_801_805_5159_5156_85366_5566	20	0.002418527	0.215248871	0.003587481
7725	hsa-mir-19a	hsa04740	Olfactory transduction	818_817_5592_808_801_805_5566	7	0.002690948	0.239494361	0.003926137
7726	hsa-mir-19a	hsa05217	Basal cell carcinoma	1499_6934_2735_2932_7157_51176_1856_2736_2737	9	0.003243108	0.288636595	0.004655429
7727	hsa-mir-19a	hsa04730	Long-term depression	5592_5578_5595_5594_4846_5519_5518_5515_5604_3265	10	0.005138341	0.457312374	0.007258927
7728	hsa-mir-19a	hsa03020	RNA polymerase	64425_25885_51082_5437_84172_5441	6	0.005784676	0.514836197	0.008007755
7729	hsa-mir-19a	hsa04270	Vascular smooth muscle contraction	5592_5578_5580_147_5499_59_5595_5594_808_801_805_5604_85366_5566	14	0.005848361	0.520504088	0.008007755
7730	hsa-mir-19a	hsa03430	Mismatch repair	5981_4436_5111_2956_6117	5	0.00967112	0.860729705	0.013041359
7731	hsa-mir-19a	hsa04360	Axon guidance	4772_4773_2534_5747_25_5879_998_5595_5594_2932_5058_3265_7852_1020	14	0.010520257	0.936302834	0.013974669
7732	hsa-mir-19a	hsa04950	Maturity onset diabetes of the young	5080_6927_4760_3651_3172	5	0.011235995	1	0.014705934
7733	hsa-mir-19a	hsa05340	Primary immunodeficiency	8517_3932_3561_695_959_3575	6	0.012581327	1	0.016228089
7734	hsa-mir-19a	hsa05010	Alzheimer's disease	7132_498_823_2902_2906_5595_5594_836_2932_4846_808_351_801_805_840_8772_1020	17	0.016210182	1	0.020610088
7735	hsa-mir-19a	hsa04612	Antigen processing and presentation	3309_3304_3305_3303_3310_3312_3320_3326_4800_4801	10	0.027680759	1	0.034698417
7736	hsa-mir-19a	hsa04670	Leukocyte transendothelial migration	1499_5578_653361_5747_1432_5879_998_5600_5603_7852_71_5781	12	0.037827534	1	0.046535049
7737	hsa-mir-19a	hsa04710	Circadian rhythm - mammal	8863_4862_1453	3	0.038169197	1	0.046535049
7738	hsa-mir-19b-1	hsa05200	Pathways in cancer	4149_3551_1398_1499_5914_595_596_598_3815_1017_8517_4193_6934_5578_3091_2735_2064_3066_3065_5925_1050_613_5743_5747_10342_25_405_9063_1956_1487_6789_7046_4436_1870_1871_2113_6774_867_10401_207_208_9915_7187_4286_3716_1147_5879_2249_998_1488_2261_5595_5594_5599_861_1387_6256_836_367_2932_6777_6772_5970_7157_7849_1869_3725_5467_6776_4087_4088_4089_5888_5728_2034_2033_5468_4846_3910_898_4790_4791_4792_3320_3326_51176_5371_675_5159_5156_5604_5601_5602_1856_1399_3265_51588_7428_8772_4609_2956_1026_2736_2353_7704_2737_8554	107	1.09E-45	9.69E-44	9.69E-44
7739	hsa-mir-19b-1	hsa04010	MAPK signaling pathway	6722_4149_3551_1398_6195_6197_2264_8517_9252_5578_1845_7132_4773_9020_5923_1956_3304_3305_3303_6789_1432_7046_22800_4763_1616_207_208_1147_5879_2249_998_3727_2261_5595_5594_5599_5598_8986_1386_1649_836_3310_3312_3315_5971_5970_3164_7157_3725_6196_5058_4790_4791_5159_9261_1326_5156_5604_4208_5601_5600_5603_5602_5608_1399_3265_6885_4609_2353_2002_8550_5566	72	1.47E-26	1.31E-24	6.54E-25
7740	hsa-mir-19b-1	hsa05220	Chronic myeloid leukemia	3551_1398_595_598_8517_4193_3066_3065_5925_613_25_1487_7046_1870_1871_867_207_208_1147_1488_5595_5594_861_6777_5970_7157_1869_6776_4088_4089_4790_4792_5604_1399_3265_5781_4609_1026_6464	39	2.88E-23	2.56E-21	8.53E-22
7741	hsa-mir-19b-1	hsa04110	Cell cycle	4174_4172_595_1017_4193_902_6500_3066_3065_5925_25_1870_1871_5111_9232_5934_5933_545_995_5347_7534_5591_1387_11200_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_898_1031_983_8454_1026_1022_1111_8556_8555_472	44	2.18E-21	1.94E-19	4.85E-20
7742	hsa-mir-19b-1	hsa05215	Prostate cancer	3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026	38	1.64E-20	1.46E-18	2.92E-19
7743	hsa-mir-19b-1	hsa05212	Pancreatic cancer	3551_1499_595_596_1017_8517_4193_6934_2064_5925_1956_1870_1871_207_208_9586_1147_5595_5594_1387_367_2932_5970_7157_1869_5728_2033_898_4790_4792_3320_3326_51176_5159_5156_5604_3265_1026	38	2.24E-20	1.99E-18	3.32E-19
7744	hsa-mir-19b-1	hsa04310	Wnt signaling pathway	818_817_1499_595_8607_6934_5578_6500_4772_4773_23291_1487_5879_1460_1488_5599_1387_1459_2932_7157_8061_3725_5467_1457_1452_4087_4088_4089_2033_51176_5519_5518_5515_5601_5602_1856_8454_8945_6885_4609_5527_5566	42	1.16E-16	1.03E-14	1.48E-15
7745	hsa-mir-19b-1	hsa04660	T cell receptor signaling pathway	3551_1493_8517_5777_4772_4773_9020_2534_3932_4794_1432_867_207_208_1147_998_5595_5594_2932_5970_3725_5058_959_4790_4792_4793_1326_5604_5601_5600_5603_919_3265_6885_2353	35	1.17E-15	1.04E-13	1.30E-14
7746	hsa-mir-19b-1	hsa05222	Small cell lung cancer	4149_3551_595_596_598_1017_8517_5925_5743_5747_9063_1870_1871_10401_207_208_7187_1147_6256_5970_7157_1869_5728_4846_3910_898_4790_4792_51588_4609_8554	31	3.05E-15	2.72E-13	3.02E-14
7747	hsa-mir-19b-1	hsa05210	Colorectal cancer	1499_595_596_6934_1956_7046_4436_207_208_5879_5595_5594_5599_836_2932_7157_3725_4087_4088_4089_51176_5159_5156_5604_5601_5602_1856_4609_2956_2353	30	1.04E-14	9.26E-13	9.26E-14
7748	hsa-mir-19b-1	hsa04012	ErbB signaling pathway	818_817_1398_5578_2064_5747_25_1956_6714_867_207_208_5595_5594_5599_2066_2932_6777_3725_6776_5058_5604_5601_5602_1399_3265_4609_1026_2002_6464	30	2.22E-14	1.98E-12	1.80E-13
7749	hsa-mir-19b-1	hsa05221	Acute myeloid leukemia	3551_5914_595_3815_8517_6934_1050_6774_207_208_1147_5595_5594_861_6777_5970_5467_6776_4790_51176_5371_5604_3265_4609_7704	25	7.83E-14	6.97E-12	5.61E-13
7750	hsa-mir-19b-1	hsa04630	Jak-STAT signaling pathway	3559_595_598_5777_3455_3594_9063_3560_3561_6773_1439_3595_2057_6774_867_2690_10401_3459_3977_207_208_3717_3716_8651_1387_6778_6777_6772_7297_6776_2033_51588_10379_5781_58985_4609_3575_8554	38	8.19E-14	7.29E-12	5.61E-13
7751	hsa-mir-19b-1	hsa04920	Adipocytokine signaling pathway	3551_10891_5465_6794_8517_7132_8717_2538_4794_8471_6774_207_208_3717_1147_5599_6256_5970_4790_4792_4793_5601_5602_5563_5781_7133	26	1.29E-13	1.15E-11	8.15E-13
7752	hsa-mir-19b-1	hsa04620	Toll-like receptor signaling pathway	3551_8517_3455_3665_3661_1432_207_208_7187_1147_5879_29110_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5601_5600_5603_5602_5608_9641_8772_6885_2353	31	1.37E-13	1.22E-11	8.15E-13
7753	hsa-mir-19b-1	hsa05214	Glioma	818_817_595_4193_5578_5925_1956_1870_1871_207_208_5595_5594_7157_1869_5728_808_801_805_5159_5156_5604_3265_1026_6464	25	4.48E-13	3.98E-11	2.49E-12
7754	hsa-mir-19b-1	hsa04520	Adherens junction	1499_6934_5770_5777_2064_2534_1956_6714_7046_5879_1460_998_5595_5594_1387_1459_1457_4087_4088_4089_2033_51176_3643_71_8826_6885	26	3.59E-12	3.20E-10	1.88E-11
7755	hsa-mir-19b-1	hsa04910	Insulin signaling pathway	3551_10891_1398_6720_5770_2538_5590_5499_8471_867_5211_207_208_8651_5595_5594_5599_2932_2194_808_801_805_3643_5604_5601_5602_5563_1399_3265_2002_6464_5566	32	2.57E-11	2.28E-09	1.27E-10
7756	hsa-mir-19b-1	hsa04662	B cell receptor signaling pathway	3551_8517_5777_4772_4773_4794_207_208_1147_5879_695_5595_5594_1380_2932_6850_5970_3725_4790_4792_4793_5604_3265_2353	24	3.15E-11	2.80E-09	1.48E-10
7757	hsa-mir-19b-1	hsa04350	TGF-beta signaling pathway	6500_90_4086_1875_6667_7046_1874_57154_5934_5933_5595_5594_1387_7027_4087_4088_4089_2033_5519_5518_5515_8454_4609_4093_4092	25	8.45E-11	7.52E-09	3.76E-10
7758	hsa-mir-19b-1	hsa04115	p53 signaling pathway	595_1017_4194_4193_900_50484_51246_545_7161_11200_836_7157_6241_64326_5728_898_27113_25898_983_1026_1111_472	22	2.19E-10	1.95E-08	9.29E-10
7759	hsa-mir-19b-1	hsa04510	Focal adhesion	1398_1499_595_596_5578_2064_5923_2534_5747_3791_1956_6714_5499_207_208_5879_998_5595_5594_5599_2932_3725_5058_5728_3910_2321_5159_5156_5604_5601_5602_1399_3265_71_2002_85366_6464	37	4.52E-10	4.03E-08	1.83E-09
7760	hsa-mir-19b-1	hsa04062	Chemokine signaling pathway	3551_1398_8517_653361_5747_5580_5590_6773_2309_6362_6774_207_208_3717_1147_5879_998_5595_5594_1234_2932_6777_6772_5970_5058_4790_4792_4793_1230_5604_1399_3265_7852_6464_5566	35	1.06E-09	9.45E-08	4.11E-09
7761	hsa-mir-19b-1	hsa05219	Bladder cancer	595_9252_4193_2064_5925_1956_1870_1871_2261_5595_5594_7157_1869_5604_3265_4609_1026	17	1.31E-09	1.16E-07	4.85E-09
7762	hsa-mir-19b-1	hsa03010	Ribosome	6193_6204_6205_6207_6202_6141_9349_6217_6137_6135_6210_6155_6156_6191_6222_6223_6229_6129_6128_6125_6130_6181_6189_6188_6232	25	1.42E-09	1.26E-07	5.05E-09
7763	hsa-mir-19b-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3551_8517_9020_1956_6714_1432_1147_5879_998_5599_836_5970_3725_5058_4790_4792_5601_5600_5603_5602_5781	21	1.74E-09	1.55E-07	5.96E-09
7764	hsa-mir-19b-1	hsa05211	Renal cell carcinoma	1398_3091_405_2113_207_208_9915_5879_998_5595_5594_1387_3725_5058_2034_2033_5604_1399_3265_7428_5781	21	2.15E-09	1.91E-07	7.08E-09
7765	hsa-mir-19b-1	hsa05213	Endometrial cancer	1499_595_6934_2064_1956_2309_207_208_5595_5594_2932_7157_5728_51176_5604_3265_4609_2002	18	3.26E-09	2.90E-07	1.04E-08
7766	hsa-mir-19b-1	hsa04912	GnRH signaling pathway	818_817_5578_5580_1956_6714_1432_998_5595_5594_5599_5598_3725_808_801_805_5604_5601_5600_5603_5602_5608_3265_2002_5566	25	3.86E-09	3.43E-07	1.18E-08
7767	hsa-mir-19b-1	hsa05223	Non-small cell lung cancer	595_5578_2064_5925_1956_2309_6789_1870_1871_207_208_5595_5594_6256_7157_1869_5604_3265	18	5.31E-09	4.73E-07	1.58E-08
7768	hsa-mir-19b-1	hsa04370	VEGF signaling pathway	5578_4772_4773_5743_5747_3791_6714_1432_207_208_5879_998_5595_5594_3315_4846_9261_5604_5600_5603_3265	21	5.87E-09	5.23E-07	1.69E-08
7769	hsa-mir-19b-1	hsa05216	Thyroid cancer	1499_595_6934_10342_5595_5594_6256_7157_7849_5468_51176_5604_3265_4609	14	6.40E-09	5.70E-07	1.78E-08
7770	hsa-mir-19b-1	hsa05218	Melanoma	595_4193_5925_1956_1870_1871_207_208_4286_2249_5595_5594_7157_1869_5728_5159_5156_5604_3265_1026	20	8.48E-09	7.55E-07	2.29E-08
7771	hsa-mir-19b-1	hsa04210	Apoptosis	3551_596_598_8517_7132_8717_9020_823_1439_207_208_1147_836_5970_7157_9131_4790_4792_840_8772_472_5566	22	1.19E-08	1.06E-06	3.10E-08
7772	hsa-mir-19b-1	hsa04720	Long-term potentiation	818_814_817_6195_6197_5578_2902_2906_5499_5595_5594_1387_6196_2033_808_801_805_5604_3265_5566	20	1.85E-08	1.65E-06	4.71E-08
7773	hsa-mir-19b-1	hsa04120	Ubiquitin mediated proteolysis	4193_55294_6500_3093_23291_9063_7319_84447_867_10401_7329_8925_57154_8651_10055_51366_64326_7337_5371_672_25898_8454_8945_51588_7428_10075_8554	27	2.40E-08	2.13E-06	5.93E-08
7774	hsa-mir-19b-1	hsa03022	Basal transcription factors	51616_6872_2965_2963_2969_6878_6874_6908_2958_2959_6880_2957_6882_9519	14	7.37E-08	6.56E-06	1.77E-07
7775	hsa-mir-19b-1	hsa04664	Fc epsilon RI signaling pathway	5578_2534_5580_1432_207_208_5879_695_5595_5594_5599_6850_5604_5601_5600_5603_5602_5608_3265	19	1.67E-07	1.49E-05	3.91E-07
7776	hsa-mir-19b-1	hsa04540	Gap junction	5592_5578_10382_1956_6714_5595_5594_5598_7846_1453_347733_5159_983_5156_5604_3265_7278_84617_203068_5566	20	3.78E-07	3.36E-05	8.62E-07
7777	hsa-mir-19b-1	hsa04330	Notch signaling pathway	3066_3065_1840_9794_1487_2648_1488_1387_22938_9612_2033_8850_1856_4851	14	8.20E-07	7.30E-05	1.83E-06
7778	hsa-mir-19b-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_598_7132_2902_2906_1432_1616_5879_836_7157_4846_5600_5603_5608_7133	15	1.04E-06	9.28E-05	2.26E-06
7779	hsa-mir-19b-1	hsa04916	Melanogenesis	818_817_1499_3815_6934_5578_4286_5595_5594_1387_2932_2033_808_801_805_51176_5604_1856_3265_5566	20	1.74E-06	0.000154611	3.68E-06
7780	hsa-mir-19b-1	hsa05131	Shigellosis	1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068	14	4.71E-06	0.00041917	9.53E-06
7781	hsa-mir-19b-1	hsa05130	Pathogenic Escherichia coli infection	1499_5578_10382_2534_25_998_7534_7846_347733_7278_71_84617_4691_203068	14	4.71E-06	0.00041917	9.53E-06
7782	hsa-mir-19b-1	hsa04530	Tight junction	1499_5578_5580_5590_6714_4627_4628_22800_8573_207_208_1460_998_1459_1457_5728_5519_5518_5515_3265_71_5520	22	7.30E-06	0.000649919	1.44E-05
7783	hsa-mir-19b-1	hsa04930	Type II diabetes mellitus	3551_5580_5590_8471_3651_8651_5595_5594_5599_3643_5601_5602	12	1.29E-05	0.001144695	2.49E-05
7784	hsa-mir-19b-1	hsa03050	Proteasome	5708_5709_5705_5706_5700_5684_5719_5717_5713_5687_5693_5707	12	2.23E-05	0.001983967	4.22E-05
7785	hsa-mir-19b-1	hsa05322	Systemic lupus erythematosus	3021_3020_8366_9555_8349_8362_8365_8368_3018_8294_8370_6628_121504_8360_8363_8364_8367_959_8359_8361	20	0.000114962	0.010231574	0.000213158
7786	hsa-mir-19b-1	hsa04650	Natural killer cell mediated cytotoxicity	5777_5578_3455_4772_4773_2534_3932_3459_5879_5595_5594_836_6850_5058_5604_919_3265_5781_6464	19	0.00018639	0.016588666	0.000338544
7787	hsa-mir-19b-1	hsa03420	Nucleotide excision repair	5981_902_5111_5886_2965_4331_2071_2074_1022_6117	10	0.000208973	0.018598561	0.000371971
7788	hsa-mir-19b-1	hsa03410	Base excision repair	4350_142_4913_252969_5111_3146_328_2237_6996	9	0.000234704	0.020888642	0.000404365
7789	hsa-mir-19b-1	hsa05016	Huntington's disease	10891_293_292_3066_3065_3064_498_25942_2902_6667_9586_1387_836_5437_7157_1213_2033_5468_27113_6874_6908_5441_9519	23	0.000236258	0.021026969	0.000404365
7790	hsa-mir-19b-1	hsa03450	Non-homologous end-joining	2547_10111_7520_2237_5591_4361	6	0.000254676	0.022666203	0.000427664
7791	hsa-mir-19b-1	hsa04060	Cytokine-cytokine receptor interaction	3559_3815_7132_3455_90_3594_3791_1956_3560_3561_1439_7046_3595_2057_6362_2690_3459_3977_1234_959_2321_1230_5159_5156_7852_58985_3575_7133	28	0.000428557	0.038141597	0.000706326
7792	hsa-mir-19b-1	hsa04150	mTOR signaling pathway	6794_6195_6197_3091_207_208_5595_5594_6196_5563	10	0.000664511	0.059141519	0.0010753
7793	hsa-mir-19b-1	hsa04810	Regulation of actin cytoskeleton	10788_1398_2264_5747_1956_5499_4627_4628_22800_5879_2249_998_2261_5595_5594_5058_5159_5156_5604_1399_3265_71_8826_85366	24	0.000734187	0.065342612	0.001166832
7794	hsa-mir-19b-1	hsa03030	DNA replication	5981_4174_4172_5111_2237_5557_6117_5422	8	0.001009998	0.089889789	0.001577014
7795	hsa-mir-19b-1	hsa03440	Homologous recombination	641_10111_4361_4683_5888_675_6117	7	0.001154958	0.102791261	0.001772263
7796	hsa-mir-19b-1	hsa04340	Hedgehog signaling pathway	2735_23291_53944_2932_1452_1453_8945_2736_2737_5566	10	0.001235803	0.10998646	0.001864177
7797	hsa-mir-19b-1	hsa04020	Calcium signaling pathway	818_814_817_293_5578_292_2064_1956_2902_2906_147_2066_4846_808_801_805_5159_5156_85366_5566	20	0.002418527	0.215248871	0.003587481
7798	hsa-mir-19b-1	hsa04740	Olfactory transduction	818_817_5592_808_801_805_5566	7	0.002690948	0.239494361	0.003926137
7799	hsa-mir-19b-1	hsa05217	Basal cell carcinoma	1499_6934_2735_2932_7157_51176_1856_2736_2737	9	0.003243108	0.288636595	0.004655429
7800	hsa-mir-19b-1	hsa04730	Long-term depression	5592_5578_5595_5594_4846_5519_5518_5515_5604_3265	10	0.005138341	0.457312374	0.007258927
7801	hsa-mir-19b-1	hsa03020	RNA polymerase	64425_25885_51082_5437_84172_5441	6	0.005784676	0.514836197	0.008007755
7802	hsa-mir-19b-1	hsa04270	Vascular smooth muscle contraction	5592_5578_5580_147_5499_59_5595_5594_808_801_805_5604_85366_5566	14	0.005848361	0.520504088	0.008007755
7803	hsa-mir-19b-1	hsa03430	Mismatch repair	5981_4436_5111_2956_6117	5	0.00967112	0.860729705	0.013041359
7804	hsa-mir-19b-1	hsa04360	Axon guidance	4772_4773_2534_5747_25_5879_998_5595_5594_2932_5058_3265_7852_1020	14	0.010520257	0.936302834	0.013974669
7805	hsa-mir-19b-1	hsa04950	Maturity onset diabetes of the young	5080_6927_4760_3651_3172	5	0.011235995	1	0.014705934
7806	hsa-mir-19b-1	hsa05340	Primary immunodeficiency	8517_3932_3561_695_959_3575	6	0.012581327	1	0.016228089
7807	hsa-mir-19b-1	hsa05010	Alzheimer's disease	7132_498_823_2902_2906_5595_5594_836_2932_4846_808_351_801_805_840_8772_1020	17	0.016210182	1	0.020610088
7808	hsa-mir-19b-1	hsa04612	Antigen processing and presentation	3309_3304_3305_3303_3310_3312_3320_3326_4800_4801	10	0.027680759	1	0.034698417
7809	hsa-mir-19b-1	hsa04670	Leukocyte transendothelial migration	1499_5578_653361_5747_1432_5879_998_5600_5603_7852_71_5781	12	0.037827534	1	0.046535049
7810	hsa-mir-19b-1	hsa04710	Circadian rhythm - mammal	8863_4862_1453	3	0.038169197	1	0.046535049
7811	hsa-mir-19b-2	hsa05200	Pathways in cancer	3320_4149_5371_5595_5594_5599_861_5914_1387_6256_595_836_6258_367_2932_4193_7704_842_6774_3091_5970_7428_1870_1871_7157_4824_4087_6688_5604_2113_5894_4609_1869_3725_841_1029_6502_4088_4089_3066_3065_4292_1050_5925_2034_2033_4846_207_9915	49	2.43E-39	1.63E-37	1.63E-37
7812	hsa-mir-19b-2	hsa05220	Chronic myeloid leukemia	5595_5594_861_595_4193_5970_1870_1871_7157_5604_5894_4609_1869_1029_4088_4089_3066_3065_5925_207_6464	21	2.12E-22	1.42E-20	7.10E-21
7813	hsa-mir-19b-2	hsa04110	Cell cycle	5591_1387_595_983_2932_4193_8454_6500_1870_1871_7157_4087_1869_1029_6502_4088_4089_3066_3065_5925_2033_5933_990	23	2.98E-21	2.00E-19	6.03E-20
7814	hsa-mir-19b-2	hsa05215	Prostate cancer	3320_5595_5594_1387_595_367_2932_4193_1385_842_5970_1870_1871_7157_4824_5604_5894_1869_5925_2033_207	21	3.67E-21	2.46E-19	6.03E-20
7815	hsa-mir-19b-2	hsa05212	Pancreatic cancer	3320_5595_5594_1387_595_367_2932_4193_1385_842_5970_1870_1871_7157_4824_5604_5894_1869_5925_2033_207	21	4.50E-21	3.02E-19	6.03E-20
7816	hsa-mir-19b-2	hsa05210	Colorectal cancer	5595_5594_5599_595_836_2932_842_7157_4087_5604_5894_4609_3725_4088_4089_4292_207	17	2.53E-16	1.69E-14	2.47E-15
7817	hsa-mir-19b-2	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_6258_842_1870_1871_7157_5604_5894_1869_1029_5925_207	15	2.58E-16	1.73E-14	2.47E-15
7818	hsa-mir-19b-2	hsa05221	Acute myeloid leukemia	5371_5595_5594_861_5914_595_7704_6774_5970_6688_5604_5894_4609_1050_207	15	7.95E-16	5.33E-14	6.66E-15
7819	hsa-mir-19b-2	hsa05214	Glioma	815_5595_5594_595_4193_1870_1871_7157_5604_5894_1869_1029_5925_207_6464	15	2.74E-15	1.84E-13	2.04E-14
7820	hsa-mir-19b-2	hsa05219	Bladder cancer	5595_5594_595_4193_1870_1871_7157_5604_5894_4609_1869_1029_5925	13	8.02E-15	5.38E-13	5.38E-14
7821	hsa-mir-19b-2	hsa05222	Small cell lung cancer	4149_6256_595_6258_842_5970_1870_1871_7157_4609_1869_6502_5925_4846_207	15	1.02E-13	6.82E-12	6.20E-13
7822	hsa-mir-19b-2	hsa04350	TGF-beta signaling pathway	3399_5595_5594_1387_6667_8454_3398_6500_4087_4609_4088_4089_2033_5933_4093	15	1.18E-13	7.92E-12	6.60E-13
7823	hsa-mir-19b-2	hsa04010	MAPK signaling pathway	4149_5595_5594_5599_5598_4208_836_3312_1386_5970_9261_7157_5604_5894_4609_3725_6195_4763_1616_207_2002_2005	22	3.71E-13	2.49E-11	1.91E-12
7824	hsa-mir-19b-2	hsa05213	Endometrial cancer	5595_5594_595_2932_842_7157_5604_5894_4609_4292_207_2002	12	1.72E-12	1.16E-10	8.25E-12
7825	hsa-mir-19b-2	hsa05218	Melanoma	5595_5594_595_4193_1870_1871_7157_5604_5894_1869_1029_5925_207	13	2.67E-12	1.79E-10	1.19E-11
7826	hsa-mir-19b-2	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_7428_5604_2113_5894_3725_2034_2033_207_9915	13	3.12E-12	2.09E-10	1.31E-11
7827	hsa-mir-19b-2	hsa04310	Wnt signaling pathway	815_5599_1387_595_2932_8454_6500_7157_4087_4609_3725_1457_1459_4088_4089_2033	16	1.66E-11	1.11E-09	6.54E-11
7828	hsa-mir-19b-2	hsa04012	ErbB signaling pathway	815_6714_5595_5594_5599_2932_5604_5894_4609_3725_207_6464_2002	13	2.63E-11	1.76E-09	9.78E-11
7829	hsa-mir-19b-2	hsa04540	Gap junction	6714_5595_5594_5598_983_7277_7278_5604_5894_7846_51807_10376	12	7.11E-10	4.76E-08	2.51E-09
7830	hsa-mir-19b-2	hsa05216	Thyroid cancer	5595_5594_6256_595_6258_7157_5604_4609	8	2.81E-09	1.88E-07	9.40E-09
7831	hsa-mir-19b-2	hsa05016	Huntington's disease	6874_1387_2902_6908_836_6667_1385_842_7157_841_3066_3065_3064_2033	14	1.95E-08	1.31E-06	6.23E-08
7832	hsa-mir-19b-2	hsa04520	Adherens junction	6714_5595_5594_1387_4087_1457_1459_4088_4089_2033	10	2.51E-08	1.68E-06	7.64E-08
7833	hsa-mir-19b-2	hsa04115	p53 signaling pathway	595_983_836_4193_842_7157_841_7161_1029	9	9.09E-08	6.09E-06	2.65E-07
7834	hsa-mir-19b-2	hsa04720	Long-term potentiation	815_5595_5594_1387_2902_5604_5894_6195_2033	9	1.74E-07	1.17E-05	4.86E-07
7835	hsa-mir-19b-2	hsa04370	VEGF signaling pathway	6714_5595_5594_842_9261_5604_5894_4846_207	9	2.14E-07	1.43E-05	5.73E-07
7836	hsa-mir-19b-2	hsa04912	GnRH signaling pathway	815_6714_5595_5594_5599_5598_5604_5894_3725_2002	10	3.34E-07	2.24E-05	8.60E-07
7837	hsa-mir-19b-2	hsa04330	Notch signaling pathway	1387_2648_9612_3066_3065_2033_4851	7	1.13E-06	7.56E-05	2.80E-06
7838	hsa-mir-19b-2	hsa04662	B cell receptor signaling pathway	5595_5594_2932_5970_5604_5894_3725_207	8	1.92E-06	0.000128789	4.60E-06
7839	hsa-mir-19b-2	hsa04916	Melanogenesis	815_5595_5594_1387_2932_1385_5604_5894_2033	9	2.19E-06	0.000146809	5.06E-06
7840	hsa-mir-19b-2	hsa04510	Focal adhesion	6714_5595_5594_5599_595_2932_5604_5894_3725_207_6464_2002	12	2.35E-06	0.000157741	5.26E-06
7841	hsa-mir-19b-2	hsa04910	Insulin signaling pathway	6720_5595_5594_5599_2932_5604_5894_207_6464_2002	10	2.68E-06	0.000179494	5.79E-06
7842	hsa-mir-19b-2	hsa04210	Apoptosis	836_839_842_840_5970_7157_841_207	8	6.24E-06	0.000418	1.31E-05
7843	hsa-mir-19b-2	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5970_5604_3725_841_207	8	1.58E-05	0.00105898	3.21E-05
7844	hsa-mir-19b-2	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_4193_8454_6500_7428_7329_6502	9	1.98E-05	0.001327234	3.90E-05
7845	hsa-mir-19b-2	hsa05010	Alzheimer's disease	22926_5595_5594_2902_836_2932_842_840_841_4846	10	2.11E-05	0.001411371	4.03E-05
7846	hsa-mir-19b-2	hsa04660	T cell receptor signaling pathway	5595_5594_2932_5970_5604_5894_3725_207	8	2.63E-05	0.001764511	4.90E-05
7847	hsa-mir-19b-2	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_842_7157_1616_4846	6	3.72E-05	0.002492517	6.39E-05
7848	hsa-mir-19b-2	hsa05131	Shigellosis	7277_7278_7846_51807_4691_10376	6	3.72E-05	0.002492517	6.39E-05
7849	hsa-mir-19b-2	hsa05130	Pathogenic Escherichia coli infection	7277_7278_7846_51807_4691_10376	6	3.72E-05	0.002492517	6.39E-05
7850	hsa-mir-19b-2	hsa04062	Chemokine signaling pathway	5595_5594_7074_2932_6774_5970_5604_5894_207_6464	10	4.24E-05	0.002842775	7.11E-05
7851	hsa-mir-19b-2	hsa03022	Basal transcription factors	2963_2962_6874_2969_6908	5	6.17E-05	0.004133438	0.000100816
7852	hsa-mir-19b-2	hsa04920	Adipocytokine signaling pathway	5599_6256_6258_6774_5970_207	6	9.39E-05	0.006293985	0.000149857
7853	hsa-mir-19b-2	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5604_5894_207	6	0.000218291	0.014625528	0.000340129
7854	hsa-mir-19b-2	hsa04150	mTOR signaling pathway	5595_5594_3091_6195_207	5	0.000268606	0.01799659	0.000409013
7855	hsa-mir-19b-2	hsa04612	Antigen processing and presentation	3320_4800_4801_4802_1385_3312	6	0.000399031	0.026735088	0.000594113
7856	hsa-mir-19b-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_5599_836_5970_3725	5	0.001015243	0.068021288	0.001447261
7857	hsa-mir-19b-2	hsa04730	Long-term depression	5595_5594_5604_5894_4846	5	0.001015243	0.068021288	0.001447261
7858	hsa-mir-19b-2	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_5604_5894_6464	6	0.003405583	0.228174089	0.004753627
7859	hsa-mir-19b-2	hsa04630	Jak-STAT signaling pathway	1387_595_6774_4609_2033_207	6	0.005847068	0.391753523	0.00799497
7860	hsa-mir-19b-2	hsa04930	Type II diabetes mellitus	5595_5594_5599	3	0.012394706	0.830445275	0.016608905
7861	hsa-mir-19b-2	hsa04270	Vascular smooth muscle contraction	5595_5594_5604_5894	4	0.034753395	1	0.045656421
7862	hsa-mir-200a	hsa05200	Pathways in cancer	3725_2249_1499_5595_5594_5914_1387_6256_367_6776_6777_5970_862_6502_2353_5925_2033	17	5.44E-15	3.92E-13	3.92E-13
7863	hsa-mir-200a	hsa04350	TGF-beta signaling pathway	6667_5595_5594_1387_3397_3399_3398_2033	8	1.58E-09	1.14E-07	3.36E-08
7864	hsa-mir-200a	hsa05215	Prostate cancer	1499_5595_5594_1387_367_5970_5925_2033	8	1.72E-09	1.24E-07	3.36E-08
7865	hsa-mir-200a	hsa05212	Pancreatic cancer	1499_5595_5594_1387_367_5970_5925_2033	8	1.87E-09	1.34E-07	3.36E-08
7866	hsa-mir-200a	hsa05221	Acute myeloid leukemia	5595_5594_5914_6776_6777_5970_862	7	3.37E-09	2.43E-07	4.85E-08
7867	hsa-mir-200a	hsa04010	MAPK signaling pathway	6722_3725_2249_5595_5594_9261_4208_7867_1432_5970_2353	11	4.93E-09	3.55E-07	5.92E-08
7868	hsa-mir-200a	hsa04916	Melanogenesis	1499_5595_5594_1387_2033_808_801_805	8	5.88E-09	4.24E-07	6.05E-08
7869	hsa-mir-200a	hsa04720	Long-term potentiation	5595_5594_1387_2033_808_801_805	7	1.57E-08	1.13E-06	1.42E-07
7870	hsa-mir-200a	hsa04912	GnRH signaling pathway	3725_5595_5594_1432_808_801_805	7	1.65E-07	1.19E-05	1.32E-06
7871	hsa-mir-200a	hsa05214	Glioma	5595_5594_5925_808_801_805	6	1.86E-07	1.34E-05	1.34E-06
7872	hsa-mir-200a	hsa05220	Chronic myeloid leukemia	5595_5594_6776_6777_5970_5925	6	4.09E-07	2.95E-05	2.68E-06
7873	hsa-mir-200a	hsa04330	Notch signaling pathway	388585_1387_9612_2033_8850	5	1.07E-06	7.70E-05	6.42E-06
7874	hsa-mir-200a	hsa04620	Toll-like receptor signaling pathway	3725_5595_5594_1432_5970_2353	6	2.24E-06	0.000160943	1.24E-05
7875	hsa-mir-200a	hsa04660	T cell receptor signaling pathway	3725_5595_5594_1432_5970_2353	6	3.39E-06	0.000244007	1.74E-05
7876	hsa-mir-200a	hsa05216	Thyroid cancer	1499_5595_5594_6256	4	5.29E-06	0.000380757	2.54E-05
7877	hsa-mir-200a	hsa05211	Renal cell carcinoma	3725_5595_5594_1387_2033	5	7.59E-06	0.000546354	3.41E-05
7878	hsa-mir-200a	hsa04662	B cell receptor signaling pathway	3725_5595_5594_5970_2353	5	9.16E-06	0.000659283	3.88E-05
7879	hsa-mir-200a	hsa04370	VEGF signaling pathway	5595_5594_9261_7867_1432	5	1.03E-05	0.000744163	4.13E-05
7880	hsa-mir-200a	hsa04520	Adherens junction	1499_5595_5594_1387_2033	5	1.23E-05	0.000887229	4.67E-05
7881	hsa-mir-200a	hsa05210	Colorectal cancer	3725_1499_5595_5594_2353	5	1.54E-05	0.001110387	5.55E-05
7882	hsa-mir-200a	hsa04012	ErbB signaling pathway	3725_5595_5594_6776_6777	5	1.81E-05	0.001304709	6.21E-05
7883	hsa-mir-200a	hsa05010	Alzheimer's disease	5595_5594_1537_808_801_805	6	4.54E-05	0.003271175	0.00014869
7884	hsa-mir-200a	hsa05223	Non-small cell lung cancer	5595_5594_6256_5925	4	5.13E-05	0.003692105	0.000160526
7885	hsa-mir-200a	hsa04270	Vascular smooth muscle contraction	5595_5594_808_801_805	5	7.31E-05	0.005262928	0.000218759
7886	hsa-mir-200a	hsa04110	Cell cycle	1387_6502_5925_2033_891	5	7.60E-05	0.005468974	0.000218759
7887	hsa-mir-200a	hsa04950	Maturity onset diabetes of the young	3651_168620_6927	3	0.000113458	0.008168967	0.000314191
7888	hsa-mir-200a	hsa05218	Melanoma	2249_5595_5594_5925	4	0.000140378	0.010107205	0.000374341
7889	hsa-mir-200a	hsa04910	Insulin signaling pathway	5595_5594_808_801_805	5	0.000148658	0.010703401	0.000382264
7890	hsa-mir-200a	hsa04630	Jak-STAT signaling pathway	1387_6776_6777_2033_3977	5	0.000250667	0.018048025	0.000622346
7891	hsa-mir-200a	hsa05222	Small cell lung cancer	6256_5970_6502_5925	4	0.000283527	0.020413938	0.000680465
7892	hsa-mir-200a	hsa05219	Bladder cancer	5595_5594_5925	3	0.000525888	0.037863942	0.001221417
7893	hsa-mir-200a	hsa05016	Huntington's disease	6667_1387_6908_1537_2033	5	0.000591087	0.04255828	0.001329946
7894	hsa-mir-200a	hsa04930	Type II diabetes mellitus	3651_5595_5594	3	0.000636154	0.045803071	0.001387972
7895	hsa-mir-200a	hsa05213	Endometrial cancer	1499_5595_5594	3	0.000948017	0.068257217	0.002007565
7896	hsa-mir-200a	hsa04120	Ubiquitin mediated proteolysis	672_7329_6502_7325	4	0.001609459	0.115881072	0.003310888
7897	hsa-mir-200a	hsa04310	Wnt signaling pathway	3725_1499_1387_2033	4	0.002210042	0.159123	0.004345032
7898	hsa-mir-200a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_1432_5970	3	0.002232864	0.160766187	0.004345032
7899	hsa-mir-200a	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.00268981	0.193666332	0.005096482
7900	hsa-mir-200a	hsa04664	Fc epsilon RI signaling pathway	5595_5594_1432	3	0.002989651	0.215254891	0.005519356
7901	hsa-mir-200a	hsa04062	Chemokine signaling pathway	5595_5594_6777_5970	4	0.005083743	0.366029462	0.009150737
7902	hsa-mir-200a	hsa04510	Focal adhesion	3725_1499_5595_5594	4	0.006355191	0.457573765	0.011160336
7903	hsa-mir-200a	hsa04150	mTOR signaling pathway	5595_5594	2	0.015324059	1	0.026269815
7904	hsa-mir-200a	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.024289515	1	0.040670816
7905	hsa-mir-200a	hsa04730	Long-term depression	5595_5594	2	0.02696631	1	0.044126689
7906	hsa-mir-200a	hsa04020	Calcium signaling pathway	808_801_805	3	0.02786291	1	0.044580655
7907	hsa-mir-200a	hsa04810	Regulation of actin cytoskeleton	2249_5595_5594	3	0.042874351	1	0.066820404
7908	hsa-mir-200a	hsa04540	Gap junction	5595_5594	2	0.043618875	1	0.066820404
7909	hsa-mir-200c	hsa05200	Pathways in cancer	5914_595_596_598_2261_4193_6934_7704_5578_3091_3066_3065_5925_613_5747_25_1956_1487_1488_6789_4824_4436_1870_1871_2885_2113_861_10401_207_4286_3716_1147_998_1026_4233_5595_5594_5599_6258_1387_2064_6256_3326_836_367_2932_6774_6776_6777_6772_5979_5879_7157_6688_1869_3725_2736_4087_4088_4089_9063_5888_5728_2034_2033_675_4846_3910_4790_4792_5970_1017_3320_5371_3480_5159_5156_5604_5601_5602_1856_842_841_51588_7428_4609_2353_1441_5743_8554	90	1.20E-57	1.04E-55	1.04E-55
7910	hsa-mir-200c	hsa04010	MAPK signaling pathway	3925_6722_6197_2261_2264_9252_5578_4773_5923_8986_1956_3304_3303_6789_1432_2885_3305_4763_207_1147_998_5595_5594_5599_1386_836_3312_3315_1649_5879_3164_7157_468_3725_3727_6195_6196_9344_4790_51701_5970_1616_5159_9261_5156_5604_4208_5601_5600_5602_6885_4609_5606_2353_8550_2002_2005	57	1.67E-31	1.45E-29	7.25E-30
7911	hsa-mir-200c	hsa05215	Prostate cancer	595_596_4193_6934_5925_1956_4824_1870_1871_2885_9586_207_1147_1026_5595_5594_1385_1387_2064_3326_367_2932_7157_468_1869_5728_2033_4790_4792_5970_1017_3320_3480_5159_5156_5604_842	37	9.08E-30	7.90E-28	2.63E-28
7912	hsa-mir-200c	hsa05212	Pancreatic cancer	595_596_4193_6934_5925_1956_4824_1870_1871_2885_9586_207_1147_1026_5595_5594_1385_1387_2064_3326_367_2932_7157_468_1869_5728_2033_4790_4792_5970_1017_3320_3480_5159_5156_5604_842	37	1.26E-29	1.09E-27	2.73E-28
7913	hsa-mir-200c	hsa04110	Cell cycle	595_4193_902_5347_1022_3066_3065_5925_25_1870_1871_5933_9232_545_995_1026_7534_5591_1387_11200_7533_7532_2932_7027_7157_1869_4087_4088_4089_2033_890_1017_1031_983_472_1111_8556_8555	38	5.66E-27	4.93E-25	9.86E-26
7914	hsa-mir-200c	hsa05220	Chronic myeloid leukemia	595_598_4193_3066_3065_5925_613_25_1487_1488_1870_1871_2885_861_207_1147_1026_5595_5594_6776_6777_7157_1869_4088_4089_4790_4792_5970_5604_5781_4609_6464	32	4.48E-26	3.89E-24	6.49E-25
7915	hsa-mir-200c	hsa05210	Colorectal cancer	595_596_6934_1956_4436_2885_207_4233_5595_5594_5599_836_2932_5879_7157_3725_4087_4088_4089_3480_5159_5156_5604_5601_5602_1856_842_4609_2353	29	1.14E-21	9.91E-20	1.42E-20
7916	hsa-mir-200c	hsa05222	Small cell lung cancer	595_596_598_5925_5747_1870_1871_10401_207_1147_6258_6256_7157_1869_9063_5728_4846_3910_4790_4792_5970_1017_842_51588_4609_5743_8554	27	2.18E-19	1.90E-17	2.37E-18
7917	hsa-mir-200c	hsa04630	Jak-STAT signaling pathway	3559_595_598_3454_3455_3560_1439_2885_2690_10401_207_3717_3716_3718_85480_1387_3575_3570_3572_6774_6775_6776_6777_6772_9063_2033_149233_3953_51588_5781_4609_1441_8554	33	5.76E-19	5.01E-17	5.56E-18
7918	hsa-mir-200c	hsa04115	p53 signaling pathway	595_4194_4193_50484_6241_27113_51246_545_1026_11200_836_7157_900_64326_5728_1017_25898_983_842_841_7161_472_1111	23	3.43E-17	2.99E-15	2.99E-16
7919	hsa-mir-200c	hsa04310	Wnt signaling pathway	815_595_6934_5578_4773_1460_1487_1488_5599_1387_2932_5879_7157_8061_3725_1457_1452_4087_4088_4089_2033_51701_5518_5515_5601_5602_1856_6885_4609_5527	30	1.40E-16	1.22E-14	1.11E-15
7920	hsa-mir-200c	hsa05214	Glioma	815_595_4193_5578_5925_1956_1870_1871_2885_207_1026_5595_5594_7157_1869_5728_3480_5159_5156_5604_6464	21	1.37E-15	1.19E-13	9.92E-15
7921	hsa-mir-200c	hsa04012	ErbB signaling pathway	815_5578_5747_25_1956_6714_2885_207_1026_5595_5594_5599_2064_2932_6776_6777_3725_5604_5601_5602_4609_6464_2002	23	2.36E-15	2.05E-13	1.58E-14
7922	hsa-mir-200c	hsa05221	Acute myeloid leukemia	5914_595_6934_7704_2885_861_207_1147_5595_5594_6774_6776_6777_6688_4790_5970_5371_5604_4609	19	3.25E-14	2.82E-12	2.02E-13
7923	hsa-mir-200c	hsa04620	Toll-like receptor signaling pathway	3454_3455_1432_207_1147_3654_5595_5594_5599_6772_5879_3725_4790_4792_5970_5604_5601_5600_5602_841_6885_5606_2353	23	4.34E-14	3.77E-12	2.52E-13
7924	hsa-mir-200c	hsa05223	Non-small cell lung cancer	595_5578_5925_1956_6789_1870_1871_2885_207_5595_5594_6258_2064_6256_7157_1869_5604_842	18	9.44E-14	8.21E-12	5.13E-13
7925	hsa-mir-200c	hsa04510	Focal adhesion	595_596_5578_5923_5747_1956_6714_5499_2885_207_998_4233_5595_5594_5599_2064_2932_5879_3725_5728_3910_2321_3480_5159_5156_5604_5601_5602_6464_2002	30	1.80E-13	1.57E-11	9.22E-13
7926	hsa-mir-200c	hsa04520	Adherens junction	6934_1460_1956_6714_2241_998_4233_5595_5594_1387_2064_5879_1457_4087_4088_4089_2033_51701_3480_6885	20	3.81E-13	3.32E-11	1.84E-12
7927	hsa-mir-200c	hsa05219	Bladder cancer	595_2261_9252_4193_5925_1956_1870_1871_1026_5595_5594_2064_7157_1869_5604_4609	16	4.21E-13	3.66E-11	1.93E-12
7928	hsa-mir-200c	hsa05218	Melanoma	595_4193_5925_1956_1870_1871_207_4286_1026_4233_5595_5594_7157_1869_5728_3480_5159_5156_5604	19	5.28E-13	4.59E-11	2.30E-12
7929	hsa-mir-200c	hsa04062	Chemokine signaling pathway	1234_1230_5747_5580_7852_2885_6362_207_3055_3717_1147_3718_998_5590_5595_5594_2932_6774_6777_6772_5879_4790_4792_5970_5604_2185_6464	27	6.75E-12	5.87E-10	2.80E-11
7930	hsa-mir-200c	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_1432_1147_998_4233_5599_836_5879_3725_4790_4792_5970_5601_5600_5602_5781	17	3.98E-11	3.47E-09	1.58E-10
7931	hsa-mir-200c	hsa04912	GnRH signaling pathway	815_5578_5580_1956_6714_1432_2885_998_5595_5594_5599_468_3725_5604_5601_5600_5602_2185_5606_2002	20	4.49E-11	3.90E-09	1.70E-10
7932	hsa-mir-200c	hsa04660	T cell receptor signaling pathway	4773_3932_1432_2885_207_1147_998_5595_5594_2932_3725_4790_4792_5970_5604_5601_5600_6885_2353_959	20	6.00E-11	5.22E-09	2.12E-10
7933	hsa-mir-200c	hsa05213	Endometrial cancer	595_6934_1956_2885_207_5595_5594_2064_2932_7157_5728_5604_842_4609_2002	15	6.08E-11	5.29E-09	2.12E-10
7934	hsa-mir-200c	hsa04210	Apoptosis	3556_596_598_823_1439_207_1147_3654_836_839_7157_4790_4792_5970_842_841_840_472	18	1.19E-10	1.04E-08	3.85E-10
7935	hsa-mir-200c	hsa04370	VEGF signaling pathway	5578_4773_5747_6714_1432_207_998_5595_5594_3315_5879_4846_9261_5604_5600_842_5743	17	1.19E-10	1.04E-08	3.85E-10
7936	hsa-mir-200c	hsa04920	Adipocytokine signaling pathway	5563_6794_207_3717_1147_5599_6258_6256_6774_4790_4792_5970_5601_5602_3953_5781	16	1.54E-10	1.34E-08	4.80E-10
7937	hsa-mir-200c	hsa05211	Renal cell carcinoma	3091_2885_2113_207_998_4233_5595_5594_1387_5879_3725_2034_2033_5604_7428_5781	16	3.86E-10	3.36E-08	1.16E-09
7938	hsa-mir-200c	hsa04350	TGF-beta signaling pathway	6667_3397_3399_3398_5933_5595_5594_1387_7027_4086_4087_4088_4089_2033_5518_5515_4609	17	6.20E-10	5.40E-08	1.80E-09
7939	hsa-mir-200c	hsa04662	B cell receptor signaling pathway	4773_6850_2885_207_1147_5595_5594_2932_5879_3725_4790_4792_5970_5604_2353_1380	16	6.49E-10	5.64E-08	1.82E-09
7940	hsa-mir-200c	hsa03022	Basal transcription factors	6880_51616_2957_2965_2963_2962_2969_6874_6872_6908_2958_2959	12	1.66E-09	1.45E-07	4.52E-09
7941	hsa-mir-200c	hsa04664	Fc epsilon RI signaling pathway	5578_5580_6850_1432_2885_207_5595_5594_5599_5879_5604_5601_5600_5602_5606	15	8.88E-09	7.72E-07	2.34E-08
7942	hsa-mir-200c	hsa04120	Ubiquitin mediated proteolysis	55294_4193_3093_7319_84447_10401_7329_83737_10055_9063_64326_7337_5371_672_25898_10075_51588_7428_8554	19	1.24E-08	1.08E-06	3.16E-08
7943	hsa-mir-200c	hsa05216	Thyroid cancer	595_6934_5595_5594_6258_6256_5979_7157_5604_4609	10	2.38E-08	2.07E-06	5.92E-08
7944	hsa-mir-200c	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_598_2902_1432_836_5879_7157_4846_1616_5600_842_5606	12	8.59E-08	7.48E-06	2.08E-07
7945	hsa-mir-200c	hsa04330	Notch signaling pathway	9612_3066_3065_1487_1488_3280_1387_2033_8850_388585_1856	11	1.37E-07	1.19E-05	3.23E-07
7946	hsa-mir-200c	hsa04060	Cytokine-cytokine receptor interaction	3556_3559_1234_1230_3454_3455_1956_3560_1439_7852_6362_2690_85480_4233_3575_3570_3572_2321_149233_5159_5156_3953_959_1441	24	1.86E-07	1.61E-05	4.25E-07
7947	hsa-mir-200c	hsa04720	Long-term potentiation	815_6197_5578_2902_5499_5595_5594_1387_468_6195_6196_2033_5604	13	2.21E-07	1.92E-05	4.93E-07
7948	hsa-mir-200c	hsa04910	Insulin signaling pathway	6720_5563_5499_2885_207_5590_5595_5594_5599_23265_2932_5604_5601_5602_6464_2002	16	1.28E-06	0.000111278	2.78E-06
7949	hsa-mir-200c	hsa04650	Natural killer cell mediated cytotoxicity	5578_3454_3455_4773_3932_6850_2885_5595_5594_836_5879_5604_5781_2185_6464	15	5.61E-06	0.000488047	1.19E-05
7950	hsa-mir-200c	hsa04540	Gap junction	5578_1956_6714_2885_5592_5595_5594_1453_5159_983_5156_5604	12	1.01E-05	0.000879877	2.09E-05
7951	hsa-mir-200c	hsa05016	Huntington's disease	3066_3065_3064_25942_2902_6667_27113_9586_1385_1387_836_7157_2033_6874_6908_842_841	17	1.30E-05	0.001131432	2.63E-05
7952	hsa-mir-200c	hsa04150	mTOR signaling pathway	5563_6794_6197_3091_207_5595_5594_6195_6196	9	1.64E-05	0.001428681	3.25E-05
7953	hsa-mir-200c	hsa04916	Melanogenesis	815_6934_5578_4286_5595_5594_1385_1387_2932_2033_5604_1856	12	2.79E-05	0.002430086	5.40E-05
7954	hsa-mir-200c	hsa04612	Antigen processing and presentation	3309_3304_3303_3305_1385_3326_3312_3320_4800_4801_2923	11	3.38E-05	0.002938282	6.39E-05
7955	hsa-mir-200c	hsa03420	Nucleotide excision repair	2074_902_1022_6117_2965_4331_2071_6118	8	3.55E-05	0.003088865	6.57E-05
7956	hsa-mir-200c	hsa04930	Type II diabetes mellitus	5580_3651_5590_5595_5594_5599_5601_5602	8	4.09E-05	0.003560763	7.42E-05
7957	hsa-mir-200c	hsa04730	Long-term depression	5578_5592_5595_5594_4846_3480_5518_5515_5604	9	0.000145499	0.012658424	0.000258335
7958	hsa-mir-200c	hsa04360	Axon guidance	4773_5747_25_7852_2242_998_4233_5595_5594_2932_5879_1020	12	0.000212439	0.018482162	0.000369643
7959	hsa-mir-200c	hsa04530	Tight junction	5578_1460_5580_6714_207_998_5590_1457_5728_5518_5515_5520	12	0.000310851	0.027044052	0.000530276
7960	hsa-mir-200c	hsa04950	Maturity onset diabetes of the young	6927_3087_3280_3651_3172	5	0.000625792	0.054443882	0.001046998
7961	hsa-mir-200c	hsa05010	Alzheimer's disease	22926_823_2902_5595_5594_836_2932_6622_4846_842_841_840_1020	13	0.000846643	0.073657946	0.001389773
7962	hsa-mir-200c	hsa03440	Homologous recombination	641_6117_5888_675_6118	5	0.001153983	0.100396488	0.001859194
7963	hsa-mir-200c	hsa03410	Base excision repair	3146_4913_142_328_6996	5	0.003104111	0.270057652	0.004910139
7964	hsa-mir-200c	hsa04670	Leukocyte transendothelial migration	5578_5747_1432_7852_998_5879_5600_5781_2185	9	0.004965859	0.432029728	0.007714817
7965	hsa-mir-200c	hsa04710	Circadian rhythm - mammal	8863_1453_8553	3	0.006406951	0.557404769	0.009779031
7966	hsa-mir-200c	hsa04740	Olfactory transduction	815_5592	2	0.007278785	0.633254337	0.010918178
7967	hsa-mir-200c	hsa05340	Primary immunodeficiency	3932_3718_3575_959	4	0.014751249	1	0.021751842
7968	hsa-mir-200c	hsa04810	Regulation of actin cytoskeleton	2261_2264_5747_1956_5499_998_5595_5594_5879_5159_5156_5604	12	0.015019307	1	0.021777996
7969	hsa-mir-200c	hsa05217	Basal cell carcinoma	6934_2932_7157_2736_1856	5	0.015514577	1	0.022127348
7970	hsa-mir-200c	hsa03030	DNA replication	6117_6118_5422_5557	4	0.016081323	1	0.022524859
7971	hsa-mir-200c	hsa05131	Shigellosis	5578_25_998_7534_4691	5	0.016570011	1	0.022524859
7972	hsa-mir-200c	hsa05130	Pathogenic Escherichia coli infection	5578_25_998_7534_4691	5	0.016570011	1	0.022524859
7973	hsa-mir-200c	hsa03430	Mismatch repair	4436_6117_6118	3	0.024845243	1	0.033254402
7974	hsa-mir-200c	hsa04640	Hematopoietic cell lineage	3559_3575_3570_914_1380_1441	6	0.026510024	1	0.034945032
7975	hsa-mir-200c	hsa04270	Vascular smooth muscle contraction	5578_5580_5499_5592_5595_5594_5604	7	0.034007217	1	0.044158626
7976	hsa-mir-202	hsa05200	Pathways in cancer	6654_5914_595_4193_7704_4089_3065_1050_5925_7184_405_1956_2308_2064_8503_2885_10401_207_208_1147_5595_5594_5599_6258_1387_6257_6256_367_2932_5970_7157_6688_3725_6776_2736_4087_4088_5295_2033_4790_3320_3326_5371_3480_8031_5601_3265_4609_2353_8554	50	1.24E-31	9.67E-30	9.67E-30
7977	hsa-mir-202	hsa03022	Basal transcription factors	54457_2958_138474_2959_6881_6879_2965_2967_2961_2960_2963_2968_6878_6877_6874_6873_6872_6908_6884_6882_6883_6880_2957_9519	24	4.28E-28	3.34E-26	1.67E-26
7978	hsa-mir-202	hsa04010	MAPK signaling pathway	6722_6654_6197_4214_9252_4616_8986_1956_1432_627_2885_22800_2872_207_208_1147_994_5595_5594_5599_1386_3312_1649_5970_7157_10912_468_3725_3727_6195_6196_5058_4790_9261_5601_5600_5603_3265_4609_2353_8550_5566	42	4.99E-27	3.89E-25	1.01E-25
7979	hsa-mir-202	hsa05215	Prostate cancer	6654_595_4193_5925_7184_1956_2308_2064_8503_2885_9586_207_208_1147_5595_5594_1387_367_2932_5970_7157_468_5295_2033_4790_3320_3326_3480_3265	29	5.20E-27	4.06E-25	1.01E-25
7980	hsa-mir-202	hsa05212	Pancreatic cancer	6654_595_4193_5925_7184_1956_2308_2064_8503_2885_9586_207_208_1147_5595_5594_1387_367_2932_5970_7157_468_5295_2033_4790_3320_3326_3480_3265	29	6.80E-27	5.30E-25	1.06E-25
7981	hsa-mir-202	hsa05220	Chronic myeloid leukemia	6654_595_4193_4089_3065_5925_8503_2885_207_208_1147_5595_5594_5970_7157_6776_4088_5295_4790_3265_4609_6464	22	7.02E-20	5.48E-18	9.13E-19
7982	hsa-mir-202	hsa05221	Acute myeloid leukemia	6654_5914_595_7704_1050_8503_2885_207_208_1147_5595_5594_5970_6688_6776_5295_4790_5371_3265_4609	20	3.21E-19	2.50E-17	3.57E-18
7983	hsa-mir-202	hsa04660	T cell receptor signaling pathway	6654_5777_3932_1432_8503_2885_207_208_1147_5595_5594_56924_2932_5970_3725_5295_5058_4790_5601_5600_5603_3265_2353	23	6.55E-18	5.11E-16	6.38E-17
7984	hsa-mir-202	hsa05210	Colorectal cancer	6654_595_4089_1956_8503_2885_207_208_5595_5594_5599_2932_7157_3725_4087_4088_5295_3480_5601_4609_2353	21	7.91E-18	6.17E-16	6.86E-17
7985	hsa-mir-202	hsa04012	ErbB signaling pathway	6654_1956_6714_2064_8503_2885_207_208_5595_5594_5599_56924_2932_3725_6776_5295_5058_5601_3265_4609_6464	21	1.46E-17	1.14E-15	1.14E-16
7986	hsa-mir-202	hsa05214	Glioma	6654_595_4193_5925_1956_8503_2885_207_208_5595_5594_7157_5295_808_801_805_3480_3265_6464	19	2.53E-17	1.97E-15	1.65E-16
7987	hsa-mir-202	hsa05223	Non-small cell lung cancer	6654_595_5925_1956_2309_2064_8503_2885_207_208_5595_5594_6258_6257_6256_7157_5295_3265	18	2.53E-17	1.98E-15	1.65E-16
7988	hsa-mir-202	hsa04910	Insulin signaling pathway	6720_10891_6654_5770_2308_8503_2885_5211_2872_207_208_5595_5594_5599_7249_2932_5295_808_801_805_5601_3265_6464_5566	24	5.06E-17	3.95E-15	3.04E-16
7989	hsa-mir-202	hsa05213	Endometrial cancer	6654_595_1956_2309_2064_8503_2885_207_208_5595_5594_2932_7157_5295_3265_4609	16	4.32E-15	3.37E-13	2.41E-14
7990	hsa-mir-202	hsa04912	GnRH signaling pathway	6654_4214_1956_6714_1432_2885_5595_5594_5599_468_3725_808_801_805_5601_5600_5603_3265_5566	19	7.86E-14	6.13E-12	4.09E-13
7991	hsa-mir-202	hsa04110	Cell cycle	595_4193_902_4089_4171_3065_4616_5925_994_1387_7533_2932_7157_10912_4085_4087_4088_2033_1022	19	3.68E-13	2.87E-11	1.79E-12
7992	hsa-mir-202	hsa04662	B cell receptor signaling pathway	6654_5777_8503_2885_207_208_1147_5595_5594_2932_5970_3725_5295_4790_3265_2353	16	5.57E-13	4.34E-11	2.55E-12
7993	hsa-mir-202	hsa04510	Focal adhesion	6654_595_857_9564_1956_6714_2064_8503_2885_207_208_5595_5594_5599_56924_2932_3725_5295_5058_3480_5601_3265_6464	23	1.11E-12	8.63E-11	4.79E-12
7994	hsa-mir-202	hsa04520	Adherens junction	5770_5777_4089_1956_6714_2064_1459_1460_5595_5594_1387_1457_4087_4088_2033_3480	16	1.32E-12	1.03E-10	5.42E-12
7995	hsa-mir-202	hsa05222	Small cell lung cancer	595_5925_8503_10401_207_208_1147_6258_6257_6256_5970_7157_5295_4790_4609_8554	16	3.48E-12	2.72E-10	1.36E-11
7996	hsa-mir-202	hsa05211	Renal cell carcinoma	6654_405_8503_2885_207_208_5595_5594_56924_1387_3725_5295_5058_2033_3265	15	4.00E-12	3.12E-10	1.49E-11
7997	hsa-mir-202	hsa04720	Long-term potentiation	6197_2902_2906_5595_5594_1387_468_6195_6196_2033_808_801_805_3265_5566	15	6.68E-12	5.21E-10	2.37E-11
7998	hsa-mir-202	hsa04620	Toll-like receptor signaling pathway	1432_8503_207_208_1147_5595_5594_5599_5970_3725_5295_4790_5601_5600_5603_2353	16	3.42E-11	2.67E-09	1.16E-10
7999	hsa-mir-202	hsa04310	Wnt signaling pathway	595_4089_1459_8607_1460_5599_1387_2932_7157_8061_3725_1457_4087_4088_2033_5601_4609_5566	18	1.35E-10	1.06E-08	4.35E-10
8000	hsa-mir-202	hsa04664	Fc epsilon RI signaling pathway	6654_1432_8503_2885_207_208_5595_5594_5599_5295_5601_5600_5603_3265	14	1.40E-10	1.09E-08	4.35E-10
8001	hsa-mir-202	hsa05216	Thyroid cancer	595_5595_5594_6258_6257_6256_7157_8031_3265_4609	10	2.51E-10	1.96E-08	7.52E-10
8002	hsa-mir-202	hsa05219	Bladder cancer	595_9252_4193_5925_1956_2064_5595_5594_7157_3265_4609	11	3.73E-10	2.91E-08	1.08E-09
8003	hsa-mir-202	hsa05218	Melanoma	595_4193_5925_1956_8503_207_208_5595_5594_7157_5295_3480_3265	13	4.47E-10	3.49E-08	1.25E-09
8004	hsa-mir-202	hsa04062	Chemokine signaling pathway	6654_9564_2309_8503_2885_207_208_1147_5595_5594_2932_5970_5295_5058_4790_2770_3265_6464_5566	19	7.32E-10	5.71E-08	1.97E-09
8005	hsa-mir-202	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_1432_1147_5599_5970_3725_5058_4790_5601_5600_5603	12	4.70E-09	3.67E-07	1.22E-08
8006	hsa-mir-202	hsa04370	VEGF signaling pathway	6714_1432_8503_207_208_5595_5594_5295_9261_5600_5603_3265	12	1.06E-08	8.28E-07	2.67E-08
8007	hsa-mir-202	hsa04920	Adipocytokine signaling pathway	10891_207_208_1147_5599_6258_6257_6256_5970_4790_5601	11	2.71E-08	2.11E-06	6.60E-08
8008	hsa-mir-202	hsa04150	mTOR signaling pathway	6197_8503_207_208_5595_5594_7249_6195_6196_5295	10	3.11E-08	2.42E-06	7.34E-08
8009	hsa-mir-202	hsa05016	Huntington's disease	10891_3065_3064_2902_6667_627_9586_1387_9001_5430_7157_23186_2033_6874_6908_9519	16	1.05E-07	8.20E-06	2.41E-07
8010	hsa-mir-202	hsa04630	Jak-STAT signaling pathway	6654_595_5777_8503_2885_10401_207_208_1387_6776_5295_2033_4609_8554	14	3.38E-07	2.64E-05	7.53E-07
8011	hsa-mir-202	hsa04540	Gap junction	6654_10382_1956_6714_2885_5592_5595_5594_2770_3265_5566	11	5.45E-07	4.25E-05	1.18E-06
8012	hsa-mir-202	hsa04916	Melanogenesis	5595_5594_1387_2932_2033_808_801_805_2770_3265_5566	11	1.50E-06	0.000116846	3.16E-06
8013	hsa-mir-202	hsa03420	Nucleotide excision repair	902_5887_2965_2967_2968_4331_1022	7	1.15E-05	0.000895231	2.36E-05
8014	hsa-mir-202	hsa04930	Type II diabetes mellitus	3651_8503_5595_5594_5599_5295_5601	7	1.31E-05	0.001021081	2.62E-05
8015	hsa-mir-202	hsa04350	TGF-beta signaling pathway	4089_6667_5595_5594_1387_4087_4088_2033_4609	9	1.59E-05	0.00123765	3.09E-05
8016	hsa-mir-202	hsa04650	Natural killer cell mediated cytotoxicity	6654_5777_3932_8503_2885_5595_5594_5295_5058_3265_6464	11	1.83E-05	0.001429477	3.48E-05
8017	hsa-mir-202	hsa04210	Apoptosis	8503_207_208_1147_5970_7157_5295_4790_5566	9	1.88E-05	0.001462651	3.48E-05
8018	hsa-mir-202	hsa04530	Tight junction	6714_1459_22800_8573_207_208_1460_1457_2770_3265	10	8.74E-05	0.006814556	0.000158478
8019	hsa-mir-202	hsa03050	Proteasome	5705_5701_5702_5719_5710_5698	6	0.000164356	0.01281979	0.000291359
8020	hsa-mir-202	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_2906_1432_7157_5600_5603	6	0.000353292	0.027556761	0.000612372
8021	hsa-mir-202	hsa04810	Regulation of actin cytoskeleton	6654_9564_1956_8503_22800_5595_5594_56924_5295_5058_3265	11	0.000836141	0.065219021	0.001417805
8022	hsa-mir-202	hsa04115	p53 signaling pathway	595_4193_4616_7249_7157_10912	6	0.000981045	0.076521502	0.001628117
8023	hsa-mir-202	hsa04730	Long-term depression	5592_5595_5594_3480_2770_3265	6	0.00112623	0.087845973	0.001807429
8024	hsa-mir-202	hsa04330	Notch signaling pathway	3065_1387_9612_2033_8850	5	0.001135436	0.088564015	0.001807429
8025	hsa-mir-202	hsa04360	Axon guidance	5998_5595_5594_56924_2932_5058_2770_3265	8	0.001316187	0.102662616	0.002053252
8026	hsa-mir-202	hsa04120	Ubiquitin mediated proteolysis	4214_4193_10401_10273_7329_5371_672_8554	8	0.001876604	0.146375137	0.002870101
8027	hsa-mir-202	hsa05010	A